data_1p1d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p1d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.792 0.33 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -131.03 98.61 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.67 119.65 8.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.931 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.1 156.55 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.16 161.29 16.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -149.63 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -122.6 163.1 20.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.58 135.68 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.76 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.8 p -108.66 122.89 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.525 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.9 mt -120.07 118.66 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.418 HG22 ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -108.95 162.12 14.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.601 -179.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.497 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.48 140.3 32.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.123 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.73 154.69 37.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.701 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.97 11.16 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.611 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.0 t -114.32 -46.98 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 t -144.64 8.77 1.33 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.21 -117.29 7.77 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.46 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 3.6 m-85 -103.77 128.92 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.424 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -92.47 27.34 10.82 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.305 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 40' ' ' GLN . 3.3 mt -94.08 157.61 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.359 0.6 . . . . 0.0 111.779 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.429 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 4.2 mt-30 -137.85 104.99 5.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.826 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 1.1 tp -95.69 144.7 25.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.272 0.558 . . . . 0.0 112.403 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -114.68 151.56 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.25 88.35 0.88 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.135 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.81 104.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.599 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 t -76.21 -65.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.549 0.69 . . . . 0.0 109.913 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 21.3 p90 -33.03 -43.75 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.037 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.61 88.65 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.933 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 49' ' ' GLU . 0.9 OUTLIER 170.08 114.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.682 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 48' ' ' THR . 11.5 pt-20 47.09 108.16 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.92 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 p 67.25 -162.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.635 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.5 mt -129.0 -72.89 0.59 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.499 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.7 t 63.69 8.83 3.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.465 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.51 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.1 m -175.63 58.76 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.569 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.591 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 8.0 Cg_exo -67.65 -59.0 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.063 1.842 . . . . 0.0 112.787 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CB ' ' A' ' 54' ' ' PRO . 59.2 Cg_endo -99.82 108.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.919 2.413 . . . . 0.0 112.694 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.89 127.39 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.549 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.426 HG23 HD13 ' A' ' 57' ' ' ILE . 37.6 mt -67.66 136.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.057 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.95 -6.23 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 33.8 t80 -178.02 138.39 0.2 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.043 0.449 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.461 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -102.07 -167.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' GLY . 51.7 tt0 -129.14 151.73 49.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.355 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -82.81 114.72 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.411 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 2.9 t70 91.73 39.55 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.534 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.419 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 2.5 p -132.92 143.96 50.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.35 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 69' ' ' CYS . 31.5 Cg_exo -58.61 -2.92 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.465 2.11 . . . . 0.0 112.953 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.45 ' CB ' ' CG2' ' A' ' 60' ' ' ILE . . . -63.68 -56.89 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -78.51 -28.66 46.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.613 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 4.1 mmt-85 -85.49 -1.55 57.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.277 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 31.3 p -58.64 -40.94 84.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 149.18 -23.75 1.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.96 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -175.05 84.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.128 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.69 123.4 23.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.726 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.26 159.59 34.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.963 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.5 mm -61.12 106.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.275 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.74 45.88 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.88 101.36 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -70.73 66.06 0.34 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.013 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.414 ' CG2' ' HG2' ' A' ' 55' ' ' PRO . 34.3 m -64.85 129.85 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.59 -29.6 11.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.23 148.7 31.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.404 . . . . 0.0 111.608 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -130.24 112.41 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.769 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 62.25 21.84 12.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.025 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.76 16.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.679 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.2 mt -74.32 136.24 75.51 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 120.537 0.208 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 -170.7 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.514 2.143 . . . . 0.0 112.232 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.6 p -150.76 -60.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -64.83 -16.62 63.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.376 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -106.35 43.9 1.1 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.652 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.47 -175.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -71.41 149.06 46.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.451 ' CB ' ' HB3' ' A' ' 54' ' ' PRO . 9.0 p90 -73.42 -33.64 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -54.92 -42.53 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.953 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.427 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 pt-20 -61.17 -39.27 89.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.498 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.61 94.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.232 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -61.36 -39.55 91.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.791 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -62.49 -39.81 94.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.484 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 14.8 mt -57.05 -49.98 74.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 7.1 mt -60.46 -58.77 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 49.8 mtt180 -50.28 -29.84 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 109.94 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.442 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.6 m-20 -114.89 33.15 5.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.845 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.8 45.27 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.865 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 1.5 m -142.75 16.82 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.84 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.8 mp -65.4 -45.24 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.552 0.691 . . . . 0.0 110.901 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.23 11.89 38.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.495 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.5 t 57.92 25.31 11.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.033 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 1.5 ttpt -165.88 145.46 6.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.744 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.469 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.7 t -141.73 135.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.559 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.1 165.12 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.391 . . . . 0.0 111.335 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -118.14 141.04 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 pt -133.15 159.12 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.522 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -123.14 143.0 50.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.527 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.441 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 1.2 p90 -161.11 174.29 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.281 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -102.95 149.6 24.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.376 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.7 m -97.98 104.8 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -179.68 -147.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.1 12.52 2.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.822 0.344 . . . . 0.0 110.811 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.6 t -178.8 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.665 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.3 t -156.29 117.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.478 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -157.24 84.53 2.91 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-O 121.233 0.539 . . . . 0.0 111.084 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 65.1 Cg_endo -94.65 -169.49 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.299 2.666 . . . . 0.0 112.636 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -178.49 34.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.745 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 58.9 114.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.89 -39.48 2.87 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.309 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.401 ' CG2' ' CG ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.9 113.43 12.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -103.57 126.29 50.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.653 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 120' ' ' ILE . 7.3 m80 -101.58 135.26 43.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.6 t -137.82 86.59 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.748 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -81.51 106.21 13.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.38 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mp -109.11 132.22 21.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.372 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 108.45 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.159 1.906 . . . . 0.0 111.057 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.64 158.62 19.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.477 . . . . 0.0 111.471 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.404 ' HG3' ' CG2' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -128.36 -174.93 3.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.167 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -56.36 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.5 m -153.94 74.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.404 ' CG2' ' HG3' ' A' ' 133' ' ' LYS . 95.5 t -113.37 156.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.45 110.44 0.78 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.437 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mt -96.61 -52.89 3.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.357 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . 93.57 9.03 60.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 21.2 mt -79.38 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.841 0.321 . . . . 0.0 111.232 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 39.7 m -116.19 128.7 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.924 0.392 . . . . 0.0 110.199 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.448 HG21 ' CD1' ' A' ' 154' ' ' LEU . 9.0 mt -103.17 164.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.585 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.9 p -163.57 152.9 14.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.265 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p -122.57 139.55 31.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 C--N 1.345 0.39 0 C-N-CA 122.494 2.129 . . . . 0.0 112.416 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.646 0.26 . . . . 0.0 111.03 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.69 149.97 30.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.976 2.45 . . . . 0.0 112.779 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.448 ' CD1' HG21 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -76.64 144.13 39.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.84 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.1 t -129.18 142.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.975 0.416 . . . . 0.0 111.941 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.52 150.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.218 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.94 -20.9 4.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 111.723 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.464 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 177.71 153.39 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 0.0 111.168 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -140.1 125.6 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.436 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -80.63 154.07 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -74.81 -178.93 3.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.01 -61.42 1.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.724 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.492 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.9 OUTLIER -56.67 161.72 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.969 0.414 . . . . 0.0 111.274 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.5 m -69.42 -20.92 24.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.77 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.43 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -47.71 -70.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 33.6 t60 -76.48 -23.92 53.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.23 -44.68 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.307 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 3.2 t -52.48 -25.85 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.54 48.91 81.98 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.2 p -137.95 -44.33 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 0.0 111.083 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.6 mp -59.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.24 139.44 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.24 119.89 16.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.19 18.47 5.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.681 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.408 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.5 OUTLIER -114.31 -177.25 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.695 0.283 . . . . 0.0 110.738 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -132.38 161.54 33.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 1.7 mp -124.54 170.9 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.56 -39.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.223 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -139.44 142.36 37.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.572 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 46.7 mt -127.48 111.57 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.881 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.0 t70 66.3 -70.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.096 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -144.92 -20.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.403 ' CG1' HG12 ' A' ' 196' ' ' ILE . 23.1 mm -98.0 156.95 3.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.17 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 38.1 mtt85 -116.18 139.3 50.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 112.241 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 154' ' ' LEU . 3.9 mm? -70.86 -2.89 16.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.628 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.52 -27.91 1.99 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.094 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m -75.17 -18.93 60.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 111.299 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.402 ' CB ' ' HB2' ' A' ' 152' ' ' ASP . 4.5 m 76.02 102.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.49 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 168.58 95.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' MET . . . . . 0.437 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 18.1 ptm -53.82 -41.56 67.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.265 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.471 ' HA ' HG21 ' A' ' 194' ' ' VAL . 3.4 mm-40 -55.63 -39.29 70.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.987 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.3 OUTLIER -55.65 -52.07 65.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.061 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.41 ' HA ' HD13 ' A' ' 196' ' ' ILE . . . -53.7 -36.4 62.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.546 ' HA ' ' CD2' ' A' ' 197' ' ' LEU . 11.8 t -66.42 -32.68 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.605 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 191' ' ' GLU . 3.0 mm-40 -76.02 -45.06 36.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.66 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 193' ' ' ALA . 1.7 mt -73.43 -31.17 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.605 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.546 ' CD2' ' HA ' ' A' ' 194' ' ' VAL . 1.6 pp -78.39 -24.73 46.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -88.01 -45.55 10.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.059 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -20.56 63.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.365 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 27.6 p -88.41 45.99 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.285 0.564 . . . . 0.0 109.784 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -68.12 60.66 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.782 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -169.27 -33.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.4 tt -175.01 105.02 0.09 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.776 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.14 126.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.478 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -100.73 107.82 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.6 mp -94.79 113.77 25.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.0 111.408 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.424 ' HD2' ' CE1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -101.1 93.5 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 1.4 mm -83.32 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.888 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 15.7 mmt180 -118.44 128.18 54.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.001 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.24 151.32 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.934 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.741 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.903 0.383 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -105.28 105.78 15.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -54.55 158.41 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -146.97 153.16 39.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.706 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -109.76 136.31 49.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 t -126.66 174.96 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -103.84 157.77 16.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.75 147.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.28 109.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.26 118.61 37.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.212 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -108.42 161.78 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 111.674 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.97 172.57 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.051 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 34' ' ' VAL . 17.2 t70 -163.22 140.76 6.0 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.347 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.86 19.09 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.464 2.11 . . . . 0.0 112.739 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' A' ' 32' ' ' ASP . 62.2 t -129.82 -51.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.5 p -156.81 36.22 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.778 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.32 127.07 7.88 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.711 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CE2' ' OG ' ' A' ' 102' ' ' SER . 24.5 m-85 63.55 71.69 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.45 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.31 21.79 8.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.146 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.519 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -111.79 133.2 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.458 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 6.4 mt-30 -97.92 126.88 43.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' CG1' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -96.03 141.52 29.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.122 0.487 . . . . 0.0 111.82 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.67 165.63 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.357 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.81 -111.11 0.11 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.532 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.8 p -115.53 104.2 11.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.846 0.355 . . . . 0.0 110.931 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.404 ' CG2' HD11 ' A' ' 56' ' ' LEU . 59.5 t -46.38 -78.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 15.5 p90 -40.65 -51.75 2.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.75 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 38.22 93.17 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.052 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.446 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER 175.55 110.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 48' ' ' THR . 6.4 pt-20 49.45 36.8 10.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.331 0.586 . . . . 0.0 110.324 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER 166.81 177.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.307 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.4 pp -176.71 33.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -63.09 29.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.8 t -147.25 73.05 12.01 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-O 120.844 0.354 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 20.9 Cg_exo -63.46 -53.07 1.56 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.544 2.163 . . . . 0.0 113.169 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 57.2 Cg_endo -96.14 102.44 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.827 2.351 . . . . 0.0 113.039 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD11 ' CG2' ' A' ' 45' ' ' VAL . 27.8 mt -131.71 85.21 2.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.474 HG23 ' HB ' ' A' ' 39' ' ' ILE . 85.7 mt -58.58 136.64 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.5 p -120.97 -8.43 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 91.3 t80 -144.47 150.52 37.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.302 0.572 . . . . 0.0 112.322 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CD1' ' CG2' ' A' ' 39' ' ' ILE . 1.7 mm -123.4 152.7 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.266 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -104.47 106.6 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.884 0.373 . . . . 0.0 110.861 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -63.45 116.51 5.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 12.4 t0 95.24 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.191 0.519 . . . . 0.0 110.558 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -139.71 -173.85 0.38 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 64.6 Cg_endo -95.01 -6.73 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.451 2.101 . . . . 0.0 113.535 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.7 -58.0 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.486 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -77.03 -29.03 55.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.961 0.41 . . . . 0.0 110.447 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.496 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -93.36 -7.33 45.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.781 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -41.89 -42.46 2.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.015 0.436 . . . . 0.0 111.263 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.39 -22.77 0.75 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.532 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -173.07 82.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.964 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.56 159.04 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.992 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.87 143.01 7.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.679 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.5 mt -55.2 132.31 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.35 16.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.893 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -55.58 -43.8 76.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.707 0.289 . . . . 0.0 111.255 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 75.56 72.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 86.1 t -71.13 152.69 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.296 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.21 -27.78 4.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -155.13 134.76 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.79 109.62 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 52.94 24.07 3.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.123 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.34 -35.74 4.11 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.496 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.51 HG21 HD12 ' A' ' 84' ' ' ILE . 21.4 mm -64.03 117.59 37.65 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 120.526 0.203 . . . . 0.0 111.315 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.09 171.65 9.82 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.405 2.07 . . . . 0.0 112.248 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 p -143.97 -45.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.9 -16.35 58.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.515 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -129.91 52.75 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -177.22 166.81 2.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.43 140.03 56.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 5.4 p90 -73.58 -29.74 62.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 mm-40 -54.55 -43.78 72.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -61.23 -37.0 81.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.759 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -64.98 -34.36 78.24 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.295 0.569 . . . . 0.0 110.528 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.542 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.9 m120 -67.06 -39.51 86.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.345 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 8.7 mm-40 -64.27 -55.98 17.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.481 ' CD2' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -52.16 -43.67 64.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 12.7 mt -59.57 -59.99 4.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.473 0.178 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 61.3 mtt180 -50.23 -29.78 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.394 0.616 . . . . 0.0 109.602 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -113.5 33.69 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.21 179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -104.77 21.08 17.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.979 179.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.418 ' OG ' ' CE2' ' A' ' 37' ' ' PHE . 3.3 m -110.46 18.0 20.23 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -68.13 -47.73 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.561 0.696 . . . . 0.0 110.948 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 6.94 37.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.3 m 59.14 25.94 14.56 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.113 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.64 153.69 2.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.264 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -149.58 146.03 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 124.54 51.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.416 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -131.21 154.8 48.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.491 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.59 123.14 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.918 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.0 pt -114.71 148.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 111.904 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.19 145.15 45.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.47 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.11 174.34 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 0.0 111.141 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -96.62 147.01 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.481 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.58 107.37 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.314 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.21 124.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 118' ' ' SER . 12.5 mm-40 -127.36 10.54 6.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.643 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.2 75.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.342 0.591 . . . . 0.0 111.366 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.82 148.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.7 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.8 pp -126.75 92.25 45.25 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 63.3 Cg_endo -95.32 -165.57 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.318 2.679 . . . . 0.0 112.876 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.0 t 177.95 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.0 p 168.56 116.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.199 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.28 -40.68 2.7 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.204 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.416 ' CG2' ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.41 104.3 7.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 1.9 t80 -100.34 115.79 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.759 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.7 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -91.75 134.25 34.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.293 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 3.2 t -117.49 82.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -80.87 102.26 9.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.1 144.71 53.73 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.135 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.44 135.73 22.74 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.428 2.085 . . . . 0.0 112.059 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 200' ' ' CYS . 0.1 OUTLIER -107.8 159.23 16.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.059 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -106.66 -171.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.583 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.415 ' N ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -66.82 -76.11 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.254 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.4 m -149.74 70.72 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.02 159.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.772 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -50.71 103.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.179 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -45.43 93.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.24 -0.38 66.18 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.977 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.401 HG12 ' CB ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -108.46 141.36 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.086 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 55.9 m -126.07 131.89 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.519 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.3 mt -98.1 163.31 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.79 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.97 149.46 19.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.3 p -112.47 132.39 22.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo . . . . . 0 C--N 1.345 0.372 0 C-N-CA 122.455 2.103 . . . . 0.0 112.317 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.02 174.78 11.43 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.425 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.97 169.96 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.433 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.1 m -150.56 149.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.0 111.525 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.6 mt -67.72 146.58 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.632 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.38 -8.51 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.23 143.08 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.01 0.433 . . . . 0.0 111.46 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.2 mt -132.7 149.32 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.628 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -124.2 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -80.91 151.94 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.456 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.41 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . 86.75 -16.45 46.17 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.898 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 1.1 m -96.45 136.96 36.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.407 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.7 m -48.2 -22.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.255 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.401 ' CB ' HG12 ' A' ' 140' ' ' ILE . . . -55.77 -50.12 71.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.403 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.449 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 2.0 t60 -83.88 -26.65 29.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 163' ' ' SER . 14.2 mmp_? -56.57 -50.04 73.08 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.5 t -53.1 -25.36 12.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.132 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.81 -162.73 50.61 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.548 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.4 t 44.78 31.53 0.67 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.843 0.354 . . . . 0.0 111.403 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.47 98.49 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.44 149.71 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.7 138.62 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.74 -17.35 33.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.689 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.92 166.39 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 110.651 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -117.91 122.88 44.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.66 138.73 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.769 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.03 -66.49 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.076 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -121.36 161.82 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 182' ' ' ASN . 33.8 mm -139.74 105.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 2.8 t0 63.82 -71.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 180' ' ' ILE . 2.6 t-20 -138.59 -23.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.1 mm -94.23 138.51 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 111.296 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 65.8 mtt180 -102.07 119.97 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.969 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 185' ' ' LEU . 0.8 OUTLIER -72.16 -13.87 61.67 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.133 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.21 -29.99 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.507 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.9 m -127.43 -4.37 6.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.508 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.43 148.85 22.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -176.51 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.46 -57.27 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -55.29 -32.02 62.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.64 -48.49 80.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.068 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 185' ' ' LEU . . . -57.29 -41.11 79.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.378 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.412 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 11.7 t -62.76 -32.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.05 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -45.91 85.97 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.877 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 199' ' ' GLN . 0.6 OUTLIER -69.98 -24.35 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.523 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -68.43 -35.83 78.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -89.43 -49.81 6.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.508 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.556 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -58.18 -15.89 11.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 132' ' ' LYS . 8.4 m -89.42 32.53 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.23 65.72 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.406 0.622 . . . . 0.0 111.418 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -172.3 -29.91 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.672 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.8 tt 171.84 111.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.768 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.411 ' CG2' ' HG3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -108.72 128.8 64.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.204 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HD3' ' CD2' ' A' ' 127' ' ' HIS . 1.7 ttmt -107.85 107.68 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.776 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 5.4 mp -90.55 119.67 31.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.001 0.429 . . . . 0.0 111.662 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.494 ' CG ' ' CE1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -98.01 93.84 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.092 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.33 163.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.364 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -106.45 118.02 35.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.831 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 124' ' ' GLY . 25.5 mttt -129.58 114.54 16.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.858 0.361 . . . . 0.0 111.42 -179.915 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.878 0.371 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -114.26 113.35 24.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -52.0 140.06 21.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -135.28 159.99 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.0 p -110.03 136.22 49.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' ' CZ ' ' A' ' 113' ' ' PHE . 4.2 m -132.54 169.6 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.855 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.67 160.59 14.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.948 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.27 148.22 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -127.14 110.0 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.751 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.83 120.62 42.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -113.26 160.48 18.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 111.43 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -90.4 132.02 35.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.849 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.87 148.93 36.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.567 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.67 14.57 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.552 2.168 . . . . 0.0 112.567 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.0 -48.97 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.48 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.65 -17.29 4.11 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 71.69 74.61 0.72 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.578 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 79.5 m-85 83.58 -25.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.113 0.565 . . . . 0.0 110.873 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 59.61 14.95 30.96 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 114.412 0.525 . . . . 0.0 114.412 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.543 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 1.1 pp -133.98 144.44 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 117.796 0.798 . . . . 0.0 112.676 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -106.8 129.01 54.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.748 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -95.75 115.98 28.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.883 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -70.13 157.24 37.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.299 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.6 106.36 2.51 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.106 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.6 p 52.5 -170.79 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.595 0.236 . . . . 0.0 110.46 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 46' ' ' PHE . 58.4 t -144.45 -96.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.708 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 53' ' ' SER . 40.7 p90 -45.79 -52.11 11.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 45.35 78.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 15.9 p -153.7 96.68 2.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.073 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 48' ' ' THR . 2.6 pt-20 54.66 118.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.736 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 28.1 m 75.1 -12.13 0.99 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.601 ' O ' ' CB ' ' A' ' 52' ' ' SER . 0.8 OUTLIER 33.56 -129.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.289 0.236 . . . . 0.0 111.464 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 7.7 t 104.84 4.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.401 0.68 . . . . 0.0 110.263 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.505 ' CB ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -76.51 110.13 10.62 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.012 178.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 52' ' ' SER . 96.0 Cg_endo -78.93 160.34 27.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.344 2.03 . . . . 0.0 112.714 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 10.2 Cg_endo -53.34 147.88 35.05 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.694 2.263 . . . . 0.0 111.357 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.85 123.9 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.812 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 68.7 mt -60.71 130.79 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -109.93 10.67 24.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.424 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -167.2 134.09 2.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.914 0.387 . . . . 0.0 111.712 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.543 ' CD1' ' CG2' ' A' ' 39' ' ' ILE . 4.1 mm -121.04 141.92 39.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.198 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -95.22 155.04 16.9 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.833 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.41 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.62 44.79 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.31 45.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.868 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.429 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -137.81 140.5 29.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.68 -12.13 8.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.618 2.212 . . . . 0.0 113.221 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.69 -57.85 6.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.446 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.45 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.24 -30.19 43.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.888 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.441 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -71.84 -18.13 62.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.758 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 51.4 t -48.15 -50.61 28.16 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.749 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.62 -4.29 7.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.441 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.411 HG12 ' HA3' ' A' ' 162' ' ' GLY . 27.3 m -152.21 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.164 0.482 . . . . 0.0 111.613 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mt -135.27 142.38 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.019 0.438 . . . . 0.0 111.198 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.52 -175.47 4.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.646 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.4 mm -69.62 67.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.33 71.79 0.22 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.762 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.14 111.18 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -68.76 144.03 54.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 109' ' ' LEU . 9.4 m -126.6 133.62 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.16 -24.95 15.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.13 133.63 12.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.108 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.6 mt -122.56 114.86 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.811 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 53.02 24.02 3.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.106 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.52 15.69 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.621 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.47 131.06 88.46 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 120.438 0.161 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.16 -157.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.498 2.132 . . . . 0.0 112.045 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.7 p -158.79 -67.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.054 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -69.88 -11.64 61.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.461 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.07 42.15 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.978 0.418 . . . . 0.0 110.765 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.07 176.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.771 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -70.41 121.6 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -49.63 -28.39 5.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -54.73 -36.65 64.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.185 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -61.66 -41.16 97.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -63.02 -37.5 87.44 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.52 0.676 . . . . 0.0 109.868 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.9 OUTLIER -61.78 -41.07 97.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.102 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.86 -56.49 16.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.42 ' CG ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -53.75 -30.16 43.02 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.424 ' CD2' ' CD1' ' A' ' 41' ' ' LEU . 48.7 mt -76.21 -48.06 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.207 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 6.3 mtt85 -50.1 -31.06 12.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.8 p30 -120.54 38.34 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.352 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.12 34.13 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.187 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -131.77 13.4 4.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.839 0.352 . . . . 0.0 111.802 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.43 -46.28 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.753 0.787 . . . . 0.0 110.403 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -2.11 56.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.549 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.5 p 62.39 25.69 15.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -167.59 153.48 7.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.071 0.462 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 101' ' ' SER . 25.1 t -154.71 137.53 7.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.75 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.15 123.66 49.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.744 0.307 . . . . 0.0 110.482 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.401 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -140.49 153.76 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.903 0.382 . . . . 0.0 111.371 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.27 137.19 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.457 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.7 pt -117.12 142.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 111.612 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -112.94 118.57 35.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.385 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.475 ' CZ ' ' HD2' ' A' ' 167' ' ' ARG . 2.4 p90 -136.84 174.22 10.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.933 0.396 . . . . 0.0 111.382 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -102.21 155.18 18.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.594 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 m -99.12 105.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.0 111.435 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 175.9 132.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.696 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.4 OUTLIER -140.57 12.89 2.33 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.87 88.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.193 0.52 . . . . 0.0 110.963 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -110.18 145.99 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.957 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.644 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.6 pp -130.44 90.9 39.75 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 121.233 0.539 . . . . 0.0 110.632 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 62.6 Cg_endo -91.33 -173.79 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.176 2.584 . . . . 0.0 113.504 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER 178.75 36.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.784 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.5 OUTLIER 54.25 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.374 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.62 -42.63 2.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.457 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.51 102.35 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.811 0.339 . . . . 0.0 110.393 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.485 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 9.7 t80 -100.54 116.08 31.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.644 ' HB2' HG13 ' A' ' 120' ' ' ILE . 38.5 m80 -95.52 138.06 33.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 206' ' ' LEU . 8.0 p -126.76 98.15 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.566 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.14 105.1 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.345 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.405 ' HB2' HG12 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -113.41 125.55 29.46 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.76 115.29 3.33 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.181 1.921 . . . . 0.0 110.702 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HD3' ' CG1' ' A' ' 204' ' ' VAL . 0.1 OUTLIER -94.36 159.08 15.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.272 0.558 . . . . 0.0 111.928 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.444 ' HD2' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -113.61 -165.84 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.011 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -73.9 0.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 m -152.83 82.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.283 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 133' ' ' LYS . 65.1 t -130.46 159.2 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -50.37 151.53 2.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.059 0.456 . . . . 0.0 111.555 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.409 ' HB3' ' CG1' ' A' ' 140' ' ' ILE . 5.2 mt -138.64 -52.95 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 89.92 36.38 7.26 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.154 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.409 ' CG1' ' HB3' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -109.61 126.1 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.354 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.9 m -126.38 131.48 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.373 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.6 mt -105.89 163.29 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.0 m -166.93 159.85 13.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.017 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.4 p -115.02 130.13 24.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.583 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 122.359 2.039 . . . . 0.0 112.206 -179.839 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.589 0.233 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -90.95 174.62 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.572 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.71 145.51 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.457 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 176' ' ' LYS . 29.8 m -149.17 172.5 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.507 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.56 152.7 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.74 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.73 -11.39 5.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.57 136.21 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 1.5 mt -131.97 143.52 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.279 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.58 178.89 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.47 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -116.25 152.83 33.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.267 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.411 ' HA3' HG12 ' A' ' 71' ' ' VAL . . . 93.47 -30.44 7.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.775 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -82.79 140.01 33.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.969 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.0 m -49.43 -23.19 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.183 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -44.92 -67.6 0.27 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.455 ' HB3' ' NH1' ' A' ' 167' ' ' ARG . 54.6 t60 -83.62 -26.55 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.475 ' HD2' ' CZ ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -58.54 -29.89 66.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 6.9 t -58.8 -21.28 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.84 49.92 4.61 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.268 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.44 HG23 ' CZ ' ' A' ' 126' ' ' PHE . 1.6 p -150.61 -52.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 110.958 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.0 mp -55.31 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.05 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -139.15 142.81 37.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.821 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 68.9 mt -56.97 114.39 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.76 16.91 4.38 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.996 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -100.83 148.16 25.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.775 0.287 . . . . 0.0 110.485 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.418 ' HA ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -107.18 130.37 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 111.281 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.04 127.84 40.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.804 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.64 -44.94 2.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -137.42 155.29 49.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.506 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 193' ' ' ALA . 20.6 mt -139.28 128.95 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.195 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 2.2 t70 49.45 42.6 22.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 2.1 t-20 82.64 -24.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.3 mm -76.56 155.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -128.63 127.15 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.453 0.644 . . . . 0.0 112.318 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -90.19 -17.01 28.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.399 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.9 t0 63.94 -71.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.23 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 185' ' ' LEU . 1.0 OUTLIER -158.27 56.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.442 . . . . 0.0 110.617 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 0.0 OUTLIER 170.06 -166.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.221 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 68.77 43.79 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.872 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.4 tpt -57.9 -58.17 9.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 109.888 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.53 -32.86 74.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 109.876 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -43.73 95.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.864 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 180' ' ' ILE . . . -57.87 -43.75 86.21 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 14.5 t -58.02 -38.93 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.73 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -50.67 71.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.104 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.1 mt -67.93 -24.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -61.1 -32.71 72.38 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.551 179.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.66 -32.97 10.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.048 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -16.2 39.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.527 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 67.3 m -84.14 41.97 0.85 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.77 59.2 0.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.119 0.485 . . . . 0.0 111.696 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.35 -33.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.101 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 tt -179.69 106.86 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.2 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.407 ' CG1' ' HD3' ' A' ' 132' ' ' LYS . 3.5 p -98.93 124.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.143 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -110.67 107.78 17.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 128' ' ' VAL . 1.6 mm? -100.18 128.77 46.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.974 0.416 . . . . 0.0 111.932 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.455 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -97.2 93.25 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.078 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.9 mm -90.63 169.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.158 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 62.5 mtt180 -108.6 130.95 55.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 142.14 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.894 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.837 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.814 0.34 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 8.3 p-80 -100.06 115.07 28.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -53.35 125.59 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -120.45 162.7 19.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 p -113.11 135.71 53.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.6 m -132.79 160.42 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.77 162.08 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.518 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.03 133.12 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.926 0.393 . . . . 0.0 111.081 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 28' ' ' VAL . 5.2 p -110.9 116.3 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 11.2 mt -112.56 136.25 52.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.482 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -119.61 159.82 23.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.92 129.12 45.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.368 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -107.48 152.82 41.49 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.96 14.46 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.42 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.01 -47.15 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.4 t -148.92 11.05 0.82 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 59.3 -102.58 0.31 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.461 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CE2' ' O ' ' A' ' 30' ' ' THR . 41.4 m-85 -121.37 124.22 44.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -96.23 28.21 13.91 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.709 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.492 HG22 HG23 ' A' ' 60' ' ' ILE . 7.4 pt -128.35 134.86 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 120.842 0.353 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.0 145.31 49.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.977 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.26 138.68 51.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.42 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -78.32 169.8 17.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.324 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -108.34 -68.2 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.764 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.3 144.26 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 ' CG2' ' CD2' ' A' ' 56' ' ' LEU . 72.8 t -141.45 -89.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.8 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 48.3 p90 -58.14 -46.51 85.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.665 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.579 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 46.61 100.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.08 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.473 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER 171.64 105.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.979 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 48' ' ' THR . 9.1 pt-20 52.92 33.61 14.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 110.539 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER 161.49 174.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.035 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -163.64 23.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.544 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.81 23.31 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.07 139.93 97.88 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.008 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.17 157.46 50.39 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.392 2.061 . . . . 0.0 111.922 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.3 155.15 5.08 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.434 2.089 . . . . 0.0 112.19 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -148.88 112.66 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 13.2 mm -53.89 141.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.0 110.996 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.82 -32.36 2.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.457 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 86.2 t80 -141.92 156.02 45.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.325 0.584 . . . . 0.0 111.861 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.7 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 17.8 mm -136.34 161.27 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.087 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -107.18 150.29 26.77 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 121.922 -0.486 . . . . 0.0 111.877 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.32 39.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.028 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 36.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.923 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.439 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 41.2 p -128.58 138.67 33.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 32' ' ' ASP . 17.6 Cg_endo -57.7 -16.05 23.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.724 2.282 . . . . 0.0 112.869 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.59 -48.74 30.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.564 0.697 . . . . 0.0 109.692 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.7 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.5 tp10 -70.25 -32.46 70.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.422 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.559 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -93.88 -5.43 48.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -42.59 62.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.824 0.345 . . . . 0.0 110.674 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.9 -19.3 4.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.38 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 m -146.89 75.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 117.108 0.454 . . . . 0.0 111.991 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.8 mt -157.87 121.62 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.931 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -144.24 -176.31 4.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.544 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.6 126.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.0 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.468 ' N ' ' HB ' ' A' ' 57' ' ' ILE . . . 57.88 84.54 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.669 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -95.07 -30.54 14.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.036 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.45 105.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 109' ' ' LEU . 14.8 p -98.47 148.39 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.494 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.7 ttp -109.34 -24.93 10.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.462 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -158.48 145.27 17.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mt -133.14 113.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.92 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 54.09 24.18 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.34 -31.83 6.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.485 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -69.53 110.45 6.4 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.383 0.135 . . . . 0.0 111.301 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.96 -27.93 66.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.304 2.003 . . . . 0.0 112.046 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p 72.28 2.15 4.22 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.678 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -14.3 42.8 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.297 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -120.95 45.72 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.93 153.04 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.784 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -60.15 163.83 4.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 6.5 p90 -65.59 -39.27 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.683 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 58.1 mt-10 -54.97 -32.94 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.478 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -53.34 58.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.135 0.493 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -37.97 66.41 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.673 0.749 . . . . 0.0 109.863 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.93 -36.85 77.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.619 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 5.3 mm-40 -62.23 -43.29 99.17 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.827 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.72 -41.93 67.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.854 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mp -75.23 -44.65 45.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.628 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -50.92 -31.99 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.275 0.559 . . . . 0.0 109.693 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 5.1 p30 -127.52 42.75 3.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.265 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.404 ' CB ' HG22 ' A' ' 107' ' ' VAL . 2.5 p -81.27 6.53 13.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.639 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.27 18.52 19.81 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 9.6 mt -70.79 -53.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.913 0.863 . . . . 0.0 110.418 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.72 9.51 29.64 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.484 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 30' ' ' THR . 2.0 m 58.93 20.87 8.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.272 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 1.6 mttt -166.61 158.42 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.575 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 101' ' ' SER . 66.1 t -155.29 106.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.426 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.77 132.82 39.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.07 163.59 32.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.067 0.461 . . . . 0.0 111.611 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -120.34 128.59 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.6 pt -119.41 153.65 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.929 0.395 . . . . 0.0 111.623 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -120.43 119.14 32.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.465 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 6.5 p90 -138.08 174.21 10.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.275 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.3 142.25 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.579 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -87.26 108.25 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.38 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.47 133.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -149.91 23.85 0.86 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.1 t 83.68 100.84 0.05 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.197 0.523 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.463 ' CG1' ' CE1' ' A' ' 126' ' ' PHE . 2.0 t -135.39 123.02 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.175 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.6 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.6 pp -96.9 106.97 34.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.267 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 69.9 Cg_endo -95.34 137.02 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.291 2.661 . . . . 0.0 112.679 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -139.81 -80.55 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.62 113.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.85 -31.9 6.53 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.529 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.402 ' CG2' ' HE2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -138.38 102.65 4.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.964 0.411 . . . . 0.0 111.316 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.463 ' CE1' ' CG1' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -103.31 121.01 41.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.861 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.6 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -105.75 130.79 53.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.369 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 3.6 t -109.46 86.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.14 98.91 8.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.722 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.53 125.35 27.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.005 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.58 115.77 2.78 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.353 2.035 . . . . 0.0 111.646 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.423 ' HB3' ' N ' ' A' ' 202' ' ' ASP . 18.1 tttp -90.59 151.35 21.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.445 ' CD ' ' HB ' ' A' ' 136' ' ' VAL . 2.4 mttt -84.95 -168.52 2.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.921 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -72.44 -33.46 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.796 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 m 175.2 40.42 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.799 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CD ' ' A' ' 133' ' ' LYS . 1.2 t -72.24 162.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.42 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.58 157.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.985 0.421 . . . . 0.0 111.341 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -164.99 107.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . -89.93 39.55 3.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.394 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.408 ' CD1' ' CB ' ' A' ' 165' ' ' ALA . 4.4 mm -84.75 124.2 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.801 0.3 . . . . 0.0 110.34 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.441 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 85.3 m -115.75 141.57 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mt -114.42 163.88 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.0 t -166.61 156.38 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.0 t -115.5 144.85 33.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.345 0.371 0 C-N-CA 122.449 2.099 . . . . 0.0 112.203 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.504 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 152' ' ' ASP . 54.3 Cg_endo -93.59 -179.77 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.906 2.404 . . . . 0.0 112.884 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -137.46 155.46 49.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.077 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.1 t -151.68 161.21 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.872 0.367 . . . . 0.0 111.922 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.5 mt -94.26 152.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.096 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.16 -16.71 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 178.91 137.83 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.28 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 1.0 OUTLIER -129.68 122.99 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.578 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.402 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -86.2 155.6 20.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 111.111 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.58 179.83 7.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.55 -54.7 4.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.804 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.45 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.6 OUTLIER -59.24 144.2 46.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.157 0.503 . . . . 0.0 111.376 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.4 -21.08 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.046 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.442 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -59.36 -71.73 0.12 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.731 0.3 . . . . 0.0 111.361 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.481 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 21.3 t60 -66.46 -24.76 66.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.952 0.406 . . . . 0.0 110.499 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.481 ' NH2' ' HB3' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -56.88 -42.58 80.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.501 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 13.2 t -50.3 -30.08 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.37 89.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.77 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.424 ' OG1' ' CE2' ' A' ' 126' ' ' PHE . 15.3 t -177.75 -38.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 110.866 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.43 152.66 44.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.814 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -147.63 151.8 36.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.23 127.82 33.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.43 23.55 4.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.61 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.416 ' CB ' ' CG2' ' A' ' 208' ' ' ILE . 21.3 m-20 -116.22 -168.98 1.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.684 0.278 . . . . 0.0 110.604 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.71 120.84 28.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.858 0.361 . . . . 0.0 111.275 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.5 mt -78.06 144.53 36.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.613 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.24 -41.43 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.41 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -148.87 166.74 27.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.6 mm -139.84 117.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.246 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 25.5 t0 57.91 -86.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -127.25 -13.85 5.5 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 27.4 mm -96.59 159.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.415 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 15.9 mtt85 -118.61 123.68 45.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.386 0.612 . . . . 0.0 112.321 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 185' ' ' LEU . 0.8 OUTLIER -77.49 -13.42 59.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.789 178.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.17 -28.99 1.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.2 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.73 -5.14 6.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.642 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -96.0 133.1 40.62 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -57.39 -178.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.074 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 5.6 ttp -66.15 -57.25 8.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.57 -38.0 71.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.256 0.55 . . . . 0.0 110.72 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.7 -44.81 93.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.935 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.417 ' CB ' HD12 ' A' ' 185' ' ' LEU . . . -57.76 -42.96 85.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.442 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 8.9 t -60.7 -33.72 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.245 0.545 . . . . 0.0 109.786 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -50.18 74.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.949 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.3 mp -73.79 -24.6 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.885 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -64.37 -28.45 69.7 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -103.44 -33.71 8.97 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -16.04 60.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.167 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 13.8 p -85.97 43.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.195 0.521 . . . . 0.0 110.456 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 5.5 pt-20 -70.75 62.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.539 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.423 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 1.9 m-20 -178.14 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.404 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 20.5 tp -176.89 107.05 0.06 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.765 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.9 t -102.01 115.7 44.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.655 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 13.2 ttmm -104.51 108.32 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.906 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 3.4 mm? -87.49 102.7 14.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.915 0.388 . . . . 0.0 111.303 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.455 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -92.51 93.43 8.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.216 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.416 ' CG2' ' CB ' ' A' ' 175' ' ' ASP . 6.9 mm -92.92 163.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 21.8 mtm-85 -107.96 126.38 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.037 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 1.6 tttm -113.22 159.49 19.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.6 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.94 0.4 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -128.1 113.77 16.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.739 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -50.27 142.87 9.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -147.77 172.02 14.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.7 p -125.61 151.97 45.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.72 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.414 HG21 ' N ' ' A' ' 26' ' ' GLU . 89.9 m -145.74 164.4 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.07 161.89 13.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.48 150.16 28.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 111.187 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.87 109.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.442 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -115.09 118.54 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -105.81 162.22 13.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.05 123.05 32.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.07 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.15 153.72 66.51 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.627 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -78.28 9.7 3.01 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.525 2.15 . . . . 0.0 112.506 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 t -112.11 -49.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 120.638 0.256 . . . . 0.0 111.356 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -145.7 3.83 0.98 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 -93.82 0.86 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.366 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CE2' ' OG ' ' A' ' 101' ' ' SER . 44.5 m-85 -125.6 120.74 31.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.2 9.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.465 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 29' ' ' LEU . 2.7 mp -93.14 151.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.32 0.581 . . . . 0.0 111.995 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -124.55 99.83 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.763 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 1.5 tp -96.17 148.55 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 28.4 pt20 -129.43 170.08 14.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.968 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.58 26.53 3.47 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.296 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.6 106.25 14.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 110.483 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 t -135.14 -85.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.616 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.517 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 4.3 p90 -34.92 -44.63 0.23 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.116 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 55.08 66.58 1.19 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.528 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 30.8 p -161.07 -166.31 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.938 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' CG2' ' A' ' 50' ' ' THR . 2.3 pt-20 -51.7 171.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 49' ' ' GLU . 11.9 t 45.25 -153.85 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.993 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -146.02 -94.29 0.09 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.707 0.289 . . . . 0.0 111.171 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 16.54 1.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.797 0.332 . . . . 0.0 111.823 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.51 133.74 85.59 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.17 137.29 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.391 2.061 . . . . 0.0 111.85 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -49.98 123.09 10.2 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.56 2.173 . . . . 0.0 111.963 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.4 pt? -139.42 119.88 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 111.512 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 48.3 mt -64.44 157.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.996 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.1 m -130.65 -12.6 3.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.354 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.0 t80 179.78 137.47 0.11 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.936 0.398 . . . . 0.0 111.259 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' ' CZ ' ' A' ' 59' ' ' TYR . 4.0 mt -111.28 171.95 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -111.13 155.1 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.663 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -79.05 59.23 2.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.286 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.08 41.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.313 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.2 p -131.27 137.67 31.11 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.6 -11.62 21.1 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.5 2.133 . . . . 0.0 112.764 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 39' ' ' ILE . . . -76.88 -56.06 4.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.013 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -73.46 -29.54 62.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.292 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.502 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.24 -42.65 68.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.4 t -47.78 -30.41 3.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.212 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.92 -9.31 74.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.916 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.71 31.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.981 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.1 mt -146.77 134.37 20.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -125.81 161.38 27.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.25 82.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.06 48.24 0.15 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.426 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -76.42 107.64 8.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.87 0.366 . . . . 0.0 110.74 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -69.96 73.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.39 125.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 ttp -95.58 -30.27 13.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -152.03 153.97 35.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.284 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 81' ' ' ILE . 4.0 mt -133.98 117.06 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 62.56 19.98 11.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.82 -24.22 22.15 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -71.23 123.14 88.88 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-O 120.519 0.2 . . . . 0.0 111.091 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.71 -26.3 33.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p 73.84 1.3 3.88 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.619 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -15.02 41.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.898 0.38 . . . . 0.0 111.358 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.18 46.37 0.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m 179.33 -177.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.4 m -93.3 153.17 18.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -52.17 -27.19 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 9.9 mt-10 -54.79 -36.73 65.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.944 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.356 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.65 88.8 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.555 0.693 . . . . 0.0 109.991 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.52 -40.82 88.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.081 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 50.0 mm-40 -61.97 -44.3 97.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 110.21 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 mt -54.37 -41.11 68.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.203 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 36.7 mt -73.56 -51.9 15.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.878 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -50.85 -29.84 12.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.962 0.41 . . . . 0.0 110.3 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 53.4 m-20 -126.63 39.66 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 98' ' ' LEU . 1.2 p -89.22 10.98 20.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.84 18.88 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.1 mt -68.79 -49.73 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.877 0.846 . . . . 0.0 110.311 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.48 13.09 32.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.397 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.2 p 54.8 24.32 5.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.258 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -165.17 148.1 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.527 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.0 t -145.99 133.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.84 141.2 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.31 146.87 47.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.569 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 106.1 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.03 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.3 pt -105.96 160.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 112.104 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -133.94 137.99 45.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.169 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 167' ' ' ARG . 5.9 p90 -161.24 174.11 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.723 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.25 113.15 22.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.807 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.8 104.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.236 0.541 . . . . 0.0 111.94 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.21 177.56 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.625 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 118' ' ' SER . 4.9 tp10 -177.95 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.449 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.5 t 163.55 109.21 0.0 OUTLIER 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.795 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.418 HG22 ' CG2' ' A' ' 170' ' ' THR . 7.1 p -140.52 147.59 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.133 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -123.34 77.87 53.51 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.95 0.405 . . . . 0.0 111.191 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 126' ' ' PHE . 20.9 Cg_exo -68.65 145.9 65.3 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.351 2.701 . . . . 0.0 112.333 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.43 13.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.47 140.37 0.01 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.857 0.361 . . . . 0.0 111.254 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.97 -59.93 3.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.131 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 23.0 m -146.37 102.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.632 ' HB2' ' HA ' ' A' ' 121' ' ' PRO . 2.3 p90 -124.94 164.77 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.67 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.609 ' NE2' ' HD2' ' A' ' 207' ' ' LYS . 0.0 OUTLIER -120.51 163.9 17.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.274 0.559 . . . . 0.0 111.84 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 206' ' ' LEU . 28.0 m -130.81 104.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.007 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -81.99 112.69 19.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mp -126.72 117.13 22.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 131.59 46.89 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.249 1.966 . . . . 0.0 111.745 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.531 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -95.64 159.55 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.032 0.444 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.09 -168.69 2.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.856 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -68.96 65.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.463 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 46.52 65.46 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.044 0.449 . . . . 0.0 111.652 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.0 t -111.35 164.98 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -38.07 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.939 0.4 . . . . 0.0 111.663 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.419 ' CD2' ' CE ' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -68.76 -42.52 77.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 163' ' ' SER . . . 90.04 -3.32 82.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.763 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.73 133.68 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.432 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 75.4 m -116.43 140.42 49.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.349 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.8 162.87 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.54 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -158.14 147.03 19.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.382 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 54.5 p -107.65 134.8 19.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.969 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo . . . . . 0 C--N 1.345 0.358 0 C-N-CA 122.582 2.188 . . . . 0.0 112.419 -179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.615 0.245 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.72 -175.23 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.492 2.128 . . . . 0.0 112.612 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.9 tp -89.7 169.84 10.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 143' ' ' SER . 22.0 t -147.77 160.51 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.906 0.384 . . . . 0.0 111.61 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.0 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.882 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.32 -7.19 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.432 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.0 OUTLIER -177.2 146.1 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.294 0.569 . . . . 0.0 112.072 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 mt -130.72 149.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.709 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 138.6 54.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.004 0.431 . . . . 0.0 111.609 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.419 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -81.76 -9.08 59.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.864 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -89.95 -16.89 55.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.673 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.411 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 2.9 m -114.12 169.94 8.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.899 0.38 . . . . 0.0 110.99 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.413 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 5.6 m -61.74 -22.58 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -43.49 -71.21 0.08 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.789 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.94 -24.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.975 0.417 . . . . 0.0 110.528 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.459 ' CD ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -57.61 -29.91 64.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.8 p -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.97 74.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.589 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.418 ' CG2' HG22 ' A' ' 119' ' ' VAL . 3.2 t -168.62 32.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.966 0.412 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.51 107.15 15.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.689 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.53 150.87 40.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.4 mt -74.95 131.42 40.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.54 -25.7 8.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.45 -172.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.309 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.93 134.43 42.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.92 142.18 31.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.439 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.0 tt -120.85 -35.73 3.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.744 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -142.07 162.45 35.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.879 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 182' ' ' ASN . 31.9 mt -139.34 116.71 11.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.37 -74.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -144.54 -19.3 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.932 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.5 mm -96.55 140.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 111.258 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 5.8 mtt180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.905 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -6.72 51.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.243 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -41.18 -32.53 0.28 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.456 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m -121.48 -11.72 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.667 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 6.2 m -88.01 -169.78 2.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.142 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 80.5 p -112.3 -175.76 2.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -56.89 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -53.97 -47.11 71.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.785 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -43.6 72.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.059 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 180' ' ' ILE . . . -56.86 -42.05 79.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.415 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 15.3 t -58.98 -39.15 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.291 0.567 . . . . 0.0 109.642 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.948 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.3 mt -69.81 -24.88 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.4 OUTLIER -59.34 -31.59 69.32 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.482 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -103.98 -33.55 8.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.141 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -19.67 55.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.709 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 19.8 p -85.49 47.12 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.281 0.563 . . . . 0.0 109.866 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.433 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 22.4 tt0 -68.37 63.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.65 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -173.23 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.875 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.531 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -178.72 107.46 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.433 ' CG2' ' CG ' ' A' ' 132' ' ' LYS . 2.9 t -85.6 108.35 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.604 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 8.9 ttmm -104.83 107.88 19.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 128' ' ' VAL . 2.5 mt -99.91 121.51 41.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.609 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 3.9 tttt -89.7 101.96 14.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.284 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.0 mm -91.97 158.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.409 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 29.9 mtp85 -113.81 121.79 45.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.686 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -114.14 106.17 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.058 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.695 0.283 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -88.24 106.24 18.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.797 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 p -53.29 161.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.202 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -168.68 169.13 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.7 p -129.33 164.74 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 12.4 t -147.78 -170.6 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.71 162.93 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.11 146.8 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.2 t -129.31 118.78 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.994 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.401 ' CD1' HD12 ' A' ' 39' ' ' ILE . 1.2 mt -114.38 118.86 35.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.82 163.27 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.83 115.75 29.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.267 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.48 152.03 59.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.576 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.65 9.21 3.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.636 2.224 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.33 -50.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 120.613 0.244 . . . . 0.0 111.428 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -132.39 -11.81 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -87.73 0.8 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.371 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.509 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.5 m-85 -133.38 118.98 19.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.094 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -95.29 28.51 11.72 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.915 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 37' ' ' PHE . 4.0 mp -93.27 149.17 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.189 0.519 . . . . 0.0 112.012 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -145.0 99.08 3.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 57' ' ' ILE . 1.8 pp -112.03 157.27 20.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 169.63 10.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.867 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.466 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -119.41 -5.89 11.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.051 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 p -137.46 151.59 48.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.153 0.501 . . . . 0.0 111.537 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 95.1 t -151.98 -76.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.133 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.64 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 21.0 p90 -35.46 -46.77 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.25 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.0 69.23 0.46 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 166.96 95.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.2 146.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.104 0.478 . . . . 0.0 111.736 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.417 ' O ' ' CE2' ' A' ' 46' ' ' PHE . 63.1 p 45.59 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.703 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.64 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -132.76 -77.32 0.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.889 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.66 17.36 0.09 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.036 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.513 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 1.7 t -108.36 99.36 32.05 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.553 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 172.44 16.19 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.426 2.084 . . . . 0.0 111.978 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -45.61 133.46 13.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.712 2.275 . . . . 0.0 112.003 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -129.0 97.23 4.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.507 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 27.4 mt -59.43 139.16 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.948 0.404 . . . . 0.0 110.904 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.409 ' HB3' ' NE2' ' A' ' 40' ' ' GLN . 2.5 t -124.2 1.48 8.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.2 t80 179.15 134.76 0.09 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.047 0.451 . . . . 0.0 111.626 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.404 ' CG2' ' CB ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -108.58 162.91 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.408 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 40.9 tt0 -98.71 152.56 19.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.401 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.485 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -82.52 56.45 3.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER 165.76 42.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.431 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 t -132.05 139.95 36.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.92 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.34 -10.23 20.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.442 2.095 . . . . 0.0 112.626 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.09 -56.18 5.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.978 0.418 . . . . 0.0 110.841 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -76.81 -29.81 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.159 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.485 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -74.49 -29.89 61.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -44.91 69.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.06 28.05 7.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.4 t -148.23 26.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.0 mt -137.36 129.77 29.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -128.72 174.61 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.2 mm -66.81 74.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 128.28 46.04 0.19 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.37 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -74.89 98.46 3.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -78.54 115.8 18.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 m -101.64 167.5 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 tpt -117.65 -40.96 2.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.43 133.48 22.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.465 HG23 HD11 ' A' ' 81' ' ' ILE . 7.0 mt -119.12 116.27 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.7 p30 47.38 26.07 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.378 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.34 -28.73 10.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.872 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.43 136.85 86.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-O 120.718 0.294 . . . . 0.0 111.567 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.3 167.47 19.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.555 2.17 . . . . 0.0 112.213 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 44.8 p -141.12 -54.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.004 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.45 -8.37 55.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.13 44.76 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.95 176.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 7.9 m -62.87 145.45 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.466 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 8.2 p90 -73.34 -27.06 61.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.151 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.9 mt-10 -54.63 -42.17 70.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.843 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.6 pt-20 -61.0 -44.49 97.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.317 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.63 75.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.6 m120 -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.88 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 39.3 mm-40 -62.07 -37.34 84.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.042 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 23.5 mt -57.43 -49.6 75.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 1.1 mt -69.92 -57.5 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 63.3 mtt180 -50.5 -31.66 16.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.44 0.638 . . . . 0.0 109.604 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.7 m-20 -119.25 39.68 3.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.675 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -93.17 26.31 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.9 t -124.43 15.71 8.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -68.33 -39.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.783 0.802 . . . . 0.0 110.409 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 11.68 30.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.552 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 m 57.92 22.2 8.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.905 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.74 156.25 2.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.362 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.48 129.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.055 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 134.07 47.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.025 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.23 138.12 31.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.59 144.04 27.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.318 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.0 pt -134.21 165.33 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.033 0.444 . . . . 0.0 111.828 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -132.16 140.95 48.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 0.5 OUTLIER -161.17 174.5 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.316 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -98.07 119.8 37.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.272 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.1 m -61.81 104.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.556 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.0 124.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.812 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -137.44 52.67 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 t 65.33 89.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.332 0.587 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.01 122.34 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.111 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.8 pp -115.6 89.59 23.3 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.315 0.578 . . . . 0.0 110.328 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.506 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.5 Cg_endo -97.04 169.55 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.211 2.608 . . . . 0.0 113.134 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.2 p -153.58 -66.58 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.145 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 166.3 109.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.02 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.05 -32.72 5.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.401 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.444 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -129.25 102.72 6.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.041 0.448 . . . . 0.0 110.768 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -105.43 125.21 50.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.045 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -113.73 129.04 56.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.959 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 206' ' ' LEU . 31.6 m -114.1 104.69 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.105 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.408 ' HG2' ' HD3' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -87.35 106.57 18.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.781 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.38 136.48 25.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.661 0.267 . . . . 0.0 111.203 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.28 139.81 51.25 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.349 2.033 . . . . 0.0 111.338 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -124.77 158.3 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.674 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.644 ' CG ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -130.48 172.98 11.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.238 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 133' ' ' LYS . 1.4 p80 -47.23 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.43 98.33 5.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.644 ' HB ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.5 -177.28 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -96.35 97.48 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.748 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.758 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.79 3.69 65.95 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.923 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.47 137.88 28.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 110.711 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 98.7 m -126.02 128.26 47.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.708 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.93 163.91 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.7 t -175.01 177.58 1.93 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.0 t -114.51 134.49 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 C--N 1.345 0.367 0 C-N-CA 122.562 2.175 . . . . 0.0 112.297 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.803 0.335 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.1 -157.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.661 2.241 . . . . 0.0 112.117 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 177' ' ' LEU . 1.6 mp -104.85 -173.43 2.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.506 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 175' ' ' ASP . 7.6 p -178.43 138.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.267 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.0 mt -70.27 154.23 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.826 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 t -134.89 -8.94 2.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.418 ' CB ' ' HB ' ' A' ' 141' ' ' THR . 0.8 OUTLIER -158.71 142.29 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.059 0.457 . . . . 0.0 111.451 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.4 mt -141.05 133.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.447 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.3 164.83 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.49 163.58 12.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.771 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.71 -11.89 54.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.902 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.5 m -113.42 148.96 34.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.69 -22.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.227 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -55.12 -64.06 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.743 0.306 . . . . 0.0 111.558 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -81.31 -24.69 37.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.77 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -55.05 -40.86 70.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.193 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 5.1 t -52.01 -26.07 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.029 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.01 67.04 2.41 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.808 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 t 178.84 40.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 110.825 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.39 -77.7 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.718 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 62.11 149.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.091 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.65 107.06 8.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.728 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.38 -18.01 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.613 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.528 ' HB3' HG23 ' A' ' 208' ' ' ILE . 1.9 m-20 -60.29 144.66 49.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.222 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 209' ' ' ARG . 0.1 OUTLIER -110.49 114.61 28.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.67 0.271 . . . . 0.0 110.917 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 0.5 OUTLIER -70.15 176.03 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -156.82 -43.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.945 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -145.87 173.37 12.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.271 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.438 HG12 HD22 ' A' ' 185' ' ' LEU . 24.3 mm -139.04 105.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.1 OUTLIER 47.18 -88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.534 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -102.49 -17.96 15.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 33.4 mm -100.28 156.68 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 111.747 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.404 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 38.0 mtp180 -125.93 119.33 27.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.555 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 187' ' ' SER . 2.7 mm? -76.08 -12.93 60.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.055 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.06 -76.56 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.809 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 185' ' ' LEU . 23.9 p -159.57 33.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.725 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 174.4 -171.05 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.679 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 192' ' ' ASP . 0.8 OUTLIER 75.68 39.72 0.32 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' MET . . . . . 0.437 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 7.8 ptm -53.87 -44.77 70.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.795 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -64.44 -37.23 86.8 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.61 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 189' ' ' SER . 3.1 m-20 -62.32 -42.21 99.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.31 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -58.9 -49.76 76.57 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.812 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.9 t -55.94 -28.46 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.378 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -50.15 48.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.484 ' HA ' ' CG ' ' A' ' 199' ' ' GLN . 3.1 mp -80.06 -24.39 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.839 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.549 ' HB3' ' O ' ' A' ' 193' ' ' ALA . 0.0 OUTLIER -77.68 -23.9 49.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.579 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -85.98 -47.69 9.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.202 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -68.29 -10.31 53.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.5 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.48 46.65 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.409 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 7.5 pt-20 -73.15 62.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.358 0.599 . . . . 0.0 111.085 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -170.07 -32.73 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.261 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.2 tt 178.95 108.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.74 122.82 64.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.219 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 35.5 ttpt -109.54 114.35 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.456 ' HB2' ' CG2' ' A' ' 128' ' ' VAL . 2.5 mm? -91.86 119.19 31.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.073 0.463 . . . . 0.0 111.461 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.484 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 3.9 tttm -92.06 93.63 8.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.984 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 175' ' ' ASP . 6.9 mt -94.9 165.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.803 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -105.75 128.52 53.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.786 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -132.33 114.52 14.49 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.234 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.828 0.347 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -119.08 115.59 24.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 p -51.67 116.02 1.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.14 168.49 10.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -125.42 134.75 52.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 7.2 t -121.58 177.23 5.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.35 162.08 16.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.751 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.21 148.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.99 109.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 3.0 mm? -107.54 118.37 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.47 162.31 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.157 0.503 . . . . 0.0 111.588 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.488 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 116.75 33.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.72 153.19 60.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.656 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.32 3.17 6.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.591 2.194 . . . . 0.0 112.624 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.09 -51.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.241 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -132.76 -4.3 3.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.35 -97.16 0.94 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.269 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.488 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 42.0 m-85 -119.01 115.57 24.6 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -83.1 11.11 56.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.94 -0.647 . . . . 0.0 114.116 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.439 HG13 ' CB ' ' A' ' 66' ' ' ALA . 26.5 mt -92.82 146.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.387 0.593 . . . . 0.0 111.981 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -139.39 99.96 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.948 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 1.4 pp -108.92 152.9 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.344 0.592 . . . . 0.0 112.267 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -99.53 170.1 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.329 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -133.21 31.95 2.81 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.872 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.22 68.38 0.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.122 0.486 . . . . 0.0 110.703 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 56' ' ' LEU . 12.4 t -57.2 -75.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.928 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 p90 -68.54 -44.65 74.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.34 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 52.55 86.64 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.544 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 70.9 p -159.19 81.15 0.77 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 44.2 60.19 2.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.857 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.681 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 177.81 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.339 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.681 ' HG ' ' C ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 36.16 22.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.367 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -70.78 20.36 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -79.42 120.22 79.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.703 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.81 168.03 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.524 2.149 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.4 142.45 37.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.709 2.273 . . . . 0.0 112.136 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.413 ' CD2' HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -144.98 108.34 4.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.65 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 57' ' ' ILE . 22.6 mt -62.9 117.23 3.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.843 0.354 . . . . 0.0 110.74 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -97.68 -22.82 16.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 58.4 t80 -162.08 127.49 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.027 0.442 . . . . 0.0 111.692 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 2.1 mt -99.17 -173.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -116.08 144.01 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.385 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -71.84 100.32 2.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.067 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 8.0 t0 99.33 49.17 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.821 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.03 140.53 38.05 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 14.4 Cg_endo -56.7 -18.66 27.47 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.359 2.04 . . . . 0.0 111.686 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 39' ' ' ILE . . . -67.53 -56.33 9.95 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 2.4 tp10 -77.75 -28.33 50.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.954 0.407 . . . . 0.0 109.986 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 4.0 mmt-85 -89.69 -1.78 58.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.652 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 22.7 t -48.87 -54.7 14.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.926 0.393 . . . . 0.0 110.76 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.4 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 140.01 -22.18 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.967 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.34 61.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 111.348 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.1 mt -147.45 145.34 29.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.305 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -141.49 172.96 11.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.26 71.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.186 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.39 88.3 0.98 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.39 101.56 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.7 mmt-85 -59.81 139.25 57.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.36 148.91 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -30.21 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.962 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.43 137.88 23.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.228 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.8 mt -120.87 109.84 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.8 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 58.03 23.14 9.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 -28.27 12.28 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.324 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.404 ' CG2' ' HD2' ' A' ' 85' ' ' PRO . 30.1 mt -70.02 137.21 87.2 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.497 0.189 . . . . 0.0 111.316 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.404 ' HD2' ' CG2' ' A' ' 84' ' ' ILE . 41.7 Cg_endo -67.49 -168.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.37 2.046 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.4 p -151.75 -54.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.008 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.42 -13.29 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.48 45.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.797 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.26 -175.87 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 m -83.73 165.39 18.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.989 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 5.1 p90 -73.88 -41.53 62.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.3 tt0 -54.64 -32.51 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.034 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -49.39 77.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.51 70.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.526 0.679 . . . . 0.0 110.067 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.449 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.6 OUTLIER -59.09 -36.41 75.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.869 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 7.5 mm-40 -61.94 -42.75 99.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.6 mt -55.43 -44.25 76.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.638 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.447 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 0.5 OUTLIER -67.81 -47.42 69.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.216 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 8.9 mtm180 -50.44 -33.1 19.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.715 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.498 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 61.4 m-20 -120.22 38.08 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.106 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -95.19 21.54 7.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.242 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.2 p -125.5 16.58 8.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 111.823 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -62.86 -49.69 82.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.935 0.874 . . . . 0.0 110.413 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.64 8.77 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.4 m 62.6 26.91 15.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.808 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 6.3 mttt -154.95 157.94 38.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.674 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -155.45 114.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.248 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.48 141.23 29.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.832 0.348 . . . . 0.0 110.961 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.05 155.89 49.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -121.24 111.19 17.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.243 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.1 pt -114.73 163.09 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 111.676 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -131.28 142.87 50.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.514 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 0.2 OUTLIER -161.11 174.71 13.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.407 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.32 155.1 21.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.07 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.75 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.426 . . . . 0.0 111.691 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 173.05 117.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.706 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.1 OUTLIER -130.78 30.89 4.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.146 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.1 t 89.45 97.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.409 0.623 . . . . 0.0 111.293 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.91 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.13 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.679 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -108.1 101.67 42.6 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.464 ' HA ' ' CE1' ' A' ' 126' ' ' PHE . 15.9 Cg_exo -68.69 156.84 64.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.865 2.376 . . . . 0.0 112.68 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.04 104.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.01 115.27 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.003 0.43 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 102.45 -47.39 1.14 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.546 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.21 107.14 11.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.925 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.464 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 1.7 t80 -113.0 120.12 40.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.679 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -113.23 121.48 44.59 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 t -104.55 99.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.685 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.25 109.43 16.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.554 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD23 ' CG2' ' A' ' 168' ' ' THR . 26.1 mt -121.76 116.35 30.39 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.588 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.35 114.78 2.65 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.337 2.025 . . . . 0.0 111.612 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.458 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -87.72 158.96 18.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 111.259 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.77 -164.66 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.66 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.92 -36.53 62.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 m -177.49 70.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.4 HG11 ' HA2' ' A' ' 70' ' ' GLY . 21.5 t -118.54 159.26 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.364 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -65.95 133.56 51.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.939 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.42 ' HB3' HG12 ' A' ' 140' ' ' ILE . 1.9 mt -92.45 -49.4 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.706 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.02 16.11 39.66 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -106.39 141.22 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.19 0.495 . . . . 0.0 111.278 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.432 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 79.8 m -122.3 114.16 20.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.593 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 5.6 mt -84.98 160.79 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.926 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 155' ' ' VAL . 1.4 m -150.02 156.15 41.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.191 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.2 t -110.12 90.9 10.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.29 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.423 ' CG ' ' CG2' ' A' ' 155' ' ' VAL . 85.5 Cg_exo . . . . . 0 C--N 1.347 0.476 0 C-N-CA 122.618 2.212 . . . . 0.0 112.341 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.437 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 152' ' ' ASP . 72.3 Cg_endo -90.22 157.93 4.68 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.692 2.261 . . . . 0.0 112.973 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.11 133.97 47.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.766 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 143' ' ' SER . 73.2 t -156.34 159.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.441 ' N ' ' CG1' ' A' ' 155' ' ' VAL . 5.3 mt -105.24 139.54 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.729 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.7 m -127.32 -12.15 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.432 ' CB ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER -144.71 124.84 13.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.503 . . . . 0.0 111.903 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.4 mt -117.98 146.63 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.219 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.7 143.88 45.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 111.287 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 168.37 20.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' NH1' ' A' ' 167' ' ' ARG . . . 83.8 -46.47 3.66 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.741 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.544 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.6 OUTLIER -72.74 175.47 6.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 111.381 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.405 HG13 ' CD2' ' A' ' 130' ' ' LEU . 40.9 t -73.63 -22.34 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.104 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -53.67 -71.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.923 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.428 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 50.4 t60 -67.05 -24.76 66.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.69 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -57.12 -34.49 68.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.422 ' CG2' HD23 ' A' ' 130' ' ' LEU . 36.3 p -39.2 -58.02 1.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.511 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.18 -23.12 35.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.556 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.0 t -127.4 35.7 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.34 78.88 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.84 78.41 2.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 175' ' ' ASP . 26.5 mt 39.93 28.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.403 ' N ' HD12 ' A' ' 156' ' ' ILE . . . 70.74 -38.98 0.5 Allowed Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.909 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 173' ' ' LEU . 0.2 OUTLIER 72.86 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -136.15 106.29 6.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.347 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.403 ' CD2' ' CG1' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -92.6 132.35 36.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.398 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.3 pp -134.77 -16.53 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.04 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -145.57 132.71 20.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.403 ' CG1' ' CD2' ' A' ' 177' ' ' LEU . 50.3 mt -135.65 118.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 16.1 m-20 57.82 43.56 21.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.212 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 3.1 t-20 83.49 -25.11 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.936 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 44.8 mm -81.31 157.96 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.744 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.4 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 19.6 mtm105 -129.59 126.45 38.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 112.175 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.89 -4.26 51.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.064 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.72 -32.37 0.38 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.0 t -115.58 -17.06 11.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.9 m -89.0 -169.76 2.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.012 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 m -109.12 -167.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 14.5 ttp -74.32 -53.44 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -53.4 -29.79 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 110.732 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.93 -52.3 66.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.228 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 196' ' ' ILE . . . -58.25 -43.02 87.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.279 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.8 t -64.05 -31.81 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.705 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -48.2 77.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.848 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 199' ' ' GLN . 2.2 mp -73.1 -24.69 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -37.61 88.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.627 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -86.43 -52.93 5.29 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.597 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.538 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -56.83 -18.17 11.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.946 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 196' ' ' ILE . 16.5 m -88.4 42.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.119 0.485 . . . . 0.0 110.123 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.48 62.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -163.89 -32.2 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.458 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 5.9 tt 177.39 106.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.55 121.33 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.666 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -104.62 108.74 20.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 127' ' ' HIS . 6.0 mp -91.82 117.43 29.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.459 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -107.21 108.64 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.221 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.6 175.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.426 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -114.29 120.04 39.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.015 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -125.87 108.85 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 121.122 0.487 . . . . 0.0 110.853 179.624 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.847 0.356 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.426 ' CD2' HG13 ' A' ' 115' ' ' VAL . 26.5 p-80 -127.31 111.54 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.703 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -50.15 131.42 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.346 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -124.6 149.7 46.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.732 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.5 p -110.21 135.93 50.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -134.96 -169.68 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -117.07 163.09 16.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.51 148.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.73 115.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.276 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.25 120.99 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.233 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -101.92 163.14 12.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.32 0.581 . . . . 0.0 111.512 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 105' ' ' SER . . . -107.5 103.71 13.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.24 149.36 55.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.424 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.28 4.47 5.37 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.532 2.155 . . . . 0.0 112.736 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.0 -46.21 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.528 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 46.3 p -127.91 -11.77 5.37 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.32 -93.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.195 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.403 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 37.6 m-85 -130.65 119.97 23.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.058 0.456 . . . . 0.0 110.104 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -79.7 3.41 69.17 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.306 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.407 ' CD1' ' CD1' ' A' ' 57' ' ' ILE . 34.5 mt -92.74 151.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.63 0.715 . . . . 0.0 112.024 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -151.53 99.56 2.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.104 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.497 ' HG ' ' HB3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -102.52 157.41 16.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.394 0.616 . . . . 0.0 112.575 -178.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 56' ' ' LEU . 1.5 pm0 -95.4 164.64 12.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.778 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -76.83 -98.34 0.17 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.854 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.1 p -112.61 148.46 34.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.115 0.483 . . . . 0.0 111.806 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.6 -64.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.409 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.63 ' CE1' ' HA ' ' A' ' 51' ' ' LEU . 30.2 p90 -40.92 -40.93 1.5 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.661 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 39.79 92.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.891 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER 173.02 70.6 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.252 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 51' ' ' LEU . 6.1 pt-20 52.44 162.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.107 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 m 69.51 -10.57 0.56 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.34 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.63 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 32.3 -103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 t 71.49 12.65 6.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.6 . . . . 0.0 110.096 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -68.51 107.42 1.97 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.581 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.26 149.31 11.85 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.763 2.309 . . . . 0.0 111.333 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 84.5 Cg_exo -45.3 110.01 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 42' ' ' GLN . 2.0 mp -105.92 92.9 4.36 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.886 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 40.3 mt -58.21 110.65 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-O 120.787 0.327 . . . . 0.0 110.558 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -91.16 -2.37 57.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.351 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 79.4 t80 178.95 142.92 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.131 0.491 . . . . 0.0 111.608 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 1.8 mt -121.48 170.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 56.8 tt0 -108.13 152.03 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.591 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.56 45.58 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.73 41.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.873 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.405 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 1.9 m -139.45 139.86 23.84 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.807 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.78 -15.3 25.81 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.782 2.321 . . . . 0.0 112.979 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.18 -56.81 12.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.94 0.4 . . . . 0.0 110.303 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -78.96 -29.62 44.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.752 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -64.1 -24.76 67.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.001 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -47.29 -29.65 2.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 137' ' ' GLU . . . 78.16 27.15 58.56 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.789 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -152.15 36.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.967 0.413 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 39' ' ' ILE . 12.0 mt -137.29 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.13 152.65 15.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 74' ' ' ILE . 46.9 mt -62.74 103.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.77 29.83 3.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.507 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.82 152.74 40.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.7 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -116.4 97.48 6.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.8 t -73.14 151.88 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.134 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -30.95 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -157.32 143.7 17.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.189 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.21 115.3 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.8 18.63 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.78 -27.96 10.52 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.604 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.8 mt -74.91 132.98 76.44 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-O 120.507 0.194 . . . . 0.0 111.167 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.85 168.68 23.98 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.407 2.071 . . . . 0.0 112.286 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.8 p -131.26 -61.68 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -62.61 -18.2 61.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.38 44.51 1.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.611 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.52 -170.67 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.72 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -73.6 139.53 45.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.444 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 11.0 p90 -73.12 -32.7 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.5 mt-10 -54.0 -36.51 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.46 -45.38 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.31 68.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.21 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -35.23 80.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.143 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 mm-40 -67.28 -41.25 85.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.591 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 101' ' ' SER . 12.5 mt -63.98 -50.28 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.903 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mt -69.76 -54.74 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -29.42 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.187 0.518 . . . . 0.0 109.829 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -124.76 40.84 3.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.531 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.9 p -87.39 13.88 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.596 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 p -109.24 15.12 23.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 5.6 mt -74.24 -47.42 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.706 0.765 . . . . 0.0 110.776 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.67 9.52 41.37 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.657 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' THR . 0.3 OUTLIER 56.32 21.38 5.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 0.1 OUTLIER -174.81 157.73 2.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.984 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.0 p -164.48 121.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.063 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.9 135.65 42.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.961 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.1 158.48 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -104.33 145.53 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 111' ' ' ILE . 29.5 pt -131.25 165.98 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.561 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -135.8 124.18 23.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.473 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 3.6 p90 -141.87 174.1 10.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.376 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.91 110.52 22.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.203 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 21' ' ' HIS . 8.9 p -61.8 104.88 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.39 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.68 137.23 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 118' ' ' SER . 3.7 tp10 -130.43 6.43 4.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.5 m 83.44 74.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.964 0.411 . . . . 0.0 111.702 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.475 ' HB ' ' CE1' ' A' ' 126' ' ' PHE . 7.1 m -100.53 146.28 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.48 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 2.1 pp -117.39 104.12 50.38 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.853 0.359 . . . . 0.0 111.459 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 96.0 Cg_endo -85.9 152.71 9.88 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.9 2.4 . . . . 0.0 112.85 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.89 24.96 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.33 113.61 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.34 -45.06 2.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.419 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -125.66 102.56 7.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.676 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.475 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -111.6 115.93 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.48 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.15 126.06 41.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 110.714 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.412 ' CG1' ' CB ' ' A' ' 168' ' ' THR . 13.0 t -99.89 87.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -81.26 105.49 12.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.883 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.95 124.94 21.84 Favored Pre-proline 0 C--N 1.333 -0.114 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -56.63 128.98 32.24 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.299 1.999 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 133' ' ' LYS . 12.0 tptm -98.22 158.19 15.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.739 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -132.82 78.2 1.78 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.268 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 69.2 m-70 45.21 29.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.196 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 132' ' ' LYS . 0.9 OUTLIER 56.31 69.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 76.9 t -87.05 -97.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.801 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' HA3' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -101.52 108.82 20.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.779 0.323 . . . . 0.0 111.055 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.6 mt -142.36 102.6 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.49 45.84 2.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.642 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.4 mt -88.35 144.16 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.755 0.312 . . . . 0.0 111.038 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.414 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 92.1 m -126.15 129.22 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.52 164.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.836 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.88 149.66 27.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.816 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.01 130.9 23.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--N 1.347 0.455 0 C-N-CA 122.448 2.099 . . . . 0.0 112.196 179.945 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 153' ' ' PRO . 6.4 p-10 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 152' ' ' ASP . 19.1 Cg_endo -58.35 151.71 58.84 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.113 . . . . 0.0 112.432 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 154' ' ' LEU . 2.9 mm? -73.16 164.48 26.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.685 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.6 m -155.38 135.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 111.304 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.37 150.34 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.41 -14.3 5.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.883 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.2 t70 179.02 147.04 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -140.66 136.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.66 145.97 24.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.88 0.372 . . . . 0.0 111.122 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -177.92 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 71.18 -60.45 1.06 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.503 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.47 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 1.0 OUTLIER -56.91 138.76 53.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.0 111.231 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 3.5 m -51.69 -21.68 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.192 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -49.24 -71.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 61.8 t60 -71.57 -24.8 61.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.84 0.353 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.47 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.8 -34.82 63.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.412 ' CB ' ' CG1' ' A' ' 128' ' ' VAL . 24.3 p -52.32 -27.13 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 74.52 64.69 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.58 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.7 t -178.91 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.97 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.85 86.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.04 -174.1 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.3 mt -94.01 117.0 29.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.98 31.29 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.58 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.44 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 2.9 m-20 -111.32 159.7 17.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.495 0.188 . . . . 0.0 110.623 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -112.84 129.85 56.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.44 146.7 27.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.007 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 tt -132.82 -42.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.117 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -127.77 156.29 42.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.8 mt -139.86 135.05 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.335 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 42.55 41.82 2.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.089 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 81.65 -19.56 0.41 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.1 mm -90.76 132.2 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 2.3 mtp-105 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 193' ' ' ALA . 0.0 OUTLIER -93.46 -17.3 23.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 58.55 39.69 24.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.498 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.4 p 58.54 74.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.005 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 192' ' ' ASP . 31.0 p -136.6 114.34 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 192' ' ' ASP . 0.4 OUTLIER 57.89 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -53.14 -33.73 53.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.58 -29.77 68.38 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.259 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 188' ' ' CYS . 3.4 t0 -63.76 -48.91 75.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.454 ' HA ' ' CD2' ' A' ' 185' ' ' LEU . . . -57.8 -43.45 85.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.142 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.611 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 14.3 t -59.95 -40.24 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.347 0.594 . . . . 0.0 109.681 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -49.56 75.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.937 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 196' ' ' ILE . 0.9 OUTLIER -65.54 -24.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -68.8 -25.76 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -98.26 -49.19 4.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.968 -178.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.476 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -59.23 -17.24 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.58 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 25.6 p -80.27 48.47 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 1.1 pt-20 -74.46 61.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.85 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -175.09 -26.49 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.415 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.4 tt 177.63 112.03 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.0 110.386 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 12.0 t -96.13 111.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.799 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -105.58 108.3 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.35 119.79 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 111.839 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.441 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 6.9 tttt -91.93 93.19 8.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 8.1 mm -84.62 163.86 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.286 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 1.5 ttt85 -107.79 116.77 32.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.572 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -103.8 159.78 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.722 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.764 0.316 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -99.65 130.28 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.82 171.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.144 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -161.91 166.29 26.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 151.03 39.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.452 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 12.9 t -136.75 -173.26 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.98 163.07 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.41 149.38 28.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.6 109.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 52.3 mt -112.21 118.11 34.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.249 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -105.33 162.83 13.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.227 0.537 . . . . 0.0 111.686 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 109.06 20.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.04 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.425 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -78.4 150.14 76.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.74 3.75 5.72 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.43 2.087 . . . . 0.0 112.73 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.76 -43.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.577 0.227 . . . . 0.0 111.596 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.85 -12.14 5.37 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 64.61 -82.89 0.06 OUTLIER Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.159 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' HB3' HD13 ' A' ' 39' ' ' ILE . 56.2 m-85 -139.09 113.58 9.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.78 26.28 15.18 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.685 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.467 ' CD1' ' CB ' ' A' ' 66' ' ' ALA . 3.9 mp -93.0 125.03 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -97.88 98.41 9.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -96.87 156.54 16.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -132.55 169.28 16.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.92 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.72 56.52 0.51 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.708 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -158.21 79.35 0.83 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -98.46 -72.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.394 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 27.8 p90 -34.72 -45.92 0.27 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.43 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 49.25 72.62 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.44 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 1.4 t 167.93 94.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 48' ' ' THR . 7.7 pt-20 49.87 178.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.3 t 44.08 -161.45 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.359 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -150.08 -90.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.204 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.12 18.46 0.57 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.888 0.375 . . . . 0.0 111.469 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.71 111.43 6.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.306 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.34 146.15 21.89 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.343 2.029 . . . . 0.0 111.441 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HG2' ' HB ' ' A' ' 78' ' ' VAL . 5.4 Cg_endo -48.71 104.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.381 2.054 . . . . 0.0 111.747 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.33 111.9 20.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.693 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.462 HG23 HD13 ' A' ' 57' ' ' ILE . 19.3 mt -59.7 157.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -128.44 -34.94 2.0 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -163.97 127.79 2.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.502 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.9 mt -96.17 168.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.71 141.55 46.38 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.52 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -69.13 63.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.456 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.6 p30 162.58 42.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.268 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -134.06 139.92 34.66 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.758 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.06 -12.69 31.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.755 2.303 . . . . 0.0 112.9 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' CB ' ' CD1' ' A' ' 39' ' ' ILE . . . -74.85 -56.3 4.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.927 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 2.7 tp10 -72.32 -29.9 64.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.742 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -76.91 -24.5 52.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.1 t -44.4 -52.4 7.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 111.045 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' A' ' 136' ' ' VAL . . . 118.15 16.73 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.113 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 m -158.58 37.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 111.067 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.32 140.21 52.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -145.18 167.57 22.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.4 mm -65.62 126.91 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.197 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.22 50.05 42.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.538 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.39 102.83 7.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.29 . . . . 0.0 110.931 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.08 156.35 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.757 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.434 ' HB ' ' HG2' ' A' ' 55' ' ' PRO . 21.2 t -147.94 157.5 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 111.403 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.5 tpt -125.11 -41.36 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.74 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.62 137.01 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.5 mt -121.12 112.39 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 59.33 20.76 8.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.38 -21.95 37.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.636 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -75.49 119.8 78.7 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 120.439 0.161 . . . . 0.0 111.278 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.63 -167.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.516 2.144 . . . . 0.0 112.142 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.75 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.084 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.45 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -117.93 47.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -175.39 179.88 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -76.08 164.23 26.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -73.43 -30.35 63.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -31.92 57.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.442 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -37.7 85.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.694 0.283 . . . . 0.0 110.746 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -71.98 -29.34 64.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.459 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.8 -38.11 54.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.849 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.44 -35.55 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.787 0.327 . . . . 0.0 111.143 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 101' ' ' SER . 1.2 pp -69.84 -45.08 68.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.09 -58.94 5.17 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.271 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -29.56 11.9 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.479 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -112.92 34.08 4.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.863 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 69.2 p -102.81 17.46 23.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.3 p -102.05 11.81 37.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.0 mt -68.9 -49.34 64.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.608 0.718 . . . . 0.0 110.998 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.23 6.91 38.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.8 p 55.76 24.68 7.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.256 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -172.72 145.94 1.57 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.711 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.478 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -146.41 132.59 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.772 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.72 141.25 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.27 140.14 41.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.352 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.53 115.77 31.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.973 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.55 163.75 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 112.144 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.59 131.73 45.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.237 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -142.62 174.62 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.117 0.484 . . . . 0.0 111.661 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.82 104.27 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.08 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 13.5 p -61.57 145.65 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 115' ' ' VAL . . . 87.39 129.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.344 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.58 24.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.987 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.2 t 176.78 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.185 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 126' ' ' PHE . 41.3 t -142.27 118.09 5.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.535 ' CG2' ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -154.74 78.51 4.96 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -177.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.448 ' HB3' ' CG ' ' A' ' 126' ' ' PHE . 69.6 Cg_endo -96.38 -167.31 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.455 2.77 . . . . 0.0 112.722 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.93 35.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.32 113.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.523 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.77 -32.77 5.8 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.922 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.66 105.2 5.78 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.823 0.344 . . . . 0.0 111.137 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.448 ' CG ' ' HB3' ' A' ' 121' ' ' PRO . 1.4 t80 -100.58 118.45 36.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.535 ' HB2' ' CG2' ' A' ' 120' ' ' ILE . 6.8 m80 -97.8 142.18 29.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 111.294 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.1 t -139.92 90.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.528 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.47 129.89 23.92 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 136.84 51.16 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.089 1.86 . . . . 0.0 111.293 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 202' ' ' ASP . 0.0 OUTLIER -100.93 158.79 15.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.051 0.453 . . . . 0.0 110.939 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.475 ' CD ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.17 -164.86 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -100.47 -29.09 12.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -164.25 48.8 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 111.497 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' CD ' ' A' ' 133' ' ' LYS . 25.3 t -112.09 137.68 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.752 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.51 129.33 38.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.71 -41.17 17.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 100.71 -12.05 59.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.712 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 pt -89.25 148.92 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.896 0.379 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 86.1 m -126.28 126.18 43.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.331 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 mt -87.31 164.18 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.095 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.2 p -163.5 164.79 24.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.9 109.89 17.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.484 2.123 . . . . 0.0 112.37 -179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 46.1 t0 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.616 0.246 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -172.51 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.67 150.9 26.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.689 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 176' ' ' LYS . 18.4 m -150.67 145.72 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.409 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 173' ' ' LEU . 1.1 mp -78.33 143.92 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.391 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -11.42 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.74 142.31 9.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -136.21 149.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 173.22 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 167' ' ' ARG . 5.6 mtpp -115.19 145.64 42.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 115.38 -24.25 10.64 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.322 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.425 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -108.28 159.55 16.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.926 0.394 . . . . 0.0 111.029 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.38 -21.85 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.877 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.422 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -43.94 -65.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 28.4 t60 -83.54 -29.92 27.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -56.83 -40.78 76.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.679 0.276 . . . . 0.0 111.448 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 4.5 t -45.04 -29.17 0.81 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.548 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 68.6 1.57 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -178.93 -38.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.344 . . . . 0.0 110.744 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.86 72.28 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.03 152.76 19.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.419 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 0.2 OUTLIER -76.48 129.34 36.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.966 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.17 5.33 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.732 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.462 ' HB3' HG21 ' A' ' 208' ' ' ILE . 1.2 t0 -113.61 -174.32 2.44 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.883 -0.186 . . . . 0.0 110.693 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.419 ' HA ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -132.46 106.81 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 0.0 111.381 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 208' ' ' ILE . 0.2 OUTLIER -74.07 157.39 36.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.716 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.2 tt -136.19 -49.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -129.76 157.46 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 111.708 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 32.6 mt -138.99 105.71 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.76 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 28.5 t70 62.01 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.45 -18.64 3.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 25.5 mm -96.99 138.03 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.027 0.442 . . . . 0.0 111.629 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -105.87 124.64 49.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.625 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.69 -7.28 49.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.84 -31.12 1.12 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.9 p -124.88 -12.72 7.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.895 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 17.7 m -83.59 -170.64 3.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 m -116.95 -175.83 2.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.58 -57.32 6.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -54.69 -41.81 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.239 0.543 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.71 -45.06 77.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.251 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.05 81.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 17.0 t -59.1 -36.73 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 29.3 mm-40 -60.83 -50.36 73.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.896 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 199' ' ' GLN . 0.6 OUTLIER -68.38 -25.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -64.87 -32.16 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.48 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -95.44 -41.46 8.97 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.583 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -85.08 13.99 5.54 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.41 32.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.2 mm-40 34.63 70.26 0.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.459 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 0.7 OUTLIER 42.83 34.61 0.61 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 178.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.433 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -171.55 103.87 0.2 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.156 0.503 . . . . 0.0 111.626 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.415 ' CG2' ' CG ' ' A' ' 132' ' ' LYS . 47.9 t -107.84 108.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.374 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 33.0 ttmt -94.02 107.5 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 107.57 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.475 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.455 ' HD3' ' CE1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -101.44 92.65 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.626 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.462 HG21 ' HB3' ' A' ' 175' ' ' ASP . 2.4 mp -87.31 166.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -111.76 123.39 50.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -115.55 95.09 4.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.323 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.776 0.322 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.66 40.76 1.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.134 0.493 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 51.62 174.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.537 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.15 142.5 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.21 143.88 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.009 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.426 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 5.6 t -141.2 159.11 42.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.84 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.71 159.17 15.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.791 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 109' ' ' LEU . 1.3 t -135.77 147.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.97 109.51 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.01 118.83 37.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.69 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -109.29 162.4 14.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -97.49 115.87 28.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.841 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.452 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -74.83 157.74 85.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.635 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.98 6.12 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.503 2.136 . . . . 0.0 112.594 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.14 -49.31 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.513 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.3 p -138.74 -1.58 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.452 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 76.04 -99.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.269 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 37' ' ' PHE . 2.8 m-85 -116.16 119.63 36.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.49 26.91 11.79 Favored Glycine 0 CA--C 1.517 0.17 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.352 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.42 ' CG2' ' CD1' ' A' ' 57' ' ' ILE . 7.0 mt -92.63 135.94 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 121.092 0.473 . . . . 0.0 111.56 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.96 99.51 5.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 1.9 pp -114.69 156.82 24.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 112.279 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -102.65 169.59 8.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.259 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.401 ' O ' ' CG ' ' A' ' 91' ' ' PHE . . . -137.18 46.28 1.02 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.88 65.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.175 0.512 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.8 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.189 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.521 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 47.3 p90 -67.41 -49.76 62.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.026 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.483 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.8 79.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.401 0.62 . . . . 0.0 111.296 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 t 170.37 116.8 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.665 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' O ' ' OG1' ' A' ' 50' ' ' THR . 1.6 tp10 60.84 84.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 49' ' ' GLU . 3.2 p 89.4 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.3 pp -166.43 26.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 111.895 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 20.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.2 t -58.81 109.3 1.76 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.583 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.8 162.54 37.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.377 2.052 . . . . 0.0 112.319 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.25 129.27 21.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.524 2.149 . . . . 0.0 112.154 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.38 99.65 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 21.5 mt -60.89 129.5 23.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.76 0.314 . . . . 0.0 110.687 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.4 p -113.66 -2.51 13.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 55.4 t80 177.72 124.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.875 0.369 . . . . 0.0 111.435 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' ' CE2' ' A' ' 59' ' ' TYR . 1.9 mt -96.63 -178.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 63' ' ' ASP . 25.3 tt0 -121.55 131.14 53.96 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.347 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HA ' ' NH1' ' A' ' 68' ' ' ARG . . . -65.5 70.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.457 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.2 m-20 164.62 44.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -145.04 -179.43 0.94 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 91.0 Cg_endo -97.87 -2.7 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.067 2.511 . . . . 0.0 112.744 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.84 -57.22 3.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.717 0.294 . . . . 0.0 111.648 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.521 ' HG3' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -77.37 -29.11 53.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 0.0 110.131 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.592 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -76.53 -30.78 57.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 -67.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.727 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -14.69 5.35 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.954 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.65 45.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.418 . . . . 0.0 110.96 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.3 mt -135.6 168.95 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -164.16 143.19 7.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.36 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.094 0.473 . . . . 0.0 111.407 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.69 42.32 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.283 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.83 113.28 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.97 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.77 79.17 2.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.74 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.96 132.32 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.75 -30.71 10.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.89 131.97 20.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.7 mt -124.89 117.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.651 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 46.56 27.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.439 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.39 -30.27 9.07 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.593 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 84' ' ' ILE . 15.7 mm -68.58 117.79 53.81 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 -167.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.364 2.043 . . . . 0.0 112.187 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.4 p -147.7 -45.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.071 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.69 -9.97 58.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.561 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.3 47.46 2.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.3 168.69 2.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -74.97 157.38 35.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 9.5 p90 -73.3 -31.0 63.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.95 -41.14 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 -33.75 74.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.343 . . . . 0.0 110.978 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.93 -31.8 64.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 110.6 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.31 -36.11 58.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.821 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -73.41 -35.73 65.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.47 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 1.1 pp -69.96 -41.92 73.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.239 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 80.7 mt -65.84 -58.78 4.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.07 -29.7 13.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.448 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.4 OUTLIER -109.44 30.7 6.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.962 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -104.5 45.64 0.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.2 p -133.36 13.02 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.88 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -69.79 -48.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.52 0.676 . . . . 0.0 111.137 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.29 7.11 40.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.817 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.3 m 56.69 25.2 9.81 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.926 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -166.28 152.77 9.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.648 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.8 t -152.84 158.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.08 141.25 52.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 109' ' ' LEU . 2.0 mp -130.26 156.04 45.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -130.92 105.85 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 111' ' ' ILE . 25.5 pt -110.47 160.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.098 0.475 . . . . 0.0 111.806 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -133.02 140.4 47.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.472 ' CZ ' ' HD2' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.26 174.31 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.95 118.34 34.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.68 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.96 118.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.426 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 179.36 117.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 168' ' ' THR . 2.7 tp10 -118.1 13.25 13.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.527 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.35 72.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.163 0.506 . . . . 0.0 111.401 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 m -97.8 147.83 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.613 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.554 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.9 pp -121.45 98.72 46.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.92 0.39 . . . . 0.0 111.304 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.472 ' HB3' ' CE1' ' A' ' 126' ' ' PHE . 89.2 Cg_endo -90.31 169.12 4.16 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.084 2.522 . . . . 0.0 112.825 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.8 m -166.61 29.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.8 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.82 113.31 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.715 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.78 -39.25 2.96 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.561 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.22 102.42 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.493 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 170' ' ' THR . 0.7 OUTLIER -109.15 117.8 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.485 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.554 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -99.96 143.01 30.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 205' ' ' LYS . 14.6 t -118.66 90.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 205' ' ' LYS . 0.3 OUTLIER -80.81 105.96 12.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.445 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.98 133.45 18.65 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.382 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.89 129.08 32.64 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.231 1.954 . . . . 0.0 111.516 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -106.98 139.4 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.075 0.464 . . . . 0.0 110.874 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -76.75 -168.28 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.767 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 0.9 OUTLIER -90.04 -40.0 12.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.235 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.62 45.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.773 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.46 161.25 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.75 145.91 8.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.274 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.74 -58.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.487 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 92.02 56.94 1.54 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.679 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.414 ' CD1' ' CB ' ' A' ' 165' ' ' ALA . 6.0 mt -125.09 136.7 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.447 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 73.4 m -125.28 142.54 51.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 154' ' ' LEU . 10.5 mt -111.49 164.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.96 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.6 m -165.35 152.52 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.01 145.94 35.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.1 t0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.678 0.275 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 159.36 5.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.665 2.243 . . . . 0.0 112.576 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 142' ' ' ILE . 2.2 mm? -101.7 155.03 18.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.302 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.1 t -153.71 160.55 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.872 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 173' ' ' LEU . 8.5 mt -104.02 148.02 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.817 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 -0.36 2.93 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.5 t0 -168.98 134.56 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 111.421 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -136.69 149.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.822 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -122.79 149.12 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.162 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.506 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 2.3 mptt -79.09 165.74 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.725 0.298 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.81 -59.34 1.78 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.595 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.508 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -61.31 160.85 9.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.922 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.62 -23.99 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.435 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -49.64 -58.51 5.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.442 ' HB3' ' NH1' ' A' ' 167' ' ' ARG . 15.8 t60 -83.87 -31.31 25.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.646 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.508 ' NE ' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.99 -29.84 58.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.733 0.302 . . . . 0.0 111.153 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 9.8 t -54.75 -20.1 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.84 24.74 76.22 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.511 ' CG2' ' CZ ' ' A' ' 126' ' ' PHE . 0.3 OUTLIER -133.27 -39.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.896 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.0 tp -64.96 93.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -110.23 155.26 22.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.692 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 0.5 OUTLIER -87.73 50.97 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.993 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.09 30.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.48 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -113.88 177.23 4.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.647 0.261 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -117.65 98.34 6.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 111.18 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.9 mt -76.97 134.89 38.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.723 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.6 2.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.857 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -165.29 154.68 12.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.876 0.369 . . . . 0.0 111.484 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 182' ' ' ASN . 9.1 mm -139.38 117.79 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.1 OUTLIER 46.81 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.407 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' ILE . 75.7 m-20 -112.34 -16.5 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 39.7 mm -96.67 157.68 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.432 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 8.8 mtt180 -127.43 126.56 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.047 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.402 ' CD2' HG12 ' A' ' 180' ' ' ILE . 3.2 mm? -78.47 -4.92 50.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.8 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -28.92 1.97 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.1 p -135.45 40.05 2.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 15.1 m -140.66 -171.42 3.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.23 173.23 6.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 17.6 ttp -59.0 -53.09 62.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 4.0 mt-10 -51.7 -41.06 61.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.613 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.26 -51.96 60.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.153 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -52.66 -41.36 63.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.251 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.64 -33.45 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.022 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 191' ' ' GLU . 17.1 mm-40 -63.32 -50.27 70.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.84 -24.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.822 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -35.44 81.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.762 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -94.76 -44.73 7.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.32 -22.58 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.888 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . 0.455 ' HB2' HG23 ' A' ' 204' ' ' VAL . 19.3 m -89.56 41.99 1.07 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.081 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 134' ' ' HIS . 12.2 pt-20 -69.06 61.6 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.535 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -168.98 -28.98 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.944 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.405 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 4.5 tt 172.67 113.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.856 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 200' ' ' CYS . 97.4 t -111.88 137.91 42.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 5.1 ttmt -111.76 108.14 17.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.955 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.76 113.12 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.436 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.463 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 6.4 tttt -100.02 103.43 14.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.521 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.34 174.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 23.0 mtp85 -102.73 125.99 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.02 94.55 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.451 -0.386 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 -179.931 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.806 0.336 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -75.55 114.97 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -55.79 149.95 13.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -155.6 168.71 26.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.91 160.26 16.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.73 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.411 ' OG1' ' CZ ' ' A' ' 113' ' ' PHE . 89.2 m -158.45 155.45 28.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.7 160.2 14.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.68 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.99 150.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.586 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.54 109.35 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.971 0.415 . . . . 0.0 111.246 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 3.4 mm? -107.26 118.23 36.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.835 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.43 ' CG2' ' CG ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.7 162.57 13.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.175 0.512 . . . . 0.0 111.942 -178.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.28 151.52 20.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.162 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -134.16 150.88 75.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.386 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.11 20.73 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.561 2.174 . . . . 0.0 112.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.7 t -133.79 -54.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.248 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 t -159.81 37.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.692 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -43.43 143.31 1.84 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.437 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 11.0 m-85 61.02 71.83 0.55 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -98.66 26.48 23.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.439 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 60' ' ' ILE . 26.9 pt -115.23 143.41 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.06 140.35 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.478 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -112.31 121.56 45.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.966 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -84.69 170.11 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.95 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.06 61.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.54 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.99 110.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.67 -73.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.376 0.608 . . . . 0.0 110.256 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 27.0 p90 -43.42 -45.07 6.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.35 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.489 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.66 74.49 0.1 Allowed 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.8 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 166.86 108.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.788 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.52 138.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.1 -164.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.815 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -138.93 -85.39 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.823 0.344 . . . . 0.0 111.717 179.45 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t 57.41 13.98 2.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 110.974 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -54.13 106.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.329 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 60.6 Cg_endo -72.53 117.9 5.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.279 1.986 . . . . 0.0 111.499 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -36.1 118.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.21 2.607 . . . . 0.0 113.231 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -118.17 176.37 5.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.198 179.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.412 HG12 ' HB2' ' A' ' 76' ' ' ASP . 21.3 mm -112.31 138.41 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.49 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 p -119.14 -8.5 10.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 80.5 t80 -172.47 157.74 4.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.362 0.601 . . . . 0.0 111.885 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 39' ' ' ILE . 8.7 mm -135.05 152.66 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.413 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.8 tm-20 -104.2 156.66 17.71 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.56 47.59 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.115 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.87 65.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.617 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -156.02 -172.25 0.31 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 54.5 Cg_endo -96.77 -10.24 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.817 2.344 . . . . 0.0 113.377 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . . . -77.68 -58.45 3.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -71.47 -29.1 64.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.415 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.52 -30.59 5.38 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.961 0.41 . . . . 0.0 110.649 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.404 ' HA3' ' CG1' ' A' ' 136' ' ' VAL . . . 78.8 36.67 28.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.855 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' CG1' ' HA2' ' A' ' 162' ' ' GLY . 16.6 t -154.26 31.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.736 0.303 . . . . 0.0 111.426 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.428 ' CD1' ' CB ' ' A' ' 66' ' ' ALA . 9.5 mt -133.11 147.55 52.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.894 0.378 . . . . 0.0 111.054 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.06 148.81 33.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.61 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.37 68.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.785 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.09 45.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.412 ' HB2' HG12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -79.71 -179.79 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.668 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -147.03 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.35 133.73 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.09 -28.33 10.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.706 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.25 120.29 9.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 mt -105.34 104.93 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.513 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 57.01 21.16 6.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.26 8.16 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -71.6 111.58 10.86 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.83 168.53 24.36 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.48 2.12 . . . . 0.0 112.005 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.5 p -143.72 10.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.59 -17.1 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.56 46.36 1.9 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.32 171.73 19.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.779 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.43 151.71 32.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -71.21 -30.0 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 pt-20 -54.44 -39.78 67.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.152 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -36.48 79.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -67.56 -33.68 75.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.42 0.629 . . . . 0.0 110.128 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.97 81.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.838 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 4.0 mm100 -70.24 -56.2 7.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.839 0.352 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -52.28 -41.84 63.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.332 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.585 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 2.6 mt -68.65 -56.13 9.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.262 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -50.84 -28.74 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.164 0.507 . . . . 0.0 109.715 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.488 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -120.67 38.96 3.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.544 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.585 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -103.84 36.16 2.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.167 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 1.4 m -121.57 15.88 11.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.488 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.7 mp -71.59 -47.48 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.564 0.697 . . . . 0.0 111.216 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.95 3.67 44.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.41 ' HA ' ' CB ' ' A' ' 31' ' ' ALA . 1.4 m 63.04 18.46 10.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.666 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.43 ' CG ' ' CG2' ' A' ' 30' ' ' THR . 0.4 OUTLIER -173.22 150.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.095 0.474 . . . . 0.0 111.956 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 106' ' ' LYS . 45.2 t -145.06 138.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.396 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.12 125.48 54.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 110.486 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 mt -119.21 164.95 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.89 105.94 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.3 pt -104.7 150.24 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.735 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -124.11 115.0 20.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 11.8 p90 -135.71 174.17 10.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.43 . . . . 0.0 111.406 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.24 155.01 18.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.636 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.9 t -91.77 104.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 0.0 111.471 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -167.95 137.25 2.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.656 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -146.63 25.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.635 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.76 65.59 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.249 0.547 . . . . 0.0 111.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.404 ' CG1' ' OG1' ' A' ' 168' ' ' THR . 6.1 m -97.84 147.57 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.215 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.546 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.7 pp -130.04 92.93 35.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 0.0 111.024 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.45 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 68.3 Cg_endo -96.37 -178.52 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.349 2.699 . . . . 0.0 112.673 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.33 35.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.415 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.51 119.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.826 0.346 . . . . 0.0 110.776 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.42 -51.73 3.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.412 ' CG2' ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -115.32 105.02 12.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.854 0.359 . . . . 0.0 110.551 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.492 ' CE1' HG22 ' A' ' 170' ' ' THR . 0.9 OUTLIER -113.34 120.94 42.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.783 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.546 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.6 m80 -109.82 152.71 25.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 206' ' ' LEU . 17.8 m -131.07 98.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.284 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.3 105.43 17.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.779 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.04 133.11 24.77 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.977 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.76 136.03 37.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.351 2.034 . . . . 0.0 112.075 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.78 158.13 26.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 -166.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.796 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -58.5 -57.2 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -164.48 48.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.404 ' CG1' ' HA3' ' A' ' 70' ' ' GLY . 97.2 t -75.94 159.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -47.54 111.9 0.48 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.321 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mt -116.11 112.5 21.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.565 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.72 45.85 2.92 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.691 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.01 130.26 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 120.65 0.262 . . . . 0.0 111.064 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.441 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 7.4 m -126.73 133.08 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.758 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.2 mt -105.4 163.44 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -166.43 123.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 p -84.0 117.15 67.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.731 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo . . . . . 0 C--N 1.347 0.452 0 C-N-CA 122.311 2.008 . . . . 0.0 112.298 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.6 t0 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.823 0.344 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.65 -161.71 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.39 173.74 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.869 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 176' ' ' LYS . 33.8 m -156.38 -176.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.093 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.4 mm -76.14 154.28 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.694 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.4 ' HB3' ' CG2' ' A' ' 141' ' ' THR . 0.3 OUTLIER -135.59 -9.18 2.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 173.21 147.44 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.392 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 3.2 mt -130.69 150.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.61 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.476 ' HE2' ' HA3' ' A' ' 162' ' ' GLY . 0.1 OUTLIER -121.77 134.7 54.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 110.438 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.11 86.33 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 0.0 111.009 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.476 ' HA3' ' HE2' ' A' ' 160' ' ' LYS . . . -177.24 -32.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.241 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.4 169.59 8.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.402 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 8.3 m -58.92 -21.53 19.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.067 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -43.57 -71.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.466 ' CG ' ' CG2' ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.63 -24.93 67.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 0.0 111.266 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.415 ' NE ' ' CE1' ' A' ' 113' ' ' PHE . 19.5 mmt-85 -58.81 -38.23 78.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.49 ' CG2' ' HB2' ' A' ' 171' ' ' LEU . 14.9 t -57.68 -30.46 65.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.49 -72.51 2.82 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.616 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.492 HG22 ' CE1' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -42.46 -29.56 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.49 ' HB2' ' CG2' ' A' ' 168' ' ' THR . 0.2 OUTLIER -60.24 86.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.38 158.75 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.6 mt -68.31 72.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.834 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.06 40.05 0.02 OUTLIER Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.634 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -121.48 118.02 28.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.538 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 208' ' ' ILE . 29.9 mmtt -75.85 108.36 8.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.6 mt -75.94 152.18 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.026 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.3 tt -139.96 -57.11 0.56 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -109.97 155.95 21.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.346 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.2 mm -139.61 110.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.267 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 38.9 t70 53.73 51.81 14.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.394 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.4 t-20 82.82 -30.5 0.09 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 37.3 mm -73.5 151.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.35 119.07 22.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.24 0.543 . . . . 0.0 112.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.13 -12.34 58.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.903 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t70 51.18 52.6 14.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.63 74.51 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.657 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.91 -169.69 2.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.061 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.0 m -58.04 154.88 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 36.2 ttp -74.17 -35.23 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -51.8 -48.52 63.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.171 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.54 -52.13 31.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.646 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -55.51 -37.83 68.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.314 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 21.6 t -62.78 -30.86 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.077 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -66.54 -50.34 63.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.089 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.1 mp -73.72 -24.69 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.124 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -63.15 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.474 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.47 -40.09 12.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -14.7 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 2.2 m -85.02 41.78 0.89 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.72 62.59 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.222 0.535 . . . . 0.0 111.076 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -174.48 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.312 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.7 tt 177.56 109.32 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.124 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.12 116.03 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.891 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 128' ' ' VAL . 4.4 ttmm -108.77 108.37 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.624 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.46 ' HB2' ' CG2' ' A' ' 128' ' ' VAL . 3.4 mt -97.12 117.16 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.415 . . . . 0.0 111.376 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.444 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 26.2 tttt -97.8 101.07 12.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -109.43 179.38 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 2.4 mtp180 -109.41 135.25 50.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.012 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 211' ' ' ASP . 0.0 OUTLIER -132.37 159.87 37.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.883 0.373 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -133.94 116.62 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.834 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -50.58 147.98 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.445 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.4 173.0 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 152.71 39.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.444 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 9.0 t -149.06 170.37 18.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -101.59 162.16 13.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 108' ' ' THR . 0.7 OUTLIER -142.22 145.85 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.58 109.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.791 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 1.2 mm? -108.18 141.05 40.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.317 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.483 HG21 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -123.43 160.95 25.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.355 0.597 . . . . 0.0 112.089 -178.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . . . -101.67 149.24 24.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.34 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -133.42 148.84 70.49 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.75 8.6 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 112.681 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.07 -48.7 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.427 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 t -136.36 -3.27 2.17 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 32' ' ' ASP . . . 89.2 -94.61 2.01 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.308 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.474 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 10.4 m-85 -121.68 -70.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.773 -0.251 . . . . 0.0 111.042 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 133.35 0.44 4.13 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 119.779 -1.201 . . . . 0.0 114.374 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.496 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -128.05 130.51 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.621 0.71 . . . . 0.0 112.03 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.08 128.77 56.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 2.4 pp -121.0 157.54 29.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.631 . . . . 0.0 112.559 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -111.25 170.04 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.199 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.57 16.23 14.36 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.385 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -97.51 85.38 3.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.116 0.484 . . . . 0.0 110.639 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.468 ' CG2' HD22 ' A' ' 56' ' ' LEU . 3.0 t -99.82 -75.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 46.2 p90 -57.19 -46.3 82.96 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.566 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 50.42 74.17 0.23 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.434 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.407 ' CB ' ' O ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER 163.66 75.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 64.57 163.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.87 -169.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -137.42 -105.06 0.19 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.107 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.416 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER 50.31 21.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.533 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.433 ' CA ' HG22 ' A' ' 45' ' ' VAL . 1.4 p -76.04 110.18 10.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.92 140.48 31.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.292 1.995 . . . . 0.0 112.052 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 41' ' ' LEU . 72.0 Cg_exo -51.06 125.81 17.22 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.482 2.121 . . . . 0.0 112.221 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.3 pt? -131.06 104.16 6.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.929 0.395 . . . . 0.0 111.515 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 37.6 mt -59.63 153.69 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.659 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.9 t -145.42 22.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 75.7 t80 -177.42 146.33 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.256 0.55 . . . . 0.0 112.088 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.496 ' CD1' ' CG2' ' A' ' 39' ' ' ILE . 7.5 mm -115.21 162.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.084 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -113.46 121.75 45.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.713 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -58.77 105.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.868 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.0 m-20 89.17 51.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.475 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -130.12 145.88 59.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.795 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 34.5 Cg_exo -57.29 -17.0 24.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.219 1.946 . . . . 0.0 112.044 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.87 -57.22 6.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 4.7 tp10 -78.62 -28.49 45.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 3.0 mmt-85 -87.66 -3.66 58.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.57 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -58.69 -53.32 59.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.504 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.16 -3.0 5.91 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.058 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -155.03 61.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 117.001 0.401 . . . . 0.0 111.671 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 29' ' ' LEU . 8.2 mt -143.06 154.15 43.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.0 111.163 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -161.85 146.25 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.2 mt -61.0 108.72 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.437 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.7 41.8 0.99 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.92 126.21 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -101.84 86.64 2.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 m -83.84 134.84 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -108.65 -26.7 10.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.07 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.19 138.95 52.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.8 mt -133.77 109.29 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.991 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.0 m120 59.53 24.05 12.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.979 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.49 -27.07 19.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.7 mt -73.06 136.88 79.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.22 -168.27 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.546 2.164 . . . . 0.0 112.3 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.7 p -157.0 -44.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.45 -17.15 62.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.444 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -116.65 41.99 2.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.036 0.446 . . . . 0.0 110.684 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m -166.7 -170.24 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.91 148.21 27.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -70.02 -36.03 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.1 tt0 -54.73 -34.63 62.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -52.18 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 109.766 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -31.88 59.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.189 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.12 -35.51 76.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.19 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 17.9 mm-40 -63.16 -41.15 99.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.215 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mt -63.04 -50.34 71.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.114 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.458 ' O ' ' OG ' ' A' ' 101' ' ' SER . 1.5 mt -70.6 -54.1 13.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -50.76 -29.39 11.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.186 0.517 . . . . 0.0 109.646 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -123.16 40.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.313 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 98' ' ' LEU . 6.1 p -90.8 20.18 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.584 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -114.63 15.57 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.7 mt -75.57 -48.75 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.81 -0.36 57.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.883 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.483 ' O ' HG21 ' A' ' 30' ' ' THR . 5.9 p 65.11 18.26 11.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.797 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 0.4 OUTLIER -166.21 157.12 13.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 101' ' ' SER . 41.7 t -158.63 131.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -111.55 124.56 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.701 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -124.48 165.15 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.374 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -126.23 107.17 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.18 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.7 pt -99.58 162.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.841 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -131.08 115.17 16.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.375 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.444 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 0.6 OUTLIER -132.84 174.04 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.37 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.1 149.05 24.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.211 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 25.8 t -89.98 103.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 111.462 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 161.33 -178.96 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.036 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 118' ' ' SER . 6.8 pt-20 172.52 -36.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.15 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 13.2 t 170.69 106.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.478 ' CG2' ' CE1' ' A' ' 126' ' ' PHE . 12.0 p -144.38 143.96 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.045 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.2 pp -132.36 101.98 14.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.9 Cg_endo -83.97 156.01 13.29 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.0 112.604 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -162.73 18.42 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.669 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.8 OUTLIER 56.2 117.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 96.46 -42.72 2.18 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.401 ' CG2' ' CD ' ' A' ' 207' ' ' LYS . 0.0 OUTLIER -135.78 102.66 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.404 . . . . 0.0 110.433 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -100.75 123.28 44.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.569 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.42 116.76 32.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.338 . . . . 0.0 111.079 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.94 105.49 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.918 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.25 113.12 19.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.931 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.7 mp -119.53 129.48 25.35 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.76 123.79 8.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.238 1.958 . . . . 0.0 111.314 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.536 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 1.8 mmtp -89.64 159.89 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.225 0.536 . . . . 0.0 111.341 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.405 ' HD3' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -133.68 -167.14 1.89 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.259 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -66.79 -69.47 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.18 93.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HD3' ' A' ' 133' ' ' LYS . 52.8 t -137.78 152.84 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.678 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.52 125.21 10.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.18 -64.18 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 103.28 -13.45 55.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.483 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -99.3 143.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.205 0.502 . . . . 0.0 111.176 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 157' ' ' SER . 10.8 m -126.12 109.72 12.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.377 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.5 mt -74.65 164.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.077 0.465 . . . . 0.0 111.351 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.8 t -152.57 152.57 32.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.649 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -94.53 -49.45 0.26 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.359 -179.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 144' ' ' SER . 90.5 Cg_endo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 122.366 2.044 . . . . 0.0 113.094 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.497 0.189 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.39 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.583 2.189 . . . . 0.0 112.445 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.61 174.92 2.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.783 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.3 m -157.31 162.95 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.399 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mm -78.11 154.73 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' THR . 0.2 OUTLIER -130.91 -33.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.578 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.1 164.75 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.186 0.517 . . . . 0.0 111.775 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 3.4 mm -138.45 149.19 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.297 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -129.51 154.93 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -91.05 163.93 14.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 86.22 -13.84 56.04 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.884 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.53 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 90.2 p -115.06 142.28 46.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.861 0.362 . . . . 0.0 111.02 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.6 m -48.12 -22.19 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.494 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 140' ' ' ILE . . . -54.59 -52.65 61.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 111.304 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.427 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 0.8 OUTLIER -83.5 -26.53 30.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.011 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 163' ' ' SER . 13.6 mmp_? -55.94 -50.76 69.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.3 t -58.62 -23.83 59.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.066 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 67.29 -152.7 52.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.131 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.6 p 56.16 23.21 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 151.72 40.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.892 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -164.02 -171.68 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.76 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.37 122.07 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.34 -7.21 12.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.843 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.25 170.14 15.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.747 0.274 . . . . 0.0 110.834 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.08 136.07 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 111.118 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.5 135.5 39.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 tt -108.95 -53.24 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.146 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -141.08 171.9 13.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.315 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 34.1 mt -139.08 105.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 6.6 t70 61.59 -79.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.732 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.01 -25.02 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 32.7 mm -91.4 158.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.411 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 72.8 mtt-85 -125.71 128.1 47.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.228 0.537 . . . . 0.0 112.234 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.17 -3.95 53.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.892 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.8 -29.27 1.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.26 51.15 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 20.0 m -156.18 160.58 39.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.974 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 60.0 p -77.43 -170.8 1.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' MET . . . . . 0.431 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 14.0 ptm -74.05 -43.39 57.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.996 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.431 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -54.94 -30.36 58.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.02 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.98 -51.85 67.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.058 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -57.12 -42.38 80.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.223 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.503 HG12 ' OE1' ' A' ' 198' ' ' GLN . 43.9 t -61.87 -35.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.818 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.92 -49.88 73.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.966 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.9 mp -72.71 -24.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.066 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -59.71 -43.27 94.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.87 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.503 ' OE1' HG12 ' A' ' 194' ' ' VAL . 1.1 mp0 -94.37 -39.87 10.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.534 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.68 -22.1 32.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.054 0.454 . . . . 0.0 110.435 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 17.2 m -85.89 44.62 1.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.11 63.05 0.09 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.486 0.66 . . . . 0.0 111.885 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.432 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 5.1 m-20 -170.36 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.515 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.536 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 3.6 tt 174.77 109.29 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.457 ' CG2' ' HG3' ' A' ' 132' ' ' LYS . 6.2 t -102.79 120.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.328 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 16.8 ttmm -106.3 108.13 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.37 114.96 21.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.183 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.457 ' CG ' ' CD2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -95.72 93.03 6.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 9.9 mm -83.31 165.04 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.788 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -118.27 121.78 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.055 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.27 108.86 9.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 115' ' ' VAL . 93.4 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.936 0.398 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -107.36 112.01 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.13 144.61 2.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.43 173.07 13.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.716 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -130.84 146.88 52.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.416 HG23 ' CE2' ' A' ' 113' ' ' PHE . 12.6 t -138.02 -171.28 2.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -111.45 161.65 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.192 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -139.37 150.23 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.654 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.97 109.78 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 111.495 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.1 118.66 37.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -106.14 163.29 12.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 0.0 111.431 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' CB ' ' CE2' ' A' ' 37' ' ' PHE . . . -98.1 106.47 18.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.153 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.07 147.65 83.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.92 9.43 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.539 2.16 . . . . 0.0 112.838 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.01 -41.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.5 p -117.95 -29.91 5.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.837 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 52.75 73.45 0.4 Allowed Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.353 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.469 ' CE2' ' CB ' ' A' ' 31' ' ' ALA . 54.9 m-85 73.46 89.67 0.09 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.027 0.441 . . . . 0.0 110.261 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.07 26.95 5.2 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.302 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.453 ' CD1' ' CB ' ' A' ' 66' ' ' ALA . 9.4 mt -92.26 151.96 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.159 0.504 . . . . 0.0 111.271 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.04 101.39 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.133 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' CD1' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -95.87 134.96 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.204 0.526 . . . . 0.0 111.755 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -90.37 152.3 21.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.261 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' CA ' ' CE2' ' A' ' 91' ' ' PHE . . . -65.01 -82.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -108.08 157.97 17.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.405 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 46' ' ' PHE . 44.7 t -138.09 -63.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.964 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 18.0 p90 -29.21 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.804 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 42.23 72.2 0.18 Allowed 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.51 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 166.08 90.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.385 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 50' ' ' THR . 29.4 tp10 63.27 156.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 51' ' ' LEU . 3.6 t 47.31 -177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.455 0.645 . . . . 0.0 111.779 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -161.87 22.31 0.11 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.202 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.61 21.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 51' ' ' LEU . 38.0 m -94.08 92.74 0.78 Allowed Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.642 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.58 171.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 0.0 112.092 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.72 128.72 19.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.641 2.228 . . . . 0.0 111.86 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.07 110.39 17.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.179 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.431 HG23 HD12 ' A' ' 57' ' ' ILE . 15.0 mt -56.42 116.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.009 0.433 . . . . 0.0 111.183 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -101.07 -6.84 23.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 60.4 t80 -178.16 131.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.482 HG22 HD11 ' A' ' 60' ' ' ILE . 2.4 mt -108.29 176.31 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -109.56 154.84 22.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.524 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -85.47 50.15 1.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.36 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 16.1 t0 178.07 36.84 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.586 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -133.61 132.12 21.62 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.75 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -10.57 12.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.537 2.158 . . . . 0.0 112.65 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.453 ' CB ' ' CD1' ' A' ' 39' ' ' ILE . . . -70.6 -52.89 18.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.05 0.453 . . . . 0.0 110.393 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -72.45 -29.18 63.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.205 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.427 ' NH1' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -94.21 -2.28 52.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.701 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 p -46.0 -31.52 2.3 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.74 0.305 . . . . 0.0 111.416 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.66 30.02 9.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.852 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.3 p -179.6 39.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.8 mt -131.35 174.07 10.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -156.04 163.37 39.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.705 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mm -68.65 70.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.39 79.65 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.756 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.45 111.83 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.718 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.31 135.21 53.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.097 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.3 t -104.46 120.61 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.0 tpt -87.59 -29.68 21.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -162.97 141.81 8.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.4 mt -113.52 109.42 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.628 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 p30 46.93 27.8 0.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.86 6.5 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.734 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mm -69.19 111.19 7.79 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 120.602 0.239 . . . . 0.0 111.512 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.73 148.62 59.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.49 -24.6 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -73.79 -6.95 50.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.587 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.18 46.4 2.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.889 0.376 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m 177.94 -179.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 m -79.46 158.65 27.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.822 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CE2' ' CA ' ' A' ' 43' ' ' GLY . 12.0 p90 -73.08 -29.45 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.08 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.3 mt-10 -54.56 -34.13 61.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.331 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 94' ' ' ALA . 14.6 pt-20 -61.47 -47.35 86.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.279 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 93' ' ' GLU . . . -57.88 -38.45 75.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.375 0.607 . . . . 0.0 110.097 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -58.86 -42.87 90.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.377 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 3.5 mm100 -63.0 -47.3 83.69 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.722 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.47 -39.72 61.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.056 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.422 HD12 ' CD1' ' A' ' 41' ' ' LEU . 1.2 mt -74.1 -42.56 59.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.738 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -50.55 -34.97 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.266 0.555 . . . . 0.0 109.669 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -121.07 38.93 3.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.168 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -86.58 10.39 15.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.644 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -109.14 16.35 22.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.772 0.32 . . . . 0.0 111.757 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.9 mt -71.47 -49.99 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.817 0.818 . . . . 0.0 110.399 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 6.96 47.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.717 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 30' ' ' THR . 31.0 t 56.26 22.71 6.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.76 156.76 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.551 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' A' ' 101' ' ' SER . 33.3 t -156.91 125.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.38 131.85 51.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.18 153.33 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 0.0 111.411 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.27 121.91 44.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.165 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.5 pt -112.5 145.49 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 111.848 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -111.36 140.29 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.116 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.449 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -153.61 174.34 14.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.89 116.19 32.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.353 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 19.2 m -61.61 145.21 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 168' ' ' THR . . . 79.57 119.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.42 19.62 0.55 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.325 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER 176.91 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.861 0.362 . . . . 0.0 111.338 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -158.16 131.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.559 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -113.53 94.41 31.99 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.8 Cg_endo -85.69 150.02 9.96 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.8 2.333 . . . . 0.0 112.769 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.27 23.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.212 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.31 116.98 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.57 -45.85 1.99 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.9 102.79 5.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 110.647 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -110.06 115.21 29.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.031 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.559 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -96.66 150.14 21.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.93 0.395 . . . . 0.0 110.791 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.3 t -124.59 95.48 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.0 mttt -81.76 98.15 8.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.21 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.12 130.65 22.51 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.69 119.3 6.13 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.511 2.141 . . . . 0.0 111.454 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.423 ' HG3' ' CG2' ' A' ' 204' ' ' VAL . 0.1 OUTLIER -108.31 158.61 17.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.169 0.509 . . . . 0.0 111.536 -179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -108.89 -164.84 0.97 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.323 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.39 -47.45 86.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.06 77.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.699 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.7 t -112.75 160.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.95 117.17 3.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.31 -61.07 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.551 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . 94.43 30.29 8.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.153 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.436 HD11 HG22 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -105.07 143.51 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.748 0.274 . . . . 0.0 110.866 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 86.6 m -126.09 136.76 53.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.796 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 mt -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.65 153.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.2 t -105.12 136.96 19.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.345 0.36 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.406 ' N ' ' CD ' ' A' ' 153' ' ' PRO . 55.2 t0 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 152' ' ' ASP . 61.4 Cg_endo -73.31 -179.26 4.24 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.52 167.4 10.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.695 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 p -155.83 136.07 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.44 151.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.663 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.85 -12.55 7.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.31 143.77 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.902 0.382 . . . . 0.0 111.204 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -131.0 149.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.433 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -98.36 146.96 25.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 111.132 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 173.16 10.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.995 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.68 -62.78 1.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 5.7 p -61.78 144.06 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 0.0 111.129 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.0 m -48.78 -21.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.144 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -48.04 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.312 . . . . 0.0 111.437 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.408 ' N ' ' CG2' ' A' ' 159' ' ' ILE . 36.3 t60 -76.15 -24.26 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.736 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.76 -45.72 74.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 116' ' ' ALA . 5.3 t -61.48 88.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -50.97 88.27 0.01 OUTLIER Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.742 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 168' ' ' THR . 0.3 OUTLIER 164.79 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 110.328 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.2 tt -84.21 57.11 4.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.96 162.82 17.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.52 54.66 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.133 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.28 25.72 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.465 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.3 OUTLIER -124.78 -176.79 3.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 110.558 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 209' ' ' ARG . 1.0 OUTLIER -134.6 130.14 36.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 111.368 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.33 152.26 33.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.0 pp -137.44 10.46 2.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.632 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -152.89 144.95 23.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 31.3 mm -139.27 111.67 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 35.6 t70 51.59 52.64 14.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 31.1 t30 84.72 -34.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 45.1 mm -68.64 159.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.752 0.31 . . . . 0.0 110.783 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.424 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 67.3 mtm180 -133.86 129.76 36.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.192 0.52 . . . . 0.0 112.299 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.08 -5.27 43.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.623 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -45.93 -29.55 1.45 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 m -123.26 30.28 6.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.42 165.11 36.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.998 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.14 -169.89 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 12.9 ptm -70.34 -42.01 72.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -53.9 -34.93 60.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.052 0.453 . . . . 0.0 111.006 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.07 -48.23 82.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.222 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -58.51 -39.11 79.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 13.5 t -63.0 -33.37 60.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.097 0.475 . . . . 0.0 109.998 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -49.65 70.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.848 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.71 -24.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.167 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -61.25 -40.67 94.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 110.216 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -89.7 -41.26 12.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.112 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.58 -18.63 60.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.752 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 4.1 m -81.74 44.95 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.235 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 1.1 pt-20 -74.53 61.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.187 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.8 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.82 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 12.4 tp -176.67 104.37 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.252 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.423 ' CG2' ' HG3' ' A' ' 132' ' ' LYS . 59.1 t -98.32 108.56 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.147 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -100.21 108.19 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.36 108.2 20.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.455 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.41 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 28.8 tttt -83.11 93.43 7.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 9.5 mm -88.99 164.13 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.352 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -126.54 127.8 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.838 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.02 123.14 39.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.111 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.786 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -115.79 111.02 19.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.996 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -55.44 139.53 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.89 173.18 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.68 150.54 41.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.715 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.427 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 8.8 t -142.87 163.48 32.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -102.5 161.14 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.636 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -145.95 147.73 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.26 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -107.51 123.23 48.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.449 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -111.16 161.86 15.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.169 0.509 . . . . 0.0 111.821 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.481 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -104.42 116.13 31.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.19 154.88 67.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.56 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.2 6.57 4.6 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.497 2.131 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.39 -49.82 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.489 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.8 p -137.2 -2.73 2.02 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -110.34 3.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.349 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 6.6 m-85 -106.05 129.24 54.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.906 0.384 . . . . 0.0 110.064 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.47 24.93 20.59 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.884 -0.674 . . . . 0.0 114.473 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 1.1 pp -122.67 128.54 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.578 0.689 . . . . 0.0 111.503 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -111.26 127.4 55.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.235 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.73 154.06 17.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.105 0.478 . . . . 0.0 111.715 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.58 168.85 8.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.494 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . -68.41 -117.68 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.801 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -108.57 132.46 53.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 46' ' ' PHE . 2.8 t -89.79 -70.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.871 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 13.4 p90 -25.3 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.854 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.75 72.28 0.16 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.562 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.409 ' O ' ' CB ' ' A' ' 49' ' ' GLU . 1.7 t 174.12 40.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' THR . 2.7 mt-10 164.71 -169.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.405 ' OG1' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.86 -94.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -152.98 -82.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.365 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.69 16.43 0.99 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.483 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -145.12 74.41 14.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.402 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 49.6 Cg_exo -55.47 -175.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 54' ' ' PRO . 87.4 Cg_exo -46.8 125.23 9.47 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.47 2.113 . . . . 0.0 112.069 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mp -115.36 113.44 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.62 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 56.7 mt -58.17 121.92 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.449 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.2 t -124.81 25.88 7.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 60' ' ' ILE . 25.8 t80 -173.52 138.9 0.71 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.053 0.454 . . . . 0.0 111.662 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.588 ' CD1' ' CG2' ' A' ' 39' ' ' ILE . 30.8 mm -112.21 160.3 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.538 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -112.52 155.79 23.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -100.29 55.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER 166.89 41.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.091 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 m -141.2 144.34 34.2 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.8 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.8 -0.11 6.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.633 2.222 . . . . 0.0 112.819 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.12 -56.92 7.08 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.341 0.591 . . . . 0.0 110.301 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.575 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 7.2 pm0 -80.12 -29.6 38.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.023 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.575 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -70.66 -27.31 63.93 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.018 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 53.6 t -49.46 -43.23 44.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 137' ' ' GLU . . . 106.16 20.88 8.85 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.728 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 t -153.66 41.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.44 157.26 35.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.02 158.2 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.8 mm -66.98 75.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.304 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 148.83 69.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.02 78.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.528 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -55.21 -40.89 71.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.6 t 65.08 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.263 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -27.98 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -155.78 137.33 14.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.1 mt -114.23 106.96 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.6 m120 58.79 20.77 8.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.169 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.46 -34.27 4.61 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.571 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.0 mt -67.73 127.42 93.37 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.497 0.189 . . . . 0.0 110.995 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.36 -179.28 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.456 2.104 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.8 p -147.45 -45.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.91 -13.11 61.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -118.93 46.55 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.4 p -171.92 -177.5 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 54.1 m -81.21 141.5 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.794 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.421 ' CE1' ' HA2' ' A' ' 43' ' ' GLY . 6.6 p90 -61.74 -37.25 83.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.8 tt0 -55.23 -36.02 65.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.264 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.51 -52.34 64.89 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.85 -33.58 61.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.412 0.625 . . . . 0.0 110.217 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.431 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -63.74 -40.3 96.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.978 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 18.0 mm-40 -61.59 -44.17 97.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.229 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.0 mt -56.29 -43.66 79.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.415 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.592 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 0.4 OUTLIER -70.41 -51.2 31.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.812 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -50.28 -30.53 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.138 0.494 . . . . 0.0 109.801 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.7 t0 -121.71 38.22 4.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.362 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.592 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.75 25.54 6.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.323 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.3 p -119.16 13.09 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.9 mt -68.12 -46.4 81.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 110.565 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -1.55 54.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.573 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.86 26.56 15.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -169.35 153.82 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 101' ' ' SER . 60.1 t -153.59 150.9 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.04 135.12 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.337 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.2 mt -136.81 149.21 47.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 111.628 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.72 105.9 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.981 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 111' ' ' ILE . 30.2 pt -103.47 154.52 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.15 0.5 . . . . 0.0 112.165 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -126.38 138.42 53.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.208 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -158.99 173.58 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 111.327 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.34 106.14 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.252 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 18.5 m -61.92 103.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.823 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 115' ' ' VAL . . . 153.0 129.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.022 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -161.96 22.54 0.11 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.253 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 129' ' ' LYS . 0.3 OUTLIER 169.48 93.75 0.0 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.033 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.2 t -139.6 118.8 12.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.869 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.557 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.1 pp -137.26 78.19 40.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 121.692 0.758 . . . . 0.0 110.691 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 70.7 Cg_endo -94.65 176.74 1.02 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.229 2.619 . . . . 0.0 112.878 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -172.96 33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.895 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.73 117.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 89.25 -44.4 3.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.032 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.7 103.94 8.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.752 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -110.62 124.46 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.504 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.557 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -118.08 144.6 45.49 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.687 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 205' ' ' LYS . 2.9 t -130.27 111.1 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.506 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' SER . 11.1 mttp -80.72 101.31 9.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -107.32 113.71 61.75 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.515 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.6 115.53 3.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.297 1.998 . . . . 0.0 111.352 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.37 158.75 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.73 -164.62 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.776 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -57.65 -48.39 79.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.71 50.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 111.277 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.63 144.13 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.402 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 40.6 tt0 -52.42 124.72 14.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mp -90.57 -66.88 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 113.69 -2.22 24.66 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.05 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.516 HG21 HD12 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -95.78 135.58 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.342 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.454 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 11.0 m -126.1 136.04 52.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.504 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.3 mt -105.35 164.12 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.63 151.61 29.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.691 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.6 p -118.78 107.47 42.38 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.05 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo . . . . . 0 C--N 1.346 0.414 0 C-N-CA 122.474 2.116 . . . . 0.0 112.106 179.85 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.8 t70 . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.04 -178.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.435 2.09 . . . . 0.0 112.359 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.8 mt -113.78 178.9 4.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.2 m -157.27 175.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.234 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mm -79.25 154.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -130.8 -10.22 3.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.651 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.454 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 170.62 156.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 4.2 mt -142.49 139.34 29.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.765 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.26 145.47 41.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.933 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -85.78 168.61 14.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.582 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.425 ' N ' ' NH1' ' A' ' 167' ' ' ARG . . . 84.95 -52.73 4.74 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.504 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 34.2 m -81.14 153.69 27.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 168' ' ' THR . 18.3 m -48.72 -21.8 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 168' ' ' THR . . . -46.88 -66.52 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.886 0.374 . . . . 0.0 111.655 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.428 ' HB3' HH22 ' A' ' 167' ' ' ARG . 0.8 OUTLIER -83.36 -24.24 32.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.4 -29.84 50.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.4 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 165' ' ' ALA . 22.3 p -45.25 -42.2 9.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.788 0.328 . . . . 0.0 111.393 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.83 -26.48 18.33 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.769 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.444 HG22 ' CE1' ' A' ' 126' ' ' PHE . 3.7 t -109.6 31.84 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.17 113.62 22.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -142.13 156.81 45.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.9 mt -75.4 113.7 13.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.23 -17.2 2.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.779 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.34 166.04 21.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.73 0.3 . . . . 0.0 110.794 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.28 114.25 24.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.019 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.72 142.55 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.691 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.27 -55.22 1.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -143.49 176.07 9.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.081 0.467 . . . . 0.0 111.592 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 182' ' ' ASN . 25.3 mt -139.26 107.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.93 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.437 ' CA ' ' HB3' ' A' ' 205' ' ' LYS . 0.1 OUTLIER 48.38 -85.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 180' ' ' ILE . 3.6 m-20 -108.07 -20.33 13.2 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 24.9 mm -100.08 140.95 18.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 111.512 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.86 120.66 42.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.06 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.81 -5.21 58.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.375 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.67 -32.07 1.37 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.367 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 -16.78 9.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.579 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.6 m -85.24 -169.78 2.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 0.0 111.22 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.33 -173.36 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.05 -52.01 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.01 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -51.8 -30.71 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 111.102 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -51.53 67.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.058 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 197' ' ' LEU . . . -56.21 -39.41 72.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.239 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 19.1 t -61.01 -36.81 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.212 0.529 . . . . 0.0 109.902 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -49.86 76.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.843 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.51 -24.13 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.027 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -59.46 -36.17 75.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -100.11 -37.65 8.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.65 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.52 -19.57 49.17 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . 0.404 ' CB ' HG12 ' A' ' 204' ' ' VAL . 1.1 m -84.4 43.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.41 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -68.56 62.87 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.283 0.563 . . . . 0.0 111.076 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -174.98 -32.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.056 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.4 tt 178.06 108.91 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.272 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.404 HG12 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.06 115.24 48.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.215 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.437 ' HB3' ' CA ' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -96.32 107.9 20.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 127' ' ' HIS . 11.1 mp -81.91 113.58 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.458 ' CG ' ' CD2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -99.75 94.39 6.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.788 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.16 170.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.989 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -112.82 131.6 55.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.919 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 115.37 29.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.824 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 115' ' ' VAL . 69.0 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -136.3 108.48 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.658 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 p -49.28 143.16 6.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 173.03 12.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -133.06 159.12 40.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 t -150.54 -169.96 3.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.01 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -121.65 161.0 23.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.409 HG12 ' HG ' ' A' ' 109' ' ' LEU . 1.7 p -136.65 151.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.392 0.615 . . . . 0.0 110.924 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.9 109.79 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CD2' HD12 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -104.36 118.34 36.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.0 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -113.51 161.74 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.34 0.59 . . . . 0.0 112.195 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.501 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -107.0 109.75 21.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.455 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 8.4 p-10 -83.68 157.23 64.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.412 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.08 7.92 2.29 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.459 2.106 . . . . 0.0 112.98 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.64 -47.29 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.634 0.255 . . . . 0.0 111.247 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.3 p -144.58 6.53 1.25 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 61.71 -86.62 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.219 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 7.9 m-85 -128.06 113.98 16.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.51 19.51 47.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.523 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.464 HG23 ' HA ' ' A' ' 60' ' ' ILE . 16.2 pt -123.89 134.47 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.905 0.353 . . . . 0.0 110.69 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.402 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 3.2 pt20 -120.74 142.76 49.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.81 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 1.4 pt? -129.41 154.65 46.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.276 0.56 . . . . 0.0 111.921 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.19 8.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.339 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.23 -58.13 0.7 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.289 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -69.53 150.39 47.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.851 0.358 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.443 ' CG2' ' CD2' ' A' ' 56' ' ' LEU . 86.4 t -142.02 -88.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.955 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 52.9 p90 -56.78 -46.17 81.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.22 0.533 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.562 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 47.35 82.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.702 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 60.3 p -159.95 98.18 1.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.134 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 48' ' ' THR . 4.7 pt-20 52.37 35.36 17.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.525 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER 165.78 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.773 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -160.67 23.78 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.789 0.328 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.12 21.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -72.28 138.18 81.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.795 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.16 156.91 33.79 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.457 2.105 . . . . 0.0 112.39 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.429 ' HG2' ' HB ' ' A' ' 78' ' ' VAL . 1.8 Cg_endo -42.71 159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.003 2.469 . . . . 0.0 112.242 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.443 ' CD2' ' CG2' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -160.62 108.88 1.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.548 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 61.5 mt -59.88 135.78 24.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -125.25 17.24 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 40' ' ' GLN . 37.6 t80 -177.68 141.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.464 ' HA ' HG23 ' A' ' 39' ' ' ILE . 12.1 mm -131.01 148.43 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.077 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -95.55 151.84 18.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.943 0.401 . . . . 0.0 111.232 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.39 45.34 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.39 42.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.486 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.24 135.25 23.76 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.779 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.81 -11.46 3.51 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.787 2.325 . . . . 0.0 113.147 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.23 -57.54 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.815 0.34 . . . . 0.0 110.542 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' CB ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.41 -31.83 42.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.977 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -61.32 -30.93 70.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.673 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.63 -31.29 64.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.776 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.36 34.19 12.67 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.676 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.1 t -151.41 28.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.652 0.263 . . . . 0.0 111.411 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.4 HD12 ' CD2' ' A' ' 29' ' ' LEU . 16.8 mt -140.42 148.89 41.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 175.92 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 mm -69.26 68.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.18 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.39 59.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.678 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.76 120.88 30.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.72 104.55 17.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HB ' ' HG2' ' A' ' 55' ' ' PRO . 17.2 t -94.08 158.65 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.051 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.74 -40.45 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.46 149.14 37.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.159 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.402 ' CG2' HD12 ' A' ' 97' ' ' LEU . 17.6 mt -132.71 120.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.68 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 m120 54.53 24.23 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.913 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.97 -18.48 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.636 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.14 137.02 56.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.42 -178.7 3.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.369 2.046 . . . . 0.0 112.254 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.6 p -157.26 -44.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -11.15 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.391 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -117.09 46.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.763 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 t -176.9 -176.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.38 151.24 45.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -70.17 -30.94 68.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -55.83 -31.56 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.69 -58.62 7.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -54.82 -28.68 51.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.806 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.22 -43.11 34.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -70.61 -36.13 73.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.807 0.336 . . . . 0.0 111.198 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 101' ' ' SER . 1.1 pp -70.09 -46.1 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.326 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.29 -57.39 9.56 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.264 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -50.75 -29.68 12.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 5.8 t70 -114.37 35.5 4.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.536 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 84.4 p -108.78 15.21 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.134 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.8 p -100.64 15.08 29.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 111.855 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.468 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.7 mt -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 5.77 44.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.656 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.1 p 59.2 26.76 15.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.009 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -171.12 148.85 2.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.907 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.52 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.5 t -149.68 131.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.31 130.59 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.697 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.409 ' HG ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -140.32 164.96 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 111.342 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -114.43 145.55 41.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.402 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.6 pt -137.46 159.94 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.959 0.409 . . . . 0.0 111.78 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -123.69 146.42 48.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.318 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -161.05 174.28 13.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.425 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.13 131.23 44.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 27.2 m -85.53 145.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.728 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 82.88 113.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.774 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -153.79 24.32 0.51 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.872 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.35 85.43 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.649 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.462 ' CG1' ' CE1' ' A' ' 126' ' ' PHE . 34.7 t -142.27 131.63 22.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.028 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.633 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -134.23 86.03 37.35 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-O 121.646 0.736 . . . . 0.0 109.894 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 60.6 Cg_endo -95.81 175.19 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.268 2.645 . . . . 0.0 113.424 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -163.25 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.463 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 169.78 113.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.2 -30.75 6.48 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.354 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.417 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -134.5 102.67 5.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.999 0.428 . . . . 0.0 110.612 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 1.9 t80 -104.45 127.56 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.633 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.6 OUTLIER -118.44 141.06 48.93 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.624 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.48 ' CG2' ' HB2' ' A' ' 206' ' ' LEU . 4.8 m -129.38 104.37 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -80.56 104.48 11.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.767 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mp -113.84 139.08 23.08 Favored Pre-proline 0 C--N 1.333 -0.126 0 CA-C-O 120.588 0.233 . . . . 0.0 111.488 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.11 108.91 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.446 2.097 . . . . 0.0 111.798 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -81.97 158.64 23.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.41 ' HE2' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -127.2 -166.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.265 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.8 -76.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.215 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.9 m -152.99 74.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.198 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.8 t -127.84 151.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.796 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -53.04 96.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.045 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.07 -38.31 67.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.19 -44.38 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.1 pt -81.84 146.41 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.857 0.361 . . . . 0.0 111.322 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.3 m -126.18 118.95 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.738 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 154' ' ' LEU . 1.4 mp -80.58 164.06 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.8 t -167.68 166.94 13.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -116.77 137.11 23.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo . . . . . 0 C--N 1.347 0.473 0 C-N-CA 122.421 2.08 . . . . 0.0 112.128 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.433 ' N ' ' CD ' ' A' ' 153' ' ' PRO . 21.5 t70 . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.731 0.301 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 152' ' ' ASP . 86.1 Cg_endo -80.24 -175.16 2.56 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.563 2.175 . . . . 0.0 112.422 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 142' ' ' ILE . 1.8 mm? -104.83 145.61 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.8 m -142.19 178.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 111.329 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.3 mm -93.23 154.83 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.58 -26.82 2.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.76 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -176.49 162.11 2.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.199 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 1.6 mt -140.53 149.08 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.756 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.0 146.23 45.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -83.35 164.93 19.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.33 -19.21 19.58 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.065 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.477 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.2 m -107.05 146.53 31.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.964 0.411 . . . . 0.0 110.997 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.8 m -48.85 -22.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.935 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -52.91 -71.17 0.07 Allowed 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.955 0.407 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 29.0 t60 -71.29 -24.8 62.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.14 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -56.88 -30.99 64.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.995 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.5 p -45.1 -42.71 9.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.253 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.71 -43.61 2.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.428 HG21 ' CZ ' ' A' ' 126' ' ' PHE . 5.6 t -96.9 34.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.9 tt -117.34 99.91 7.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -109.36 -179.98 3.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.0 mt -107.84 148.66 29.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.806 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.53 -11.17 39.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.814 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.431 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 3.1 t0 -78.48 175.68 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.641 0.258 . . . . 0.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -117.25 151.53 36.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.326 . . . . 0.0 111.132 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.71 170.8 7.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.063 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.07 -44.89 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -150.2 169.33 21.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 16.3 mt -139.62 114.38 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 18.3 t0 59.28 -83.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.375 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -128.69 -14.95 4.51 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 20.2 mm -102.32 133.58 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 9.6 mtm105 -100.13 114.47 27.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.597 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 187' ' ' SER . 2.9 mm? -72.32 -17.07 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.411 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.56 -81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 185' ' ' LEU . 8.2 m -153.28 24.44 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.837 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -171.05 0.65 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.071 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.7 14.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' MET . . . . . 0.414 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 14.8 ptm -74.23 -42.64 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.0 mt-10 -53.7 -31.89 49.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -48.13 80.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.195 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.73 82.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.476 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.461 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 8.6 t -63.79 -34.42 67.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 109.749 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.408 ' O ' ' HG3' ' A' ' 199' ' ' GLN . 0.9 OUTLIER -61.44 -50.29 73.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.966 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.5 ' HA ' ' HG3' ' A' ' 199' ' ' GLN . 2.6 mp -70.08 -24.78 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.172 0.51 . . . . 0.0 109.764 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -64.23 -33.92 76.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.721 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -87.75 -39.78 14.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.515 ' C ' ' H ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -86.48 13.26 8.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.833 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.29 33.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.7 pt-20 32.53 68.17 0.15 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.78 24.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.451 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 mt -153.96 93.66 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.135 0.493 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 204' ' ' VAL . 13.8 p -97.11 108.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.714 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 24.1 ttmt -104.54 107.06 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.48 ' HB2' ' CG2' ' A' ' 128' ' ' VAL . 3.4 mt -83.4 114.16 21.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.523 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 12.0 tttt -97.16 93.26 6.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.356 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 0.7 OUTLIER -84.95 168.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.826 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 10.2 ttp180 -118.98 123.42 44.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.34 159.49 15.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.554 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.823 0.344 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 51.6 p-80 -106.04 110.77 23.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -55.94 152.17 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 170.44 12.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.764 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.68 137.13 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.432 HG22 ' CZ ' ' A' ' 113' ' ' PHE . 2.2 t -139.3 176.88 8.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -106.76 162.93 13.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.33 150.41 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.634 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.53 109.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 111.411 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 3.9 mm? -106.63 121.72 44.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.798 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -110.67 162.18 15.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.63 . . . . 0.0 112.406 -178.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -109.34 103.73 12.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.168 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.4 148.32 55.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.41 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.88 1.96 7.1 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.596 2.198 . . . . 0.0 112.674 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.55 -48.45 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.371 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t -125.51 -11.24 6.82 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.02 -87.88 0.57 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.406 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.475 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 27.7 m-85 -130.94 117.94 19.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.0 110.285 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.502 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -70.34 -3.69 47.78 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.517 ' C ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -105.61 167.6 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.958 0.879 . . . . 0.0 112.189 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 4.8 mt-30 -138.61 122.28 17.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.097 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' CD2' ' CB ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -96.34 143.3 27.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 112.061 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.409 ' CG ' ' CD1' ' A' ' 56' ' ' LEU . 6.0 pt20 -105.19 166.09 10.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.559 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -122.41 107.28 1.13 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.299 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 57.24 112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 111.398 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.62 -75.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.485 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.509 ' CD2' ' N ' ' A' ' 47' ' ' ALA . 36.1 p90 -49.97 -48.07 52.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.036 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 41.58 80.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.66 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t 170.11 114.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.565 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 50' ' ' THR . 1.9 tt0 61.32 86.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 1.3 m 90.56 -179.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.4 pp -167.01 30.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.165 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -64.45 30.73 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -112.75 86.8 9.13 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.601 0.238 . . . . 0.0 110.578 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.29 176.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.486 2.124 . . . . 0.0 112.133 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.422 ' CB ' ' CD2' ' A' ' 41' ' ' LEU . 52.2 Cg_exo -53.16 137.9 63.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.412 2.075 . . . . 0.0 111.838 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' CD1' ' CG ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -137.67 113.76 9.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.489 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 81.8 mt -62.21 138.68 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 110.801 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -119.82 -24.04 6.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.502 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 72.4 t80 -136.83 159.09 42.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.664 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 9.4 mm -138.33 164.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.47 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.0 tp10 -119.87 147.13 45.07 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.866 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.95 42.72 1.11 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.187 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.15 36.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.068 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.502 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -137.17 138.13 24.57 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.081 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.71 -15.83 13.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.038 2.492 . . . . 0.0 113.643 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.9 -44.09 56.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.664 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.6 tp10 -76.06 -29.22 57.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.719 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.538 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.41 -14.83 39.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.307 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.7 t -47.25 -40.84 17.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.941 0.4 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.406 ' HA2' ' CG1' ' A' ' 136' ' ' VAL . . . 105.3 11.44 29.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.439 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -153.85 53.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 111.637 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.4 mt -141.3 134.83 29.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -141.08 174.44 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.5 mm -73.11 78.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.28 43.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.26 83.31 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.783 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 101.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.77 115.4 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -97.14 24.52 6.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.33 131.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.1 mt -131.23 115.71 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 56.39 23.31 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.8 -26.3 24.53 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.536 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mt -74.26 136.67 75.44 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-O 120.565 0.222 . . . . 0.0 111.229 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.2 171.35 15.11 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.384 2.056 . . . . 0.0 112.162 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 p -139.42 -46.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -71.05 -11.36 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -113.16 45.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.015 0.436 . . . . 0.0 110.794 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -178.09 -170.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.798 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 148.65 32.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.423 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 21.7 p90 -73.52 -31.21 63.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -59.16 -31.78 69.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.24 -58.88 6.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -55.73 -39.9 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.142 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.4 m120 -64.6 -36.99 86.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.322 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.593 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -69.95 -44.07 70.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.354 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.593 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 2.3 pp -62.65 -28.78 70.16 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 39.3 mt -67.62 -46.38 72.66 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 28.8 mtt-85 -50.28 -40.26 47.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.487 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.0 m-20 -115.55 40.93 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.431 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.481 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.19 6.46 47.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.619 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -105.23 18.23 22.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.341 . . . . 0.0 111.82 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.487 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.8 mt -71.41 -51.63 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.814 0.816 . . . . 0.0 110.919 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 7.99 31.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.806 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' THR . 45.4 t 57.1 22.47 7.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.337 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -168.99 159.16 9.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.036 0.446 . . . . 0.0 111.745 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 101' ' ' SER . 39.8 t -157.5 128.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.683 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.87 133.34 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.585 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.63 157.26 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 0.0 111.439 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 118.03 30.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.197 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 pt -112.27 155.37 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.155 0.503 . . . . 0.0 111.813 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.56 117.52 18.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.198 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.432 ' CZ ' HG22 ' A' ' 25' ' ' THR . 6.2 p90 -136.34 174.11 10.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 0.0 111.407 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -91.08 155.33 18.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.559 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 167' ' ' ARG . 27.9 m -108.55 104.96 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.455 . . . . 0.0 111.635 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -172.35 95.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.6 OUTLIER -107.15 20.44 19.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.794 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 86.32 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.219 0.533 . . . . 0.0 111.714 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 126' ' ' PHE . 2.5 m -112.96 140.76 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.115 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 127' ' ' HIS . 2.2 pp -121.53 104.76 39.57 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.771 0.32 . . . . 0.0 111.455 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.487 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 92.7 Cg_endo -86.01 164.28 10.15 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.848 2.365 . . . . 0.0 112.754 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -167.28 22.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.582 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.7 OUTLIER 55.34 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.934 0.397 . . . . 0.0 111.244 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.36 -42.24 2.49 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.877 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.41 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.89 102.59 5.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.512 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 6.1 t80 -104.66 130.58 52.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.525 ' HB2' HG13 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -112.68 144.76 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.454 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.46 89.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.473 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -81.29 106.15 13.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 pp -132.31 134.83 25.43 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 53.8 Cg_endo -69.15 125.63 12.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.407 2.072 . . . . 0.0 111.817 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 158.96 15.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.081 0.467 . . . . 0.0 111.061 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HD2' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -92.9 -175.27 3.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.804 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -40.79 83.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.21 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 171.79 65.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 133' ' ' LYS . 17.2 t -109.76 165.05 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 136' ' ' VAL . 34.9 tt0 -29.19 132.6 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.06 101.29 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.745 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.94 49.24 3.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.342 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 165' ' ' ALA . 32.7 mm -94.64 134.59 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.581 0.229 . . . . 0.0 110.878 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.422 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 29.6 m -126.44 139.93 52.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.893 0.377 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.8 mt -113.24 164.09 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.1 m -160.79 147.56 15.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.9 t -96.08 148.01 33.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 179.945 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.62 0.248 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 164.57 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.445 2.097 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 12.8 mt -114.72 -177.97 3.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.704 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.5 m -161.85 154.0 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.261 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 mt -71.09 147.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.441 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.2 t -128.09 -2.86 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.422 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 172.4 135.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.828 0.347 . . . . 0.0 110.607 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 6.5 mt -137.16 136.66 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.476 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 150.52 26.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.505 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -85.12 66.97 10.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.33 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.255 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.432 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -154.21 139.86 17.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.054 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.41 HG21 ' NZ ' ' A' ' 133' ' ' LYS . 25.4 m -48.79 -24.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.441 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -46.8 -71.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 86.3 t60 -76.67 -25.52 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 111.099 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.505 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -56.47 -29.98 62.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.784 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 9.2 t -62.78 -23.94 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.811 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.43 71.08 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.887 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -172.39 -42.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.953 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.48 100.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -128.3 139.97 52.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.29 102.02 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.22 -18.81 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.97 134.6 44.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.73 103.98 16.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 137.51 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.4 tt -133.43 -40.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -129.78 149.1 51.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.92 0.391 . . . . 0.0 111.387 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 193' ' ' ALA . 27.3 mt -139.23 113.86 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.294 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 24.9 t70 47.65 55.35 8.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.18 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.8 t30 84.9 -35.88 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.428 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 44.1 mm -67.3 159.18 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 110.63 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 10.1 mtp180 -134.74 129.49 34.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 180' ' ' ILE . 3.4 mm? -74.53 -6.23 47.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.574 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -41.33 7.91 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.3 t -115.85 -18.06 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -171.14 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.7 -176.9 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 6.7 ttp -69.12 -57.14 5.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -54.31 -31.1 53.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -48.79 77.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.097 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 180' ' ' ILE . . . -57.02 -39.41 74.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.164 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 21.7 t -60.14 -41.19 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.867 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -50.04 75.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.856 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 193' ' ' ALA . 3.0 mp -69.51 -24.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.7 OUTLIER -57.92 -37.59 74.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.357 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -96.73 -35.67 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.028 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -16.68 61.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 8.5 m -86.04 41.23 0.91 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.339 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.64 62.37 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.238 0.542 . . . . 0.0 111.068 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -174.18 -30.67 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.465 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.6 tt 176.72 109.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.393 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.3 125.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.613 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -108.16 108.32 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.883 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.37 108.2 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.505 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 7.6 tttt -97.37 98.5 10.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.653 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.34 172.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 3.4 mmt180 -108.94 138.82 44.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.451 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HE2' ' CD2' ' A' ' 126' ' ' PHE . 6.4 mptt -119.27 157.25 28.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.971 0.415 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 21' ' ' HIS . 11.1 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.357 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.402 ' N ' HG22 ' A' ' 20' ' ' VAL . 51.3 p-80 -109.38 136.09 49.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -54.68 167.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.409 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -162.96 156.66 20.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -113.25 149.05 34.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.179 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -144.07 165.62 27.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -101.91 158.9 15.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.97 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 28' ' ' VAL . 2.9 p -143.65 151.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.496 0.665 . . . . 0.0 111.612 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.408 ' N ' HG21 ' A' ' 27' ' ' VAL . 44.5 t -128.76 110.82 21.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.102 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 39' ' ' ILE . 5.7 mp -109.77 118.75 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -109.4 161.54 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.271 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.89 112.51 24.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.06 156.0 44.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.609 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.7 7.6 3.06 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.556 2.171 . . . . 0.0 112.953 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 t -107.58 -47.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.8 p -146.35 6.75 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 37' ' ' PHE . . . 66.86 -79.04 0.14 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.501 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 37' ' ' PHE . 4.8 m-85 -132.67 113.76 13.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.187 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.18 -2.55 62.76 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.916 -0.584 . . . . 0.0 114.07 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 72' ' ' LEU . 18.1 mt -92.98 136.32 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 111.944 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 mt-30 -113.84 120.62 41.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.038 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.408 ' CD1' HG12 ' A' ' 57' ' ' ILE . 6.8 mp -95.35 136.89 35.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.195 0.521 . . . . 0.0 111.935 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 169.46 8.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.74 64.88 0.35 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.384 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -161.78 63.16 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.126 0.488 . . . . 0.0 111.021 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.76 -70.4 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.671 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.0 p90 -40.85 -43.97 2.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.17 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 54.81 76.24 0.26 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 49' ' ' GLU . 2.7 t 169.88 -164.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.864 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 48' ' ' THR . 16.3 pt-20 -46.81 167.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.603 0.24 . . . . 0.0 110.717 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.417 ' CG2' ' O ' ' A' ' 49' ' ' GLU . 11.0 t 45.53 -159.42 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.194 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -149.18 -85.8 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.342 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.42 14.48 1.15 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.79 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 t -75.59 113.87 30.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 151.48 56.11 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.27 1.98 . . . . 0.0 111.696 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -47.84 111.2 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.341 2.027 . . . . 0.0 112.189 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.12 110.69 16.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 39.4 mt -56.21 124.92 10.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.858 0.361 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -8.25 27.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 45.7 t80 177.61 138.58 0.08 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.005 0.431 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 67' ' ' GLU . 5.0 mt -113.82 169.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.337 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -108.46 151.97 25.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 111.368 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.404 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -91.61 46.59 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.356 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 177.46 44.34 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.892 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.423 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -142.44 142.18 22.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.998 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.79 -13.06 24.48 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.655 2.237 . . . . 0.0 112.889 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.77 -56.75 11.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 110.255 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.421 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -79.08 -29.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.896 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -69.42 -20.22 63.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.238 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.0 t -47.3 -29.31 2.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.22 58.24 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' CG1' ' HA2' ' A' ' 162' ' ' GLY . 4.0 t -152.63 37.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' CD1' HD12 ' A' ' 39' ' ' ILE . 10.7 mt -142.15 172.53 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 111.624 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.22 150.15 10.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.441 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.5 98.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.922 0.392 . . . . 0.0 111.337 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.62 40.8 4.05 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.248 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.17 -14.21 59.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.631 0.253 . . . . 0.0 111.399 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 63.09 136.05 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 t -114.07 152.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.212 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -114.25 -34.12 5.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.7 142.86 26.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.2 mt -128.39 111.13 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 54.24 25.11 5.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.13 -21.89 36.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.567 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 84' ' ' ILE . 44.2 mt -75.32 128.84 83.68 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-O 120.531 0.205 . . . . 0.0 111.142 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -57.65 -160.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.456 2.104 . . . . 0.0 112.212 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 p -158.22 -49.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -7.25 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.42 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -112.22 45.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 t -178.31 175.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.04 144.32 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -51.61 -27.35 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.155 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.79 -35.07 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.28 -37.41 87.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.786 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -69.24 -35.83 76.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.255 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.95 -42.71 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.963 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -69.1 -42.37 76.21 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.164 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.488 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 4.0 pp -64.8 -32.37 74.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 4.2 mt -63.09 -57.42 10.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.737 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -52.33 -30.41 28.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 68.6 m-20 -115.67 36.62 3.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.927 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -105.36 15.06 27.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.326 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.32 18.73 18.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.1 mt -63.73 -46.55 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.689 0.757 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.92 0.13 57.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.502 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m 63.26 26.27 15.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.495 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -166.16 146.03 6.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.78 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.495 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.2 t -149.02 111.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.624 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.12 133.67 36.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.25 165.27 27.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 111.222 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.18 136.98 52.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.393 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.6 pt -128.85 166.07 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.677 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -128.48 142.77 50.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.729 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.451 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -161.2 174.72 13.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.922 0.392 . . . . 0.0 111.236 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -88.75 150.49 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 m -101.57 104.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.006 0.431 . . . . 0.0 111.41 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -168.09 130.3 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.616 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' A' ' 118' ' ' SER . 69.7 mm-40 -130.2 6.56 4.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.01 71.21 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.34 0.59 . . . . 0.0 111.247 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.456 ' HB ' ' CZ ' ' A' ' 126' ' ' PHE . 3.1 m -97.69 147.45 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.718 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.427 HD12 ' CG ' ' A' ' 127' ' ' HIS . 2.1 pp -122.92 102.31 38.09 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.889 0.376 . . . . 0.0 111.473 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.3 Cg_endo -87.71 154.81 7.52 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.96 2.44 . . . . 0.0 112.605 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -162.61 24.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.429 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 118.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.859 0.361 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.61 -45.95 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.088 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.5 102.43 6.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.643 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.456 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 8.4 t80 -107.14 115.93 31.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' A' ' 207' ' ' LYS . 0.5 OUTLIER -99.72 144.96 28.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.145 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.3 97.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.978 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -81.29 99.01 8.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.072 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.43 ' CD2' ' CG2' ' A' ' 168' ' ' THR . 3.0 mp -109.82 114.73 56.24 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.415 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.94 110.39 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.164 1.91 . . . . 0.0 111.307 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -89.7 158.65 17.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.611 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -122.85 178.23 5.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.629 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.665 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 34.4 t-80 -41.77 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.715 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.0 m -138.63 97.37 3.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.883 0.373 . . . . 0.0 111.63 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.484 ' CG2' ' HD2' ' A' ' 133' ' ' LYS . 2.2 t -143.21 141.46 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.49 141.98 58.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 tp -95.88 -41.94 8.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.424 ' HA3' ' HG3' ' A' ' 160' ' ' LYS . . . 94.0 13.84 53.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.267 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.17 139.38 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.421 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 41.0 m -111.86 142.18 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.6 mt -103.35 164.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.033 0.444 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.18 158.64 30.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.724 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.8 p -129.33 106.38 17.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.527 2.151 . . . . 0.0 112.381 179.889 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.717 0.294 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.17 172.04 15.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.573 2.182 . . . . 0.0 112.404 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -123.92 141.85 51.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 176' ' ' LYS . 34.9 m -156.38 148.69 11.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.0 152.19 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.17 -6.94 3.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.73 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 179.68 147.82 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.0 111.448 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.437 HG21 ' CG ' ' A' ' 166' ' ' HIS . 17.1 mt -139.13 149.79 23.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.465 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -138.7 144.26 39.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.373 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.52 72.58 5.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.584 ' N ' ' HD3' ' A' ' 160' ' ' LYS . . . -134.08 -44.37 0.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.194 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.14 176.61 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.248 0.547 . . . . 0.0 111.424 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.0 m -53.69 -21.52 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.384 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -42.69 -69.72 0.13 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.437 ' CG ' HG21 ' A' ' 159' ' ' ILE . 5.4 t60 -68.07 -27.25 66.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -29.42 67.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.27 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.43 ' CG2' ' CD2' ' A' ' 130' ' ' LEU . 70.5 p -45.83 -29.83 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.53 58.61 8.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 t -178.83 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.67 93.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.019 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.71 146.9 27.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 35.4 mt -69.05 84.3 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.47 43.2 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.585 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.58 145.01 46.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 0.0 110.457 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.409 ' HA ' HG12 ' A' ' 155' ' ' VAL . 10.2 mmtp -97.15 115.71 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 111.151 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.87 135.04 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.75 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.97 -27.13 6.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -148.13 162.23 39.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.943 0.401 . . . . 0.0 111.551 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.3 mm -139.44 110.22 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.968 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 21.2 t70 63.52 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.157 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -128.29 -22.6 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 43.3 mm -87.83 157.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.801 0.334 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 9.1 mtt180 -126.31 129.75 49.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.076 0.465 . . . . 0.0 112.051 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.98 -6.36 41.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.727 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -45.51 -42.18 10.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.6 p -116.16 -19.67 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.211 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.78 -176.01 5.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.34 -175.67 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 11.9 ttp -63.05 -55.18 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.56 -29.87 18.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.771 ' O ' ' NE2' ' A' ' 195' ' ' GLN . 1.1 m-20 -64.32 -54.09 38.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.749 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.532 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -52.06 -32.57 35.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.899 0.38 . . . . 0.0 110.206 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.0 t -64.77 -47.81 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.819 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.771 ' NE2' ' O ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -70.77 -32.35 69.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.208 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 193' ' ' ALA . 2.5 mt -75.77 -26.21 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 193' ' ' ALA . 0.1 OUTLIER -63.93 -40.56 96.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.287 179.033 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -86.64 -42.66 13.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.224 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -18.56 48.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.497 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.25 42.23 0.98 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.374 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.98 62.42 0.87 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.247 0.546 . . . . 0.0 111.147 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -171.3 -33.01 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.058 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.0 tt 177.89 106.93 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.308 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.3 121.77 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.349 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 0.6 OUTLIER -100.81 107.71 19.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.935 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 127' ' ' HIS . 3.1 mp -85.81 104.27 15.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.976 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.458 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -89.73 93.79 9.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 172.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.65 133.52 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.72 159.15 33.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.732 0.301 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -92.93 134.17 35.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.092 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.37 174.21 3.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -168.49 162.11 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.711 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 144.97 51.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -139.52 -173.51 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.944 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -103.15 161.14 14.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.01 149.08 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.156 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.58 113.89 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.1 118.92 37.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -110.66 161.81 15.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.22 0.533 . . . . 0.0 111.742 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -103.79 119.93 39.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.104 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 8.8 t0 -88.53 141.96 30.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.338 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.18 3.94 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.48 2.12 . . . . 0.0 113.04 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -101.27 -53.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.767 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 t -141.25 6.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.947 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 67.96 -107.93 2.25 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.162 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.483 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 6.2 m-85 -106.87 128.26 54.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -91.88 25.15 17.7 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.863 -0.684 . . . . 0.0 114.798 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.646 HG22 ' CD1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -126.39 130.93 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.68 0.74 . . . . 0.0 111.826 179.213 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 116.21 29.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.175 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -96.87 145.6 25.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.389 0.614 . . . . 0.0 112.552 -178.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.25 169.59 10.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.818 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.46 -47.59 0.5 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.791 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -47.04 123.92 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.554 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.42 ' CG2' ' CD2' ' A' ' 56' ' ' LEU . 98.8 t -140.2 -83.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.901 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 39.0 p90 -40.5 -45.54 2.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.175 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.511 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 51.94 73.63 0.31 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.264 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 165.33 90.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.401 ' O ' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER 55.17 176.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 t 44.89 -163.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.355 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -147.8 -101.41 0.09 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.193 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.94 18.36 1.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.842 0.353 . . . . 0.0 111.555 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.46 107.85 1.75 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.038 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.441 ' O ' ' CD2' ' A' ' 56' ' ' LEU . 7.7 Cg_exo -72.91 167.4 27.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.653 2.235 . . . . 0.0 111.998 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB3' HD22 ' A' ' 41' ' ' LEU . 24.4 Cg_exo -63.83 128.63 22.51 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.711 2.274 . . . . 0.0 112.132 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.3 pt? -145.84 100.65 3.44 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.811 0.339 . . . . 0.0 111.804 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 46.2 mt -64.62 156.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.519 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -139.15 8.14 2.46 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 52.8 t80 -178.14 134.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 112.081 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.646 ' CD1' HG22 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.89 -173.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 38' ' ' GLY . 29.0 tt0 -125.3 125.61 43.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.967 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -53.01 109.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.963 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER 84.72 46.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.353 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.92 154.28 76.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.89 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 22.4 Cg_exo -63.4 -12.04 28.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.392 2.061 . . . . 0.0 112.261 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' CB ' HG13 ' A' ' 39' ' ' ILE . . . -72.01 -57.1 4.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.514 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 1.1 tp10 -79.08 -29.03 43.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.093 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -89.11 -7.19 56.25 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.582 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -46.88 -46.85 21.37 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.844 0.354 . . . . 0.0 111.204 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.16 -25.45 6.36 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.264 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.39 63.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.437 . . . . 0.0 110.803 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.0 mt -148.28 169.67 19.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.012 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -164.07 162.09 22.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.742 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.7 mm -60.54 85.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.286 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.08 90.94 1.87 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.659 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -112.26 115.63 29.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.735 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 t -72.98 115.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.163 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.5 tpt -83.25 -42.04 17.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.21 28.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.2 mt -131.54 119.64 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.95 23.16 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.94 -22.39 31.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.645 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 84' ' ' ILE . 45.2 mt -70.39 127.77 91.83 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.429 0.157 . . . . 0.0 111.229 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.14 -31.15 65.06 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.44 2.094 . . . . 0.0 112.238 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p 75.74 -54.96 0.62 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.152 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -66.93 -13.79 62.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.09 44.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.78 -175.91 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.787 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 m -68.52 156.58 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -73.1 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.007 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -55.54 -32.78 63.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -36.09 82.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.801 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.16 -34.96 71.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 110.504 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -74.13 -32.15 63.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.651 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.519 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -72.5 -37.27 68.45 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.519 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -70.58 -38.74 74.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.206 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 71.1 mt -73.47 -55.81 5.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.308 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.25 -30.01 16.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.4 OUTLIER -119.01 37.95 3.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.584 178.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -95.87 26.67 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.004 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -119.17 12.01 12.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.65 -47.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.642 0.734 . . . . 0.0 110.596 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -2.89 56.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.62 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.69 26.97 15.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.992 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -170.03 154.95 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.101 0.477 . . . . 0.0 111.099 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.4 t -155.8 145.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.38 120.42 32.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.315 . . . . 0.0 110.805 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.05 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -105.6 145.85 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.5 pt -125.49 142.65 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 111.531 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -107.97 129.35 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.401 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.409 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 3.4 p90 -153.87 174.42 14.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.188 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -98.5 135.41 40.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.62 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.47 104.97 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.995 0.426 . . . . 0.0 111.395 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.17 124.45 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 118' ' ' SER . 1.4 mm-40 -135.62 33.3 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 2.1 t 80.7 91.53 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.297 0.57 . . . . 0.0 110.982 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.461 ' HB ' ' CE1' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -128.28 127.15 67.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.668 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.508 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.7 pp -109.95 97.18 28.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.537 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 88.9 Cg_endo -84.11 159.91 13.47 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.752 2.301 . . . . 0.0 112.691 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.74 27.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.68 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.84 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.7 -40.97 3.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.233 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.86 102.93 7.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -109.98 119.43 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.487 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.508 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -105.59 120.76 42.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.311 . . . . 0.0 110.774 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.3 t -99.74 95.52 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.549 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -81.49 102.75 10.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.6 125.01 29.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 121.37 7.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.403 2.069 . . . . 0.0 111.762 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.551 ' HB3' ' N ' ' A' ' 202' ' ' ASP . 0.5 OUTLIER -92.5 159.4 15.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 111.345 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -164.88 0.98 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.17 -38.74 78.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 m -175.57 69.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.232 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.3 t -107.3 145.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.817 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 145.62 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.956 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.433 ' HB3' ' CG1' ' A' ' 140' ' ' ILE . 10.6 mt -105.93 -60.38 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.64 19.61 40.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.125 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.433 ' CG1' ' HB3' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -98.45 146.86 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.73 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.414 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 27.1 m -126.19 128.41 47.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 154' ' ' LEU . 7.2 mt -101.87 163.07 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.061 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.84 149.12 34.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.1 t -97.48 106.64 34.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 C--N 1.344 0.306 0 C-N-CA 122.614 2.209 . . . . 0.0 112.334 -179.799 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.9 t0 . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.529 0.204 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.35 -167.95 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.537 2.158 . . . . 0.0 112.435 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.404 ' CD1' ' CG2' ' A' ' 142' ' ' ILE . 3.1 mm? -131.15 155.88 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -142.22 162.23 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.335 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mm -89.72 154.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.546 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.8 t -132.45 -20.93 2.31 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.4 OUTLIER 174.78 136.19 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.425 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -123.64 149.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.837 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.78 164.4 11.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -96.86 166.16 11.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.47 -30.18 6.65 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.988 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 1.6 t -97.95 149.65 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 111.476 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.0 m -52.76 -21.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.843 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.409 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -51.08 -64.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.412 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.425 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 16.5 t60 -83.19 -24.26 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.52 -39.27 67.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.038 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 2.7 t -56.41 -28.14 58.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.947 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.607 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 126' ' ' PHE . 66.9 p -57.57 -25.15 59.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.58 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.795 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.29 166.61 11.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.973 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.5 mt -92.38 116.65 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.04 29.25 2.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.698 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 138.12 41.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.767 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -90.31 106.17 18.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.775 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.1 mt -70.56 134.9 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.043 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.18 -51.37 2.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.688 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -128.19 156.54 42.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 182' ' ' ASN . 28.6 mm -139.59 105.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.081 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.4 OUTLIER 68.13 -67.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.038 0.447 . . . . 0.0 110.738 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' ILE . 1.5 m120 -147.99 -24.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.665 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.52 139.69 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.161 0.505 . . . . 0.0 111.199 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 4.1 mtp-105 -102.48 123.7 46.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.803 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 193' ' ' ALA . 3.2 mm? -74.89 -5.52 44.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.446 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -45.87 -28.92 1.21 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 m -134.31 42.73 2.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.685 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.29 153.55 38.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -177.53 0.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.458 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -54.47 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.55 -29.82 18.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.81 -52.15 66.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.25 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.407 ' N ' HD12 ' A' ' 185' ' ' LEU . . . -57.18 -40.59 77.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.191 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.542 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 11.9 t -62.31 -39.4 84.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.674 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -46.92 87.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.117 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.466 ' CD1' ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -72.52 -24.71 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -58.94 -36.14 74.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.848 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 1.0 OUTLIER -104.04 -44.57 4.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.262 -179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -26.02 19.79 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.014 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -95.43 44.52 1.09 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.76 53.34 0.08 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.241 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.551 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -141.59 -25.93 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.719 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.3 tt 165.14 112.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.422 HG22 ' CE ' ' A' ' 132' ' ' LYS . 3.5 m -105.26 132.51 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -107.89 107.97 18.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.457 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.28 104.3 15.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.402 . . . . 0.0 111.807 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.424 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 19.6 tttt -97.29 93.69 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.165 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.82 -177.54 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.208 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.42 127.33 44.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -115.97 159.56 21.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.622 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.746 0.308 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -76.06 120.7 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.6 p -55.29 174.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.275 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -164.55 140.99 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -107.13 160.31 15.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.439 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -151.12 -178.49 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.29 162.7 15.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.93 150.5 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.693 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.2 t -122.83 112.68 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mt -108.51 118.71 37.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.181 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -107.4 162.27 14.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 111.883 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.89 128.5 45.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 147.1 32.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.412 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.63 16.59 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.479 2.119 . . . . 0.0 112.666 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.06 -47.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 t -131.58 -18.92 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.17 87.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.278 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 54.4 m-85 65.62 93.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 109.767 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -74.49 13.96 4.57 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.567 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.54 HG21 ' CG2' ' A' ' 57' ' ' ILE . 0.8 OUTLIER -109.9 133.91 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 117.38 0.59 . . . . 0.0 111.707 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 3.3 mt-30 -97.65 128.27 44.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.15 155.82 16.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.306 0.574 . . . . 0.0 112.239 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.5 169.1 17.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.204 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.74 23.92 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.821 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -122.12 93.63 4.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 t -111.08 -78.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.254 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.2 p90 -39.87 -44.36 1.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.207 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 51.77 73.27 0.33 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.94 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 47' ' ' ALA . 4.3 t 165.87 -166.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.677 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' N ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -46.01 147.93 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.871 179.652 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 66.9 178.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.482 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -142.63 -101.43 0.13 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.362 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.67 16.75 3.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 0.0 111.572 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -62.0 118.41 38.88 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.11 155.29 52.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.31 2.006 . . . . 0.0 111.922 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 45.9 Cg_exo -54.85 123.8 14.65 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.243 1.962 . . . . 0.0 111.952 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.1 pt? -136.23 118.03 15.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 111.264 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.54 ' CG2' HG21 ' A' ' 39' ' ' ILE . 78.2 mt -76.12 141.23 16.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 57' ' ' ILE . 4.6 m -113.4 -19.64 11.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.727 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.6 t80 -152.22 139.18 19.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -107.72 177.17 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.731 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' GLY . 40.5 tt0 -117.49 119.09 34.0 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.186 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -57.35 122.31 12.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.182 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 1.6 t0 82.53 42.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.254 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -138.29 154.53 73.89 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.409 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 46.2 Cg_endo -67.72 -1.38 6.65 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.363 2.042 . . . . 0.0 112.8 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.431 ' CB ' HG13 ' A' ' 39' ' ' ILE . . . -70.97 -56.62 5.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.694 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -78.92 -29.21 44.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.273 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -92.22 -1.66 56.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.668 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -44.75 -30.74 1.01 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.316 . . . . 0.0 111.315 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.75 -50.34 0.89 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.0 m -137.93 53.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 mt -127.68 137.7 52.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -131.85 -179.5 5.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.038 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 74' ' ' ILE . 29.0 mm -76.24 73.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.99 77.48 0.22 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.457 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.29 92.42 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -65.18 101.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 55' ' ' PRO . 28.6 m -97.78 149.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.57 -30.15 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -132.91 130.24 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.26 116.64 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.42 25.48 3.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.35 -26.13 24.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.582 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.82 124.73 91.22 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-O 120.541 0.21 . . . . 0.0 111.134 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.27 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.1 p -143.42 -45.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -68.31 -12.57 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -113.83 44.33 1.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.38 -174.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.867 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 165.4 12.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -73.1 -27.26 61.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -54.92 -41.4 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -34.19 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.731 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -71.43 -32.52 68.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.248 0.547 . . . . 0.0 110.582 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.27 -36.42 63.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.076 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.489 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.89 -39.63 61.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.382 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.489 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 2.1 pp -67.61 -40.22 84.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.539 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.44 ' N ' HD11 ' A' ' 97' ' ' LEU . 22.4 mt -65.43 -56.03 14.72 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.6 ppt_? -50.7 -31.31 16.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.493 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.8 p30 -112.28 33.22 5.01 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.801 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 97.9 p -100.26 9.39 42.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.4 t -100.02 15.3 27.69 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.6 mt -67.99 -42.09 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.664 0.745 . . . . 0.0 110.504 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.52 11.19 37.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.598 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' HG21 ' A' ' 30' ' ' THR . 5.8 m 54.53 24.58 5.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.235 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.402 ' CG ' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -162.9 154.68 18.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.46 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -155.31 126.86 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.88 128.4 45.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.68 158.27 31.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -118.18 118.38 31.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.535 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 pt -113.34 163.89 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.424 . . . . 0.0 111.685 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -131.62 144.62 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.46 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.36 174.18 15.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.937 0.399 . . . . 0.0 111.343 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.1 114.45 27.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.492 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 167' ' ' ARG . 17.4 m -61.88 105.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.337 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -176.07 -135.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 116' ' ' ALA . 9.9 pt-20 48.3 30.55 2.31 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.416 ' CB ' HD21 ' A' ' 130' ' ' LEU . 14.6 t 176.89 61.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.076 0.465 . . . . 0.0 111.153 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.66 118.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.295 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.596 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -138.31 97.96 9.35 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.791 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 90.7 Cg_endo -83.27 150.93 13.63 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.75 2.3 . . . . 0.0 112.91 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -153.55 19.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.18 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.75 114.75 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.051 0.453 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.7 -41.18 2.58 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.128 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.4 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -135.12 108.49 7.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -102.76 128.09 49.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.549 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.596 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.3 134.26 52.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.0 110.487 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.22 94.79 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.628 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -83.38 97.94 9.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.402 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.421 HD21 ' HB ' ' A' ' 168' ' ' THR . 26.7 mt -104.3 117.73 58.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.67 95.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.177 1.918 . . . . 0.0 111.371 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -81.55 159.25 24.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -165.95 1.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.654 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -66.08 -43.64 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.85 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.5 m -179.3 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.1 t -94.32 159.84 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -51.04 113.63 0.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.686 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.11 112.08 20.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.915 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . -90.45 47.88 3.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.029 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.95 137.06 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.599 0.238 . . . . 0.0 110.384 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.1 m -120.78 109.76 15.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.781 0.324 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 mt -87.68 164.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.1 t -157.67 161.01 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 21.0 p -115.25 107.79 48.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.346 0.434 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.937 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.9 t0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.756 0.312 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -174.13 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.656 2.237 . . . . 0.0 112.434 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.412 ' CD2' ' CB ' ' A' ' 193' ' ' ALA . 1.1 mp -121.84 165.41 15.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 m -158.22 148.08 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 mt -74.97 150.7 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.373 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.5 m -136.48 -12.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.17 150.09 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 1.1 mt -139.94 145.43 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.198 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.452 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -114.85 154.77 28.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 111.398 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.78 76.65 3.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.69 -36.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.457 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 8.4 t -101.81 158.87 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.094 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 16.8 m -48.88 -22.34 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.096 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.443 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -43.82 -59.41 2.26 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.414 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 42.5 t60 -83.66 -25.2 30.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.862 0.363 . . . . 0.0 110.8 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -58.4 -29.61 66.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.379 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 t -55.96 -44.9 78.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.1 -20.41 46.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.836 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.2 t -113.2 37.58 3.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.999 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.49 41.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.764 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.64 144.45 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -85.05 108.02 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.99 -20.28 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.33 157.79 22.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.671 0.272 . . . . 0.0 110.751 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -108.33 100.91 10.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.74 165.93 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.6 pp -158.25 -40.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.076 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -125.95 129.88 50.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.892 0.377 . . . . 0.0 111.061 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 46.9 mt -118.68 107.47 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.1 t70 66.05 -72.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.7 -19.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 40.7 mm -96.8 157.13 3.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 120.99 0.424 . . . . 0.0 111.251 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.4 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 79.2 mtt180 -122.38 132.9 54.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.911 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.7 -8.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.558 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -47.56 -28.09 2.12 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.038 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.1 p -144.1 46.78 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.26 160.65 30.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.17 -175.92 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.99 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' MET . . . . . 0.404 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 8.7 ptm -74.24 -45.59 46.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 190' ' ' MET . 1.5 mm-40 -52.05 -50.09 62.18 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.197 0.522 . . . . 0.0 110.89 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -52.12 -45.58 64.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.128 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 154' ' ' LEU . . . -56.62 -41.58 77.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.517 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 10.7 t -60.75 -33.9 56.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 109.82 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -61.92 -50.2 73.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.708 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 200' ' ' CYS . 1.3 mt -71.08 -24.93 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -60.98 -37.46 82.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.21 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -92.17 -34.5 14.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.656 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -84.9 11.77 8.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.643 178.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 196' ' ' ILE . 30.0 p -66.1 28.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 199' ' ' GLN . 1.5 mm-40 46.82 46.45 15.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.73 27.51 16.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.769 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mt -162.87 94.39 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.415 ' CG1' ' HB2' ' A' ' 130' ' ' LEU . 13.1 p -90.34 123.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 2.9 ttmp? -108.8 107.73 18.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.219 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.35 107.09 18.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.084 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.424 ' HD2' ' CE1' ' A' ' 127' ' ' HIS . 0.9 OUTLIER -96.99 100.74 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.759 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 126' ' ' PHE . 0.1 OUTLIER -109.77 173.39 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 8.0 mtp180 -105.06 132.88 50.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.23 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -115.88 159.21 21.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.828 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.0 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.992 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -139.72 107.68 5.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.01 133.63 38.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.147 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -148.78 157.73 43.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.0 p -110.43 144.93 38.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.43 ' OG1' ' CZ ' ' A' ' 113' ' ' PHE . 27.4 m -140.57 163.29 33.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -104.63 159.33 15.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 136.18 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 p -115.97 122.42 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.1 mp -115.66 118.99 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.896 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.49 162.58 12.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.271 0.558 . . . . 0.0 111.932 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -107.33 103.86 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -75.02 153.27 86.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.332 179.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.4 7.89 3.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.447 2.098 . . . . 0.0 112.675 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.42 -45.29 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.567 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -133.7 -8.59 2.8 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.439 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 65.6 -90.48 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.929 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 37' ' ' PHE . 3.5 m-85 -131.66 119.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.58 28.27 15.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.361 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 25.5 pt -126.84 133.35 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -122.36 139.96 53.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.86 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -130.09 157.51 42.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 112.054 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -112.1 170.07 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.204 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.58 17.59 6.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -111.28 67.8 0.65 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.351 0.596 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.425 HG22 ' CB ' ' A' ' 53' ' ' SER . 3.4 t -71.43 -35.11 55.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.961 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 45.6 p90 -132.07 -49.59 0.94 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.252 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 42.09 85.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.099 0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 171.0 120.86 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.232 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 58.5 80.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 0.6 OUTLIER 85.5 -178.17 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.507 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.1 pp -154.82 -147.2 0.2 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.355 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 2.0 t 81.43 20.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.227 0.537 . . . . 0.0 111.588 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.425 ' CB ' HG22 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -47.51 139.13 8.47 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.964 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.414 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 25.0 Cg_endo -61.96 133.33 43.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.551 2.167 . . . . 0.0 112.406 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.49 141.67 25.21 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.513 2.142 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -141.11 115.98 9.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.637 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -66.12 141.35 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.441 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.0 p -113.69 -26.16 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.519 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.407 ' HB3' ' CG ' ' A' ' 40' ' ' GLN . 56.2 t80 -144.18 154.49 43.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 0.0 111.496 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 61' ' ' GLU . 25.7 mm -137.51 151.24 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.718 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -101.01 148.99 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.209 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.55 44.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.038 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.72 41.5 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.724 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 17.5 m -136.93 138.49 26.05 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.958 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.75 -12.77 9.61 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.79 2.327 . . . . 0.0 113.276 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.41 -58.33 6.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 0.0 110.349 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -80.12 -30.97 39.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.041 178.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -57.84 -33.41 68.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.0 t -49.58 -30.44 8.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.006 0.432 . . . . 0.0 110.523 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 137' ' ' GLU . . . 87.95 26.13 29.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.982 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.52 29.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 0.0 110.912 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 mt -133.55 121.63 22.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -136.01 154.95 50.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.295 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.484 HD13 HG23 ' A' ' 74' ' ' ILE . 54.3 mt -58.14 87.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.233 0.54 . . . . 0.0 111.194 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.428 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 132.66 39.55 0.22 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -87.01 132.08 33.9 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.8 102.19 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 t -85.68 121.89 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -29.28 17.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.53 143.51 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mt -119.39 110.36 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 59.98 20.13 9.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.73 -33.79 4.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.632 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.4 mt -69.71 116.81 47.21 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 120.45 0.166 . . . . 0.0 111.167 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.93 -33.36 63.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.403 2.069 . . . . 0.0 112.049 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p 74.17 0.52 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.776 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.66 -20.73 27.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.924 0.392 . . . . 0.0 111.199 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -101.9 44.53 1.01 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 m -179.12 -176.95 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.12 161.97 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -73.28 -29.74 62.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.012 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.18 -31.65 63.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.355 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.37 -53.49 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.19 71.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.29 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -65.05 -39.91 93.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -35.42 80.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.922 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.1 mt -57.44 -51.08 70.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mp -58.81 -45.12 90.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.427 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.21 -38.01 49.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.232 0.539 . . . . 0.0 109.939 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.5 m-20 -122.06 40.86 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.516 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.416 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 54.7 p -94.32 6.74 47.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 p -102.7 15.56 28.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.838 0.351 . . . . 0.0 111.81 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.0 mt -69.24 -47.85 71.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.789 0.804 . . . . 0.0 110.338 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.4 12.11 28.24 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.396 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.411 ' HA ' ' CB ' ' A' ' 31' ' ' ALA . 14.5 m 52.58 26.13 4.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -162.83 156.93 20.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 101' ' ' SER . 1.4 t -155.9 99.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.696 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 132.49 35.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.12 157.0 45.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.271 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.68 127.85 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.424 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.8 pt -114.19 145.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 111.571 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -116.7 115.72 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CZ ' ' OG1' ' A' ' 25' ' ' THR . 3.6 p90 -132.89 174.12 10.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 0.0 111.274 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.15 131.7 54.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.4 m -66.58 105.69 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.458 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.08 108.43 0.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.88 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -133.86 39.47 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.3 t 66.78 89.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.374 0.607 . . . . 0.0 111.286 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.447 ' HB ' ' CE1' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -125.53 120.3 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.901 179.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.549 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.9 pp -102.41 103.81 33.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.338 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 94.0 Cg_endo -85.85 148.21 9.53 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 112.55 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -154.49 22.89 0.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.83 113.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.004 0.431 . . . . 0.0 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.5 -43.86 2.62 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.162 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.01 103.73 7.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 110.995 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -107.65 119.56 39.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.549 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.38 124.1 47.35 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.796 0.332 . . . . 0.0 110.483 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 3.4 t -101.76 90.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.63 98.36 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.293 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.68 144.15 48.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 0.0 111.56 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.55 119.68 6.66 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.528 2.152 . . . . 0.0 111.48 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -86.94 153.39 21.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.336 0.588 . . . . 0.0 111.628 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -88.72 -164.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.28 34.96 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.693 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.04 47.99 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.824 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.4 t -89.84 -121.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.436 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 1.1 tt0 -90.72 102.62 15.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 122.1 -0.375 . . . . 0.0 111.442 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.7 tp -122.63 95.24 4.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.88 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -86.1 45.37 3.46 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.2 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.5 mt -92.81 123.61 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.424 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 97.8 m -110.41 101.81 10.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.0 mt -91.8 163.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.52 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.2 t -176.22 176.66 1.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.021 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 t -129.38 129.43 23.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.809 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.345 0.368 0 C-N-CA 122.491 2.127 . . . . 0.0 112.237 -179.955 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.858 0.361 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.09 -167.32 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.586 2.191 . . . . 0.0 112.333 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -126.94 149.88 49.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -154.01 156.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.286 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.3 152.57 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 141' ' ' THR . 1.6 m -130.95 -19.03 2.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.922 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 141' ' ' THR . 28.6 t70 -177.8 143.66 0.34 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.4 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -136.77 131.82 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.485 ' HG3' ' H ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -63.59 130.59 44.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 0.9 5.92 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 160' ' ' LYS . . . -124.35 0.15 8.78 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.868 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.426 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 4.6 t -95.11 145.97 24.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.3 m -48.89 -25.87 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.765 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.62 -69.46 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.333 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' HIS . . . . . 0.4 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 12.0 t60 -64.53 -25.66 68.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.426 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -56.7 -39.85 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 110.926 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.4 ' CG2' HG11 ' A' ' 128' ' ' VAL . 17.1 p -49.0 -27.75 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.323 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 71.04 1.06 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.51 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 tp -66.45 74.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.91 -170.87 3.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.25 119.97 40.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.78 20.5 4.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.82 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.419 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 2.0 m-20 -106.98 173.66 6.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.653 0.226 . . . . 0.0 110.459 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.34 142.63 47.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 111.177 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tp -101.96 138.63 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.581 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.46 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.364 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -146.96 165.45 29.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.011 0.434 . . . . 0.0 111.541 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.5 mm -139.61 107.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER 64.98 -73.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.39 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -134.59 -25.24 1.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 46.4 mm -87.59 157.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 8.2 mtp180 -123.57 124.54 43.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 112.113 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 185' ' ' LEU . 3.0 mm? -78.94 -4.62 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -45.33 -29.39 1.03 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 m -141.7 51.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.792 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.48 159.31 37.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.29 175.95 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' MET . . . . . 0.45 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 25.8 ptm -74.11 -41.86 60.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.988 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 190' ' ' MET . 0.7 OUTLIER -53.81 -29.98 42.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.99 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -52.49 64.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.093 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.416 ' HA ' HD13 ' A' ' 196' ' ' ILE . . . -56.24 -39.49 72.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.209 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.559 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 18.4 t -61.61 -39.9 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.673 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -50.33 74.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.124 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 200' ' ' CYS . 1.6 mt -69.79 -24.92 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -58.59 -35.48 72.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.588 179.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.29 -40.74 7.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.733 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -22.98 41.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.714 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' CYS . . . . . 0.487 ' HB2' HG23 ' A' ' 204' ' ' VAL . 2.0 m -91.16 42.68 1.11 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.72 62.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.353 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -171.91 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.543 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.407 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 3.2 tt 175.13 110.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 200' ' ' CYS . 98.9 t -108.18 138.81 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.477 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 7.3 tttt -109.12 108.03 18.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 7.1 mp -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 111.412 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . 0.439 ' HE3' ' CE1' ' A' ' 127' ' ' HIS . 2.9 tttt -92.73 93.17 8.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.298 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 6.6 mm -90.71 163.39 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.015 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 5.7 mtp-105 -107.98 120.72 43.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 150.53 21.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.798 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.77 0.319 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -130.31 136.3 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.3 t -139.8 158.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.977 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -131.03 98.61 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.67 119.65 8.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.931 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.1 156.55 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.16 161.29 16.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -149.63 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -122.6 163.1 20.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.58 135.68 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.76 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.8 p -108.66 122.89 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.525 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 31.9 mt -120.07 118.66 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 HG22 ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -108.95 162.12 14.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.601 -179.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.497 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.48 140.3 32.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.123 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.73 154.69 37.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.701 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.97 11.16 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.611 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.0 t -114.32 -46.98 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 t -144.64 8.77 1.33 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.21 -117.29 7.77 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.46 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.497 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 3.6 m-85 -103.77 128.92 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.424 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -92.47 27.34 10.82 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.305 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 40' ' ' GLN . 3.3 mt -94.08 157.61 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.359 0.6 . . . . 0.0 111.779 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.429 ' N ' ' CG2' ' A' ' 39' ' ' ILE . 4.2 mt-30 -137.85 104.99 5.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.826 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 98' ' ' LEU . 1.1 tp -95.69 144.7 25.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.272 0.558 . . . . 0.0 112.403 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -114.68 151.56 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.25 88.35 0.88 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.135 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.81 104.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.599 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 t -76.21 -65.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.549 0.69 . . . . 0.0 109.913 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 21.3 p90 -33.03 -43.75 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.037 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.61 88.65 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.933 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 49' ' ' GLU . 0.9 OUTLIER 170.08 114.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.682 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 48' ' ' THR . 11.5 pt-20 47.09 108.16 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.92 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 p 67.25 -162.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.635 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.5 mt -129.0 -72.89 0.59 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.499 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.7 t 63.69 8.83 3.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.465 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.51 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.1 m -175.63 58.76 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.569 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.591 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 8.0 Cg_exo -67.65 -59.0 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.063 1.842 . . . . 0.0 112.787 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CB ' ' A' ' 54' ' ' PRO . 59.2 Cg_endo -99.82 108.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.919 2.413 . . . . 0.0 112.694 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -143.89 127.39 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.549 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.426 HG23 HD13 ' A' ' 57' ' ' ILE . 37.6 mt -67.66 136.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.057 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.95 -6.23 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.431 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 33.8 t80 -178.02 138.39 0.2 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.043 0.449 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.461 ' CG2' ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -102.07 -167.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 38' ' ' GLY . 51.7 tt0 -129.14 151.73 49.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.355 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -82.81 114.72 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.411 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 2.9 t70 91.73 39.55 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.534 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.419 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 2.5 p -132.92 143.96 50.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.35 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 69' ' ' CYS . 31.5 Cg_exo -58.61 -2.92 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.465 2.11 . . . . 0.0 112.953 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.45 ' CB ' ' CG2' ' A' ' 60' ' ' ILE . . . -63.68 -56.89 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HB2' ' NH1' ' A' ' 68' ' ' ARG . 1.0 OUTLIER -78.51 -28.66 46.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.613 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 4.1 mmt-85 -85.49 -1.55 57.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.277 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 65' ' ' PRO . 31.3 p -58.64 -40.94 84.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 149.18 -23.75 1.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.96 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -175.05 84.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.128 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.69 123.4 23.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.726 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.26 159.59 34.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.963 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.5 mm -61.12 106.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.275 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.74 45.88 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.88 101.36 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -70.73 66.06 0.34 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.013 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.414 ' CG2' ' HG2' ' A' ' 55' ' ' PRO . 34.3 m -64.85 129.85 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.59 -29.6 11.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.23 148.7 31.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.404 . . . . 0.0 111.608 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 6.7 mt -130.24 112.41 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.769 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 62.25 21.84 12.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.025 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.76 16.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.679 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.2 mt -74.32 136.24 75.51 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 120.537 0.208 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 -170.7 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.514 2.143 . . . . 0.0 112.232 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.6 p -150.76 -60.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -64.83 -16.62 63.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.376 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -106.35 43.9 1.1 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.652 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.47 -175.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -71.41 149.06 46.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.451 ' CB ' ' HB3' ' A' ' 54' ' ' PRO . 9.0 p90 -73.42 -33.64 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -54.92 -42.53 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.953 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.427 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 pt-20 -61.17 -39.27 89.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.498 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.61 94.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.232 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -61.36 -39.55 91.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.791 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -62.49 -39.81 94.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.484 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 14.8 mt -57.05 -49.98 74.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 7.1 mt -60.46 -58.77 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 49.8 mtt180 -50.28 -29.84 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 109.94 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.442 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.6 m-20 -114.89 33.15 5.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.845 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.635 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.8 45.27 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.865 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 1.5 m -142.75 16.82 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.84 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.442 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.8 mp -65.4 -45.24 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.552 0.691 . . . . 0.0 110.901 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.23 11.89 38.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.495 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 20.5 t 57.92 25.31 11.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.033 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 1.5 ttpt -165.88 145.46 6.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.744 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.469 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.7 t -141.73 135.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.559 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.1 165.12 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.391 . . . . 0.0 111.335 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -118.14 141.04 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 pt -133.15 159.12 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.522 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -123.14 143.0 50.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.527 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.441 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 1.2 p90 -161.11 174.29 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.281 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -102.95 149.6 24.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.376 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.7 m -97.98 104.8 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -179.68 -147.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.1 12.52 2.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.822 0.344 . . . . 0.0 110.811 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.6 t -178.8 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.665 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.3 t -156.29 117.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.478 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -157.24 84.53 2.91 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-O 121.233 0.539 . . . . 0.0 111.084 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 65.1 Cg_endo -94.65 -169.49 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.299 2.666 . . . . 0.0 112.636 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -178.49 34.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.745 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 58.9 114.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.89 -39.48 2.87 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.309 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.401 ' CG2' ' CG ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.9 113.43 12.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.429 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -103.57 126.29 50.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.653 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB2' ' CG2' ' A' ' 120' ' ' ILE . 7.3 m80 -101.58 135.26 43.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.6 t -137.82 86.59 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.748 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -81.51 106.21 13.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.38 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.8 mp -109.11 132.22 21.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.372 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 108.45 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.159 1.906 . . . . 0.0 111.057 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.64 158.62 19.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.477 . . . . 0.0 111.471 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.404 ' HG3' ' CG2' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -128.36 -174.93 3.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.167 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -56.36 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.5 m -153.94 74.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.404 ' CG2' ' HG3' ' A' ' 133' ' ' LYS . 95.5 t -113.37 156.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -56.45 110.44 0.78 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.437 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.8 mt -96.61 -52.89 3.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.357 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . 93.57 9.03 60.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 21.2 mt -79.38 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.841 0.321 . . . . 0.0 111.232 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.464 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 39.7 m -116.19 128.7 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.924 0.392 . . . . 0.0 110.199 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.448 HG21 ' CD1' ' A' ' 154' ' ' LEU . 9.0 mt -103.17 164.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.585 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.9 p -163.57 152.9 14.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.265 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p -122.57 139.55 31.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.83 -45.3 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.494 2.129 . . . . 0.0 112.416 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.5 m -179.26 132.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.9 m -94.73 59.14 2.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.58 46.53 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.018 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.58 145.63 1.77 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.876 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.19 113.67 3.84 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.521 2.147 . . . . 0.0 112.45 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.19 21.68 5.15 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.841 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER -46.48 99.96 0.22 Allowed Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 120.646 0.26 . . . . 0.0 111.03 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.69 149.97 30.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.976 2.45 . . . . 0.0 112.779 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.448 ' CD1' HG21 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -76.64 144.13 39.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.84 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.1 t -129.18 142.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.975 0.416 . . . . 0.0 111.941 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.52 150.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.218 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.94 -20.9 4.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 111.723 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.464 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 177.71 153.39 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 0.0 111.168 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -140.1 125.6 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.436 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -80.63 154.07 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -74.81 -178.93 3.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.01 -61.42 1.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.724 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.492 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.9 OUTLIER -56.67 161.72 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.969 0.414 . . . . 0.0 111.274 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 5.5 m -69.42 -20.92 24.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.77 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.43 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -47.71 -70.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 33.6 t60 -76.48 -23.92 53.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.23 -44.68 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.307 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 3.2 t -52.48 -25.85 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.54 48.91 81.98 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 35.2 p -137.95 -44.33 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 0.0 111.083 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.6 mp -59.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.24 139.44 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.24 119.89 16.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.19 18.47 5.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.681 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.408 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.5 OUTLIER -114.31 -177.25 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.695 0.283 . . . . 0.0 110.738 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -132.38 161.54 33.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 1.7 mp -124.54 170.9 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.56 -39.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.223 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -139.44 142.36 37.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.572 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 46.7 mt -127.48 111.57 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.881 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.0 t70 66.3 -70.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.096 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -144.92 -20.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.403 ' CG1' HG12 ' A' ' 196' ' ' ILE . 23.1 mm -98.0 156.95 3.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.17 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 38.1 mtt85 -116.18 139.3 50.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 112.241 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 154' ' ' LEU . 3.9 mm? -70.86 -2.89 16.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.628 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.52 -27.91 1.99 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.094 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m -75.17 -18.93 60.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 111.299 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.402 ' CB ' ' HB2' ' A' ' 152' ' ' ASP . 4.5 m 76.02 102.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.49 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.4 m 168.58 95.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' MET . . . . . 0.437 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 18.1 ptm -53.82 -41.56 67.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.265 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.471 ' HA ' HG21 ' A' ' 194' ' ' VAL . 3.4 mm-40 -55.63 -39.29 70.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.987 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.412 ' HA ' ' HG2' ' A' ' 195' ' ' GLN . 0.3 OUTLIER -55.65 -52.07 65.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.061 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.41 ' HA ' HD13 ' A' ' 196' ' ' ILE . . . -53.7 -36.4 62.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.546 ' HA ' ' CD2' ' A' ' 197' ' ' LEU . 11.8 t -66.42 -32.68 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.605 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 191' ' ' GLU . 3.0 mm-40 -76.02 -45.06 36.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.66 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 193' ' ' ALA . 1.7 mt -73.43 -31.17 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.605 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.546 ' CD2' ' HA ' ' A' ' 194' ' ' VAL . 1.6 pp -78.39 -24.73 46.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -88.01 -45.55 10.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.059 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -20.56 63.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.365 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 27.6 p -88.41 45.99 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.285 0.564 . . . . 0.0 109.784 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -68.12 60.66 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.782 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -169.27 -33.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.4 tt -175.01 105.02 0.09 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.776 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 9.8 p -96.14 126.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.478 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -100.73 107.82 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.127 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.6 mp -94.79 113.77 25.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.0 111.408 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.424 ' HD2' ' CE1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -101.1 93.5 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 1.4 mm -83.32 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.888 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 15.7 mmt180 -118.44 128.18 54.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.001 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.24 151.32 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.934 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 176.43 78.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.741 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.68 174.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.226 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.453 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.234 -179.855 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.822 0.344 . . . . 0.0 110.812 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.9 116.68 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.0 t -136.07 133.65 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.383 . . . . 0.0 111.183 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -105.28 105.78 15.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -54.55 158.41 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -146.97 153.16 39.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.706 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -109.76 136.31 49.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 t -126.66 174.96 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -103.84 157.77 16.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.75 147.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.28 109.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.26 118.61 37.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.212 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -108.42 161.78 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 111.674 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -93.97 172.57 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.051 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 34' ' ' VAL . 17.2 t70 -163.22 140.76 6.0 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.347 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.86 19.09 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.464 2.11 . . . . 0.0 112.739 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.425 ' H ' ' C ' ' A' ' 32' ' ' ASP . 62.2 t -129.82 -51.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 20.5 p -156.81 36.22 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.778 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.32 127.07 7.88 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.711 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CE2' ' OG ' ' A' ' 102' ' ' SER . 24.5 m-85 63.55 71.69 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.45 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.31 21.79 8.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.146 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.519 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 0.8 OUTLIER -111.79 133.2 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.458 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 6.4 mt-30 -97.92 126.88 43.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.4 ' HG ' ' CG1' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -96.03 141.52 29.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.122 0.487 . . . . 0.0 111.82 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.67 165.63 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.357 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.81 -111.11 0.11 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.532 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.8 p -115.53 104.2 11.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.846 0.355 . . . . 0.0 110.931 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.404 ' CG2' HD11 ' A' ' 56' ' ' LEU . 59.5 t -46.38 -78.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.521 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 15.5 p90 -40.65 -51.75 2.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.75 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 38.22 93.17 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.052 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.446 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER 175.55 110.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 48' ' ' THR . 6.4 pt-20 49.45 36.8 10.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.331 0.586 . . . . 0.0 110.324 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER 166.81 177.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.307 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.4 pp -176.71 33.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -63.09 29.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.8 t -147.25 73.05 12.01 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-O 120.844 0.354 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HB2' ' HD3' ' A' ' 55' ' ' PRO . 20.9 Cg_exo -63.46 -53.07 1.56 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.544 2.163 . . . . 0.0 113.169 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 54' ' ' PRO . 57.2 Cg_endo -96.14 102.44 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.827 2.351 . . . . 0.0 113.039 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD11 ' CG2' ' A' ' 45' ' ' VAL . 27.8 mt -131.71 85.21 2.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.474 HG23 ' HB ' ' A' ' 39' ' ' ILE . 85.7 mt -58.58 136.64 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.5 p -120.97 -8.43 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 91.3 t80 -144.47 150.52 37.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.302 0.572 . . . . 0.0 112.322 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.519 ' CD1' ' CG2' ' A' ' 39' ' ' ILE . 1.7 mm -123.4 152.7 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.266 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -104.47 106.6 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.884 0.373 . . . . 0.0 110.861 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -63.45 116.51 5.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 12.4 t0 95.24 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.191 0.519 . . . . 0.0 110.558 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.51 ' CB ' ' CD ' ' A' ' 65' ' ' PRO . 0.7 OUTLIER -139.71 -173.85 0.38 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 64.6 Cg_endo -95.01 -6.73 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.451 2.101 . . . . 0.0 113.535 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.7 -58.0 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.486 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -77.03 -29.03 55.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.961 0.41 . . . . 0.0 110.447 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.496 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -93.36 -7.33 45.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.781 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -41.89 -42.46 2.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.015 0.436 . . . . 0.0 111.263 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.39 -22.77 0.75 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.532 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.2 p -173.07 82.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.964 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.56 159.04 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.992 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.87 143.01 7.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.679 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.5 mt -55.2 132.31 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.35 16.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.893 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -55.58 -43.8 76.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.707 0.289 . . . . 0.0 111.255 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 75.56 72.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.416 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 86.1 t -71.13 152.69 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.296 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.21 -27.78 4.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -155.13 134.76 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.1 mp -114.79 109.62 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 52.94 24.07 3.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.123 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.34 -35.74 4.11 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.496 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.51 HG21 HD12 ' A' ' 84' ' ' ILE . 21.4 mm -64.03 117.59 37.65 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 120.526 0.203 . . . . 0.0 111.315 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.09 171.65 9.82 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.405 2.07 . . . . 0.0 112.248 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 p -143.97 -45.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.9 -16.35 58.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.515 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -129.91 52.75 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -177.22 166.81 2.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.43 140.03 56.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 5.4 p90 -73.58 -29.74 62.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.486 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 mm-40 -54.55 -43.78 72.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -61.23 -37.0 81.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.759 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -64.98 -34.36 78.24 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.295 0.569 . . . . 0.0 110.528 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.542 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.9 m120 -67.06 -39.51 86.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.345 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 8.7 mm-40 -64.27 -55.98 17.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.481 ' CD2' ' HA ' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -52.16 -43.67 64.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 12.7 mt -59.57 -59.99 4.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.473 0.178 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 61.3 mtt180 -50.23 -29.78 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.394 0.616 . . . . 0.0 109.602 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.494 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -113.5 33.69 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.21 179.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -104.77 21.08 17.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.979 179.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.418 ' OG ' ' CE2' ' A' ' 37' ' ' PHE . 3.3 m -110.46 18.0 20.23 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.494 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -68.13 -47.73 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.561 0.696 . . . . 0.0 110.948 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 6.94 37.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 8.3 m 59.14 25.94 14.56 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.113 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.64 153.69 2.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.264 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -149.58 146.03 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 124.54 51.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.416 ' HB3' ' CG1' ' A' ' 78' ' ' VAL . 0.9 OUTLIER -131.21 154.8 48.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.491 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.59 123.14 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.918 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 33.0 pt -114.71 148.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 111.904 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.19 145.15 45.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.47 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.11 174.34 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 0.0 111.141 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -96.62 147.01 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.481 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.58 107.37 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.314 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.21 124.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 118' ' ' SER . 12.5 mm-40 -127.36 10.54 6.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.643 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.2 75.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.342 0.591 . . . . 0.0 111.366 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.9 m -97.82 148.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.7 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.8 pp -126.75 92.25 45.25 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 63.3 Cg_endo -95.32 -165.57 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.318 2.679 . . . . 0.0 112.876 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.0 t 177.95 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.0 p 168.56 116.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.199 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.28 -40.68 2.7 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.204 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.416 ' CG2' ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.41 104.3 7.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.451 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 1.9 t80 -100.34 115.79 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.759 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.7 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -91.75 134.25 34.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.293 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 3.2 t -117.49 82.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -80.87 102.26 9.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.1 144.71 53.73 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.135 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.44 135.73 22.74 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.428 2.085 . . . . 0.0 112.059 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 200' ' ' CYS . 0.1 OUTLIER -107.8 159.23 16.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.059 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -106.66 -171.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.583 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.415 ' N ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -66.82 -76.11 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.254 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.4 m -149.74 70.72 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.3 t -122.02 159.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.772 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -50.71 103.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.179 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.8 -45.43 93.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 94.24 -0.38 66.18 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.977 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.401 HG12 ' CB ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -108.46 141.36 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.086 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 55.9 m -126.07 131.89 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.519 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.3 mt -98.1 163.31 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.79 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.97 149.46 19.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.3 p -112.47 132.39 22.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.74 -59.2 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.455 2.103 . . . . 0.0 112.317 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.7 m -166.06 -177.11 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.811 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t -117.41 29.58 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -112.3 43.79 1.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.713 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 149.93 32.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.809 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.14 -25.49 29.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.446 2.097 . . . . 0.0 112.194 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 169.23 55.8 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.342 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.44 145.61 14.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.02 174.78 11.43 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.425 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.97 169.96 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.433 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.1 m -150.56 149.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.0 111.525 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.6 mt -67.72 146.58 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.632 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.38 -8.51 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.23 143.08 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.01 0.433 . . . . 0.0 111.46 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.2 mt -132.7 149.32 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.628 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -124.2 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -80.91 151.94 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.456 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.41 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . 86.75 -16.45 46.17 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.898 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 1.1 m -96.45 136.96 36.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.407 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.7 m -48.2 -22.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.255 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.401 ' CB ' HG12 ' A' ' 140' ' ' ILE . . . -55.77 -50.12 71.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.403 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.449 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 2.0 t60 -83.88 -26.65 29.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 163' ' ' SER . 14.2 mmp_? -56.57 -50.04 73.08 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 6.5 t -53.1 -25.36 12.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.132 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 77.81 -162.73 50.61 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.548 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 14.4 t 44.78 31.53 0.67 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.843 0.354 . . . . 0.0 111.403 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.47 98.49 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.44 149.71 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.7 138.62 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.74 -17.35 33.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.689 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.92 166.39 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 110.651 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -117.91 122.88 44.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.6 mp -82.66 138.73 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.769 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.03 -66.49 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.076 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -121.36 161.82 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 182' ' ' ASN . 33.8 mm -139.74 105.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 2.8 t0 63.82 -71.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 180' ' ' ILE . 2.6 t-20 -138.59 -23.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 26.1 mm -94.23 138.51 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 111.296 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 65.8 mtt180 -102.07 119.97 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.969 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 185' ' ' LEU . 0.8 OUTLIER -72.16 -13.87 61.67 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.133 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.21 -29.99 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.507 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.9 m -127.43 -4.37 6.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.508 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.43 148.85 22.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -176.51 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.46 -57.27 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.829 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -55.29 -32.02 62.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.64 -48.49 80.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.068 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.404 ' HB1' ' CD1' ' A' ' 185' ' ' LEU . . . -57.29 -41.11 79.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.378 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.412 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 11.7 t -62.76 -32.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.05 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -45.91 85.97 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.877 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.556 ' HA ' ' CG ' ' A' ' 199' ' ' GLN . 0.6 OUTLIER -69.98 -24.35 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.523 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -68.43 -35.83 78.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -89.43 -49.81 6.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.508 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.556 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -58.18 -15.89 11.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . 0.507 ' O ' ' HD3' ' A' ' 132' ' ' LYS . 8.4 m -89.42 32.53 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.23 65.72 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.406 0.622 . . . . 0.0 111.418 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -172.3 -29.91 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.672 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.8 tt 171.84 111.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.768 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.411 ' CG2' ' HG3' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -108.72 128.8 64.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.204 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HD3' ' CD2' ' A' ' 127' ' ' HIS . 1.7 ttmt -107.85 107.68 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.776 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 5.4 mp -90.55 119.67 31.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.001 0.429 . . . . 0.0 111.662 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.494 ' CG ' ' CE1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -98.01 93.84 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.092 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.9 mm -82.33 163.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.364 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -106.45 118.02 35.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.831 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 124' ' ' GLY . 25.5 mttt -129.58 114.54 16.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -87.47 43.57 1.12 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.858 0.361 . . . . 0.0 111.42 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 213' ' ' ASP . 25.0 mt-10 -125.59 156.82 38.56 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.258 0.551 . . . . 0.0 111.691 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 212' ' ' GLU . 18.1 t70 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.622 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.831 0.348 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.4 m -150.0 116.86 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.257 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 t -115.96 95.65 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -114.26 113.35 24.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -52.0 140.06 21.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -135.28 159.99 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.0 p -110.03 136.22 49.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.431 ' OG1' ' CZ ' ' A' ' 113' ' ' PHE . 4.2 m -132.54 169.6 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.855 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.67 160.59 14.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.948 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -147.27 148.22 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -127.14 110.0 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.751 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.83 120.62 42.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -113.26 160.48 18.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 111.43 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -90.4 132.02 35.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.849 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.87 148.93 36.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.567 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.67 14.57 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.552 2.168 . . . . 0.0 112.567 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.0 -48.97 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.48 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.65 -17.29 4.11 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 71.69 74.61 0.72 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.578 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 79.5 m-85 83.58 -25.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.113 0.565 . . . . 0.0 110.873 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 59.61 14.95 30.96 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 114.412 0.525 . . . . 0.0 114.412 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.543 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 1.1 pp -133.98 144.44 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 117.796 0.798 . . . . 0.0 112.676 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -106.8 129.01 54.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.748 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.449 ' CD2' ' HB2' ' A' ' 55' ' ' PRO . 0.2 OUTLIER -95.75 115.98 28.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.883 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -70.13 157.24 37.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.299 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.6 106.36 2.51 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.106 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.436 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.6 p 52.5 -170.79 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.595 0.236 . . . . 0.0 110.46 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 46' ' ' PHE . 58.4 t -144.45 -96.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.708 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 53' ' ' SER . 40.7 p90 -45.79 -52.11 11.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 45.35 78.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 15.9 p -153.7 96.68 2.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.073 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 48' ' ' THR . 2.6 pt-20 54.66 118.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.736 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 28.1 m 75.1 -12.13 0.99 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.601 ' O ' ' CB ' ' A' ' 52' ' ' SER . 0.8 OUTLIER 33.56 -129.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.289 0.236 . . . . 0.0 111.464 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 7.7 t 104.84 4.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.401 0.68 . . . . 0.0 110.263 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.505 ' CB ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -76.51 110.13 10.62 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.012 178.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 52' ' ' SER . 96.0 Cg_endo -78.93 160.34 27.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.344 2.03 . . . . 0.0 112.714 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.449 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 10.2 Cg_endo -53.34 147.88 35.05 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.694 2.263 . . . . 0.0 111.357 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.85 123.9 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.812 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 68.7 mt -60.71 130.79 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -109.93 10.67 24.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.424 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -167.2 134.09 2.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.914 0.387 . . . . 0.0 111.712 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.543 ' CD1' ' CG2' ' A' ' 39' ' ' ILE . 4.1 mm -121.04 141.92 39.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.198 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -95.22 155.04 16.9 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.833 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.41 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.62 44.79 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.31 45.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.868 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.429 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -137.81 140.5 29.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.68 -12.13 8.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.618 2.212 . . . . 0.0 113.221 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.69 -57.85 6.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.446 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.45 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.24 -30.19 43.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.888 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.441 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -71.84 -18.13 62.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.758 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 51.4 t -48.15 -50.61 28.16 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.749 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.62 -4.29 7.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.441 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.411 HG12 ' HA3' ' A' ' 162' ' ' GLY . 27.3 m -152.21 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.164 0.482 . . . . 0.0 111.613 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.9 mt -135.27 142.38 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.019 0.438 . . . . 0.0 111.198 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.52 -175.47 4.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.646 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.4 mm -69.62 67.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.089 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.33 71.79 0.22 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.762 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -97.14 111.18 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -68.76 144.03 54.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 109' ' ' LEU . 9.4 m -126.6 133.62 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.16 -24.95 15.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.13 133.63 12.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.108 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 24.6 mt -122.56 114.86 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.811 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 53.02 24.02 3.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.106 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.52 15.69 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.621 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.47 131.06 88.46 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 120.438 0.161 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.16 -157.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.498 2.132 . . . . 0.0 112.045 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 22.7 p -158.79 -67.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.054 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -69.88 -11.64 61.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.461 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.07 42.15 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.978 0.418 . . . . 0.0 110.765 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.07 176.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.771 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -70.41 121.6 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -49.63 -28.39 5.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -54.73 -36.65 64.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.185 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -61.66 -41.16 97.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' O ' ' HG ' ' A' ' 98' ' ' LEU . . . -63.02 -37.5 87.44 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.52 0.676 . . . . 0.0 109.868 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.407 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.9 OUTLIER -61.78 -41.07 97.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.102 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.86 -56.49 16.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.42 ' CG ' ' HA ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -53.75 -30.16 43.02 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.424 ' CD2' ' CD1' ' A' ' 41' ' ' LEU . 48.7 mt -76.21 -48.06 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.207 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 6.3 mtt85 -50.1 -31.06 12.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.8 p30 -120.54 38.34 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.352 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.12 34.13 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.187 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -131.77 13.4 4.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.839 0.352 . . . . 0.0 111.802 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.43 -46.28 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.753 0.787 . . . . 0.0 110.403 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -2.11 56.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.549 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.5 p 62.39 25.69 15.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -167.59 153.48 7.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.071 0.462 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 101' ' ' SER . 25.1 t -154.71 137.53 7.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.75 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.15 123.66 49.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.744 0.307 . . . . 0.0 110.482 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.401 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -140.49 153.76 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.903 0.382 . . . . 0.0 111.371 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.27 137.19 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.457 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 45.7 pt -117.12 142.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 111.612 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -112.94 118.57 35.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.385 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.475 ' CZ ' ' HD2' ' A' ' 167' ' ' ARG . 2.4 p90 -136.84 174.22 10.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.933 0.396 . . . . 0.0 111.382 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -102.21 155.18 18.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.594 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 m -99.12 105.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.0 111.435 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 175.9 132.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.696 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.451 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.4 OUTLIER -140.57 12.89 2.33 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.87 88.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.193 0.52 . . . . 0.0 110.963 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.3 m -110.18 145.99 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.957 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.644 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.6 pp -130.44 90.9 39.75 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 121.233 0.539 . . . . 0.0 110.632 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 62.6 Cg_endo -91.33 -173.79 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.176 2.584 . . . . 0.0 113.504 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER 178.75 36.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.784 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.5 OUTLIER 54.25 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.374 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.62 -42.63 2.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.457 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.51 102.35 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.811 0.339 . . . . 0.0 110.393 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.485 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 9.7 t80 -100.54 116.08 31.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.644 ' HB2' HG13 ' A' ' 120' ' ' ILE . 38.5 m80 -95.52 138.06 33.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 206' ' ' LEU . 8.0 p -126.76 98.15 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.566 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.14 105.1 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.345 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.405 ' HB2' HG12 ' A' ' 204' ' ' VAL . 0.7 OUTLIER -113.41 125.55 29.46 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.76 115.29 3.33 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.181 1.921 . . . . 0.0 110.702 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HD3' ' CG1' ' A' ' 204' ' ' VAL . 0.1 OUTLIER -94.36 159.08 15.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.272 0.558 . . . . 0.0 111.928 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.444 ' HD2' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -113.61 -165.84 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.011 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -73.9 0.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 m -152.83 82.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.283 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 133' ' ' LYS . 65.1 t -130.46 159.2 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -50.37 151.53 2.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.059 0.456 . . . . 0.0 111.555 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.409 ' HB3' ' CG1' ' A' ' 140' ' ' ILE . 5.2 mt -138.64 -52.95 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 89.92 36.38 7.26 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.154 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.409 ' CG1' ' HB3' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -109.61 126.1 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.354 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.9 m -126.38 131.48 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.373 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.6 mt -105.89 163.29 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.0 m -166.93 159.85 13.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.017 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.4 p -115.02 130.13 24.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.583 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -62.39 -52.1 2.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.359 2.039 . . . . 0.0 112.206 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.4 m -161.86 140.62 9.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.1 t -103.88 31.07 4.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.019 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.33 45.22 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.79 152.35 0.89 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.72 -9.22 25.57 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.657 2.238 . . . . 0.0 112.782 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -98.4 26.24 24.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.648 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -47.16 102.21 0.3 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.589 0.233 . . . . 0.0 111.395 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -90.95 174.62 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.572 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.71 145.51 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.457 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.418 HG11 ' HA ' ' A' ' 176' ' ' LYS . 29.8 m -149.17 172.5 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.507 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 mp -81.56 152.7 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.74 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.73 -11.39 5.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.57 136.21 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 1.5 mt -131.97 143.52 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.279 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.58 178.89 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.47 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -116.25 152.83 33.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.267 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.411 ' HA3' HG12 ' A' ' 71' ' ' VAL . . . 93.47 -30.44 7.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.775 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -82.79 140.01 33.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.969 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.0 m -49.43 -23.19 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.183 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -44.92 -67.6 0.27 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.455 ' HB3' ' NH1' ' A' ' 167' ' ' ARG . 54.6 t60 -83.62 -26.55 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.475 ' HD2' ' CZ ' ' A' ' 113' ' ' PHE . 0.2 OUTLIER -58.54 -29.89 66.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 6.9 t -58.8 -21.28 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.84 49.92 4.61 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.268 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.44 HG23 ' CZ ' ' A' ' 126' ' ' PHE . 1.6 p -150.61 -52.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 110.958 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 4.0 mp -55.31 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.05 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -139.15 142.81 37.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.821 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 68.9 mt -56.97 114.39 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.76 16.91 4.38 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.996 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -100.83 148.16 25.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.775 0.287 . . . . 0.0 110.485 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.418 ' HA ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -107.18 130.37 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 111.281 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.04 127.84 40.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.804 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.64 -44.94 2.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -137.42 155.29 49.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.506 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 193' ' ' ALA . 20.6 mt -139.28 128.95 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.195 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 2.2 t70 49.45 42.6 22.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 2.1 t-20 82.64 -24.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 38.3 mm -76.56 155.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -128.63 127.15 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.453 0.644 . . . . 0.0 112.318 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -90.19 -17.01 28.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.399 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.9 t0 63.94 -71.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.23 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 185' ' ' LEU . 1.0 OUTLIER -158.27 56.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.442 . . . . 0.0 110.617 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.433 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 0.0 OUTLIER 170.06 -166.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.221 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 68.77 43.79 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.872 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 4.4 tpt -57.9 -58.17 9.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 109.888 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.53 -32.86 74.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 109.876 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -43.73 95.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.864 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 180' ' ' ILE . . . -57.87 -43.75 86.21 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.552 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 14.5 t -58.02 -38.93 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.73 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -50.67 71.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.104 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.1 mt -67.93 -24.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.539 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -61.1 -32.71 72.38 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.551 179.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.66 -32.97 10.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.048 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -16.2 39.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.527 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 67.3 m -84.14 41.97 0.85 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.77 59.2 0.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.119 0.485 . . . . 0.0 111.696 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.35 -33.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.101 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.5 tt -179.69 106.86 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.2 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.407 ' CG1' ' HD3' ' A' ' 132' ' ' LYS . 3.5 p -98.93 124.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.143 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -110.67 107.78 17.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.461 ' HB2' ' CG1' ' A' ' 128' ' ' VAL . 1.6 mm? -100.18 128.77 46.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.974 0.416 . . . . 0.0 111.932 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.455 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -97.2 93.25 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.078 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.9 mm -90.63 169.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.158 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 62.5 mtt180 -108.6 130.95 55.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 142.14 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.894 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 178.65 80.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -52.08 161.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.178 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.843 0.354 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 m -143.4 129.74 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.57 96.25 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.078 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 8.3 p-80 -100.06 115.07 28.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -53.35 125.59 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -120.45 162.7 19.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 p -113.11 135.71 53.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 93.6 m -132.79 160.42 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.77 162.08 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.518 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.03 133.12 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.926 0.393 . . . . 0.0 111.081 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.428 ' O ' ' CG1' ' A' ' 28' ' ' VAL . 5.2 p -110.9 116.3 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 11.2 mt -112.56 136.25 52.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.482 ' O ' ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -119.61 159.82 23.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.92 129.12 45.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.368 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -107.48 152.82 41.49 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.96 14.46 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.42 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.01 -47.15 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.4 t -148.92 11.05 0.82 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 59.3 -102.58 0.31 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.461 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CE2' ' O ' ' A' ' 30' ' ' THR . 41.4 m-85 -121.37 124.22 44.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -96.23 28.21 13.91 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.709 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.492 HG22 HG23 ' A' ' 60' ' ' ILE . 7.4 pt -128.35 134.86 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 120.842 0.353 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.0 145.31 49.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.977 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.26 138.68 51.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.42 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -78.32 169.8 17.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.324 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -108.34 -68.2 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.764 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.3 144.26 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 ' CG2' ' CD2' ' A' ' 56' ' ' LEU . 72.8 t -141.45 -89.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.8 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 48.3 p90 -58.14 -46.51 85.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.665 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.579 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 46.61 100.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.08 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.473 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER 171.64 105.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.979 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 48' ' ' THR . 9.1 pt-20 52.92 33.61 14.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 110.539 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER 161.49 174.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.035 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -163.64 23.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.544 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.81 23.31 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.07 139.93 97.88 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.008 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.17 157.46 50.39 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.392 2.061 . . . . 0.0 111.922 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -50.3 155.15 5.08 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.434 2.089 . . . . 0.0 112.19 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -148.88 112.66 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 13.2 mm -53.89 141.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.0 110.996 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.82 -32.36 2.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.457 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 86.2 t80 -141.92 156.02 45.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.325 0.584 . . . . 0.0 111.861 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.7 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 17.8 mm -136.34 161.27 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.087 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -107.18 150.29 26.77 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 121.922 -0.486 . . . . 0.0 111.877 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.32 39.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.028 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 36.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.923 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.439 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 41.2 p -128.58 138.67 33.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HG3' ' HB2' ' A' ' 32' ' ' ASP . 17.6 Cg_endo -57.7 -16.05 23.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.724 2.282 . . . . 0.0 112.869 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.59 -48.74 30.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.564 0.697 . . . . 0.0 109.692 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.7 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.5 tp10 -70.25 -32.46 70.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.422 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.559 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -93.88 -5.43 48.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -42.59 62.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.824 0.345 . . . . 0.0 110.674 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.9 -19.3 4.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.38 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 m -146.89 75.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 117.108 0.454 . . . . 0.0 111.991 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.8 mt -157.87 121.62 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.931 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -144.24 -176.31 4.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.544 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.6 126.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.0 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.468 ' N ' ' HB ' ' A' ' 57' ' ' ILE . . . 57.88 84.54 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.669 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -95.07 -30.54 14.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.036 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 63.45 105.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 109' ' ' LEU . 14.8 p -98.47 148.39 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.494 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.7 ttp -109.34 -24.93 10.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.462 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -158.48 145.27 17.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.2 mt -133.14 113.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.92 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 54.09 24.18 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.34 -31.83 6.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.485 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -69.53 110.45 6.4 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.383 0.135 . . . . 0.0 111.301 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.96 -27.93 66.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.304 2.003 . . . . 0.0 112.046 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 p 72.28 2.15 4.22 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.678 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -14.3 42.8 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.297 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -120.95 45.72 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.93 153.04 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.784 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.7 m -60.15 163.83 4.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 6.5 p90 -65.59 -39.27 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.683 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 58.1 mt-10 -54.97 -32.94 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.478 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -53.34 58.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.135 0.493 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.68 -37.97 66.41 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.673 0.749 . . . . 0.0 109.863 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -59.93 -36.85 77.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.619 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 5.3 mm-40 -62.23 -43.29 99.17 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.827 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.6 mt -53.72 -41.93 67.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.854 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.4 mp -75.23 -44.65 45.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.628 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -50.92 -31.99 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.275 0.559 . . . . 0.0 109.693 178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 5.1 p30 -127.52 42.75 3.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.265 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.404 ' CB ' HG22 ' A' ' 107' ' ' VAL . 2.5 p -81.27 6.53 13.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.639 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.27 18.52 19.81 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 9.6 mt -70.79 -53.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.913 0.863 . . . . 0.0 110.418 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.72 9.51 29.64 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.484 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 30' ' ' THR . 2.0 m 58.93 20.87 8.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.272 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 1.6 mttt -166.61 158.42 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.575 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.404 HG22 ' CB ' ' A' ' 101' ' ' SER . 66.1 t -155.29 106.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.426 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.77 132.82 39.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.07 163.59 32.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.067 0.461 . . . . 0.0 111.611 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -120.34 128.59 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.6 pt -119.41 153.65 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.929 0.395 . . . . 0.0 111.623 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -120.43 119.14 32.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.465 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.433 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 6.5 p90 -138.08 174.21 10.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.275 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.3 142.25 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.579 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.8 m -87.26 108.25 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.38 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.47 133.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.424 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.2 OUTLIER -149.91 23.85 0.86 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.1 t 83.68 100.84 0.05 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.197 0.523 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.463 ' CG1' ' CE1' ' A' ' 126' ' ' PHE . 2.0 t -135.39 123.02 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.175 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.6 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.6 pp -96.9 106.97 34.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.267 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 69.9 Cg_endo -95.34 137.02 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.291 2.661 . . . . 0.0 112.679 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -139.81 -80.55 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.62 113.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.85 -31.9 6.53 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.529 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.402 ' CG2' ' HE2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -138.38 102.65 4.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.964 0.411 . . . . 0.0 111.316 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.463 ' CE1' ' CG1' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -103.31 121.01 41.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.861 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.6 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -105.75 130.79 53.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.369 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 3.6 t -109.46 86.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.14 98.91 8.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.722 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.53 125.35 27.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.005 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.58 115.77 2.78 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.353 2.035 . . . . 0.0 111.646 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.423 ' HB3' ' N ' ' A' ' 202' ' ' ASP . 18.1 tttp -90.59 151.35 21.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.445 ' CD ' ' HB ' ' A' ' 136' ' ' VAL . 2.4 mttt -84.95 -168.52 2.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.921 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -72.44 -33.46 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.796 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 m 175.2 40.42 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.799 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' HB ' ' CD ' ' A' ' 133' ' ' LYS . 1.2 t -72.24 162.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.42 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.58 157.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.985 0.421 . . . . 0.0 111.341 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -164.99 107.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . -89.93 39.55 3.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.394 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.408 ' CD1' ' CB ' ' A' ' 165' ' ' ALA . 4.4 mm -84.75 124.2 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.801 0.3 . . . . 0.0 110.34 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.441 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 85.3 m -115.75 141.57 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 mt -114.42 163.88 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.868 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.0 t -166.61 156.38 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.766 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.0 t -115.5 144.85 33.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.4 174.42 10.1 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.449 2.099 . . . . 0.0 112.203 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.77 47.83 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.974 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.2 t -86.74 2.92 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.294 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 60.72 45.17 10.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.984 0.421 . . . . 0.0 111.12 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.461 ' HD3' ' CD ' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -124.2 161.03 49.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.504 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.34 61.78 2.06 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.459 2.106 . . . . 0.0 112.354 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 50.43 41.59 41.15 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.42 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.504 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -55.34 -59.98 9.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.504 ' HD3' ' CB ' ' A' ' 152' ' ' ASP . 54.3 Cg_endo -93.59 -179.77 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.906 2.404 . . . . 0.0 112.884 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -137.46 155.46 49.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.077 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.1 t -151.68 161.21 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.872 0.367 . . . . 0.0 111.922 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.5 mt -94.26 152.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.096 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.16 -16.71 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 178.91 137.83 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.28 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.457 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 1.0 OUTLIER -129.68 122.99 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.578 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.402 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -86.2 155.6 20.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 111.111 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -79.58 179.83 7.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.55 -54.7 4.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.804 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.45 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.6 OUTLIER -59.24 144.2 46.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.157 0.503 . . . . 0.0 111.376 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.8 m -56.4 -21.08 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.046 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.442 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -59.36 -71.73 0.12 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.731 0.3 . . . . 0.0 111.361 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.481 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 21.3 t60 -66.46 -24.76 66.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.952 0.406 . . . . 0.0 110.499 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.481 ' NH2' ' HB3' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -56.88 -42.58 80.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.501 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 13.2 t -50.3 -30.08 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 59.37 89.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.77 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.424 ' OG1' ' CE2' ' A' ' 126' ' ' PHE . 15.3 t -177.75 -38.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 110.866 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.43 152.66 44.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.814 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -147.63 151.8 36.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.23 127.82 33.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.43 23.55 4.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.61 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.416 ' CB ' ' CG2' ' A' ' 208' ' ' ILE . 21.3 m-20 -116.22 -168.98 1.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.684 0.278 . . . . 0.0 110.604 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.71 120.84 28.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.858 0.361 . . . . 0.0 111.275 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.5 mt -78.06 144.53 36.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.613 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.24 -41.43 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.41 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -148.87 166.74 27.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.6 mm -139.84 117.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.246 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 25.5 t0 57.91 -86.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -127.25 -13.85 5.5 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.415 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 27.4 mm -96.59 159.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.415 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 15.9 mtt85 -118.61 123.68 45.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.386 0.612 . . . . 0.0 112.321 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.427 ' N ' ' CD2' ' A' ' 185' ' ' LEU . 0.8 OUTLIER -77.49 -13.42 59.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.789 178.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.17 -28.99 1.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.2 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.73 -5.14 6.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.642 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -96.0 133.1 40.62 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -57.39 -178.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.074 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 5.6 ttp -66.15 -57.25 8.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.57 -38.0 71.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.256 0.55 . . . . 0.0 110.72 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.7 -44.81 93.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.935 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.417 ' CB ' HD12 ' A' ' 185' ' ' LEU . . . -57.76 -42.96 85.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.442 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 8.9 t -60.7 -33.72 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.245 0.545 . . . . 0.0 109.786 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -50.18 74.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.949 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 2.3 mp -73.79 -24.6 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.885 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -64.37 -28.45 69.7 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -103.44 -33.71 8.97 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -16.04 60.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.167 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 13.8 p -85.97 43.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.195 0.521 . . . . 0.0 110.456 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.418 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 5.5 pt-20 -70.75 62.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.539 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.423 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 1.9 m-20 -178.14 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.404 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 20.5 tp -176.89 107.05 0.06 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.765 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 6.9 t -102.01 115.7 44.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.655 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 13.2 ttmm -104.51 108.32 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.906 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 3.4 mm? -87.49 102.7 14.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.915 0.388 . . . . 0.0 111.303 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.455 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -92.51 93.43 8.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.216 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.416 ' CG2' ' CB ' ' A' ' 175' ' ' ASP . 6.9 mm -92.92 163.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.545 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 21.8 mtm-85 -107.96 126.38 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.037 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.4 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 1.6 tttm -113.22 159.49 19.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.92 44.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.56 168.35 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.957 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.71 0.291 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.57 118.48 55.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.6 t -152.99 152.55 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -128.1 113.77 16.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.739 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -50.27 142.87 9.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -147.77 172.02 14.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.7 p -125.61 151.97 45.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.72 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.414 HG21 ' N ' ' A' ' 26' ' ' GLU . 89.9 m -145.74 164.4 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.07 161.89 13.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.48 150.16 28.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 111.187 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.87 109.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.442 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 0.7 OUTLIER -115.09 118.54 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -105.81 162.22 13.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.05 123.05 32.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.07 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.15 153.72 66.51 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.627 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -78.28 9.7 3.01 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.525 2.15 . . . . 0.0 112.506 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 t -112.11 -49.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 120.638 0.256 . . . . 0.0 111.356 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -145.7 3.83 0.98 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 -93.82 0.86 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.366 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CE2' ' OG ' ' A' ' 101' ' ' SER . 44.5 m-85 -125.6 120.74 31.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.2 9.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.465 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 29' ' ' LEU . 2.7 mp -93.14 151.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.32 0.581 . . . . 0.0 111.995 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -124.55 99.83 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.763 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 1.5 tp -96.17 148.55 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 28.4 pt20 -129.43 170.08 14.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.968 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.58 26.53 3.47 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.296 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.6 106.25 14.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 110.483 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.4 t -135.14 -85.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.616 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.517 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 4.3 p90 -34.92 -44.63 0.23 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.116 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 55.08 66.58 1.19 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.528 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 30.8 p -161.07 -166.31 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.938 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' O ' ' CG2' ' A' ' 50' ' ' THR . 2.3 pt-20 -51.7 171.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 49' ' ' GLU . 11.9 t 45.25 -153.85 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.993 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -146.02 -94.29 0.09 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.707 0.289 . . . . 0.0 111.171 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 16.54 1.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.797 0.332 . . . . 0.0 111.823 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.51 133.74 85.59 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.17 137.29 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.391 2.061 . . . . 0.0 111.85 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -49.98 123.09 10.2 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.56 2.173 . . . . 0.0 111.963 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.465 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.4 pt? -139.42 119.88 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 111.512 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 48.3 mt -64.44 157.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.996 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.1 m -130.65 -12.6 3.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.354 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.0 t80 179.78 137.47 0.11 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.936 0.398 . . . . 0.0 111.259 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' ' CZ ' ' A' ' 59' ' ' TYR . 4.0 mt -111.28 171.95 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -111.13 155.1 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.663 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -79.05 59.23 2.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.286 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.08 41.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.313 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.2 p -131.27 137.67 31.11 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -61.6 -11.62 21.1 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.5 2.133 . . . . 0.0 112.764 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 39' ' ' ILE . . . -76.88 -56.06 4.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.013 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -73.46 -29.54 62.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.292 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.502 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.24 -42.65 68.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.4 t -47.78 -30.41 3.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.212 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.92 -9.31 74.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.916 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.1 t -101.71 31.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.981 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.1 mt -146.77 134.37 20.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -125.81 161.38 27.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.25 82.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.06 48.24 0.15 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.426 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -76.42 107.64 8.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.87 0.366 . . . . 0.0 110.74 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -69.96 73.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.39 125.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 ttp -95.58 -30.27 13.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -152.03 153.97 35.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.284 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 81' ' ' ILE . 4.0 mt -133.98 117.06 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 62.56 19.98 11.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.82 -24.22 22.15 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -71.23 123.14 88.88 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-O 120.519 0.2 . . . . 0.0 111.091 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -68.71 -26.3 33.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p 73.84 1.3 3.88 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.619 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -15.02 41.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.898 0.38 . . . . 0.0 111.358 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.18 46.37 0.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m 179.33 -177.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.4 m -93.3 153.17 18.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -52.17 -27.19 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 9.9 mt-10 -54.79 -36.73 65.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.944 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.356 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.77 -38.65 88.8 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.555 0.693 . . . . 0.0 109.991 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -59.52 -40.82 88.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.081 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 50.0 mm-40 -61.97 -44.3 97.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 110.21 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.4 mt -54.37 -41.11 68.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.203 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.63 ' HA ' ' HB3' ' A' ' 101' ' ' SER . 36.7 mt -73.56 -51.9 15.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.878 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -50.85 -29.84 12.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.962 0.41 . . . . 0.0 110.3 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 53.4 m-20 -126.63 39.66 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.63 ' HB3' ' HA ' ' A' ' 98' ' ' LEU . 1.2 p -89.22 10.98 20.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.84 18.88 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.1 mt -68.79 -49.73 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.877 0.846 . . . . 0.0 110.311 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.48 13.09 32.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.397 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 24.2 p 54.8 24.32 5.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.258 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -165.17 148.1 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.527 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.0 t -145.99 133.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.84 141.2 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 mp -136.31 146.87 47.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.569 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 106.1 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.03 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.3 pt -105.96 160.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 112.104 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -133.94 137.99 45.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.169 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 167' ' ' ARG . 5.9 p90 -161.24 174.11 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.723 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.25 113.15 22.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.807 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.8 104.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.236 0.541 . . . . 0.0 111.94 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.21 177.56 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.625 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 118' ' ' SER . 4.9 tp10 -177.95 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.449 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.5 t 163.55 109.21 0.0 OUTLIER 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.795 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.418 HG22 ' CG2' ' A' ' 170' ' ' THR . 7.1 p -140.52 147.59 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.133 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.477 ' CD1' ' HB2' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -123.34 77.87 53.51 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.95 0.405 . . . . 0.0 111.191 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.632 ' HA ' ' HB2' ' A' ' 126' ' ' PHE . 20.9 Cg_exo -68.65 145.9 65.3 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.351 2.701 . . . . 0.0 112.333 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.43 13.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.47 140.37 0.01 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.857 0.361 . . . . 0.0 111.254 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.97 -59.93 3.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.131 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 23.0 m -146.37 102.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.632 ' HB2' ' HA ' ' A' ' 121' ' ' PRO . 2.3 p90 -124.94 164.77 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.67 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.609 ' NE2' ' HD2' ' A' ' 207' ' ' LYS . 0.0 OUTLIER -120.51 163.9 17.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.274 0.559 . . . . 0.0 111.84 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 206' ' ' LEU . 28.0 m -130.81 104.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.007 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -81.99 112.69 19.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mp -126.72 117.13 22.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 131.59 46.89 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.249 1.966 . . . . 0.0 111.745 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.531 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -95.64 159.55 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.032 0.444 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.09 -168.69 2.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.856 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -68.96 65.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.463 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 46.52 65.46 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.044 0.449 . . . . 0.0 111.652 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.0 t -111.35 164.98 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -38.07 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.939 0.4 . . . . 0.0 111.663 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.419 ' CD2' ' CE ' ' A' ' 132' ' ' LYS . 0.2 OUTLIER -68.76 -42.52 77.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 163' ' ' SER . . . 90.04 -3.32 82.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.763 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.73 133.68 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.432 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 75.4 m -116.43 140.42 49.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.349 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.8 162.87 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.54 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 155' ' ' VAL . 0.6 OUTLIER -158.14 147.03 19.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.382 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 54.5 p -107.65 134.8 19.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.969 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -78.59 79.16 3.42 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.582 2.188 . . . . 0.0 112.419 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.0 p 58.2 -174.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.67 133.94 47.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.76 -170.59 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.32 161.85 5.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.2 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.25 62.56 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.901 2.401 . . . . 0.0 112.118 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.21 -38.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.637 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -45.75 126.68 6.65 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.615 0.245 . . . . 0.0 111.254 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.72 -175.23 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.492 2.128 . . . . 0.0 112.612 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.9 tp -89.7 169.84 10.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 143' ' ' SER . 22.0 t -147.77 160.51 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.906 0.384 . . . . 0.0 111.61 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.0 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.882 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -131.32 -7.19 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.432 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.0 OUTLIER -177.2 146.1 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.294 0.569 . . . . 0.0 112.072 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.8 mt -130.72 149.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.709 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 138.6 54.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.004 0.431 . . . . 0.0 111.609 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.419 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -81.76 -9.08 59.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.864 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -89.95 -16.89 55.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.673 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.411 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 2.9 m -114.12 169.94 8.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.899 0.38 . . . . 0.0 110.99 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.413 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 5.6 m -61.74 -22.58 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -43.49 -71.21 0.08 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.789 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.94 -24.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.975 0.417 . . . . 0.0 110.528 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.459 ' CD ' ' CE1' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -57.61 -29.91 64.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.8 p -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.97 74.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.589 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.418 ' CG2' HG22 ' A' ' 119' ' ' VAL . 3.2 t -168.62 32.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.966 0.412 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.51 107.15 15.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.689 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.53 150.87 40.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.4 mt -74.95 131.42 40.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.54 -25.7 8.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.45 -172.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.309 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.93 134.43 42.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.92 142.18 31.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.439 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.0 tt -120.85 -35.73 3.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.744 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -142.07 162.45 35.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.879 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.421 ' O ' ' N ' ' A' ' 182' ' ' ASN . 31.9 mt -139.34 116.71 11.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.37 -74.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -144.54 -19.3 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.932 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 28.5 mm -96.55 140.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 111.258 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.419 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 5.8 mtt180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.905 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.55 -6.72 51.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.243 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -41.18 -32.53 0.28 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.456 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m -121.48 -11.72 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.667 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 6.2 m -88.01 -169.78 2.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.142 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 80.5 p -112.3 -175.76 2.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -70.91 -56.89 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -53.97 -47.11 71.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.785 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -43.6 72.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.059 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 180' ' ' ILE . . . -56.86 -42.05 79.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.415 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.56 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 15.3 t -58.98 -39.15 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.291 0.567 . . . . 0.0 109.642 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.948 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.3 mt -69.81 -24.88 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.4 OUTLIER -59.34 -31.59 69.32 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.482 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -103.98 -33.55 8.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.141 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -19.67 55.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.709 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 19.8 p -85.49 47.12 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.281 0.563 . . . . 0.0 109.866 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.433 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 22.4 tt0 -68.37 63.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.65 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -173.23 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.875 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.531 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -178.72 107.46 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.433 ' CG2' ' CG ' ' A' ' 132' ' ' LYS . 2.9 t -85.6 108.35 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.604 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 8.9 ttmm -104.83 107.88 19.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 128' ' ' VAL . 2.5 mt -99.91 121.51 41.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.609 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 3.9 tttt -89.7 101.96 14.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.284 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.0 mm -91.97 158.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.409 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 29.9 mtp85 -113.81 121.79 45.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.686 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -114.14 106.17 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.058 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 177.89 42.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.65 168.69 19.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.162 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.51 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 12.7 p -112.96 115.18 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.74 0.305 . . . . 0.0 111.133 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.51 ' HB ' ' O ' ' A' ' 19' ' ' VAL . 5.3 p 172.71 163.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.758 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 33.0 t60 -88.24 106.24 18.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.797 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 p -53.29 161.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.202 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -168.68 169.13 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.7 p -129.33 164.74 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.879 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 12.4 t -147.78 -170.6 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.71 162.93 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.11 146.8 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.2 t -129.31 118.78 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.994 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.401 ' CD1' HD12 ' A' ' 39' ' ' ILE . 1.2 mt -114.38 118.86 35.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.82 163.27 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -98.83 115.75 29.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.267 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.48 152.03 59.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.576 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.65 9.21 3.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.636 2.224 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.33 -50.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 120.613 0.244 . . . . 0.0 111.428 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -132.39 -11.81 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -87.73 0.8 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.371 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.509 ' HB3' HD13 ' A' ' 39' ' ' ILE . 4.5 m-85 -133.38 118.98 19.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.094 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -95.29 28.51 11.72 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.915 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.509 HD13 ' HB3' ' A' ' 37' ' ' PHE . 4.0 mp -93.27 149.17 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.189 0.519 . . . . 0.0 112.012 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -145.0 99.08 3.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 57' ' ' ILE . 1.8 pp -112.03 157.27 20.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 169.63 10.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.867 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -119.41 -5.89 11.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.051 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 p -137.46 151.59 48.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.153 0.501 . . . . 0.0 111.537 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 95.1 t -151.98 -76.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.133 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.64 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 21.0 p90 -35.46 -46.77 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.25 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.0 69.23 0.46 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 166.96 95.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.2 146.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.104 0.478 . . . . 0.0 111.736 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.417 ' O ' ' CE2' ' A' ' 46' ' ' PHE . 63.1 p 45.59 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.703 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.64 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -132.76 -77.32 0.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.889 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.66 17.36 0.09 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.036 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.513 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 1.7 t -108.36 99.36 32.05 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.553 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 172.44 16.19 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.426 2.084 . . . . 0.0 111.978 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -45.61 133.46 13.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.712 2.275 . . . . 0.0 112.003 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -129.0 97.23 4.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.507 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.503 ' HA ' ' HB3' ' A' ' 41' ' ' LEU . 27.4 mt -59.43 139.16 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.948 0.404 . . . . 0.0 110.904 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.409 ' HB3' ' NE2' ' A' ' 40' ' ' GLN . 2.5 t -124.2 1.48 8.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.2 t80 179.15 134.76 0.09 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.047 0.451 . . . . 0.0 111.626 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.404 ' CG2' ' CB ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -108.58 162.91 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.408 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 40.9 tt0 -98.71 152.56 19.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.401 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.485 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -82.52 56.45 3.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER 165.76 42.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.431 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 t -132.05 139.95 36.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.92 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.34 -10.23 20.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.442 2.095 . . . . 0.0 112.626 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.09 -56.18 5.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.978 0.418 . . . . 0.0 110.841 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -76.81 -29.81 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.159 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.485 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -74.49 -29.89 61.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -44.91 69.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.06 28.05 7.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.4 t -148.23 26.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.0 mt -137.36 129.77 29.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -128.72 174.61 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.2 mm -66.81 74.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 128.28 46.04 0.19 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.37 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -74.89 98.46 3.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -78.54 115.8 18.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.4 m -101.64 167.5 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 tpt -117.65 -40.96 2.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.43 133.48 22.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.465 HG23 HD11 ' A' ' 81' ' ' ILE . 7.0 mt -119.12 116.27 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.7 p30 47.38 26.07 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.378 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.34 -28.73 10.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.872 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.43 136.85 86.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-O 120.718 0.294 . . . . 0.0 111.567 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.3 167.47 19.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.555 2.17 . . . . 0.0 112.213 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 44.8 p -141.12 -54.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.004 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.45 -8.37 55.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.13 44.76 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.95 176.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.406 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 7.9 m -62.87 145.45 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.466 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 8.2 p90 -73.34 -27.06 61.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.151 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.9 mt-10 -54.63 -42.17 70.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.843 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.419 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.6 pt-20 -61.0 -44.49 97.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.317 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.83 -35.63 75.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.6 m120 -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.88 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 39.3 mm-40 -62.07 -37.34 84.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.042 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 93' ' ' GLU . 23.5 mt -57.43 -49.6 75.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.421 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 1.1 mt -69.92 -57.5 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 63.3 mtt180 -50.5 -31.66 16.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.44 0.638 . . . . 0.0 109.604 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.7 m-20 -119.25 39.68 3.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.675 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -93.17 26.31 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.9 t -124.43 15.71 8.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -68.33 -39.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.783 0.802 . . . . 0.0 110.409 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 11.68 30.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.552 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.8 m 57.92 22.2 8.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.905 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.74 156.25 2.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.362 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.48 129.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.055 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 134.07 47.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.025 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.23 138.12 31.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.59 144.04 27.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.318 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.0 pt -134.21 165.33 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.033 0.444 . . . . 0.0 111.828 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -132.16 140.95 48.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 0.5 OUTLIER -161.17 174.5 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.316 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -98.07 119.8 37.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.272 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.1 m -61.81 104.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.556 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.0 124.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.812 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -137.44 52.67 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 t 65.33 89.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.332 0.587 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.01 122.34 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.111 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.8 pp -115.6 89.59 23.3 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.315 0.578 . . . . 0.0 110.328 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.506 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.5 Cg_endo -97.04 169.55 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.211 2.608 . . . . 0.0 113.134 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.2 p -153.58 -66.58 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.145 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 166.3 109.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.02 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.05 -32.72 5.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.401 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.444 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -129.25 102.72 6.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.041 0.448 . . . . 0.0 110.768 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -105.43 125.21 50.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.045 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.525 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -113.73 129.04 56.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.959 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 206' ' ' LEU . 31.6 m -114.1 104.69 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.105 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.408 ' HG2' ' HD3' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -87.35 106.57 18.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.781 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.38 136.48 25.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.661 0.267 . . . . 0.0 111.203 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.28 139.81 51.25 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.349 2.033 . . . . 0.0 111.338 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -124.77 158.3 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.674 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.644 ' CG ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -130.48 172.98 11.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.238 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 133' ' ' LYS . 1.4 p80 -47.23 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.43 98.33 5.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.644 ' HB ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.5 -177.28 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -96.35 97.48 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.748 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 mt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.758 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.79 3.69 65.95 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.923 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.47 137.88 28.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 110.711 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 98.7 m -126.02 128.26 47.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.708 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.7 mt -95.93 163.91 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 22.7 t -175.01 177.58 1.93 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.0 t -114.51 134.49 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.26 176.49 9.89 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.562 2.175 . . . . 0.0 112.297 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.82 -164.8 0.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 58.18 85.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 110.621 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.402 ' HD3' ' N ' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -67.54 72.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.959 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.414 ' HB3' ' HD2' ' A' ' 150' ' ' PRO . 19.9 mttt -80.24 159.78 69.5 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.698 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 149' ' ' LYS . 1.9 Cg_endo -44.94 -28.79 3.28 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.805 2.337 . . . . 0.0 112.024 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.37 -71.65 1.0 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.116 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.6 t70 65.14 73.06 0.44 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 0.0 111.267 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.1 -157.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.661 2.241 . . . . 0.0 112.117 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 177' ' ' LEU . 1.6 mp -104.85 -173.43 2.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.506 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 175' ' ' ASP . 7.6 p -178.43 138.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.267 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.0 mt -70.27 154.23 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.826 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 t -134.89 -8.94 2.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.418 ' CB ' ' HB ' ' A' ' 141' ' ' THR . 0.8 OUTLIER -158.71 142.29 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.059 0.457 . . . . 0.0 111.451 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.4 mt -141.05 133.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.447 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.3 164.83 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.49 163.58 12.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.771 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.71 -11.89 54.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.902 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.5 m -113.42 148.96 34.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.69 -22.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.227 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -55.12 -64.06 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.743 0.306 . . . . 0.0 111.558 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -81.31 -24.69 37.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.77 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -55.05 -40.86 70.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.193 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 5.1 t -52.01 -26.07 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.029 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.01 67.04 2.41 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.808 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 t 178.84 40.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 110.825 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.39 -77.7 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.718 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 62.11 149.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.091 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.65 107.06 8.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.728 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.38 -18.01 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.613 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.528 ' HB3' HG23 ' A' ' 208' ' ' ILE . 1.9 m-20 -60.29 144.66 49.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.222 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 209' ' ' ARG . 0.1 OUTLIER -110.49 114.61 28.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.67 0.271 . . . . 0.0 110.917 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 0.5 OUTLIER -70.15 176.03 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -156.82 -43.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.945 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -145.87 173.37 12.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.271 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.438 HG12 HD22 ' A' ' 185' ' ' LEU . 24.3 mm -139.04 105.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.1 OUTLIER 47.18 -88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.534 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -102.49 -17.96 15.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 33.4 mm -100.28 156.68 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 111.747 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.404 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 38.0 mtp180 -125.93 119.33 27.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.555 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 187' ' ' SER . 2.7 mm? -76.08 -12.93 60.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.055 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.06 -76.56 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.809 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 185' ' ' LEU . 23.9 p -159.57 33.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.725 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 174.4 -171.05 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.679 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 192' ' ' ASP . 0.8 OUTLIER 75.68 39.72 0.32 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' MET . . . . . 0.437 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 7.8 ptm -53.87 -44.77 70.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.795 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -64.44 -37.23 86.8 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.61 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 189' ' ' SER . 3.1 m-20 -62.32 -42.21 99.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.31 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.549 ' O ' ' HB3' ' A' ' 197' ' ' LEU . . . -58.9 -49.76 76.57 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.812 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.9 t -55.94 -28.46 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.378 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -50.15 48.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.484 ' HA ' ' CG ' ' A' ' 199' ' ' GLN . 3.1 mp -80.06 -24.39 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.839 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.549 ' HB3' ' O ' ' A' ' 193' ' ' ALA . 0.0 OUTLIER -77.68 -23.9 49.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.579 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -85.98 -47.69 9.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.202 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.484 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -68.29 -10.31 53.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.5 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.48 46.65 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.409 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 7.5 pt-20 -73.15 62.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.358 0.599 . . . . 0.0 111.085 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -170.07 -32.73 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.261 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 5.2 tt 178.95 108.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.74 122.82 64.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.219 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 35.5 ttpt -109.54 114.35 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.456 ' HB2' ' CG2' ' A' ' 128' ' ' VAL . 2.5 mm? -91.86 119.19 31.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.073 0.463 . . . . 0.0 111.461 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.484 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 3.9 tttm -92.06 93.63 8.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.984 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.528 HG23 ' HB3' ' A' ' 175' ' ' ASP . 6.9 mt -94.9 165.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.803 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -105.75 128.52 53.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.786 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -132.33 114.52 14.49 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.234 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.28 54.92 2.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.78 -172.47 2.39 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.197 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 29.1 t0 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.006 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.9 p -148.9 121.74 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.057 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.5 128.74 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.0 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -119.08 115.59 24.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 p -51.67 116.02 1.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.14 168.49 10.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -125.42 134.75 52.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 7.2 t -121.58 177.23 5.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.35 162.08 16.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.751 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.21 148.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.99 109.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 3.0 mm? -107.54 118.37 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.47 162.31 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.157 0.503 . . . . 0.0 111.588 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.488 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 116.75 33.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.72 153.19 60.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.656 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.32 3.17 6.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.591 2.194 . . . . 0.0 112.624 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.09 -51.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.241 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -132.76 -4.3 3.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.35 -97.16 0.94 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.269 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.488 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 42.0 m-85 -119.01 115.57 24.6 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -83.1 11.11 56.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.94 -0.647 . . . . 0.0 114.116 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.439 HG13 ' CB ' ' A' ' 66' ' ' ALA . 26.5 mt -92.82 146.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.387 0.593 . . . . 0.0 111.981 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -139.39 99.96 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.948 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 1.4 pp -108.92 152.9 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.344 0.592 . . . . 0.0 112.267 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -99.53 170.1 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.329 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -133.21 31.95 2.81 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.872 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.22 68.38 0.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.122 0.486 . . . . 0.0 110.703 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 56' ' ' LEU . 12.4 t -57.2 -75.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.928 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 p90 -68.54 -44.65 74.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.34 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 52.55 86.64 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.544 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 70.9 p -159.19 81.15 0.77 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 44.2 60.19 2.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.857 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.681 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 177.81 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.339 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.681 ' HG ' ' C ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 36.16 22.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.367 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -70.78 20.36 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -79.42 120.22 79.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.703 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.81 168.03 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.524 2.149 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -51.4 142.45 37.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.709 2.273 . . . . 0.0 112.136 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.413 ' CD2' HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -144.98 108.34 4.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.65 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.492 HG21 HD12 ' A' ' 57' ' ' ILE . 22.6 mt -62.9 117.23 3.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.843 0.354 . . . . 0.0 110.74 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -97.68 -22.82 16.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 58.4 t80 -162.08 127.49 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.027 0.442 . . . . 0.0 111.692 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 2.1 mt -99.17 -173.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -116.08 144.01 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.385 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -71.84 100.32 2.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.067 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 8.0 t0 99.33 49.17 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.821 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.03 140.53 38.05 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 14.4 Cg_endo -56.7 -18.66 27.47 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.359 2.04 . . . . 0.0 111.686 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 39' ' ' ILE . . . -67.53 -56.33 9.95 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 2.4 tp10 -77.75 -28.33 50.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.954 0.407 . . . . 0.0 109.986 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 4.0 mmt-85 -89.69 -1.78 58.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.652 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 22.7 t -48.87 -54.7 14.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.926 0.393 . . . . 0.0 110.76 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.4 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 140.01 -22.18 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.967 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.34 61.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 111.348 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 11.1 mt -147.45 145.34 29.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.305 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -141.49 172.96 11.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.1 mm -68.26 71.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.186 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.39 88.3 0.98 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.39 101.56 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.7 mmt-85 -59.81 139.25 57.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.36 148.91 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.002 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -30.21 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.962 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.43 137.88 23.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.228 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 11.8 mt -120.87 109.84 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.8 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 58.03 23.14 9.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 -28.27 12.28 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.324 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.404 ' CG2' ' HD2' ' A' ' 85' ' ' PRO . 30.1 mt -70.02 137.21 87.2 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.497 0.189 . . . . 0.0 111.316 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.404 ' HD2' ' CG2' ' A' ' 84' ' ' ILE . 41.7 Cg_endo -67.49 -168.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.37 2.046 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.4 p -151.75 -54.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.008 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.42 -13.29 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.48 45.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.797 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.26 -175.87 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.4 m -83.73 165.39 18.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.989 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 5.1 p90 -73.88 -41.53 62.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.3 tt0 -54.64 -32.51 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.034 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -49.39 77.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.51 70.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.526 0.679 . . . . 0.0 110.067 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.449 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.6 OUTLIER -59.09 -36.41 75.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.869 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 7.5 mm-40 -61.94 -42.75 99.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 10.6 mt -55.43 -44.25 76.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.638 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.447 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 0.5 OUTLIER -67.81 -47.42 69.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.216 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 8.9 mtm180 -50.44 -33.1 19.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.715 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.498 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 61.4 m-20 -120.22 38.08 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.106 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.447 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -95.19 21.54 7.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.242 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.2 p -125.5 16.58 8.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 111.823 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -62.86 -49.69 82.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.935 0.874 . . . . 0.0 110.413 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.64 8.77 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 15.4 m 62.6 26.91 15.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.808 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 6.3 mttt -154.95 157.94 38.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.674 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -155.45 114.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.248 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.48 141.23 29.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.832 0.348 . . . . 0.0 110.961 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.05 155.89 49.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -121.24 111.19 17.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.243 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.1 pt -114.73 163.09 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 111.676 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -131.28 142.87 50.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.514 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 0.2 OUTLIER -161.11 174.71 13.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.407 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.32 155.1 21.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.07 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -106.75 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.426 . . . . 0.0 111.691 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 173.05 117.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.706 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.1 OUTLIER -130.78 30.89 4.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.146 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.1 t 89.45 97.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.409 0.623 . . . . 0.0 111.293 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.3 p -139.91 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.13 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.679 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -108.1 101.67 42.6 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.464 ' HA ' ' CE1' ' A' ' 126' ' ' PHE . 15.9 Cg_exo -68.69 156.84 64.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.865 2.376 . . . . 0.0 112.68 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.04 104.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.01 115.27 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.003 0.43 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 102.45 -47.39 1.14 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.546 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.21 107.14 11.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.925 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.464 ' CE1' ' HA ' ' A' ' 121' ' ' PRO . 1.7 t80 -113.0 120.12 40.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.679 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -113.23 121.48 44.59 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 t -104.55 99.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.685 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.25 109.43 16.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.554 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD23 ' CG2' ' A' ' 168' ' ' THR . 26.1 mt -121.76 116.35 30.39 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.588 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.35 114.78 2.65 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.337 2.025 . . . . 0.0 111.612 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.458 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -87.72 158.96 18.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 111.259 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.77 -164.66 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.66 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.92 -36.53 62.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 m -177.49 70.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.4 HG11 ' HA2' ' A' ' 70' ' ' GLY . 21.5 t -118.54 159.26 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.364 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -65.95 133.56 51.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.939 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.42 ' HB3' HG12 ' A' ' 140' ' ' ILE . 1.9 mt -92.45 -49.4 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.706 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.02 16.11 39.66 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.42 HG12 ' HB3' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -106.39 141.22 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.19 0.495 . . . . 0.0 111.278 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.432 ' HB ' ' CB ' ' A' ' 158' ' ' ASP . 79.8 m -122.3 114.16 20.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.593 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 5.6 mt -84.98 160.79 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.926 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 155' ' ' VAL . 1.4 m -150.02 156.15 41.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.191 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.2 t -110.12 90.9 10.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.29 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.423 ' CG ' ' CG2' ' A' ' 155' ' ' VAL . 85.5 Cg_exo -44.49 165.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.618 2.212 . . . . 0.0 112.341 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.9 -161.81 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.56 170.02 21.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.006 0.431 . . . . 0.0 111.336 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 79.24 29.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.485 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -145.59 133.9 10.75 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.125 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.65 -23.16 14.56 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.952 1.768 . . . . 0.0 111.554 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 156.19 45.66 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.437 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -53.67 -56.25 27.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.437 ' HD3' ' CB ' ' A' ' 152' ' ' ASP . 72.3 Cg_endo -90.22 157.93 4.68 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.692 2.261 . . . . 0.0 112.973 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.11 133.97 47.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.766 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 143' ' ' SER . 73.2 t -156.34 159.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.441 ' N ' ' CG1' ' A' ' 155' ' ' VAL . 5.3 mt -105.24 139.54 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.729 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.7 m -127.32 -12.15 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.432 ' CB ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER -144.71 124.84 13.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.503 . . . . 0.0 111.903 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.4 mt -117.98 146.63 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.219 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.7 143.88 45.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 111.287 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 168.37 20.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.471 ' N ' ' NH1' ' A' ' 167' ' ' ARG . . . 83.8 -46.47 3.66 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.741 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.544 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.6 OUTLIER -72.74 175.47 6.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 111.381 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.405 HG13 ' CD2' ' A' ' 130' ' ' LEU . 40.9 t -73.63 -22.34 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.104 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HB2' HD12 ' A' ' 140' ' ' ILE . . . -53.67 -71.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.923 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.428 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 50.4 t60 -67.05 -24.76 66.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.69 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -57.12 -34.49 68.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.422 ' CG2' HD23 ' A' ' 130' ' ' LEU . 36.3 p -39.2 -58.02 1.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.511 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.18 -23.12 35.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.556 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.0 t -127.4 35.7 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.34 78.88 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.84 78.41 2.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 175' ' ' ASP . 26.5 mt 39.93 28.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.403 ' N ' HD12 ' A' ' 156' ' ' ILE . . . 70.74 -38.98 0.5 Allowed Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.909 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 173' ' ' LEU . 0.2 OUTLIER 72.86 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 -179.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -136.15 106.29 6.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.347 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.403 ' CD2' ' CG1' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -92.6 132.35 36.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.398 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.3 pp -134.77 -16.53 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.04 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -145.57 132.71 20.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.403 ' CG1' ' CD2' ' A' ' 177' ' ' LEU . 50.3 mt -135.65 118.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 16.1 m-20 57.82 43.56 21.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.212 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 3.1 t-20 83.49 -25.11 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.936 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 44.8 mm -81.31 157.96 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.744 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.4 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 19.6 mtm105 -129.59 126.45 38.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 112.175 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -79.89 -4.26 51.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.064 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.72 -32.37 0.38 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.0 t -115.58 -17.06 11.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.9 m -89.0 -169.76 2.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.012 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 m -109.12 -167.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 14.5 ttp -74.32 -53.44 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -53.4 -29.79 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 110.732 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.93 -52.3 66.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.228 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.413 ' HA ' HD13 ' A' ' 196' ' ' ILE . . . -58.25 -43.02 87.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.279 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.8 t -64.05 -31.81 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.705 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -48.2 77.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.848 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.538 ' HA ' ' CG ' ' A' ' 199' ' ' GLN . 2.2 mp -73.1 -24.69 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -37.61 88.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.627 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -86.43 -52.93 5.29 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.597 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.538 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -56.83 -18.17 11.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.946 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 196' ' ' ILE . 16.5 m -88.4 42.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.119 0.485 . . . . 0.0 110.123 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.48 62.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -163.89 -32.2 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.458 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 5.9 tt 177.39 106.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.55 121.33 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.666 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -104.62 108.74 20.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 127' ' ' HIS . 6.0 mp -91.82 117.43 29.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.459 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -107.21 108.64 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.221 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.6 175.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.426 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -114.29 120.04 39.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.015 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -125.87 108.85 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -179.01 43.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.122 0.487 . . . . 0.0 110.853 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.67 -168.91 2.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.038 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.439 179.767 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.869 0.366 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.69 131.87 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.066 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.1 t -124.98 133.08 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.285 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.426 ' CD2' HG13 ' A' ' 115' ' ' VAL . 26.5 p-80 -127.31 111.54 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.703 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -50.15 131.42 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.346 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -124.6 149.7 46.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.732 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.5 p -110.21 135.93 50.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -134.96 -169.68 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -117.07 163.09 16.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -141.51 148.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.3 t -127.73 115.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.276 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.4 mp -112.25 120.99 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.233 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -101.92 163.14 12.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.32 0.581 . . . . 0.0 111.512 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 105' ' ' SER . . . -107.5 103.71 13.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.24 149.36 55.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.424 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.28 4.47 5.37 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.532 2.155 . . . . 0.0 112.736 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.0 -46.21 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.528 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 46.3 p -127.91 -11.77 5.37 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.32 -93.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.195 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.403 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 37.6 m-85 -130.65 119.97 23.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.058 0.456 . . . . 0.0 110.104 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -79.7 3.41 69.17 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.306 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.407 ' CD1' ' CD1' ' A' ' 57' ' ' ILE . 34.5 mt -92.74 151.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.63 0.715 . . . . 0.0 112.024 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -151.53 99.56 2.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.104 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.497 ' HG ' ' HB3' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -102.52 157.41 16.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.394 0.616 . . . . 0.0 112.575 -178.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.401 ' HG2' ' HB2' ' A' ' 56' ' ' LEU . 1.5 pm0 -95.4 164.64 12.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.778 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -76.83 -98.34 0.17 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.854 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.1 p -112.61 148.46 34.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.115 0.483 . . . . 0.0 111.806 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.6 -64.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.409 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.63 ' CE1' ' HA ' ' A' ' 51' ' ' LEU . 30.2 p90 -40.92 -40.93 1.5 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.661 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 39.79 92.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.891 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER 173.02 70.6 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.252 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.445 ' C ' ' H ' ' A' ' 51' ' ' LEU . 6.1 pt-20 52.44 162.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.107 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 47.1 m 69.51 -10.57 0.56 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.34 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.63 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 32.3 -103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 t 71.49 12.65 6.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.6 . . . . 0.0 110.096 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.492 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -68.51 107.42 1.97 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.581 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.26 149.31 11.85 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.763 2.309 . . . . 0.0 111.333 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.497 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 84.5 Cg_exo -45.3 110.01 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' HB2' ' HG2' ' A' ' 42' ' ' GLN . 2.0 mp -105.92 92.9 4.36 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.886 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 40.3 mt -58.21 110.65 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-O 120.787 0.327 . . . . 0.0 110.558 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -91.16 -2.37 57.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.351 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 79.4 t80 178.95 142.92 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.131 0.491 . . . . 0.0 111.608 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 1.8 mt -121.48 170.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 56.8 tt0 -108.13 152.03 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.591 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.56 45.58 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.73 41.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.873 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.405 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 1.9 m -139.45 139.86 23.84 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.807 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.78 -15.3 25.81 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.782 2.321 . . . . 0.0 112.979 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.18 -56.81 12.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.94 0.4 . . . . 0.0 110.303 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -78.96 -29.62 44.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.752 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -64.1 -24.76 67.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.001 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -47.29 -29.65 2.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 137' ' ' GLU . . . 78.16 27.15 58.56 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.789 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 m -152.15 36.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.967 0.413 . . . . 0.0 110.935 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 39' ' ' ILE . 12.0 mt -137.29 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.13 152.65 15.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 74' ' ' ILE . 46.9 mt -62.74 103.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.77 29.83 3.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.507 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.82 152.74 40.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.7 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -116.4 97.48 6.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.8 t -73.14 151.88 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.134 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -30.95 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -157.32 143.7 17.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.189 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.21 115.3 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.8 18.63 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.78 -27.96 10.52 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.604 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 35.8 mt -74.91 132.98 76.44 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-O 120.507 0.194 . . . . 0.0 111.167 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.85 168.68 23.98 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.407 2.071 . . . . 0.0 112.286 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.8 p -131.26 -61.68 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -62.61 -18.2 61.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.38 44.51 1.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.611 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.52 -170.67 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.72 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -73.6 139.53 45.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.444 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 11.0 p90 -73.12 -32.7 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.5 mt-10 -54.0 -36.51 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.46 -45.38 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.74 -39.31 68.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.21 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -35.23 80.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.143 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 mm-40 -67.28 -41.25 85.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.591 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 101' ' ' SER . 12.5 mt -63.98 -50.28 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.903 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mt -69.76 -54.74 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 -29.42 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.187 0.518 . . . . 0.0 109.829 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -124.76 40.84 3.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.531 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.9 p -87.39 13.88 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.596 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 p -109.24 15.12 23.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 5.6 mt -74.24 -47.42 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.706 0.765 . . . . 0.0 110.776 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.67 9.52 41.37 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.657 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.445 ' O ' HG23 ' A' ' 30' ' ' THR . 0.3 OUTLIER 56.32 21.38 5.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.409 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 0.1 OUTLIER -174.81 157.73 2.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.984 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.0 p -164.48 121.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.063 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.9 135.65 42.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.961 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.1 158.48 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.974 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -104.33 145.53 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 111' ' ' ILE . 29.5 pt -131.25 165.98 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.561 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -135.8 124.18 23.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.473 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.425 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 3.6 p90 -141.87 174.1 10.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.376 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.91 110.52 22.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.203 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 21' ' ' HIS . 8.9 p -61.8 104.88 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.39 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.68 137.23 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.439 ' O ' ' CB ' ' A' ' 118' ' ' SER . 3.7 tp10 -130.43 6.43 4.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.5 m 83.44 74.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.964 0.411 . . . . 0.0 111.702 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.475 ' HB ' ' CE1' ' A' ' 126' ' ' PHE . 7.1 m -100.53 146.28 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.48 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 2.1 pp -117.39 104.12 50.38 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.853 0.359 . . . . 0.0 111.459 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 96.0 Cg_endo -85.9 152.71 9.88 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.9 2.4 . . . . 0.0 112.85 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.89 24.96 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.33 113.61 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.34 -45.06 2.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.419 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -125.66 102.56 7.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.676 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.475 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -111.6 115.93 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.48 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.15 126.06 41.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 110.714 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.412 ' CG1' ' CB ' ' A' ' 168' ' ' THR . 13.0 t -99.89 87.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -81.26 105.49 12.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.883 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.95 124.94 21.84 Favored Pre-proline 0 C--N 1.333 -0.114 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -56.63 128.98 32.24 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.299 1.999 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 133' ' ' LYS . 12.0 tptm -98.22 158.19 15.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.739 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.485 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -132.82 78.2 1.78 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.268 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 69.2 m-70 45.21 29.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.196 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.4 ' HA ' ' CE ' ' A' ' 132' ' ' LYS . 0.9 OUTLIER 56.31 69.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 137' ' ' GLU . 76.9 t -87.05 -97.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.801 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' HA3' ' A' ' 70' ' ' GLY . 0.0 OUTLIER -101.52 108.82 20.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.779 0.323 . . . . 0.0 111.055 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 17.6 mt -142.36 102.6 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.49 45.84 2.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.642 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.4 mt -88.35 144.16 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.755 0.312 . . . . 0.0 111.038 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.414 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 92.1 m -126.15 129.22 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 mt -107.52 164.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.836 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.88 149.66 27.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.816 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.01 130.9 23.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.45 170.82 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.448 2.099 . . . . 0.0 112.196 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -57.15 4.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.7 m -165.07 59.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.822 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -93.05 105.23 17.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.984 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER 48.65 167.64 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.047 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.409 ' CD ' ' HB2' ' A' ' 149' ' ' LYS . 15.8 Cg_exo -68.44 63.1 1.15 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.832 2.355 . . . . 0.0 112.269 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.63 -37.74 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.768 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 153' ' ' PRO . 6.4 p-10 43.4 94.36 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 111.373 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 152' ' ' ASP . 19.1 Cg_endo -58.35 151.71 58.84 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.113 . . . . 0.0 112.432 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 154' ' ' LEU . 2.9 mm? -73.16 164.48 26.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.685 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.6 m -155.38 135.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 111.304 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.37 150.34 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.41 -14.3 5.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.883 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.2 t70 179.02 147.04 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -140.66 136.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -95.66 145.97 24.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.88 0.372 . . . . 0.0 111.122 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -177.92 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 71.18 -60.45 1.06 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.503 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.47 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 1.0 OUTLIER -56.91 138.76 53.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.0 111.231 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 3.5 m -51.69 -21.68 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.192 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -49.24 -71.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 61.8 t60 -71.57 -24.8 61.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.84 0.353 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.47 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.8 -34.82 63.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.412 ' CB ' ' CG1' ' A' ' 128' ' ' VAL . 24.3 p -52.32 -27.13 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 74.52 64.69 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.58 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.7 t -178.91 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.97 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.85 86.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.04 -174.1 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.3 mt -94.01 117.0 29.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.91 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.98 31.29 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.58 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.44 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 2.9 m-20 -111.32 159.7 17.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.495 0.188 . . . . 0.0 110.623 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -112.84 129.85 56.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.44 146.7 27.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.007 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 tt -132.82 -42.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.117 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -127.77 156.29 42.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 17.8 mt -139.86 135.05 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.335 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 42.55 41.82 2.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.089 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 81.65 -19.56 0.41 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 18.1 mm -90.76 132.2 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 2.3 mtp-105 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 193' ' ' ALA . 0.0 OUTLIER -93.46 -17.3 23.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 58.55 39.69 24.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.498 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.4 p 58.54 74.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.005 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 192' ' ' ASP . 31.0 p -136.6 114.34 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 192' ' ' ASP . 0.4 OUTLIER 57.89 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 16.2 tmm? -53.14 -33.73 53.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.58 -29.77 68.38 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.259 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 188' ' ' CYS . 3.4 t0 -63.76 -48.91 75.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.454 ' HA ' ' CD2' ' A' ' 185' ' ' LEU . . . -57.8 -43.45 85.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.142 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.611 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 14.3 t -59.95 -40.24 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.347 0.594 . . . . 0.0 109.681 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -49.56 75.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.937 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 196' ' ' ILE . 0.9 OUTLIER -65.54 -24.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -68.8 -25.76 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.611 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -98.26 -49.19 4.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.968 -178.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.476 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -59.23 -17.24 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.58 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 25.6 p -80.27 48.47 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 1.1 pt-20 -74.46 61.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.85 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -175.09 -26.49 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.415 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 2.4 tt 177.63 112.03 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.0 110.386 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 12.0 t -96.13 111.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.799 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -105.58 108.3 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.35 119.79 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 111.839 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.441 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 6.9 tttt -91.93 93.19 8.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 8.1 mm -84.62 163.86 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.286 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 1.5 ttt85 -107.79 116.77 32.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.572 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -103.8 159.78 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -158.02 44.16 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -58.47 177.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.358 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.883 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 36.0 m -101.15 115.67 43.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.914 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 19' ' ' VAL . 8.4 p 172.49 159.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.773 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -99.65 130.28 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.82 171.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.144 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -161.91 166.29 26.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.39 151.03 39.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.452 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 12.9 t -136.75 -173.26 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.98 163.07 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.41 149.38 28.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.6 109.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 52.3 mt -112.21 118.11 34.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.249 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -105.33 162.83 13.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.227 0.537 . . . . 0.0 111.686 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 109.06 20.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.04 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.425 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -78.4 150.14 76.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.74 3.75 5.72 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.43 2.087 . . . . 0.0 112.73 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.76 -43.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.577 0.227 . . . . 0.0 111.596 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.85 -12.14 5.37 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 64.61 -82.89 0.06 OUTLIER Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.159 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' HB3' HD13 ' A' ' 39' ' ' ILE . 56.2 m-85 -139.09 113.58 9.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.78 26.28 15.18 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.685 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.467 ' CD1' ' CB ' ' A' ' 66' ' ' ALA . 3.9 mp -93.0 125.03 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -97.88 98.41 9.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.4 OUTLIER -96.87 156.54 16.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -132.55 169.28 16.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.92 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.72 56.52 0.51 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.708 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -158.21 79.35 0.83 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.9 t -98.46 -72.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.394 -179.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.53 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 27.8 p90 -34.72 -45.92 0.27 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.43 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 49.25 72.62 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.44 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 1.4 t 167.93 94.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 48' ' ' THR . 7.7 pt-20 49.87 178.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.3 t 44.08 -161.45 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.359 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -150.08 -90.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.204 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.12 18.46 0.57 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.888 0.375 . . . . 0.0 111.469 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.71 111.43 6.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.306 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.34 146.15 21.89 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.343 2.029 . . . . 0.0 111.441 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HG2' ' HB ' ' A' ' 78' ' ' VAL . 5.4 Cg_endo -48.71 104.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.381 2.054 . . . . 0.0 111.747 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.33 111.9 20.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.693 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.462 HG23 HD13 ' A' ' 57' ' ' ILE . 19.3 mt -59.7 157.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.4 t -128.44 -34.94 2.0 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -163.97 127.79 2.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.502 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.9 mt -96.17 168.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.71 141.55 46.38 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.52 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.51 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -69.13 63.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.456 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.6 p30 162.58 42.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.268 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -134.06 139.92 34.66 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.758 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.06 -12.69 31.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.755 2.303 . . . . 0.0 112.9 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' CB ' ' CD1' ' A' ' 39' ' ' ILE . . . -74.85 -56.3 4.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.927 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.432 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 2.7 tp10 -72.32 -29.9 64.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.742 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -76.91 -24.5 52.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.1 t -44.4 -52.4 7.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 111.045 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.41 ' HA2' ' CG1' ' A' ' 136' ' ' VAL . . . 118.15 16.73 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.113 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 m -158.58 37.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 111.067 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.32 140.21 52.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -145.18 167.57 22.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.4 mm -65.62 126.91 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.197 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.22 50.05 42.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.538 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.39 102.83 7.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.29 . . . . 0.0 110.931 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -53.08 156.35 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.757 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.434 ' HB ' ' HG2' ' A' ' 55' ' ' PRO . 21.2 t -147.94 157.5 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 111.403 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.5 tpt -125.11 -41.36 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.74 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.62 137.01 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.5 mt -121.12 112.39 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 59.33 20.76 8.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.38 -21.95 37.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.636 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -75.49 119.8 78.7 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 120.439 0.161 . . . . 0.0 111.278 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.63 -167.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.516 2.144 . . . . 0.0 112.142 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.75 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.084 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.45 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -117.93 47.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -175.39 179.88 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -76.08 164.23 26.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -73.43 -30.35 63.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -31.92 57.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.442 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -37.7 85.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.694 0.283 . . . . 0.0 110.746 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -71.98 -29.34 64.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.459 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.8 -38.11 54.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.849 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.44 -35.55 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.787 0.327 . . . . 0.0 111.143 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 101' ' ' SER . 1.2 pp -69.84 -45.08 68.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.09 -58.94 5.17 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.271 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -29.56 11.9 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.479 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -112.92 34.08 4.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.863 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 69.2 p -102.81 17.46 23.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.3 p -102.05 11.81 37.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.0 mt -68.9 -49.34 64.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.608 0.718 . . . . 0.0 110.998 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.23 6.91 38.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 27.8 p 55.76 24.68 7.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.256 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -172.72 145.94 1.57 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.711 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.478 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 1.0 OUTLIER -146.41 132.59 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.772 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.72 141.25 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.27 140.14 41.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.352 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.53 115.77 31.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.973 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.7 pp -117.55 163.75 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 112.144 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.59 131.73 45.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.237 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -142.62 174.62 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.117 0.484 . . . . 0.0 111.661 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.82 104.27 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.08 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 13.5 p -61.57 145.65 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 115' ' ' VAL . . . 87.39 129.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.344 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.58 24.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.987 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.2 t 176.78 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.185 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 126' ' ' PHE . 41.3 t -142.27 118.09 5.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.535 ' CG2' ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -154.74 78.51 4.96 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -177.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.448 ' HB3' ' CG ' ' A' ' 126' ' ' PHE . 69.6 Cg_endo -96.38 -167.31 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.455 2.77 . . . . 0.0 112.722 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.93 35.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.32 113.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.523 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.77 -32.77 5.8 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.922 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.66 105.2 5.78 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.823 0.344 . . . . 0.0 111.137 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.448 ' CG ' ' HB3' ' A' ' 121' ' ' PRO . 1.4 t80 -100.58 118.45 36.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.535 ' HB2' ' CG2' ' A' ' 120' ' ' ILE . 6.8 m80 -97.8 142.18 29.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 111.294 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.1 t -139.92 90.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.528 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.47 129.89 23.92 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 136.84 51.16 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.089 1.86 . . . . 0.0 111.293 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 202' ' ' ASP . 0.0 OUTLIER -100.93 158.79 15.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.051 0.453 . . . . 0.0 110.939 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.475 ' CD ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.17 -164.86 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -100.47 -29.09 12.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -164.25 48.8 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 111.497 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.475 ' HB ' ' CD ' ' A' ' 133' ' ' LYS . 25.3 t -112.09 137.68 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.752 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.51 129.33 38.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.71 -41.17 17.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 100.71 -12.05 59.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.712 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 pt -89.25 148.92 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.896 0.379 . . . . 0.0 111.374 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 86.1 m -126.28 126.18 43.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.331 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 mt -87.31 164.18 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.095 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.2 p -163.5 164.79 24.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.9 109.89 17.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -57.16 -39.32 91.46 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.484 2.123 . . . . 0.0 112.37 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.52 88.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 t -99.09 16.11 23.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.276 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 53.43 54.56 9.93 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.888 0.375 . . . . 0.0 111.05 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.19 155.63 39.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.85 82.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.609 2.206 . . . . 0.0 112.133 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 173.54 -82.52 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.526 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 46.1 t0 60.0 77.74 0.37 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.616 0.246 . . . . 0.0 110.997 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -172.51 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.67 150.9 26.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.689 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 176' ' ' LYS . 18.4 m -150.67 145.72 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.409 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 173' ' ' LEU . 1.1 mp -78.33 143.92 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.391 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -11.42 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.74 142.31 9.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.142 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.445 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.2 OUTLIER -136.21 149.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 173.22 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 167' ' ' ARG . 5.6 mtpp -115.19 145.64 42.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 115.38 -24.25 10.64 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.322 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.425 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -108.28 159.55 16.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.926 0.394 . . . . 0.0 111.029 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.38 -21.85 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.877 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.422 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -43.94 -65.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.445 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 28.4 t60 -83.54 -29.92 27.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -56.83 -40.78 76.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.679 0.276 . . . . 0.0 111.448 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 4.5 t -45.04 -29.17 0.81 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.548 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 68.6 1.57 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -178.93 -38.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.344 . . . . 0.0 110.744 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.86 72.28 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.03 152.76 19.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.419 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 0.2 OUTLIER -76.48 129.34 36.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.966 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.17 5.33 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.732 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.462 ' HB3' HG21 ' A' ' 208' ' ' ILE . 1.2 t0 -113.61 -174.32 2.44 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.883 -0.186 . . . . 0.0 110.693 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.419 ' HA ' HG11 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -132.46 106.81 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 0.0 111.381 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 208' ' ' ILE . 0.2 OUTLIER -74.07 157.39 36.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.716 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.2 tt -136.19 -49.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -129.76 157.46 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 111.708 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 32.6 mt -138.99 105.71 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.76 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 28.5 t70 62.01 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.45 -18.64 3.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 25.5 mm -96.99 138.03 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.027 0.442 . . . . 0.0 111.629 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -105.87 124.64 49.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.625 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -72.69 -7.28 49.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.84 -31.12 1.12 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.9 p -124.88 -12.72 7.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.895 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 17.7 m -83.59 -170.64 3.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 m -116.95 -175.83 2.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -67.58 -57.32 6.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -54.69 -41.81 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.239 0.543 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.71 -45.06 77.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.251 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -57.36 -42.05 81.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 17.0 t -59.1 -36.73 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 29.3 mm-40 -60.83 -50.36 73.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.896 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 199' ' ' GLN . 0.6 OUTLIER -68.38 -25.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -64.87 -32.16 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.48 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -95.44 -41.46 8.97 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.583 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -85.08 13.99 5.54 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.41 32.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.2 mm-40 34.63 70.26 0.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.459 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 0.7 OUTLIER 42.83 34.61 0.61 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 178.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.433 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -171.55 103.87 0.2 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.156 0.503 . . . . 0.0 111.626 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.415 ' CG2' ' CG ' ' A' ' 132' ' ' LYS . 47.9 t -107.84 108.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.374 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.504 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 33.0 ttmt -94.02 107.5 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.84 107.57 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.475 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.455 ' HD3' ' CE1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -101.44 92.65 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.626 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.462 HG21 ' HB3' ' A' ' 175' ' ' ASP . 2.4 mp -87.31 166.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -111.76 123.39 50.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -115.55 95.09 4.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.22 47.67 1.54 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.323 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -56.85 -169.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.815 0.34 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.12 126.38 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.124 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.3 t -137.32 150.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.66 40.76 1.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.134 0.493 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 51.62 174.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.537 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.15 142.5 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.21 143.88 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.009 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.426 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 5.6 t -141.2 159.11 42.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.84 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.71 159.17 15.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.791 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 109' ' ' LEU . 1.3 t -135.77 147.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.1 t -125.97 109.51 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.01 118.83 37.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.69 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -109.29 162.4 14.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -97.49 115.87 28.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.841 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -74.83 157.74 85.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.635 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.98 6.12 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.503 2.136 . . . . 0.0 112.594 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.14 -49.31 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.513 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.3 p -138.74 -1.58 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.452 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 76.04 -99.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.269 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 37' ' ' PHE . 2.8 m-85 -116.16 119.63 36.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.49 26.91 11.79 Favored Glycine 0 CA--C 1.517 0.17 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.352 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.42 ' CG2' ' CD1' ' A' ' 57' ' ' ILE . 7.0 mt -92.63 135.94 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 121.092 0.473 . . . . 0.0 111.56 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.96 99.51 5.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 1.9 pp -114.69 156.82 24.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 112.279 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -102.65 169.59 8.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.259 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.401 ' O ' ' CG ' ' A' ' 91' ' ' PHE . . . -137.18 46.28 1.02 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.88 65.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.175 0.512 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.8 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.189 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.521 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 47.3 p90 -67.41 -49.76 62.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.026 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.483 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.8 79.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.401 0.62 . . . . 0.0 111.296 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 t 170.37 116.8 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.665 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' O ' ' OG1' ' A' ' 50' ' ' THR . 1.6 tp10 60.84 84.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 49' ' ' GLU . 3.2 p 89.4 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.524 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.3 pp -166.43 26.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 111.895 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 20.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.524 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.2 t -58.81 109.3 1.76 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.583 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.8 162.54 37.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.377 2.052 . . . . 0.0 112.319 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.25 129.27 21.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.524 2.149 . . . . 0.0 112.154 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.38 99.65 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 21.5 mt -60.89 129.5 23.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.76 0.314 . . . . 0.0 110.687 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.4 p -113.66 -2.51 13.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 55.4 t80 177.72 124.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.875 0.369 . . . . 0.0 111.435 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' O ' ' CE2' ' A' ' 59' ' ' TYR . 1.9 mt -96.63 -178.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 63' ' ' ASP . 25.3 tt0 -121.55 131.14 53.96 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.347 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HA ' ' NH1' ' A' ' 68' ' ' ARG . . . -65.5 70.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.457 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.2 m-20 164.62 44.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -145.04 -179.43 0.94 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 91.0 Cg_endo -97.87 -2.7 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.067 2.511 . . . . 0.0 112.744 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.84 -57.22 3.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.717 0.294 . . . . 0.0 111.648 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.521 ' HG3' ' HD3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -77.37 -29.11 53.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 0.0 110.131 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.592 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -76.53 -30.78 57.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 -67.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.727 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -14.69 5.35 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.954 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 m -125.65 45.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.418 . . . . 0.0 110.96 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.3 mt -135.6 168.95 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -164.16 143.19 7.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.36 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.094 0.473 . . . . 0.0 111.407 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.69 42.32 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.283 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.83 113.28 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.97 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.77 79.17 2.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.74 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.96 132.32 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.75 -30.71 10.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.89 131.97 20.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.7 mt -124.89 117.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.651 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 46.56 27.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.439 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.39 -30.27 9.07 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.593 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 84' ' ' ILE . 15.7 mm -68.58 117.79 53.81 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 -167.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.364 2.043 . . . . 0.0 112.187 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.4 p -147.7 -45.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.071 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.69 -9.97 58.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.561 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.3 47.46 2.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.3 168.69 2.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -74.97 157.38 35.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 9.5 p90 -73.3 -31.0 63.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.95 -41.14 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 -33.75 74.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.343 . . . . 0.0 110.978 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.93 -31.8 64.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 110.6 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.31 -36.11 58.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.821 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -73.41 -35.73 65.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.47 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 1.1 pp -69.96 -41.92 73.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.239 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 80.7 mt -65.84 -58.78 4.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.07 -29.7 13.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.448 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.4 OUTLIER -109.44 30.7 6.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.962 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.567 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -104.5 45.64 0.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.2 p -133.36 13.02 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.88 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -69.79 -48.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.52 0.676 . . . . 0.0 111.137 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.29 7.11 40.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.817 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.3 m 56.69 25.2 9.81 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.926 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -166.28 152.77 9.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.648 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.8 t -152.84 158.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -125.08 141.25 52.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 109' ' ' LEU . 2.0 mp -130.26 156.04 45.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -130.92 105.85 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 111' ' ' ILE . 25.5 pt -110.47 160.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.098 0.475 . . . . 0.0 111.806 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -133.02 140.4 47.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.472 ' CZ ' ' HD2' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.26 174.31 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -97.95 118.34 34.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.68 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 m -61.96 118.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.426 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 179.36 117.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 168' ' ' THR . 2.7 tp10 -118.1 13.25 13.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.527 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.35 72.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.163 0.506 . . . . 0.0 111.401 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.1 m -97.8 147.83 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.613 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.554 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.9 pp -121.45 98.72 46.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.92 0.39 . . . . 0.0 111.304 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.472 ' HB3' ' CE1' ' A' ' 126' ' ' PHE . 89.2 Cg_endo -90.31 169.12 4.16 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.084 2.522 . . . . 0.0 112.825 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.8 m -166.61 29.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.8 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.82 113.31 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.715 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.78 -39.25 2.96 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.561 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.22 102.42 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.493 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 170' ' ' THR . 0.7 OUTLIER -109.15 117.8 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.485 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.554 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -99.96 143.01 30.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 205' ' ' LYS . 14.6 t -118.66 90.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.433 ' HG2' ' HG3' ' A' ' 205' ' ' LYS . 0.3 OUTLIER -80.81 105.96 12.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.445 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.98 133.45 18.65 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.382 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -56.89 129.08 32.64 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.231 1.954 . . . . 0.0 111.516 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -106.98 139.4 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.075 0.464 . . . . 0.0 110.874 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -76.75 -168.28 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.767 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 0.9 OUTLIER -90.04 -40.0 12.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.235 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.62 45.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.773 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.46 161.25 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -51.75 145.91 8.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.274 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.74 -58.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.487 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 92.02 56.94 1.54 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.679 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.414 ' CD1' ' CB ' ' A' ' 165' ' ' ALA . 6.0 mt -125.09 136.7 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.447 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 73.4 m -125.28 142.54 51.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 154' ' ' LEU . 10.5 mt -111.49 164.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.96 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.6 m -165.35 152.52 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.01 145.94 35.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.23 -35.47 11.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.6 m 60.01 52.11 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.964 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.59 29.1 3.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 59.3 59.53 2.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.68 131.98 24.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.16 -25.92 48.44 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.448 2.099 . . . . 0.0 112.263 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.61 -39.33 7.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.678 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.1 t0 56.03 83.81 0.22 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.678 0.275 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 159.36 5.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.665 2.243 . . . . 0.0 112.576 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.421 HD11 HG23 ' A' ' 142' ' ' ILE . 2.2 mm? -101.7 155.03 18.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.302 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 14.1 t -153.71 160.55 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.872 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.478 ' HB ' ' HA ' ' A' ' 173' ' ' LEU . 8.5 mt -104.02 148.02 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.817 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 -0.36 2.93 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.5 t0 -168.98 134.56 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 111.421 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.422 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -136.69 149.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.822 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -122.79 149.12 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.162 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.506 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 2.3 mptt -79.09 165.74 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.725 0.298 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.81 -59.34 1.78 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.595 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.508 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -61.31 160.85 9.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.922 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.62 -23.99 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.435 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -49.64 -58.51 5.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.442 ' HB3' ' NH1' ' A' ' 167' ' ' ARG . 15.8 t60 -83.87 -31.31 25.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.646 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.508 ' NE ' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.99 -29.84 58.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.733 0.302 . . . . 0.0 111.153 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 9.8 t -54.75 -20.1 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.84 24.74 76.22 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.511 ' CG2' ' CZ ' ' A' ' 126' ' ' PHE . 0.3 OUTLIER -133.27 -39.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.896 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 12.0 tp -64.96 93.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -110.23 155.26 22.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.692 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 0.5 OUTLIER -87.73 50.97 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.993 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.09 30.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.48 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -113.88 177.23 4.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.647 0.261 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -117.65 98.34 6.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 111.18 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 3.9 mt -76.97 134.89 38.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.723 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.6 2.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.857 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -165.29 154.68 12.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.876 0.369 . . . . 0.0 111.484 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.432 ' O ' ' N ' ' A' ' 182' ' ' ASN . 9.1 mm -139.38 117.79 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.579 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.1 OUTLIER 46.81 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.407 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' ILE . 75.7 m-20 -112.34 -16.5 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 39.7 mm -96.67 157.68 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.432 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.423 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 8.8 mtt180 -127.43 126.56 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.047 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.402 ' CD2' HG12 ' A' ' 180' ' ' ILE . 3.2 mm? -78.47 -4.92 50.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.8 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -28.92 1.97 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.1 p -135.45 40.05 2.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 15.1 m -140.66 -171.42 3.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.23 173.23 6.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 17.6 ttp -59.0 -53.09 62.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 4.0 mt-10 -51.7 -41.06 61.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.613 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -53.26 -51.96 60.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.153 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -52.66 -41.36 63.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.251 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.64 -33.45 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.022 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 191' ' ' GLU . 17.1 mm-40 -63.32 -50.27 70.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.84 -24.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.822 178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.76 -35.44 81.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.762 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -94.76 -44.73 7.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.32 -22.58 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.888 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . 0.455 ' HB2' HG23 ' A' ' 204' ' ' VAL . 19.3 m -89.56 41.99 1.07 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.081 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 134' ' ' HIS . 12.2 pt-20 -69.06 61.6 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.535 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -168.98 -28.98 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.944 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.405 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 4.5 tt 172.67 113.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.856 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 200' ' ' CYS . 97.4 t -111.88 137.91 42.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.579 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 5.1 ttmt -111.76 108.14 17.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.955 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.76 113.12 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.436 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.463 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 6.4 tttt -100.02 103.43 14.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.521 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.34 174.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 23.0 mtp85 -102.73 125.99 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.02 94.55 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -85.32 55.01 3.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.4 168.95 11.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.238 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.226 179.782 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.777 0.322 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.03 121.06 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.273 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.4 m -133.83 92.41 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 30.2 t60 -75.55 114.97 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -55.79 149.95 13.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -155.6 168.71 26.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.91 160.26 16.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.73 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.411 ' OG1' ' CZ ' ' A' ' 113' ' ' PHE . 89.2 m -158.45 155.45 28.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.7 160.2 14.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.68 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.99 150.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.586 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.54 109.35 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.971 0.415 . . . . 0.0 111.246 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 3.4 mm? -107.26 118.23 36.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.835 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.43 ' CG2' ' CG ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.7 162.57 13.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.175 0.512 . . . . 0.0 111.942 -178.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.28 151.52 20.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.162 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -134.16 150.88 75.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.386 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.11 20.73 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.561 2.174 . . . . 0.0 112.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.7 t -133.79 -54.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.248 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 t -159.81 37.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.692 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -43.43 143.31 1.84 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.437 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.551 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 11.0 m-85 61.02 71.83 0.55 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -98.66 26.48 23.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.439 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 60' ' ' ILE . 26.9 pt -115.23 143.41 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.06 140.35 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.478 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -112.31 121.56 45.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.966 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -84.69 170.11 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.95 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.06 61.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.54 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.99 110.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.67 -73.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.376 0.608 . . . . 0.0 110.256 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 27.0 p90 -43.42 -45.07 6.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.35 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.489 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.66 74.49 0.1 Allowed 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.8 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 166.86 108.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.788 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.52 138.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.1 -164.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.815 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -138.93 -85.39 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.823 0.344 . . . . 0.0 111.717 179.45 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t 57.41 13.98 2.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 110.974 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -54.13 106.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.329 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 60.6 Cg_endo -72.53 117.9 5.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.279 1.986 . . . . 0.0 111.499 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -36.1 118.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.21 2.607 . . . . 0.0 113.231 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -118.17 176.37 5.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.198 179.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.412 HG12 ' HB2' ' A' ' 76' ' ' ASP . 21.3 mm -112.31 138.41 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.49 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 p -119.14 -8.5 10.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 80.5 t80 -172.47 157.74 4.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.362 0.601 . . . . 0.0 111.885 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.513 HD12 ' HB ' ' A' ' 39' ' ' ILE . 8.7 mm -135.05 152.66 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.413 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.8 tm-20 -104.2 156.66 17.71 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.56 47.59 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.115 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.87 65.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.617 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -156.02 -172.25 0.31 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 54.5 Cg_endo -96.77 -10.24 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.817 2.344 . . . . 0.0 113.377 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . . . -77.68 -58.45 3.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -71.47 -29.1 64.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.415 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.52 -30.59 5.38 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.961 0.41 . . . . 0.0 110.649 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.404 ' HA3' ' CG1' ' A' ' 136' ' ' VAL . . . 78.8 36.67 28.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.855 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' CG1' ' HA2' ' A' ' 162' ' ' GLY . 16.6 t -154.26 31.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.736 0.303 . . . . 0.0 111.426 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' CD1' ' CB ' ' A' ' 66' ' ' ALA . 9.5 mt -133.11 147.55 52.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.894 0.378 . . . . 0.0 111.054 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.06 148.81 33.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.61 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.37 68.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.785 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.09 45.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.412 ' HB2' HG12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -79.71 -179.79 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.668 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -147.03 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.4 t -65.35 133.73 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.09 -28.33 10.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.706 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.25 120.29 9.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.8 mt -105.34 104.93 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.513 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 57.01 21.16 6.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.26 8.16 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -71.6 111.58 10.86 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.83 168.53 24.36 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.48 2.12 . . . . 0.0 112.005 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.5 p -143.72 10.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.59 -17.1 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.56 46.36 1.9 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.32 171.73 19.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.779 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.43 151.71 32.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.778 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -71.21 -30.0 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 pt-20 -54.44 -39.78 67.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.152 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -36.48 79.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -67.56 -33.68 75.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.42 0.629 . . . . 0.0 110.128 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.97 81.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.838 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 4.0 mm100 -70.24 -56.2 7.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.839 0.352 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' CD2' ' HA ' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -52.28 -41.84 63.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.332 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.585 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 2.6 mt -68.65 -56.13 9.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.262 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.432 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -50.84 -28.74 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.164 0.507 . . . . 0.0 109.715 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.488 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.2 OUTLIER -120.67 38.96 3.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.544 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.585 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -103.84 36.16 2.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.167 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 1.4 m -121.57 15.88 11.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.488 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.7 mp -71.59 -47.48 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.564 0.697 . . . . 0.0 111.216 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.95 3.67 44.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.41 ' HA ' ' CB ' ' A' ' 31' ' ' ALA . 1.4 m 63.04 18.46 10.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.666 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.43 ' CG ' ' CG2' ' A' ' 30' ' ' THR . 0.4 OUTLIER -173.22 150.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.095 0.474 . . . . 0.0 111.956 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 106' ' ' LYS . 45.2 t -145.06 138.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.396 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.12 125.48 54.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 110.486 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.3 mt -119.21 164.95 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.89 105.94 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.3 pt -104.7 150.24 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.735 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -124.11 115.0 20.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 11.8 p90 -135.71 174.17 10.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.43 . . . . 0.0 111.406 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.24 155.01 18.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.636 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.9 t -91.77 104.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 0.0 111.471 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -167.95 137.25 2.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.656 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -146.63 25.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.635 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.76 65.59 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.249 0.547 . . . . 0.0 111.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.404 ' CG1' ' OG1' ' A' ' 168' ' ' THR . 6.1 m -97.84 147.57 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.215 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.546 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.7 pp -130.04 92.93 35.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 0.0 111.024 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.45 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 68.3 Cg_endo -96.37 -178.52 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.349 2.699 . . . . 0.0 112.673 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.33 35.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.415 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.51 119.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.826 0.346 . . . . 0.0 110.776 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.42 -51.73 3.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.412 ' CG2' ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -115.32 105.02 12.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.854 0.359 . . . . 0.0 110.551 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.492 ' CE1' HG22 ' A' ' 170' ' ' THR . 0.9 OUTLIER -113.34 120.94 42.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.783 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.546 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.6 m80 -109.82 152.71 25.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 206' ' ' LEU . 17.8 m -131.07 98.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.284 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.3 105.43 17.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.779 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.04 133.11 24.77 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.977 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.76 136.03 37.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.351 2.034 . . . . 0.0 112.075 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.78 158.13 26.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 -166.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.796 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -58.5 -57.2 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -164.48 48.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.404 ' CG1' ' HA3' ' A' ' 70' ' ' GLY . 97.2 t -75.94 159.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -47.54 111.9 0.48 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.321 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mt -116.11 112.5 21.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.565 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.72 45.85 2.92 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.691 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.01 130.26 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 120.65 0.262 . . . . 0.0 111.064 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.441 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 7.4 m -126.73 133.08 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.758 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.2 mt -105.4 163.44 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -166.43 123.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.937 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 p -84.0 117.15 67.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.731 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.08 -174.98 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.311 2.008 . . . . 0.0 112.298 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.2 p -58.85 165.27 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.968 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.4 p -105.66 73.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -119.68 46.06 2.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 149' ' ' LYS . 0.2 OUTLIER -178.33 154.89 0.93 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.952 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.23 75.23 3.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.503 2.135 . . . . 0.0 112.332 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.57 -59.96 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.6 t0 62.45 70.3 0.82 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 111.212 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.65 -161.71 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.39 173.74 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.869 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 176' ' ' LYS . 33.8 m -156.38 -176.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.093 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.4 mm -76.14 154.28 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.694 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.4 ' HB3' ' CG2' ' A' ' 141' ' ' THR . 0.3 OUTLIER -135.59 -9.18 2.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 173.21 147.44 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.392 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 3.2 mt -130.69 150.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.61 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.476 ' HE2' ' HA3' ' A' ' 162' ' ' GLY . 0.1 OUTLIER -121.77 134.7 54.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 110.438 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.11 86.33 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 0.0 111.009 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.476 ' HA3' ' HE2' ' A' ' 160' ' ' LYS . . . -177.24 -32.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.241 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.4 169.59 8.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.402 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 8.3 m -58.92 -21.53 19.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.067 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -43.57 -71.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.466 ' CG ' ' CG2' ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.63 -24.93 67.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 0.0 111.266 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.415 ' NE ' ' CE1' ' A' ' 113' ' ' PHE . 19.5 mmt-85 -58.81 -38.23 78.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.49 ' CG2' ' HB2' ' A' ' 171' ' ' LEU . 14.9 t -57.68 -30.46 65.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.49 -72.51 2.82 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.616 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.492 HG22 ' CE1' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -42.46 -29.56 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.49 ' HB2' ' CG2' ' A' ' 168' ' ' THR . 0.2 OUTLIER -60.24 86.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.38 158.75 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.6 mt -68.31 72.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.834 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.06 40.05 0.02 OUTLIER Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.634 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -121.48 118.02 28.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.538 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 208' ' ' ILE . 29.9 mmtt -75.85 108.36 8.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.6 mt -75.94 152.18 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.026 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.3 tt -139.96 -57.11 0.56 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -109.97 155.95 21.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.346 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.2 mm -139.61 110.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.267 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 38.9 t70 53.73 51.81 14.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.394 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.4 t-20 82.82 -30.5 0.09 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 37.3 mm -73.5 151.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.35 119.07 22.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.24 0.543 . . . . 0.0 112.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.13 -12.34 58.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.903 178.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t70 51.18 52.6 14.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.63 74.51 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.657 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.91 -169.69 2.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.061 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.0 m -58.04 154.88 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 36.2 ttp -74.17 -35.23 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -51.8 -48.52 63.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.171 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -49.54 -52.13 31.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.646 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -55.51 -37.83 68.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.314 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 21.6 t -62.78 -30.86 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.077 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -66.54 -50.34 63.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.089 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.1 mp -73.72 -24.69 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.124 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -63.15 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.474 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -89.47 -40.09 12.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -14.7 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 2.2 m -85.02 41.78 0.89 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.72 62.59 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.222 0.535 . . . . 0.0 111.076 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -174.48 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.312 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.7 tt 177.56 109.32 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.124 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.12 116.03 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.891 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 128' ' ' VAL . 4.4 ttmm -108.77 108.37 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.624 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.46 ' HB2' ' CG2' ' A' ' 128' ' ' VAL . 3.4 mt -97.12 117.16 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.415 . . . . 0.0 111.376 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.444 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 26.2 tttt -97.8 101.07 12.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 176' ' ' LYS . 0.1 OUTLIER -109.43 179.38 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 2.4 mtp180 -109.41 135.25 50.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.012 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 211' ' ' ASP . 0.0 OUTLIER -132.37 159.87 37.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER 82.49 85.34 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -60.54 163.18 5.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.176 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 179.872 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.846 0.355 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -150.32 116.82 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.719 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.1 m -145.09 -178.87 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 111.522 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -133.94 116.62 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.834 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -50.58 147.98 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.445 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.4 173.0 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 152.71 39.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.444 ' CG2' ' CE2' ' A' ' 113' ' ' PHE . 9.0 t -149.06 170.37 18.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -101.59 162.16 13.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 108' ' ' THR . 0.7 OUTLIER -142.22 145.85 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.58 109.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.791 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' HB3' ' CE2' ' A' ' 37' ' ' PHE . 1.2 mm? -108.18 141.05 40.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.317 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.483 HG21 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -123.43 160.95 25.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.355 0.597 . . . . 0.0 112.089 -178.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . . . -101.67 149.24 24.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.34 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -133.42 148.84 70.49 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.75 8.6 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 112.681 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.07 -48.7 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.427 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 t -136.36 -3.27 2.17 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 32' ' ' ASP . . . 89.2 -94.61 2.01 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.308 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.474 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 10.4 m-85 -121.68 -70.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.773 -0.251 . . . . 0.0 111.042 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 133.35 0.44 4.13 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 119.779 -1.201 . . . . 0.0 114.374 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.496 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -128.05 130.51 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.621 0.71 . . . . 0.0 112.03 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.08 128.77 56.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 2.4 pp -121.0 157.54 29.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.631 . . . . 0.0 112.559 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -111.25 170.04 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.199 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.57 16.23 14.36 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.385 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -97.51 85.38 3.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.116 0.484 . . . . 0.0 110.639 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.468 ' CG2' HD22 ' A' ' 56' ' ' LEU . 3.0 t -99.82 -75.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 46.2 p90 -57.19 -46.3 82.96 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.566 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 50.42 74.17 0.23 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.434 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.407 ' CB ' ' O ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER 163.66 75.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 64.57 163.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.87 -169.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -137.42 -105.06 0.19 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.107 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.416 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER 50.31 21.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.533 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.433 ' CA ' HG22 ' A' ' 45' ' ' VAL . 1.4 p -76.04 110.18 10.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -72.92 140.48 31.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.292 1.995 . . . . 0.0 112.052 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HB3' ' CD1' ' A' ' 41' ' ' LEU . 72.0 Cg_exo -51.06 125.81 17.22 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.482 2.121 . . . . 0.0 112.221 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.558 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.3 pt? -131.06 104.16 6.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.929 0.395 . . . . 0.0 111.515 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 37.6 mt -59.63 153.69 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.659 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.9 t -145.42 22.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 75.7 t80 -177.42 146.33 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.256 0.55 . . . . 0.0 112.088 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.496 ' CD1' ' CG2' ' A' ' 39' ' ' ILE . 7.5 mm -115.21 162.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.084 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -113.46 121.75 45.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.713 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -58.77 105.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.868 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.0 m-20 89.17 51.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.475 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -130.12 145.88 59.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.795 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 34.5 Cg_exo -57.29 -17.0 24.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.219 1.946 . . . . 0.0 112.044 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.87 -57.22 6.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 4.7 tp10 -78.62 -28.49 45.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 3.0 mmt-85 -87.66 -3.66 58.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.57 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -58.69 -53.32 59.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.504 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.16 -3.0 5.91 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.058 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.8 t -155.03 61.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 117.001 0.401 . . . . 0.0 111.671 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 29' ' ' LEU . 8.2 mt -143.06 154.15 43.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.0 111.163 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -161.85 146.25 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.2 mt -61.0 108.72 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.437 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.7 41.8 0.99 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.92 126.21 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -101.84 86.64 2.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 m -83.84 134.84 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -108.65 -26.7 10.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.07 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.19 138.95 52.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.8 mt -133.77 109.29 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.991 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.0 m120 59.53 24.05 12.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.979 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.49 -27.07 19.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.7 mt -73.06 136.88 79.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.22 -168.27 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.546 2.164 . . . . 0.0 112.3 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.7 p -157.0 -44.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.45 -17.15 62.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.444 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -116.65 41.99 2.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.036 0.446 . . . . 0.0 110.684 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m -166.7 -170.24 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.91 148.21 27.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -70.02 -36.03 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.1 tt0 -54.73 -34.63 62.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -52.18 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 109.766 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.84 -31.88 59.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.189 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.12 -35.51 76.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.19 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 17.9 mm-40 -63.16 -41.15 99.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.215 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mt -63.04 -50.34 71.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.114 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.458 ' O ' ' OG ' ' A' ' 101' ' ' SER . 1.5 mt -70.6 -54.1 13.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -50.76 -29.39 11.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.186 0.517 . . . . 0.0 109.646 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -123.16 40.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.313 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 98' ' ' LEU . 6.1 p -90.8 20.18 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.584 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -114.63 15.57 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.7 mt -75.57 -48.75 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.81 -0.36 57.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.883 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.483 ' O ' HG21 ' A' ' 30' ' ' THR . 5.9 p 65.11 18.26 11.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.797 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.422 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 0.4 OUTLIER -166.21 157.12 13.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 101' ' ' SER . 41.7 t -158.63 131.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -111.55 124.56 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.701 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -124.48 165.15 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.374 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -126.23 107.17 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.18 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.7 pt -99.58 162.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.841 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -131.08 115.17 16.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.375 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.444 ' CE2' ' CG2' ' A' ' 25' ' ' THR . 0.6 OUTLIER -132.84 174.04 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.37 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.1 149.05 24.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.211 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 25.8 t -89.98 103.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 111.462 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 161.33 -178.96 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.036 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 118' ' ' SER . 6.8 pt-20 172.52 -36.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.15 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 13.2 t 170.69 106.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.478 ' CG2' ' CE1' ' A' ' 126' ' ' PHE . 12.0 p -144.38 143.96 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.045 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.2 pp -132.36 101.98 14.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.9 Cg_endo -83.97 156.01 13.29 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.0 112.604 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -162.73 18.42 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.669 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.8 OUTLIER 56.2 117.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 96.46 -42.72 2.18 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.401 ' CG2' ' CD ' ' A' ' 207' ' ' LYS . 0.0 OUTLIER -135.78 102.66 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.404 . . . . 0.0 110.433 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CE1' ' CG2' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -100.75 123.28 44.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.569 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.42 116.76 32.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.338 . . . . 0.0 111.079 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.1 t -100.94 105.49 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.918 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.25 113.12 19.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.931 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.7 mp -119.53 129.48 25.35 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.76 123.79 8.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.238 1.958 . . . . 0.0 111.314 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.536 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 1.8 mmtp -89.64 159.89 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.225 0.536 . . . . 0.0 111.341 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.405 ' HD3' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -133.68 -167.14 1.89 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.259 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -66.79 -69.47 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.18 93.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.405 ' HB ' ' HD3' ' A' ' 133' ' ' LYS . 52.8 t -137.78 152.84 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.678 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.52 125.21 10.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.18 -64.18 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 103.28 -13.45 55.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.483 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -99.3 143.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.205 0.502 . . . . 0.0 111.176 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 157' ' ' SER . 10.8 m -126.12 109.72 12.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.377 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.5 mt -74.65 164.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.077 0.465 . . . . 0.0 111.351 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.8 t -152.57 152.57 32.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.649 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.425 ' N ' ' HD2' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -94.53 -49.45 0.26 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.359 -179.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 144' ' ' SER . 90.5 Cg_endo -79.1 176.85 9.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.366 2.044 . . . . 0.0 113.094 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.18 -164.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.747 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.41 46.57 1.21 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.813 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -138.75 -171.9 3.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 162.43 26.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.78 136.69 16.58 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.676 2.251 . . . . 0.0 112.472 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 109.93 -23.3 21.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.413 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -49.6 133.91 19.24 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.497 0.189 . . . . 0.0 111.363 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.39 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.583 2.189 . . . . 0.0 112.445 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -66.61 174.92 2.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.783 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.3 m -157.31 162.95 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.399 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mm -78.11 154.73 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' THR . 0.2 OUTLIER -130.91 -33.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.578 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.1 164.75 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.186 0.517 . . . . 0.0 111.775 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 3.4 mm -138.45 149.19 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.297 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -129.51 154.93 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -91.05 163.93 14.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 86.22 -13.84 56.04 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.884 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.53 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 90.2 p -115.06 142.28 46.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.861 0.362 . . . . 0.0 111.02 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.6 m -48.12 -22.19 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.494 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.418 ' CB ' HG12 ' A' ' 140' ' ' ILE . . . -54.59 -52.65 61.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 111.304 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.427 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 0.8 OUTLIER -83.5 -26.53 30.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.011 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 163' ' ' SER . 13.6 mmp_? -55.94 -50.76 69.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 13.3 t -58.62 -23.83 59.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.066 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 67.29 -152.7 52.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.131 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.6 p 56.16 23.21 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 151.72 40.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.892 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -164.02 -171.68 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.76 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.37 122.07 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.34 -7.21 12.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.843 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.25 170.14 15.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.747 0.274 . . . . 0.0 110.834 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.08 136.07 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 111.118 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.5 135.5 39.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.8 tt -108.95 -53.24 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.146 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -141.08 171.9 13.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.315 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 34.1 mt -139.08 105.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 6.6 t70 61.59 -79.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.732 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.01 -25.02 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.411 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 32.7 mm -91.4 158.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.411 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 72.8 mtt-85 -125.71 128.1 47.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.228 0.537 . . . . 0.0 112.234 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.17 -3.95 53.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.892 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.8 -29.27 1.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.26 51.15 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 20.0 m -156.18 160.58 39.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.974 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 60.0 p -77.43 -170.8 1.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' MET . . . . . 0.431 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 14.0 ptm -74.05 -43.39 57.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.996 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.431 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -54.94 -30.36 58.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.02 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -60.98 -51.85 67.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.058 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.44 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -57.12 -42.38 80.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.223 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.503 HG12 ' OE1' ' A' ' 198' ' ' GLN . 43.9 t -61.87 -35.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.818 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.92 -49.88 73.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.966 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.9 mp -72.71 -24.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.066 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -59.71 -43.27 94.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.87 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.503 ' OE1' HG12 ' A' ' 194' ' ' VAL . 1.1 mp0 -94.37 -39.87 10.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.534 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.68 -22.1 32.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.054 0.454 . . . . 0.0 110.435 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 17.2 m -85.89 44.62 1.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.11 63.05 0.09 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.486 0.66 . . . . 0.0 111.885 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.432 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 5.1 m-20 -170.36 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.515 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.536 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 3.6 tt 174.77 109.29 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.457 ' CG2' ' HG3' ' A' ' 132' ' ' LYS . 6.2 t -102.79 120.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.328 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 16.8 ttmm -106.3 108.13 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.37 114.96 21.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.183 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.457 ' CG ' ' CD2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -95.72 93.03 6.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 9.9 mm -83.31 165.04 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.788 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -118.27 121.78 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.055 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.27 108.86 9.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.63 48.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.63 154.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.583 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.546 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.907 0.384 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.6 p -144.89 116.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.885 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.421 ' CG1' ' O ' ' A' ' 115' ' ' VAL . 93.4 t -109.53 113.0 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.257 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -107.36 112.01 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.13 144.61 2.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.43 173.07 13.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.716 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -130.84 146.88 52.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.416 HG23 ' CE2' ' A' ' 113' ' ' PHE . 12.6 t -138.02 -171.28 2.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -111.45 161.65 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.192 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -139.37 150.23 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.654 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.97 109.78 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 111.495 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -107.1 118.66 37.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -106.14 163.29 12.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 0.0 111.431 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' CB ' ' CE2' ' A' ' 37' ' ' PHE . . . -98.1 106.47 18.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.153 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.07 147.65 83.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.92 9.43 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.539 2.16 . . . . 0.0 112.838 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.01 -41.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.5 p -117.95 -29.91 5.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.837 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 52.75 73.45 0.4 Allowed Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.353 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.469 ' CE2' ' CB ' ' A' ' 31' ' ' ALA . 54.9 m-85 73.46 89.67 0.09 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.027 0.441 . . . . 0.0 110.261 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.07 26.95 5.2 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.302 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.453 ' CD1' ' CB ' ' A' ' 66' ' ' ALA . 9.4 mt -92.26 151.96 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.159 0.504 . . . . 0.0 111.271 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.04 101.39 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.133 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.422 ' CD1' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -95.87 134.96 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.204 0.526 . . . . 0.0 111.755 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -90.37 152.3 21.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.261 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' CA ' ' CE2' ' A' ' 91' ' ' PHE . . . -65.01 -82.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -108.08 157.97 17.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.405 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 46' ' ' PHE . 44.7 t -138.09 -63.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.964 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 18.0 p90 -29.21 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.804 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 42.23 72.2 0.18 Allowed 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.51 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 166.08 90.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.385 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 50' ' ' THR . 29.4 tp10 63.27 156.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 51' ' ' LEU . 3.6 t 47.31 -177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.455 0.645 . . . . 0.0 111.779 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -161.87 22.31 0.11 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.202 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.61 21.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 51' ' ' LEU . 38.0 m -94.08 92.74 0.78 Allowed Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.642 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.58 171.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 0.0 112.092 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -48.72 128.72 19.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.641 2.228 . . . . 0.0 111.86 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.07 110.39 17.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.179 -179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.431 HG23 HD12 ' A' ' 57' ' ' ILE . 15.0 mt -56.42 116.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.009 0.433 . . . . 0.0 111.183 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -101.07 -6.84 23.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 60.4 t80 -178.16 131.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.482 HG22 HD11 ' A' ' 60' ' ' ILE . 2.4 mt -108.29 176.31 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -109.56 154.84 22.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.524 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -85.47 50.15 1.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.36 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 16.1 t0 178.07 36.84 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.586 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -133.61 132.12 21.62 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.75 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -10.57 12.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.537 2.158 . . . . 0.0 112.65 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.453 ' CB ' ' CD1' ' A' ' 39' ' ' ILE . . . -70.6 -52.89 18.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.05 0.453 . . . . 0.0 110.393 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HG3' ' CZ ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -72.45 -29.18 63.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.205 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.427 ' NH1' ' HG2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -94.21 -2.28 52.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.701 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 21.8 p -46.0 -31.52 2.3 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.74 0.305 . . . . 0.0 111.416 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.66 30.02 9.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.852 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.3 p -179.6 39.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.8 mt -131.35 174.07 10.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -156.04 163.37 39.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.705 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mm -68.65 70.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.39 79.65 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.756 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.45 111.83 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.718 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.31 135.21 53.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.097 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.3 t -104.46 120.61 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.0 tpt -87.59 -29.68 21.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -162.97 141.81 8.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.4 mt -113.52 109.42 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.628 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 p30 46.93 27.8 0.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.86 6.5 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.734 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mm -69.19 111.19 7.79 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 120.602 0.239 . . . . 0.0 111.512 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.73 148.62 59.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.49 -24.6 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -73.79 -6.95 50.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.587 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.18 46.4 2.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.889 0.376 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m 177.94 -179.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 m -79.46 158.65 27.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.822 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CE2' ' CA ' ' A' ' 43' ' ' GLY . 12.0 p90 -73.08 -29.45 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.08 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.3 mt-10 -54.56 -34.13 61.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.331 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 94' ' ' ALA . 14.6 pt-20 -61.47 -47.35 86.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.279 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.404 ' N ' ' CG ' ' A' ' 93' ' ' GLU . . . -57.88 -38.45 75.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.375 0.607 . . . . 0.0 110.097 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -58.86 -42.87 90.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.377 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 3.5 mm100 -63.0 -47.3 83.69 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.722 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.47 -39.72 61.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.056 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.422 HD12 ' CD1' ' A' ' 41' ' ' LEU . 1.2 mt -74.1 -42.56 59.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.738 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -50.55 -34.97 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.266 0.555 . . . . 0.0 109.669 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -121.07 38.93 3.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.168 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -86.58 10.39 15.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.644 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -109.14 16.35 22.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.772 0.32 . . . . 0.0 111.757 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.9 mt -71.47 -49.99 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.817 0.818 . . . . 0.0 110.399 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 6.96 47.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.717 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 30' ' ' THR . 31.0 t 56.26 22.71 6.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.76 156.76 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.551 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' A' ' 101' ' ' SER . 33.3 t -156.91 125.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.38 131.85 51.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.18 153.33 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 0.0 111.411 -179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.27 121.91 44.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.165 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.5 pt -112.5 145.49 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 111.848 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -111.36 140.29 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.116 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.449 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -153.61 174.34 14.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.89 116.19 32.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.353 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.421 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 19.2 m -61.61 145.21 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 168' ' ' THR . . . 79.57 119.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.42 19.62 0.55 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.325 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER 176.91 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.861 0.362 . . . . 0.0 111.338 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.441 HG13 ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -158.16 131.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.559 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -113.53 94.41 31.99 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.8 Cg_endo -85.69 150.02 9.96 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.8 2.333 . . . . 0.0 112.769 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.27 23.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.212 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.31 116.98 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.57 -45.85 1.99 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.9 102.79 5.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 110.647 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -110.06 115.21 29.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.031 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.559 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -96.66 150.14 21.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.93 0.395 . . . . 0.0 110.791 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 18.3 t -124.59 95.48 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.0 mttt -81.76 98.15 8.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.21 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 mt -108.12 130.65 22.51 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.69 119.3 6.13 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.511 2.141 . . . . 0.0 111.454 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.423 ' HG3' ' CG2' ' A' ' 204' ' ' VAL . 0.1 OUTLIER -108.31 158.61 17.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.169 0.509 . . . . 0.0 111.536 -179.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -108.89 -164.84 0.97 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.323 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.39 -47.45 86.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.06 77.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.699 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.7 t -112.75 160.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -54.95 117.17 3.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.31 -61.07 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.551 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . 94.43 30.29 8.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.153 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.436 HD11 HG22 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -105.07 143.51 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.748 0.274 . . . . 0.0 110.866 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 86.6 m -126.09 136.76 53.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.796 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 mt -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.65 153.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.2 t -105.12 136.96 19.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.82 130.57 12.57 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.4 m -68.88 -29.84 68.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.7 94.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.59 92.24 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.33 158.31 74.72 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.09 94.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.525 2.15 . . . . 0.0 112.312 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 153.86 -61.69 0.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.561 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.406 ' N ' ' CD ' ' A' ' 153' ' ' PRO . 55.2 t0 59.6 53.71 4.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 152' ' ' ASP . 61.4 Cg_endo -73.31 -179.26 4.24 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.52 167.4 10.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.695 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.5 p -155.83 136.07 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.0 mt -65.44 151.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.663 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.85 -12.55 7.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.31 143.77 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.902 0.382 . . . . 0.0 111.204 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -131.0 149.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.433 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -98.36 146.96 25.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 111.132 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 173.16 10.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.995 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.68 -62.78 1.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 5.7 p -61.78 144.06 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 0.0 111.129 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.0 m -48.78 -21.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.144 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -48.04 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.312 . . . . 0.0 111.437 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.408 ' N ' ' CG2' ' A' ' 159' ' ' ILE . 36.3 t60 -76.15 -24.26 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.736 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.76 -45.72 74.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 116' ' ' ALA . 5.3 t -61.48 88.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -50.97 88.27 0.01 OUTLIER Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.742 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 168' ' ' THR . 0.3 OUTLIER 164.79 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 110.328 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 3.2 tt -84.21 57.11 4.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.96 162.82 17.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.52 54.66 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.133 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.28 25.72 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.465 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.3 OUTLIER -124.78 -176.79 3.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 110.558 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 209' ' ' ARG . 1.0 OUTLIER -134.6 130.14 36.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 111.368 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.33 152.26 33.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.0 pp -137.44 10.46 2.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.632 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -152.89 144.95 23.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 31.3 mm -139.27 111.67 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 35.6 t70 51.59 52.64 14.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 31.1 t30 84.72 -34.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 45.1 mm -68.64 159.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.752 0.31 . . . . 0.0 110.783 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.424 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 67.3 mtm180 -133.86 129.76 36.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.192 0.52 . . . . 0.0 112.299 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.08 -5.27 43.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.623 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -45.93 -29.55 1.45 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 m -123.26 30.28 6.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.42 165.11 36.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.998 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.14 -169.89 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 12.9 ptm -70.34 -42.01 72.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -53.9 -34.93 60.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.052 0.453 . . . . 0.0 111.006 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.07 -48.23 82.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.222 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -58.51 -39.11 79.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 13.5 t -63.0 -33.37 60.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.097 0.475 . . . . 0.0 109.998 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -49.65 70.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.848 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.71 -24.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.167 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -61.25 -40.67 94.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 110.216 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -89.7 -41.26 12.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.112 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.58 -18.63 60.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.752 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 4.1 m -81.74 44.95 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.235 178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 1.1 pt-20 -74.53 61.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.187 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.8 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.82 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 12.4 tp -176.67 104.37 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.252 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.423 ' CG2' ' HG3' ' A' ' 132' ' ' LYS . 59.1 t -98.32 108.56 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.147 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -100.21 108.19 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.1 mt -94.36 108.2 20.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.455 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.41 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 28.8 tttt -83.11 93.43 7.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.465 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 9.5 mm -88.99 164.13 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.352 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -126.54 127.8 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.838 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.02 123.14 39.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.111 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -178.59 91.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 46.1 -169.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.504 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.006 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.419 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 2.4 tt0 . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.419 ' N ' ' HG3' ' A' ' 18' ' ' GLN . 12.4 m -130.16 118.3 43.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.404 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -179.78 173.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -115.79 111.02 19.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.996 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -55.44 139.53 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.89 173.18 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.68 150.54 41.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.715 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.427 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 8.8 t -142.87 163.48 32.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -102.5 161.14 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.636 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -145.95 147.73 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.7 t -126.26 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -107.51 123.23 48.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.449 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -111.16 161.86 15.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.169 0.509 . . . . 0.0 111.821 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.481 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -104.42 116.13 31.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.19 154.88 67.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.56 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.2 6.57 4.6 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.497 2.131 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.39 -49.82 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.489 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.8 p -137.2 -2.73 2.02 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -110.34 3.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.349 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.481 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 6.6 m-85 -106.05 129.24 54.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.906 0.384 . . . . 0.0 110.064 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.47 24.93 20.59 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.884 -0.674 . . . . 0.0 114.473 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 1.1 pp -122.67 128.54 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.578 0.689 . . . . 0.0 111.503 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -111.26 127.4 55.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.235 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.3 OUTLIER -96.73 154.06 17.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.105 0.478 . . . . 0.0 111.715 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.58 168.85 8.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.494 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.421 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . -68.41 -117.68 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.801 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -108.57 132.46 53.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 46' ' ' PHE . 2.8 t -89.79 -70.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.871 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 13.4 p90 -25.3 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.854 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.75 72.28 0.16 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.562 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.409 ' O ' ' CB ' ' A' ' 49' ' ' GLU . 1.7 t 174.12 40.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' THR . 2.7 mt-10 164.71 -169.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.405 ' OG1' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.86 -94.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.589 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -152.98 -82.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.365 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.69 16.43 0.99 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.483 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -145.12 74.41 14.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.402 ' CB ' ' CD ' ' A' ' 55' ' ' PRO . 49.6 Cg_exo -55.47 -175.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.402 ' CD ' ' CB ' ' A' ' 54' ' ' PRO . 87.4 Cg_exo -46.8 125.23 9.47 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.47 2.113 . . . . 0.0 112.069 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mp -115.36 113.44 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.62 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 56.7 mt -58.17 121.92 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.449 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.2 t -124.81 25.88 7.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 60' ' ' ILE . 25.8 t80 -173.52 138.9 0.71 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.053 0.454 . . . . 0.0 111.662 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.588 ' CD1' ' CG2' ' A' ' 39' ' ' ILE . 30.8 mm -112.21 160.3 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.538 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.453 ' O ' ' OE2' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -112.52 155.79 23.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -100.29 55.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER 166.89 41.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.091 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.9 m -141.2 144.34 34.2 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.8 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.8 -0.11 6.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.633 2.222 . . . . 0.0 112.819 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.12 -56.92 7.08 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.341 0.591 . . . . 0.0 110.301 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.575 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 7.2 pm0 -80.12 -29.6 38.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.023 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.575 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -70.66 -27.31 63.93 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.018 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 53.6 t -49.46 -43.23 44.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 137' ' ' GLU . . . 106.16 20.88 8.85 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.728 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 t -153.66 41.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -124.44 157.26 35.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.02 158.2 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.8 mm -66.98 75.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.304 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 148.83 69.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.02 78.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.528 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -55.21 -40.89 71.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.6 t 65.08 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.263 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -27.98 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -155.78 137.33 14.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.1 mt -114.23 106.96 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.6 m120 58.79 20.77 8.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.169 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.46 -34.27 4.61 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.571 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.0 mt -67.73 127.42 93.37 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.497 0.189 . . . . 0.0 110.995 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.36 -179.28 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.456 2.104 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.8 p -147.45 -45.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.91 -13.11 61.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -118.93 46.55 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.4 p -171.92 -177.5 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 54.1 m -81.21 141.5 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.794 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.421 ' CE1' ' HA2' ' A' ' 43' ' ' GLY . 6.6 p90 -61.74 -37.25 83.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.8 tt0 -55.23 -36.02 65.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.264 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.51 -52.34 64.89 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.85 -33.58 61.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.412 0.625 . . . . 0.0 110.217 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.431 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -63.74 -40.3 96.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.978 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 18.0 mm-40 -61.59 -44.17 97.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.229 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.0 mt -56.29 -43.66 79.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.415 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.592 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 0.4 OUTLIER -70.41 -51.2 31.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.812 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -50.28 -30.53 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.138 0.494 . . . . 0.0 109.801 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.7 t0 -121.71 38.22 4.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.362 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.592 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.75 25.54 6.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.323 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.3 p -119.16 13.09 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.9 mt -68.12 -46.4 81.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 110.565 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -1.55 54.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.573 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.86 26.56 15.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -169.35 153.82 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 101' ' ' SER . 60.1 t -153.59 150.9 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.04 135.12 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.337 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.2 mt -136.81 149.21 47.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 111.628 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.72 105.9 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.981 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 111' ' ' ILE . 30.2 pt -103.47 154.52 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.15 0.5 . . . . 0.0 112.165 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -126.38 138.42 53.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.208 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.447 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -158.99 173.58 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 111.327 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.34 106.14 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.252 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 116' ' ' ALA . 18.5 m -61.92 103.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.823 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 115' ' ' VAL . . . 153.0 129.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.022 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -161.96 22.54 0.11 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.253 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 129' ' ' LYS . 0.3 OUTLIER 169.48 93.75 0.0 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.033 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.2 t -139.6 118.8 12.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.869 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.557 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.1 pp -137.26 78.19 40.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 121.692 0.758 . . . . 0.0 110.691 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 70.7 Cg_endo -94.65 176.74 1.02 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.229 2.619 . . . . 0.0 112.878 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -172.96 33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.895 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.73 117.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 89.25 -44.4 3.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.032 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.7 103.94 8.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.752 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -110.62 124.46 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.504 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.557 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -118.08 144.6 45.49 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.687 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 205' ' ' LYS . 2.9 t -130.27 111.1 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.506 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' SER . 11.1 mttp -80.72 101.31 9.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.9 mp -107.32 113.71 61.75 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.515 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.6 115.53 3.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.297 1.998 . . . . 0.0 111.352 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.37 158.75 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.73 -164.62 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.776 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -57.65 -48.39 79.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.71 50.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 111.277 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.1 t -89.63 144.13 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.402 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 40.6 tt0 -52.42 124.72 14.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.5 mp -90.57 -66.88 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 113.69 -2.22 24.66 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.05 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.516 HG21 HD12 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -95.78 135.58 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.342 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.454 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 11.0 m -126.1 136.04 52.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.504 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.3 mt -105.35 164.12 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.63 151.61 29.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.691 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.6 p -118.78 107.47 42.38 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.05 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.97 -159.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.474 2.116 . . . . 0.0 112.106 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 53.1 p -59.23 98.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.3 87.15 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mtt180 -151.1 42.8 0.77 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.851 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.39 161.16 45.69 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.751 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.02 -24.66 20.11 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.445 2.097 . . . . 0.0 112.241 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -163.44 59.09 0.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.461 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -49.21 105.72 0.54 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 111.179 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.04 -178.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.435 2.09 . . . . 0.0 112.359 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.8 mt -113.78 178.9 4.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.2 m -157.27 175.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.234 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.2 mm -79.25 154.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -130.8 -10.22 3.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.651 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.454 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 170.62 156.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 139' ' ' GLY . 4.2 mt -142.49 139.34 29.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.765 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.26 145.47 41.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.933 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -85.78 168.61 14.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.582 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.425 ' N ' ' NH1' ' A' ' 167' ' ' ARG . . . 84.95 -52.73 4.74 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.504 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 34.2 m -81.14 153.69 27.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 168' ' ' THR . 18.3 m -48.72 -21.8 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 168' ' ' THR . . . -46.88 -66.52 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.886 0.374 . . . . 0.0 111.655 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.428 ' HB3' HH22 ' A' ' 167' ' ' ARG . 0.8 OUTLIER -83.36 -24.24 32.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.4 -29.84 50.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.4 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 165' ' ' ALA . 22.3 p -45.25 -42.2 9.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.788 0.328 . . . . 0.0 111.393 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.83 -26.48 18.33 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.769 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.444 HG22 ' CE1' ' A' ' 126' ' ' PHE . 3.7 t -109.6 31.84 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.17 113.62 22.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -142.13 156.81 45.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 14.9 mt -75.4 113.7 13.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.23 -17.2 2.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.779 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.34 166.04 21.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.73 0.3 . . . . 0.0 110.794 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.28 114.25 24.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.019 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.72 142.55 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.691 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.5 tt -122.27 -55.22 1.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -143.49 176.07 9.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.081 0.467 . . . . 0.0 111.592 -179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 182' ' ' ASN . 25.3 mt -139.26 107.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.93 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.437 ' CA ' ' HB3' ' A' ' 205' ' ' LYS . 0.1 OUTLIER 48.38 -85.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 180' ' ' ILE . 3.6 m-20 -108.07 -20.33 13.2 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 24.9 mm -100.08 140.95 18.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 111.512 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -112.86 120.66 42.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.06 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.81 -5.21 58.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.375 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.67 -32.07 1.37 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.367 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 -16.78 9.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.579 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.6 m -85.24 -169.78 2.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 0.0 111.22 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.33 -173.36 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -74.05 -52.01 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.01 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -51.8 -30.71 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 111.102 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -51.53 67.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.058 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 197' ' ' LEU . . . -56.21 -39.41 72.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.239 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.529 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 19.1 t -61.01 -36.81 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.212 0.529 . . . . 0.0 109.902 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -49.86 76.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.843 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . . . . . . . . . 1.5 mp -75.51 -24.13 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.027 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -59.46 -36.17 75.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -100.11 -37.65 8.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.65 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.52 -19.57 49.17 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . 0.404 ' CB ' HG12 ' A' ' 204' ' ' VAL . 1.1 m -84.4 43.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.41 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -68.56 62.87 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.283 0.563 . . . . 0.0 111.076 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -174.98 -32.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.056 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.4 tt 178.06 108.91 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.272 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.404 HG12 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.06 115.24 48.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.215 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.437 ' HB3' ' CA ' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -96.32 107.9 20.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 127' ' ' HIS . 11.1 mp -81.91 113.58 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.458 ' CG ' ' CD2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -99.75 94.39 6.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.788 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.16 170.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.989 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -112.82 131.6 55.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.919 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 115.37 29.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 178.95 82.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.58 152.12 7.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.387 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.19 -179.946 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.2 p -114.39 132.53 63.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 115' ' ' VAL . 69.0 t -139.55 150.31 22.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -136.3 108.48 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.658 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 p -49.28 143.16 6.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 173.03 12.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -133.06 159.12 40.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 t -150.54 -169.96 3.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.01 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -121.65 161.0 23.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.409 HG12 ' HG ' ' A' ' 109' ' ' LEU . 1.7 p -136.65 151.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.392 0.615 . . . . 0.0 110.924 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.9 109.79 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.4 ' CD2' HD12 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -104.36 118.34 36.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.0 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -113.51 161.74 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.34 0.59 . . . . 0.0 112.195 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.501 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -107.0 109.75 21.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.455 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 8.4 p-10 -83.68 157.23 64.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.412 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.08 7.92 2.29 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.459 2.106 . . . . 0.0 112.98 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.64 -47.29 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.634 0.255 . . . . 0.0 111.247 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.3 p -144.58 6.53 1.25 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 61.71 -86.62 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.219 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.501 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 7.9 m-85 -128.06 113.98 16.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.51 19.51 47.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.523 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.464 HG23 ' HA ' ' A' ' 60' ' ' ILE . 16.2 pt -123.89 134.47 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.905 0.353 . . . . 0.0 110.69 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.402 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 3.2 pt20 -120.74 142.76 49.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.81 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 1.4 pt? -129.41 154.65 46.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.276 0.56 . . . . 0.0 111.921 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.19 8.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.339 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.23 -58.13 0.7 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.289 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -69.53 150.39 47.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.851 0.358 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.443 ' CG2' ' CD2' ' A' ' 56' ' ' LEU . 86.4 t -142.02 -88.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.955 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 52.9 p90 -56.78 -46.17 81.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.22 0.533 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.562 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 47.35 82.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.702 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 60.3 p -159.95 98.18 1.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.134 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 48' ' ' THR . 4.7 pt-20 52.37 35.36 17.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.525 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 48' ' ' THR . 0.0 OUTLIER 165.78 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.773 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.515 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -160.67 23.78 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.789 0.328 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.12 21.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -72.28 138.18 81.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.795 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.16 156.91 33.79 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.457 2.105 . . . . 0.0 112.39 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.429 ' HG2' ' HB ' ' A' ' 78' ' ' VAL . 1.8 Cg_endo -42.71 159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.003 2.469 . . . . 0.0 112.242 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.443 ' CD2' ' CG2' ' A' ' 45' ' ' VAL . 0.5 OUTLIER -160.62 108.88 1.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.548 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 61.5 mt -59.88 135.78 24.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -125.25 17.24 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.402 ' HB3' ' CG ' ' A' ' 40' ' ' GLN . 37.6 t80 -177.68 141.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 ' HA ' HG23 ' A' ' 39' ' ' ILE . 12.1 mm -131.01 148.43 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.077 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -95.55 151.84 18.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.943 0.401 . . . . 0.0 111.232 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.39 45.34 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.39 42.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.486 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.24 135.25 23.76 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.779 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.81 -11.46 3.51 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.787 2.325 . . . . 0.0 113.147 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.23 -57.54 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.815 0.34 . . . . 0.0 110.542 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' CB ' ' CG2' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.41 -31.83 42.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.977 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -61.32 -30.93 70.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.673 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.63 -31.29 64.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.776 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.36 34.19 12.67 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.676 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.1 t -151.41 28.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.652 0.263 . . . . 0.0 111.411 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.4 HD12 ' CD2' ' A' ' 29' ' ' LEU . 16.8 mt -140.42 148.89 41.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 175.92 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.1 mm -69.26 68.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.18 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.39 59.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.678 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.76 120.88 30.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.75 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -90.72 104.55 17.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' HB ' ' HG2' ' A' ' 55' ' ' PRO . 17.2 t -94.08 158.65 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.051 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.74 -40.45 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.46 149.14 37.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.159 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.402 ' CG2' HD12 ' A' ' 97' ' ' LEU . 17.6 mt -132.71 120.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.68 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 m120 54.53 24.23 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.913 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.97 -18.48 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.636 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.14 137.02 56.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.42 -178.7 3.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.369 2.046 . . . . 0.0 112.254 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.6 p -157.26 -44.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -11.15 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.391 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -117.09 46.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.763 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 t -176.9 -176.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.38 151.24 45.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -70.17 -30.94 68.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -55.83 -31.56 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.69 -58.62 7.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -54.82 -28.68 51.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.806 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.22 -43.11 34.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.491 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -70.61 -36.13 73.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.807 0.336 . . . . 0.0 111.198 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.536 ' O ' ' HB3' ' A' ' 101' ' ' SER . 1.1 pp -70.09 -46.1 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.326 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.29 -57.39 9.56 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.264 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -50.75 -29.68 12.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 5.8 t70 -114.37 35.5 4.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.536 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 84.4 p -108.78 15.21 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.134 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.8 p -100.64 15.08 29.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 111.855 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.468 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 1.7 mt -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 5.77 44.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.656 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 13.1 p 59.2 26.76 15.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.009 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -171.12 148.85 2.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.907 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.52 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.5 t -149.68 131.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.31 130.59 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.697 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.409 ' HG ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -140.32 164.96 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 111.342 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -114.43 145.55 41.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.402 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.6 pt -137.46 159.94 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.959 0.409 . . . . 0.0 111.78 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -123.69 146.42 48.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.318 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -161.05 174.28 13.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.425 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.13 131.23 44.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 27.2 m -85.53 145.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.728 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 82.88 113.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.774 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -153.79 24.32 0.51 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.872 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.35 85.43 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.649 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.462 ' CG1' ' CE1' ' A' ' 126' ' ' PHE . 34.7 t -142.27 131.63 22.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.028 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.633 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -134.23 86.03 37.35 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-O 121.646 0.736 . . . . 0.0 109.894 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 60.6 Cg_endo -95.81 175.19 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.268 2.645 . . . . 0.0 113.424 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -163.25 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.463 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 169.78 113.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.2 -30.75 6.48 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.354 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.417 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -134.5 102.67 5.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.999 0.428 . . . . 0.0 110.612 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 1.9 t80 -104.45 127.56 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.633 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.6 OUTLIER -118.44 141.06 48.93 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.624 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.48 ' CG2' ' HB2' ' A' ' 206' ' ' LEU . 4.8 m -129.38 104.37 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -80.56 104.48 11.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.767 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mp -113.84 139.08 23.08 Favored Pre-proline 0 C--N 1.333 -0.126 0 CA-C-O 120.588 0.233 . . . . 0.0 111.488 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.11 108.91 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.446 2.097 . . . . 0.0 111.798 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.451 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -81.97 158.64 23.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.41 ' HE2' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -127.2 -166.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.265 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.8 -76.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.215 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.9 m -152.99 74.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.198 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.8 t -127.84 151.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.796 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -53.04 96.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.045 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.07 -38.31 67.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.19 -44.38 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.1 pt -81.84 146.41 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.857 0.361 . . . . 0.0 111.322 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.3 m -126.18 118.95 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.738 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.414 ' CG2' ' CD1' ' A' ' 154' ' ' LEU . 1.4 mp -80.58 164.06 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 10.8 t -167.68 166.94 13.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -116.77 137.11 23.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -55.56 -39.5 90.7 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.421 2.08 . . . . 0.0 112.128 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.0 t -169.24 -166.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.824 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.1 m -134.05 40.23 3.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.65 74.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.79 153.03 13.75 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.15 -25.93 50.29 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.689 2.259 . . . . 0.0 112.58 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.52 -67.88 1.47 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.595 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.433 ' N ' ' CD ' ' A' ' 153' ' ' PRO . 21.5 t70 55.59 50.7 5.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.301 . . . . 0.0 111.249 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 152' ' ' ASP . 86.1 Cg_endo -80.24 -175.16 2.56 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.563 2.175 . . . . 0.0 112.422 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 142' ' ' ILE . 1.8 mm? -104.83 145.61 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 16.8 m -142.19 178.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 111.329 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.3 mm -93.23 154.83 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.58 -26.82 2.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.76 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -176.49 162.11 2.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.199 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 1.6 mt -140.53 149.08 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.756 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.0 146.23 45.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -83.35 164.93 19.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.33 -19.21 19.58 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.065 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.477 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.2 m -107.05 146.53 31.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.964 0.411 . . . . 0.0 110.997 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 34.8 m -48.85 -22.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.935 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -52.91 -71.17 0.07 Allowed 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.955 0.407 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 29.0 t60 -71.29 -24.8 62.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.14 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -56.88 -30.99 64.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.995 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 72.5 p -45.1 -42.71 9.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.253 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.71 -43.61 2.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.428 HG21 ' CZ ' ' A' ' 126' ' ' PHE . 5.6 t -96.9 34.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.9 tt -117.34 99.91 7.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -109.36 -179.98 3.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.0 mt -107.84 148.66 29.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.806 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.53 -11.17 39.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.814 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.431 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 3.1 t0 -78.48 175.68 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.641 0.258 . . . . 0.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -117.25 151.53 36.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.326 . . . . 0.0 111.132 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.71 170.8 7.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.063 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.07 -44.89 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -150.2 169.33 21.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 16.3 mt -139.62 114.38 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 18.3 t0 59.28 -83.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.375 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -128.69 -14.95 4.51 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 20.2 mm -102.32 133.58 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 9.6 mtm105 -100.13 114.47 27.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.597 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 187' ' ' SER . 2.9 mm? -72.32 -17.07 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.411 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.56 -81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 185' ' ' LEU . 8.2 m -153.28 24.44 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.837 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -171.05 0.65 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.071 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.7 14.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' MET . . . . . 0.414 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 14.8 ptm -74.23 -42.64 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.414 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.0 mt-10 -53.7 -31.89 49.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -48.13 80.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.195 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.73 82.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.476 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.461 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 8.6 t -63.79 -34.42 67.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 109.749 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.408 ' O ' ' HG3' ' A' ' 199' ' ' GLN . 0.9 OUTLIER -61.44 -50.29 73.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.966 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.5 ' HA ' ' HG3' ' A' ' 199' ' ' GLN . 2.6 mp -70.08 -24.78 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.172 0.51 . . . . 0.0 109.764 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -64.23 -33.92 76.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.721 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -87.75 -39.78 14.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.515 ' C ' ' H ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -86.48 13.26 8.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.833 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.29 33.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.7 pt-20 32.53 68.17 0.15 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.78 24.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.451 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 mt -153.96 93.66 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.135 0.493 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.42 ' O ' ' CG1' ' A' ' 204' ' ' VAL . 13.8 p -97.11 108.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.714 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 24.1 ttmt -104.54 107.06 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.48 ' HB2' ' CG2' ' A' ' 128' ' ' VAL . 3.4 mt -83.4 114.16 21.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.523 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 12.0 tttt -97.16 93.26 6.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.356 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 0.7 OUTLIER -84.95 168.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.826 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 10.2 ttp180 -118.98 123.42 44.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.34 159.49 15.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.554 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -164.65 46.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.49 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.936 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.1 t0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.81 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.8 0.333 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 p -125.76 128.63 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.2 p -137.79 143.38 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.171 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 51.6 p-80 -106.04 110.77 23.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -55.94 152.17 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 170.44 12.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.764 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.68 137.13 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.432 HG22 ' CZ ' ' A' ' 113' ' ' PHE . 2.2 t -139.3 176.88 8.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -106.76 162.93 13.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.33 150.41 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.634 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.53 109.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 111.411 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 106' ' ' LYS . 3.9 mm? -106.63 121.72 44.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.798 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -110.67 162.18 15.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.63 . . . . 0.0 112.406 -178.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -109.34 103.73 12.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.168 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.4 148.32 55.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.41 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.88 1.96 7.1 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.596 2.198 . . . . 0.0 112.674 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.55 -48.45 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.371 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t -125.51 -11.24 6.82 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.02 -87.88 0.57 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.406 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.475 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 27.7 m-85 -130.94 117.94 19.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.0 110.285 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.502 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -70.34 -3.69 47.78 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.517 ' C ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -105.61 167.6 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.958 0.879 . . . . 0.0 112.189 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 4.8 mt-30 -138.61 122.28 17.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.097 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.422 ' CD2' ' CB ' ' A' ' 55' ' ' PRO . 0.5 OUTLIER -96.34 143.3 27.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 112.061 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.409 ' CG ' ' CD1' ' A' ' 56' ' ' LEU . 6.0 pt20 -105.19 166.09 10.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.559 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.423 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -122.41 107.28 1.13 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.299 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 57.24 112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 111.398 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.62 -75.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.485 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.509 ' CD2' ' N ' ' A' ' 47' ' ' ALA . 36.1 p90 -49.97 -48.07 52.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.036 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 41.58 80.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.66 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 t 170.11 114.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.565 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 50' ' ' THR . 1.9 tt0 61.32 86.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 1.3 m 90.56 -179.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.4 pp -167.01 30.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.165 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -64.45 30.73 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -112.75 86.8 9.13 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.601 0.238 . . . . 0.0 110.578 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.29 176.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.486 2.124 . . . . 0.0 112.133 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' CB ' ' CD2' ' A' ' 41' ' ' LEU . 52.2 Cg_exo -53.16 137.9 63.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.412 2.075 . . . . 0.0 111.838 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' CD1' ' CG ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -137.67 113.76 9.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.489 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 81.8 mt -62.21 138.68 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 110.801 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.3 t -119.82 -24.04 6.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.502 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 72.4 t80 -136.83 159.09 42.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.664 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 9.4 mm -138.33 164.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.47 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 38' ' ' GLY . 4.0 tp10 -119.87 147.13 45.07 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.866 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.95 42.72 1.11 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.187 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.15 36.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.068 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.502 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -137.17 138.13 24.57 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.081 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.71 -15.83 13.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.038 2.492 . . . . 0.0 113.643 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.9 -44.09 56.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.664 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.6 tp10 -76.06 -29.22 57.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.719 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.538 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.41 -14.83 39.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.307 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.7 t -47.25 -40.84 17.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.941 0.4 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.406 ' HA2' ' CG1' ' A' ' 136' ' ' VAL . . . 105.3 11.44 29.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.439 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -153.85 53.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 111.637 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 10.4 mt -141.3 134.83 29.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -141.08 174.44 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.5 mm -73.11 78.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.28 43.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.26 83.31 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.783 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 101.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.9 m -95.77 115.4 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -97.14 24.52 6.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.33 131.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.1 mt -131.23 115.71 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 56.39 23.31 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.8 -26.3 24.53 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.536 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mt -74.26 136.67 75.44 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-O 120.565 0.222 . . . . 0.0 111.229 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.2 171.35 15.11 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.384 2.056 . . . . 0.0 112.162 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 p -139.42 -46.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -71.05 -11.36 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -113.16 45.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.015 0.436 . . . . 0.0 110.794 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -178.09 -170.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.798 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 148.65 32.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.423 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 21.7 p90 -73.52 -31.21 63.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -59.16 -31.78 69.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.24 -58.88 6.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -55.73 -39.9 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.142 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.424 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.4 m120 -64.6 -36.99 86.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.322 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.593 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -69.95 -44.07 70.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.354 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.593 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 2.3 pp -62.65 -28.78 70.16 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.445 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 39.3 mt -67.62 -46.38 72.66 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 28.8 mtt-85 -50.28 -40.26 47.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.487 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.0 m-20 -115.55 40.93 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.431 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.481 ' HB3' HG22 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.19 6.46 47.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.619 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -105.23 18.23 22.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.341 . . . . 0.0 111.82 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.487 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.8 mt -71.41 -51.63 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.814 0.816 . . . . 0.0 110.919 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 7.99 31.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.806 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 30' ' ' THR . 45.4 t 57.1 22.47 7.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.337 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -168.99 159.16 9.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.036 0.446 . . . . 0.0 111.745 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' A' ' 101' ' ' SER . 39.8 t -157.5 128.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.683 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.87 133.34 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.585 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.63 157.26 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 0.0 111.439 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 118.03 30.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.197 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 pt -112.27 155.37 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.155 0.503 . . . . 0.0 111.813 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.56 117.52 18.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.198 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.432 ' CZ ' HG22 ' A' ' 25' ' ' THR . 6.2 p90 -136.34 174.11 10.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 0.0 111.407 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -91.08 155.33 18.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.559 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 167' ' ' ARG . 27.9 m -108.55 104.96 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.455 . . . . 0.0 111.635 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -172.35 95.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.6 OUTLIER -107.15 20.44 19.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.794 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 86.32 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.219 0.533 . . . . 0.0 111.714 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.464 ' HB ' ' CZ ' ' A' ' 126' ' ' PHE . 2.5 m -112.96 140.76 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.115 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 127' ' ' HIS . 2.2 pp -121.53 104.76 39.57 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.771 0.32 . . . . 0.0 111.455 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 92.7 Cg_endo -86.01 164.28 10.15 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.848 2.365 . . . . 0.0 112.754 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -167.28 22.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.582 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.7 OUTLIER 55.34 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.934 0.397 . . . . 0.0 111.244 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.36 -42.24 2.49 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.877 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.41 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.89 102.59 5.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.512 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 6.1 t80 -104.66 130.58 52.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.525 ' HB2' HG13 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -112.68 144.76 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.454 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.46 89.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.473 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -81.29 106.15 13.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 pp -132.31 134.83 25.43 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 53.8 Cg_endo -69.15 125.63 12.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.407 2.072 . . . . 0.0 111.817 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 158.96 15.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.081 0.467 . . . . 0.0 111.061 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HD2' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -92.9 -175.27 3.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.804 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -40.79 83.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.21 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 171.79 65.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 133' ' ' LYS . 17.2 t -109.76 165.05 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 136' ' ' VAL . 34.9 tt0 -29.19 132.6 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.06 101.29 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.745 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.94 49.24 3.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.342 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.4 ' CD1' ' HB3' ' A' ' 165' ' ' ALA . 32.7 mm -94.64 134.59 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.581 0.229 . . . . 0.0 110.878 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.422 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 29.6 m -126.44 139.93 52.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.893 0.377 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 11.8 mt -113.24 164.09 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.1 m -160.79 147.56 15.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.9 t -96.08 148.01 33.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.09 -55.55 3.76 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.6 t -154.87 29.92 0.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.3 m 58.75 51.91 7.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.826 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -82.03 177.71 8.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.81 156.62 4.74 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.051 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.05 86.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.691 2.261 . . . . 0.0 112.258 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 171.02 -33.55 0.15 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.494 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -53.22 140.66 43.25 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.62 0.248 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 164.57 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.445 2.097 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 12.8 mt -114.72 -177.97 3.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.704 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.5 m -161.85 154.0 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.261 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 mt -71.09 147.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.441 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.2 t -128.09 -2.86 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.422 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 172.4 135.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.828 0.347 . . . . 0.0 110.607 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.442 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 6.5 mt -137.16 136.66 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.476 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 150.52 26.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.505 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -85.12 66.97 10.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.33 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.255 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.432 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -154.21 139.86 17.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.054 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.41 HG21 ' NZ ' ' A' ' 133' ' ' LYS . 25.4 m -48.79 -24.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.441 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.476 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -46.8 -71.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 86.3 t60 -76.67 -25.52 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 111.099 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.505 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -56.47 -29.98 62.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.784 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 9.2 t -62.78 -23.94 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.811 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.43 71.08 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.887 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -172.39 -42.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.953 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.48 100.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.944 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -128.3 139.97 52.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.29 102.02 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.22 -18.81 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -72.97 134.6 44.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.73 103.98 16.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 137.51 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 8.4 tt -133.43 -40.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -129.78 149.1 51.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.92 0.391 . . . . 0.0 111.387 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 193' ' ' ALA . 27.3 mt -139.23 113.86 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.294 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 24.9 t70 47.65 55.35 8.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.18 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.8 t30 84.9 -35.88 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.428 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 44.1 mm -67.3 159.18 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 110.63 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.456 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 10.1 mtp180 -134.74 129.49 34.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.407 HD21 ' CD1' ' A' ' 180' ' ' ILE . 3.4 mm? -74.53 -6.23 47.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.574 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -41.33 7.91 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.3 t -115.85 -18.06 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -171.14 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.7 -176.9 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 6.7 ttp -69.12 -57.14 5.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -54.31 -31.1 53.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -48.79 77.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.097 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 180' ' ' ILE . . . -57.02 -39.41 74.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.164 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 21.7 t -60.14 -41.19 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.867 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -50.04 75.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.856 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 193' ' ' ALA . 3.0 mp -69.51 -24.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.7 OUTLIER -57.92 -37.59 74.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.357 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -96.73 -35.67 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.028 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -16.68 61.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 8.5 m -86.04 41.23 0.91 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.339 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.64 62.37 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.238 0.542 . . . . 0.0 111.068 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -174.18 -30.67 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.465 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.6 tt 176.72 109.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.393 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.3 125.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.613 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -108.16 108.32 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.883 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.37 108.2 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.446 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.505 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 7.6 tttt -97.37 98.5 10.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.653 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.34 172.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 3.4 mmt180 -108.94 138.82 44.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.451 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.412 ' HE2' ' CD2' ' A' ' 126' ' ' PHE . 6.4 mptt -119.27 157.25 28.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.46 70.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.971 0.415 . . . . 0.0 110.963 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.65 140.69 50.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.083 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.826 0.346 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.54 139.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 21' ' ' HIS . 11.1 p -162.9 156.22 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.402 ' N ' HG22 ' A' ' 20' ' ' VAL . 51.3 p-80 -109.38 136.09 49.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -54.68 167.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.409 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -162.96 156.66 20.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -113.25 149.05 34.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.179 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -144.07 165.62 27.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -101.91 158.9 15.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.97 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 28' ' ' VAL . 2.9 p -143.65 151.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.496 0.665 . . . . 0.0 111.612 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.408 ' N ' HG21 ' A' ' 27' ' ' VAL . 44.5 t -128.76 110.82 21.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.102 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.405 HD22 ' CD1' ' A' ' 39' ' ' ILE . 5.7 mp -109.77 118.75 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -109.4 161.54 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.271 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.89 112.51 24.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.06 156.0 44.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.609 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.7 7.6 3.06 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.556 2.171 . . . . 0.0 112.953 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.3 t -107.58 -47.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 111.181 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.8 p -146.35 6.75 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 37' ' ' PHE . . . 66.86 -79.04 0.14 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.501 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' A' ' 37' ' ' PHE . 4.8 m-85 -132.67 113.76 13.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.187 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.18 -2.55 62.76 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.916 -0.584 . . . . 0.0 114.07 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' A' ' 72' ' ' LEU . 18.1 mt -92.98 136.32 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 111.944 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 mt-30 -113.84 120.62 41.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.038 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.408 ' CD1' HG12 ' A' ' 57' ' ' ILE . 6.8 mp -95.35 136.89 35.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.195 0.521 . . . . 0.0 111.935 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 169.46 8.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.74 64.88 0.35 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.384 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -161.78 63.16 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.126 0.488 . . . . 0.0 111.021 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.76 -70.4 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.671 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.566 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.0 p90 -40.85 -43.97 2.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.17 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 54.81 76.24 0.26 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 49' ' ' GLU . 2.7 t 169.88 -164.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.864 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 48' ' ' THR . 16.3 pt-20 -46.81 167.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.603 0.24 . . . . 0.0 110.717 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.417 ' CG2' ' O ' ' A' ' 49' ' ' GLU . 11.0 t 45.53 -159.42 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.194 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.566 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -149.18 -85.8 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.342 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.42 14.48 1.15 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.79 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 t -75.59 113.87 30.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 151.48 56.11 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.27 1.98 . . . . 0.0 111.696 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -47.84 111.2 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.341 2.027 . . . . 0.0 112.189 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.12 110.69 16.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 39.4 mt -56.21 124.92 10.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.858 0.361 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -8.25 27.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 45.7 t80 177.61 138.58 0.08 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.005 0.431 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.42 HG23 ' HB3' ' A' ' 67' ' ' GLU . 5.0 mt -113.82 169.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.337 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -108.46 151.97 25.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 111.368 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.404 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -91.61 46.59 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.356 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 177.46 44.34 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.892 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.423 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -142.44 142.18 22.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.998 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.79 -13.06 24.48 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.655 2.237 . . . . 0.0 112.889 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.77 -56.75 11.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 110.255 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.421 ' HG3' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -79.08 -29.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.896 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -69.42 -20.22 63.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.238 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.0 t -47.3 -29.31 2.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.22 58.24 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' CG1' ' HA2' ' A' ' 162' ' ' GLY . 4.0 t -152.63 37.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' CD1' HD12 ' A' ' 39' ' ' ILE . 10.7 mt -142.15 172.53 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 111.624 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.22 150.15 10.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.441 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.5 98.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.922 0.392 . . . . 0.0 111.337 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.62 40.8 4.05 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.248 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.17 -14.21 59.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.631 0.253 . . . . 0.0 111.399 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 63.09 136.05 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.2 t -114.07 152.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.212 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -114.25 -34.12 5.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.7 142.86 26.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.2 mt -128.39 111.13 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 54.24 25.11 5.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.13 -21.89 36.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.567 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 84' ' ' ILE . 44.2 mt -75.32 128.84 83.68 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-O 120.531 0.205 . . . . 0.0 111.142 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -57.65 -160.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.456 2.104 . . . . 0.0 112.212 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.3 p -158.22 -49.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -7.25 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.42 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -112.22 45.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 t -178.31 175.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.04 144.32 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -51.61 -27.35 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.155 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.79 -35.07 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -64.28 -37.41 87.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.786 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -69.24 -35.83 76.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.255 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.95 -42.71 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.963 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -69.1 -42.37 76.21 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.164 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.488 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 4.0 pp -64.8 -32.37 74.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.522 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 4.2 mt -63.09 -57.42 10.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.737 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -52.33 -30.41 28.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.459 ' N ' ' HG2' ' A' ' 99' ' ' ARG . 68.6 m-20 -115.67 36.62 3.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.927 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.522 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -105.36 15.06 27.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.326 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.32 18.73 18.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.1 mt -63.73 -46.55 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.689 0.757 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.92 0.13 57.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.502 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.2 m 63.26 26.27 15.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.495 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -166.16 146.03 6.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.78 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.495 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.2 t -149.02 111.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.624 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.12 133.67 36.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.25 165.27 27.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 111.222 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.18 136.98 52.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.393 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.6 pt -128.85 166.07 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.677 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -128.48 142.77 50.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.729 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.451 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.0 OUTLIER -161.2 174.72 13.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.922 0.392 . . . . 0.0 111.236 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -88.75 150.49 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 m -101.57 104.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.006 0.431 . . . . 0.0 111.41 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -168.09 130.3 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.616 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.412 ' O ' ' CB ' ' A' ' 118' ' ' SER . 69.7 mm-40 -130.2 6.56 4.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.01 71.21 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.34 0.59 . . . . 0.0 111.247 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.456 ' HB ' ' CZ ' ' A' ' 126' ' ' PHE . 3.1 m -97.69 147.45 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.718 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.427 HD12 ' CG ' ' A' ' 127' ' ' HIS . 2.1 pp -122.92 102.31 38.09 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.889 0.376 . . . . 0.0 111.473 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.3 Cg_endo -87.71 154.81 7.52 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.96 2.44 . . . . 0.0 112.605 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -162.61 24.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.429 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 118.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.859 0.361 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 92.61 -45.95 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.088 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.5 102.43 6.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.643 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.456 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 8.4 t80 -107.14 115.93 31.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.458 ' CE1' ' HG3' ' A' ' 207' ' ' LYS . 0.5 OUTLIER -99.72 144.96 28.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.145 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.3 97.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.978 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -81.29 99.01 8.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.072 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.43 ' CD2' ' CG2' ' A' ' 168' ' ' THR . 3.0 mp -109.82 114.73 56.24 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.415 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.94 110.39 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.164 1.91 . . . . 0.0 111.307 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -89.7 158.65 17.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.611 -179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 134' ' ' HIS . 0.0 OUTLIER -122.85 178.23 5.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.629 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.665 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 34.4 t-80 -41.77 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.715 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.0 m -138.63 97.37 3.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.883 0.373 . . . . 0.0 111.63 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.484 ' CG2' ' HD2' ' A' ' 133' ' ' LYS . 2.2 t -143.21 141.46 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.49 141.98 58.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.3 tp -95.88 -41.94 8.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.424 ' HA3' ' HG3' ' A' ' 160' ' ' LYS . . . 94.0 13.84 53.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.267 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.17 139.38 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.421 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 41.0 m -111.86 142.18 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 6.6 mt -103.35 164.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.033 0.444 . . . . 0.0 111.18 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.18 158.64 30.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.724 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.8 p -129.33 106.38 17.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.72 -61.51 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.527 2.151 . . . . 0.0 112.381 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.18 -68.95 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.4 30.56 18.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.998 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -131.31 44.55 2.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.5 139.32 0.14 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.741 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.75 106.11 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.352 2.034 . . . . 0.0 112.279 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 117.23 23.24 3.9 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.789 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -55.32 148.75 30.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.17 172.04 15.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.573 2.182 . . . . 0.0 112.404 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -123.92 141.85 51.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 176' ' ' LYS . 34.9 m -156.38 148.69 11.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.4 mp -68.0 152.19 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.17 -6.94 3.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.73 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.421 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 179.68 147.82 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.0 111.448 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.437 HG21 ' CG ' ' A' ' 166' ' ' HIS . 17.1 mt -139.13 149.79 23.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.465 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -138.7 144.26 39.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.373 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.52 72.58 5.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.584 ' N ' ' HD3' ' A' ' 160' ' ' LYS . . . -134.08 -44.37 0.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.194 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.14 176.61 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.248 0.547 . . . . 0.0 111.424 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.0 m -53.69 -21.52 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.384 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -42.69 -69.72 0.13 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.437 ' CG ' HG21 ' A' ' 159' ' ' ILE . 5.4 t60 -68.07 -27.25 66.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -29.42 67.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.27 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.43 ' CG2' ' CD2' ' A' ' 130' ' ' LEU . 70.5 p -45.83 -29.83 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.53 58.61 8.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 t -178.83 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.67 93.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.019 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.71 146.9 27.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 35.4 mt -69.05 84.3 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.47 43.2 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.585 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.58 145.01 46.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 0.0 110.457 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.409 ' HA ' HG12 ' A' ' 155' ' ' VAL . 10.2 mmtp -97.15 115.71 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 111.151 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.87 135.04 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.75 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.97 -27.13 6.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -148.13 162.23 39.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.943 0.401 . . . . 0.0 111.551 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.3 mm -139.44 110.22 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.968 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 21.2 t70 63.52 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.157 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -128.29 -22.6 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 43.3 mm -87.83 157.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.801 0.334 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 9.1 mtt180 -126.31 129.75 49.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.076 0.465 . . . . 0.0 112.051 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -71.98 -6.36 41.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.727 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -45.51 -42.18 10.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.6 p -116.16 -19.67 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.211 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.78 -176.01 5.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.34 -175.67 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 11.9 ttp -63.05 -55.18 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.56 -29.87 18.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.771 ' O ' ' NE2' ' A' ' 195' ' ' GLN . 1.1 m-20 -64.32 -54.09 38.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.749 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.532 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -52.06 -32.57 35.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.899 0.38 . . . . 0.0 110.206 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 23.0 t -64.77 -47.81 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.819 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.771 ' NE2' ' O ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -70.77 -32.35 69.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.208 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.532 HD12 ' HA ' ' A' ' 193' ' ' ALA . 2.5 mt -75.77 -26.21 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 193' ' ' ALA . 0.1 OUTLIER -63.93 -40.56 96.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.287 179.033 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -86.64 -42.66 13.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.224 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -18.56 48.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.497 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 4.6 m -86.25 42.23 0.98 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.374 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.98 62.42 0.87 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.247 0.546 . . . . 0.0 111.147 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -171.3 -33.01 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.058 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.0 tt 177.89 106.93 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.308 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.3 121.77 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.349 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 0.6 OUTLIER -100.81 107.71 19.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.935 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 127' ' ' HIS . 3.1 mp -85.81 104.27 15.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.976 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.458 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -89.73 93.79 9.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.72 172.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.65 133.52 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.72 159.15 33.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.69 43.58 25.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.5 149.07 46.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.125 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.833 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 4.3 tp60 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.785 0.326 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.416 ' N ' ' HG3' ' A' ' 18' ' ' GLN . 11.9 p -141.35 127.75 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.3 p -158.93 165.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.223 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -92.93 134.17 35.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.092 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.37 174.21 3.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -168.49 162.11 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.711 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.21 144.97 51.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -139.52 -173.51 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.944 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -103.15 161.14 14.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -147.01 149.08 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.156 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.58 113.89 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.1 118.92 37.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -110.66 161.81 15.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.22 0.533 . . . . 0.0 111.742 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -103.79 119.93 39.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.104 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 8.8 t0 -88.53 141.96 30.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.338 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.18 3.94 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.48 2.12 . . . . 0.0 113.04 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.3 t -101.27 -53.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.767 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 t -141.25 6.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.947 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 67.96 -107.93 2.25 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.162 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.483 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 6.2 m-85 -106.87 128.26 54.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -91.88 25.15 17.7 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.863 -0.684 . . . . 0.0 114.798 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.646 HG22 ' CD1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -126.39 130.93 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.68 0.74 . . . . 0.0 111.826 179.213 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 116.21 29.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.175 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.9 OUTLIER -96.87 145.6 25.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.389 0.614 . . . . 0.0 112.552 -178.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.25 169.59 10.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.818 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.46 -47.59 0.5 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.791 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -47.04 123.92 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.554 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.42 ' CG2' ' CD2' ' A' ' 56' ' ' LEU . 98.8 t -140.2 -83.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.901 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 39.0 p90 -40.5 -45.54 2.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.175 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.511 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 51.94 73.63 0.31 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.264 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 165.33 90.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.636 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.401 ' O ' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER 55.17 176.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 t 44.89 -163.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.355 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -147.8 -101.41 0.09 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.193 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.94 18.36 1.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.842 0.353 . . . . 0.0 111.555 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.46 107.85 1.75 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.038 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.441 ' O ' ' CD2' ' A' ' 56' ' ' LEU . 7.7 Cg_exo -72.91 167.4 27.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.653 2.235 . . . . 0.0 111.998 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB3' HD22 ' A' ' 41' ' ' LEU . 24.4 Cg_exo -63.83 128.63 22.51 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.711 2.274 . . . . 0.0 112.132 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.3 pt? -145.84 100.65 3.44 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.811 0.339 . . . . 0.0 111.804 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.567 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 46.2 mt -64.62 156.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.519 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -139.15 8.14 2.46 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 52.8 t80 -178.14 134.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 112.081 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.646 ' CD1' HG22 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.89 -173.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 38' ' ' GLY . 29.0 tt0 -125.3 125.61 43.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.967 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -53.01 109.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.963 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER 84.72 46.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.353 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.92 154.28 76.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.89 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 22.4 Cg_exo -63.4 -12.04 28.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.392 2.061 . . . . 0.0 112.261 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' CB ' HG13 ' A' ' 39' ' ' ILE . . . -72.01 -57.1 4.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.514 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 1.1 tp10 -79.08 -29.03 43.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.093 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -89.11 -7.19 56.25 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.582 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -46.88 -46.85 21.37 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.844 0.354 . . . . 0.0 111.204 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.16 -25.45 6.36 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.264 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.3 t -139.39 63.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.437 . . . . 0.0 110.803 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.0 mt -148.28 169.67 19.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.012 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -164.07 162.09 22.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.742 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.7 mm -60.54 85.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.286 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.08 90.94 1.87 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.659 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.5 p30 -112.26 115.63 29.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.735 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.0 t -72.98 115.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.163 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.5 tpt -83.25 -42.04 17.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.21 28.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.2 mt -131.54 119.64 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.95 23.16 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.94 -22.39 31.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.645 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 84' ' ' ILE . 45.2 mt -70.39 127.77 91.83 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.429 0.157 . . . . 0.0 111.229 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.14 -31.15 65.06 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.44 2.094 . . . . 0.0 112.238 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p 75.74 -54.96 0.62 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.152 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -66.93 -13.79 62.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.09 44.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.78 -175.91 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.787 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 m -68.52 156.58 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -73.1 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.007 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -55.54 -32.78 63.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -36.09 82.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.801 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -71.16 -34.96 71.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 110.504 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -74.13 -32.15 63.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.651 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.519 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -72.5 -37.27 68.45 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.519 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -70.58 -38.74 74.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.206 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 101' ' ' SER . 71.1 mt -73.47 -55.81 5.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.308 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.25 -30.01 16.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.4 OUTLIER -119.01 37.95 3.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.584 178.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -95.87 26.67 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.004 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -119.17 12.01 12.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.65 -47.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.642 0.734 . . . . 0.0 110.596 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -2.89 56.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.62 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.69 26.97 15.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.992 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -170.03 154.95 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.101 0.477 . . . . 0.0 111.099 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.4 t -155.8 145.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.38 120.42 32.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.315 . . . . 0.0 110.805 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.05 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -105.6 145.85 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.5 pt -125.49 142.65 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 111.531 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -107.97 129.35 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.401 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.409 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 3.4 p90 -153.87 174.42 14.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.188 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -98.5 135.41 40.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.62 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 35.1 m -75.47 104.97 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.995 0.426 . . . . 0.0 111.395 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.17 124.45 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 118' ' ' SER . 1.4 mm-40 -135.62 33.3 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 2.1 t 80.7 91.53 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.297 0.57 . . . . 0.0 110.982 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.461 ' HB ' ' CE1' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -128.28 127.15 67.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.668 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.508 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.7 pp -109.95 97.18 28.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.537 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 88.9 Cg_endo -84.11 159.91 13.47 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.752 2.301 . . . . 0.0 112.691 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.74 27.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.68 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.84 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.7 -40.97 3.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.233 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.86 102.93 7.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 0.0 110.994 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -109.98 119.43 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.487 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.508 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -105.59 120.76 42.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.311 . . . . 0.0 110.774 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.3 t -99.74 95.52 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.549 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -81.49 102.75 10.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.6 125.01 29.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 121.37 7.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.403 2.069 . . . . 0.0 111.762 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.551 ' HB3' ' N ' ' A' ' 202' ' ' ASP . 0.5 OUTLIER -92.5 159.4 15.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 111.345 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.78 -164.88 0.98 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.863 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.17 -38.74 78.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 m -175.57 69.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.232 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.3 t -107.3 145.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.817 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 145.62 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.956 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.433 ' HB3' ' CG1' ' A' ' 140' ' ' ILE . 10.6 mt -105.93 -60.38 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 91.64 19.61 40.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.125 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.433 ' CG1' ' HB3' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -98.45 146.86 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.73 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.414 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 27.1 m -126.19 128.41 47.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.404 ' CG2' ' CD1' ' A' ' 154' ' ' LEU . 7.2 mt -101.87 163.07 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.061 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -144.84 149.12 34.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.1 t -97.48 106.64 34.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.62 -168.96 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.614 2.209 . . . . 0.0 112.334 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.3 m -72.66 100.44 2.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' A' ' 149' ' ' LYS . 25.4 t -53.02 -82.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.272 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 65.82 35.61 6.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.323 0.582 . . . . 0.0 110.529 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.407 ' CD ' ' O ' ' A' ' 147' ' ' SER . 0.0 OUTLIER 178.96 154.69 0.57 Allowed Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.521 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 62.62 1.72 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.4 2.067 . . . . 0.0 112.218 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.41 -55.05 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.721 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.9 t0 65.59 109.75 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.529 0.204 . . . . 0.0 110.976 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.35 -167.95 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.537 2.158 . . . . 0.0 112.435 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.404 ' CD1' ' CG2' ' A' ' 142' ' ' ILE . 3.1 mm? -131.15 155.88 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -142.22 162.23 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.335 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mm -89.72 154.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.546 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.8 t -132.45 -20.93 2.31 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.4 OUTLIER 174.78 136.19 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.425 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -123.64 149.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.837 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.78 164.4 11.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -96.86 166.16 11.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.47 -30.18 6.65 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.988 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 1.6 t -97.95 149.65 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 111.476 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.0 m -52.76 -21.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.843 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.409 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -51.08 -64.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.412 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.425 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 16.5 t60 -83.19 -24.26 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.52 -39.27 67.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.038 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 2.7 t -56.41 -28.14 58.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.947 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.607 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.44 HG21 ' CZ ' ' A' ' 126' ' ' PHE . 66.9 p -57.57 -25.15 59.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.58 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.795 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.29 166.61 11.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.973 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.5 mt -92.38 116.65 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.04 29.25 2.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.698 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 138.12 41.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.767 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -90.31 106.17 18.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.775 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.1 mt -70.56 134.9 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.043 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.3 tt -120.18 -51.37 2.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.688 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -128.19 156.54 42.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 182' ' ' ASN . 28.6 mm -139.59 105.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.081 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 181' ' ' ASP . 0.4 OUTLIER 68.13 -67.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.038 0.447 . . . . 0.0 110.738 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' ILE . 1.5 m120 -147.99 -24.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.665 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.52 139.69 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.161 0.505 . . . . 0.0 111.199 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 4.1 mtp-105 -102.48 123.7 46.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.803 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 193' ' ' ALA . 3.2 mm? -74.89 -5.52 44.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.446 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -45.87 -28.92 1.21 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 m -134.31 42.73 2.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.685 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.29 153.55 38.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -177.53 0.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.458 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -54.47 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.55 -29.82 18.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.81 -52.15 66.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.25 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.407 ' N ' HD12 ' A' ' 185' ' ' LEU . . . -57.18 -40.59 77.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.191 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.542 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 11.9 t -62.31 -39.4 84.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.674 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -46.92 87.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.117 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.466 ' CD1' ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -72.52 -24.71 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -58.94 -36.14 74.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.848 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 1.0 OUTLIER -104.04 -44.57 4.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.262 -179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -26.02 19.79 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.014 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -95.43 44.52 1.09 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -68.76 53.34 0.08 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.241 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.551 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -141.59 -25.93 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.719 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.3 tt 165.14 112.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.422 HG22 ' CE ' ' A' ' 132' ' ' LYS . 3.5 m -105.26 132.51 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -107.89 107.97 18.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.457 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.28 104.3 15.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.402 . . . . 0.0 111.807 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.424 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 19.6 tttt -97.29 93.69 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.165 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.82 -177.54 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.208 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.42 127.33 44.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -115.97 159.56 21.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.92 50.24 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.622 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -54.91 165.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.344 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.888 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.853 0.359 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -142.95 132.15 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.031 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.5 p -178.34 159.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.102 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -76.06 120.7 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.6 p -55.29 174.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.275 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -164.55 140.99 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -107.13 160.31 15.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.439 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -151.12 -178.49 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.29 162.7 15.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -141.93 150.5 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.693 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.2 t -122.83 112.68 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mt -108.51 118.71 37.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.181 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -107.4 162.27 14.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 111.883 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.89 128.5 45.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.29 147.1 32.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.412 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.63 16.59 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.479 2.119 . . . . 0.0 112.666 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.06 -47.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 t -131.58 -18.92 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.17 87.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.278 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 54.4 m-85 65.62 93.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 109.767 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -74.49 13.96 4.57 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.567 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.54 HG21 ' CG2' ' A' ' 57' ' ' ILE . 0.8 OUTLIER -109.9 133.91 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 117.38 0.59 . . . . 0.0 111.707 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 3.3 mt-30 -97.65 128.27 44.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.15 155.82 16.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.306 0.574 . . . . 0.0 112.239 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.5 169.1 17.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.204 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.74 23.92 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.821 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -122.12 93.63 4.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.8 t -111.08 -78.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.254 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.2 p90 -39.87 -44.36 1.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.207 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 51.77 73.27 0.33 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.94 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 47' ' ' ALA . 4.3 t 165.87 -166.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.677 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' N ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -46.01 147.93 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.871 179.652 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 66.9 178.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.482 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -142.63 -101.43 0.13 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.362 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.67 16.75 3.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 0.0 111.572 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -62.0 118.41 38.88 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.11 155.29 52.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.31 2.006 . . . . 0.0 111.922 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 45.9 Cg_exo -54.85 123.8 14.65 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.243 1.962 . . . . 0.0 111.952 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.434 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 1.1 pt? -136.23 118.03 15.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 111.264 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.54 ' CG2' HG21 ' A' ' 39' ' ' ILE . 78.2 mt -76.12 141.23 16.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 57' ' ' ILE . 4.6 m -113.4 -19.64 11.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.727 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.6 t80 -152.22 139.18 19.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CD1' HG22 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -107.72 177.17 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.731 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' GLY . 40.5 tt0 -117.49 119.09 34.0 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.186 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -57.35 122.31 12.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.182 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 1.6 t0 82.53 42.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.254 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -138.29 154.53 73.89 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.409 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 46.2 Cg_endo -67.72 -1.38 6.65 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.363 2.042 . . . . 0.0 112.8 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' CB ' HG13 ' A' ' 39' ' ' ILE . . . -70.97 -56.62 5.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.694 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -78.92 -29.21 44.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.273 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -92.22 -1.66 56.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.668 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -44.75 -30.74 1.01 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.316 . . . . 0.0 111.315 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.75 -50.34 0.89 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 29.0 m -137.93 53.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 mt -127.68 137.7 52.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -131.85 -179.5 5.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.038 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 74' ' ' ILE . 29.0 mm -76.24 73.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.99 77.48 0.22 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.457 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -103.29 92.42 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -65.18 101.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 55' ' ' PRO . 28.6 m -97.78 149.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.57 -30.15 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -132.91 130.24 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 21.9 mt -128.26 116.64 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.42 25.48 3.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.35 -26.13 24.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.582 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 50.6 mt -69.82 124.73 91.22 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-O 120.541 0.21 . . . . 0.0 111.134 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.27 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.1 p -143.42 -45.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -68.31 -12.57 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -113.83 44.33 1.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.38 -174.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.867 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 165.4 12.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -73.1 -27.26 61.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -54.92 -41.4 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -34.19 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.731 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -71.43 -32.52 68.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.248 0.547 . . . . 0.0 110.582 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.27 -36.42 63.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.076 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.489 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.89 -39.63 61.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.382 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.489 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 2.1 pp -67.61 -40.22 84.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.539 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.44 ' N ' HD11 ' A' ' 97' ' ' LEU . 22.4 mt -65.43 -56.03 14.72 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.6 ppt_? -50.7 -31.31 16.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.493 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.8 p30 -112.28 33.22 5.01 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.801 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 97.9 p -100.26 9.39 42.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.4 t -100.02 15.3 27.69 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.6 mt -67.99 -42.09 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.664 0.745 . . . . 0.0 110.504 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.52 11.19 37.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.598 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' HG21 ' A' ' 30' ' ' THR . 5.8 m 54.53 24.58 5.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.235 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.402 ' CG ' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -162.9 154.68 18.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.46 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -155.31 126.86 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.88 128.4 45.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -123.68 158.27 31.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -118.18 118.38 31.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.535 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.4 pt -113.34 163.89 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.424 . . . . 0.0 111.685 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -131.62 144.62 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.46 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.36 174.18 15.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.937 0.399 . . . . 0.0 111.343 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.1 114.45 27.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.492 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 167' ' ' ARG . 17.4 m -61.88 105.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.337 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -176.07 -135.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 116' ' ' ALA . 9.9 pt-20 48.3 30.55 2.31 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.416 ' CB ' HD21 ' A' ' 130' ' ' LEU . 14.6 t 176.89 61.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.076 0.465 . . . . 0.0 111.153 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.1 p -158.66 118.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.295 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.596 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -138.31 97.96 9.35 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.791 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 90.7 Cg_endo -83.27 150.93 13.63 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.75 2.3 . . . . 0.0 112.91 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -153.55 19.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.18 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.75 114.75 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.051 0.453 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.7 -41.18 2.58 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.128 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.4 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -135.12 108.49 7.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.439 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -102.76 128.09 49.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.549 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.596 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.3 134.26 52.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.0 110.487 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.9 t -118.22 94.79 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.628 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -83.38 97.94 9.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.402 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.421 HD21 ' HB ' ' A' ' 168' ' ' THR . 26.7 mt -104.3 117.73 58.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.67 95.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.177 1.918 . . . . 0.0 111.371 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -81.55 159.25 24.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.5 -165.95 1.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.654 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -66.08 -43.64 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.85 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.5 m -179.3 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 40.1 t -94.32 159.84 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -51.04 113.63 0.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.686 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.11 112.08 20.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.915 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . -90.45 47.88 3.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.029 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.95 137.06 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.599 0.238 . . . . 0.0 110.384 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.1 m -120.78 109.76 15.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.781 0.324 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 mt -87.68 164.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 31.1 t -157.67 161.01 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.912 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 21.0 p -115.25 107.79 48.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -52.8 -176.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.32 97.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.865 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.4 t -59.17 95.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.63 44.79 2.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.43 158.65 0.73 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.834 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.4 70.48 1.92 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.498 2.132 . . . . 0.0 112.236 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -170.14 -60.44 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.604 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.9 t0 61.57 82.14 0.23 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -174.13 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.656 2.237 . . . . 0.0 112.434 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.412 ' CD2' ' CB ' ' A' ' 193' ' ' ALA . 1.1 mp -121.84 165.41 15.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 22.1 m -158.22 148.08 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 7.7 mt -74.97 150.7 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.373 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.5 m -136.48 -12.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.17 150.09 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 1.1 mt -139.94 145.43 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.198 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.452 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -114.85 154.77 28.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 111.398 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.78 76.65 3.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.69 -36.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.457 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 8.4 t -101.81 158.87 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.094 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 16.8 m -48.88 -22.34 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.096 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.443 ' O ' ' CG2' ' A' ' 168' ' ' THR . . . -43.82 -59.41 2.26 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.414 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 42.5 t60 -83.66 -25.2 30.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.862 0.363 . . . . 0.0 110.8 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.457 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -58.4 -29.61 66.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.379 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 165' ' ' ALA . 3.4 t -55.96 -44.9 78.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.1 -20.41 46.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.836 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.2 t -113.2 37.58 3.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.999 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.49 41.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.764 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.64 144.45 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.2 mt -85.05 108.02 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.82 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.99 -20.28 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.33 157.79 22.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.671 0.272 . . . . 0.0 110.751 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -108.33 100.91 10.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.74 165.93 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.6 pp -158.25 -40.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.076 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -125.95 129.88 50.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.892 0.377 . . . . 0.0 111.061 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 205' ' ' LYS . 46.9 mt -118.68 107.47 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.1 t70 66.05 -72.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.7 -19.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 40.7 mm -96.8 157.13 3.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 120.99 0.424 . . . . 0.0 111.251 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.4 ' N ' ' CG2' ' A' ' 183' ' ' ILE . 79.2 mtt180 -122.38 132.9 54.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.911 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.7 -8.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.558 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -47.56 -28.09 2.12 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.038 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.1 p -144.1 46.78 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.26 160.65 30.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.17 -175.92 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.99 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' MET . . . . . 0.404 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 8.7 ptm -74.24 -45.59 46.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 190' ' ' MET . 1.5 mm-40 -52.05 -50.09 62.18 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.197 0.522 . . . . 0.0 110.89 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -52.12 -45.58 64.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.128 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.412 ' CB ' ' CD2' ' A' ' 154' ' ' LEU . . . -56.62 -41.58 77.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.517 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 197' ' ' LEU . 10.7 t -60.75 -33.9 56.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 109.82 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -61.92 -50.2 73.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.708 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 200' ' ' CYS . 1.3 mt -71.08 -24.93 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.451 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.2 OUTLIER -60.98 -37.46 82.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.21 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -92.17 -34.5 14.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.656 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.537 ' C ' ' H ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -84.9 11.77 8.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.643 178.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 196' ' ' ILE . 30.0 p -66.1 28.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 199' ' ' GLN . 1.5 mm-40 46.82 46.45 15.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.73 27.51 16.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.769 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.6 mt -162.87 94.39 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.415 ' CG1' ' HB2' ' A' ' 130' ' ' LEU . 13.1 p -90.34 123.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 2.9 ttmp? -108.8 107.73 18.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.219 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.35 107.09 18.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.084 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.424 ' HD2' ' CE1' ' A' ' 127' ' ' HIS . 0.9 OUTLIER -96.99 100.74 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.759 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 126' ' ' PHE . 0.1 OUTLIER -109.77 173.39 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.518 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 8.0 mtp180 -105.06 132.88 50.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.23 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -115.88 159.21 21.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.828 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -176.82 101.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.992 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.89 160.15 3.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.236 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.036 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.91 129.61 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.197 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.37 170.73 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.163 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -139.72 107.68 5.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.01 133.63 38.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.147 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -148.78 157.73 43.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.0 p -110.43 144.93 38.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.43 ' OG1' ' CZ ' ' A' ' 113' ' ' PHE . 27.4 m -140.57 163.29 33.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -104.63 159.33 15.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 136.18 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 p -115.97 122.42 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.1 mp -115.66 118.99 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.896 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.49 162.58 12.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.271 0.558 . . . . 0.0 111.932 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 37' ' ' PHE . . . -107.33 103.86 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -75.02 153.27 86.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.332 179.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.4 7.89 3.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.447 2.098 . . . . 0.0 112.675 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.42 -45.29 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.567 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -133.7 -8.59 2.8 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.439 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 65.6 -90.48 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.929 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 37' ' ' PHE . 3.5 m-85 -131.66 119.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.58 28.27 15.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.361 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.475 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 25.5 pt -126.84 133.35 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -122.36 139.96 53.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.86 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -130.09 157.51 42.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 112.054 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -112.1 170.07 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.204 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.58 17.59 6.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -111.28 67.8 0.65 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.351 0.596 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.425 HG22 ' CB ' ' A' ' 53' ' ' SER . 3.4 t -71.43 -35.11 55.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.961 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 45.6 p90 -132.07 -49.59 0.94 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.252 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 42.09 85.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.099 0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 171.0 120.86 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.232 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 58.5 80.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 0.6 OUTLIER 85.5 -178.17 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.507 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.1 pp -154.82 -147.2 0.2 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.355 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 2.0 t 81.43 20.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.227 0.537 . . . . 0.0 111.588 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.425 ' CB ' HG22 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -47.51 139.13 8.47 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.964 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.414 ' O ' ' CG2' ' A' ' 45' ' ' VAL . 25.0 Cg_endo -61.96 133.33 43.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.551 2.167 . . . . 0.0 112.406 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.49 141.67 25.21 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.513 2.142 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -141.11 115.98 9.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.637 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -66.12 141.35 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.441 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 64.0 p -113.69 -26.16 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.519 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.407 ' HB3' ' CG ' ' A' ' 40' ' ' GLN . 56.2 t80 -144.18 154.49 43.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 0.0 111.496 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.482 HG23 ' N ' ' A' ' 61' ' ' GLU . 25.7 mm -137.51 151.24 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.718 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.482 ' N ' HG23 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -101.01 148.99 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.209 -179.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.55 44.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.038 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.72 41.5 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.724 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 17.5 m -136.93 138.49 26.05 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.958 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -56.75 -12.77 9.61 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.79 2.327 . . . . 0.0 113.276 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.41 -58.33 6.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 0.0 110.349 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.462 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -80.12 -30.97 39.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.041 178.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -57.84 -33.41 68.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.0 t -49.58 -30.44 8.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.006 0.432 . . . . 0.0 110.523 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 137' ' ' GLU . . . 87.95 26.13 29.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.982 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.52 29.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 0.0 110.912 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.8 mt -133.55 121.63 22.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -136.01 154.95 50.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.295 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.484 HD13 HG23 ' A' ' 74' ' ' ILE . 54.3 mt -58.14 87.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.233 0.54 . . . . 0.0 111.194 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.428 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 132.66 39.55 0.22 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -87.01 132.08 33.9 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.8 102.19 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 t -85.68 121.89 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -29.28 17.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.53 143.51 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 1.7 mt -119.39 110.36 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 59.98 20.13 9.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.73 -33.79 4.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.632 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.4 mt -69.71 116.81 47.21 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 120.45 0.166 . . . . 0.0 111.167 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.93 -33.36 63.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.403 2.069 . . . . 0.0 112.049 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 p 74.17 0.52 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.776 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.66 -20.73 27.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.924 0.392 . . . . 0.0 111.199 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -101.9 44.53 1.01 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 m -179.12 -176.95 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.12 161.97 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -73.28 -29.74 62.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.012 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.18 -31.65 63.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.355 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.37 -53.49 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.85 -42.19 71.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.29 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -65.05 -39.91 93.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -35.42 80.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.922 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 86.1 mt -57.44 -51.08 70.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mp -58.81 -45.12 90.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.427 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.21 -38.01 49.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.232 0.539 . . . . 0.0 109.939 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.5 m-20 -122.06 40.86 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.516 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.416 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 54.7 p -94.32 6.74 47.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 p -102.7 15.56 28.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.838 0.351 . . . . 0.0 111.81 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.0 mt -69.24 -47.85 71.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.789 0.804 . . . . 0.0 110.338 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.4 12.11 28.24 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.396 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.411 ' HA ' ' CB ' ' A' ' 31' ' ' ALA . 14.5 m 52.58 26.13 4.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -162.83 156.93 20.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' A' ' 101' ' ' SER . 1.4 t -155.9 99.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.696 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 132.49 35.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.12 157.0 45.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.271 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.68 127.85 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.424 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.8 pt -114.19 145.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 111.571 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -116.7 115.72 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.43 ' CZ ' ' OG1' ' A' ' 25' ' ' THR . 3.6 p90 -132.89 174.12 10.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 0.0 111.274 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.15 131.7 54.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.4 m -66.58 105.69 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.458 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -170.08 108.43 0.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.88 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -133.86 39.47 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.3 t 66.78 89.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.374 0.607 . . . . 0.0 111.286 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.447 ' HB ' ' CE1' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -125.53 120.3 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.901 179.51 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.549 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.9 pp -102.41 103.81 33.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.338 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 94.0 Cg_endo -85.85 148.21 9.53 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 112.55 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -154.49 22.89 0.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.83 113.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.004 0.431 . . . . 0.0 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.506 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.5 -43.86 2.62 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.162 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.01 103.73 7.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 110.995 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -107.65 119.56 39.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.549 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.38 124.1 47.35 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.796 0.332 . . . . 0.0 110.483 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 3.4 t -101.76 90.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.63 98.36 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.293 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.68 144.15 48.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 0.0 111.56 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.55 119.68 6.66 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.528 2.152 . . . . 0.0 111.48 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.407 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -86.94 153.39 21.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.336 0.588 . . . . 0.0 111.628 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -88.72 -164.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.28 34.96 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.693 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.04 47.99 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.824 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.4 t -89.84 -121.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.436 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 1.1 tt0 -90.72 102.62 15.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 122.1 -0.375 . . . . 0.0 111.442 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.7 tp -122.63 95.24 4.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.88 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -86.1 45.37 3.46 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.2 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 62.5 mt -92.81 123.61 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.424 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 97.8 m -110.41 101.81 10.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.0 mt -91.8 163.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.52 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.2 t -176.22 176.66 1.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.021 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 t -129.38 129.43 23.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.809 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.58 -62.06 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.491 2.127 . . . . 0.0 112.237 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.0 p -133.99 122.08 22.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -106.28 51.48 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -134.74 55.55 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.159 0.504 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.54 157.86 0.44 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.62 82.81 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.612 2.208 . . . . 0.0 112.306 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 173.81 -68.03 0.1 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 42.43 82.87 0.22 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.858 0.361 . . . . 0.0 111.554 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.09 -167.32 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.586 2.191 . . . . 0.0 112.333 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -126.94 149.88 49.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -154.01 156.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.286 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.3 152.57 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 141' ' ' THR . 1.6 m -130.95 -19.03 2.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.922 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 141' ' ' THR . 28.6 t70 -177.8 143.66 0.34 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.4 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -136.77 131.82 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.485 ' HG3' ' H ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -63.59 130.59 44.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 0.9 5.92 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 160' ' ' LYS . . . -124.35 0.15 8.78 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.868 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.426 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 4.6 t -95.11 145.97 24.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 4.3 m -48.89 -25.87 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.765 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.62 -69.46 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.333 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.4 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 12.0 t60 -64.53 -25.66 68.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.426 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -56.7 -39.85 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 110.926 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.4 ' CG2' HG11 ' A' ' 128' ' ' VAL . 17.1 p -49.0 -27.75 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.323 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 71.04 1.06 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.51 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 tp -66.45 74.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.91 -170.87 3.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.25 119.97 40.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.78 20.5 4.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.82 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.419 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 2.0 m-20 -106.98 173.66 6.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.653 0.226 . . . . 0.0 110.459 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.34 142.63 47.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 111.177 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tp -101.96 138.63 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.581 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.46 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.364 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 184' ' ' ARG . . . -146.96 165.45 29.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.011 0.434 . . . . 0.0 111.541 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.5 mm -139.61 107.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.182 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER 64.98 -73.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.39 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -134.59 -25.24 1.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 184' ' ' ARG . 46.4 mm -87.59 157.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 8.2 mtp180 -123.57 124.54 43.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 112.113 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 185' ' ' LEU . 3.0 mm? -78.94 -4.62 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -45.33 -29.39 1.03 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 m -141.7 51.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.792 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.48 159.31 37.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.29 175.95 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' MET . . . . . 0.45 ' HG3' ' N ' ' A' ' 191' ' ' GLU . 25.8 ptm -74.11 -41.86 60.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.988 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 190' ' ' MET . 0.7 OUTLIER -53.81 -29.98 42.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.99 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -52.49 64.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.093 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.416 ' HA ' HD13 ' A' ' 196' ' ' ILE . . . -56.24 -39.49 72.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.209 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.559 ' O ' ' HG2' ' A' ' 198' ' ' GLN . 18.4 t -61.61 -39.9 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.673 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -50.33 74.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.124 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 200' ' ' CYS . 1.6 mt -69.79 -24.92 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -58.59 -35.48 72.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.588 179.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLN . . . . . 0.559 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.29 -40.74 7.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.733 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -22.98 41.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.714 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' CYS . . . . . 0.487 ' HB2' HG23 ' A' ' 204' ' ' VAL . 2.0 m -91.16 42.68 1.11 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.72 62.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.353 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -171.91 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.543 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.407 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 3.2 tt 175.13 110.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.487 HG23 ' HB2' ' A' ' 200' ' ' CYS . 98.9 t -108.18 138.81 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.477 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 7.3 tttt -109.12 108.03 18.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 7.1 mp -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 111.412 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.439 ' HE3' ' CE1' ' A' ' 127' ' ' HIS . 2.9 tttt -92.73 93.17 8.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.298 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.419 ' CG2' ' HB3' ' A' ' 175' ' ' ASP . 6.6 mm -90.71 163.39 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.015 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 5.7 mtp-105 -107.98 120.72 43.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 150.53 21.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.63 84.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.798 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -57.18 170.42 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.082 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 21' ' ' HIS . 20.3 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.792 0.33 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.2 t60 -131.03 98.61 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.408 HG23 ' OD1' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -60.67 119.65 8.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.931 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.1 156.55 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.16 161.29 16.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -149.63 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -122.6 163.1 20.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.58 135.68 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.76 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 28' ' ' VAL . 8.8 p -108.66 122.89 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.525 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 39' ' ' ILE . 31.9 mt -120.07 118.66 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.95 162.12 14.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.601 -179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.898 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.48 140.3 32.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.123 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.73 154.69 37.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.701 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.97 11.16 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.611 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.0 t -114.32 -46.98 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 t -144.64 8.77 1.33 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.21 -117.29 7.77 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.46 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 3.6 m-85 -103.77 128.92 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.424 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -92.47 27.34 10.82 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.305 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 29' ' ' LEU . 3.3 mt -94.08 157.61 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.359 0.6 . . . . 0.0 111.779 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.494 ' N ' HG22 ' A' ' 39' ' ' ILE . 4.2 mt-30 -137.85 104.99 5.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.826 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.829 HD22 HD12 ' A' ' 98' ' ' LEU . 1.1 tp -95.69 144.7 25.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.272 0.558 . . . . 0.0 112.403 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -114.68 151.56 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.25 88.35 0.88 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.135 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.81 104.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.599 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.904 HG23 HD11 ' A' ' 56' ' ' LEU . 13.4 t -76.21 -65.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.549 0.69 . . . . 0.0 109.913 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 21.3 p90 -33.03 -43.75 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.037 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.61 88.65 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.933 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 49' ' ' GLU . 0.9 OUTLIER 170.08 114.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.682 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 48' ' ' THR . 11.5 pt-20 47.09 108.16 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.92 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 49' ' ' GLU . 1.4 p 67.25 -162.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.635 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.5 mt -129.0 -72.89 0.59 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.499 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.7 t 63.69 8.83 3.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.465 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.518 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.1 m -175.63 58.76 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.569 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.608 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 8.0 Cg_exo -67.65 -59.0 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.063 1.842 . . . . 0.0 112.787 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.697 ' HB2' HD21 ' A' ' 41' ' ' LEU . 59.2 Cg_endo -99.82 108.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.919 2.413 . . . . 0.0 112.694 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 45' ' ' VAL . 1.9 pt? -143.89 127.39 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.549 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.675 HD13 HG23 ' A' ' 39' ' ' ILE . 37.6 mt -67.66 136.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.057 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.95 -6.23 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.612 ' HA ' HD12 ' A' ' 74' ' ' ILE . 33.8 t80 -178.02 138.39 0.2 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.043 0.449 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.727 HG21 ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -102.07 -167.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 60' ' ' ILE . 51.7 tt0 -129.14 151.73 49.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.355 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -82.81 114.72 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.411 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 2.9 t70 91.73 39.55 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.534 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 2.5 p -132.92 143.96 50.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.35 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 69' ' ' CYS . 31.5 Cg_exo -58.61 -2.92 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.465 2.11 . . . . 0.0 112.953 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -63.68 -56.89 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.727 ' HG2' HG21 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -78.51 -28.66 46.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.617 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 4.1 mmt-85 -85.49 -1.55 57.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.277 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.533 ' SG ' HD23 ' A' ' 72' ' ' LEU . 31.3 p -58.64 -40.94 84.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 137' ' ' GLU . . . 149.18 -23.75 1.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.96 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.4 p -175.05 84.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' SG ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -134.69 123.4 23.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.726 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.26 159.59 34.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.963 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 59' ' ' TYR . 22.5 mm -61.12 106.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.275 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.74 45.88 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.496 ' OD1' HG21 ' A' ' 111' ' ' ILE . 1.1 t70 -70.88 101.36 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -70.73 66.06 0.34 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.013 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.757 HG12 HD13 ' A' ' 109' ' ' LEU . 34.3 m -64.85 129.85 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.59 -29.6 11.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.23 148.7 31.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.404 . . . . 0.0 111.608 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.461 HD12 HD12 ' A' ' 97' ' ' LEU . 6.7 mt -130.24 112.41 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.769 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 m120 62.25 21.84 12.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.025 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.76 16.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.679 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.2 mt -74.32 136.24 75.51 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 120.537 0.208 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 -170.7 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.514 2.143 . . . . 0.0 112.232 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.6 p -150.76 -60.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -64.83 -16.62 63.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.376 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -106.35 43.9 1.1 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.652 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.47 -175.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -71.41 149.06 46.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.465 ' CB ' ' HB3' ' A' ' 54' ' ' PRO . 9.0 p90 -73.42 -33.64 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -54.92 -42.53 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.953 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 pt-20 -61.17 -39.27 89.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.498 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.61 94.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.232 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.501 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -61.36 -39.55 91.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.791 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.402 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 2.1 mm-40 -62.49 -39.81 94.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.484 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.461 HD12 HD12 ' A' ' 81' ' ' ILE . 14.8 mt -57.05 -49.98 74.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.829 HD12 HD22 ' A' ' 41' ' ' LEU . 7.1 mt -60.46 -58.77 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 49.8 mtt180 -50.28 -29.84 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 109.94 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.548 ' O ' HD11 ' A' ' 103' ' ' ILE . 3.6 m-20 -114.89 33.15 5.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.845 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.664 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.8 45.27 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.865 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -142.75 16.82 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.548 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.8 mp -65.4 -45.24 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.552 0.691 . . . . 0.0 110.901 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.23 11.89 38.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.495 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.8 ' O ' HG22 ' A' ' 30' ' ' THR . 20.5 t 57.92 25.31 11.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.033 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 1.5 ttpt -165.88 145.46 6.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.744 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.512 HG11 ' OG ' ' A' ' 101' ' ' SER . 2.7 t -141.73 135.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.559 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.757 HD13 HG12 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -139.1 165.12 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.391 . . . . 0.0 111.335 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -118.14 141.04 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 78' ' ' VAL . 30.4 pt -133.15 159.12 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -123.14 143.0 50.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.527 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.44 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 1.2 p90 -161.11 174.29 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.281 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' OD1' HG23 ' A' ' 22' ' ' THR . 3.1 m-20 -102.95 149.6 24.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.376 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.7 m -97.98 104.8 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -179.68 -147.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.1 12.52 2.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.822 0.344 . . . . 0.0 110.811 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.6 t -178.8 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.665 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.412 HG22 ' CG2' ' A' ' 170' ' ' THR . 41.3 t -156.29 117.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.478 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 1.039 HG23 ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -157.24 84.53 2.91 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-O 121.233 0.539 . . . . 0.0 111.084 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 65.1 Cg_endo -94.65 -169.49 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.299 2.666 . . . . 0.0 112.636 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -178.49 34.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.745 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 58.9 114.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.89 -39.48 2.87 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.309 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.706 HG22 ' HG3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.9 113.43 12.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -103.57 126.29 50.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.653 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 1.039 ' HB2' HG23 ' A' ' 120' ' ' ILE . 7.3 m80 -101.58 135.26 43.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.756 HG12 HD13 ' A' ' 130' ' ' LEU . 14.6 t -137.82 86.59 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.748 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -81.51 106.21 13.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.38 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.792 HD11 ' HB ' ' A' ' 168' ' ' THR . 2.8 mp -109.11 132.22 21.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.372 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 108.45 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.159 1.906 . . . . 0.0 111.057 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.1 OUTLIER -86.64 158.62 19.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.477 . . . . 0.0 111.471 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.428 ' HG3' ' CG2' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -128.36 -174.93 3.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.167 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -56.36 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.5 m -153.94 74.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 137' ' ' GLU . 95.5 t -113.37 156.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' HG12 ' A' ' 136' ' ' VAL . 36.7 tt0 -56.45 110.44 0.78 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.437 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 140' ' ' ILE . 2.8 mt -96.61 -52.89 3.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.357 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . 93.57 9.03 60.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.799 HD12 HD13 ' A' ' 138' ' ' LEU . 21.2 mt -79.38 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.841 0.321 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 157' ' ' SER . 39.7 m -116.19 128.7 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.924 0.392 . . . . 0.0 110.199 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.898 HG23 HD11 ' A' ' 154' ' ' LEU . 9.0 mt -103.17 164.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.585 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.551 ' N ' HG22 ' A' ' 142' ' ' ILE . 45.9 p -163.57 152.9 14.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.265 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p -122.57 139.55 31.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 C--N 1.345 0.39 0 C-N-CA 122.494 2.129 . . . . 0.0 112.416 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.646 0.26 . . . . 0.0 111.03 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.69 149.97 30.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.976 2.45 . . . . 0.0 112.779 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.898 HD11 HG23 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -76.64 144.13 39.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.84 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.482 ' N ' HD13 ' A' ' 154' ' ' LEU . 5.1 t -129.18 142.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.975 0.416 . . . . 0.0 111.941 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.52 150.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.218 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.751 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.5 OUTLIER -124.94 -20.9 4.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 111.723 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 177.71 153.39 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 0.0 111.168 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -140.1 125.6 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.453 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -80.63 154.07 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -74.81 -178.93 3.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.521 ' C ' HG21 ' A' ' 71' ' ' VAL . . . 72.01 -61.42 1.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.724 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.492 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.9 OUTLIER -56.67 161.72 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.969 0.414 . . . . 0.0 111.274 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.68 ' O ' HD21 ' A' ' 130' ' ' LEU . 5.5 m -69.42 -20.92 24.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.77 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.794 ' O ' HG22 ' A' ' 168' ' ' THR . . . -47.71 -70.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 33.6 t60 -76.48 -23.92 53.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.23 -44.68 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.307 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 165' ' ' ALA . 3.2 t -52.48 -25.85 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.54 48.91 81.98 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.412 ' CG2' HG22 ' A' ' 119' ' ' VAL . 35.2 p -137.95 -44.33 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 0.0 111.083 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 206' ' ' LEU . 3.6 mp -59.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.24 139.44 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.24 119.89 16.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.19 18.47 5.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.681 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.421 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.5 OUTLIER -114.31 -177.25 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.695 0.283 . . . . 0.0 110.738 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -132.38 161.54 33.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 154' ' ' LEU . 1.7 mp -124.54 170.9 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -139.56 -39.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.223 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -139.44 142.36 37.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.572 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.674 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 46.7 mt -127.48 111.57 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.881 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.0 t70 66.3 -70.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.096 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -144.92 -20.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.602 ' HB ' HG21 ' A' ' 196' ' ' ILE . 23.1 mm -98.0 156.95 3.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.17 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 38.1 mtt85 -116.18 139.3 50.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 112.241 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.932 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.9 mm? -70.86 -2.89 16.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.628 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.52 -27.91 1.99 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.094 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m -75.17 -18.93 60.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 111.299 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 152' ' ' ASP . 4.5 m 76.02 102.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.49 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 192' ' ' ASP . 1.4 m 168.58 95.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.543 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.1 ptm -53.82 -41.56 67.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.265 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.4 mm-40 -55.63 -39.29 70.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.987 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.657 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -55.65 -52.07 65.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.061 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -53.7 -36.4 62.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.834 HG22 ' CD1' ' A' ' 142' ' ' ILE . 11.8 t -66.42 -32.68 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.605 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 191' ' ' GLU . 3.0 mm-40 -76.02 -45.06 36.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.66 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.7 mt -73.43 -31.17 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.605 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.792 HD21 HD11 ' A' ' 142' ' ' ILE . 1.6 pp -78.39 -24.73 46.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.542 ' OE1' HG12 ' A' ' 194' ' ' VAL . 64.3 mt-30 -88.01 -45.55 10.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.059 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -61.65 -20.56 63.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.365 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' A' ' 204' ' ' VAL . 27.6 p -88.41 45.99 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.285 0.564 . . . . 0.0 109.784 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -68.12 60.66 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.782 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -169.27 -33.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.4 tt -175.01 105.02 0.09 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.776 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.572 HG23 ' SG ' ' A' ' 200' ' ' CYS . 9.8 p -96.14 126.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -100.73 107.82 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.127 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.579 ' CD2' HD21 ' A' ' 171' ' ' LEU . 3.6 mp -94.79 113.77 25.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.0 111.408 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.1 OUTLIER -101.1 93.5 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 208' ' ' ILE . 1.4 mm -83.32 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.888 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.504 ' H ' HG22 ' A' ' 208' ' ' ILE . 15.7 mmt180 -118.44 128.18 54.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.001 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.24 151.32 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.934 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.741 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 114' ' ' ASP . 18.0 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.903 0.383 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -105.28 105.78 15.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -54.55 158.41 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -146.97 153.16 39.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.706 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -109.76 136.31 49.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 t -126.66 174.96 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -103.84 157.77 16.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.75 147.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.28 109.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 29' ' ' LEU . 3.9 mt -101.26 118.61 37.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.212 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.42 161.78 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 111.674 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -93.97 172.57 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.051 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -163.22 140.76 6.0 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.347 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.86 19.09 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.464 2.11 . . . . 0.0 112.739 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 35' ' ' THR . 62.2 t -129.82 -51.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 34' ' ' VAL . 20.5 p -156.81 36.22 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.778 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.32 127.07 7.88 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.711 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 24.5 m-85 63.55 71.69 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.45 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -83.31 21.79 8.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.146 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.982 HG23 HD13 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -111.79 133.2 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.458 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 6.4 mt-30 -97.92 126.88 43.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.049 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -96.03 141.52 29.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.122 0.487 . . . . 0.0 111.82 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.67 165.63 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.357 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.81 -111.11 0.11 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.532 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 90.8 p -115.53 104.2 11.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.846 0.355 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.896 HG23 HD13 ' A' ' 56' ' ' LEU . 59.5 t -46.38 -78.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 15.5 p90 -40.65 -51.75 2.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.75 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 44' ' ' SER . . . 38.22 93.17 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.052 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.662 ' O ' HG22 ' A' ' 50' ' ' THR . 0.1 OUTLIER 175.55 110.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.471 ' C ' HG22 ' A' ' 50' ' ' THR . 6.4 pt-20 49.45 36.8 10.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.331 0.586 . . . . 0.0 110.324 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER 166.81 177.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.307 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 51' ' ' LEU . 2.4 pp -176.71 33.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -63.09 29.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.711 ' HB3' HD11 ' A' ' 56' ' ' LEU . 1.8 t -147.25 73.05 12.01 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-O 120.844 0.354 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HB3' ' HA ' ' A' ' 91' ' ' PHE . 20.9 Cg_exo -63.46 -53.07 1.56 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.544 2.163 . . . . 0.0 113.169 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.619 ' HA ' HD23 ' A' ' 41' ' ' LEU . 57.2 Cg_endo -96.14 102.44 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.827 2.351 . . . . 0.0 113.039 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.896 HD13 HG23 ' A' ' 45' ' ' VAL . 27.8 mt -131.71 85.21 2.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.714 HD13 ' HB ' ' A' ' 39' ' ' ILE . 85.7 mt -58.58 136.64 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.5 p -120.97 -8.43 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 91.3 t80 -144.47 150.52 37.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.302 0.572 . . . . 0.0 112.322 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.982 HD13 HG23 ' A' ' 39' ' ' ILE . 1.7 mm -123.4 152.7 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.266 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 72.8 tt0 -104.47 106.6 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.884 0.373 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -63.45 116.51 5.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 12.4 t0 95.24 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.191 0.519 . . . . 0.0 110.558 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.537 ' H ' ' CZ ' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -139.71 -173.85 0.38 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 64.6 Cg_endo -95.01 -6.73 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.451 2.101 . . . . 0.0 113.535 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 38' ' ' GLY . . . -74.7 -58.0 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' H ' ' NH2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -77.03 -29.03 55.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.961 0.41 . . . . 0.0 110.447 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.537 ' CZ ' ' H ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -93.36 -7.33 45.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.781 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -41.89 -42.46 2.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.015 0.436 . . . . 0.0 111.263 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.39 -22.77 0.75 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.532 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.2 p -173.07 82.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -134.56 159.04 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.992 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.87 143.01 7.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.679 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.5 mt -55.2 132.31 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.35 16.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.893 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.725 ' HB3' HG21 ' A' ' 111' ' ' ILE . 50.7 m-20 -55.58 -43.8 76.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.707 0.289 . . . . 0.0 111.255 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 75.56 72.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 109' ' ' LEU . 86.1 t -71.13 152.69 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.296 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.615 ' HE2' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -121.21 -27.78 4.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB2' ' HE2' ' A' ' 79' ' ' MET . . . -155.13 134.76 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.935 HD13 HD11 ' A' ' 97' ' ' LEU . 2.1 mp -114.79 109.62 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 52.94 24.07 3.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.123 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.34 -35.74 4.11 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.496 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.03 117.59 37.65 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 120.526 0.203 . . . . 0.0 111.315 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.09 171.65 9.82 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.405 2.07 . . . . 0.0 112.248 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 p -143.97 -45.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.9 -16.35 58.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.515 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -129.91 52.75 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -177.22 166.81 2.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.43 140.03 56.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 5.4 p90 -73.58 -29.74 62.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 mm-40 -54.55 -43.78 72.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -61.23 -37.0 81.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.759 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.7 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -64.98 -34.36 78.24 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.295 0.569 . . . . 0.0 110.528 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.546 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.9 m120 -67.06 -39.51 86.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.345 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 8.7 mm-40 -64.27 -55.98 17.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.935 HD11 HD13 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -52.16 -43.67 64.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.049 HD13 HD13 ' A' ' 41' ' ' LEU . 12.7 mt -59.57 -59.99 4.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.473 0.178 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 61.3 mtt180 -50.23 -29.78 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.394 0.616 . . . . 0.0 109.602 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.674 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -113.5 33.69 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.21 179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -104.77 21.08 17.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.979 179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 m -110.46 18.0 20.23 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.674 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -68.13 -47.73 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.561 0.696 . . . . 0.0 110.948 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 6.94 37.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.684 ' O ' HG22 ' A' ' 30' ' ' THR . 8.3 m 59.14 25.94 14.56 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.113 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.64 153.69 2.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.264 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -149.58 146.03 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 124.54 51.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.723 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.9 OUTLIER -131.21 154.8 48.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.491 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.59 123.14 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.918 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.725 HG21 ' HB3' ' A' ' 76' ' ' ASP . 33.0 pt -114.71 148.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 111.904 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.19 145.15 45.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.47 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.11 174.34 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 0.0 111.141 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.715 ' HB2' HG11 ' A' ' 20' ' ' VAL . 2.7 p-10 -96.62 147.01 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.481 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' A' ' 167' ' ' ARG . 2.8 m -99.58 107.37 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.21 124.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 118' ' ' SER . 12.5 mm-40 -127.36 10.54 6.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.643 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.2 75.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.342 0.591 . . . . 0.0 111.366 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 128' ' ' VAL . 15.9 m -97.82 148.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.737 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.8 pp -126.75 92.25 45.25 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 63.3 Cg_endo -95.32 -165.57 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.318 2.679 . . . . 0.0 112.876 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.0 t 177.95 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.0 p 168.56 116.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.199 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.28 -40.68 2.7 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.204 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.8 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.41 104.3 7.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 1.9 t80 -100.34 115.79 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.759 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.737 ' HB2' HG13 ' A' ' 120' ' ' ILE . 12.0 m170 -91.75 134.25 34.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.293 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.883 ' HA ' HG12 ' A' ' 119' ' ' VAL . 3.2 t -117.49 82.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -80.87 102.26 9.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.662 HD22 HG21 ' A' ' 168' ' ' THR . 0.8 OUTLIER -129.1 144.71 53.73 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.135 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.44 135.73 22.74 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.428 2.085 . . . . 0.0 112.059 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 200' ' ' CYS . 0.1 OUTLIER -107.8 159.23 16.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.059 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.515 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -106.66 -171.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.583 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -66.82 -76.11 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.254 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.4 m -149.74 70.72 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 137' ' ' GLU . 42.3 t -122.02 159.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.772 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' HG12 ' A' ' 136' ' ' VAL . 32.8 tt0 -50.71 103.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.179 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.86 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -61.8 -45.43 93.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.401 ' CA ' ' HB3' ' A' ' 160' ' ' LYS . . . 94.24 -0.38 66.18 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.977 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.86 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -108.46 141.36 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.086 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 55.9 m -126.07 131.89 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.519 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.054 HD13 HG22 ' A' ' 194' ' ' VAL . 1.3 mt -98.1 163.31 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.79 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.491 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -158.97 149.46 19.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.3 p -112.47 132.39 22.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo . . . . . 0 C--N 1.345 0.372 0 C-N-CA 122.455 2.103 . . . . 0.0 112.317 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.02 174.78 11.43 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.425 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.848 HD11 ' HA ' ' A' ' 190' ' ' MET . 4.4 mm? -91.97 169.96 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.433 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 175' ' ' ASP . 20.1 m -150.56 149.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.0 111.525 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.6 mt -67.72 146.58 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.632 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.38 -8.51 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.23 143.08 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.01 0.433 . . . . 0.0 111.46 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.2 mt -132.7 149.32 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.628 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.401 ' HB3' ' CA ' ' A' ' 139' ' ' GLY . 1.5 tttm -124.2 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -80.91 151.94 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.456 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.41 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . 86.75 -16.45 46.17 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.898 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 1.1 m -96.45 136.96 36.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.438 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.7 m -48.2 -22.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.255 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -55.77 -50.12 71.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.403 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.442 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 2.0 t60 -83.88 -26.65 29.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HA ' HG12 ' A' ' 115' ' ' VAL . 14.2 mmp_? -56.57 -50.04 73.08 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.662 HG21 HD22 ' A' ' 130' ' ' LEU . 6.5 t -53.1 -25.36 12.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 170' ' ' THR . . . 77.81 -162.73 50.61 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.548 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 169' ' ' GLY . 14.4 t 44.78 31.53 0.67 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.843 0.354 . . . . 0.0 111.403 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.47 98.49 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.44 149.71 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.7 138.62 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.74 -17.35 33.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.689 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.58 ' CG ' HG21 ' A' ' 208' ' ' ILE . 0.8 OUTLIER -74.92 166.39 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 110.651 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -117.91 122.88 44.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.78 HD23 HD11 ' A' ' 180' ' ' ILE . 2.6 mp -82.66 138.73 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.769 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.03 -66.49 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.076 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.869 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -121.36 161.82 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.78 HD11 HD23 ' A' ' 177' ' ' LEU . 33.8 mm -139.74 105.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 2.8 t0 63.82 -71.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 180' ' ' ILE . 2.6 t-20 -138.59 -23.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.629 ' HB ' HG21 ' A' ' 196' ' ' ILE . 26.1 mm -94.23 138.51 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 111.296 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.51 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 65.8 mtt180 -102.07 119.97 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.969 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -72.16 -13.87 61.67 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.133 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.21 -29.99 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.507 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.9 m -127.43 -4.37 6.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.508 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.43 148.85 22.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -176.51 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.848 ' HA ' HD11 ' A' ' 154' ' ' LEU . 1.4 ttt -68.46 -57.27 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.829 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -55.29 -32.02 62.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.64 -48.49 80.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.068 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.718 ' HB2' HD13 ' A' ' 185' ' ' LEU . . . -57.29 -41.11 79.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.378 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 1.054 HG22 HD13 ' A' ' 142' ' ' ILE . 11.7 t -62.76 -32.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.05 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -45.91 85.97 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.877 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -69.98 -24.35 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.523 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 142' ' ' ILE . 0.0 OUTLIER -68.43 -35.83 78.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.533 ' NE2' HG12 ' A' ' 194' ' ' VAL . 14.9 mt-30 -89.43 -49.81 6.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.508 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.55 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -58.18 -15.89 11.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.557 ' CB ' HG13 ' A' ' 204' ' ' VAL . 8.4 m -89.42 32.53 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.23 65.72 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.406 0.622 . . . . 0.0 111.418 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -172.3 -29.91 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.672 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 203' ' ' LEU . 2.8 tt 171.84 111.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.768 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.557 HG13 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.72 128.8 64.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.204 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 1.7 ttmt -107.85 107.68 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.776 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 128' ' ' VAL . 5.4 mp -90.55 119.67 31.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.001 0.429 . . . . 0.0 111.662 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.869 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -98.01 93.84 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.092 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.58 HG21 ' CG ' ' A' ' 175' ' ' ASP . 3.9 mm -82.33 163.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.364 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -106.45 118.02 35.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.831 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 124' ' ' GLY . 25.5 mttt -129.58 114.54 16.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.858 0.361 . . . . 0.0 111.42 -179.915 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.878 0.371 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -114.26 113.35 24.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -52.0 140.06 21.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -135.28 159.99 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.0 p -110.03 136.22 49.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.581 HG23 ' HB3' ' A' ' 161' ' ' LYS . 4.2 m -132.54 169.6 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.855 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' H ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.67 160.59 14.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.948 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.8 HG13 HG23 ' A' ' 71' ' ' VAL . 1.8 t -147.27 148.22 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -127.14 110.0 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.751 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.731 HD12 HD21 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -106.83 120.62 42.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -113.26 160.48 18.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 111.43 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.705 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -90.4 132.02 35.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.849 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.87 148.93 36.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.567 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.67 14.57 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.552 2.168 . . . . 0.0 112.567 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.0 -48.97 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.48 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.65 -17.29 4.11 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 71.69 74.61 0.72 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.705 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 79.5 m-85 83.58 -25.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.113 0.565 . . . . 0.0 110.873 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 59.61 14.95 30.96 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 114.412 0.525 . . . . 0.0 114.412 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.104 ' CG2' HD13 ' A' ' 60' ' ' ILE . 1.1 pp -133.98 144.44 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 117.796 0.798 . . . . 0.0 112.676 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -106.8 129.01 54.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.748 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.938 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -95.75 115.98 28.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.883 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.866 ' HB3' HD12 ' A' ' 56' ' ' LEU . 4.0 tt0 -70.13 157.24 37.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.299 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.6 106.36 2.51 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.106 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.6 p 52.5 -170.79 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.595 0.236 . . . . 0.0 110.46 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' PHE . 58.4 t -144.45 -96.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.708 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 53' ' ' SER . 40.7 p90 -45.79 -52.11 11.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 45.35 78.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 15.9 p -153.7 96.68 2.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.073 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.6 pt-20 54.66 118.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.736 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 28.1 m 75.1 -12.13 0.99 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.601 ' O ' ' CB ' ' A' ' 52' ' ' SER . 0.8 OUTLIER 33.56 -129.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.289 0.236 . . . . 0.0 111.464 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 7.7 t 104.84 4.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.401 0.68 . . . . 0.0 110.263 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.505 ' CB ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -76.51 110.13 10.62 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.012 178.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 52' ' ' SER . 96.0 Cg_endo -78.93 160.34 27.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.344 2.03 . . . . 0.0 112.714 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 10.2 Cg_endo -53.34 147.88 35.05 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.694 2.263 . . . . 0.0 111.357 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.866 HD12 ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -156.85 123.9 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.812 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 59' ' ' TYR . 68.7 mt -60.71 130.79 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -109.93 10.67 24.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.424 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.581 ' O ' HG22 ' A' ' 39' ' ' ILE . 35.6 t80 -167.2 134.09 2.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.914 0.387 . . . . 0.0 111.712 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.104 HD13 ' CG2' ' A' ' 39' ' ' ILE . 4.1 mm -121.04 141.92 39.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.198 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -95.22 155.04 16.9 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.833 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.62 44.79 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.31 45.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.868 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -137.81 140.5 29.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 64' ' ' SER . 44.3 Cg_exo -56.68 -12.13 8.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.618 2.212 . . . . 0.0 113.221 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.793 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -66.69 -57.85 6.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.446 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.24 -30.19 43.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.888 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.441 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -71.84 -18.13 62.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.758 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 51.4 t -48.15 -50.61 28.16 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.749 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' HA3' ' HB3' ' A' ' 137' ' ' GLU . . . 127.62 -4.29 7.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.441 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.8 HG23 HG13 ' A' ' 27' ' ' VAL . 27.3 m -152.21 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.164 0.482 . . . . 0.0 111.613 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 66' ' ' ALA . 6.9 mt -135.27 142.38 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.019 0.438 . . . . 0.0 111.198 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.52 -175.47 4.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.646 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.645 HD13 ' CG1' ' A' ' 60' ' ' ILE . 29.4 mm -69.62 67.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.33 71.79 0.22 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.762 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.733 ' OD2' HD23 ' A' ' 72' ' ' LEU . 4.2 t0 -97.14 111.18 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.5 mpt_? -68.76 144.03 54.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.909 ' CG1' HD13 ' A' ' 109' ' ' LEU . 9.4 m -126.6 133.62 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.16 -24.95 15.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.13 133.63 12.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.108 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 97' ' ' LEU . 24.6 mt -122.56 114.86 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.811 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 53.02 24.02 3.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.106 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.52 15.69 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.621 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.47 131.06 88.46 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 120.438 0.161 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 86' ' ' THR . 31.9 Cg_exo -58.16 -157.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.498 2.132 . . . . 0.0 112.045 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 85' ' ' PRO . 22.7 p -158.79 -67.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.054 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -69.88 -11.64 61.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.461 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.07 42.15 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.978 0.418 . . . . 0.0 110.765 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.07 176.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.771 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 1.4 m -70.41 121.6 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -49.63 -28.39 5.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -54.73 -36.65 64.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.185 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 90' ' ' THR . 1.6 pp20? -61.66 -41.16 97.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HA ' HD11 ' A' ' 97' ' ' LEU . . . -63.02 -37.5 87.44 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.52 0.676 . . . . 0.0 109.868 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.9 OUTLIER -61.78 -41.07 97.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.102 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.86 -56.49 16.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.571 HD11 HD12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -53.75 -30.16 43.02 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.938 HD13 HD13 ' A' ' 41' ' ' LEU . 48.7 mt -76.21 -48.06 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.207 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 6.3 mtt85 -50.1 -31.06 12.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.8 p30 -120.54 38.34 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.352 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.12 34.13 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.187 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -131.77 13.4 4.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.839 0.352 . . . . 0.0 111.802 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.43 -46.28 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.753 0.787 . . . . 0.0 110.403 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -2.11 56.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.549 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.806 ' O ' HG22 ' A' ' 30' ' ' THR . 9.5 p 62.39 25.69 15.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -167.59 153.48 7.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.071 0.462 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 101' ' ' SER . 25.1 t -154.71 137.53 7.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.75 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.15 123.66 49.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.744 0.307 . . . . 0.0 110.482 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.909 HD13 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -140.49 153.76 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.903 0.382 . . . . 0.0 111.371 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.27 137.19 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.457 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 27' ' ' VAL . 45.7 pt -117.12 142.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 111.612 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -112.94 118.57 35.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.385 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.473 ' CE1' ' CG ' ' A' ' 167' ' ' ARG . 2.4 p90 -136.84 174.22 10.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.933 0.396 . . . . 0.0 111.382 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -102.21 155.18 18.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.594 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 167' ' ' ARG . 3.0 m -99.12 105.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.0 111.435 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 115' ' ' VAL . . . 175.9 132.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.696 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.536 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -140.57 12.89 2.33 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.87 88.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.193 0.52 . . . . 0.0 110.963 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 128' ' ' VAL . 1.3 m -110.18 145.99 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.957 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.68 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.6 pp -130.44 90.9 39.75 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 121.233 0.539 . . . . 0.0 110.632 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.497 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 62.6 Cg_endo -91.33 -173.79 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.176 2.584 . . . . 0.0 113.504 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER 178.75 36.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.784 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.5 OUTLIER 54.25 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.374 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.62 -42.63 2.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.457 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.702 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -127.51 102.35 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.811 0.339 . . . . 0.0 110.393 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 9.7 t80 -100.54 116.08 31.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.68 ' HB2' HG13 ' A' ' 120' ' ' ILE . 38.5 m80 -95.52 138.06 33.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.689 ' HA ' HG12 ' A' ' 119' ' ' VAL . 8.0 p -126.76 98.15 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.566 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.482 ' HD3' HD21 ' A' ' 203' ' ' LEU . 0.1 OUTLIER -84.14 105.1 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.345 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' A' ' 168' ' ' THR . 0.7 OUTLIER -113.41 125.55 29.46 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 130' ' ' LEU . 16.5 Cg_exo -65.76 115.29 3.33 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.181 1.921 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HD3' HG12 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -94.36 159.08 15.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.272 0.558 . . . . 0.0 111.928 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -113.61 -165.84 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.011 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -73.9 0.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 m -152.83 82.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.283 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 137' ' ' GLU . 65.1 t -130.46 159.2 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.491 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.0 tt0 -50.37 151.53 2.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.059 0.456 . . . . 0.0 111.555 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 140' ' ' ILE . 5.2 mt -138.64 -52.95 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 89.92 36.38 7.26 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.154 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.784 HG23 HD21 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -109.61 126.1 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.354 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 157' ' ' SER . 90.9 m -126.38 131.48 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.373 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.962 HD13 HG22 ' A' ' 194' ' ' VAL . 1.6 mt -105.89 163.29 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 142' ' ' ILE . 5.0 m -166.93 159.85 13.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.017 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.4 p -115.02 130.13 24.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.583 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HG3' ' HG2' ' A' ' 153' ' ' PRO . 25.7 Cg_endo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 122.359 2.039 . . . . 0.0 112.206 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.589 0.233 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.421 ' HG2' ' HG3' ' A' ' 145' ' ' PRO . 92.6 Cg_endo -90.95 174.62 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.572 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 190' ' ' MET . 2.1 mp -122.71 145.51 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.457 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 175' ' ' ASP . 29.8 m -149.17 172.5 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.507 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.433 HG21 HG12 ' A' ' 159' ' ' ILE . 2.8 mp -81.56 152.7 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.74 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.477 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.3 OUTLIER -127.73 -11.39 5.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.57 136.21 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' ' 166' ' ' HIS . 1.5 mt -131.97 143.52 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.279 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.419 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -101.58 178.89 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.581 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.0 OUTLIER -116.25 152.83 33.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.267 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.453 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 93.47 -30.44 7.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.775 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -82.79 140.01 33.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.969 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.0 m -49.43 -23.19 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.183 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' ' 168' ' ' THR . . . -44.92 -67.6 0.27 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.559 ' HB2' HG21 ' A' ' 159' ' ' ILE . 54.6 t60 -83.62 -26.55 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.483 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -58.54 -29.89 66.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.85 HG22 ' O ' ' A' ' 165' ' ' ALA . 6.9 t -58.8 -21.28 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.84 49.92 4.61 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.268 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 168' ' ' THR . 1.6 p -150.61 -52.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 110.958 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.784 HD21 HG23 ' A' ' 140' ' ' ILE . 4.0 mp -55.31 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -139.15 142.81 37.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.821 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 68.9 mt -56.97 114.39 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.76 16.91 4.38 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.996 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.719 ' O ' HG12 ' A' ' 155' ' ' VAL . 2.1 m-20 -100.83 148.16 25.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.775 0.287 . . . . 0.0 110.485 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.432 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -107.18 130.37 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 111.281 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.04 127.84 40.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.804 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.64 -44.94 2.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -137.42 155.29 49.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.506 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.69 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 20.6 mt -139.28 128.95 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.195 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 2.2 t70 49.45 42.6 22.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 2.1 t-20 82.64 -24.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 184' ' ' ARG . 38.3 mm -76.56 155.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 11.7 mtp180 -128.63 127.15 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.453 0.644 . . . . 0.0 112.318 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -90.19 -17.01 28.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.399 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.9 t0 63.94 -71.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.23 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 185' ' ' LEU . 1.0 OUTLIER -158.27 56.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.442 . . . . 0.0 110.617 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 0.0 OUTLIER 170.06 -166.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.221 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 192' ' ' ASP . 0.6 OUTLIER 68.77 43.79 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.872 179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.642 ' HA ' HD21 ' A' ' 154' ' ' LEU . 4.4 tpt -57.9 -58.17 9.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 109.888 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.53 -32.86 74.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 109.876 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.417 ' CB ' ' HB3' ' A' ' 189' ' ' SER . 0.2 OUTLIER -63.88 -43.73 95.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.864 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.815 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -57.87 -43.75 86.21 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.962 HG22 HD13 ' A' ' 142' ' ' ILE . 14.5 t -58.02 -38.93 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.73 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -50.67 71.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.104 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.1 mt -67.93 -24.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.718 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -61.1 -32.71 72.38 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.551 179.122 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.66 -32.97 10.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.048 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -16.2 39.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.527 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.792 ' SG ' HG23 ' A' ' 204' ' ' VAL . 67.3 m -84.14 41.97 0.85 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.77 59.2 0.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.119 0.485 . . . . 0.0 111.696 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.35 -33.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.101 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.5 tt -179.69 106.86 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.792 HG23 ' SG ' ' A' ' 200' ' ' CYS . 3.5 p -98.93 124.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.143 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -110.67 107.78 17.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.667 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.6 mm? -100.18 128.77 46.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.974 0.416 . . . . 0.0 111.932 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.759 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 0.2 OUTLIER -97.2 93.25 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.078 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.669 HG21 ' OD2' ' A' ' 175' ' ' ASP . 2.9 mm -90.63 169.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.158 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.541 ' H ' HG22 ' A' ' 208' ' ' ILE . 62.5 mtt180 -108.6 130.95 55.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 142.14 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.894 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.837 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.814 0.34 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 8.3 p-80 -100.06 115.07 28.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.697 HG22 ' OD1' ' A' ' 114' ' ' ASP . 36.0 p -53.35 125.59 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -120.45 162.7 19.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 p -113.11 135.71 53.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 161' ' ' LYS . 93.6 m -132.79 160.42 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' N ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.77 162.08 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.518 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.656 ' CG1' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -142.03 133.12 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.926 0.393 . . . . 0.0 111.081 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 28' ' ' VAL . 5.2 p -110.9 116.3 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.976 HD21 HD11 ' A' ' 72' ' ' LEU . 11.2 mt -112.56 136.25 52.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -119.61 159.82 23.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -98.92 129.12 45.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.368 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.461 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -107.48 152.82 41.49 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.96 14.46 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.42 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.01 -47.15 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.4 t -148.92 11.05 0.82 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 59.3 -102.58 0.31 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.461 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CE2' ' O ' ' A' ' 30' ' ' THR . 41.4 m-85 -121.37 124.22 44.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -96.23 28.21 13.91 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.709 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.804 HD13 HD13 ' A' ' 72' ' ' LEU . 7.4 pt -128.35 134.86 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 120.842 0.353 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -124.0 145.31 49.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.977 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.93 HD23 ' CD1' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.26 138.68 51.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.42 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -78.32 169.8 17.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.324 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -108.34 -68.2 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.764 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.3 144.26 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 56' ' ' LEU . 72.8 t -141.45 -89.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.8 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.608 ' CE1' HG23 ' A' ' 50' ' ' THR . 48.3 p90 -58.14 -46.51 85.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.665 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.579 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 46.61 100.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.08 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.473 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER 171.64 105.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.979 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' C ' HG22 ' A' ' 50' ' ' THR . 9.1 pt-20 52.92 33.61 14.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 110.539 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.608 HG23 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 161.49 174.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.035 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -163.64 23.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.544 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.81 23.31 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.07 139.93 97.88 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.008 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.17 157.46 50.39 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.392 2.061 . . . . 0.0 111.922 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.889 ' HB3' HD13 ' A' ' 41' ' ' LEU . 77.4 Cg_exo -50.3 155.15 5.08 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.434 2.089 . . . . 0.0 112.19 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.59 HD13 HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -148.88 112.66 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.93 ' CD1' HD23 ' A' ' 41' ' ' LEU . 13.2 mm -53.89 141.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.0 110.996 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.82 -32.36 2.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.457 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 86.2 t80 -141.92 156.02 45.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.325 0.584 . . . . 0.0 111.861 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.709 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 17.8 mm -136.34 161.27 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.087 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.456 ' N ' HG22 ' A' ' 60' ' ' ILE . 1.5 tt0 -107.18 150.29 26.77 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 121.922 -0.486 . . . . 0.0 111.877 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.32 39.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.028 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 36.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.923 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.443 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 41.2 p -128.58 138.67 33.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 32' ' ' ASP . 17.6 Cg_endo -57.7 -16.05 23.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.724 2.282 . . . . 0.0 112.869 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.853 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -73.59 -48.74 30.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.564 0.697 . . . . 0.0 109.692 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.709 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.5 tp10 -70.25 -32.46 70.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.422 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.562 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -93.88 -5.43 48.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -42.59 62.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.824 0.345 . . . . 0.0 110.674 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 136' ' ' VAL . . . 133.9 -19.3 4.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.38 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.656 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.2 m -146.89 75.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 117.108 0.454 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.976 HD11 HD21 ' A' ' 29' ' ' LEU . 13.8 mt -157.87 121.62 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.931 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -144.24 -176.31 4.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.544 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.6 126.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.0 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.469 ' N ' ' HB ' ' A' ' 57' ' ' ILE . . . 57.88 84.54 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.669 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 72' ' ' LEU . 70.6 m-20 -95.07 -30.54 14.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.036 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.702 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER 63.45 105.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' HB2' ' A' ' 109' ' ' LEU . 14.8 p -98.47 148.39 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.494 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.7 ttp -109.34 -24.93 10.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.462 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -158.48 145.27 17.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.56 HD12 HD12 ' A' ' 97' ' ' LEU . 1.2 mt -133.14 113.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.92 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.7 m120 54.09 24.18 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.34 -31.83 6.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.485 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -69.53 110.45 6.4 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.383 0.135 . . . . 0.0 111.301 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.522 ' C ' HG23 ' A' ' 86' ' ' THR . 31.6 Cg_endo -63.96 -27.93 66.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.304 2.003 . . . . 0.0 112.046 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.522 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.2 p 72.28 2.15 4.22 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.678 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -14.3 42.8 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.297 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -120.95 45.72 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.93 153.04 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.784 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 91' ' ' PHE . 9.7 m -60.15 163.83 4.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 6.5 p90 -65.59 -39.27 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.683 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 58.1 mt-10 -54.97 -32.94 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.478 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -53.34 58.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.135 0.493 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -54.68 -37.97 66.41 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.673 0.749 . . . . 0.0 109.863 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -59.93 -36.85 77.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.619 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 5.3 mm-40 -62.23 -43.29 99.17 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.827 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.56 HD12 HD12 ' A' ' 81' ' ' ILE . 17.6 mt -53.72 -41.93 67.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.854 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.828 HD21 HD21 ' A' ' 41' ' ' LEU . 3.4 mp -75.23 -44.65 45.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.628 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 3.5 mtt-85 -50.92 -31.99 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.275 0.559 . . . . 0.0 109.693 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 5.1 p30 -127.52 42.75 3.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.265 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.783 ' HB2' HG21 ' A' ' 107' ' ' VAL . 2.5 p -81.27 6.53 13.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.639 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.27 18.52 19.81 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 9.6 mt -70.79 -53.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.913 0.863 . . . . 0.0 110.418 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.72 9.51 29.64 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.484 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 m 58.93 20.87 8.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.272 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.561 ' HG2' HG23 ' A' ' 30' ' ' THR . 1.6 mttt -166.61 158.42 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.575 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.783 HG21 ' HB2' ' A' ' 101' ' ' SER . 66.1 t -155.29 106.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.426 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.77 132.82 39.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.767 ' HB2' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.07 163.59 32.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.067 0.461 . . . . 0.0 111.611 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -120.34 128.59 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 77' ' ' ARG . 26.6 pt -119.41 153.65 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.929 0.395 . . . . 0.0 111.623 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -120.43 119.14 32.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.465 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 6.5 p90 -138.08 174.21 10.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.275 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.697 ' OD1' HG22 ' A' ' 22' ' ' THR . 7.5 m-20 -91.3 142.25 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.579 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 115' ' ' VAL . 26.8 m -87.26 108.25 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.38 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.47 133.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 168' ' ' THR . 0.2 OUTLIER -149.91 23.85 0.86 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.1 t 83.68 100.84 0.05 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.197 0.523 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.922 HG11 HG21 ' A' ' 170' ' ' THR . 2.0 t -135.39 123.02 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.175 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.705 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.6 pp -96.9 106.97 34.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.267 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 69.9 Cg_endo -95.34 137.02 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.291 2.661 . . . . 0.0 112.679 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -139.81 -80.55 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.62 113.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.85 -31.9 6.53 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.529 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.502 HG22 ' CG ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -138.38 102.65 4.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.964 0.411 . . . . 0.0 111.316 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.812 ' CE1' HG12 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -103.31 121.01 41.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.861 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.705 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -105.75 130.79 53.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.369 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.833 HG11 HG21 ' A' ' 168' ' ' THR . 3.6 t -109.46 86.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 118' ' ' SER . 0.3 OUTLIER -81.14 98.91 8.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.722 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -120.53 125.35 27.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.005 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.58 115.77 2.78 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.353 2.035 . . . . 0.0 111.646 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.545 ' HB2' HG23 ' A' ' 204' ' ' VAL . 18.1 tttp -90.59 151.35 21.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.499 ' CD ' HG21 ' A' ' 136' ' ' VAL . 2.4 mttt -84.95 -168.52 2.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.921 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -72.44 -33.46 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.796 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 m 175.2 40.42 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.799 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.628 HG22 ' HA2' ' A' ' 70' ' ' GLY . 1.2 t -72.24 162.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.58 157.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.985 0.421 . . . . 0.0 111.341 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.495 HD12 ' OG ' ' A' ' 163' ' ' SER . 0.9 OUTLIER -164.99 107.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -89.93 39.55 3.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.394 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.628 HD11 ' CB ' ' A' ' 165' ' ' ALA . 4.4 mm -84.75 124.2 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.801 0.3 . . . . 0.0 110.34 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.754 HG22 ' HB2' ' A' ' 157' ' ' SER . 85.3 m -115.75 141.57 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.974 HD11 HD22 ' A' ' 197' ' ' LEU . 1.9 mt -114.42 163.88 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.868 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.493 ' N ' HG22 ' A' ' 142' ' ' ILE . 48.0 t -166.61 156.38 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.766 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.0 t -115.5 144.85 33.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.345 0.371 0 C-N-CA 122.449 2.099 . . . . 0.0 112.203 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.517 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.717 ' O ' HD22 ' A' ' 154' ' ' LEU . 54.3 Cg_endo -93.59 -179.77 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.906 2.404 . . . . 0.0 112.884 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 190' ' ' MET . 2.9 mm? -137.46 155.46 49.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.077 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 156' ' ' ILE . 14.1 t -151.68 161.21 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.872 0.367 . . . . 0.0 111.922 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.515 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.5 mt -94.26 152.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.096 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.754 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.4 OUTLIER -127.16 -16.71 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.325 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 178.91 137.83 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.28 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.591 HG22 ' HB2' ' A' ' 166' ' ' HIS . 1.0 OUTLIER -129.68 122.99 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.578 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -86.2 155.6 20.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 111.111 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.517 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.4 OUTLIER -79.58 179.83 7.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.608 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 80.55 -54.7 4.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.495 ' OG ' HD12 ' A' ' 138' ' ' LEU . 0.6 OUTLIER -59.24 144.2 46.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.157 0.503 . . . . 0.0 111.376 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 26.8 m -56.4 -21.08 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.046 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.945 ' O ' HG22 ' A' ' 168' ' ' THR . . . -59.36 -71.73 0.12 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.731 0.3 . . . . 0.0 111.361 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.591 ' HB2' HG22 ' A' ' 159' ' ' ILE . 21.3 t60 -66.46 -24.76 66.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.952 0.406 . . . . 0.0 110.499 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.486 ' NH2' ' HB3' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -56.88 -42.58 80.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.501 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.945 HG22 ' O ' ' A' ' 165' ' ' ALA . 13.2 t -50.3 -30.08 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 170' ' ' THR . . . 59.37 89.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.77 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.922 HG21 HG11 ' A' ' 119' ' ' VAL . 15.3 t -177.75 -38.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 110.866 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -69.43 152.66 44.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.814 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -147.63 151.8 36.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.451 HD23 ' HB ' ' A' ' 156' ' ' ILE . 6.5 mt -82.23 127.82 33.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.43 23.55 4.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.61 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.416 ' CB ' ' CG2' ' A' ' 208' ' ' ILE . 21.3 m-20 -116.22 -168.98 1.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.684 0.278 . . . . 0.0 110.604 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.71 120.84 28.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.858 0.361 . . . . 0.0 111.275 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 180' ' ' ILE . 2.5 mt -78.06 144.53 36.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.5 tt -120.24 -41.43 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.695 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -148.87 166.74 27.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.814 HD11 HD22 ' A' ' 177' ' ' LEU . 27.6 mm -139.84 117.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.246 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 25.5 t0 57.91 -86.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -127.25 -13.85 5.5 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.856 ' HB ' HG21 ' A' ' 196' ' ' ILE . 27.4 mm -96.59 159.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.628 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 15.9 mtt85 -118.61 123.68 45.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.386 0.612 . . . . 0.0 112.321 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 185' ' ' LEU . 0.8 OUTLIER -77.49 -13.42 59.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.789 178.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.17 -28.99 1.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.2 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.73 -5.14 6.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.642 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -96.0 133.1 40.62 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -57.39 -178.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.074 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.742 ' HA ' HD11 ' A' ' 154' ' ' LEU . 5.6 ttp -66.15 -57.25 8.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.57 -38.0 71.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.256 0.55 . . . . 0.0 110.72 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.792 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -59.7 -44.81 93.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.935 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 185' ' ' LEU . . . -57.76 -42.96 85.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.442 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.937 HG22 HD13 ' A' ' 142' ' ' ILE . 8.9 t -60.7 -33.72 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.245 0.545 . . . . 0.0 109.786 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -50.18 74.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.949 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.856 HG21 ' HB ' ' A' ' 183' ' ' ILE . 2.3 mp -73.79 -24.6 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.885 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.974 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -64.37 -28.45 69.7 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.775 ' NE2' HG12 ' A' ' 194' ' ' VAL . 19.7 mt-30 -103.44 -33.71 8.97 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.95 -16.04 60.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.167 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.794 ' SG ' HG22 ' A' ' 204' ' ' VAL . 13.8 p -85.97 43.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.195 0.521 . . . . 0.0 110.456 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 5.5 pt-20 -70.75 62.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.539 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.426 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 1.9 m-20 -178.14 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.404 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.404 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 20.5 tp -176.89 107.05 0.06 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.765 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.794 HG22 ' SG ' ' A' ' 200' ' ' CYS . 6.9 t -102.01 115.7 44.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.655 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 13.2 ttmm -104.51 108.32 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.906 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.523 ' N ' HD22 ' A' ' 206' ' ' LEU . 3.4 mm? -87.49 102.7 14.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.915 0.388 . . . . 0.0 111.303 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.552 ' NZ ' HD22 ' A' ' 178' ' ' LEU . 0.1 OUTLIER -92.51 93.43 8.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.216 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 209' ' ' ARG . 6.9 mm -92.92 163.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 21.8 mtm-85 -107.96 126.38 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.037 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 1.6 tttm -113.22 159.49 19.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 114' ' ' ASP . 26.6 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.94 0.4 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.638 ' CE1' HG11 ' A' ' 115' ' ' VAL . 46.1 p-80 -128.1 113.77 16.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.739 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -50.27 142.87 9.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -147.77 172.02 14.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.471 HG22 ' HB2' ' A' ' 112' ' ' GLU . 28.7 p -125.61 151.97 45.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 26' ' ' GLU . 89.9 m -145.74 164.4 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.07 161.89 13.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.551 HG11 HD21 ' A' ' 72' ' ' LEU . 2.2 t -135.48 150.16 28.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.87 109.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.442 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -115.09 118.54 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -105.81 162.22 13.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.05 123.05 32.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.07 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.15 153.72 66.51 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.627 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -78.28 9.7 3.01 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.525 2.15 . . . . 0.0 112.506 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 t -112.11 -49.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 120.638 0.256 . . . . 0.0 111.356 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -145.7 3.83 0.98 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 -93.82 0.86 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.366 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.642 ' HD1' HD22 ' A' ' 29' ' ' LEU . 44.5 m-85 -125.6 120.74 31.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.2 9.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.465 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.979 HD11 ' HB2' ' A' ' 66' ' ' ALA . 2.7 mp -93.14 151.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.32 0.581 . . . . 0.0 111.995 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -124.55 99.83 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.763 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 98' ' ' LEU . 1.5 tp -96.17 148.55 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 28.4 pt20 -129.43 170.08 14.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.968 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.58 26.53 3.47 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.296 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.6 106.25 14.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 110.483 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 56' ' ' LEU . 27.4 t -135.14 -85.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.616 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 4.3 p90 -34.92 -44.63 0.23 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.116 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 55.08 66.58 1.19 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.528 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 30.8 p -161.07 -166.31 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.938 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' HG22 ' A' ' 50' ' ' THR . 2.3 pt-20 -51.7 171.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 49' ' ' GLU . 11.9 t 45.25 -153.85 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.993 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.708 HD22 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -146.02 -94.29 0.09 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.707 0.289 . . . . 0.0 111.171 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 16.54 1.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.797 0.332 . . . . 0.0 111.823 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.51 133.74 85.59 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.17 137.29 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.391 2.061 . . . . 0.0 111.85 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.885 ' CB ' HD21 ' A' ' 41' ' ' LEU . 8.1 Cg_endo -49.98 123.09 10.2 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.56 2.173 . . . . 0.0 111.963 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.494 ' CD1' HG22 ' A' ' 45' ' ' VAL . 1.4 pt? -139.42 119.88 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 111.512 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.596 HD13 HG23 ' A' ' 39' ' ' ILE . 48.3 mt -64.44 157.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.996 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.493 ' N ' HG22 ' A' ' 57' ' ' ILE . 12.1 m -130.65 -12.6 3.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.354 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.0 t80 179.78 137.47 0.11 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.936 0.398 . . . . 0.0 111.259 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 61' ' ' GLU . 4.0 mt -111.28 171.95 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 60' ' ' ILE . 43.0 tt0 -111.13 155.1 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.663 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -79.05 59.23 2.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.286 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.08 41.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.313 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 5.2 p -131.27 137.67 31.11 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 64' ' ' SER . 28.5 Cg_exo -61.6 -11.62 21.1 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.5 2.133 . . . . 0.0 112.764 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.001 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -76.88 -56.06 4.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.013 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -73.46 -29.54 62.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.292 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.52 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.24 -42.65 68.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.4 t -47.78 -30.41 3.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.92 -9.31 74.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.916 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 162' ' ' GLY . 18.1 t -101.71 31.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.981 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.741 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 34.1 mt -146.77 134.37 20.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -125.81 161.38 27.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.25 82.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.06 48.24 0.15 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.426 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -76.42 107.64 8.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.87 0.366 . . . . 0.0 110.74 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -69.96 73.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.39 125.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 ttp -95.58 -30.27 13.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -152.03 153.97 35.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.284 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.691 HD12 HD12 ' A' ' 97' ' ' LEU . 4.0 mt -133.98 117.06 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 62.56 19.98 11.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.82 -24.22 22.15 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -71.23 123.14 88.88 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-O 120.519 0.2 . . . . 0.0 111.091 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.52 ' C ' HG23 ' A' ' 86' ' ' THR . 50.3 Cg_endo -68.71 -26.3 33.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 73.84 1.3 3.88 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.619 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -15.02 41.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.898 0.38 . . . . 0.0 111.358 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.18 46.37 0.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m 179.33 -177.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.708 HG23 HD22 ' A' ' 51' ' ' LEU . 15.4 m -93.3 153.17 18.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -52.17 -27.19 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 9.9 mt-10 -54.79 -36.73 65.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.944 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.356 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -61.77 -38.65 88.8 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.555 0.693 . . . . 0.0 109.991 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -59.52 -40.82 88.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.081 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 50.0 mm-40 -61.97 -44.3 97.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 110.21 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 81' ' ' ILE . 36.4 mt -54.37 -41.11 68.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.203 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.904 HD11 HD22 ' A' ' 41' ' ' LEU . 36.7 mt -73.56 -51.9 15.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.878 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 1.5 mtp180 -50.85 -29.84 12.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.962 0.41 . . . . 0.0 110.3 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 53.4 m-20 -126.63 39.66 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.657 ' HB3' ' HA ' ' A' ' 98' ' ' LEU . 1.2 p -89.22 10.98 20.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.84 18.88 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.1 mt -68.79 -49.73 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.877 0.846 . . . . 0.0 110.311 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.48 13.09 32.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.397 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.843 ' O ' HG22 ' A' ' 30' ' ' THR . 24.2 p 54.8 24.32 5.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.258 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -165.17 148.1 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 101' ' ' SER . 2.0 t -145.99 133.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.84 141.2 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' VAL . 1.6 mp -136.31 146.87 47.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.569 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 106.1 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.03 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.3 pt -105.96 160.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 112.104 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 24' ' ' THR . 50.6 tt0 -133.94 137.99 45.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.169 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 167' ' ' ARG . 5.9 p90 -161.24 174.11 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.723 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.548 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -86.25 113.15 22.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.807 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.638 HG11 ' CE1' ' A' ' 21' ' ' HIS . 12.7 p -61.8 104.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.236 0.541 . . . . 0.0 111.94 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 167' ' ' ARG . . . 178.21 177.56 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.625 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 118' ' ' SER . 4.9 tp10 -177.95 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.449 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.5 t 163.55 109.21 0.0 OUTLIER 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.795 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.966 HG21 HG21 ' A' ' 170' ' ' THR . 7.1 p -140.52 147.59 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.133 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -123.34 77.87 53.51 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.95 0.405 . . . . 0.0 111.191 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 126' ' ' PHE . 20.9 Cg_exo -68.65 145.9 65.3 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.351 2.701 . . . . 0.0 112.333 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.43 13.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.47 140.37 0.01 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.857 0.361 . . . . 0.0 111.254 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 77.97 -59.93 3.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.131 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 23.0 m -146.37 102.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.713 ' HB2' ' HA ' ' A' ' 121' ' ' PRO . 2.3 p90 -124.94 164.77 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.67 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.927 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -120.51 163.9 17.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.274 0.559 . . . . 0.0 111.84 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 128' ' ' VAL . 28.0 m -130.81 104.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.007 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -81.99 112.69 19.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.922 HD21 HG23 ' A' ' 168' ' ' THR . 3.4 mp -126.72 117.13 22.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 131.59 46.89 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.249 1.966 . . . . 0.0 111.745 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.615 ' HE3' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -95.64 159.55 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.032 0.444 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.09 -168.69 2.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.856 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -68.96 65.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.463 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 46.52 65.46 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.044 0.449 . . . . 0.0 111.652 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 137' ' ' GLU . 15.0 t -111.35 164.98 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 136' ' ' VAL . 20.9 tt0 -38.07 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.939 0.4 . . . . 0.0 111.663 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -68.76 -42.52 77.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 163' ' ' SER . . . 90.04 -3.32 82.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.763 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -110.73 133.68 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 157' ' ' SER . 75.4 m -116.43 140.42 49.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.349 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.009 HD11 HD22 ' A' ' 197' ' ' LEU . 5.7 mt -97.8 162.87 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.54 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.6 OUTLIER -158.14 147.03 19.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.382 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 54.5 p -107.65 134.8 19.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.969 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.415 ' HD3' HG23 ' A' ' 155' ' ' VAL . 83.8 Cg_endo . . . . . 0 C--N 1.345 0.358 0 C-N-CA 122.582 2.188 . . . . 0.0 112.419 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.615 0.245 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.72 -175.23 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.492 2.128 . . . . 0.0 112.612 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 142' ' ' ILE . 5.9 tp -89.7 169.84 10.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 156' ' ' ILE . 22.0 t -147.77 160.51 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.906 0.384 . . . . 0.0 111.61 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' HG12 ' A' ' 155' ' ' VAL . 39.0 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.882 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.435 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.4 OUTLIER -131.32 -7.19 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.0 OUTLIER -177.2 146.1 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.294 0.569 . . . . 0.0 112.072 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.658 HG22 ' HB2' ' A' ' 166' ' ' HIS . 7.8 mt -130.72 149.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.709 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 138.6 54.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.004 0.431 . . . . 0.0 111.609 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.419 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -81.76 -9.08 59.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.864 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 71' ' ' VAL . . . -89.95 -16.89 55.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.673 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 2.9 m -114.12 169.94 8.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.899 0.38 . . . . 0.0 110.99 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.786 ' HB ' HD23 ' A' ' 130' ' ' LEU . 5.6 m -61.74 -22.58 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.773 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.49 -71.21 0.08 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.789 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.658 ' HB2' HG22 ' A' ' 159' ' ' ILE . 6.4 t-160 -64.94 -24.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.975 0.417 . . . . 0.0 110.528 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.54 ' HA ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -57.61 -29.91 64.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.922 HG23 HD21 ' A' ' 130' ' ' LEU . 42.8 p -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.97 74.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.589 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.966 HG21 HG21 ' A' ' 119' ' ' VAL . 3.2 t -168.62 32.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.966 0.412 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 159' ' ' ILE . 1.0 OUTLIER -113.51 107.15 15.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.689 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.53 150.87 40.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.4 mt -74.95 131.42 40.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.54 -25.7 8.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.45 -172.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.309 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.93 134.43 42.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -99.92 142.18 31.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.439 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 178' ' ' LEU . 6.0 tt -120.85 -35.73 3.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.744 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.841 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -142.07 162.45 35.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.879 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.707 ' CD1' HD21 ' A' ' 185' ' ' LEU . 31.9 mt -139.34 116.71 11.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.37 -74.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -144.54 -19.3 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.932 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 196' ' ' ILE . 28.5 mm -96.55 140.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 111.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.841 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 5.8 mtt180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.905 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.707 HD21 ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -75.55 -6.72 51.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.243 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -41.18 -32.53 0.28 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.456 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m -121.48 -11.72 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.667 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 6.2 m -88.01 -169.78 2.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.142 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 80.5 p -112.3 -175.76 2.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.418 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.7 OUTLIER -70.91 -56.89 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -53.97 -47.11 71.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.785 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -43.6 72.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.059 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.66 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -56.86 -42.05 79.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.415 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.683 HG22 ' CD1' ' A' ' 142' ' ' ILE . 15.3 t -58.98 -39.15 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.291 0.567 . . . . 0.0 109.642 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.948 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.3 mt -69.81 -24.88 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 1.009 HD22 HD11 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -59.34 -31.59 69.32 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.482 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -103.98 -33.55 8.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.141 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -19.67 55.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.709 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 19.8 p -85.49 47.12 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.281 0.563 . . . . 0.0 109.866 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.445 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 22.4 tt0 -68.37 63.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.65 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.402 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 8.8 m-20 -173.23 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.875 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.547 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -178.72 107.46 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 132' ' ' LYS . 2.9 t -85.6 108.35 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.604 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 8.9 ttmm -104.83 107.88 19.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.588 HD12 HG21 ' A' ' 128' ' ' VAL . 2.5 mt -99.91 121.51 41.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.616 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 3.9 tttt -89.7 101.96 14.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.284 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 208' ' ' ILE . 2.0 mm -91.97 158.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.409 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 29.9 mtp85 -113.81 121.79 45.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -114.14 106.17 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.058 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.81 HG21 ' O ' ' A' ' 115' ' ' VAL . 5.3 p . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.695 0.283 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.434 ' O ' HG22 ' A' ' 115' ' ' VAL . 33.0 t60 -88.24 106.24 18.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.797 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 p -53.29 161.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.202 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -168.68 169.13 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.615 HG22 ' HG3' ' A' ' 112' ' ' GLU . 29.7 p -129.33 164.74 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.494 HG22 ' CE2' ' A' ' 113' ' ' PHE . 12.4 t -147.78 -170.6 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.71 162.93 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.11 146.8 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.421 HG13 ' CD ' ' A' ' 106' ' ' LYS . 45.2 t -129.31 118.78 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.994 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.006 HD21 ' HB2' ' A' ' 66' ' ' ALA . 1.2 mt -114.38 118.86 35.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.82 163.27 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.526 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.83 115.75 29.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.267 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.48 152.03 59.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.576 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.65 9.21 3.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.636 2.224 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.33 -50.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 120.613 0.244 . . . . 0.0 111.428 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -132.39 -11.81 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -87.73 0.8 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.371 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 29' ' ' LEU . 4.5 m-85 -133.38 118.98 19.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.094 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -95.29 28.51 11.72 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.915 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 66' ' ' ALA . 4.0 mp -93.27 149.17 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.189 0.519 . . . . 0.0 112.012 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' NE2' ' HB3' ' A' ' 58' ' ' SER . 0.0 OUTLIER -145.0 99.08 3.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.049 HD21 HD13 ' A' ' 98' ' ' LEU . 1.8 pp -112.03 157.27 20.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 169.63 10.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.867 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -119.41 -5.89 11.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.051 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 p -137.46 151.59 48.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.153 0.501 . . . . 0.0 111.537 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.619 ' CG2' HD13 ' A' ' 56' ' ' LEU . 95.1 t -151.98 -76.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.133 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.783 ' O ' HG22 ' A' ' 48' ' ' THR . 21.0 p90 -35.46 -46.77 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.25 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.0 69.23 0.46 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.783 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER 166.96 95.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.2 146.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.104 0.478 . . . . 0.0 111.736 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.417 ' O ' ' CE2' ' A' ' 46' ' ' PHE . 63.1 p 45.59 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.703 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -132.76 -77.32 0.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.889 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.66 17.36 0.09 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.036 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.528 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 1.7 t -108.36 99.36 32.05 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.553 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 172.44 16.19 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.426 2.084 . . . . 0.0 111.978 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.53 ' HB3' HD13 ' A' ' 41' ' ' LEU . 2.4 Cg_endo -45.61 133.46 13.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.712 2.275 . . . . 0.0 112.003 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.619 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -129.0 97.23 4.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.507 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.634 HD13 HG23 ' A' ' 39' ' ' ILE . 27.4 mt -59.43 139.16 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.948 0.404 . . . . 0.0 110.904 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' HG23 ' A' ' 74' ' ' ILE . 2.5 t -124.2 1.48 8.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HA ' HD12 ' A' ' 74' ' ' ILE . 58.2 t80 179.15 134.76 0.09 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.047 0.451 . . . . 0.0 111.626 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.705 HG21 ' CB ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -108.58 162.91 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 40.9 tt0 -98.71 152.56 19.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.401 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.504 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -82.52 56.45 3.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER 165.76 42.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.431 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 t -132.05 139.95 36.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.92 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.34 -10.23 20.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.442 2.095 . . . . 0.0 112.626 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 1.006 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -73.09 -56.18 5.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.978 0.418 . . . . 0.0 110.841 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.705 ' CB ' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -76.81 -29.81 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.159 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -74.49 -29.89 61.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -44.91 69.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 100.06 28.05 7.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 162' ' ' GLY . 10.4 t -148.23 26.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.845 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 12.0 mt -137.36 129.77 29.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -128.72 174.61 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 59' ' ' TYR . 25.2 mm -66.81 74.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 128.28 46.04 0.19 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.37 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -74.89 98.46 3.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -78.54 115.8 18.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 109' ' ' LEU . 14.4 m -101.64 167.5 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 tpt -117.65 -40.96 2.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.43 133.48 22.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.682 HD12 HD12 ' A' ' 97' ' ' LEU . 7.0 mt -119.12 116.27 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.7 p30 47.38 26.07 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.378 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.34 -28.73 10.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.872 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 97' ' ' LEU . 13.0 mm -70.43 136.85 86.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-O 120.718 0.294 . . . . 0.0 111.567 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.3 167.47 19.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.555 2.17 . . . . 0.0 112.213 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 44.8 p -141.12 -54.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.004 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.45 -8.37 55.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.13 44.76 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.95 176.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 92' ' ' GLU . 7.9 m -62.87 145.45 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.477 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 8.2 p90 -73.34 -27.06 61.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.151 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.547 ' H ' HG22 ' A' ' 90' ' ' THR . 6.9 mt-10 -54.63 -42.17 70.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.843 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.6 pt-20 -61.0 -44.49 97.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.317 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -59.83 -35.63 75.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.6 m120 -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.88 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 39.3 mm-40 -62.07 -37.34 84.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.042 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.682 HD12 HD12 ' A' ' 81' ' ' ILE . 23.5 mt -57.43 -49.6 75.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.049 HD13 HD21 ' A' ' 41' ' ' LEU . 1.1 mt -69.92 -57.5 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 63.3 mtt180 -50.5 -31.66 16.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.44 0.638 . . . . 0.0 109.604 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.7 m-20 -119.25 39.68 3.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.675 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -93.17 26.31 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.9 t -124.43 15.71 8.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -68.33 -39.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.783 0.802 . . . . 0.0 110.409 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 11.68 30.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.552 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.49 ' O ' HG22 ' A' ' 30' ' ' THR . 1.8 m 57.92 22.2 8.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.905 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.74 156.25 2.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.362 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.48 129.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.055 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 134.07 47.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.025 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 HG11 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.23 138.12 31.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.59 144.04 27.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.318 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.544 ' CG2' HG12 ' A' ' 78' ' ' VAL . 32.0 pt -134.21 165.33 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.033 0.444 . . . . 0.0 111.828 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.615 ' HG3' HG22 ' A' ' 24' ' ' THR . 51.6 tt0 -132.16 140.95 48.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 25' ' ' THR . 0.5 OUTLIER -161.17 174.5 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.316 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.534 ' HB2' HG11 ' A' ' 20' ' ' VAL . 14.0 p30 -98.07 119.8 37.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.272 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.81 ' O ' HG21 ' A' ' 20' ' ' VAL . 24.1 m -61.81 104.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.556 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.0 124.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.812 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -137.44 52.67 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 t 65.33 89.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.332 0.587 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 1.016 HG12 HG12 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -118.01 122.34 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.111 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.664 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.8 pp -115.6 89.59 23.3 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.315 0.578 . . . . 0.0 110.328 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.533 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.5 Cg_endo -97.04 169.55 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.211 2.608 . . . . 0.0 113.134 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.2 p -153.58 -66.58 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.145 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 166.3 109.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.02 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.05 -32.72 5.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.401 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.513 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -129.25 102.72 6.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.041 0.448 . . . . 0.0 110.768 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -105.43 125.21 50.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.045 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.546 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -113.73 129.04 56.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.959 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.016 HG12 HG12 ' A' ' 119' ' ' VAL . 31.6 m -114.1 104.69 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.105 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.43 ' HG2' ' HD3' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -87.35 106.57 18.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.781 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 204' ' ' VAL . 0.1 OUTLIER -121.38 136.48 25.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.661 0.267 . . . . 0.0 111.203 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.28 139.81 51.25 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.349 2.033 . . . . 0.0 111.338 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -124.77 158.3 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.674 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.661 ' CG ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -130.48 172.98 11.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.238 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.627 ' CE1' ' HE2' ' A' ' 133' ' ' LYS . 1.4 p-80 -47.23 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -127.43 98.33 5.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.085 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.661 ' HB ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.5 -177.28 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 136' ' ' VAL . 4.5 tt0 -96.35 97.48 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.748 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.856 HD22 HD11 ' A' ' 140' ' ' ILE . 3.1 mt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.758 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.79 3.69 65.95 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.923 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.856 HD11 HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -102.47 137.88 28.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 110.711 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 98.7 m -126.02 128.26 47.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.708 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.883 HD13 HG22 ' A' ' 194' ' ' VAL . 1.7 mt -95.93 163.91 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 142' ' ' ILE . 22.7 t -175.01 177.58 1.93 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.0 t -114.51 134.49 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.622 ' HD3' HG12 ' A' ' 155' ' ' VAL . 94.4 Cg_endo . . . . . 0 C--N 1.345 0.367 0 C-N-CA 122.562 2.175 . . . . 0.0 112.297 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.803 0.335 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.1 -157.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.661 2.241 . . . . 0.0 112.117 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.892 HD21 ' HA ' ' A' ' 190' ' ' MET . 1.6 mp -104.85 -173.43 2.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.506 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 175' ' ' ASP . 7.6 p -178.43 138.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.267 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 1.022 HD13 HD23 ' A' ' 171' ' ' LEU . 12.0 mt -70.27 154.23 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 t -134.89 -8.94 2.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.71 142.29 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.059 0.457 . . . . 0.0 111.451 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' HB2' ' A' ' 166' ' ' HIS . 4.4 mt -141.05 133.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.3 164.83 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.49 163.58 12.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.771 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.589 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . 83.71 -11.89 54.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.902 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.5 m -113.42 148.96 34.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.69 -22.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.227 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 168' ' ' THR . . . -55.12 -64.06 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.743 0.306 . . . . 0.0 111.558 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.789 ' HB2' HG22 ' A' ' 159' ' ' ILE . 9.5 t-160 -81.31 -24.69 37.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.77 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -55.05 -40.86 70.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.193 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.81 HG22 ' O ' ' A' ' 165' ' ' ALA . 5.1 t -52.01 -26.07 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.029 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.01 67.04 2.41 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.808 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.798 HG21 HG11 ' A' ' 119' ' ' VAL . 2.9 t 178.84 40.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 110.825 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.022 HD23 HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -114.39 -77.7 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.718 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 62.11 149.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.091 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.65 107.06 8.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.728 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.38 -18.01 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.613 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.869 ' O ' HG23 ' A' ' 155' ' ' VAL . 1.9 m-20 -60.29 144.66 49.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.222 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 209' ' ' ARG . 0.1 OUTLIER -110.49 114.61 28.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.67 0.271 . . . . 0.0 110.917 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 0.5 OUTLIER -70.15 176.03 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.559 ' C ' HD13 ' A' ' 178' ' ' LEU . 3.4 tm? -156.82 -43.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.494 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -145.87 173.37 12.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.674 HG22 ' OD2' ' A' ' 181' ' ' ASP . 24.3 mm -139.04 105.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.674 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 47.18 -88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.534 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -102.49 -17.96 15.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 184' ' ' ARG . 33.4 mm -100.28 156.68 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 111.747 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.494 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 38.0 mtp180 -125.93 119.33 27.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.555 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 193' ' ' ALA . 2.7 mm? -76.08 -12.93 60.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.055 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.06 -76.56 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.809 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 185' ' ' LEU . 23.9 p -159.57 33.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.725 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 174.4 -171.05 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.679 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 185' ' ' LEU . 0.8 OUTLIER 75.68 39.72 0.32 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.892 ' HA ' HD21 ' A' ' 154' ' ' LEU . 7.8 ptm -53.87 -44.77 70.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.795 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -64.44 -37.23 86.8 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.61 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.851 ' O ' HD12 ' A' ' 196' ' ' ILE . 3.1 m-20 -62.32 -42.21 99.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.31 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -58.9 -49.76 76.57 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.812 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.883 HG22 HD13 ' A' ' 142' ' ' ILE . 7.9 t -55.94 -28.46 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.378 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -50.15 48.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 192' ' ' ASP . 3.1 mp -80.06 -24.39 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.839 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.83 HD22 ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -77.68 -23.9 49.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.579 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.464 ' OE1' HG12 ' A' ' 194' ' ' VAL . 36.5 mt-30 -85.98 -47.69 9.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.202 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.493 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 1.3 pp0? -68.29 -10.31 53.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.5 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.842 ' HB3' HG22 ' A' ' 204' ' ' VAL . 1.3 m -78.48 46.65 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.409 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 7.5 pt-20 -73.15 62.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.358 0.599 . . . . 0.0 111.085 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -170.07 -32.73 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.261 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.2 tt 178.95 108.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 200' ' ' CYS . 25.1 t -109.74 122.82 64.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 35.5 ttpt -109.54 114.35 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 206' ' ' LEU . 2.5 mm? -91.86 119.19 31.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.073 0.463 . . . . 0.0 111.461 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 125' ' ' THR . 3.9 tttm -92.06 93.63 8.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.984 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 209' ' ' ARG . 6.9 mt -94.9 165.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.803 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -105.75 128.52 53.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.786 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -132.33 114.52 14.49 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.234 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.954 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.828 0.347 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -119.08 115.59 24.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 p -51.67 116.02 1.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.14 168.49 10.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.583 HG23 ' HG3' ' A' ' 112' ' ' GLU . 1.2 p -125.42 134.75 52.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.512 HG21 ' CE2' ' A' ' 113' ' ' PHE . 7.2 t -121.58 177.23 5.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.35 162.08 16.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.751 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.21 148.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.99 109.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.036 HD21 HD11 ' A' ' 72' ' ' LEU . 3.0 mm? -107.54 118.37 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.47 162.31 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.157 0.503 . . . . 0.0 111.588 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 116.75 33.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.72 153.19 60.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.656 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.32 3.17 6.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.591 2.194 . . . . 0.0 112.624 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.09 -51.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.241 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -132.76 -4.3 3.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.35 -97.16 0.94 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.269 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 42.0 m-85 -119.01 115.57 24.6 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -83.1 11.11 56.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.94 -0.647 . . . . 0.0 114.116 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 72' ' ' LEU . 26.5 mt -92.82 146.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.387 0.593 . . . . 0.0 111.981 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -139.39 99.96 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.948 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 55' ' ' PRO . 1.4 pp -108.92 152.9 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.344 0.592 . . . . 0.0 112.267 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -99.53 170.1 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.329 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -133.21 31.95 2.81 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.872 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.22 68.38 0.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.122 0.486 . . . . 0.0 110.703 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.94 HG22 HD13 ' A' ' 56' ' ' LEU . 12.4 t -57.2 -75.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.928 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 p90 -68.54 -44.65 74.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.34 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 52.55 86.64 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.544 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 70.9 p -159.19 81.15 0.77 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' C ' ' HG1' ' A' ' 50' ' ' THR . 8.4 pt-20 44.2 60.19 2.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.857 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.677 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 177.81 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.339 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HG ' ' C ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 36.16 22.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.367 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -70.78 20.36 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -79.42 120.22 79.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.703 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.81 168.03 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.524 2.149 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.804 ' HB3' HD13 ' A' ' 41' ' ' LEU . 61.1 Cg_exo -51.4 142.45 37.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.709 2.273 . . . . 0.0 112.136 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.94 HD13 HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -144.98 108.34 4.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.65 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.783 ' CD1' HD13 ' A' ' 39' ' ' ILE . 22.6 mt -62.9 117.23 3.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.843 0.354 . . . . 0.0 110.74 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -97.68 -22.82 16.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 58.4 t80 -162.08 127.49 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.027 0.442 . . . . 0.0 111.692 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.761 HG21 ' HB2' ' A' ' 67' ' ' GLU . 2.1 mt -99.17 -173.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.715 ' H ' HG22 ' A' ' 60' ' ' ILE . 68.2 tt0 -116.08 144.01 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.385 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -71.84 100.32 2.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.067 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 8.0 t0 99.33 49.17 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.821 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.03 140.53 38.05 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 14.4 Cg_endo -56.7 -18.66 27.47 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.359 2.04 . . . . 0.0 111.686 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.803 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -67.53 -56.33 9.95 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.761 ' HB2' HG21 ' A' ' 60' ' ' ILE . 2.4 tp10 -77.75 -28.33 50.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.954 0.407 . . . . 0.0 109.986 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 4.0 mmt-85 -89.69 -1.78 58.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.652 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 22.7 t -48.87 -54.7 14.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.926 0.393 . . . . 0.0 110.76 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.01 -22.18 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.967 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.495 HG11 ' HA3' ' A' ' 162' ' ' GLY . 17.5 t -139.34 61.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 111.348 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 39' ' ' ILE . 11.1 mt -147.45 145.34 29.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.305 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -141.49 172.96 11.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.635 HD13 HG13 ' A' ' 60' ' ' ILE . 29.1 mm -68.26 71.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.39 88.3 0.98 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.39 101.56 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 111' ' ' ILE . 23.7 mmt-85 -59.81 139.25 57.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.412 HG23 ' HD2' ' A' ' 55' ' ' PRO . 3.4 m -122.36 148.91 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.002 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -30.21 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.962 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.43 137.88 23.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.228 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.92 HD12 HD12 ' A' ' 97' ' ' LEU . 11.8 mt -120.87 109.84 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.8 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 58.03 23.14 9.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 -28.27 12.28 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.324 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 85' ' ' PRO . 30.1 mt -70.02 137.21 87.2 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.497 0.189 . . . . 0.0 111.316 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 84' ' ' ILE . 41.7 Cg_endo -67.49 -168.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.37 2.046 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.4 p -151.75 -54.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.008 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.42 -13.29 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.48 45.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.797 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.26 -175.87 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 5.4 m -83.73 165.39 18.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.989 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HD2' HD13 ' A' ' 51' ' ' LEU . 5.1 p90 -73.88 -41.53 62.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.3 tt0 -54.64 -32.51 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.034 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -61.42 -49.39 77.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -54.36 -42.51 70.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.526 0.679 . . . . 0.0 110.067 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.6 OUTLIER -59.09 -36.41 75.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.869 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 7.5 mm-40 -61.94 -42.75 99.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.92 HD12 HD12 ' A' ' 81' ' ' ILE . 10.6 mt -55.43 -44.25 76.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.638 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.522 HD13 HD11 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -67.81 -47.42 69.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.216 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 8.9 mtm180 -50.44 -33.1 19.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.715 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.498 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 61.4 m-20 -120.22 38.08 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.106 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -95.19 21.54 7.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.242 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.2 p -125.5 16.58 8.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 111.823 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -62.86 -49.69 82.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.935 0.874 . . . . 0.0 110.413 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.64 8.77 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.555 ' O ' HG22 ' A' ' 30' ' ' THR . 15.4 m 62.6 26.91 15.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.808 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 6.3 mttt -154.95 157.94 38.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.674 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -155.45 114.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.248 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.48 141.23 29.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.832 0.348 . . . . 0.0 110.961 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 81' ' ' ILE . 1.1 mt -137.05 155.89 49.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -121.24 111.19 17.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.243 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.708 HG22 ' O ' ' A' ' 77' ' ' ARG . 41.1 pt -114.73 163.09 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 111.676 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.583 ' HG3' HG23 ' A' ' 24' ' ' THR . 25.3 tt0 -131.28 142.87 50.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.514 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 25' ' ' THR . 0.2 OUTLIER -161.11 174.71 13.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.407 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.32 155.1 21.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.07 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -106.75 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.426 . . . . 0.0 111.691 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 115' ' ' VAL . . . 173.05 117.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.706 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CG ' HG13 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -130.78 30.89 4.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.146 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.1 t 89.45 97.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.409 0.623 . . . . 0.0 111.293 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 170' ' ' THR . 9.3 p -139.91 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.13 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.748 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.5 pp -108.1 101.67 42.6 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.415 ' HA ' ' CE1' ' A' ' 126' ' ' PHE . 15.9 Cg_exo -68.69 156.84 64.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.865 2.376 . . . . 0.0 112.68 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.04 104.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.01 115.27 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.003 0.43 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 102.45 -47.39 1.14 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.546 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.21 107.14 11.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.925 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.477 ' HE2' HG21 ' A' ' 119' ' ' VAL . 1.7 t80 -113.0 120.12 40.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.748 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -113.23 121.48 44.59 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.796 HG11 HG21 ' A' ' 168' ' ' THR . 12.1 t -104.55 99.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.685 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.25 109.43 16.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.554 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.825 HD21 HG22 ' A' ' 168' ' ' THR . 26.1 mt -121.76 116.35 30.39 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.588 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.35 114.78 2.65 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.337 2.025 . . . . 0.0 111.612 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.474 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -87.72 158.96 18.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 111.259 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.601 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -101.77 -164.66 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.66 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.92 -36.53 62.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 m -177.49 70.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 133' ' ' LYS . 21.5 t -118.54 159.26 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.364 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.492 ' N ' HG12 ' A' ' 136' ' ' VAL . 16.0 pt-20 -65.95 133.56 51.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.939 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.769 HD22 HD11 ' A' ' 140' ' ' ILE . 1.9 mt -92.45 -49.4 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.706 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.02 16.11 39.66 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.769 HD11 HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -106.39 141.22 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.19 0.495 . . . . 0.0 111.278 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.8 m -122.3 114.16 20.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.593 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.995 HD12 HG22 ' A' ' 194' ' ' VAL . 5.6 mt -84.98 160.79 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.926 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 142' ' ' ILE . 1.4 m -150.02 156.15 41.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.191 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.2 t -110.12 90.9 10.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.29 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 155' ' ' VAL . 85.5 Cg_exo . . . . . 0 C--N 1.347 0.476 0 C-N-CA 122.618 2.212 . . . . 0.0 112.341 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.45 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.702 ' O ' HD22 ' A' ' 154' ' ' LEU . 72.3 Cg_endo -90.22 157.93 4.68 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.692 2.261 . . . . 0.0 112.973 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 153' ' ' PRO . 4.0 mm? -130.11 133.97 47.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.766 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.516 HG21 ' HG3' ' A' ' 145' ' ' PRO . 73.2 t -156.34 159.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.826 HD12 ' HA3' ' A' ' 174' ' ' GLY . 5.3 mt -105.24 139.54 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.729 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.7 m -127.32 -12.15 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.71 124.84 13.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.503 . . . . 0.0 111.903 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.561 HG22 ' HB2' ' A' ' 166' ' ' HIS . 16.4 mt -117.98 146.63 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.219 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.7 143.88 45.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 111.287 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 168.37 20.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.495 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 83.8 -46.47 3.66 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.741 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.544 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.6 OUTLIER -72.74 175.47 6.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 111.381 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.78 HG12 HD22 ' A' ' 130' ' ' LEU . 40.9 t -73.63 -22.34 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.104 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.755 ' HB2' ' CD1' ' A' ' 140' ' ' ILE . . . -53.67 -71.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.923 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.561 ' HB2' HG22 ' A' ' 159' ' ' ILE . 15.7 t-80 -67.05 -24.76 66.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.69 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -57.12 -34.49 68.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.825 HG22 HD21 ' A' ' 130' ' ' LEU . 36.3 p -39.2 -58.02 1.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.511 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.18 -23.12 35.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.556 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.479 ' CG2' HG11 ' A' ' 119' ' ' VAL . 3.0 t -127.4 35.7 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.477 HD23 HD13 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -104.34 78.88 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.84 78.41 2.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 173' ' ' LEU . 26.5 mt 39.93 28.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.826 ' HA3' HD12 ' A' ' 156' ' ' ILE . . . 70.74 -38.98 0.5 Allowed Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.909 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.86 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 176' ' ' LYS . 4.7 mmmm -136.15 106.29 6.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.347 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.686 HD22 HD11 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -92.6 132.35 36.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.398 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.3 pp -134.77 -16.53 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.04 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 207' ' ' LYS . . . -145.57 132.71 20.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.686 HD11 HD22 ' A' ' 177' ' ' LEU . 50.3 mt -135.65 118.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 16.1 m-20 57.82 43.56 21.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.212 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 3.1 t-20 83.49 -25.11 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.936 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 184' ' ' ARG . 44.8 mm -81.31 157.96 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.744 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.465 ' N ' HG22 ' A' ' 183' ' ' ILE . 19.6 mtm105 -129.59 126.45 38.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 112.175 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.819 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 1.4 mm? -79.89 -4.26 51.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.064 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.72 -32.37 0.38 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.0 t -115.58 -17.06 11.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.9 m -89.0 -169.76 2.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.012 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 m -109.12 -167.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.411 ' O ' HG23 ' A' ' 194' ' ' VAL . 14.5 ttp -74.32 -53.44 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -53.4 -29.79 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 110.732 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.817 ' O ' HD12 ' A' ' 196' ' ' ILE . 1.1 t0 -59.93 -52.3 66.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.228 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.819 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -58.25 -43.02 87.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.279 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.995 HG22 HD12 ' A' ' 142' ' ' ILE . 7.8 t -64.05 -31.81 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.705 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -48.2 77.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.848 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.2 mp -73.1 -24.69 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 180' ' ' ILE . 0.2 OUTLIER -64.02 -37.61 88.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.627 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.588 ' NE2' HG12 ' A' ' 194' ' ' VAL . 14.7 mt-30 -86.43 -52.93 5.29 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.597 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.543 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 1.5 pp0? -56.83 -18.17 11.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.946 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' ' 196' ' ' ILE . 16.5 m -88.4 42.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.119 0.485 . . . . 0.0 110.123 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.48 62.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -163.89 -32.2 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.9 tt 177.39 106.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.55 121.33 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.666 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -104.62 108.74 20.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 206' ' ' LEU . 6.0 mp -91.82 117.43 29.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.459 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 179' ' ' ALA . 16.0 tttt -107.21 108.64 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.221 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.487 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -111.6 175.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.426 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -114.29 120.04 39.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.015 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -125.87 108.85 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 121.122 0.487 . . . . 0.0 110.853 179.624 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.494 HG12 ' OD1' ' A' ' 114' ' ' ASP . 29.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.847 0.356 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.49 ' NE2' HG11 ' A' ' 115' ' ' VAL . 26.5 p-80 -127.31 111.54 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.703 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -50.15 131.42 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.346 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -124.6 149.7 46.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.732 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.5 p -110.21 135.93 50.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -134.96 -169.68 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -117.07 163.09 16.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.538 HG13 HG23 ' A' ' 71' ' ' VAL . 1.5 t -141.51 148.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.424 ' C ' HD12 ' A' ' 29' ' ' LEU . 41.3 t -127.73 115.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.276 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 109' ' ' LEU . 10.4 mp -112.25 120.99 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.233 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.681 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -101.92 163.14 12.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.32 0.581 . . . . 0.0 111.512 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -107.5 103.71 13.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.24 149.36 55.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.424 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.28 4.47 5.37 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.532 2.155 . . . . 0.0 112.736 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.0 -46.21 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.528 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.601 HG21 ' OE2' ' A' ' 61' ' ' GLU . 46.3 p -127.91 -11.77 5.37 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.32 -93.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.195 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 37.6 m-85 -130.65 119.97 23.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.058 0.456 . . . . 0.0 110.104 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -79.7 3.41 69.17 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.306 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 72' ' ' LEU . 34.5 mt -92.74 151.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.63 0.715 . . . . 0.0 112.024 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -151.53 99.56 2.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.104 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.793 HD11 HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.52 157.41 16.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.394 0.616 . . . . 0.0 112.575 -178.192 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' HG2' HD13 ' A' ' 56' ' ' LEU . 1.5 pm0 -95.4 164.64 12.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.778 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -76.83 -98.34 0.17 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.854 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.1 p -112.61 148.46 34.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.115 0.483 . . . . 0.0 111.806 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.6 -64.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.409 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.661 ' CE1' ' HA ' ' A' ' 51' ' ' LEU . 30.2 p90 -40.92 -40.93 1.5 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.661 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 39.79 92.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.891 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER 173.02 70.6 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.252 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 48' ' ' THR . 6.1 pt-20 52.44 162.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.107 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 47.1 m 69.51 -10.57 0.56 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.34 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.661 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 32.3 -103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 t 71.49 12.65 6.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.6 . . . . 0.0 110.096 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -68.51 107.42 1.97 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.581 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.26 149.31 11.85 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.763 2.309 . . . . 0.0 111.333 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.74 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 84.5 Cg_exo -45.3 110.01 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.455 HD13 ' HG2' ' A' ' 42' ' ' GLN . 2.0 mp -105.92 92.9 4.36 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.886 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.816 ' CD1' HD13 ' A' ' 39' ' ' ILE . 40.3 mt -58.21 110.65 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-O 120.787 0.327 . . . . 0.0 110.558 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -91.16 -2.37 57.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.351 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 79.4 t80 178.95 142.92 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.131 0.491 . . . . 0.0 111.608 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.777 HG21 ' HB2' ' A' ' 67' ' ' GLU . 1.8 mt -121.48 170.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.601 ' OE2' HG21 ' A' ' 35' ' ' THR . 56.8 tt0 -108.13 152.03 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.591 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.56 45.58 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.73 41.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.873 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.411 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 1.9 m -139.45 139.86 23.84 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.807 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 18.7 Cg_endo -58.78 -15.3 25.81 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.782 2.321 . . . . 0.0 112.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.673 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -64.18 -56.81 12.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.94 0.4 . . . . 0.0 110.303 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.777 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -78.96 -29.62 44.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.752 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.447 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -64.1 -24.76 67.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.001 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -47.29 -29.65 2.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 137' ' ' GLU . . . 78.16 27.15 58.56 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.789 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.538 HG23 HG13 ' A' ' 27' ' ' VAL . 3.5 m -152.15 36.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.967 0.413 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.011 HD13 HD11 ' A' ' 39' ' ' ILE . 12.0 mt -137.29 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.13 152.65 15.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.9 mt -62.74 103.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.77 29.83 3.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.507 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.557 ' OD2' HD23 ' A' ' 72' ' ' LEU . 15.8 m-20 -73.82 152.74 40.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -116.4 97.48 6.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 109' ' ' LEU . 23.8 t -73.14 151.88 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -30.95 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -157.32 143.7 17.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.189 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.813 ' HB ' HD13 ' A' ' 97' ' ' LEU . 19.2 mt -127.21 115.3 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.8 18.63 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.78 -27.96 10.52 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.604 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.643 HD12 ' CD2' ' A' ' 97' ' ' LEU . 35.8 mt -74.91 132.98 76.44 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-O 120.507 0.194 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.85 168.68 23.98 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.407 2.071 . . . . 0.0 112.286 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.8 p -131.26 -61.68 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -62.61 -18.2 61.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.38 44.51 1.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.611 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.52 -170.67 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.72 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -73.6 139.53 45.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 11.0 p90 -73.12 -32.7 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.5 mt-10 -54.0 -36.51 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.46 -45.38 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.74 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -54.74 -39.31 68.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.21 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -64.79 -35.23 80.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.143 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 mm-40 -67.28 -41.25 85.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.591 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.813 HD13 ' HB ' ' A' ' 81' ' ' ILE . 12.5 mt -63.98 -50.28 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.903 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 HD11 ' A' ' 41' ' ' LEU . 2.1 mt -69.76 -54.74 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -50.91 -29.42 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.187 0.518 . . . . 0.0 109.829 179.064 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -124.76 40.84 3.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.531 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.9 p -87.39 13.88 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.596 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 p -109.24 15.12 23.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 5.6 mt -74.24 -47.42 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.706 0.765 . . . . 0.0 110.776 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.67 9.52 41.37 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.657 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.723 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 56.32 21.38 5.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.681 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.1 OUTLIER -174.81 157.73 2.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.984 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.0 p -164.48 121.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.9 135.65 42.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.961 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -142.1 158.48 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.974 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -104.33 145.53 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.5 pt -131.25 165.98 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.561 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -135.8 124.18 23.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.473 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.414 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 3.6 p90 -141.87 174.1 10.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.376 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' OD1' HG12 ' A' ' 20' ' ' VAL . 1.2 m-20 -94.91 110.52 22.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.203 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 115' ' ' VAL . 8.9 p -61.8 104.88 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.39 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.68 137.23 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.641 ' HB3' HG22 ' A' ' 168' ' ' THR . 3.7 tp10 -130.43 6.43 4.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.5 m 83.44 74.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.964 0.411 . . . . 0.0 111.702 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.857 HG12 ' HA ' ' A' ' 128' ' ' VAL . 7.1 m -100.53 146.28 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.738 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.1 pp -117.39 104.12 50.38 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.853 0.359 . . . . 0.0 111.459 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 96.0 Cg_endo -85.9 152.71 9.88 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.9 2.4 . . . . 0.0 112.85 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.89 24.96 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.33 113.61 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.34 -45.06 2.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -125.66 102.56 7.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.676 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.489 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -111.6 115.93 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.665 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.15 126.06 41.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 110.714 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.857 ' HA ' HG12 ' A' ' 119' ' ' VAL . 13.0 t -99.89 87.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -81.26 105.49 12.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.883 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -129.95 124.94 21.84 Favored Pre-proline 0 C--N 1.333 -0.114 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -56.63 128.98 32.24 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.299 1.999 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 12.0 tptm -98.22 158.19 15.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.739 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.925 ' O ' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -132.82 78.2 1.78 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.268 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 69.2 m-70 45.21 29.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.196 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.402 ' HA ' ' CE ' ' A' ' 132' ' ' LYS . 0.9 OUTLIER 56.31 69.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 133' ' ' LYS . 76.9 t -87.05 -97.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.801 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -101.52 108.82 20.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.779 0.323 . . . . 0.0 111.055 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 163' ' ' SER . 17.6 mt -142.36 102.6 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -90.49 45.84 2.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.642 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 165' ' ' ALA . 47.4 mt -88.35 144.16 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.755 0.312 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.415 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 92.1 m -126.15 129.22 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.8 ' CD1' HG22 ' A' ' 194' ' ' VAL . 5.2 mt -107.52 164.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.836 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.521 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -153.88 149.66 27.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.816 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.01 130.9 23.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--N 1.347 0.455 0 C-N-CA 122.448 2.099 . . . . 0.0 112.196 179.945 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.441 ' HA ' ' HD2' ' A' ' 153' ' ' PRO . 6.4 p-10 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 152' ' ' ASP . 19.1 Cg_endo -58.35 151.71 58.84 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.113 . . . . 0.0 112.432 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.818 HD11 ' HA ' ' A' ' 190' ' ' MET . 2.9 mm? -73.16 164.48 26.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.685 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 175' ' ' ASP . 27.6 m -155.38 135.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 111.304 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.37 150.34 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.41 -14.3 5.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.883 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.547 ' HA ' HD21 ' A' ' 173' ' ' LEU . 1.2 t70 179.02 147.04 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -140.66 136.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.401 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -95.66 145.97 24.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.88 0.372 . . . . 0.0 111.122 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -177.92 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 71' ' ' VAL . . . 71.18 -60.45 1.06 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.551 ' HB3' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -56.91 138.76 53.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.0 111.231 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 168' ' ' THR . 3.5 m -51.69 -21.68 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.192 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -49.24 -71.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 61.8 t60 -71.57 -24.8 61.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.84 0.353 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.47 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.8 -34.82 63.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.869 HG21 HD22 ' A' ' 130' ' ' LEU . 24.3 p -52.32 -27.13 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 74.52 64.69 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.58 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.433 HG21 HG22 ' A' ' 128' ' ' VAL . 3.7 t -178.91 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.444 HD11 HD22 ' A' ' 206' ' ' LEU . 0.3 OUTLIER -60.85 86.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.04 -174.1 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 158' ' ' ASP . 4.3 mt -94.01 117.0 29.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.98 31.29 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.58 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.511 ' HB3' HG23 ' A' ' 208' ' ' ILE . 2.9 m-20 -111.32 159.7 17.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.495 0.188 . . . . 0.0 110.623 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -112.84 129.85 56.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.784 HD11 ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -102.44 146.7 27.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.007 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.612 HD21 ' NE ' ' A' ' 184' ' ' ARG . 7.8 tt -132.82 -42.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.117 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -127.77 156.29 42.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.765 HG22 ' OD1' ' A' ' 181' ' ' ASP . 17.8 mt -139.86 135.05 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.765 ' OD1' HG22 ' A' ' 180' ' ' ILE . 3.5 p-10 42.55 41.82 2.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.089 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 81.65 -19.56 0.41 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 183' ' ' ILE . 18.1 mm -90.76 132.2 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.612 ' NE ' HD21 ' A' ' 178' ' ' LEU . 2.3 mtp-105 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.612 HD21 HD12 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -93.46 -17.3 23.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 58.55 39.69 24.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.498 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.4 p 58.54 74.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.005 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 192' ' ' ASP . 31.0 p -136.6 114.34 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 192' ' ' ASP . 0.4 OUTLIER 57.89 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.818 ' HA ' HD11 ' A' ' 154' ' ' LEU . 16.2 tmm? -53.14 -33.73 53.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.58 -29.77 68.38 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.259 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 189' ' ' SER . 3.4 t0 -63.76 -48.91 75.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 185' ' ' LEU . . . -57.8 -43.45 85.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.142 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.8 HG22 ' CD1' ' A' ' 142' ' ' ILE . 14.3 t -59.95 -40.24 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.347 0.594 . . . . 0.0 109.681 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -49.56 75.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.937 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.725 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.9 OUTLIER -65.54 -24.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -68.8 -25.76 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -98.26 -49.19 4.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.968 -178.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -59.23 -17.24 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.58 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.833 ' SG ' HG22 ' A' ' 204' ' ' VAL . 25.6 p -80.27 48.47 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.532 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 1.1 pt-20 -74.46 61.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.85 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.404 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -175.09 -26.49 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.415 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 203' ' ' LEU . 2.4 tt 177.63 112.03 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.0 110.386 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.833 HG22 ' SG ' ' A' ' 200' ' ' CYS . 12.0 t -96.13 111.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.799 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -105.58 108.3 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.784 ' CD2' HD11 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -97.35 119.79 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 111.839 -178.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.686 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 6.9 tttt -91.93 93.19 8.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 175' ' ' ASP . 8.1 mm -84.62 163.86 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.286 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.458 ' N ' HG22 ' A' ' 208' ' ' ILE . 1.5 ttt85 -107.79 116.77 32.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.572 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -103.8 159.78 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.722 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.814 HG21 HG13 ' A' ' 115' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.764 0.316 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.513 ' N ' HG22 ' A' ' 20' ' ' VAL . 18.1 p-80 -99.65 130.28 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.82 171.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.144 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -161.91 166.29 26.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.474 HG23 ' CG ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -120.39 151.03 39.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.527 ' CG2' HD11 ' A' ' 111' ' ' ILE . 12.9 t -136.75 -173.26 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.98 163.07 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 109' ' ' LEU . 2.1 t -135.41 149.38 28.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.6 109.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.554 HD22 ' CB ' ' A' ' 66' ' ' ALA . 52.3 mt -112.21 118.11 34.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.249 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -105.33 162.83 13.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.227 0.537 . . . . 0.0 111.686 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.739 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 109.06 20.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.04 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -78.4 150.14 76.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.74 3.75 5.72 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.43 2.087 . . . . 0.0 112.73 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.76 -43.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.577 0.227 . . . . 0.0 111.596 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.85 -12.14 5.37 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 64.61 -82.89 0.06 OUTLIER Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.159 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 56.2 m-85 -139.09 113.58 9.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.78 26.28 15.18 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.685 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.983 HD11 ' HB2' ' A' ' 66' ' ' ALA . 3.9 mp -93.0 125.03 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -97.88 98.41 9.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.95 HD21 ' HA ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -96.87 156.54 16.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -132.55 169.28 16.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.92 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.72 56.52 0.51 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.708 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -158.21 79.35 0.83 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.489 ' CG2' HD22 ' A' ' 56' ' ' LEU . 1.9 t -98.46 -72.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.394 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 27.8 p90 -34.72 -45.92 0.27 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.43 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 49.25 72.62 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.4 t 167.93 94.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 48' ' ' THR . 7.7 pt-20 49.87 178.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.818 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t 44.08 -161.45 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.359 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.818 HD23 ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.08 -90.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.204 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 51.12 18.46 0.57 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.888 0.375 . . . . 0.0 111.469 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -66.71 111.43 6.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.306 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.725 ' O ' HD23 ' A' ' 56' ' ' LEU . 83.7 Cg_endo -78.34 146.15 21.89 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.343 2.029 . . . . 0.0 111.441 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.95 ' HA ' HD21 ' A' ' 41' ' ' LEU . 5.4 Cg_endo -48.71 104.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.381 2.054 . . . . 0.0 111.747 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -117.33 111.9 20.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.693 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 39' ' ' ILE . 19.3 mt -59.7 157.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 57' ' ' ILE . 26.4 t -128.44 -34.94 2.0 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.9 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -163.97 127.79 2.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.502 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.722 HG21 ' CB ' ' A' ' 67' ' ' GLU . 3.9 mt -96.17 168.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.53 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.71 141.55 46.38 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.52 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -69.13 63.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.456 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.6 p30 162.58 42.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.268 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -134.06 139.92 34.66 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.758 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.06 -12.69 31.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.755 2.303 . . . . 0.0 112.9 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.983 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -74.85 -56.3 4.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.927 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.722 ' CB ' HG21 ' A' ' 60' ' ' ILE . 2.7 tp10 -72.32 -29.9 64.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.742 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.524 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -76.91 -24.5 52.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.1 t -44.4 -52.4 7.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 111.045 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.876 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 118.15 16.73 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.113 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 70' ' ' GLY . 10.0 m -158.58 37.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 111.067 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 71' ' ' VAL . 3.3 mm? -122.32 140.21 52.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -145.18 167.57 22.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.4 mm -65.62 126.91 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.197 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.22 50.05 42.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.538 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.39 102.83 7.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.29 . . . . 0.0 110.931 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.661 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -53.08 156.35 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.757 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 79' ' ' MET . 21.2 t -147.94 157.5 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 111.403 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.46 ' N ' HG12 ' A' ' 78' ' ' VAL . 9.5 tpt -125.11 -41.36 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.74 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.62 137.01 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.838 HG12 HD23 ' A' ' 109' ' ' LEU . 9.5 mt -121.12 112.39 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.616 ' ND2' HG13 ' A' ' 107' ' ' VAL . 18.8 m-20 59.33 20.76 8.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.38 -21.95 37.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.636 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -75.49 119.8 78.7 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 120.439 0.161 . . . . 0.0 111.278 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 86' ' ' THR . 51.3 Cg_exo -55.63 -167.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.516 2.144 . . . . 0.0 112.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -170.75 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.084 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.45 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -117.93 47.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -175.39 179.88 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -76.08 164.23 26.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 31.3 p90 -73.43 -30.35 63.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -31.92 57.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.442 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -37.7 85.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.694 0.283 . . . . 0.0 110.746 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -71.98 -29.34 64.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.459 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.8 -38.11 54.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.849 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -74.44 -35.55 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.787 0.327 . . . . 0.0 111.143 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.2 pp -69.84 -45.08 68.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.569 ' CD1' HD13 ' A' ' 41' ' ' LEU . 9.1 mt -64.09 -58.94 5.17 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.271 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -29.56 11.9 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.505 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -112.92 34.08 4.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.863 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 69.2 p -102.81 17.46 23.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.3 p -102.05 11.81 37.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.505 HD11 ' O ' ' A' ' 100' ' ' ASP . 2.0 mt -68.9 -49.34 64.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.608 0.718 . . . . 0.0 110.998 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.23 6.91 38.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.746 ' O ' HG22 ' A' ' 30' ' ' THR . 27.8 p 55.76 24.68 7.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.256 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -172.72 145.94 1.57 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.711 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.616 HG13 ' ND2' ' A' ' 82' ' ' ASN . 1.0 OUTLIER -146.41 132.59 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.772 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.72 141.25 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.838 HD23 HG12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -137.27 140.14 41.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.352 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.53 115.77 31.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.973 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 77' ' ' ARG . 1.7 pp -117.55 163.75 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 112.144 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' CG ' HG23 ' A' ' 24' ' ' THR . 0.7 OUTLIER -130.59 131.73 45.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.237 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -142.62 174.62 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.117 0.484 . . . . 0.0 111.661 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.82 104.27 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.08 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 20' ' ' VAL . 13.5 p -61.57 145.65 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . 87.39 129.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.344 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.58 24.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.987 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.2 t 176.78 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.185 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.614 HG13 ' CZ ' ' A' ' 126' ' ' PHE . 41.3 t -142.27 118.09 5.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 1.07 HG23 ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -154.74 78.51 4.96 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -177.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.465 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 69.6 Cg_endo -96.38 -167.31 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.455 2.77 . . . . 0.0 112.722 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.93 35.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.32 113.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.523 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.77 -32.77 5.8 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.922 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.582 HG22 ' HD3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -136.66 105.2 5.78 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.823 0.344 . . . . 0.0 111.137 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.614 ' CZ ' HG13 ' A' ' 119' ' ' VAL . 1.4 t80 -100.58 118.45 36.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 1.07 ' HB2' HG23 ' A' ' 120' ' ' ILE . 6.8 m80 -97.8 142.18 29.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 111.294 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 170' ' ' THR . 6.1 t -139.92 90.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.528 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.497 HD21 HG21 ' A' ' 168' ' ' THR . 0.2 OUTLIER -112.47 129.89 23.92 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 136.84 51.16 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.089 1.86 . . . . 0.0 111.293 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.707 ' CG ' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -100.93 158.79 15.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.051 0.453 . . . . 0.0 110.939 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.49 ' CD ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.17 -164.86 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -100.47 -29.09 12.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -164.25 48.8 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 111.497 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.876 HG13 ' HA2' ' A' ' 70' ' ' GLY . 25.3 t -112.09 137.68 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.752 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.51 129.33 38.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.71 -41.17 17.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 100.71 -12.05 59.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.712 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.827 HG23 ' HB1' ' A' ' 165' ' ' ALA . 1.2 pt -89.25 148.92 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.896 0.379 . . . . 0.0 111.374 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 158' ' ' ASP . 86.1 m -126.28 126.18 43.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.331 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.896 ' CG2' HD12 ' A' ' 154' ' ' LEU . 7.4 mt -87.31 164.18 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.095 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.537 ' OG ' HG23 ' A' ' 155' ' ' VAL . 69.2 p -163.5 164.79 24.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.9 109.89 17.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.497 ' HD3' HG22 ' A' ' 155' ' ' VAL . 39.8 Cg_exo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.484 2.123 . . . . 0.0 112.37 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 46.1 t0 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.616 0.246 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -172.51 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.896 HD12 ' CG2' ' A' ' 142' ' ' ILE . 4.2 mm? -107.67 150.9 26.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.689 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 175' ' ' ASP . 18.4 m -150.67 145.72 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.409 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.509 HG12 HD23 ' A' ' 171' ' ' LEU . 1.1 mp -78.33 143.92 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.391 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -11.42 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 141' ' ' THR . 0.6 OUTLIER -162.74 142.31 9.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.142 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.745 HG23 HG22 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -136.21 149.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 173.22 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 167' ' ' ARG . 5.6 mtpp -115.19 145.64 42.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 71' ' ' VAL . . . 115.38 -24.25 10.64 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.322 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.425 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -108.28 159.55 16.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.926 0.394 . . . . 0.0 111.029 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.38 -21.85 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.877 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.827 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.94 -65.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.452 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 28.4 t60 -83.54 -29.92 27.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.484 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -56.83 -40.78 76.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.679 0.276 . . . . 0.0 111.448 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 165' ' ' ALA . 4.5 t -45.04 -29.17 0.81 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.548 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 68.6 1.57 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.514 HG21 HG22 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -178.93 -38.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.344 . . . . 0.0 110.744 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.721 HD21 ' CD2' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -71.86 72.28 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.47 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -100.03 152.76 19.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.458 HD23 HD11 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.48 129.34 36.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.966 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.17 5.33 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.732 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.588 ' O ' HG12 ' A' ' 155' ' ' VAL . 1.2 t0 -113.61 -174.32 2.44 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.883 -0.186 . . . . 0.0 110.693 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.463 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -132.46 106.81 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 0.0 111.381 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.528 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -74.07 157.39 36.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.716 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.2 tt -136.19 -49.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' A' ' 178' ' ' LEU . . . -129.76 157.46 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 111.708 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' A' ' 185' ' ' LEU . 32.6 mt -138.99 105.71 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.76 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 28.5 t70 62.01 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -130.45 -18.64 3.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 196' ' ' ILE . 25.5 mm -96.99 138.03 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.027 0.442 . . . . 0.0 111.629 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.482 ' HE ' HD21 ' A' ' 178' ' ' LEU . 16.2 mtt180 -105.87 124.64 49.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.625 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' A' ' 180' ' ' ILE . 2.0 mm? -72.69 -7.28 49.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.84 -31.12 1.12 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.9 p -124.88 -12.72 7.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.895 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 17.7 m -83.59 -170.64 3.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 m -116.95 -175.83 2.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.728 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -67.58 -57.32 6.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -54.69 -41.81 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.239 0.543 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.71 -45.06 77.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.251 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HB2' ' CD1' ' A' ' 185' ' ' LEU . . . -57.36 -42.05 81.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.69 HG22 HD12 ' A' ' 142' ' ' ILE . 17.0 t -59.1 -36.73 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 29.3 mm-40 -60.83 -50.36 73.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.896 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -68.38 -25.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -64.87 -32.16 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.48 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.54 ' NE2' HG12 ' A' ' 194' ' ' VAL . 10.9 mt-30 -95.44 -41.46 8.97 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.591 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -85.08 13.99 5.54 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.828 ' CB ' HG22 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -65.41 32.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.2 mm-40 34.63 70.26 0.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.496 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 0.7 OUTLIER 42.83 34.61 0.61 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 178.135 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.445 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -171.55 103.87 0.2 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.156 0.503 . . . . 0.0 111.626 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.828 HG22 ' CB ' ' A' ' 200' ' ' CYS . 47.9 t -107.84 108.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.374 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 33.0 ttmt -94.02 107.5 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.721 ' CD2' HD21 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -88.84 107.57 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.475 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.582 ' HD3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -101.44 92.65 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.626 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.505 HG21 ' CG ' ' A' ' 175' ' ' ASP . 2.4 mp -87.31 166.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -111.76 123.39 50.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -115.55 95.09 4.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.323 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 114' ' ' ASP . 17.3 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.776 0.322 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.66 40.76 1.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.134 0.493 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 51.62 174.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.537 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.15 142.5 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.21 143.88 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.009 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.426 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 5.6 t -141.2 159.11 42.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.84 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.71 159.17 15.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.791 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 109' ' ' LEU . 1.3 t -135.77 147.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.442 HG13 ' CD ' ' A' ' 106' ' ' LYS . 61.1 t -125.97 109.51 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.681 HD23 HD13 ' A' ' 109' ' ' LEU . 4.4 mm? -110.01 118.83 37.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.69 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -109.29 162.4 14.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -97.49 115.87 28.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.841 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -74.83 157.74 85.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.635 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.98 6.12 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.503 2.136 . . . . 0.0 112.594 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.14 -49.31 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.513 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.3 p -138.74 -1.58 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 76.04 -99.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.269 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.826 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 2.8 m-85 -116.16 119.63 36.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -92.49 26.91 11.79 Favored Glycine 0 CA--C 1.517 0.17 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.352 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 66' ' ' ALA . 7.0 mt -92.63 135.94 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 121.092 0.473 . . . . 0.0 111.56 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.96 99.51 5.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.067 HD21 HD13 ' A' ' 98' ' ' LEU . 1.9 pp -114.69 156.82 24.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 112.279 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -102.65 169.59 8.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.259 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.401 ' O ' ' CG ' ' A' ' 91' ' ' PHE . . . -137.18 46.28 1.02 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.88 65.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.175 0.512 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.9 HG22 HD13 ' A' ' 56' ' ' LEU . 7.4 t -61.8 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.189 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 47.3 p90 -67.41 -49.76 62.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.026 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.483 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.8 79.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.401 0.62 . . . . 0.0 111.296 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.3 t 170.37 116.8 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.665 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 50' ' ' THR . 1.6 tp10 60.84 84.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 49' ' ' GLU . 3.2 p 89.4 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 pp -166.43 26.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 111.895 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 20.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.666 ' OG ' HG23 ' A' ' 45' ' ' VAL . 1.2 t -58.81 109.3 1.76 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.583 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.405 ' O ' HD23 ' A' ' 56' ' ' LEU . 39.4 Cg_endo -66.8 162.54 37.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.377 2.052 . . . . 0.0 112.319 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.647 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 76.1 Cg_exo -49.25 129.27 21.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.524 2.149 . . . . 0.0 112.154 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.9 HD13 HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -133.38 99.65 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.573 HD13 HG23 ' A' ' 39' ' ' ILE . 21.5 mt -60.89 129.5 23.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.76 0.314 . . . . 0.0 110.687 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.4 p -113.66 -2.51 13.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 55.4 t80 177.72 124.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.875 0.369 . . . . 0.0 111.435 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.699 HG22 ' H ' ' A' ' 61' ' ' GLU . 1.9 mt -96.63 -178.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.699 ' H ' HG22 ' A' ' 60' ' ' ILE . 25.3 tt0 -121.55 131.14 53.96 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.347 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.482 ' HA ' ' NH1' ' A' ' 68' ' ' ARG . . . -65.5 70.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.457 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.2 m-20 164.62 44.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -145.04 -179.43 0.94 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 91.0 Cg_endo -97.87 -2.7 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.067 2.511 . . . . 0.0 112.744 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.768 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -76.84 -57.22 3.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.717 0.294 . . . . 0.0 111.648 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -77.37 -29.11 53.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 0.0 110.131 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.592 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -76.53 -30.78 57.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 -67.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.727 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -14.69 5.35 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.954 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 163' ' ' SER . 14.7 m -125.65 45.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.418 . . . . 0.0 110.96 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 66' ' ' ALA . 10.3 mt -135.6 168.95 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -164.16 143.19 7.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.36 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.094 0.473 . . . . 0.0 111.407 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.69 42.32 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.283 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD2' HD13 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -74.83 113.28 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.97 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.77 79.17 2.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.74 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.787 ' HA ' HG22 ' A' ' 111' ' ' ILE . 26.9 m -69.96 132.32 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.75 -30.71 10.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -144.89 131.97 20.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.489 HG21 HD11 ' A' ' 97' ' ' LEU . 17.7 mt -124.89 117.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.651 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 46.56 27.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.439 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.39 -30.27 9.07 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.593 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -68.58 117.79 53.81 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 -167.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.364 2.043 . . . . 0.0 112.187 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.4 p -147.7 -45.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.071 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.69 -9.97 58.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.561 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.3 47.46 2.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.3 168.69 2.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -74.97 157.38 35.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 9.5 p90 -73.3 -31.0 63.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.95 -41.14 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 -33.75 74.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.343 . . . . 0.0 110.978 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.647 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -72.93 -31.8 64.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 110.6 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.31 -36.11 58.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.821 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER -73.41 -35.73 65.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.567 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.1 pp -69.96 -41.92 73.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.239 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.067 HD13 HD21 ' A' ' 41' ' ' LEU . 80.7 mt -65.84 -58.78 4.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.416 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.07 -29.7 13.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -109.44 30.7 6.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.962 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -104.5 45.64 0.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.2 p -133.36 13.02 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.88 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.525 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -69.79 -48.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.52 0.676 . . . . 0.0 111.137 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.29 7.11 40.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.817 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.852 ' O ' HG22 ' A' ' 30' ' ' THR . 74.3 m 56.69 25.2 9.81 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.926 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -166.28 152.77 9.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.648 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 108' ' ' THR . 4.8 t -152.84 158.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -125.08 141.25 52.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.696 HD23 HG11 ' A' ' 78' ' ' VAL . 2.0 mp -130.26 156.04 45.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 3.0 mt-10 -130.92 105.85 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.787 HG22 ' HA ' ' A' ' 78' ' ' VAL . 25.5 pt -110.47 160.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.098 0.475 . . . . 0.0 111.806 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -133.02 140.4 47.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.26 174.31 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB3' HG11 ' A' ' 20' ' ' VAL . 68.4 m-20 -97.95 118.34 34.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.68 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 167' ' ' ARG . 2.9 m -61.96 118.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 179.36 117.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 168' ' ' THR . 2.7 tp10 -118.1 13.25 13.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.527 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.35 72.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.163 0.506 . . . . 0.0 111.401 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.905 HG11 ' OG1' ' A' ' 170' ' ' THR . 25.1 m -97.8 147.83 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.613 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.682 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.9 pp -121.45 98.72 46.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.92 0.39 . . . . 0.0 111.304 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HB3' ' CE1' ' A' ' 126' ' ' PHE . 89.2 Cg_endo -90.31 169.12 4.16 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.084 2.522 . . . . 0.0 112.825 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.8 m -166.61 29.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.8 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.82 113.31 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.715 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.78 -39.25 2.96 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.561 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.428 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.22 102.42 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.493 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 170' ' ' THR . 0.7 OUTLIER -109.15 117.8 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.485 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.575 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -99.96 143.01 30.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 HG21 ' A' ' 168' ' ' THR . 14.6 t -118.66 90.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 205' ' ' LYS . 0.3 OUTLIER -80.81 105.96 12.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.445 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.671 HD23 HG12 ' A' ' 128' ' ' VAL . 3.2 pp -136.98 133.45 18.65 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 164' ' ' VAL . 35.3 Cg_exo -56.89 129.08 32.64 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.231 1.954 . . . . 0.0 111.516 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -106.98 139.4 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.075 0.464 . . . . 0.0 110.874 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -76.75 -168.28 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.767 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 4.0 t60 -90.04 -40.0 12.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.235 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.62 45.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.773 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 137' ' ' GLU . 7.3 t -100.46 161.25 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.472 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.3 tt0 -51.75 145.91 8.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.274 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.606 ' HB3' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -143.74 -58.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.487 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 92.02 56.94 1.54 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.679 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 165' ' ' ALA . 6.0 mt -125.09 136.7 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.457 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 73.4 m -125.28 142.54 51.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.051 HD12 HG22 ' A' ' 194' ' ' VAL . 10.5 mt -111.49 164.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.96 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 142' ' ' ILE . 29.6 m -165.35 152.52 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.01 145.94 35.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.1 t0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.678 0.275 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 159.36 5.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.665 2.243 . . . . 0.0 112.576 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 190' ' ' MET . 2.2 mm? -101.7 155.03 18.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.302 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 156' ' ' ILE . 14.1 t -153.71 160.55 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.872 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.525 HD11 HD12 ' A' ' 171' ' ' LEU . 8.5 mt -104.02 148.02 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.817 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 -0.36 2.93 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.5 t0 -168.98 134.56 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 111.421 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.514 HG22 ' HB2' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -136.69 149.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.822 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.583 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -122.79 149.12 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.162 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.523 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 2.3 mptt -79.09 165.74 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.725 0.298 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.81 -59.34 1.78 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.595 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.514 ' OG ' HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -61.31 160.85 9.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.922 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 131' ' ' PRO . 28.9 m -72.62 -23.99 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 168' ' ' THR . . . -49.64 -58.51 5.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.514 ' HB2' HG22 ' A' ' 159' ' ' ILE . 15.8 t60 -83.87 -31.31 25.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.646 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -54.99 -29.84 58.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.733 0.302 . . . . 0.0 111.153 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.823 HG21 HG11 ' A' ' 128' ' ' VAL . 9.8 t -54.75 -20.1 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.84 24.74 76.22 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.905 ' OG1' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -133.27 -39.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.896 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 165' ' ' ALA . 12.0 tp -64.96 93.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -110.23 155.26 22.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.692 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.5 OUTLIER -87.73 50.97 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.993 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.09 30.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.48 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -113.88 177.23 4.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.647 0.261 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -117.65 98.34 6.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 111.18 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.647 HD11 ' CD2' ' A' ' 206' ' ' LEU . 3.9 mt -76.97 134.89 38.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.6 2.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.857 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.829 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -165.29 154.68 12.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.876 0.369 . . . . 0.0 111.484 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 179' ' ' ALA . 9.1 mm -139.38 117.79 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.799 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 46.81 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.407 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' ILE . 75.7 m-20 -112.34 -16.5 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 184' ' ' ARG . 39.7 mm -96.67 157.68 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.432 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.485 ' N ' HG22 ' A' ' 183' ' ' ILE . 8.8 mtt180 -127.43 126.56 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.047 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.2 mm? -78.47 -4.92 50.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.8 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -28.92 1.97 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.1 p -135.45 40.05 2.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 15.1 m -140.66 -171.42 3.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.23 173.23 6.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.611 ' HA ' HD21 ' A' ' 154' ' ' LEU . 17.6 ttp -59.0 -53.09 62.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 4.0 mt-10 -51.7 -41.06 61.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.613 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 9.1 t70 -53.26 -51.96 60.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.153 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -52.66 -41.36 63.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.251 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 1.051 HG22 HD12 ' A' ' 142' ' ' ILE . 21.6 t -59.64 -33.45 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.022 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.435 ' HG3' ' HA ' ' A' ' 192' ' ' ASP . 17.1 mm-40 -63.32 -50.27 70.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.0 OUTLIER -70.84 -24.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.822 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.876 HD22 HD11 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -64.76 -35.44 81.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.762 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.71 ' NE2' HG12 ' A' ' 194' ' ' VAL . 12.7 mt-30 -94.76 -44.73 7.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.32 -22.58 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.888 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.707 ' CB ' HG22 ' A' ' 204' ' ' VAL . 19.3 m -89.56 41.99 1.07 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.081 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 12.2 pt-20 -69.06 61.6 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.535 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -168.98 -28.98 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.944 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.5 tt 172.67 113.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.856 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.707 HG22 ' CB ' ' A' ' 200' ' ' CYS . 97.4 t -111.88 137.91 42.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 5.1 ttmt -111.76 108.14 17.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.955 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.647 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -82.76 113.12 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.436 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.633 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 6.4 tttt -100.02 103.43 14.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.521 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -110.34 174.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 23.0 mtp85 -102.73 125.99 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.02 94.55 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.451 -0.386 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 -179.931 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.816 HG12 ' HB2' ' A' ' 116' ' ' ALA . 3.4 m . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.806 0.336 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.508 ' O ' HG23 ' A' ' 115' ' ' VAL . 54.2 t-80 -75.55 114.97 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -55.79 149.95 13.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -155.6 168.71 26.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.91 160.26 16.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.73 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.757 HG23 ' HB3' ' A' ' 161' ' ' LYS . 89.2 m -158.45 155.45 28.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.7 160.2 14.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.68 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.99 150.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.586 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.54 109.35 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.971 0.415 . . . . 0.0 111.246 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.657 HD21 HD11 ' A' ' 72' ' ' LEU . 3.4 mm? -107.26 118.23 36.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.835 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.7 162.57 13.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.175 0.512 . . . . 0.0 111.942 -178.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.28 151.52 20.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.162 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 35.5 m-20 -134.16 150.88 75.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.386 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.11 20.73 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.561 2.174 . . . . 0.0 112.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.7 t -133.79 -54.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.248 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 t -159.81 37.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.692 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA3' ' H ' ' A' ' 32' ' ' ASP . . . -43.43 143.31 1.84 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.437 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 11.0 m-85 61.02 71.83 0.55 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -98.66 26.48 23.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.439 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.979 HD13 HD13 ' A' ' 72' ' ' LEU . 26.9 pt -115.23 143.41 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.06 140.35 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.478 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.863 HD13 HD13 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -112.31 121.56 45.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.966 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -84.69 170.11 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.95 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.06 61.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.54 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.99 110.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 56' ' ' LEU . 20.7 t -129.67 -73.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.376 0.608 . . . . 0.0 110.256 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.83 ' O ' HG22 ' A' ' 48' ' ' THR . 27.0 p90 -43.42 -45.07 6.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.35 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.489 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.66 74.49 0.1 Allowed 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.8 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 166.86 108.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.788 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.52 138.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.549 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER 46.1 -164.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.815 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.673 HD13 HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -138.93 -85.39 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.823 0.344 . . . . 0.0 111.717 179.45 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t 57.41 13.98 2.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 110.974 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -54.13 106.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.329 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 60.6 Cg_endo -72.53 117.9 5.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.279 1.986 . . . . 0.0 111.499 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HG3' HG21 ' A' ' 86' ' ' THR . 9.4 Cg_exo -36.1 118.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.21 2.607 . . . . 0.0 113.231 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 176.37 5.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.198 179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 39' ' ' ILE . 21.3 mm -112.31 138.41 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.49 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 p -119.14 -8.5 10.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 80.5 t80 -172.47 157.74 4.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.362 0.601 . . . . 0.0 111.885 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.788 HG21 ' HB2' ' A' ' 67' ' ' GLU . 8.7 mm -135.05 152.66 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.413 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.8 tm-20 -104.2 156.66 17.71 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.56 47.59 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.115 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.87 65.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.617 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -156.02 -172.25 0.31 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 54.5 Cg_endo -96.77 -10.24 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.817 2.344 . . . . 0.0 113.377 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -77.68 -58.45 3.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.788 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -71.47 -29.1 64.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.415 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.52 -30.59 5.38 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.961 0.41 . . . . 0.0 110.649 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.425 ' HA3' ' CG1' ' A' ' 136' ' ' VAL . . . 78.8 36.67 28.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.855 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 162' ' ' GLY . 16.6 t -154.26 31.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.736 0.303 . . . . 0.0 111.426 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.979 HD13 HD13 ' A' ' 39' ' ' ILE . 9.5 mt -133.11 147.55 52.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.894 0.378 . . . . 0.0 111.054 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.06 148.81 33.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.61 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.37 68.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.785 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.09 45.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -79.71 -179.79 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.668 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -147.03 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 109' ' ' LEU . 86.4 t -65.35 133.73 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.09 -28.33 10.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.706 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.25 120.29 9.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.924 HD13 HD11 ' A' ' 97' ' ' LEU . 2.8 mt -105.34 104.93 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 57.01 21.16 6.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.26 8.16 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -71.6 111.58 10.86 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.83 168.53 24.36 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.48 2.12 . . . . 0.0 112.005 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.456 HG21 ' HG3' ' A' ' 55' ' ' PRO . 17.5 p -143.72 10.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.59 -17.1 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.56 46.36 1.9 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.32 171.73 19.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.779 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.673 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -78.43 151.71 32.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.778 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -71.21 -30.0 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 pt-20 -54.44 -39.78 67.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.152 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -36.48 79.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.691 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -67.56 -33.68 75.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.42 0.629 . . . . 0.0 110.128 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.97 81.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.838 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 4.0 mm100 -70.24 -56.2 7.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.839 0.352 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.924 HD11 HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -52.28 -41.84 63.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.332 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.863 HD13 HD13 ' A' ' 41' ' ' LEU . 2.6 mt -68.65 -56.13 9.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.262 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -50.84 -28.74 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.164 0.507 . . . . 0.0 109.715 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.643 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -120.67 38.96 3.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.544 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.837 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -103.84 36.16 2.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.167 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 1.4 m -121.57 15.88 11.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.643 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.7 mp -71.59 -47.48 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.564 0.697 . . . . 0.0 111.216 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.95 3.67 44.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 m 63.04 18.46 10.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.666 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER -173.22 150.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.095 0.474 . . . . 0.0 111.956 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' A' ' 101' ' ' SER . 45.2 t -145.06 138.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.396 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.594 ' C ' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -113.12 125.48 54.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 110.486 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.624 HD22 HG23 ' A' ' 81' ' ' ILE . 1.3 mt -119.21 164.95 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.89 105.94 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.42 HD13 ' OD2' ' A' ' 76' ' ' ASP . 24.3 pt -104.7 150.24 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.735 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -124.11 115.0 20.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 11.8 p90 -135.71 174.17 10.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.43 . . . . 0.0 111.406 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.24 155.01 18.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.636 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 21' ' ' HIS . 20.9 t -91.77 104.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 0.0 111.471 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.816 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -167.95 137.25 2.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.656 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HG2' ' CB ' ' A' ' 167' ' ' ARG . 6.9 mm-40 -146.63 25.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.635 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.76 65.59 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.249 0.547 . . . . 0.0 111.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.506 HG12 HG12 ' A' ' 128' ' ' VAL . 6.1 m -97.84 147.57 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.215 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.645 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.7 pp -130.04 92.93 35.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 0.0 111.024 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 68.3 Cg_endo -96.37 -178.52 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.349 2.699 . . . . 0.0 112.673 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.33 35.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.415 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.51 119.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.826 0.346 . . . . 0.0 110.776 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.42 -51.73 3.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.434 ' CG2' ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -115.32 105.02 12.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.854 0.359 . . . . 0.0 110.551 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.869 ' CE1' HG21 ' A' ' 170' ' ' THR . 0.9 OUTLIER -113.34 120.94 42.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.783 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.568 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.6 m80 -109.82 152.71 25.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 206' ' ' LEU . 17.8 m -131.07 98.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.284 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.3 105.43 17.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.779 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.472 HD13 HG23 ' A' ' 164' ' ' VAL . 0.6 OUTLIER -128.04 133.11 24.77 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.977 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.76 136.03 37.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.351 2.034 . . . . 0.0 112.075 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.495 ' NZ ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -118.78 158.13 26.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.683 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -115.62 -166.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.796 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -58.5 -57.2 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -164.48 48.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 133' ' ' LYS . 97.2 t -75.94 159.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.504 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.1 tt0 -47.54 111.9 0.48 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.321 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.845 HD22 ' CD1' ' A' ' 140' ' ' ILE . 4.4 mt -116.11 112.5 21.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.565 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.72 45.85 2.92 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.691 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.845 ' CD1' HD22 ' A' ' 138' ' ' LEU . 20.7 mt -111.01 130.26 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 120.65 0.262 . . . . 0.0 111.064 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 157' ' ' SER . 7.4 m -126.73 133.08 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.758 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.73 ' CD1' HD13 ' A' ' 197' ' ' LEU . 3.2 mt -105.4 163.44 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.489 ' N ' HG22 ' A' ' 142' ' ' ILE . 5.3 p -166.43 123.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 p -84.0 117.15 67.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.731 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo . . . . . 0 C--N 1.347 0.452 0 C-N-CA 122.311 2.008 . . . . 0.0 112.298 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.6 t0 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.823 0.344 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.65 -161.71 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.876 HD22 ' HA ' ' A' ' 190' ' ' MET . 0.3 OUTLIER -134.39 173.74 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.869 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 175' ' ' ASP . 33.8 m -156.38 -176.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.093 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.593 ' N ' HD13 ' A' ' 156' ' ' ILE . 1.4 mm -76.14 154.28 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.694 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.564 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.3 OUTLIER -135.59 -9.18 2.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 173.21 147.44 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.392 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.713 HG21 ' CG ' ' A' ' 166' ' ' HIS . 3.2 mt -130.69 150.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.61 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HE2' ' HA3' ' A' ' 162' ' ' GLY . 0.1 OUTLIER -121.77 134.7 54.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 110.438 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.757 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.6 OUTLIER -80.11 86.33 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 0.0 111.009 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 71' ' ' VAL . . . -177.24 -32.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.241 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.4 169.59 8.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.472 HG23 HD13 ' A' ' 130' ' ' LEU . 8.3 m -58.92 -21.53 19.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.067 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.932 ' O ' HG22 ' A' ' 168' ' ' THR . . . -43.57 -71.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.713 ' CG ' HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.63 -24.93 67.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 0.0 111.266 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.436 HH22 ' N ' ' A' ' 162' ' ' GLY . 19.5 mmt-85 -58.81 -38.23 78.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.022 HG21 HD12 ' A' ' 171' ' ' LEU . 14.9 t -57.68 -30.46 65.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.43 ' HA2' HG11 ' A' ' 115' ' ' VAL . . . 83.49 -72.51 2.82 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.616 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.869 HG21 ' CE1' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -42.46 -29.56 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 1.022 HD12 HG21 ' A' ' 168' ' ' THR . 0.2 OUTLIER -60.24 86.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.38 158.75 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.6 mt -68.31 72.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.834 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.06 40.05 0.02 OUTLIER Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.634 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.538 ' O ' HG12 ' A' ' 155' ' ' VAL . 54.2 m-20 -121.48 118.02 28.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' A' ' 155' ' ' VAL . 29.9 mmtt -75.85 108.36 8.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 206' ' ' LEU . 1.6 mt -75.94 152.18 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.69 HD22 ' NZ ' ' A' ' 207' ' ' LYS . 7.3 tt -139.96 -57.11 0.56 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.744 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -109.97 155.95 21.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.346 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 179' ' ' ALA . 23.2 mm -139.61 110.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.267 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 38.9 t70 53.73 51.81 14.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.394 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.4 t-20 82.82 -30.5 0.09 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 37.3 mm -73.5 151.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.35 119.07 22.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.24 0.543 . . . . 0.0 112.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -82.13 -12.34 58.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.903 178.389 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t70 51.18 52.6 14.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.63 74.51 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.657 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.91 -169.69 2.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.061 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.0 m -58.04 154.88 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.876 ' HA ' HD22 ' A' ' 154' ' ' LEU . 36.2 ttp -74.17 -35.23 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.6 mt-10 -51.8 -48.52 63.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.171 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 0.8 OUTLIER -49.54 -52.13 31.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.646 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 154' ' ' LEU . . . -55.51 -37.83 68.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.314 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.814 HG12 ' NE2' ' A' ' 198' ' ' GLN . 21.6 t -62.78 -30.86 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.077 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 192' ' ' ASP . 13.3 mm-40 -66.54 -50.34 63.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.089 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.478 HG22 ' SG ' ' A' ' 200' ' ' CYS . 1.1 mp -73.72 -24.69 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.124 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.73 HD13 ' CD1' ' A' ' 142' ' ' ILE . 0.1 OUTLIER -63.15 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.474 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.814 ' NE2' HG12 ' A' ' 194' ' ' VAL . 21.9 mt-30 -89.47 -40.09 12.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.57 -14.7 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.804 ' HB3' HG22 ' A' ' 204' ' ' VAL . 2.2 m -85.02 41.78 0.89 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.72 62.59 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.222 0.535 . . . . 0.0 111.076 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -174.48 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.312 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.7 tt 177.56 109.32 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.124 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.804 HG22 ' HB3' ' A' ' 200' ' ' CYS . 24.0 t -103.12 116.03 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.891 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 4.4 ttmm -108.77 108.37 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.624 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.579 HD12 HG21 ' A' ' 128' ' ' VAL . 3.4 mt -97.12 117.16 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.415 . . . . 0.0 111.376 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.69 ' NZ ' HD22 ' A' ' 178' ' ' LEU . 26.2 tttt -97.8 101.07 12.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -109.43 179.38 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 2.4 mtp180 -109.41 135.25 50.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.012 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 211' ' ' ASP . 0.0 OUTLIER -132.37 159.87 37.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' A' ' 116' ' ' ALA . 35.1 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.883 0.373 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -133.94 116.62 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.834 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -50.58 147.98 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.445 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.4 173.0 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 152.71 39.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.56 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 9.0 t -149.06 170.37 18.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -101.59 162.16 13.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 108' ' ' THR . 0.7 OUTLIER -142.22 145.85 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.58 109.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.791 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.055 HD11 HD11 ' A' ' 72' ' ' LEU . 1.2 mm? -108.18 141.05 40.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.317 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -123.43 160.95 25.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.355 0.597 . . . . 0.0 112.089 -178.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.627 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -101.67 149.24 24.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.34 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -133.42 148.84 70.49 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.75 8.6 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 112.681 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.07 -48.7 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.427 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 t -136.36 -3.27 2.17 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 32' ' ' ASP . . . 89.2 -94.61 2.01 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.308 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 10.4 m-85 -121.68 -70.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.773 -0.251 . . . . 0.0 111.042 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 133.35 0.44 4.13 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 119.779 -1.201 . . . . 0.0 114.374 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.963 HG23 HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -128.05 130.51 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.621 0.71 . . . . 0.0 112.03 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.08 128.77 56.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 98' ' ' LEU . 2.4 pp -121.0 157.54 29.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.631 . . . . 0.0 112.559 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.464 ' O ' HD23 ' A' ' 56' ' ' LEU . 3.3 pt20 -111.25 170.04 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.199 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.57 16.23 14.36 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.385 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -97.51 85.38 3.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.116 0.484 . . . . 0.0 110.639 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.986 HG22 HD22 ' A' ' 56' ' ' LEU . 3.0 t -99.82 -75.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 46.2 p90 -57.19 -46.3 82.96 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.566 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 50.42 74.17 0.23 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.434 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER 163.66 75.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 64.57 163.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.87 -169.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.677 HD13 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -137.42 -105.06 0.19 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.107 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.461 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER 50.31 21.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.533 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.64 ' HB2' HG23 ' A' ' 45' ' ' VAL . 1.4 p -76.04 110.18 10.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.66 ' HD2' HG21 ' A' ' 45' ' ' VAL . 65.0 Cg_endo -72.92 140.48 31.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.292 1.995 . . . . 0.0 112.052 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.627 ' HB3' HD13 ' A' ' 41' ' ' LEU . 72.0 Cg_exo -51.06 125.81 17.22 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.482 2.121 . . . . 0.0 112.221 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.986 HD22 HG22 ' A' ' 45' ' ' VAL . 1.3 pt? -131.06 104.16 6.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.929 0.395 . . . . 0.0 111.515 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.743 HD13 ' HB ' ' A' ' 39' ' ' ILE . 37.6 mt -59.63 153.69 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.659 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.423 ' N ' HG22 ' A' ' 57' ' ' ILE . 35.9 t -145.42 22.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' H ' HG22 ' A' ' 57' ' ' ILE . 75.7 t80 -177.42 146.33 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.256 0.55 . . . . 0.0 112.088 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.963 HD13 HG23 ' A' ' 39' ' ' ILE . 7.5 mm -115.21 162.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.084 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -113.46 121.75 45.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.713 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -58.77 105.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.868 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.0 m-20 89.17 51.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.475 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -130.12 145.88 59.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.795 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 34.5 Cg_exo -57.29 -17.0 24.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.219 1.946 . . . . 0.0 112.044 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.792 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -67.87 -57.22 6.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 4.7 tp10 -78.62 -28.49 45.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 3.0 mmt-85 -87.66 -3.66 58.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.57 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -58.69 -53.32 59.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.504 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.16 -3.0 5.91 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.058 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 71' ' ' VAL . 43.8 t -155.03 61.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 117.001 0.401 . . . . 0.0 111.671 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.055 HD11 HD11 ' A' ' 29' ' ' LEU . 8.2 mt -143.06 154.15 43.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.0 111.163 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -161.85 146.25 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 59' ' ' TYR . 23.2 mt -61.0 108.72 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.7 41.8 0.99 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.92 126.21 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -101.84 86.64 2.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 19.1 m -83.84 134.84 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -108.65 -26.7 10.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.07 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.19 138.95 52.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.815 HG23 ' CD1' ' A' ' 109' ' ' LEU . 12.8 mt -133.77 109.29 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.991 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.0 m120 59.53 24.05 12.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.979 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.49 -27.07 19.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.7 mt -73.06 136.88 79.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.22 -168.27 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.546 2.164 . . . . 0.0 112.3 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.7 p -157.0 -44.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.45 -17.15 62.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.444 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -116.65 41.99 2.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.036 0.446 . . . . 0.0 110.684 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m -166.7 -170.24 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.677 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -83.91 148.21 27.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -70.02 -36.03 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.1 tt0 -54.73 -34.63 62.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -52.18 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 109.766 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -54.84 -31.88 59.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.189 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.12 -35.51 76.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.19 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 17.9 mm-40 -63.16 -41.15 99.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.215 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.687 HD12 ' HA ' ' A' ' 94' ' ' ALA . 8.8 mt -63.04 -50.34 71.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.114 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.836 HD13 HD21 ' A' ' 41' ' ' LEU . 1.5 mt -70.6 -54.1 13.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.8 ppt_? -50.76 -29.39 11.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.186 0.517 . . . . 0.0 109.646 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -123.16 40.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.313 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.849 ' HB2' HG21 ' A' ' 107' ' ' VAL . 6.1 p -90.8 20.18 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.584 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -114.63 15.57 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.7 mt -75.57 -48.75 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.81 -0.36 57.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.883 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.621 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 5.9 p 65.11 18.26 11.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.797 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.66 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER -166.21 157.12 13.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.849 HG21 ' HB2' ' A' ' 101' ' ' SER . 41.7 t -158.63 131.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -111.55 124.56 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.701 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.815 ' CD1' HG23 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -124.48 165.15 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.374 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -126.23 107.17 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.18 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.7 pt -99.58 162.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.841 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -131.08 115.17 16.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.375 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.56 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.6 OUTLIER -132.84 174.04 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.37 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.1 149.05 24.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.211 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 25.8 t -89.98 103.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 111.462 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.62 ' HB2' HG11 ' A' ' 20' ' ' VAL . . . 161.33 -178.96 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.036 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' SER . 6.8 pt-20 172.52 -36.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.15 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 13.2 t 170.69 106.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.795 HG21 HG21 ' A' ' 170' ' ' THR . 12.0 p -144.38 143.96 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.045 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.756 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.2 pp -132.36 101.98 14.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.9 Cg_endo -83.97 156.01 13.29 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.0 112.604 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -162.73 18.42 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.669 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.8 OUTLIER 56.2 117.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 96.46 -42.72 2.18 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.701 HG22 ' CD ' ' A' ' 207' ' ' LYS . 0.0 OUTLIER -135.78 102.66 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.404 . . . . 0.0 110.433 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.696 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.4 OUTLIER -100.75 123.28 44.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.756 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.42 116.76 32.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.338 . . . . 0.0 111.079 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 168' ' ' THR . 12.1 t -100.94 105.49 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.918 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.814 ' CD ' HD11 ' A' ' 203' ' ' LEU . 0.0 OUTLIER -81.25 113.12 19.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.931 -179.23 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 128' ' ' VAL . 1.7 mp -119.53 129.48 25.35 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.76 123.79 8.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.238 1.958 . . . . 0.0 111.314 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.819 ' HZ1' HD21 ' A' ' 138' ' ' LEU . 1.8 mmtp -89.64 159.89 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.225 0.536 . . . . 0.0 111.341 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.477 ' H ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.68 -167.14 1.89 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.259 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -66.79 -69.47 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.18 93.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 133' ' ' LYS . 52.8 t -137.78 152.84 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.678 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.52 125.21 10.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.819 HD21 ' HZ1' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -78.18 -64.18 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.28 -13.45 55.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.483 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.814 HG13 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -99.3 143.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.205 0.502 . . . . 0.0 111.176 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 157' ' ' SER . 10.8 m -126.12 109.72 12.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.377 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.907 HD13 HG22 ' A' ' 194' ' ' VAL . 2.5 mt -74.65 164.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.077 0.465 . . . . 0.0 111.351 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.68 ' HB3' HG23 ' A' ' 155' ' ' VAL . 2.8 t -152.57 152.57 32.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.649 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.452 ' N ' ' HD2' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -94.53 -49.45 0.26 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.359 -179.306 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.87 ' O ' HG21 ' A' ' 155' ' ' VAL . 90.5 Cg_endo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 122.366 2.044 . . . . 0.0 113.094 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.497 0.189 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.39 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.583 2.189 . . . . 0.0 112.445 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 190' ' ' MET . 4.0 mm? -66.61 174.92 2.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.783 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.87 HG21 ' O ' ' A' ' 145' ' ' PRO . 28.3 m -157.31 162.95 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.399 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 172' ' ' GLU . 3.7 mm -78.11 154.73 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -130.91 -33.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.578 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.805 ' O ' HD13 ' A' ' 159' ' ' ILE . 0.9 OUTLIER -175.1 164.75 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.186 0.517 . . . . 0.0 111.775 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 158' ' ' ASP . 3.4 mm -138.45 149.19 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.297 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -129.51 154.93 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -91.05 163.93 14.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 71' ' ' VAL . . . 86.22 -13.84 56.04 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.884 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.549 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 90.2 p -115.06 142.28 46.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.861 0.362 . . . . 0.0 111.02 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.416 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 12.6 m -48.12 -22.19 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.494 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.426 ' CB ' HG12 ' A' ' 140' ' ' ILE . . . -54.59 -52.65 61.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 111.304 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -83.5 -26.53 30.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.011 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 163' ' ' SER . 13.6 mmp_? -55.94 -50.76 69.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.463 HG21 HG11 ' A' ' 128' ' ' VAL . 13.3 t -58.62 -23.83 59.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.066 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 67.29 -152.7 52.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.131 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.795 HG21 HG21 ' A' ' 119' ' ' VAL . 2.6 p 56.16 23.21 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 151.72 40.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.892 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.596 ' O ' HG21 ' A' ' 156' ' ' ILE . 3.5 mt-10 -164.02 -171.68 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.37 122.07 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.34 -7.21 12.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.843 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.508 ' CG ' HG21 ' A' ' 208' ' ' ILE . 0.4 OUTLIER -73.25 170.14 15.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.747 0.274 . . . . 0.0 110.834 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.08 136.07 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 111.118 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.541 HD11 HD23 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.5 135.5 39.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.432 HD12 ' HE ' ' A' ' 209' ' ' ARG . 7.8 tt -108.95 -53.24 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.75 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -141.08 171.9 13.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.315 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.662 HD11 ' HB1' ' A' ' 193' ' ' ALA . 34.1 mt -139.08 105.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 6.6 t70 61.59 -79.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.732 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.01 -25.02 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 184' ' ' ARG . 32.7 mm -91.4 158.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.75 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 72.8 mtt-85 -125.71 128.1 47.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.228 0.537 . . . . 0.0 112.234 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.599 HD11 ' N ' ' A' ' 193' ' ' ALA . 3.6 mm? -81.17 -3.95 53.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.892 178.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.8 -29.27 1.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.26 51.15 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 20.0 m -156.18 160.58 39.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.974 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 60.0 p -77.43 -170.8 1.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.752 ' HA ' HD11 ' A' ' 154' ' ' LEU . 14.0 ptm -74.05 -43.39 57.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.996 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -54.94 -30.36 58.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.02 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.79 ' O ' HD12 ' A' ' 196' ' ' ILE . 3.4 m-20 -60.98 -51.85 67.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.058 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.662 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -57.12 -42.38 80.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.223 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.907 HG22 HD13 ' A' ' 142' ' ' ILE . 43.9 t -61.87 -35.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.818 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.92 -49.88 73.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.966 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.79 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.9 mp -72.71 -24.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.066 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -59.71 -43.27 94.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.87 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.754 HE22 HG12 ' A' ' 194' ' ' VAL . 1.1 mp0 -94.37 -39.87 10.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.534 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.68 -22.1 32.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.054 0.454 . . . . 0.0 110.435 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.546 ' SG ' HG22 ' A' ' 196' ' ' ILE . 17.2 m -85.89 44.62 1.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.11 63.05 0.09 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.486 0.66 . . . . 0.0 111.885 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.456 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 5.1 m-20 -170.36 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.515 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.814 HD11 ' CD ' ' A' ' 129' ' ' LYS . 3.6 tt 174.77 109.29 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 132' ' ' LYS . 6.2 t -102.79 120.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.328 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 16.8 ttmm -106.3 108.13 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.541 HD23 HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -83.37 114.96 21.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.183 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.701 ' CD ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -95.72 93.03 6.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.508 HG21 ' CG ' ' A' ' 175' ' ' ASP . 9.9 mm -83.31 165.04 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.788 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -118.27 121.78 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.055 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.27 108.86 9.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 115' ' ' VAL . 93.4 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.936 0.398 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -107.36 112.01 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.13 144.61 2.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.43 173.07 13.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.716 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -130.84 146.88 52.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.6 t -138.02 -171.28 2.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -111.45 161.65 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.192 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 111' ' ' ILE . 2.2 t -139.37 150.23 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.654 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.97 109.78 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 111.495 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 72' ' ' LEU . 3.1 mm? -107.1 118.66 37.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.14 163.29 12.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 0.0 111.431 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.688 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -98.1 106.47 18.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.153 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.07 147.65 83.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.92 9.43 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.539 2.16 . . . . 0.0 112.838 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.01 -41.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.5 p -117.95 -29.91 5.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.837 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 52.75 73.45 0.4 Allowed Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.353 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.688 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 54.9 m-85 73.46 89.67 0.09 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.027 0.441 . . . . 0.0 110.261 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.07 26.95 5.2 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.302 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.949 HD11 ' HB1' ' A' ' 66' ' ' ALA . 9.4 mt -92.26 151.96 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.159 0.504 . . . . 0.0 111.271 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.04 101.39 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.133 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.969 HD13 HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -95.87 134.96 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.204 0.526 . . . . 0.0 111.755 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -90.37 152.3 21.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.261 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' CA ' ' CE2' ' A' ' 91' ' ' PHE . . . -65.01 -82.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -108.08 157.97 17.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.405 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.024 HG21 HD22 ' A' ' 56' ' ' LEU . 44.7 t -138.09 -63.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.964 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.807 ' O ' HG22 ' A' ' 48' ' ' THR . 18.0 p90 -29.21 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.804 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 42.23 72.2 0.18 Allowed 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.51 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 166.08 90.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.385 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 50' ' ' THR . 29.4 tp10 63.27 156.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 51' ' ' LEU . 3.6 t 47.31 -177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.455 0.645 . . . . 0.0 111.779 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -161.87 22.31 0.11 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.202 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.61 21.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 51' ' ' LEU . 38.0 m -94.08 92.74 0.78 Allowed Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.642 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.58 171.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 0.0 112.092 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.726 ' HB2' HD22 ' A' ' 41' ' ' LEU . 6.6 Cg_endo -48.72 128.72 19.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.641 2.228 . . . . 0.0 111.86 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.024 HD22 HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -119.07 110.39 17.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.179 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.574 HD13 HG23 ' A' ' 39' ' ' ILE . 15.0 mt -56.42 116.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.009 0.433 . . . . 0.0 111.183 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -101.07 -6.84 23.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 60.4 t80 -178.16 131.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 61' ' ' GLU . 2.4 mt -108.29 176.31 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.636 ' H ' HG22 ' A' ' 60' ' ' ILE . 76.5 tt0 -109.56 154.84 22.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.524 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -85.47 50.15 1.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.36 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 16.1 t0 178.07 36.84 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.586 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.426 ' H ' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -133.61 132.12 21.62 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.75 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -10.57 12.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.537 2.158 . . . . 0.0 112.65 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.949 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -70.6 -52.89 18.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.05 0.453 . . . . 0.0 110.393 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' CB ' HG21 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -72.45 -29.18 63.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.205 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -94.21 -2.28 52.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.701 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.409 ' HG ' ' HB2' ' A' ' 72' ' ' LEU . 21.8 p -46.0 -31.52 2.3 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.74 0.305 . . . . 0.0 111.416 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.62 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 93.66 30.02 9.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.852 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 71' ' ' VAL . 14.3 p -179.6 39.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.862 HD12 ' O ' ' A' ' 66' ' ' ALA . 7.8 mt -131.35 174.07 10.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -156.04 163.37 39.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.705 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.532 HD13 HG13 ' A' ' 60' ' ' ILE . 32.4 mm -68.65 70.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.39 79.65 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.756 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.759 ' OD2' HD22 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -114.45 111.83 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.718 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.31 135.21 53.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.097 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 109' ' ' LEU . 20.3 t -104.46 120.61 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.0 tpt -87.59 -29.68 21.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -162.97 141.81 8.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.92 HG23 ' CD2' ' A' ' 109' ' ' LEU . 5.4 mt -113.52 109.42 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.628 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 46.93 27.8 0.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.86 6.5 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.734 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mm -69.19 111.19 7.79 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 120.602 0.239 . . . . 0.0 111.512 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.73 148.62 59.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.49 -24.6 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -73.79 -6.95 50.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.587 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.18 46.4 2.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.889 0.376 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m 177.94 -179.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 m -79.46 158.65 27.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.822 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CE2' ' CA ' ' A' ' 43' ' ' GLY . 12.0 p90 -73.08 -29.45 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.08 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.3 mt-10 -54.56 -34.13 61.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.331 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 94' ' ' ALA . 14.6 pt-20 -61.47 -47.35 86.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.279 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.818 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -57.88 -38.45 75.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.375 0.607 . . . . 0.0 110.097 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 2.5 m120 -58.86 -42.87 90.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.377 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 3.5 mm100 -63.0 -47.3 83.69 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.722 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.821 HD12 HD12 ' A' ' 81' ' ' ILE . 39.3 mt -52.47 -39.72 61.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.969 HD13 HD13 ' A' ' 41' ' ' LEU . 1.2 mt -74.1 -42.56 59.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.738 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 11.0 mtm180 -50.55 -34.97 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.266 0.555 . . . . 0.0 109.669 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -121.07 38.93 3.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.168 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.428 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -86.58 10.39 15.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.644 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -109.14 16.35 22.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.772 0.32 . . . . 0.0 111.757 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.9 mt -71.47 -49.99 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.817 0.818 . . . . 0.0 110.399 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 6.96 47.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.717 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.0 t 56.26 22.71 6.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.6 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.1 OUTLIER -163.76 156.76 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.551 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 109' ' ' LEU . 33.3 t -156.91 125.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.38 131.85 51.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.92 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -139.18 153.33 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 0.0 111.411 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.27 121.91 44.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.165 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.482 HG23 HG21 ' A' ' 27' ' ' VAL . 28.5 pt -112.5 145.49 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 111.848 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -111.36 140.29 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.116 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -153.61 174.34 14.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.621 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -100.89 116.19 32.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.353 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.813 ' O ' HG13 ' A' ' 20' ' ' VAL . 19.2 m -61.61 145.21 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.658 ' HB3' HG22 ' A' ' 20' ' ' VAL . . . 79.57 119.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.42 19.62 0.55 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.325 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER 176.91 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.861 0.362 . . . . 0.0 111.338 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.935 HG11 ' CG2' ' A' ' 170' ' ' THR . 0.0 OUTLIER -158.16 131.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -113.53 94.41 31.99 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.8 Cg_endo -85.69 150.02 9.96 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.8 2.333 . . . . 0.0 112.769 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.27 23.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.212 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.31 116.98 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.57 -45.85 1.99 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.9 102.79 5.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 110.647 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CE1' HG12 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -110.06 115.21 29.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.031 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.569 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -96.66 150.14 21.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.93 0.395 . . . . 0.0 110.791 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.549 HG12 ' HG ' ' A' ' 130' ' ' LEU . 18.3 t -124.59 95.48 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.0 mttt -81.76 98.15 8.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.21 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.549 ' HG ' HG12 ' A' ' 128' ' ' VAL . 7.2 mt -108.12 130.65 22.51 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.69 119.3 6.13 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.511 2.141 . . . . 0.0 111.454 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.828 ' HG3' HG23 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -108.31 158.61 17.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.169 0.509 . . . . 0.0 111.536 -179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -108.89 -164.84 0.97 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.323 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.39 -47.45 86.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.06 77.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.699 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.62 HG11 ' HA2' ' A' ' 70' ' ' GLY . 16.7 t -112.75 160.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.489 ' N ' HG12 ' A' ' 136' ' ' VAL . 29.6 tt0 -54.95 117.17 3.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.57 HD21 ' HD3' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -98.31 -61.07 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.551 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . 94.43 30.29 8.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.153 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -105.07 143.51 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.748 0.274 . . . . 0.0 110.866 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 157' ' ' SER . 86.6 m -126.09 136.76 53.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.796 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.959 HD13 HG22 ' A' ' 194' ' ' VAL . 2.3 mt -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.497 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -161.65 153.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.2 t -105.12 136.96 19.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.345 0.36 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.406 ' N ' ' CD ' ' A' ' 153' ' ' PRO . 55.2 t0 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 152' ' ' ASP . 61.4 Cg_endo -73.31 -179.26 4.24 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.818 HD12 ' CG2' ' A' ' 142' ' ' ILE . 4.4 mm? -100.52 167.4 10.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.695 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 175' ' ' ASP . 6.5 p -155.83 136.07 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.418 HD13 HD23 ' A' ' 171' ' ' LEU . 2.0 mt -65.44 151.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.663 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.401 ' HB3' ' CG2' ' A' ' 141' ' ' THR . 0.1 OUTLIER -124.85 -12.55 7.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.31 143.77 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.902 0.382 . . . . 0.0 111.204 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.43 HG21 ' CA ' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -131.0 149.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -98.36 146.96 25.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 111.132 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 173.16 10.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.995 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.68 -62.78 1.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 5.7 p -61.78 144.06 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 0.0 111.129 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.0 m -48.78 -21.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.144 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 168' ' ' THR . . . -48.04 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.312 . . . . 0.0 111.437 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.43 ' CA ' HG21 ' A' ' 159' ' ' ILE . 36.3 t60 -76.15 -24.26 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.736 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.76 -45.72 74.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 165' ' ' ALA . 5.3 t -61.48 88.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.476 ' C ' HG22 ' A' ' 170' ' ' THR . . . -50.97 88.27 0.01 OUTLIER Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.742 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.935 ' CG2' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER 164.79 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 110.328 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.861 HD11 HD12 ' A' ' 206' ' ' LEU . 3.2 tt -84.21 57.11 4.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.96 162.82 17.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.598 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -82.52 54.66 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.133 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.28 25.72 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.869 ' O ' HG23 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -124.78 -176.79 3.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 110.558 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 209' ' ' ARG . 1.0 OUTLIER -134.6 130.14 36.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 111.368 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 180' ' ' ILE . 0.8 OUTLIER -115.33 152.26 33.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 178' ' ' LEU . 4.0 pp -137.44 10.46 2.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.632 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.866 ' HB3' ' CB ' ' A' ' 207' ' ' LYS . . . -152.89 144.95 23.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 177' ' ' LEU . 31.3 mm -139.27 111.67 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 35.6 t70 51.59 52.64 14.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 31.1 t30 84.72 -34.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 184' ' ' ARG . 45.1 mm -68.64 159.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.752 0.31 . . . . 0.0 110.783 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 183' ' ' ILE . 67.3 mtm180 -133.86 129.76 36.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.192 0.52 . . . . 0.0 112.299 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.561 ' HG ' HD23 ' A' ' 154' ' ' LEU . 3.4 mm? -75.08 -5.27 43.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.623 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -45.93 -29.55 1.45 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 m -123.26 30.28 6.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.42 165.11 36.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.998 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.14 -169.89 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.667 ' CB ' HD11 ' A' ' 154' ' ' LEU . 12.9 ptm -70.34 -42.01 72.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.6 mt-10 -53.9 -34.93 60.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.052 0.453 . . . . 0.0 111.006 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.711 ' O ' HD12 ' A' ' 196' ' ' ILE . 35.8 t70 -61.07 -48.23 82.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.222 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -58.51 -39.11 79.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.959 HG22 HD13 ' A' ' 142' ' ' ILE . 13.5 t -63.0 -33.37 60.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.097 0.475 . . . . 0.0 109.998 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -49.65 70.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.848 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.8 mp -74.71 -24.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.167 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.771 HD22 HD11 ' A' ' 142' ' ' ILE . 0.0 OUTLIER -61.25 -40.67 94.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 110.216 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.647 ' NE2' HG12 ' A' ' 194' ' ' VAL . 18.1 mt-30 -89.7 -41.26 12.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.112 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.58 -18.63 60.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.752 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.65 ' SG ' HG22 ' A' ' 196' ' ' ILE . 4.1 m -81.74 44.95 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.235 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 1.1 pt-20 -74.53 61.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.187 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.8 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.82 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 130' ' ' LEU . 12.4 tp -176.67 104.37 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 132' ' ' LYS . 59.1 t -98.32 108.56 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.147 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 28.1 ttmt -100.21 108.19 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.861 HD12 HD11 ' A' ' 171' ' ' LEU . 43.1 mt -94.36 108.2 20.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.455 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.866 ' CB ' ' HB3' ' A' ' 179' ' ' ALA . 28.8 tttt -83.11 93.43 7.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.648 HD13 ' HB3' ' A' ' 177' ' ' LEU . 9.5 mm -88.99 164.13 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.352 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -126.54 127.8 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.838 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.02 123.14 39.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.111 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.786 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.608 HG11 ' CB ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.448 ' O ' HG22 ' A' ' 115' ' ' VAL . 64.7 t-80 -115.79 111.02 19.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.996 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -55.44 139.53 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' HB2' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -134.89 173.18 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.6 OUTLIER -121.68 150.54 41.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.715 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 8.8 t -142.87 163.48 32.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -102.5 161.14 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.636 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -145.95 147.73 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG13 ' CD ' ' A' ' 106' ' ' LYS . 45.7 t -126.26 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.944 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.88 HD21 HD21 ' A' ' 72' ' ' LEU . 4.3 mm? -107.51 123.23 48.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.449 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -111.16 161.86 15.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.169 0.509 . . . . 0.0 111.821 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.839 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -104.42 116.13 31.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -83.19 154.88 67.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.56 179.597 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.2 6.57 4.6 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.497 2.131 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.39 -49.82 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.489 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.8 p -137.2 -2.73 2.02 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -110.34 3.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.349 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.839 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 6.6 m-85 -106.05 129.24 54.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.906 0.384 . . . . 0.0 110.064 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.47 24.93 20.59 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.884 -0.674 . . . . 0.0 114.473 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.833 ' CG2' HD13 ' A' ' 60' ' ' ILE . 1.1 pp -122.67 128.54 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.578 0.689 . . . . 0.0 111.503 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -111.26 127.4 55.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.235 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -96.73 154.06 17.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.105 0.478 . . . . 0.0 111.715 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.58 168.85 8.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.494 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . -68.41 -117.68 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.801 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -108.57 132.46 53.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 46' ' ' PHE . 2.8 t -89.79 -70.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.871 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.696 ' O ' HG22 ' A' ' 48' ' ' THR . 13.4 p90 -25.3 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.854 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.75 72.28 0.16 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.562 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.7 t 174.12 40.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' THR . 2.7 mt-10 164.71 -169.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.747 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.86 -94.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -152.98 -82.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.365 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.69 16.43 0.99 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -145.12 74.41 14.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' A' ' 91' ' ' PHE . 49.6 Cg_exo -55.47 -175.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.785 ' HB2' HD22 ' A' ' 41' ' ' LEU . 87.4 Cg_exo -46.8 125.23 9.47 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.47 2.113 . . . . 0.0 112.069 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 56' ' ' LEU . 1.9 mp -115.36 113.44 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.62 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 76' ' ' ASP . 56.7 mt -58.17 121.92 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.449 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.431 ' HA ' HG23 ' A' ' 74' ' ' ILE . 7.2 t -124.81 25.88 7.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 60' ' ' ILE . 25.8 t80 -173.52 138.9 0.71 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.053 0.454 . . . . 0.0 111.662 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.833 HD13 ' CG2' ' A' ' 39' ' ' ILE . 30.8 mm -112.21 160.3 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.538 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -112.52 155.79 23.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -100.29 55.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER 166.89 41.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.091 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.42 ' H ' ' NH1' ' A' ' 68' ' ' ARG . 2.9 m -141.2 144.34 34.2 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.8 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 32' ' ' ASP . 55.6 Cg_endo -69.8 -0.11 6.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.633 2.222 . . . . 0.0 112.819 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HA ' HD13 ' A' ' 29' ' ' LEU . . . -68.12 -56.92 7.08 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.341 0.591 . . . . 0.0 110.301 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 7.2 pm0 -80.12 -29.6 38.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.023 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.575 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -70.66 -27.31 63.93 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.018 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 53.6 t -49.46 -43.23 44.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.541 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 106.16 20.88 8.85 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.728 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 71' ' ' VAL . 13.5 t -153.66 41.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.88 HD21 HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -124.44 157.26 35.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.02 158.2 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 60' ' ' ILE . 19.8 mm -66.98 75.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.304 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 148.83 69.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.728 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -106.02 78.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.528 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -55.21 -40.89 71.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 109' ' ' LEU . 46.6 t 65.08 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.263 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -27.98 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -155.78 137.33 14.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.883 HD12 HD12 ' A' ' 97' ' ' LEU . 8.1 mt -114.23 106.96 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.79 ' OD1' HG22 ' A' ' 81' ' ' ILE . 6.6 m120 58.79 20.77 8.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.169 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.46 -34.27 4.61 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.571 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.0 mt -67.73 127.42 93.37 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.497 0.189 . . . . 0.0 110.995 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.36 -179.28 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.456 2.104 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.8 p -147.45 -45.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.91 -13.11 61.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -118.93 46.55 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.4 p -171.92 -177.5 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.649 ' HA ' HD13 ' A' ' 51' ' ' LEU . 54.1 m -81.21 141.5 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.794 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 6.6 p90 -61.74 -37.25 83.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 90' ' ' THR . 1.8 tt0 -55.23 -36.02 65.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.264 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 90' ' ' THR . 0.6 OUTLIER -61.51 -52.34 64.89 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -54.85 -33.58 61.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.412 0.625 . . . . 0.0 110.217 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -63.74 -40.3 96.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.978 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 18.0 mm-40 -61.59 -44.17 97.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.229 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.883 HD12 HD12 ' A' ' 81' ' ' ILE . 44.0 mt -56.29 -43.66 79.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.415 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.751 HD22 HD11 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -70.41 -51.2 31.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.812 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -50.28 -30.53 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.138 0.494 . . . . 0.0 109.801 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.7 t0 -121.71 38.22 4.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.362 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.604 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.75 25.54 6.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.323 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.3 p -119.16 13.09 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.9 mt -68.12 -46.4 81.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 110.565 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -1.55 54.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.573 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.797 ' O ' HG22 ' A' ' 30' ' ' THR . 0.8 OUTLIER 62.86 26.56 15.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -169.35 153.82 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 101' ' ' SER . 60.1 t -153.59 150.9 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.04 135.12 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.337 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.775 ' HB3' HG13 ' A' ' 78' ' ' VAL . 3.2 mt -136.81 149.21 47.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 111.628 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.72 105.9 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.981 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.462 HG13 HG22 ' A' ' 25' ' ' THR . 30.2 pt -103.47 154.52 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.15 0.5 . . . . 0.0 112.165 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 24' ' ' THR . 32.5 tt0 -126.38 138.42 53.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.99 173.58 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 111.327 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.34 106.14 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.252 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 18.5 m -61.92 103.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.823 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.608 ' CB ' HG11 ' A' ' 20' ' ' VAL . . . 153.0 129.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.022 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -161.96 22.54 0.11 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.253 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER 169.48 93.75 0.0 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.033 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.597 HG13 ' CE1' ' A' ' 126' ' ' PHE . 23.2 t -139.6 118.8 12.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.869 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 127' ' ' HIS . 1.1 pp -137.26 78.19 40.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 121.692 0.758 . . . . 0.0 110.691 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 119' ' ' VAL . 70.7 Cg_endo -94.65 176.74 1.02 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.229 2.619 . . . . 0.0 112.878 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -172.96 33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.895 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.73 117.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 89.25 -44.4 3.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.032 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.842 HG22 ' HD3' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -122.7 103.94 8.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.752 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.597 ' CE1' HG13 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -110.62 124.46 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.504 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.587 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -118.08 144.6 45.49 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.687 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.543 HG12 HD12 ' A' ' 130' ' ' LEU . 2.9 t -130.27 111.1 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.506 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' SER . 11.1 mttp -80.72 101.31 9.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.885 HD11 ' CG2' ' A' ' 168' ' ' THR . 1.9 mp -107.32 113.71 61.75 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.515 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.6 115.53 3.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.297 1.998 . . . . 0.0 111.352 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.55 ' HG2' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -100.37 158.75 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.73 -164.62 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.776 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -57.65 -48.39 79.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.71 50.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 111.277 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.673 HG23 ' HB2' ' A' ' 133' ' ' LYS . 46.1 t -89.63 144.13 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.414 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 40.6 tt0 -52.42 124.72 14.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' A' ' 165' ' ' ALA . 1.5 mp -90.57 -66.88 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 113.69 -2.22 24.66 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.05 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.559 HG23 HD21 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -95.78 135.58 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.342 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.689 HG22 ' HB3' ' A' ' 157' ' ' SER . 11.0 m -126.1 136.04 52.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.504 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.872 HD11 ' HG ' ' A' ' 197' ' ' LEU . 5.3 mt -105.35 164.12 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.543 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -154.63 151.61 29.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.691 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.6 p -118.78 107.47 42.38 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.05 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo . . . . . 0 C--N 1.346 0.414 0 C-N-CA 122.474 2.116 . . . . 0.0 112.106 179.85 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.8 t70 . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.04 -178.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.435 2.09 . . . . 0.0 112.359 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.552 HD11 ' HG ' ' A' ' 185' ' ' LEU . 2.8 mt -113.78 178.9 4.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.493 HG23 ' OG ' ' A' ' 143' ' ' SER . 24.2 m -157.27 175.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.42 ' HB ' HD23 ' A' ' 173' ' ' LEU . 4.2 mm -79.25 154.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.689 ' HB3' HG22 ' A' ' 141' ' ' THR . 10.7 t -130.8 -10.22 3.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.651 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.449 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 170.62 156.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.805 HG22 ' HB2' ' A' ' 166' ' ' HIS . 4.2 mt -142.49 139.34 29.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.765 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.409 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -114.26 145.47 41.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.933 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -85.78 168.61 14.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.582 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.425 ' N ' ' NH1' ' A' ' 167' ' ' ARG . . . 84.95 -52.73 4.74 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.504 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 34.2 m -81.14 153.69 27.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.854 HG23 HD23 ' A' ' 130' ' ' LEU . 18.3 m -48.72 -21.8 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 138' ' ' LEU . . . -46.88 -66.52 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.886 0.374 . . . . 0.0 111.655 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.805 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -83.36 -24.24 32.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.4 -29.84 50.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.4 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.885 ' CG2' HD11 ' A' ' 130' ' ' LEU . 22.3 p -45.25 -42.2 9.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.788 0.328 . . . . 0.0 111.393 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.83 -26.48 18.33 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.769 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.459 HG21 ' CE1' ' A' ' 126' ' ' PHE . 3.7 t -109.6 31.84 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -117.17 113.62 22.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -142.13 156.81 45.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 156' ' ' ILE . 14.9 mt -75.4 113.7 13.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.23 -17.2 2.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.779 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.631 ' HB3' HG21 ' A' ' 208' ' ' ILE . 5.4 m-20 -70.34 166.04 21.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.73 0.3 . . . . 0.0 110.794 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.28 114.25 24.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.019 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.675 HD12 HD12 ' A' ' 208' ' ' ILE . 0.3 OUTLIER -70.72 142.55 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.691 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.571 ' C ' HD23 ' A' ' 178' ' ' LEU . 7.5 tt -122.27 -55.22 1.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -143.49 176.07 9.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.081 0.467 . . . . 0.0 111.592 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 193' ' ' ALA . 25.3 mt -139.26 107.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.93 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.815 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 48.38 -85.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 180' ' ' ILE . 3.6 m-20 -108.07 -20.33 13.2 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.552 HG21 ' CD1' ' A' ' 196' ' ' ILE . 24.9 mm -100.08 140.95 18.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 111.512 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 0.9 OUTLIER -112.86 120.66 42.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.06 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.901 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 2.9 mm? -82.81 -5.21 58.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.375 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.67 -32.07 1.37 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.367 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 -16.78 9.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.579 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.6 m -85.24 -169.78 2.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 0.0 111.22 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.33 -173.36 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.414 ' CB ' HD22 ' A' ' 154' ' ' LEU . 1.0 OUTLIER -74.05 -52.01 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.01 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -51.8 -30.71 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 111.102 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.4 OUTLIER -62.19 -51.53 67.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.058 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.901 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -56.21 -39.41 72.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.239 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.708 HG12 ' NE2' ' A' ' 198' ' ' GLN . 19.1 t -61.01 -36.81 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.212 0.529 . . . . 0.0 109.902 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -49.86 76.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.843 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.552 ' CD1' HG21 ' A' ' 183' ' ' ILE . 1.5 mp -75.51 -24.13 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.027 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.872 ' HG ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -59.46 -36.17 75.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.708 ' NE2' HG12 ' A' ' 194' ' ' VAL . 5.1 mt-30 -100.11 -37.65 8.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.65 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.52 -19.57 49.17 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.931 ' CB ' HG13 ' A' ' 204' ' ' VAL . 1.1 m -84.4 43.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.41 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -68.56 62.87 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.283 0.563 . . . . 0.0 111.076 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 200' ' ' CYS . 1.8 m-20 -174.98 -32.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.056 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.4 tt 178.06 108.91 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.272 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.931 HG13 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.06 115.24 48.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.215 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HB3' ' CA ' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -96.32 107.9 20.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 208' ' ' ILE . 11.1 mp -81.91 113.58 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.842 ' HD3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -99.75 94.39 6.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.788 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.675 HD12 HD12 ' A' ' 177' ' ' LEU . 1.1 mm -94.16 170.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.989 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -112.82 131.6 55.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.919 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 115.37 29.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.824 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 115' ' ' VAL . 69.0 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -136.3 108.48 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.658 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 p -49.28 143.16 6.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 173.03 12.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -133.06 159.12 40.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.556 HG21 ' HA2' ' A' ' 162' ' ' GLY . 14.1 t -150.54 -169.96 3.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -121.65 161.0 23.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.428 HG13 ' HG ' ' A' ' 109' ' ' LEU . 1.7 p -136.65 151.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.392 0.615 . . . . 0.0 110.924 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.9 109.79 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.095 HD21 HD11 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -104.36 118.34 36.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.0 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -113.51 161.74 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.34 0.59 . . . . 0.0 112.195 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.891 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -107.0 109.75 21.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.457 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 8.4 p-10 -83.68 157.23 64.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.412 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.08 7.92 2.29 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.459 2.106 . . . . 0.0 112.98 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.64 -47.29 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.634 0.255 . . . . 0.0 111.247 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.3 p -144.58 6.53 1.25 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 61.71 -86.62 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.219 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 7.9 m-85 -128.06 113.98 16.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.51 19.51 47.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.523 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.095 HD13 HD13 ' A' ' 72' ' ' LEU . 16.2 pt -123.89 134.47 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.905 0.353 . . . . 0.0 110.69 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 3.2 pt20 -120.74 142.76 49.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.81 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.891 HD11 ' CD1' ' A' ' 98' ' ' LEU . 1.4 pt? -129.41 154.65 46.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.276 0.56 . . . . 0.0 111.921 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.19 8.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.339 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -104.23 -58.13 0.7 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.289 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -69.53 150.39 47.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.851 0.358 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 56' ' ' LEU . 86.4 t -142.02 -88.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.955 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.563 ' CE1' HG23 ' A' ' 50' ' ' THR . 52.9 p90 -56.78 -46.17 81.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.22 0.533 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.562 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 47.35 82.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.702 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 60.3 p -159.95 98.18 1.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.134 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' C ' HG22 ' A' ' 50' ' ' THR . 4.7 pt-20 52.37 35.36 17.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.525 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.563 HG23 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 165.78 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.773 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -160.67 23.78 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.789 0.328 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.12 21.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -72.28 138.18 81.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.795 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.16 156.91 33.79 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.457 2.105 . . . . 0.0 112.39 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.667 ' CB ' HD12 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -42.71 159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.003 2.469 . . . . 0.0 112.242 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.687 ' CD1' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -160.62 108.88 1.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.548 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.79 ' CD1' HD12 ' A' ' 39' ' ' ILE . 61.5 mt -59.88 135.78 24.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -125.25 17.24 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HB3' ' CG ' ' A' ' 40' ' ' GLN . 37.6 t80 -177.68 141.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.834 HG21 ' HB2' ' A' ' 67' ' ' GLU . 12.1 mm -131.01 148.43 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.077 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 62' ' ' ALA . 39.0 tt0 -95.55 151.84 18.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.943 0.401 . . . . 0.0 111.232 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.39 45.34 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.39 42.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.501 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.24 135.25 23.76 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.779 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 11.8 Cg_endo -54.81 -11.46 3.51 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.787 2.325 . . . . 0.0 113.147 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -66.23 -57.54 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.815 0.34 . . . . 0.0 110.542 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.834 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.41 -31.83 42.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.977 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.501 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -61.32 -30.93 70.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.673 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.63 -31.29 64.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.776 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.818 ' HA3' HG11 ' A' ' 136' ' ' VAL . . . 86.36 34.19 12.67 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.676 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 71' ' ' VAL . 13.1 t -151.41 28.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.652 0.263 . . . . 0.0 111.411 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.095 HD11 HD21 ' A' ' 29' ' ' LEU . 16.8 mt -140.42 148.89 41.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 175.92 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.666 HD13 HG12 ' A' ' 60' ' ' ILE . 21.1 mm -69.26 68.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.18 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.39 59.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.678 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.525 ' OD2' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -88.76 120.88 30.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.75 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.474 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -90.72 104.55 17.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.685 ' HA ' HG22 ' A' ' 111' ' ' ILE . 17.2 t -94.08 158.65 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.051 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.451 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -122.74 -40.45 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.46 149.14 37.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.159 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.766 HG23 ' CD2' ' A' ' 109' ' ' LEU . 17.6 mt -132.71 120.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.68 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 m120 54.53 24.23 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.913 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.97 -18.48 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.636 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.14 137.02 56.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.42 -178.7 3.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.369 2.046 . . . . 0.0 112.254 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.6 p -157.26 -44.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -11.15 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.391 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -117.09 46.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.763 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 t -176.9 -176.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.38 151.24 45.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 16.4 p90 -70.17 -30.94 68.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -55.83 -31.56 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 93' ' ' GLU . 5.6 mm-40 -61.69 -58.62 7.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -54.82 -28.68 51.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.806 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.22 -43.11 34.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -70.61 -36.13 73.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.807 0.336 . . . . 0.0 111.198 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 81' ' ' ILE . 1.1 pp -70.09 -46.1 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.326 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.891 ' CD1' HD11 ' A' ' 41' ' ' LEU . 69.8 mt -64.29 -57.39 9.56 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.264 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -50.75 -29.68 12.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' O ' HD11 ' A' ' 103' ' ' ILE . 5.8 t70 -114.37 35.5 4.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 84.4 p -108.78 15.21 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.134 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.8 p -100.64 15.08 29.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 111.855 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.7 mt -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 5.77 44.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.656 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 30' ' ' THR . 13.1 p 59.2 26.76 15.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -171.12 148.85 2.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.907 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.53 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.5 t -149.68 131.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.31 130.59 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.697 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.766 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -140.32 164.96 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 111.342 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -114.43 145.55 41.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.402 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 78' ' ' VAL . 40.6 pt -137.46 159.94 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.959 0.409 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -123.69 146.42 48.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.318 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -161.05 174.28 13.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.425 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.13 131.23 44.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 20' ' ' VAL . 27.2 m -85.53 145.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.728 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . 82.88 113.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.774 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -153.79 24.32 0.51 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.872 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.35 85.43 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.649 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.678 HG13 ' HE1' ' A' ' 126' ' ' PHE . 34.7 t -142.27 131.63 22.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.028 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.66 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -134.23 86.03 37.35 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-O 121.646 0.736 . . . . 0.0 109.894 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.518 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 60.6 Cg_endo -95.81 175.19 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.268 2.645 . . . . 0.0 113.424 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -163.25 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.463 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 169.78 113.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.2 -30.75 6.48 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.354 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.547 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -134.5 102.67 5.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.999 0.428 . . . . 0.0 110.612 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.678 ' HE1' HG13 ' A' ' 119' ' ' VAL . 1.9 t80 -104.45 127.56 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.66 ' HB2' HG13 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -118.44 141.06 48.93 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.624 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.778 HG21 HD12 ' A' ' 206' ' ' LEU . 4.8 m -129.38 104.37 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -80.56 104.48 11.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.767 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.926 HD11 HG22 ' A' ' 168' ' ' THR . 4.3 mp -113.84 139.08 23.08 Favored Pre-proline 0 C--N 1.333 -0.126 0 CA-C-O 120.588 0.233 . . . . 0.0 111.488 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.11 108.91 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.446 2.097 . . . . 0.0 111.798 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -81.97 158.64 23.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.407 ' HE2' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -127.2 -166.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.265 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.8 -76.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.215 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.9 m -152.99 74.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.198 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.818 HG11 ' HA3' ' A' ' 70' ' ' GLY . 40.8 t -127.84 151.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.796 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -53.04 96.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.045 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.665 HD22 HG12 ' A' ' 140' ' ' ILE . 1.1 tt -55.07 -38.31 67.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.19 -44.38 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.032 HG23 ' HB1' ' A' ' 165' ' ' ALA . 5.1 pt -81.84 146.41 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.857 0.361 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.3 m -126.18 118.95 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.738 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.008 HD13 HG22 ' A' ' 194' ' ' VAL . 1.4 mp -80.58 164.06 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 142' ' ' ILE . 10.8 t -167.68 166.94 13.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -116.77 137.11 23.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo . . . . . 0 C--N 1.347 0.473 0 C-N-CA 122.421 2.08 . . . . 0.0 112.128 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' N ' ' HD3' ' A' ' 153' ' ' PRO . 21.5 t70 . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.731 0.301 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 152' ' ' ASP . 86.1 Cg_endo -80.24 -175.16 2.56 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.563 2.175 . . . . 0.0 112.422 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.897 HD12 ' CG2' ' A' ' 142' ' ' ILE . 1.8 mm? -104.83 145.61 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 175' ' ' ASP . 16.8 m -142.19 178.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 111.329 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.651 HG21 HD23 ' A' ' 173' ' ' LEU . 1.3 mm -93.23 154.83 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.58 -26.82 2.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.76 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -176.49 162.11 2.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.199 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.968 HD13 HD23 ' A' ' 171' ' ' LEU . 1.6 mt -140.53 149.08 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.756 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.0 146.23 45.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -83.35 164.93 19.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.556 ' HA2' HG21 ' A' ' 25' ' ' THR . . . 84.33 -19.21 19.58 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.065 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.477 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.2 m -107.05 146.53 31.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.964 0.411 . . . . 0.0 110.997 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.798 HG23 HD23 ' A' ' 130' ' ' LEU . 34.8 m -48.85 -22.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 1.032 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -52.91 -71.17 0.07 Allowed 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.955 0.407 . . . . 0.0 110.979 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.679 ' HB2' HG22 ' A' ' 159' ' ' ILE . 29.0 t60 -71.29 -24.8 62.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.14 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -56.88 -30.99 64.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.995 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.926 HG22 HD11 ' A' ' 130' ' ' LEU . 72.5 p -45.1 -42.71 9.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.253 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.71 -43.61 2.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.581 HG21 HG11 ' A' ' 119' ' ' VAL . 5.6 t -96.9 34.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.968 HD23 HD13 ' A' ' 159' ' ' ILE . 2.9 tt -117.34 99.91 7.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -109.36 -179.98 3.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 156' ' ' ILE . 4.0 mt -107.84 148.66 29.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.806 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.53 -11.17 39.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.814 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 155' ' ' VAL . 3.1 t0 -78.48 175.68 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.641 0.258 . . . . 0.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.448 ' HD3' HG12 ' A' ' 155' ' ' VAL . 41.5 mmtm -117.25 151.53 36.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.326 . . . . 0.0 111.132 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.634 HD23 ' H ' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -101.71 170.8 7.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.063 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.634 ' H ' HD23 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -148.07 -44.89 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.885 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -150.2 169.33 21.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.752 HD11 ' HB1' ' A' ' 193' ' ' ALA . 16.3 mt -139.62 114.38 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 18.3 t0 59.28 -83.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.375 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -128.69 -14.95 4.51 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.775 ' HB ' HG21 ' A' ' 196' ' ' ILE . 20.2 mm -102.32 133.58 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 9.6 mtm105 -100.13 114.47 27.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.597 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.759 HD21 HD13 ' A' ' 196' ' ' ILE . 2.9 mm? -72.32 -17.07 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.411 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.56 -81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 185' ' ' LEU . 8.2 m -153.28 24.44 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.837 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -171.05 0.65 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.071 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.7 14.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.845 ' HA ' HD11 ' A' ' 154' ' ' LEU . 14.8 ptm -74.23 -42.64 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.0 mt-10 -53.7 -31.89 49.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.825 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -62.68 -48.13 80.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.195 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.752 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -59.02 -39.73 82.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.476 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 1.008 HG22 HD13 ' A' ' 142' ' ' ILE . 8.6 t -63.79 -34.42 67.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 109.749 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 199' ' ' GLN . 0.9 OUTLIER -61.44 -50.29 73.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.966 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.825 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.6 mp -70.08 -24.78 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.172 0.51 . . . . 0.0 109.764 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.707 HD12 HD13 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.23 -33.92 76.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.721 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.408 ' HA ' ' NZ ' ' A' ' 132' ' ' LYS . 11.4 mt-30 -87.75 -39.78 14.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.727 ' OE1' HG23 ' A' ' 196' ' ' ILE . 0.0 OUTLIER -86.48 13.26 8.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.833 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 180' ' ' ILE . 0.5 OUTLIER -64.29 33.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.7 pt-20 32.53 68.17 0.15 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.78 24.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.471 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 mt -153.96 93.66 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.135 0.493 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 204' ' ' VAL . 13.8 p -97.11 108.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.714 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 24.1 ttmt -104.54 107.06 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.778 HD12 HG21 ' A' ' 128' ' ' VAL . 3.4 mt -83.4 114.16 21.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.628 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 12.0 tttt -97.16 93.26 6.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.356 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.58 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.7 OUTLIER -84.95 168.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.826 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 10.2 ttp180 -118.98 123.42 44.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.34 159.49 15.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.554 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 115' ' ' VAL . 10.2 p . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.823 0.344 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 51.6 p-80 -106.04 110.77 23.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 t -55.94 152.17 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 170.44 12.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.764 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.801 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -129.68 137.13 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -139.3 176.88 8.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -106.76 162.93 13.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.33 150.41 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.634 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.53 109.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 111.411 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 72' ' ' LEU . 3.9 mm? -106.63 121.72 44.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.798 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -110.67 162.18 15.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.63 . . . . 0.0 112.406 -178.777 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.754 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -109.34 103.73 12.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.168 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.4 148.32 55.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.41 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.88 1.96 7.1 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.596 2.198 . . . . 0.0 112.674 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.55 -48.45 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.371 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t -125.51 -11.24 6.82 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.02 -87.88 0.57 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.406 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.678 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 27.7 m-85 -130.94 117.94 19.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.0 110.285 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -70.34 -3.69 47.78 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.991 HG21 HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.61 167.6 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.958 0.879 . . . . 0.0 112.189 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 4.8 mt-30 -138.61 122.28 17.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.097 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.754 HD13 ' CD2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -96.34 143.3 27.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 112.061 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' CG ' HD13 ' A' ' 56' ' ' LEU . 6.0 pt20 -105.19 166.09 10.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.559 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -122.41 107.28 1.13 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.299 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 57.24 112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 111.398 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.62 -75.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.485 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 36.1 p90 -49.97 -48.07 52.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.036 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 41.58 80.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.66 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.2 t 170.11 114.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.565 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 50' ' ' THR . 1.9 tt0 61.32 86.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 51' ' ' LEU . 1.3 m 90.56 -179.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.623 ' H ' HG22 ' A' ' 50' ' ' THR . 1.4 pp -167.01 30.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.165 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -64.45 30.73 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -112.75 86.8 9.13 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.601 0.238 . . . . 0.0 110.578 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.29 176.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.486 2.124 . . . . 0.0 112.133 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.504 ' HG3' ' HB3' ' A' ' 94' ' ' ALA . 52.2 Cg_exo -53.16 137.9 63.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.412 2.075 . . . . 0.0 111.838 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.568 HD13 ' CG ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -137.67 113.76 9.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.489 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 81.8 mt -62.21 138.68 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 110.801 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 74' ' ' ILE . 6.3 t -119.82 -24.04 6.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.502 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 72.4 t80 -136.83 159.09 42.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.916 ' CD1' HG22 ' A' ' 39' ' ' ILE . 9.4 mm -138.33 164.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.47 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 60' ' ' ILE . 4.0 tp10 -119.87 147.13 45.07 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.866 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.95 42.72 1.11 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.187 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.15 36.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.068 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -137.17 138.13 24.57 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.081 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.71 -15.83 13.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.038 2.492 . . . . 0.0 113.643 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.871 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -73.9 -44.09 56.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.6 tp10 -76.06 -29.22 57.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.719 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.541 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.41 -14.83 39.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.307 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.7 t -47.25 -40.84 17.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.941 0.4 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.424 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 105.3 11.44 29.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.439 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -153.85 53.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 111.637 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.991 HD13 HG21 ' A' ' 39' ' ' ILE . 10.4 mt -141.3 134.83 29.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -141.08 174.44 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 58' ' ' SER . 26.5 mm -73.11 78.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.28 43.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -75.26 83.31 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.783 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 101.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.643 HG11 HD13 ' A' ' 109' ' ' LEU . 35.9 m -95.77 115.4 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -97.14 24.52 6.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.33 131.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.718 HG23 ' CD2' ' A' ' 109' ' ' LEU . 35.1 mt -131.23 115.71 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' A' ' 107' ' ' VAL . 7.7 m120 56.39 23.31 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.8 -26.3 24.53 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.536 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mt -74.26 136.67 75.44 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-O 120.565 0.222 . . . . 0.0 111.229 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.2 171.35 15.11 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.384 2.056 . . . . 0.0 112.162 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 94' ' ' ALA . 1.1 p -139.42 -46.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -71.05 -11.36 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -113.16 45.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.015 0.436 . . . . 0.0 110.794 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -178.09 -170.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.798 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 148.65 32.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.436 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 21.7 p90 -73.52 -31.21 63.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -59.16 -31.78 69.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.24 -58.88 6.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -55.73 -39.9 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.142 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.729 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.4 m120 -64.6 -36.99 86.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.322 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -69.95 -44.07 70.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.354 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.597 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 2.3 pp -62.65 -28.78 70.16 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.754 ' CD2' HD13 ' A' ' 41' ' ' LEU . 39.3 mt -67.62 -46.38 72.66 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 28.8 mtt-85 -50.28 -40.26 47.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.487 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.0 m-20 -115.55 40.93 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.431 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.19 6.46 47.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.619 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -105.23 18.23 22.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.341 . . . . 0.0 111.82 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.487 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.8 mt -71.41 -51.63 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.814 0.816 . . . . 0.0 110.919 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 7.99 31.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.806 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.754 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 45.4 t 57.1 22.47 7.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.337 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.66 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -168.99 159.16 9.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.036 0.446 . . . . 0.0 111.745 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 101' ' ' SER . 39.8 t -157.5 128.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.683 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.87 133.34 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.585 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.718 ' CD2' HG23 ' A' ' 81' ' ' ILE . 1.6 mt -131.63 157.26 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 0.0 111.439 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 118.03 30.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.197 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 pt -112.27 155.37 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.155 0.503 . . . . 0.0 111.813 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.801 ' HG3' HG23 ' A' ' 24' ' ' THR . 0.4 OUTLIER -132.56 117.52 18.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.198 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 167' ' ' ARG . 6.2 p90 -136.34 174.11 10.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 0.0 111.407 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 3.7 p30 -91.08 155.33 18.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.559 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 115' ' ' VAL . 27.9 m -108.55 104.96 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.455 . . . . 0.0 111.635 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -172.35 95.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.6 OUTLIER -107.15 20.44 19.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.794 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 86.32 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.219 0.533 . . . . 0.0 111.714 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.657 ' CG1' HG13 ' A' ' 128' ' ' VAL . 2.5 m -112.96 140.76 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.115 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.707 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.2 pp -121.53 104.76 39.57 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.771 0.32 . . . . 0.0 111.455 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.488 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 92.7 Cg_endo -86.01 164.28 10.15 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.848 2.365 . . . . 0.0 112.754 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -167.28 22.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.582 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.7 OUTLIER 55.34 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.934 0.397 . . . . 0.0 111.244 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.36 -42.24 2.49 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.877 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.551 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.89 102.59 5.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.512 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.762 ' CE1' HG21 ' A' ' 170' ' ' THR . 6.1 t80 -104.66 130.58 52.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.566 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -112.68 144.76 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.454 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.657 HG13 ' CG1' ' A' ' 119' ' ' VAL . 21.4 t -122.46 89.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.473 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -81.29 106.15 13.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.777 HD13 HG23 ' A' ' 164' ' ' VAL . 4.1 pp -132.31 134.83 25.43 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.128 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 53.8 Cg_endo -69.15 125.63 12.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.407 2.072 . . . . 0.0 111.817 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 158.96 15.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.081 0.467 . . . . 0.0 111.061 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' HG3' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -92.9 -175.27 3.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.804 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -40.79 83.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.21 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 171.79 65.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 137' ' ' GLU . 17.2 t -109.76 165.05 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' N ' HG12 ' A' ' 136' ' ' VAL . 34.9 tt0 -29.19 132.6 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.06 101.29 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.745 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.94 49.24 3.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.342 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.851 HD11 ' HB3' ' A' ' 165' ' ' ALA . 32.7 mm -94.64 134.59 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.581 0.229 . . . . 0.0 110.878 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.691 HG22 ' HB3' ' A' ' 157' ' ' SER . 29.6 m -126.44 139.93 52.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.893 0.377 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.967 HD12 HG22 ' A' ' 194' ' ' VAL . 11.8 mt -113.24 164.09 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.485 ' N ' HG22 ' A' ' 142' ' ' ILE . 1.1 m -160.79 147.56 15.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.9 t -96.08 148.01 33.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 179.945 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.62 0.248 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 164.57 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.445 2.097 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.619 ' O ' HG13 ' A' ' 155' ' ' VAL . 12.8 mt -114.72 -177.97 3.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.704 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 154' ' ' LEU . 3.5 m -161.85 154.0 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.615 HG21 HD11 ' A' ' 159' ' ' ILE . 2.7 mt -71.09 147.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.441 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.691 ' HB3' HG22 ' A' ' 141' ' ' THR . 29.2 t -128.09 -2.86 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.416 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 172.4 135.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.828 0.347 . . . . 0.0 110.607 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.809 HG21 ' HB2' ' A' ' 166' ' ' HIS . 6.5 mt -137.16 136.66 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.476 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 150.52 26.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.519 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -85.12 66.97 10.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.33 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.255 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.432 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -154.21 139.86 17.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.054 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.777 HG23 HD13 ' A' ' 130' ' ' LEU . 25.4 m -48.79 -24.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.441 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.955 ' O ' HG22 ' A' ' 168' ' ' THR . . . -46.8 -71.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.809 ' HB2' HG21 ' A' ' 159' ' ' ILE . 86.3 t60 -76.67 -25.52 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 111.099 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -56.47 -29.98 62.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.784 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.955 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.2 t -62.78 -23.94 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.811 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.43 71.08 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.887 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.762 HG21 ' CE1' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -172.39 -42.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.953 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.661 HD13 ' O ' ' A' ' 165' ' ' ALA . 1.1 mp -59.48 100.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -128.3 139.97 52.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.29 102.02 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.22 -18.81 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.641 ' CB ' HG21 ' A' ' 208' ' ' ILE . 8.1 m-20 -72.97 134.6 44.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.73 103.98 16.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.555 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -70.47 137.51 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 178' ' ' LEU . 8.4 tt -133.43 -40.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.655 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -129.78 149.1 51.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.92 0.391 . . . . 0.0 111.387 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.755 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 27.3 mt -139.23 113.86 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.294 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 24.9 t70 47.65 55.35 8.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.18 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.8 t30 84.9 -35.88 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.428 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 184' ' ' ARG . 44.1 mm -67.3 159.18 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 110.63 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.497 ' N ' HG22 ' A' ' 183' ' ' ILE . 10.1 mtp180 -134.74 129.49 34.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 1.036 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.4 mm? -74.53 -6.23 47.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.574 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -41.33 7.91 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.3 t -115.85 -18.06 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -171.14 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -120.7 -176.9 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.557 ' HG3' HD22 ' A' ' 154' ' ' LEU . 6.7 ttp -69.12 -57.14 5.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -54.31 -31.1 53.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.864 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.8 OUTLIER -62.99 -48.79 77.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.097 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 1.036 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -57.02 -39.41 74.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.164 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.967 HG22 HD12 ' A' ' 142' ' ' ILE . 21.7 t -60.14 -41.19 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.867 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -50.04 75.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.856 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 192' ' ' ASP . 3.0 mp -69.51 -24.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.614 HD13 HD11 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -57.92 -37.59 74.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.357 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -96.73 -35.67 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.028 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -16.68 61.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.847 ' HB3' HG22 ' A' ' 204' ' ' VAL . 8.5 m -86.04 41.23 0.91 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.339 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.64 62.37 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.238 0.542 . . . . 0.0 111.068 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -174.18 -30.67 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.465 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 203' ' ' LEU . 3.6 tt 176.72 109.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.393 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 200' ' ' CYS . 21.8 t -104.3 125.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.613 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -108.16 108.32 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.883 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.555 ' HG ' HD21 ' A' ' 177' ' ' LEU . 1.1 mp -87.37 108.2 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.446 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.655 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 7.6 tttt -97.37 98.5 10.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.653 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.641 HG21 ' CB ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -106.34 172.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 3.4 mmt180 -108.94 138.82 44.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.451 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . 0.419 ' HE2' ' CD2' ' A' ' 126' ' ' PHE . 6.4 mptt -119.27 157.25 28.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.971 0.415 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 21' ' ' HIS . 11.1 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.357 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.432 ' N ' HG22 ' A' ' 20' ' ' VAL . 51.3 p-80 -109.38 136.09 49.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -54.68 167.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.409 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -162.96 156.66 20.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -113.25 149.05 34.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.179 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.521 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -144.07 165.62 27.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -101.91 158.9 15.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.97 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 109' ' ' LEU . 2.9 p -143.65 151.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.496 0.665 . . . . 0.0 111.612 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.76 110.82 21.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.102 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD21 HD12 ' A' ' 39' ' ' ILE . 5.7 mp -109.77 118.75 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.885 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -109.4 161.54 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.271 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -92.89 112.51 24.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.06 156.0 44.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.609 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.7 7.6 3.06 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.556 2.171 . . . . 0.0 112.953 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 35' ' ' THR . 31.3 t -107.58 -47.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 111.181 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 34' ' ' VAL . 34.8 p -146.35 6.75 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 37' ' ' PHE . . . 66.86 -79.04 0.14 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.501 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 4.8 m-85 -132.67 113.76 13.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.187 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.18 -2.55 62.76 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.916 -0.584 . . . . 0.0 114.07 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.001 HD11 HD13 ' A' ' 72' ' ' LEU . 18.1 mt -92.98 136.32 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 111.944 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 mt-30 -113.84 120.62 41.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.038 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 55' ' ' PRO . 6.8 mp -95.35 136.89 35.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.195 0.521 . . . . 0.0 111.935 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 169.46 8.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.74 64.88 0.35 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.384 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -161.78 63.16 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.126 0.488 . . . . 0.0 111.021 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.523 HG22 HD13 ' A' ' 56' ' ' LEU . 2.1 t -85.76 -70.4 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.671 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.0 p90 -40.85 -43.97 2.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.17 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 54.81 76.24 0.26 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 49' ' ' GLU . 2.7 t 169.88 -164.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.864 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 48' ' ' THR . 16.3 pt-20 -46.81 167.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.603 0.24 . . . . 0.0 110.717 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 49' ' ' GLU . 11.0 t 45.53 -159.42 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.194 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.841 HD13 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -149.18 -85.8 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.342 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.42 14.48 1.15 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.79 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 3.9 t -75.59 113.87 30.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.58 ' O ' HD23 ' A' ' 56' ' ' LEU . 59.9 Cg_endo -72.01 151.48 56.11 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.27 1.98 . . . . 0.0 111.696 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.645 ' HB3' HD23 ' A' ' 41' ' ' LEU . 71.7 Cg_exo -47.84 111.2 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.341 2.027 . . . . 0.0 112.189 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -120.12 110.69 16.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.824 ' CD1' HD13 ' A' ' 39' ' ' ILE . 39.4 mt -56.21 124.92 10.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.858 0.361 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -8.25 27.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 45.7 t80 177.61 138.58 0.08 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.005 0.431 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.815 HG21 ' HB2' ' A' ' 67' ' ' GLU . 5.0 mt -113.82 169.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.337 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.54 ' H ' HG22 ' A' ' 60' ' ' ILE . 65.9 tt0 -108.46 151.97 25.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 111.368 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.423 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -91.61 46.59 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.356 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 177.46 44.34 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.892 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.433 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -142.44 142.18 22.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.998 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.79 -13.06 24.48 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.655 2.237 . . . . 0.0 112.889 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.611 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -64.77 -56.75 11.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 110.255 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.815 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -79.08 -29.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.896 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.44 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -69.42 -20.22 63.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.238 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.0 t -47.3 -29.31 2.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.22 58.24 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.456 HG13 ' HA2' ' A' ' 162' ' ' GLY . 4.0 t -152.63 37.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.001 HD13 HD11 ' A' ' 39' ' ' ILE . 10.7 mt -142.15 172.53 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 111.624 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.22 150.15 10.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.441 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.5 98.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.922 0.392 . . . . 0.0 111.337 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 95.62 40.8 4.05 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.248 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.806 ' CG ' HD12 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -78.17 -14.21 59.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.631 0.253 . . . . 0.0 111.399 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.7 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.8 mtm-85 63.09 136.05 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 109' ' ' LEU . 10.2 t -114.07 152.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.212 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.708 ' HE2' ' HB2' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -114.25 -34.12 5.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.708 ' HB2' ' HE2' ' A' ' 79' ' ' MET . . . -148.7 142.86 26.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.682 HG23 HD22 ' A' ' 109' ' ' LEU . 28.2 mt -128.39 111.13 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.916 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 54.24 25.11 5.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.13 -21.89 36.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.567 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.2 mt -75.32 128.84 83.68 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-O 120.531 0.205 . . . . 0.0 111.142 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 86' ' ' THR . 33.2 Cg_exo -57.65 -160.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.456 2.104 . . . . 0.0 112.212 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 85' ' ' PRO . 23.3 p -158.22 -49.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -7.25 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.42 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -112.22 45.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 t -178.31 175.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.841 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.04 144.32 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -51.61 -27.35 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.155 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.79 -35.07 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 1.7 pp20? -64.28 -37.41 87.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.786 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -69.24 -35.83 76.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.255 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.95 -42.71 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.963 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.788 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 0.9 OUTLIER -69.1 -42.37 76.21 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.164 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 98' ' ' LEU . 4.0 pp -64.8 -32.37 74.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 97' ' ' LEU . 4.2 mt -63.09 -57.42 10.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.788 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -52.33 -30.41 28.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.607 ' O ' HD11 ' A' ' 103' ' ' ILE . 68.6 m-20 -115.67 36.62 3.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.927 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -105.36 15.06 27.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.326 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -112.32 18.73 18.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 100' ' ' ASP . 2.1 mt -63.73 -46.55 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.689 0.757 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.92 0.13 57.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.502 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.885 ' O ' HG22 ' A' ' 30' ' ' THR . 1.2 m 63.26 26.27 15.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -166.16 146.03 6.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.78 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.504 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.2 t -149.02 111.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.624 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.535 ' C ' HD23 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -93.12 133.67 36.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.682 HD22 HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -142.25 165.27 27.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 111.222 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.18 136.98 52.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.393 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.806 HD12 ' CG ' ' A' ' 76' ' ' ASP . 27.6 pt -128.85 166.07 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.677 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -128.48 142.77 50.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.729 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -161.2 174.72 13.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.922 0.392 . . . . 0.0 111.236 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -88.75 150.49 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.401 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.4 m -101.57 104.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.006 0.431 . . . . 0.0 111.41 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -168.09 130.3 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.616 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.618 ' HB2' HG22 ' A' ' 168' ' ' THR . 69.7 mm-40 -130.2 6.56 4.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.01 71.21 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.34 0.59 . . . . 0.0 111.247 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.752 ' CG1' HG13 ' A' ' 128' ' ' VAL . 3.1 m -97.69 147.45 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.718 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.792 HD11 ' CG ' ' A' ' 127' ' ' HIS . 2.1 pp -122.92 102.31 38.09 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.889 0.376 . . . . 0.0 111.473 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.3 Cg_endo -87.71 154.81 7.52 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.96 2.44 . . . . 0.0 112.605 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -162.61 24.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.429 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 118.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.859 0.361 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.61 -45.95 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.5 102.43 6.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.643 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 8.4 t80 -107.14 115.93 31.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.792 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -99.72 144.96 28.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.145 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.752 HG13 ' CG1' ' A' ' 119' ' ' VAL . 2.7 t -118.3 97.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.978 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HE2' HD11 ' A' ' 203' ' ' LEU . 2.0 mttt -81.29 99.01 8.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.072 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 128' ' ' VAL . 3.0 mp -109.82 114.73 56.24 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.415 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.94 110.39 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.164 1.91 . . . . 0.0 111.307 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.754 ' HG3' HG23 ' A' ' 204' ' ' VAL . 1.1 mttt -89.7 158.65 17.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.611 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.791 ' HD2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -122.85 178.23 5.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.629 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.656 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 34.4 t-80 -41.77 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.715 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.422 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 3.0 m -138.63 97.37 3.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.883 0.373 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.791 HG23 ' HD2' ' A' ' 133' ' ' LYS . 2.2 t -143.21 141.46 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.49 141.98 58.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.027 HD23 HD11 ' A' ' 140' ' ' ILE . 1.3 tp -95.88 -41.94 8.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' A' ' 160' ' ' LYS . . . 94.0 13.84 53.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.267 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 1.027 HD11 HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -112.17 139.38 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.424 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 41.0 m -111.86 142.18 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 143' ' ' SER . 6.6 mt -103.35 164.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.033 0.444 . . . . 0.0 111.18 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.553 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -160.18 158.64 30.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.724 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.8 p -129.33 106.38 17.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.611 ' HD3' HG22 ' A' ' 155' ' ' VAL . 76.1 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.527 2.151 . . . . 0.0 112.381 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.717 0.294 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.536 ' O ' HD22 ' A' ' 154' ' ' LEU . 59.5 Cg_endo -72.17 172.04 15.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.573 2.182 . . . . 0.0 112.404 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.723 HD21 ' HA ' ' A' ' 190' ' ' MET . 4.0 mm? -123.92 141.85 51.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.611 HG22 ' HD3' ' A' ' 145' ' ' PRO . 34.9 m -156.38 148.69 11.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 156' ' ' ILE . 3.4 mp -68.0 152.19 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.17 -6.94 3.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.73 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 179.68 147.82 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.0 111.448 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.569 HG21 ' ND1' ' A' ' 166' ' ' HIS . 17.1 mt -139.13 149.79 23.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.465 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.613 ' HD3' ' N ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -138.7 144.26 39.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.373 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.52 72.58 5.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.613 ' N ' ' HD3' ' A' ' 160' ' ' LYS . . . -134.08 -44.37 0.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.194 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.14 176.61 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.248 0.547 . . . . 0.0 111.424 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.0 m -53.69 -21.52 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.384 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -42.69 -69.72 0.13 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.569 ' ND1' HG21 ' A' ' 159' ' ' ILE . 5.4 t60 -68.07 -27.25 66.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -59.6 -29.42 67.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.27 -179.618 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 128' ' ' VAL . 70.5 p -45.83 -29.83 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.53 58.61 8.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.541 HG21 HG11 ' A' ' 119' ' ' VAL . 4.5 t -178.83 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.67 93.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.019 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.71 146.9 27.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 35.4 mt -69.05 84.3 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.47 43.2 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.585 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.409 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.9 OUTLIER -119.58 145.01 46.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 0.0 110.457 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.401 ' HA ' HG12 ' A' ' 155' ' ' VAL . 10.2 mmtp -97.15 115.71 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 111.151 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.562 HD22 ' CD1' ' A' ' 180' ' ' ILE . 4.6 mt -87.87 135.04 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.75 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.97 -27.13 6.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.742 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -148.13 162.23 39.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.943 0.401 . . . . 0.0 111.551 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 179' ' ' ALA . 20.3 mm -139.44 110.22 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.968 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 21.2 t70 63.52 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.157 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -128.29 -22.6 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 184' ' ' ARG . 43.3 mm -87.83 157.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.801 0.334 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.695 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 9.1 mtt180 -126.31 129.75 49.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.076 0.465 . . . . 0.0 112.051 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.881 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.3 mm? -71.98 -6.36 41.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.727 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -45.51 -42.18 10.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.6 p -116.16 -19.67 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.211 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.78 -176.01 5.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -118.34 -175.67 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.723 ' HA ' HD21 ' A' ' 154' ' ' LEU . 11.9 ttp -63.05 -55.18 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.56 -29.87 18.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.799 ' O ' HD12 ' A' ' 196' ' ' ILE . 1.1 m-20 -64.32 -54.09 38.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.749 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.881 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -52.06 -32.57 35.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.899 0.38 . . . . 0.0 110.206 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.474 HG22 HD13 ' A' ' 142' ' ' ILE . 23.0 t -64.77 -47.81 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.819 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.632 ' OE1' ' O ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -70.77 -32.35 69.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.208 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.799 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.5 mt -75.77 -26.21 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -63.93 -40.56 96.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.287 179.033 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -86.64 -42.66 13.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.224 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.12 -18.56 48.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.497 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.861 ' HB3' HG22 ' A' ' 204' ' ' VAL . 4.6 m -86.25 42.23 0.98 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.374 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.98 62.42 0.87 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.247 0.546 . . . . 0.0 111.147 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.42 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 3.2 m-20 -171.3 -33.01 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.058 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.0 tt 177.89 106.93 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.308 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.861 HG22 ' HB3' ' A' ' 200' ' ' CYS . 21.6 t -102.3 121.77 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.349 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 0.6 OUTLIER -100.81 107.71 19.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.935 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.575 ' O ' HD13 ' A' ' 208' ' ' ILE . 3.1 mp -85.81 104.27 15.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.976 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.465 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -89.73 93.79 9.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -101.72 172.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.65 133.52 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.72 159.15 33.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.617 HG21 ' O ' ' A' ' 115' ' ' VAL . 9.3 p . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.732 0.301 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.448 ' N ' HG22 ' A' ' 20' ' ' VAL . 65.4 t60 -92.93 134.17 35.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.37 174.21 3.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -168.49 162.11 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.711 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -131.21 144.97 51.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -139.52 -173.51 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.944 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -103.15 161.14 14.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 111' ' ' ILE . 2.2 t -147.01 149.08 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.58 113.89 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.578 HD22 ' HD2' ' A' ' 37' ' ' PHE . 3.6 mt -110.1 118.92 37.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -110.66 161.81 15.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.22 0.533 . . . . 0.0 111.742 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.892 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.79 119.93 39.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.104 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.777 ' OD1' HG23 ' A' ' 34' ' ' VAL . 8.8 t0 -88.53 141.96 30.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.338 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.18 3.94 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.48 2.12 . . . . 0.0 113.04 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.777 HG23 ' OD1' ' A' ' 32' ' ' ASP . 28.3 t -101.27 -53.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 t -141.25 6.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.947 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 67.96 -107.93 2.25 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.162 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.892 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 6.2 m-85 -106.87 128.26 54.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -91.88 25.15 17.7 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.863 -0.684 . . . . 0.0 114.798 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -126.39 130.93 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.68 0.74 . . . . 0.0 111.826 179.213 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 116.21 29.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.175 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -96.87 145.6 25.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.389 0.614 . . . . 0.0 112.552 -178.179 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -122.25 169.59 10.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.818 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 45' ' ' VAL . . . -116.46 -47.59 0.5 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.791 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -47.04 123.92 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.554 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 43' ' ' GLY . 98.8 t -140.2 -83.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.901 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 39.0 p90 -40.5 -45.54 2.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.175 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.511 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 51.94 73.63 0.31 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.264 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER 165.33 90.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.636 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 50' ' ' THR . 0.3 OUTLIER 55.17 176.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 49' ' ' GLU . 12.7 t 44.89 -163.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -147.8 -101.41 0.09 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.193 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.94 18.36 1.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.842 0.353 . . . . 0.0 111.555 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.46 107.85 1.75 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.038 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.441 ' O ' ' CD2' ' A' ' 56' ' ' LEU . 7.7 Cg_exo -72.91 167.4 27.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.653 2.235 . . . . 0.0 111.998 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.698 ' HA ' HD21 ' A' ' 41' ' ' LEU . 24.4 Cg_exo -63.83 128.63 22.51 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.711 2.274 . . . . 0.0 112.132 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.737 HD13 HG22 ' A' ' 45' ' ' VAL . 1.3 pt? -145.84 100.65 3.44 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.811 0.339 . . . . 0.0 111.804 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 39' ' ' ILE . 46.2 mt -64.62 156.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.519 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 57' ' ' ILE . 2.0 m -139.15 8.14 2.46 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' H ' HG22 ' A' ' 57' ' ' ILE . 52.8 t80 -178.14 134.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 112.081 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.709 HG13 HG23 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.89 -173.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.655 ' N ' HG23 ' A' ' 60' ' ' ILE . 29.0 tt0 -125.3 125.61 43.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.967 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -53.01 109.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.963 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER 84.72 46.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.353 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.92 154.28 76.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.89 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 22.4 Cg_exo -63.4 -12.04 28.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.392 2.061 . . . . 0.0 112.261 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.648 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -72.01 -57.1 4.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HB2' HG21 ' A' ' 60' ' ' ILE . 1.1 tp10 -79.08 -29.03 43.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.093 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -89.11 -7.19 56.25 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.582 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -46.88 -46.85 21.37 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.844 0.354 . . . . 0.0 111.204 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.791 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 123.16 -25.45 6.36 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.264 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.616 HG13 ' CA ' ' A' ' 162' ' ' GLY . 40.3 t -139.39 63.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.437 . . . . 0.0 110.803 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 66' ' ' ALA . 15.0 mt -148.28 169.67 19.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.012 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -164.07 162.09 22.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.742 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.7 mm -60.54 85.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.286 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.08 90.94 1.87 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.659 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB2' HG21 ' A' ' 111' ' ' ILE . 13.5 p30 -112.26 115.63 29.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.735 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 109' ' ' LEU . 29.0 t -72.98 115.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.5 tpt -83.25 -42.04 17.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.21 28.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.728 HG21 ' CD1' ' A' ' 97' ' ' LEU . 9.2 mt -131.54 119.64 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.95 23.16 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.94 -22.39 31.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.645 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' THR . 45.2 mt -70.39 127.77 91.83 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.429 0.157 . . . . 0.0 111.229 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.543 ' C ' HG23 ' A' ' 86' ' ' THR . 33.3 Cg_endo -64.14 -31.15 65.06 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.44 2.094 . . . . 0.0 112.238 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.543 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 75.74 -54.96 0.62 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.152 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -66.93 -13.79 62.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.09 44.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.78 -175.91 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.787 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 m -68.52 156.58 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -73.1 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.007 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -55.54 -32.78 63.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -66.18 -36.09 82.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.801 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.709 ' HA ' HD23 ' A' ' 97' ' ' LEU . . . -71.16 -34.96 71.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -74.13 -32.15 63.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.651 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -72.5 -37.27 68.45 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' CD1' HG21 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -70.58 -38.74 74.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.206 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 41' ' ' LEU . 71.1 mt -73.47 -55.81 5.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.308 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.25 -30.01 16.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.4 OUTLIER -119.01 37.95 3.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.584 178.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -95.87 26.67 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.004 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -119.17 12.01 12.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.65 -47.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.642 0.734 . . . . 0.0 110.596 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -2.89 56.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.62 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.742 ' O ' HG22 ' A' ' 30' ' ' THR . 0.3 OUTLIER 62.69 26.97 15.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.992 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -170.03 154.95 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.101 0.477 . . . . 0.0 111.099 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 101' ' ' SER . 27.4 t -155.8 145.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.38 120.42 32.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.315 . . . . 0.0 110.805 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -142.05 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -105.6 145.85 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 27' ' ' VAL . 28.5 pt -125.49 142.65 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.702 ' HG3' HG23 ' A' ' 24' ' ' THR . 17.3 tt0 -107.97 129.35 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.401 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 3.4 p90 -153.87 174.42 14.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.188 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.522 ' HB3' HG11 ' A' ' 20' ' ' VAL . 2.3 m-20 -98.5 135.41 40.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.62 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.617 ' O ' HG21 ' A' ' 20' ' ' VAL . 35.1 m -75.47 104.97 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.995 0.426 . . . . 0.0 111.395 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.17 124.45 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' OE2' HG12 ' A' ' 164' ' ' VAL . 1.4 mm-40 -135.62 33.3 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 2.1 t 80.7 91.53 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.297 0.57 . . . . 0.0 110.982 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.815 ' CG1' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -128.28 127.15 67.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.668 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.614 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.7 pp -109.95 97.18 28.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.537 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 88.9 Cg_endo -84.11 159.91 13.47 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.752 2.301 . . . . 0.0 112.691 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.74 27.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.68 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.84 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.7 -40.97 3.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.233 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.402 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -126.86 102.93 7.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 0.0 110.994 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -109.98 119.43 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.487 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -105.59 120.76 42.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.311 . . . . 0.0 110.774 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.815 HG13 ' CG1' ' A' ' 119' ' ' VAL . 4.3 t -99.74 95.52 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -81.49 102.75 10.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -115.6 125.01 29.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 121.37 7.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.403 2.069 . . . . 0.0 111.762 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.82 ' HZ1' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -92.5 159.4 15.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 111.345 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -108.78 -164.88 0.98 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.863 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.17 -38.74 78.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 m -175.57 69.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.232 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.791 HG13 ' HA2' ' A' ' 70' ' ' GLY . 90.3 t -107.3 145.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 145.62 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.956 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.82 HD21 ' HZ1' ' A' ' 132' ' ' LYS . 10.6 mt -105.93 -60.38 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 91.64 19.61 40.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.125 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -98.45 146.86 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.73 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 157' ' ' SER . 27.1 m -126.19 128.41 47.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 1.006 HD12 HG22 ' A' ' 194' ' ' VAL . 7.2 mt -101.87 163.07 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.061 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -144.84 149.12 34.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.1 t -97.48 106.64 34.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.432 ' HG3' HG23 ' A' ' 155' ' ' VAL . 89.9 Cg_endo . . . . . 0 C--N 1.344 0.306 0 C-N-CA 122.614 2.209 . . . . 0.0 112.334 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.9 t0 . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.529 0.204 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.521 ' O ' HD22 ' A' ' 154' ' ' LEU . 56.2 Cg_endo -70.35 -167.95 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.537 2.158 . . . . 0.0 112.435 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.951 HD12 ' CG2' ' A' ' 142' ' ' ILE . 3.1 mm? -131.15 155.88 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 156' ' ' ILE . 11.9 t -142.22 162.23 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.335 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.513 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.7 mm -89.72 154.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.546 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.666 ' HB3' HG22 ' A' ' 141' ' ' THR . 8.8 t -132.45 -20.93 2.31 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.4 OUTLIER 174.78 136.19 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.861 HG12 HD12 ' A' ' 171' ' ' LEU . 0.7 OUTLIER -123.64 149.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.837 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.408 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -105.78 164.4 11.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -96.86 166.16 11.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.616 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . 91.47 -30.18 6.65 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.988 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 1.6 t -97.95 149.65 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 111.476 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.486 HG12 ' OE2' ' A' ' 117' ' ' GLU . 17.0 m -52.76 -21.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.843 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.716 ' O ' HG22 ' A' ' 168' ' ' THR . . . -51.08 -64.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.412 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 16.5 t60 -83.19 -24.26 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.52 -39.27 67.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.038 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.792 HG21 HG11 ' A' ' 128' ' ' VAL . 2.7 t -56.41 -28.14 58.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.947 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.607 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.633 ' CG2' HG11 ' A' ' 119' ' ' VAL . 66.9 p -57.57 -25.15 59.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.861 HD12 HG12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.58 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.795 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.29 166.61 11.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.973 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.5 mt -92.38 116.65 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.04 29.25 2.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.698 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 138.12 41.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.767 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -90.31 106.17 18.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.775 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.039 HD22 HD11 ' A' ' 180' ' ' ILE . 9.1 mt -70.56 134.9 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.043 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.637 HD22 ' NZ ' ' A' ' 207' ' ' LYS . 7.3 tt -120.18 -51.37 2.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.674 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -128.19 156.54 42.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 1.039 HD11 HD22 ' A' ' 177' ' ' LEU . 28.6 mm -139.59 105.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.081 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.675 ' OD2' HG12 ' A' ' 204' ' ' VAL . 0.4 OUTLIER 68.13 -67.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.038 0.447 . . . . 0.0 110.738 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' ILE . 1.5 m120 -147.99 -24.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.665 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.52 139.69 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.161 0.505 . . . . 0.0 111.199 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 4.1 mtp-105 -102.48 123.7 46.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.803 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.782 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 3.2 mm? -74.89 -5.52 44.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.446 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -45.87 -28.92 1.21 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 m -134.31 42.73 2.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.685 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.29 153.55 38.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -177.53 0.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.458 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.696 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.03 -54.47 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.55 -29.82 18.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.81 -52.15 66.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.25 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.782 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -57.18 -40.59 77.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.191 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 1.006 HG22 HD12 ' A' ' 142' ' ' ILE . 11.9 t -62.31 -39.4 84.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.674 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -46.92 87.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.117 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -72.52 -24.71 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -58.94 -36.14 74.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.848 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 1.0 OUTLIER -104.04 -44.57 4.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.262 -179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.58 -26.02 19.79 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.014 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 196' ' ' ILE . 0.2 OUTLIER -95.43 44.52 1.09 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.394 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 3.2 tt0 -68.76 53.34 0.08 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.241 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.572 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -141.59 -25.93 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.719 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 203' ' ' LEU . 1.3 tt 165.14 112.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.675 HG12 ' OD2' ' A' ' 181' ' ' ASP . 3.5 m -105.26 132.51 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -107.89 107.97 18.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.457 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.28 104.3 15.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.402 . . . . 0.0 111.807 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.674 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 19.6 tttt -97.29 93.69 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.165 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.546 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -106.82 -177.54 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.208 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.42 127.33 44.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -115.97 159.56 21.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.622 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 115' ' ' VAL . 11.5 p . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.746 0.308 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.485 ' N ' HG22 ' A' ' 20' ' ' VAL . 86.5 t60 -76.06 120.7 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.6 p -55.29 174.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.275 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' OE1' HG11 ' A' ' 115' ' ' VAL . 6.5 mt-10 -164.55 140.99 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -107.13 160.31 15.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.439 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -151.12 -178.49 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.29 162.7 15.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG13 HG23 ' A' ' 71' ' ' VAL . 2.2 t -141.93 150.5 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.414 HG13 ' HD3' ' A' ' 106' ' ' LYS . 28.2 t -122.83 112.68 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HG ' HD11 ' A' ' 72' ' ' LEU . 3.5 mt -108.51 118.71 37.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.181 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -107.4 162.27 14.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 111.883 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.89 128.5 45.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.411 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -97.29 147.1 32.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.412 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.63 16.59 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.479 2.119 . . . . 0.0 112.666 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.06 -47.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 t -131.58 -18.92 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 62.17 87.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.278 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.724 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 54.4 m-85 65.62 93.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 109.767 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -74.49 13.96 4.57 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.567 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.981 HG22 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -109.9 133.91 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 117.38 0.59 . . . . 0.0 111.707 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.607 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.3 mt-30 -97.65 128.27 44.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -96.15 155.82 16.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.306 0.574 . . . . 0.0 112.239 -178.272 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.5 169.1 17.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.204 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.74 23.92 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.821 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -122.12 93.63 4.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.537 HG22 HD13 ' A' ' 56' ' ' LEU . 34.8 t -111.08 -78.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.2 p90 -39.87 -44.36 1.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.207 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.524 ' O ' ' HB ' ' A' ' 48' ' ' THR . . . 51.77 73.27 0.33 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.94 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 47' ' ' ALA . 4.3 t 165.87 -166.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.677 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' N ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -46.01 147.93 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.871 179.652 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 66.9 178.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.482 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -142.63 -101.43 0.13 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.362 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.67 16.75 3.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 0.0 111.572 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 1.9 t -62.0 118.41 38.88 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.11 155.29 52.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.31 2.006 . . . . 0.0 111.922 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.759 ' HG2' HD11 ' A' ' 81' ' ' ILE . 45.9 Cg_exo -54.85 123.8 14.65 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.243 1.962 . . . . 0.0 111.952 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD13 HG22 ' A' ' 45' ' ' VAL . 1.1 pt? -136.23 118.03 15.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 111.264 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.981 HG21 HG22 ' A' ' 39' ' ' ILE . 78.2 mt -76.12 141.23 16.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -113.4 -19.64 11.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.727 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.6 t80 -152.22 139.18 19.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.763 ' CD1' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -107.72 177.17 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.731 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 60' ' ' ILE . 40.5 tt0 -117.49 119.09 34.0 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.186 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -57.35 122.31 12.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.182 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 1.6 t0 82.53 42.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.254 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -138.29 154.53 73.89 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.409 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 46.2 Cg_endo -67.72 -1.38 6.65 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.363 2.042 . . . . 0.0 112.8 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -70.97 -56.62 5.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.694 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -78.92 -29.21 44.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.273 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -92.22 -1.66 56.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.668 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -44.75 -30.74 1.01 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.316 . . . . 0.0 111.315 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.75 -50.34 0.89 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 HG13 ' A' ' 27' ' ' VAL . 29.0 m -137.93 53.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.576 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.8 mt -127.68 137.7 52.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -131.85 -179.5 5.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.038 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.24 73.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.99 77.48 0.22 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.457 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' OD2' HD23 ' A' ' 72' ' ' LEU . 5.5 m-20 -103.29 92.42 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -65.18 101.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 55' ' ' PRO . 28.6 m -97.78 149.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -114.57 -30.15 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -132.91 130.24 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.902 HG23 ' CD1' ' A' ' 109' ' ' LEU . 21.9 mt -128.26 116.64 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.42 25.48 3.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.35 -26.13 24.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.582 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 97' ' ' LEU . 50.6 mt -69.82 124.73 91.22 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-O 120.541 0.21 . . . . 0.0 111.134 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.27 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 79' ' ' MET . 33.1 p -143.42 -45.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -68.31 -12.57 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -113.83 44.33 1.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.38 -174.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.867 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 165.4 12.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -73.1 -27.26 61.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -54.92 -41.4 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -34.19 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.731 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -71.43 -32.52 68.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.248 0.547 . . . . 0.0 110.582 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.27 -36.42 63.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.076 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -74.89 -39.63 61.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.382 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.525 HD11 HG21 ' A' ' 81' ' ' ILE . 2.1 pp -67.61 -40.22 84.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.539 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 41' ' ' LEU . 22.4 mt -65.43 -56.03 14.72 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.6 ppt_? -50.7 -31.31 16.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.493 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.8 p30 -112.28 33.22 5.01 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.801 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 97.9 p -100.26 9.39 42.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.4 t -100.02 15.3 27.69 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.6 mt -67.99 -42.09 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.664 0.745 . . . . 0.0 110.504 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.52 11.19 37.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.598 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 30' ' ' THR . 5.8 m 54.53 24.58 5.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.235 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -162.9 154.68 18.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.46 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -155.31 126.86 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.683 ' C ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -99.88 128.4 45.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.902 ' CD1' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -123.68 158.27 31.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -118.18 118.38 31.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.535 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 25' ' ' THR . 5.4 pt -113.34 163.89 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.424 . . . . 0.0 111.685 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -131.62 144.62 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.46 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.36 174.18 15.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.937 0.399 . . . . 0.0 111.343 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.1 114.45 27.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.492 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.562 HG11 ' OE1' ' A' ' 23' ' ' GLU . 17.4 m -61.88 105.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.337 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -176.07 -135.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 116' ' ' ALA . 9.9 pt-20 48.3 30.55 2.31 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 128' ' ' VAL . 14.6 t 176.89 61.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.076 0.465 . . . . 0.0 111.153 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 119' ' ' VAL . 13.1 p -158.66 118.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.295 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.627 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.5 pp -138.31 97.96 9.35 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.791 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.436 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 90.7 Cg_endo -83.27 150.93 13.63 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.75 2.3 . . . . 0.0 112.91 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -153.55 19.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.18 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.75 114.75 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.051 0.453 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.7 -41.18 2.58 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.128 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.605 HG22 ' HG3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -135.12 108.49 7.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -102.76 128.09 49.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.549 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.627 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.3 134.26 52.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.0 110.487 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 2.9 t -118.22 94.79 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.628 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -83.38 97.94 9.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.402 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.919 HD22 ' HB ' ' A' ' 164' ' ' VAL . 26.7 mt -104.3 117.73 58.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.67 95.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.177 1.918 . . . . 0.0 111.371 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -81.55 159.25 24.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.717 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -114.5 -165.95 1.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.654 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -66.08 -43.64 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.85 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.5 m -179.3 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.717 HG23 ' HB2' ' A' ' 133' ' ' LYS . 40.1 t -94.32 159.84 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.509 ' N ' HG12 ' A' ' 136' ' ' VAL . 33.3 tt0 -51.04 113.63 0.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.686 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.769 HD12 HG12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -117.11 112.08 20.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.915 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . -90.45 47.88 3.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.029 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.971 HG23 ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -109.95 137.06 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.599 0.238 . . . . 0.0 110.384 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 157' ' ' SER . 88.1 m -120.78 109.76 15.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.781 0.324 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.909 HD11 HD22 ' A' ' 197' ' ' LEU . 5.4 mt -87.68 164.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.505 ' N ' HG22 ' A' ' 142' ' ' ILE . 31.1 t -157.67 161.01 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.912 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 21.0 p -115.25 107.79 48.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.548 ' HD3' HG22 ' A' ' 155' ' ' VAL . 50.9 Cg_exo . . . . . 0 C--N 1.346 0.434 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.9 t0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.756 0.312 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -174.13 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.656 2.237 . . . . 0.0 112.434 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 190' ' ' MET . 1.1 mp -121.84 165.41 15.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 175' ' ' ASP . 22.1 m -158.22 148.08 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.474 HG22 ' CD2' ' A' ' 173' ' ' LEU . 7.7 mt -74.97 150.7 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.373 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.45 ' HB2' HG22 ' A' ' 141' ' ' THR . 24.5 m -136.48 -12.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.17 150.09 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 166' ' ' HIS . 1.1 mt -139.94 145.43 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.198 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.467 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -114.85 154.77 28.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 111.398 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.78 76.65 3.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.69 -36.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.568 ' OG ' HD13 ' A' ' 138' ' ' LEU . 8.4 t -101.81 158.87 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.094 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HB ' HD22 ' A' ' 130' ' ' LEU . 16.8 m -48.88 -22.34 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.096 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.971 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.82 -59.41 2.26 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.65 ' HB2' HG22 ' A' ' 159' ' ' ILE . 42.5 t60 -83.66 -25.2 30.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.862 0.363 . . . . 0.0 110.8 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 164' ' ' VAL . 0.0 OUTLIER -58.4 -29.61 66.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.379 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.85 ' HB ' HD21 ' A' ' 130' ' ' LEU . 3.4 t -55.96 -44.9 78.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.1 -20.41 46.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.836 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.506 HG21 HG23 ' A' ' 119' ' ' VAL . 9.2 t -113.2 37.58 3.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.468 HD21 HG22 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -108.49 41.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.764 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.64 144.45 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD2' HG22 ' A' ' 156' ' ' ILE . 19.2 mt -85.05 108.02 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.82 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.99 -20.28 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 155' ' ' VAL . 1.9 m-20 -63.33 157.79 22.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.671 0.272 . . . . 0.0 110.751 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -108.33 100.91 10.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -69.74 165.93 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 179' ' ' ALA . 2.6 pp -158.25 -40.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.076 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 178' ' ' LEU . . . -125.95 129.88 50.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.892 0.377 . . . . 0.0 111.061 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.991 HD12 ' HB1' ' A' ' 193' ' ' ALA . 46.9 mt -118.68 107.47 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.1 t70 66.05 -72.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.7 -19.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.571 ' HB ' HD13 ' A' ' 196' ' ' ILE . 40.7 mm -96.8 157.13 3.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 120.99 0.424 . . . . 0.0 111.251 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.468 ' N ' HG22 ' A' ' 183' ' ' ILE . 79.2 mtt180 -122.38 132.9 54.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.911 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 1.128 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.4 mm? -67.7 -8.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.558 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -47.56 -28.09 2.12 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.038 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.1 p -144.1 46.78 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.26 160.65 30.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.17 -175.92 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.99 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.843 ' HA ' HD11 ' A' ' 154' ' ' LEU . 8.7 ptm -74.24 -45.59 46.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.419 ' N ' ' HG3' ' A' ' 190' ' ' MET . 1.5 mm-40 -52.05 -50.09 62.18 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.197 0.522 . . . . 0.0 110.89 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -52.12 -45.58 64.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.128 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 1.128 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -56.62 -41.58 77.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.517 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.705 HG22 HD12 ' A' ' 142' ' ' ILE . 10.7 t -60.75 -33.9 56.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 109.82 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -61.92 -50.2 73.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.708 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.3 mt -71.08 -24.93 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -60.98 -37.46 82.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.21 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -92.17 -34.5 14.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.656 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -84.9 11.77 8.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.643 178.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 196' ' ' ILE . 30.0 p -66.1 28.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.503 ' H ' ' C ' ' A' ' 199' ' ' GLN . 1.5 mm-40 46.82 46.45 15.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.73 27.51 16.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.769 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 203' ' ' LEU . 1.6 mt -162.87 94.39 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 204' ' ' VAL . 13.1 p -90.34 123.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 2.9 ttmp? -108.8 107.73 18.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.219 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.612 ' HG ' HD21 ' A' ' 177' ' ' LEU . 10.3 mp -89.35 107.09 18.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.605 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.9 OUTLIER -96.99 100.74 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.759 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.54 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -109.77 173.39 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 8.0 mtp180 -105.06 132.88 50.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.23 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -115.88 159.21 21.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.828 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.0 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.992 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 116' ' ' ALA . 2.7 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -139.72 107.68 5.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.01 133.63 38.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.147 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -148.78 157.73 43.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 112' ' ' GLU . 73.0 p -110.43 144.93 38.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 26' ' ' GLU . 27.4 m -140.57 163.29 33.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' N ' HG22 ' A' ' 25' ' ' THR . 1.2 pm0 -104.63 159.33 15.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 136.18 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' C ' HD12 ' A' ' 29' ' ' LEU . 3.9 p -115.97 122.42 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 28' ' ' VAL . 7.1 mp -115.66 118.99 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.896 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -102.49 162.58 12.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.271 0.558 . . . . 0.0 111.932 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -107.33 103.86 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.441 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -75.02 153.27 86.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.332 179.547 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.4 7.89 3.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.447 2.098 . . . . 0.0 112.675 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.42 -45.29 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.567 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -133.7 -8.59 2.8 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.441 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 65.6 -90.48 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.929 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.708 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 3.5 m-85 -131.66 119.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.58 28.27 15.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.361 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.988 HD13 HD13 ' A' ' 72' ' ' LEU . 25.5 pt -126.84 133.35 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -122.36 139.96 53.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.86 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.758 HD12 HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -130.09 157.51 42.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 112.054 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.766 ' HG3' HD13 ' A' ' 56' ' ' LEU . 10.7 pt20 -112.1 170.07 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.204 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.58 17.59 6.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -111.28 67.8 0.65 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.351 0.596 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.005 HG22 HD21 ' A' ' 56' ' ' LEU . 3.4 t -71.43 -35.11 55.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.961 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 45.6 p90 -132.07 -49.59 0.94 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.252 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 42.09 85.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.099 0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 171.0 120.86 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.232 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 58.5 80.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER 85.5 -178.17 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.18 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' H ' HG22 ' A' ' 50' ' ' THR . 1.1 pp -154.82 -147.2 0.2 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.355 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.454 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 2.0 t 81.43 20.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.227 0.537 . . . . 0.0 111.588 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.643 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -47.51 139.13 8.47 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.964 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' HG21 ' A' ' 45' ' ' VAL . 25.0 Cg_endo -61.96 133.33 43.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.551 2.167 . . . . 0.0 112.406 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.49 141.67 25.21 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.513 2.142 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.005 HD21 HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -141.11 115.98 9.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.637 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -66.12 141.35 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.441 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.486 ' C ' HG23 ' A' ' 74' ' ' ILE . 64.0 p -113.69 -26.16 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.519 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB3' ' HG3' ' A' ' 40' ' ' GLN . 56.2 t80 -144.18 154.49 43.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 0.0 111.496 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' A' ' 67' ' ' GLU . 25.7 mm -137.51 151.24 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.718 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.01 148.99 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.209 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.55 44.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.038 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.72 41.5 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.724 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.494 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 17.5 m -136.93 138.49 26.05 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.958 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.4 Cg_endo -56.75 -12.77 9.61 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.79 2.327 . . . . 0.0 113.276 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -65.41 -58.33 6.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 0.0 110.349 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.633 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -80.12 -30.97 39.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.041 178.607 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -57.84 -33.41 68.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.0 t -49.58 -30.44 8.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.006 0.432 . . . . 0.0 110.523 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 137' ' ' GLU . . . 87.95 26.13 29.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.982 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -151.52 29.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 0.0 110.912 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.988 HD13 HD13 ' A' ' 39' ' ' ILE . 6.8 mt -133.55 121.63 22.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -136.01 154.95 50.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.295 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.486 HG23 ' C ' ' A' ' 58' ' ' SER . 54.3 mt -58.14 87.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.233 0.54 . . . . 0.0 111.194 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 132.66 39.55 0.22 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -87.01 132.08 33.9 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.8 102.19 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 109' ' ' LEU . 35.0 t -85.68 121.89 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -29.28 17.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.53 143.51 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 97' ' ' LEU . 1.7 mt -119.39 110.36 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.459 ' OD1' HG13 ' A' ' 107' ' ' VAL . 3.8 m120 59.98 20.13 9.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.73 -33.79 4.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.632 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.4 mt -69.71 116.81 47.21 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 120.45 0.166 . . . . 0.0 111.167 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.53 ' C ' HG23 ' A' ' 86' ' ' THR . 31.2 Cg_endo -63.93 -33.36 63.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.403 2.069 . . . . 0.0 112.049 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.53 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 74.17 0.52 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.66 -20.73 27.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.924 0.392 . . . . 0.0 111.199 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -101.9 44.53 1.01 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 m -179.12 -176.95 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.12 161.97 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -73.28 -29.74 62.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.012 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.18 -31.65 63.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.355 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.37 -53.49 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.765 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -54.85 -42.19 71.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.29 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -65.05 -39.91 93.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -35.42 80.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.922 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.515 HD12 HD12 ' A' ' 81' ' ' ILE . 86.1 mt -57.44 -51.08 70.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 94' ' ' ALA . 3.2 mp -58.81 -45.12 90.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.427 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.21 -38.01 49.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.232 0.539 . . . . 0.0 109.939 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.5 m-20 -122.06 40.86 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.516 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.415 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 54.7 p -94.32 6.74 47.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 p -102.7 15.56 28.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.838 0.351 . . . . 0.0 111.81 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.0 mt -69.24 -47.85 71.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.789 0.804 . . . . 0.0 110.338 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.4 12.11 28.24 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.396 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 14.5 m 52.58 26.13 4.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HD3' HG22 ' A' ' 28' ' ' VAL . 2.2 mmtp -162.83 156.93 20.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.459 HG13 ' OD1' ' A' ' 82' ' ' ASN . 1.4 t -155.9 99.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.696 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 132.49 35.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.618 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -142.12 157.0 45.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.271 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.68 127.85 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.424 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.8 pt -114.19 145.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 111.571 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.531 ' HG3' HG22 ' A' ' 24' ' ' THR . 2.3 tt0 -116.7 115.72 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -132.89 174.12 10.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 0.0 111.274 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.15 131.7 54.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.4 m -66.58 105.69 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.458 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.722 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -170.08 108.43 0.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.88 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.877 ' HB3' HG22 ' A' ' 168' ' ' THR . 2.9 tp10 -133.86 39.47 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.3 t 66.78 89.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.374 0.607 . . . . 0.0 111.286 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.878 HG11 HG21 ' A' ' 170' ' ' THR . 0.0 OUTLIER -125.53 120.3 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.901 179.51 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.616 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.9 pp -102.41 103.81 33.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.338 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 94.0 Cg_endo -85.85 148.21 9.53 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 112.55 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -154.49 22.89 0.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.83 113.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.004 0.431 . . . . 0.0 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.5 -43.86 2.62 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.162 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.01 103.73 7.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 110.995 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -107.65 119.56 39.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.577 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.38 124.1 47.35 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.796 0.332 . . . . 0.0 110.483 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.726 HG13 ' CG1' ' A' ' 119' ' ' VAL . 3.4 t -101.76 90.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.63 98.36 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.293 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 168' ' ' THR . 0.5 OUTLIER -126.68 144.15 48.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 0.0 111.56 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.405 ' HD2' ' HG3' ' A' ' 117' ' ' GLU . 45.1 Cg_endo -68.55 119.68 6.66 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.528 2.152 . . . . 0.0 111.48 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -86.94 153.39 21.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.336 0.588 . . . . 0.0 111.628 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -88.72 -164.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.28 34.96 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.693 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.04 47.99 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.824 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 137' ' ' GLU . 7.4 t -89.84 -121.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 1.1 tt0 -90.72 102.62 15.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 122.1 -0.375 . . . . 0.0 111.442 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 138' ' ' LEU . 10.7 tp -122.63 95.24 4.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.88 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -86.1 45.37 3.46 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.2 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.52 HD11 ' HB2' ' A' ' 165' ' ' ALA . 62.5 mt -92.81 123.61 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 157' ' ' SER . 97.8 m -110.41 101.81 10.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.767 ' CG2' HD12 ' A' ' 154' ' ' LEU . 3.0 mt -91.8 163.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.52 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.509 ' N ' HG22 ' A' ' 142' ' ' ILE . 3.2 t -176.22 176.66 1.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.021 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 t -129.38 129.43 23.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.809 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.345 0.368 0 C-N-CA 122.491 2.127 . . . . 0.0 112.237 -179.955 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.858 0.361 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.09 -167.32 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.586 2.191 . . . . 0.0 112.333 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.767 HD12 ' CG2' ' A' ' 142' ' ' ILE . 2.6 mm? -126.94 149.88 49.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 175' ' ' ASP . 34.0 m -154.01 156.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.286 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 172' ' ' GLU . 1.7 mp -87.3 152.57 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.768 ' HB2' HG22 ' A' ' 141' ' ' THR . 1.6 m -130.95 -19.03 2.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.922 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.433 ' N ' ' HB ' ' A' ' 141' ' ' THR . 28.6 t70 -177.8 143.66 0.34 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -136.77 131.82 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.566 ' HG3' ' H ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -63.59 130.59 44.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 0.9 5.92 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.566 ' H ' ' HG3' ' A' ' 160' ' ' LYS . . . -124.35 0.15 8.78 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.868 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.426 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 4.6 t -95.11 145.97 24.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 168' ' ' THR . 4.3 m -48.89 -25.87 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.765 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -53.62 -69.46 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' HIS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 8.8 t-160 -64.53 -25.66 68.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -56.7 -39.85 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 110.926 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.877 HG22 ' HB3' ' A' ' 117' ' ' GLU . 17.1 p -49.0 -27.75 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.323 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 71.04 1.06 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.878 HG21 HG11 ' A' ' 119' ' ' VAL . 0.1 OUTLIER 176.51 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.863 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 tp -66.45 74.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.441 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -87.91 -170.87 3.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.25 119.97 40.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.78 20.5 4.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.82 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.558 ' O ' HG12 ' A' ' 155' ' ' VAL . 2.0 m-20 -106.98 173.66 6.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.653 0.226 . . . . 0.0 110.459 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.34 142.63 47.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 111.177 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.946 ' CD2' HD11 ' A' ' 180' ' ' ILE . 1.2 tp -101.96 138.63 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.581 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.46 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.364 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.707 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -146.96 165.45 29.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.011 0.434 . . . . 0.0 111.541 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.946 HD11 ' CD2' ' A' ' 177' ' ' LEU . 25.5 mm -139.61 107.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.182 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER 64.98 -73.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.39 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -134.59 -25.24 1.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 184' ' ' ARG . 46.4 mm -87.59 157.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.707 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 8.2 mtp180 -123.57 124.54 43.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 112.113 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.0 mm? -78.94 -4.62 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -45.33 -29.39 1.03 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 m -141.7 51.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.792 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.48 159.31 37.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.45 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -68.29 175.95 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 190' ' ' MET . . . . . 0.677 ' HB2' HD11 ' A' ' 154' ' ' LEU . 25.8 ptm -74.11 -41.86 60.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.988 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 190' ' ' MET . 0.7 OUTLIER -53.81 -29.98 42.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.99 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.8 OUTLIER -61.58 -52.49 64.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.093 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.667 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -56.24 -39.49 72.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.209 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 142' ' ' ILE . 18.4 t -61.61 -39.9 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.673 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -50.33 74.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.124 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.6 mt -69.79 -24.92 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -58.59 -35.48 72.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.588 179.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.29 -40.74 7.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.733 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -22.98 41.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.714 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' CYS . . . . . 0.71 ' CB ' HG22 ' A' ' 204' ' ' VAL . 2.0 m -91.16 42.68 1.11 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.72 62.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.353 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -171.91 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.543 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 203' ' ' LEU . 3.2 tt 175.13 110.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.71 HG22 ' CB ' ' A' ' 200' ' ' CYS . 98.9 t -108.18 138.81 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.477 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 7.3 tttt -109.12 108.03 18.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 7.1 mp -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 111.412 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' LYS . . . . . 0.583 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 2.9 tttt -92.73 93.17 8.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.298 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.473 HD13 HD12 ' A' ' 177' ' ' LEU . 6.6 mm -90.71 163.39 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.015 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 5.7 mtp-105 -107.98 120.72 43.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 150.53 21.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.798 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.77 0.319 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -130.31 136.3 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 21' ' ' HIS . 20.3 t -139.8 158.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.977 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.2 t60 -131.03 98.61 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.408 HG23 ' OD1' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -60.67 119.65 8.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.931 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.1 156.55 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.16 161.29 16.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -149.63 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -122.6 163.1 20.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.58 135.68 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.76 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 28' ' ' VAL . 8.8 p -108.66 122.89 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.525 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 39' ' ' ILE . 31.9 mt -120.07 118.66 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.95 162.12 14.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.601 -179.315 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.898 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.48 140.3 32.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.123 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.73 154.69 37.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.701 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.97 11.16 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.611 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.0 t -114.32 -46.98 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 t -144.64 8.77 1.33 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.21 -117.29 7.77 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.46 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 3.6 m-85 -103.77 128.92 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.424 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -92.47 27.34 10.82 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.305 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 29' ' ' LEU . 3.3 mt -94.08 157.61 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.359 0.6 . . . . 0.0 111.779 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.494 ' N ' HG22 ' A' ' 39' ' ' ILE . 4.2 mt-30 -137.85 104.99 5.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.826 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.829 HD22 HD12 ' A' ' 98' ' ' LEU . 1.1 tp -95.69 144.7 25.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.272 0.558 . . . . 0.0 112.403 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -114.68 151.56 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.25 88.35 0.88 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.135 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.81 104.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.599 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.904 HG23 HD11 ' A' ' 56' ' ' LEU . 13.4 t -76.21 -65.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.549 0.69 . . . . 0.0 109.913 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 21.3 p90 -33.03 -43.75 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.037 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.61 88.65 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.933 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 49' ' ' GLU . 0.9 OUTLIER 170.08 114.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.682 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 48' ' ' THR . 11.5 pt-20 47.09 108.16 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.92 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 49' ' ' GLU . 1.4 p 67.25 -162.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.635 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.5 mt -129.0 -72.89 0.59 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.499 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.7 t 63.69 8.83 3.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.465 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.518 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.1 m -175.63 58.76 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.569 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.608 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 8.0 Cg_exo -67.65 -59.0 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.063 1.842 . . . . 0.0 112.787 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.697 ' HB2' HD21 ' A' ' 41' ' ' LEU . 59.2 Cg_endo -99.82 108.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.919 2.413 . . . . 0.0 112.694 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 45' ' ' VAL . 1.9 pt? -143.89 127.39 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.549 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.675 HD13 HG23 ' A' ' 39' ' ' ILE . 37.6 mt -67.66 136.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.057 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.95 -6.23 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.612 ' HA ' HD12 ' A' ' 74' ' ' ILE . 33.8 t80 -178.02 138.39 0.2 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.043 0.449 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.727 HG21 ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -102.07 -167.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 60' ' ' ILE . 51.7 tt0 -129.14 151.73 49.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.355 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -82.81 114.72 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.411 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 2.9 t70 91.73 39.55 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.534 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 2.5 p -132.92 143.96 50.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.35 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 69' ' ' CYS . 31.5 Cg_exo -58.61 -2.92 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.465 2.11 . . . . 0.0 112.953 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -63.68 -56.89 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.727 ' HG2' HG21 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -78.51 -28.66 46.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.617 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 4.1 mmt-85 -85.49 -1.55 57.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.277 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.533 ' SG ' HD23 ' A' ' 72' ' ' LEU . 31.3 p -58.64 -40.94 84.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 137' ' ' GLU . . . 149.18 -23.75 1.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.96 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.4 p -175.05 84.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' SG ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -134.69 123.4 23.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.726 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.26 159.59 34.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.963 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 59' ' ' TYR . 22.5 mm -61.12 106.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.275 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.74 45.88 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.496 ' OD1' HG21 ' A' ' 111' ' ' ILE . 1.1 t70 -70.88 101.36 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -70.73 66.06 0.34 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.013 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.757 HG12 HD13 ' A' ' 109' ' ' LEU . 34.3 m -64.85 129.85 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.59 -29.6 11.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.23 148.7 31.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.404 . . . . 0.0 111.608 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.461 HD12 HD12 ' A' ' 97' ' ' LEU . 6.7 mt -130.24 112.41 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.769 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.3 m120 62.25 21.84 12.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.025 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.76 16.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.679 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.2 mt -74.32 136.24 75.51 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 120.537 0.208 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 -170.7 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.514 2.143 . . . . 0.0 112.232 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.6 p -150.76 -60.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -64.83 -16.62 63.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.376 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -106.35 43.9 1.1 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.652 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.47 -175.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -71.41 149.06 46.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.465 ' CB ' ' HB3' ' A' ' 54' ' ' PRO . 9.0 p90 -73.42 -33.64 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -54.92 -42.53 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.953 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 pt-20 -61.17 -39.27 89.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.498 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.61 94.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.232 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.501 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -61.36 -39.55 91.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.791 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.402 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 2.1 mm-40 -62.49 -39.81 94.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.484 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.461 HD12 HD12 ' A' ' 81' ' ' ILE . 14.8 mt -57.05 -49.98 74.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.829 HD12 HD22 ' A' ' 41' ' ' LEU . 7.1 mt -60.46 -58.77 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 49.8 mtt180 -50.28 -29.84 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 109.94 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.548 ' O ' HD11 ' A' ' 103' ' ' ILE . 3.6 m-20 -114.89 33.15 5.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.845 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.664 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.8 45.27 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.865 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -142.75 16.82 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.548 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.8 mp -65.4 -45.24 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.552 0.691 . . . . 0.0 110.901 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.23 11.89 38.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.495 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.8 ' O ' HG22 ' A' ' 30' ' ' THR . 20.5 t 57.92 25.31 11.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.033 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 1.5 ttpt -165.88 145.46 6.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.744 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.512 HG11 ' OG ' ' A' ' 101' ' ' SER . 2.7 t -141.73 135.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.559 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.757 HD13 HG12 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -139.1 165.12 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.391 . . . . 0.0 111.335 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -118.14 141.04 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 78' ' ' VAL . 30.4 pt -133.15 159.12 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -123.14 143.0 50.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.527 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.44 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 1.2 p90 -161.11 174.29 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.281 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' OD1' HG23 ' A' ' 22' ' ' THR . 3.1 m-20 -102.95 149.6 24.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.376 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.7 m -97.98 104.8 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -179.68 -147.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.1 12.52 2.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.822 0.344 . . . . 0.0 110.811 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.6 t -178.8 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.665 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.412 HG22 ' CG2' ' A' ' 170' ' ' THR . 41.3 t -156.29 117.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.478 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 1.039 HG23 ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -157.24 84.53 2.91 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-O 121.233 0.539 . . . . 0.0 111.084 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 65.1 Cg_endo -94.65 -169.49 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.299 2.666 . . . . 0.0 112.636 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -178.49 34.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.745 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 58.9 114.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.89 -39.48 2.87 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.309 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.706 HG22 ' HG3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.9 113.43 12.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -103.57 126.29 50.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.653 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 1.039 ' HB2' HG23 ' A' ' 120' ' ' ILE . 7.3 m80 -101.58 135.26 43.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.756 HG12 HD13 ' A' ' 130' ' ' LEU . 14.6 t -137.82 86.59 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.748 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -81.51 106.21 13.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.38 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.792 HD11 ' HB ' ' A' ' 168' ' ' THR . 2.8 mp -109.11 132.22 21.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.372 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 108.45 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.159 1.906 . . . . 0.0 111.057 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.1 OUTLIER -86.64 158.62 19.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.477 . . . . 0.0 111.471 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.428 ' HG3' ' CG2' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -128.36 -174.93 3.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.167 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -56.36 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.5 m -153.94 74.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 137' ' ' GLU . 95.5 t -113.37 156.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' HG12 ' A' ' 136' ' ' VAL . 36.7 tt0 -56.45 110.44 0.78 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.437 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 140' ' ' ILE . 2.8 mt -96.61 -52.89 3.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.357 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . 93.57 9.03 60.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.799 HD12 HD13 ' A' ' 138' ' ' LEU . 21.2 mt -79.38 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.841 0.321 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 157' ' ' SER . 39.7 m -116.19 128.7 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.924 0.392 . . . . 0.0 110.199 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.898 HG23 HD11 ' A' ' 154' ' ' LEU . 9.0 mt -103.17 164.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.585 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.551 ' N ' HG22 ' A' ' 142' ' ' ILE . 45.9 p -163.57 152.9 14.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.265 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p -122.57 139.55 31.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.83 -45.3 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.494 2.129 . . . . 0.0 112.416 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.5 m -179.26 132.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.9 m -94.73 59.14 2.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.58 46.53 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.018 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.58 145.63 1.77 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.876 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.19 113.67 3.84 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.521 2.147 . . . . 0.0 112.45 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.19 21.68 5.15 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.841 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER -46.48 99.96 0.22 Allowed Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 120.646 0.26 . . . . 0.0 111.03 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.69 149.97 30.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.976 2.45 . . . . 0.0 112.779 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.898 HD11 HG23 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -76.64 144.13 39.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.84 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.482 ' N ' HD13 ' A' ' 154' ' ' LEU . 5.1 t -129.18 142.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.975 0.416 . . . . 0.0 111.941 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.52 150.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.218 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.751 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.5 OUTLIER -124.94 -20.9 4.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 111.723 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 177.71 153.39 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 0.0 111.168 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -140.1 125.6 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.453 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -80.63 154.07 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -74.81 -178.93 3.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.521 ' C ' HG21 ' A' ' 71' ' ' VAL . . . 72.01 -61.42 1.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.724 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.492 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.9 OUTLIER -56.67 161.72 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.969 0.414 . . . . 0.0 111.274 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.68 ' O ' HD21 ' A' ' 130' ' ' LEU . 5.5 m -69.42 -20.92 24.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.77 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.794 ' O ' HG22 ' A' ' 168' ' ' THR . . . -47.71 -70.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 33.6 t60 -76.48 -23.92 53.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.23 -44.68 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.307 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 165' ' ' ALA . 3.2 t -52.48 -25.85 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.54 48.91 81.98 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.412 ' CG2' HG22 ' A' ' 119' ' ' VAL . 35.2 p -137.95 -44.33 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 0.0 111.083 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 206' ' ' LEU . 3.6 mp -59.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.24 139.44 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.24 119.89 16.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.19 18.47 5.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.681 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.421 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.5 OUTLIER -114.31 -177.25 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.695 0.283 . . . . 0.0 110.738 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -132.38 161.54 33.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 154' ' ' LEU . 1.7 mp -124.54 170.9 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -139.56 -39.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.223 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -139.44 142.36 37.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.572 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.674 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 46.7 mt -127.48 111.57 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.881 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.0 t70 66.3 -70.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.096 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -144.92 -20.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.602 ' HB ' HG21 ' A' ' 196' ' ' ILE . 23.1 mm -98.0 156.95 3.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.17 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 38.1 mtt85 -116.18 139.3 50.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 112.241 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.932 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.9 mm? -70.86 -2.89 16.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.628 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.52 -27.91 1.99 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.094 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m -75.17 -18.93 60.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 111.299 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 152' ' ' ASP . 4.5 m 76.02 102.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.49 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 192' ' ' ASP . 1.4 m 168.58 95.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.543 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.1 ptm -53.82 -41.56 67.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.265 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.4 mm-40 -55.63 -39.29 70.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.987 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.657 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -55.65 -52.07 65.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.061 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -53.7 -36.4 62.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.834 HG22 ' CD1' ' A' ' 142' ' ' ILE . 11.8 t -66.42 -32.68 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.605 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 191' ' ' GLU . 3.0 mm-40 -76.02 -45.06 36.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.66 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.7 mt -73.43 -31.17 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.605 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.792 HD21 HD11 ' A' ' 142' ' ' ILE . 1.6 pp -78.39 -24.73 46.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.542 ' OE1' HG12 ' A' ' 194' ' ' VAL . 64.3 mt-30 -88.01 -45.55 10.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.059 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -61.65 -20.56 63.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.365 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' A' ' 204' ' ' VAL . 27.6 p -88.41 45.99 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.285 0.564 . . . . 0.0 109.784 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -68.12 60.66 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.782 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -169.27 -33.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.4 tt -175.01 105.02 0.09 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.776 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.572 HG23 ' SG ' ' A' ' 200' ' ' CYS . 9.8 p -96.14 126.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -100.73 107.82 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.127 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.579 ' CD2' HD21 ' A' ' 171' ' ' LEU . 3.6 mp -94.79 113.77 25.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.0 111.408 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.1 OUTLIER -101.1 93.5 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 208' ' ' ILE . 1.4 mm -83.32 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.888 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.504 ' H ' HG22 ' A' ' 208' ' ' ILE . 15.7 mmt180 -118.44 128.18 54.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.001 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.24 151.32 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.934 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 176.43 78.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.741 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.68 174.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.226 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.453 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.234 -179.855 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.822 0.344 . . . . 0.0 110.812 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.9 116.68 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 114' ' ' ASP . 18.0 t -136.07 133.65 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.383 . . . . 0.0 111.183 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -105.28 105.78 15.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -54.55 158.41 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -146.97 153.16 39.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.706 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -109.76 136.31 49.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 t -126.66 174.96 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -103.84 157.77 16.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.75 147.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.28 109.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 29' ' ' LEU . 3.9 mt -101.26 118.61 37.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.212 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.42 161.78 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 111.674 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -93.97 172.57 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.051 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -163.22 140.76 6.0 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.347 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.86 19.09 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.464 2.11 . . . . 0.0 112.739 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 35' ' ' THR . 62.2 t -129.82 -51.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 34' ' ' VAL . 20.5 p -156.81 36.22 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.778 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.32 127.07 7.88 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.711 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 24.5 m-85 63.55 71.69 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.45 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -83.31 21.79 8.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.146 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.982 HG23 HD13 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -111.79 133.2 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.458 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 6.4 mt-30 -97.92 126.88 43.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.049 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -96.03 141.52 29.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.122 0.487 . . . . 0.0 111.82 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.67 165.63 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.357 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.81 -111.11 0.11 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.532 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 90.8 p -115.53 104.2 11.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.846 0.355 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.896 HG23 HD13 ' A' ' 56' ' ' LEU . 59.5 t -46.38 -78.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 15.5 p90 -40.65 -51.75 2.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.75 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 44' ' ' SER . . . 38.22 93.17 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.052 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.662 ' O ' HG22 ' A' ' 50' ' ' THR . 0.1 OUTLIER 175.55 110.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' C ' HG22 ' A' ' 50' ' ' THR . 6.4 pt-20 49.45 36.8 10.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.331 0.586 . . . . 0.0 110.324 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER 166.81 177.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.307 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 51' ' ' LEU . 2.4 pp -176.71 33.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -63.09 29.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.711 ' HB3' HD11 ' A' ' 56' ' ' LEU . 1.8 t -147.25 73.05 12.01 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-O 120.844 0.354 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HB3' ' HA ' ' A' ' 91' ' ' PHE . 20.9 Cg_exo -63.46 -53.07 1.56 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.544 2.163 . . . . 0.0 113.169 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.619 ' HA ' HD23 ' A' ' 41' ' ' LEU . 57.2 Cg_endo -96.14 102.44 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.827 2.351 . . . . 0.0 113.039 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.896 HD13 HG23 ' A' ' 45' ' ' VAL . 27.8 mt -131.71 85.21 2.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.714 HD13 ' HB ' ' A' ' 39' ' ' ILE . 85.7 mt -58.58 136.64 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.5 p -120.97 -8.43 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 91.3 t80 -144.47 150.52 37.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.302 0.572 . . . . 0.0 112.322 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.982 HD13 HG23 ' A' ' 39' ' ' ILE . 1.7 mm -123.4 152.7 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.266 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 72.8 tt0 -104.47 106.6 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.884 0.373 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -63.45 116.51 5.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 12.4 t0 95.24 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.191 0.519 . . . . 0.0 110.558 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.537 ' H ' ' CZ ' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -139.71 -173.85 0.38 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 64.6 Cg_endo -95.01 -6.73 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.451 2.101 . . . . 0.0 113.535 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 38' ' ' GLY . . . -74.7 -58.0 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' H ' ' NH2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -77.03 -29.03 55.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.961 0.41 . . . . 0.0 110.447 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.537 ' CZ ' ' H ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -93.36 -7.33 45.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.781 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -41.89 -42.46 2.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.015 0.436 . . . . 0.0 111.263 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.39 -22.77 0.75 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.532 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.2 p -173.07 82.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -134.56 159.04 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.992 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.87 143.01 7.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.679 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.5 mt -55.2 132.31 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.35 16.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.893 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.725 ' HB3' HG21 ' A' ' 111' ' ' ILE . 50.7 m-20 -55.58 -43.8 76.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.707 0.289 . . . . 0.0 111.255 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 75.56 72.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 109' ' ' LEU . 86.1 t -71.13 152.69 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.296 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.615 ' HE2' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -121.21 -27.78 4.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB2' ' HE2' ' A' ' 79' ' ' MET . . . -155.13 134.76 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.935 HD13 HD11 ' A' ' 97' ' ' LEU . 2.1 mp -114.79 109.62 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 52.94 24.07 3.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.123 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.34 -35.74 4.11 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.496 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.03 117.59 37.65 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 120.526 0.203 . . . . 0.0 111.315 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.09 171.65 9.82 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.405 2.07 . . . . 0.0 112.248 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 p -143.97 -45.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.9 -16.35 58.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.515 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -129.91 52.75 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -177.22 166.81 2.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.43 140.03 56.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 5.4 p90 -73.58 -29.74 62.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 mm-40 -54.55 -43.78 72.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -61.23 -37.0 81.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.759 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.7 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -64.98 -34.36 78.24 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.295 0.569 . . . . 0.0 110.528 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.546 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.9 m120 -67.06 -39.51 86.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.345 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 8.7 mm-40 -64.27 -55.98 17.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.935 HD11 HD13 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -52.16 -43.67 64.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.049 HD13 HD13 ' A' ' 41' ' ' LEU . 12.7 mt -59.57 -59.99 4.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.473 0.178 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 61.3 mtt180 -50.23 -29.78 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.394 0.616 . . . . 0.0 109.602 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.674 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -113.5 33.69 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.21 179.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -104.77 21.08 17.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.979 179.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 m -110.46 18.0 20.23 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.674 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -68.13 -47.73 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.561 0.696 . . . . 0.0 110.948 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 6.94 37.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.684 ' O ' HG22 ' A' ' 30' ' ' THR . 8.3 m 59.14 25.94 14.56 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.113 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.64 153.69 2.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.264 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -149.58 146.03 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 124.54 51.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.723 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.9 OUTLIER -131.21 154.8 48.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.491 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.59 123.14 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.918 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.725 HG21 ' HB3' ' A' ' 76' ' ' ASP . 33.0 pt -114.71 148.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 111.904 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.19 145.15 45.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.47 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.11 174.34 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 0.0 111.141 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.715 ' HB2' HG11 ' A' ' 20' ' ' VAL . 2.7 p-10 -96.62 147.01 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.481 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' A' ' 167' ' ' ARG . 2.8 m -99.58 107.37 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.21 124.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 118' ' ' SER . 12.5 mm-40 -127.36 10.54 6.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.643 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.2 75.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.342 0.591 . . . . 0.0 111.366 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 128' ' ' VAL . 15.9 m -97.82 148.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.737 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.8 pp -126.75 92.25 45.25 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 63.3 Cg_endo -95.32 -165.57 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.318 2.679 . . . . 0.0 112.876 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.0 t 177.95 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 213' ' ' ASP . 3.0 p 168.56 116.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.199 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.28 -40.68 2.7 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.204 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.8 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.41 104.3 7.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 1.9 t80 -100.34 115.79 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.759 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.737 ' HB2' HG13 ' A' ' 120' ' ' ILE . 12.0 m170 -91.75 134.25 34.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.293 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.883 ' HA ' HG12 ' A' ' 119' ' ' VAL . 3.2 t -117.49 82.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -80.87 102.26 9.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.662 HD22 HG21 ' A' ' 168' ' ' THR . 0.8 OUTLIER -129.1 144.71 53.73 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.135 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.44 135.73 22.74 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.428 2.085 . . . . 0.0 112.059 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 200' ' ' CYS . 0.1 OUTLIER -107.8 159.23 16.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.059 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.515 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -106.66 -171.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.583 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -66.82 -76.11 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.254 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.4 m -149.74 70.72 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 137' ' ' GLU . 42.3 t -122.02 159.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.772 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' HG12 ' A' ' 136' ' ' VAL . 32.8 tt0 -50.71 103.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.179 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.86 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -61.8 -45.43 93.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.401 ' CA ' ' HB3' ' A' ' 160' ' ' LYS . . . 94.24 -0.38 66.18 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.977 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.86 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -108.46 141.36 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.086 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 55.9 m -126.07 131.89 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.519 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.054 HD13 HG22 ' A' ' 194' ' ' VAL . 1.3 mt -98.1 163.31 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.79 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.491 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -158.97 149.46 19.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.3 p -112.47 132.39 22.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.74 -59.2 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.455 2.103 . . . . 0.0 112.317 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.7 m -166.06 -177.11 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.811 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t -117.41 29.58 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -112.3 43.79 1.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.713 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 149.93 32.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.809 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.14 -25.49 29.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.446 2.097 . . . . 0.0 112.194 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 169.23 55.8 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.342 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.44 145.61 14.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.02 174.78 11.43 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.425 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.848 HD11 ' HA ' ' A' ' 190' ' ' MET . 4.4 mm? -91.97 169.96 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.433 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 175' ' ' ASP . 20.1 m -150.56 149.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.0 111.525 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.6 mt -67.72 146.58 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.632 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.38 -8.51 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.23 143.08 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.01 0.433 . . . . 0.0 111.46 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.2 mt -132.7 149.32 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.628 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.401 ' HB3' ' CA ' ' A' ' 139' ' ' GLY . 1.5 tttm -124.2 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -80.91 151.94 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.456 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.41 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . 86.75 -16.45 46.17 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.898 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 1.1 m -96.45 136.96 36.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.438 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.7 m -48.2 -22.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.255 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -55.77 -50.12 71.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.403 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.442 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 2.0 t60 -83.88 -26.65 29.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HA ' HG12 ' A' ' 115' ' ' VAL . 14.2 mmp_? -56.57 -50.04 73.08 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.662 HG21 HD22 ' A' ' 130' ' ' LEU . 6.5 t -53.1 -25.36 12.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 170' ' ' THR . . . 77.81 -162.73 50.61 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.548 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 169' ' ' GLY . 14.4 t 44.78 31.53 0.67 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.843 0.354 . . . . 0.0 111.403 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.47 98.49 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.44 149.71 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.7 138.62 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.74 -17.35 33.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.689 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.58 ' CG ' HG21 ' A' ' 208' ' ' ILE . 0.8 OUTLIER -74.92 166.39 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 110.651 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -117.91 122.88 44.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.78 HD23 HD11 ' A' ' 180' ' ' ILE . 2.6 mp -82.66 138.73 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.769 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.03 -66.49 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.076 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.869 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -121.36 161.82 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.78 HD11 HD23 ' A' ' 177' ' ' LEU . 33.8 mm -139.74 105.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 2.8 t0 63.82 -71.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 180' ' ' ILE . 2.6 t-20 -138.59 -23.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.629 ' HB ' HG21 ' A' ' 196' ' ' ILE . 26.1 mm -94.23 138.51 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 111.296 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.51 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 65.8 mtt180 -102.07 119.97 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.969 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -72.16 -13.87 61.67 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.133 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.21 -29.99 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.507 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.9 m -127.43 -4.37 6.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.508 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.43 148.85 22.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -176.51 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.848 ' HA ' HD11 ' A' ' 154' ' ' LEU . 1.4 ttt -68.46 -57.27 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.829 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -55.29 -32.02 62.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.64 -48.49 80.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.068 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.718 ' HB2' HD13 ' A' ' 185' ' ' LEU . . . -57.29 -41.11 79.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.378 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 1.054 HG22 HD13 ' A' ' 142' ' ' ILE . 11.7 t -62.76 -32.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.05 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -45.91 85.97 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.877 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -69.98 -24.35 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.523 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 142' ' ' ILE . 0.0 OUTLIER -68.43 -35.83 78.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.533 ' NE2' HG12 ' A' ' 194' ' ' VAL . 14.9 mt-30 -89.43 -49.81 6.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.508 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.55 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -58.18 -15.89 11.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.557 ' CB ' HG13 ' A' ' 204' ' ' VAL . 8.4 m -89.42 32.53 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.23 65.72 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.406 0.622 . . . . 0.0 111.418 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -172.3 -29.91 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.672 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 203' ' ' LEU . 2.8 tt 171.84 111.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.768 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.557 HG13 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.72 128.8 64.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.204 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 1.7 ttmt -107.85 107.68 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.776 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 128' ' ' VAL . 5.4 mp -90.55 119.67 31.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.001 0.429 . . . . 0.0 111.662 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.869 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -98.01 93.84 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.092 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.58 HG21 ' CG ' ' A' ' 175' ' ' ASP . 3.9 mm -82.33 163.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.364 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -106.45 118.02 35.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.831 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 124' ' ' GLY . 25.5 mttt -129.58 114.54 16.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -87.47 43.57 1.12 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.858 0.361 . . . . 0.0 111.42 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 213' ' ' ASP . 25.0 mt-10 -125.59 156.82 38.56 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.258 0.551 . . . . 0.0 111.691 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 212' ' ' GLU . 18.1 t70 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.622 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.831 0.348 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.4 m -150.0 116.86 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.257 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 t -115.96 95.65 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -114.26 113.35 24.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -52.0 140.06 21.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -135.28 159.99 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.0 p -110.03 136.22 49.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.581 HG23 ' HB3' ' A' ' 161' ' ' LYS . 4.2 m -132.54 169.6 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.855 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' H ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.67 160.59 14.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.948 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.8 HG13 HG23 ' A' ' 71' ' ' VAL . 1.8 t -147.27 148.22 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -127.14 110.0 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.751 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.731 HD12 HD21 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -106.83 120.62 42.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -113.26 160.48 18.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 111.43 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.705 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -90.4 132.02 35.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.849 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.87 148.93 36.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.567 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.67 14.57 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.552 2.168 . . . . 0.0 112.567 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.0 -48.97 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.48 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.65 -17.29 4.11 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 71.69 74.61 0.72 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.705 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 79.5 m-85 83.58 -25.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.113 0.565 . . . . 0.0 110.873 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 59.61 14.95 30.96 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 114.412 0.525 . . . . 0.0 114.412 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.104 ' CG2' HD13 ' A' ' 60' ' ' ILE . 1.1 pp -133.98 144.44 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 117.796 0.798 . . . . 0.0 112.676 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -106.8 129.01 54.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.748 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.938 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -95.75 115.98 28.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.883 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.866 ' HB3' HD12 ' A' ' 56' ' ' LEU . 4.0 tt0 -70.13 157.24 37.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.299 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.6 106.36 2.51 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.106 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.6 p 52.5 -170.79 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.595 0.236 . . . . 0.0 110.46 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' PHE . 58.4 t -144.45 -96.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.708 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 53' ' ' SER . 40.7 p90 -45.79 -52.11 11.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 45.35 78.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 15.9 p -153.7 96.68 2.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.073 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.6 pt-20 54.66 118.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.736 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 28.1 m 75.1 -12.13 0.99 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.601 ' O ' ' CB ' ' A' ' 52' ' ' SER . 0.8 OUTLIER 33.56 -129.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.289 0.236 . . . . 0.0 111.464 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 7.7 t 104.84 4.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.401 0.68 . . . . 0.0 110.263 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.505 ' CB ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -76.51 110.13 10.62 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.012 178.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 52' ' ' SER . 96.0 Cg_endo -78.93 160.34 27.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.344 2.03 . . . . 0.0 112.714 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 10.2 Cg_endo -53.34 147.88 35.05 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.694 2.263 . . . . 0.0 111.357 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.866 HD12 ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -156.85 123.9 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.812 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 59' ' ' TYR . 68.7 mt -60.71 130.79 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -109.93 10.67 24.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.424 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.581 ' O ' HG22 ' A' ' 39' ' ' ILE . 35.6 t80 -167.2 134.09 2.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.914 0.387 . . . . 0.0 111.712 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.104 HD13 ' CG2' ' A' ' 39' ' ' ILE . 4.1 mm -121.04 141.92 39.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.198 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -95.22 155.04 16.9 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.833 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.62 44.79 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.31 45.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.868 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -137.81 140.5 29.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 64' ' ' SER . 44.3 Cg_exo -56.68 -12.13 8.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.618 2.212 . . . . 0.0 113.221 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.793 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -66.69 -57.85 6.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.446 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.24 -30.19 43.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.888 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.441 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -71.84 -18.13 62.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.758 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 51.4 t -48.15 -50.61 28.16 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.749 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' HA3' ' HB3' ' A' ' 137' ' ' GLU . . . 127.62 -4.29 7.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.441 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.8 HG23 HG13 ' A' ' 27' ' ' VAL . 27.3 m -152.21 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.164 0.482 . . . . 0.0 111.613 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 66' ' ' ALA . 6.9 mt -135.27 142.38 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.019 0.438 . . . . 0.0 111.198 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.52 -175.47 4.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.646 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.645 HD13 ' CG1' ' A' ' 60' ' ' ILE . 29.4 mm -69.62 67.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.33 71.79 0.22 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.762 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.733 ' OD2' HD23 ' A' ' 72' ' ' LEU . 4.2 t0 -97.14 111.18 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.5 mpt_? -68.76 144.03 54.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.909 ' CG1' HD13 ' A' ' 109' ' ' LEU . 9.4 m -126.6 133.62 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.16 -24.95 15.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.13 133.63 12.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.108 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 97' ' ' LEU . 24.6 mt -122.56 114.86 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.811 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 53.02 24.02 3.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.106 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.52 15.69 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.621 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.47 131.06 88.46 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 120.438 0.161 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 86' ' ' THR . 31.9 Cg_exo -58.16 -157.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.498 2.132 . . . . 0.0 112.045 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 85' ' ' PRO . 22.7 p -158.79 -67.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.054 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -69.88 -11.64 61.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.461 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.07 42.15 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.978 0.418 . . . . 0.0 110.765 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.07 176.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.771 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 1.4 m -70.41 121.6 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -49.63 -28.39 5.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -54.73 -36.65 64.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.185 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 90' ' ' THR . 1.6 pp20? -61.66 -41.16 97.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HA ' HD11 ' A' ' 97' ' ' LEU . . . -63.02 -37.5 87.44 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.52 0.676 . . . . 0.0 109.868 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.9 OUTLIER -61.78 -41.07 97.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.102 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.86 -56.49 16.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.571 HD11 HD12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -53.75 -30.16 43.02 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.938 HD13 HD13 ' A' ' 41' ' ' LEU . 48.7 mt -76.21 -48.06 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.207 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 6.3 mtt85 -50.1 -31.06 12.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.8 p30 -120.54 38.34 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.352 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.12 34.13 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.187 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -131.77 13.4 4.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.839 0.352 . . . . 0.0 111.802 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.43 -46.28 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.753 0.787 . . . . 0.0 110.403 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -2.11 56.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.549 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.806 ' O ' HG22 ' A' ' 30' ' ' THR . 9.5 p 62.39 25.69 15.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -167.59 153.48 7.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.071 0.462 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 101' ' ' SER . 25.1 t -154.71 137.53 7.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.75 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.15 123.66 49.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.744 0.307 . . . . 0.0 110.482 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.909 HD13 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -140.49 153.76 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.903 0.382 . . . . 0.0 111.371 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.27 137.19 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.457 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 27' ' ' VAL . 45.7 pt -117.12 142.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 111.612 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -112.94 118.57 35.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.385 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.473 ' CE1' ' CG ' ' A' ' 167' ' ' ARG . 2.4 p90 -136.84 174.22 10.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.933 0.396 . . . . 0.0 111.382 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -102.21 155.18 18.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.594 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 167' ' ' ARG . 3.0 m -99.12 105.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.0 111.435 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 115' ' ' VAL . . . 175.9 132.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.696 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.536 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -140.57 12.89 2.33 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.87 88.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.193 0.52 . . . . 0.0 110.963 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 128' ' ' VAL . 1.3 m -110.18 145.99 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.957 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.68 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.6 pp -130.44 90.9 39.75 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 121.233 0.539 . . . . 0.0 110.632 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.497 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 62.6 Cg_endo -91.33 -173.79 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.176 2.584 . . . . 0.0 113.504 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER 178.75 36.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.784 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.5 OUTLIER 54.25 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.374 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.62 -42.63 2.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.457 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.702 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -127.51 102.35 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.811 0.339 . . . . 0.0 110.393 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 9.7 t80 -100.54 116.08 31.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.68 ' HB2' HG13 ' A' ' 120' ' ' ILE . 38.5 m80 -95.52 138.06 33.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.689 ' HA ' HG12 ' A' ' 119' ' ' VAL . 8.0 p -126.76 98.15 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.566 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.482 ' HD3' HD21 ' A' ' 203' ' ' LEU . 0.1 OUTLIER -84.14 105.1 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.345 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' A' ' 168' ' ' THR . 0.7 OUTLIER -113.41 125.55 29.46 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 130' ' ' LEU . 16.5 Cg_exo -65.76 115.29 3.33 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.181 1.921 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HD3' HG12 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -94.36 159.08 15.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.272 0.558 . . . . 0.0 111.928 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -113.61 -165.84 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.011 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -73.9 0.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 m -152.83 82.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.283 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 137' ' ' GLU . 65.1 t -130.46 159.2 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.491 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.0 tt0 -50.37 151.53 2.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.059 0.456 . . . . 0.0 111.555 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 140' ' ' ILE . 5.2 mt -138.64 -52.95 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 89.92 36.38 7.26 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.154 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.784 HG23 HD21 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -109.61 126.1 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.354 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 157' ' ' SER . 90.9 m -126.38 131.48 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.373 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.962 HD13 HG22 ' A' ' 194' ' ' VAL . 1.6 mt -105.89 163.29 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 142' ' ' ILE . 5.0 m -166.93 159.85 13.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.017 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.4 p -115.02 130.13 24.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.583 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HG3' ' HG2' ' A' ' 153' ' ' PRO . 25.7 Cg_endo -62.39 -52.1 2.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.359 2.039 . . . . 0.0 112.206 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.4 m -161.86 140.62 9.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.1 t -103.88 31.07 4.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.019 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.33 45.22 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.79 152.35 0.89 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.72 -9.22 25.57 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.657 2.238 . . . . 0.0 112.782 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -98.4 26.24 24.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.648 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -47.16 102.21 0.3 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.589 0.233 . . . . 0.0 111.395 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.421 ' HG2' ' HG3' ' A' ' 145' ' ' PRO . 92.6 Cg_endo -90.95 174.62 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.572 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 190' ' ' MET . 2.1 mp -122.71 145.51 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.457 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 175' ' ' ASP . 29.8 m -149.17 172.5 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.507 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.433 HG21 HG12 ' A' ' 159' ' ' ILE . 2.8 mp -81.56 152.7 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.74 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.477 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.3 OUTLIER -127.73 -11.39 5.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.57 136.21 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' ' 166' ' ' HIS . 1.5 mt -131.97 143.52 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.279 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.419 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -101.58 178.89 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.581 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.0 OUTLIER -116.25 152.83 33.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.267 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.453 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 93.47 -30.44 7.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.775 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -82.79 140.01 33.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.969 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.0 m -49.43 -23.19 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.183 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' ' 168' ' ' THR . . . -44.92 -67.6 0.27 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.559 ' HB2' HG21 ' A' ' 159' ' ' ILE . 54.6 t60 -83.62 -26.55 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.483 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -58.54 -29.89 66.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.85 HG22 ' O ' ' A' ' 165' ' ' ALA . 6.9 t -58.8 -21.28 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.84 49.92 4.61 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.268 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 168' ' ' THR . 1.6 p -150.61 -52.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 110.958 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.784 HD21 HG23 ' A' ' 140' ' ' ILE . 4.0 mp -55.31 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -139.15 142.81 37.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.821 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 68.9 mt -56.97 114.39 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.76 16.91 4.38 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.996 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.719 ' O ' HG12 ' A' ' 155' ' ' VAL . 2.1 m-20 -100.83 148.16 25.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.775 0.287 . . . . 0.0 110.485 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.432 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -107.18 130.37 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 111.281 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.04 127.84 40.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.804 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.64 -44.94 2.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -137.42 155.29 49.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.506 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.69 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 20.6 mt -139.28 128.95 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.195 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 2.2 t70 49.45 42.6 22.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 2.1 t-20 82.64 -24.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 184' ' ' ARG . 38.3 mm -76.56 155.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 11.7 mtp180 -128.63 127.15 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.453 0.644 . . . . 0.0 112.318 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -90.19 -17.01 28.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.399 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.9 t0 63.94 -71.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.23 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 185' ' ' LEU . 1.0 OUTLIER -158.27 56.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.442 . . . . 0.0 110.617 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 0.0 OUTLIER 170.06 -166.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.221 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 192' ' ' ASP . 0.6 OUTLIER 68.77 43.79 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.872 179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.642 ' HA ' HD21 ' A' ' 154' ' ' LEU . 4.4 tpt -57.9 -58.17 9.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 109.888 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.53 -32.86 74.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 109.876 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.417 ' CB ' ' HB3' ' A' ' 189' ' ' SER . 0.2 OUTLIER -63.88 -43.73 95.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.864 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.815 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -57.87 -43.75 86.21 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.962 HG22 HD13 ' A' ' 142' ' ' ILE . 14.5 t -58.02 -38.93 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.73 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -50.67 71.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.104 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.1 mt -67.93 -24.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.718 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -61.1 -32.71 72.38 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.551 179.122 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.66 -32.97 10.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.048 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -60.89 -16.2 39.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.527 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.792 ' SG ' HG23 ' A' ' 204' ' ' VAL . 67.3 m -84.14 41.97 0.85 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.77 59.2 0.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.119 0.485 . . . . 0.0 111.696 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.35 -33.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.101 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.5 tt -179.69 106.86 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.792 HG23 ' SG ' ' A' ' 200' ' ' CYS . 3.5 p -98.93 124.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.143 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -110.67 107.78 17.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.667 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.6 mm? -100.18 128.77 46.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.974 0.416 . . . . 0.0 111.932 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.759 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 0.2 OUTLIER -97.2 93.25 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.078 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.669 HG21 ' OD2' ' A' ' 175' ' ' ASP . 2.9 mm -90.63 169.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.158 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.541 ' H ' HG22 ' A' ' 208' ' ' ILE . 62.5 mtt180 -108.6 130.95 55.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 142.14 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.894 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 178.65 80.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -52.08 161.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.178 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.843 0.354 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 m -143.4 129.74 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.57 96.25 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.078 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 8.3 p-80 -100.06 115.07 28.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.697 HG22 ' OD1' ' A' ' 114' ' ' ASP . 36.0 p -53.35 125.59 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -120.45 162.7 19.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 p -113.11 135.71 53.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 161' ' ' LYS . 93.6 m -132.79 160.42 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' N ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.77 162.08 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.518 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.656 ' CG1' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -142.03 133.12 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.926 0.393 . . . . 0.0 111.081 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 28' ' ' VAL . 5.2 p -110.9 116.3 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.976 HD21 HD11 ' A' ' 72' ' ' LEU . 11.2 mt -112.56 136.25 52.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -119.61 159.82 23.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -98.92 129.12 45.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.368 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.461 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -107.48 152.82 41.49 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.96 14.46 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.42 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.01 -47.15 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.4 t -148.92 11.05 0.82 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 59.3 -102.58 0.31 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.461 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CE2' ' O ' ' A' ' 30' ' ' THR . 41.4 m-85 -121.37 124.22 44.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -96.23 28.21 13.91 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.709 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.804 HD13 HD13 ' A' ' 72' ' ' LEU . 7.4 pt -128.35 134.86 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 120.842 0.353 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -124.0 145.31 49.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.977 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.93 HD23 ' CD1' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.26 138.68 51.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.42 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -78.32 169.8 17.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.324 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -108.34 -68.2 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.764 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.3 144.26 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 56' ' ' LEU . 72.8 t -141.45 -89.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.8 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.608 ' CE1' HG23 ' A' ' 50' ' ' THR . 48.3 p90 -58.14 -46.51 85.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.665 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.579 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 46.61 100.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.08 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.473 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER 171.64 105.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.979 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' C ' HG22 ' A' ' 50' ' ' THR . 9.1 pt-20 52.92 33.61 14.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 110.539 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.608 HG23 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 161.49 174.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.035 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -163.64 23.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.544 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.81 23.31 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.07 139.93 97.88 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.008 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.17 157.46 50.39 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.392 2.061 . . . . 0.0 111.922 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.889 ' HB3' HD13 ' A' ' 41' ' ' LEU . 77.4 Cg_exo -50.3 155.15 5.08 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.434 2.089 . . . . 0.0 112.19 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.59 HD13 HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -148.88 112.66 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.93 ' CD1' HD23 ' A' ' 41' ' ' LEU . 13.2 mm -53.89 141.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.0 110.996 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.82 -32.36 2.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.457 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 86.2 t80 -141.92 156.02 45.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.325 0.584 . . . . 0.0 111.861 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.709 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 17.8 mm -136.34 161.27 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.087 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.456 ' N ' HG22 ' A' ' 60' ' ' ILE . 1.5 tt0 -107.18 150.29 26.77 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 121.922 -0.486 . . . . 0.0 111.877 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.32 39.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.028 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 36.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.923 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.443 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 41.2 p -128.58 138.67 33.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 32' ' ' ASP . 17.6 Cg_endo -57.7 -16.05 23.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.724 2.282 . . . . 0.0 112.869 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.853 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -73.59 -48.74 30.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.564 0.697 . . . . 0.0 109.692 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.709 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.5 tp10 -70.25 -32.46 70.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.422 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.562 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -93.88 -5.43 48.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -42.59 62.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.824 0.345 . . . . 0.0 110.674 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 136' ' ' VAL . . . 133.9 -19.3 4.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.38 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.656 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.2 m -146.89 75.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 117.108 0.454 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.976 HD11 HD21 ' A' ' 29' ' ' LEU . 13.8 mt -157.87 121.62 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.931 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -144.24 -176.31 4.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.544 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.6 126.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.0 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.469 ' N ' ' HB ' ' A' ' 57' ' ' ILE . . . 57.88 84.54 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.669 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 72' ' ' LEU . 70.6 m-20 -95.07 -30.54 14.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.036 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.702 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER 63.45 105.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' HB2' ' A' ' 109' ' ' LEU . 14.8 p -98.47 148.39 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.494 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.7 ttp -109.34 -24.93 10.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.462 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -158.48 145.27 17.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.56 HD12 HD12 ' A' ' 97' ' ' LEU . 1.2 mt -133.14 113.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.92 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.7 m120 54.09 24.18 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.34 -31.83 6.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.485 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -69.53 110.45 6.4 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.383 0.135 . . . . 0.0 111.301 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.522 ' C ' HG23 ' A' ' 86' ' ' THR . 31.6 Cg_endo -63.96 -27.93 66.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.304 2.003 . . . . 0.0 112.046 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.522 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.2 p 72.28 2.15 4.22 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.678 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -14.3 42.8 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.297 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -120.95 45.72 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.93 153.04 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.784 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 91' ' ' PHE . 9.7 m -60.15 163.83 4.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 6.5 p90 -65.59 -39.27 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.683 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 58.1 mt-10 -54.97 -32.94 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.478 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -53.34 58.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.135 0.493 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -54.68 -37.97 66.41 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.673 0.749 . . . . 0.0 109.863 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -59.93 -36.85 77.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.619 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 5.3 mm-40 -62.23 -43.29 99.17 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.827 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.56 HD12 HD12 ' A' ' 81' ' ' ILE . 17.6 mt -53.72 -41.93 67.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.854 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.828 HD21 HD21 ' A' ' 41' ' ' LEU . 3.4 mp -75.23 -44.65 45.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.628 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 3.5 mtt-85 -50.92 -31.99 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.275 0.559 . . . . 0.0 109.693 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 5.1 p30 -127.52 42.75 3.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.265 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.783 ' HB2' HG21 ' A' ' 107' ' ' VAL . 2.5 p -81.27 6.53 13.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.639 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.27 18.52 19.81 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 9.6 mt -70.79 -53.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.913 0.863 . . . . 0.0 110.418 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.72 9.51 29.64 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.484 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 m 58.93 20.87 8.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.272 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.561 ' HG2' HG23 ' A' ' 30' ' ' THR . 1.6 mttt -166.61 158.42 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.575 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.783 HG21 ' HB2' ' A' ' 101' ' ' SER . 66.1 t -155.29 106.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.426 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.77 132.82 39.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.767 ' HB2' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.07 163.59 32.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.067 0.461 . . . . 0.0 111.611 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -120.34 128.59 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 77' ' ' ARG . 26.6 pt -119.41 153.65 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.929 0.395 . . . . 0.0 111.623 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -120.43 119.14 32.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.465 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 6.5 p90 -138.08 174.21 10.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.275 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.697 ' OD1' HG22 ' A' ' 22' ' ' THR . 7.5 m-20 -91.3 142.25 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.579 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 115' ' ' VAL . 26.8 m -87.26 108.25 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.38 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.47 133.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 168' ' ' THR . 0.2 OUTLIER -149.91 23.85 0.86 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.1 t 83.68 100.84 0.05 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.197 0.523 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.922 HG11 HG21 ' A' ' 170' ' ' THR . 2.0 t -135.39 123.02 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.175 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.705 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.6 pp -96.9 106.97 34.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.267 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 69.9 Cg_endo -95.34 137.02 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.291 2.661 . . . . 0.0 112.679 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -139.81 -80.55 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.62 113.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.85 -31.9 6.53 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.529 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.502 HG22 ' CG ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -138.38 102.65 4.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.964 0.411 . . . . 0.0 111.316 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.812 ' CE1' HG12 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -103.31 121.01 41.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.861 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.705 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -105.75 130.79 53.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.369 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.833 HG11 HG21 ' A' ' 168' ' ' THR . 3.6 t -109.46 86.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 118' ' ' SER . 0.3 OUTLIER -81.14 98.91 8.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.722 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -120.53 125.35 27.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.005 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.58 115.77 2.78 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.353 2.035 . . . . 0.0 111.646 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.545 ' HB2' HG23 ' A' ' 204' ' ' VAL . 18.1 tttp -90.59 151.35 21.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.499 ' CD ' HG21 ' A' ' 136' ' ' VAL . 2.4 mttt -84.95 -168.52 2.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.921 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -72.44 -33.46 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.796 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 m 175.2 40.42 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.799 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.628 HG22 ' HA2' ' A' ' 70' ' ' GLY . 1.2 t -72.24 162.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.58 157.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.985 0.421 . . . . 0.0 111.341 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.495 HD12 ' OG ' ' A' ' 163' ' ' SER . 0.9 OUTLIER -164.99 107.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -89.93 39.55 3.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.394 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.628 HD11 ' CB ' ' A' ' 165' ' ' ALA . 4.4 mm -84.75 124.2 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.801 0.3 . . . . 0.0 110.34 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.754 HG22 ' HB2' ' A' ' 157' ' ' SER . 85.3 m -115.75 141.57 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.974 HD11 HD22 ' A' ' 197' ' ' LEU . 1.9 mt -114.42 163.88 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.868 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.493 ' N ' HG22 ' A' ' 142' ' ' ILE . 48.0 t -166.61 156.38 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.766 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.0 t -115.5 144.85 33.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.4 174.42 10.1 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.449 2.099 . . . . 0.0 112.203 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.77 47.83 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.974 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.2 t -86.74 2.92 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.294 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 60.72 45.17 10.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.984 0.421 . . . . 0.0 111.12 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.477 ' HD3' ' CD ' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -124.2 161.03 49.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.504 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.34 61.78 2.06 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.459 2.106 . . . . 0.0 112.354 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 50.43 41.59 41.15 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.42 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.517 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -55.34 -59.98 9.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.717 ' O ' HD22 ' A' ' 154' ' ' LEU . 54.3 Cg_endo -93.59 -179.77 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.906 2.404 . . . . 0.0 112.884 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 190' ' ' MET . 2.9 mm? -137.46 155.46 49.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.077 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 156' ' ' ILE . 14.1 t -151.68 161.21 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.872 0.367 . . . . 0.0 111.922 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.515 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.5 mt -94.26 152.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.096 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.754 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.4 OUTLIER -127.16 -16.71 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 178.91 137.83 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.28 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.591 HG22 ' HB2' ' A' ' 166' ' ' HIS . 1.0 OUTLIER -129.68 122.99 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.578 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -86.2 155.6 20.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 111.111 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.517 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.4 OUTLIER -79.58 179.83 7.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.608 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 80.55 -54.7 4.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.495 ' OG ' HD12 ' A' ' 138' ' ' LEU . 0.6 OUTLIER -59.24 144.2 46.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.157 0.503 . . . . 0.0 111.376 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 26.8 m -56.4 -21.08 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.046 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.945 ' O ' HG22 ' A' ' 168' ' ' THR . . . -59.36 -71.73 0.12 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.731 0.3 . . . . 0.0 111.361 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.591 ' HB2' HG22 ' A' ' 159' ' ' ILE . 21.3 t60 -66.46 -24.76 66.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.952 0.406 . . . . 0.0 110.499 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.486 ' NH2' ' HB3' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -56.88 -42.58 80.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.501 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.945 HG22 ' O ' ' A' ' 165' ' ' ALA . 13.2 t -50.3 -30.08 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 170' ' ' THR . . . 59.37 89.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.77 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.922 HG21 HG11 ' A' ' 119' ' ' VAL . 15.3 t -177.75 -38.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 110.866 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -69.43 152.66 44.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.814 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -147.63 151.8 36.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.451 HD23 ' HB ' ' A' ' 156' ' ' ILE . 6.5 mt -82.23 127.82 33.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.43 23.55 4.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.61 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.416 ' CB ' ' CG2' ' A' ' 208' ' ' ILE . 21.3 m-20 -116.22 -168.98 1.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.684 0.278 . . . . 0.0 110.604 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.71 120.84 28.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.858 0.361 . . . . 0.0 111.275 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 180' ' ' ILE . 2.5 mt -78.06 144.53 36.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.5 tt -120.24 -41.43 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.695 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -148.87 166.74 27.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.814 HD11 HD22 ' A' ' 177' ' ' LEU . 27.6 mm -139.84 117.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.246 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 25.5 t0 57.91 -86.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -127.25 -13.85 5.5 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.856 ' HB ' HG21 ' A' ' 196' ' ' ILE . 27.4 mm -96.59 159.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.628 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 15.9 mtt85 -118.61 123.68 45.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.386 0.612 . . . . 0.0 112.321 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 185' ' ' LEU . 0.8 OUTLIER -77.49 -13.42 59.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.789 178.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.17 -28.99 1.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.2 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.73 -5.14 6.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.642 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -96.0 133.1 40.62 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -57.39 -178.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.074 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.742 ' HA ' HD11 ' A' ' 154' ' ' LEU . 5.6 ttp -66.15 -57.25 8.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.57 -38.0 71.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.256 0.55 . . . . 0.0 110.72 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.792 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -59.7 -44.81 93.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.935 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 185' ' ' LEU . . . -57.76 -42.96 85.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.442 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.937 HG22 HD13 ' A' ' 142' ' ' ILE . 8.9 t -60.7 -33.72 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.245 0.545 . . . . 0.0 109.786 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -50.18 74.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.949 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.856 HG21 ' HB ' ' A' ' 183' ' ' ILE . 2.3 mp -73.79 -24.6 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.885 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.974 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -64.37 -28.45 69.7 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.775 ' NE2' HG12 ' A' ' 194' ' ' VAL . 19.7 mt-30 -103.44 -33.71 8.97 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.95 -16.04 60.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.167 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.794 ' SG ' HG22 ' A' ' 204' ' ' VAL . 13.8 p -85.97 43.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.195 0.521 . . . . 0.0 110.456 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 5.5 pt-20 -70.75 62.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.539 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.426 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 1.9 m-20 -178.14 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.404 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.404 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 20.5 tp -176.89 107.05 0.06 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.765 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.794 HG22 ' SG ' ' A' ' 200' ' ' CYS . 6.9 t -102.01 115.7 44.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.655 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 13.2 ttmm -104.51 108.32 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.906 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.523 ' N ' HD22 ' A' ' 206' ' ' LEU . 3.4 mm? -87.49 102.7 14.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.915 0.388 . . . . 0.0 111.303 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.552 ' NZ ' HD22 ' A' ' 178' ' ' LEU . 0.1 OUTLIER -92.51 93.43 8.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.216 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 209' ' ' ARG . 6.9 mm -92.92 163.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 21.8 mtm-85 -107.96 126.38 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.037 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 1.6 tttm -113.22 159.49 19.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.92 44.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.56 168.35 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.957 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.71 0.291 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 19' ' ' VAL . 12.6 p -107.57 118.48 55.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 114' ' ' ASP . 26.6 t -152.99 152.55 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.638 ' CE1' HG11 ' A' ' 115' ' ' VAL . 46.1 p-80 -128.1 113.77 16.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.739 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -50.27 142.87 9.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -147.77 172.02 14.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.471 HG22 ' HB2' ' A' ' 112' ' ' GLU . 28.7 p -125.61 151.97 45.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 26' ' ' GLU . 89.9 m -145.74 164.4 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.07 161.89 13.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.551 HG11 HD21 ' A' ' 72' ' ' LEU . 2.2 t -135.48 150.16 28.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.87 109.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.442 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -115.09 118.54 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -105.81 162.22 13.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.05 123.05 32.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.07 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.15 153.72 66.51 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.627 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -78.28 9.7 3.01 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.525 2.15 . . . . 0.0 112.506 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 t -112.11 -49.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 120.638 0.256 . . . . 0.0 111.356 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -145.7 3.83 0.98 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 -93.82 0.86 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.366 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.642 ' HD1' HD22 ' A' ' 29' ' ' LEU . 44.5 m-85 -125.6 120.74 31.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.2 9.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.465 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.979 HD11 ' HB2' ' A' ' 66' ' ' ALA . 2.7 mp -93.14 151.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.32 0.581 . . . . 0.0 111.995 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -124.55 99.83 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.763 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 98' ' ' LEU . 1.5 tp -96.17 148.55 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 28.4 pt20 -129.43 170.08 14.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.968 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.58 26.53 3.47 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.296 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.6 106.25 14.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 110.483 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 56' ' ' LEU . 27.4 t -135.14 -85.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.616 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 4.3 p90 -34.92 -44.63 0.23 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.116 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 55.08 66.58 1.19 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.528 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 30.8 p -161.07 -166.31 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.938 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' HG22 ' A' ' 50' ' ' THR . 2.3 pt-20 -51.7 171.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 49' ' ' GLU . 11.9 t 45.25 -153.85 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.993 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.708 HD22 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -146.02 -94.29 0.09 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.707 0.289 . . . . 0.0 111.171 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 16.54 1.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.797 0.332 . . . . 0.0 111.823 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.51 133.74 85.59 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.17 137.29 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.391 2.061 . . . . 0.0 111.85 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.885 ' CB ' HD21 ' A' ' 41' ' ' LEU . 8.1 Cg_endo -49.98 123.09 10.2 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.56 2.173 . . . . 0.0 111.963 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.494 ' CD1' HG22 ' A' ' 45' ' ' VAL . 1.4 pt? -139.42 119.88 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 111.512 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.596 HD13 HG23 ' A' ' 39' ' ' ILE . 48.3 mt -64.44 157.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.996 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.493 ' N ' HG22 ' A' ' 57' ' ' ILE . 12.1 m -130.65 -12.6 3.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.354 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.0 t80 179.78 137.47 0.11 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.936 0.398 . . . . 0.0 111.259 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 61' ' ' GLU . 4.0 mt -111.28 171.95 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 60' ' ' ILE . 43.0 tt0 -111.13 155.1 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.663 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -79.05 59.23 2.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.286 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.08 41.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.313 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 5.2 p -131.27 137.67 31.11 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 64' ' ' SER . 28.5 Cg_exo -61.6 -11.62 21.1 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.5 2.133 . . . . 0.0 112.764 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.001 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -76.88 -56.06 4.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.013 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -73.46 -29.54 62.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.292 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.52 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.24 -42.65 68.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.4 t -47.78 -30.41 3.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.92 -9.31 74.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.916 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 162' ' ' GLY . 18.1 t -101.71 31.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.981 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.741 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 34.1 mt -146.77 134.37 20.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -125.81 161.38 27.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.25 82.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.06 48.24 0.15 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.426 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -76.42 107.64 8.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.87 0.366 . . . . 0.0 110.74 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -69.96 73.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.39 125.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 ttp -95.58 -30.27 13.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -152.03 153.97 35.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.284 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.691 HD12 HD12 ' A' ' 97' ' ' LEU . 4.0 mt -133.98 117.06 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 62.56 19.98 11.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.82 -24.22 22.15 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -71.23 123.14 88.88 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-O 120.519 0.2 . . . . 0.0 111.091 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.52 ' C ' HG23 ' A' ' 86' ' ' THR . 50.3 Cg_endo -68.71 -26.3 33.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 73.84 1.3 3.88 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.619 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -15.02 41.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.898 0.38 . . . . 0.0 111.358 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.18 46.37 0.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m 179.33 -177.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.708 HG23 HD22 ' A' ' 51' ' ' LEU . 15.4 m -93.3 153.17 18.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -52.17 -27.19 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 9.9 mt-10 -54.79 -36.73 65.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.944 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.356 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -61.77 -38.65 88.8 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.555 0.693 . . . . 0.0 109.991 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -59.52 -40.82 88.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.081 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 50.0 mm-40 -61.97 -44.3 97.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 110.21 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 81' ' ' ILE . 36.4 mt -54.37 -41.11 68.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.203 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.904 HD11 HD22 ' A' ' 41' ' ' LEU . 36.7 mt -73.56 -51.9 15.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.878 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 1.5 mtp180 -50.85 -29.84 12.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.962 0.41 . . . . 0.0 110.3 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 53.4 m-20 -126.63 39.66 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.657 ' HB3' ' HA ' ' A' ' 98' ' ' LEU . 1.2 p -89.22 10.98 20.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.84 18.88 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.1 mt -68.79 -49.73 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.877 0.846 . . . . 0.0 110.311 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.48 13.09 32.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.397 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.843 ' O ' HG22 ' A' ' 30' ' ' THR . 24.2 p 54.8 24.32 5.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.258 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -165.17 148.1 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 101' ' ' SER . 2.0 t -145.99 133.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.84 141.2 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' VAL . 1.6 mp -136.31 146.87 47.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.569 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 106.1 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.03 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.3 pt -105.96 160.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 112.104 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 24' ' ' THR . 50.6 tt0 -133.94 137.99 45.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.169 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 167' ' ' ARG . 5.9 p90 -161.24 174.11 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.723 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.548 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -86.25 113.15 22.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.807 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.638 HG11 ' CE1' ' A' ' 21' ' ' HIS . 12.7 p -61.8 104.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.236 0.541 . . . . 0.0 111.94 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 167' ' ' ARG . . . 178.21 177.56 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.625 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 118' ' ' SER . 4.9 tp10 -177.95 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.449 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.5 t 163.55 109.21 0.0 OUTLIER 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.795 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.966 HG21 HG21 ' A' ' 170' ' ' THR . 7.1 p -140.52 147.59 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.133 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -123.34 77.87 53.51 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.95 0.405 . . . . 0.0 111.191 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 126' ' ' PHE . 20.9 Cg_exo -68.65 145.9 65.3 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.351 2.701 . . . . 0.0 112.333 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.43 13.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.47 140.37 0.01 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.857 0.361 . . . . 0.0 111.254 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 77.97 -59.93 3.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.131 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 23.0 m -146.37 102.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.713 ' HB2' ' HA ' ' A' ' 121' ' ' PRO . 2.3 p90 -124.94 164.77 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.67 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.927 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -120.51 163.9 17.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.274 0.559 . . . . 0.0 111.84 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 128' ' ' VAL . 28.0 m -130.81 104.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.007 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -81.99 112.69 19.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.922 HD21 HG23 ' A' ' 168' ' ' THR . 3.4 mp -126.72 117.13 22.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 131.59 46.89 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.249 1.966 . . . . 0.0 111.745 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.615 ' HE3' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -95.64 159.55 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.032 0.444 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.09 -168.69 2.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.856 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -68.96 65.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.463 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 46.52 65.46 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.044 0.449 . . . . 0.0 111.652 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 137' ' ' GLU . 15.0 t -111.35 164.98 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 136' ' ' VAL . 20.9 tt0 -38.07 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.939 0.4 . . . . 0.0 111.663 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -68.76 -42.52 77.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 163' ' ' SER . . . 90.04 -3.32 82.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.763 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -110.73 133.68 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 157' ' ' SER . 75.4 m -116.43 140.42 49.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.349 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.009 HD11 HD22 ' A' ' 197' ' ' LEU . 5.7 mt -97.8 162.87 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.54 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.6 OUTLIER -158.14 147.03 19.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.382 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 54.5 p -107.65 134.8 19.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.969 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.415 ' HD3' HG23 ' A' ' 155' ' ' VAL . 83.8 Cg_endo -78.59 79.16 3.42 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.582 2.188 . . . . 0.0 112.419 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.0 p 58.2 -174.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.67 133.94 47.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.4 ' HG3' ' HB3' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -163.76 -170.59 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -57.32 161.85 5.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.2 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.25 62.56 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.901 2.401 . . . . 0.0 112.118 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.21 -38.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.637 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.4 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . 10.7 p-10 -45.75 126.68 6.65 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.615 0.245 . . . . 0.0 111.254 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.72 -175.23 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.492 2.128 . . . . 0.0 112.612 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 142' ' ' ILE . 5.9 tp -89.7 169.84 10.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 156' ' ' ILE . 22.0 t -147.77 160.51 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.906 0.384 . . . . 0.0 111.61 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' HG12 ' A' ' 155' ' ' VAL . 39.0 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.882 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.435 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.4 OUTLIER -131.32 -7.19 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.0 OUTLIER -177.2 146.1 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.294 0.569 . . . . 0.0 112.072 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.658 HG22 ' HB2' ' A' ' 166' ' ' HIS . 7.8 mt -130.72 149.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.709 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 138.6 54.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.004 0.431 . . . . 0.0 111.609 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.419 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -81.76 -9.08 59.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.864 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 71' ' ' VAL . . . -89.95 -16.89 55.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.673 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 2.9 m -114.12 169.94 8.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.899 0.38 . . . . 0.0 110.99 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.786 ' HB ' HD23 ' A' ' 130' ' ' LEU . 5.6 m -61.74 -22.58 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.773 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.49 -71.21 0.08 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.789 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.658 ' HB2' HG22 ' A' ' 159' ' ' ILE . 6.4 t-160 -64.94 -24.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.975 0.417 . . . . 0.0 110.528 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.54 ' HA ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -57.61 -29.91 64.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.922 HG23 HD21 ' A' ' 130' ' ' LEU . 42.8 p -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.97 74.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.589 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.966 HG21 HG21 ' A' ' 119' ' ' VAL . 3.2 t -168.62 32.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.966 0.412 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 159' ' ' ILE . 1.0 OUTLIER -113.51 107.15 15.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.689 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.53 150.87 40.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.4 mt -74.95 131.42 40.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.54 -25.7 8.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.45 -172.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.309 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.93 134.43 42.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -99.92 142.18 31.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.439 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 178' ' ' LEU . 6.0 tt -120.85 -35.73 3.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.744 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.841 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -142.07 162.45 35.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.879 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.707 ' CD1' HD21 ' A' ' 185' ' ' LEU . 31.9 mt -139.34 116.71 11.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.37 -74.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -144.54 -19.3 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.932 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 196' ' ' ILE . 28.5 mm -96.55 140.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 111.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.841 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 5.8 mtt180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.905 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.707 HD21 ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -75.55 -6.72 51.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.243 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -41.18 -32.53 0.28 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.456 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m -121.48 -11.72 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.667 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 6.2 m -88.01 -169.78 2.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.142 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 80.5 p -112.3 -175.76 2.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.418 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.7 OUTLIER -70.91 -56.89 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -53.97 -47.11 71.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.785 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -43.6 72.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.059 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.66 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -56.86 -42.05 79.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.415 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.683 HG22 ' CD1' ' A' ' 142' ' ' ILE . 15.3 t -58.98 -39.15 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.291 0.567 . . . . 0.0 109.642 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.948 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.3 mt -69.81 -24.88 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.009 HD22 HD11 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -59.34 -31.59 69.32 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.482 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -103.98 -33.55 8.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.141 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.25 -19.67 55.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.709 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 19.8 p -85.49 47.12 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.281 0.563 . . . . 0.0 109.866 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.445 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 22.4 tt0 -68.37 63.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.65 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.402 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 8.8 m-20 -173.23 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.875 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.547 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -178.72 107.46 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 132' ' ' LYS . 2.9 t -85.6 108.35 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.604 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 8.9 ttmm -104.83 107.88 19.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.588 HD12 HG21 ' A' ' 128' ' ' VAL . 2.5 mt -99.91 121.51 41.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.616 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 3.9 tttt -89.7 101.96 14.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.284 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 208' ' ' ILE . 2.0 mm -91.97 158.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.409 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 29.9 mtp85 -113.81 121.79 45.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -114.14 106.17 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.058 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 177.89 42.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.65 168.69 19.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.162 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 19' ' ' VAL . 12.7 p -112.96 115.18 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.74 0.305 . . . . 0.0 111.133 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.81 HG21 ' O ' ' A' ' 115' ' ' VAL . 5.3 p 172.71 163.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.758 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.434 ' O ' HG22 ' A' ' 115' ' ' VAL . 33.0 t60 -88.24 106.24 18.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.797 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 p -53.29 161.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.202 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -168.68 169.13 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.615 HG22 ' HG3' ' A' ' 112' ' ' GLU . 29.7 p -129.33 164.74 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.494 HG22 ' CE2' ' A' ' 113' ' ' PHE . 12.4 t -147.78 -170.6 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.71 162.93 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.11 146.8 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG13 ' CD ' ' A' ' 106' ' ' LYS . 45.2 t -129.31 118.78 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.994 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.006 HD21 ' HB2' ' A' ' 66' ' ' ALA . 1.2 mt -114.38 118.86 35.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.82 163.27 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.526 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.83 115.75 29.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.267 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.48 152.03 59.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.576 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.65 9.21 3.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.636 2.224 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.33 -50.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 120.613 0.244 . . . . 0.0 111.428 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -132.39 -11.81 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -87.73 0.8 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.371 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 29' ' ' LEU . 4.5 m-85 -133.38 118.98 19.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.094 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -95.29 28.51 11.72 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.915 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 66' ' ' ALA . 4.0 mp -93.27 149.17 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.189 0.519 . . . . 0.0 112.012 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' NE2' ' HB3' ' A' ' 58' ' ' SER . 0.0 OUTLIER -145.0 99.08 3.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.049 HD21 HD13 ' A' ' 98' ' ' LEU . 1.8 pp -112.03 157.27 20.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 169.63 10.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.867 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -119.41 -5.89 11.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.051 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 p -137.46 151.59 48.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.153 0.501 . . . . 0.0 111.537 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.619 ' CG2' HD13 ' A' ' 56' ' ' LEU . 95.1 t -151.98 -76.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.133 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.783 ' O ' HG22 ' A' ' 48' ' ' THR . 21.0 p90 -35.46 -46.77 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.25 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.0 69.23 0.46 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.783 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER 166.96 95.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.2 146.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.104 0.478 . . . . 0.0 111.736 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.417 ' O ' ' CE2' ' A' ' 46' ' ' PHE . 63.1 p 45.59 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.703 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -132.76 -77.32 0.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.889 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.66 17.36 0.09 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.036 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.528 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 1.7 t -108.36 99.36 32.05 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.553 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 172.44 16.19 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.426 2.084 . . . . 0.0 111.978 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.53 ' HB3' HD13 ' A' ' 41' ' ' LEU . 2.4 Cg_endo -45.61 133.46 13.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.712 2.275 . . . . 0.0 112.003 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.619 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -129.0 97.23 4.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.507 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.634 HD13 HG23 ' A' ' 39' ' ' ILE . 27.4 mt -59.43 139.16 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.948 0.404 . . . . 0.0 110.904 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' HG23 ' A' ' 74' ' ' ILE . 2.5 t -124.2 1.48 8.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HA ' HD12 ' A' ' 74' ' ' ILE . 58.2 t80 179.15 134.76 0.09 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.047 0.451 . . . . 0.0 111.626 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.705 HG21 ' CB ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -108.58 162.91 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 40.9 tt0 -98.71 152.56 19.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.401 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.504 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -82.52 56.45 3.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER 165.76 42.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.431 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 t -132.05 139.95 36.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.92 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.34 -10.23 20.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.442 2.095 . . . . 0.0 112.626 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 1.006 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -73.09 -56.18 5.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.978 0.418 . . . . 0.0 110.841 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.705 ' CB ' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -76.81 -29.81 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.159 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -74.49 -29.89 61.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -44.91 69.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 100.06 28.05 7.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 162' ' ' GLY . 10.4 t -148.23 26.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.845 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 12.0 mt -137.36 129.77 29.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -128.72 174.61 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 59' ' ' TYR . 25.2 mm -66.81 74.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 128.28 46.04 0.19 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.37 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -74.89 98.46 3.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -78.54 115.8 18.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 109' ' ' LEU . 14.4 m -101.64 167.5 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 tpt -117.65 -40.96 2.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.43 133.48 22.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.682 HD12 HD12 ' A' ' 97' ' ' LEU . 7.0 mt -119.12 116.27 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.7 p30 47.38 26.07 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.378 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.34 -28.73 10.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.872 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 97' ' ' LEU . 13.0 mm -70.43 136.85 86.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-O 120.718 0.294 . . . . 0.0 111.567 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.3 167.47 19.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.555 2.17 . . . . 0.0 112.213 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 44.8 p -141.12 -54.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.004 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.45 -8.37 55.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.13 44.76 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.95 176.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 92' ' ' GLU . 7.9 m -62.87 145.45 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.477 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 8.2 p90 -73.34 -27.06 61.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.151 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.547 ' H ' HG22 ' A' ' 90' ' ' THR . 6.9 mt-10 -54.63 -42.17 70.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.843 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.6 pt-20 -61.0 -44.49 97.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.317 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -59.83 -35.63 75.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.6 m120 -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.88 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 39.3 mm-40 -62.07 -37.34 84.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.042 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.682 HD12 HD12 ' A' ' 81' ' ' ILE . 23.5 mt -57.43 -49.6 75.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.049 HD13 HD21 ' A' ' 41' ' ' LEU . 1.1 mt -69.92 -57.5 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 63.3 mtt180 -50.5 -31.66 16.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.44 0.638 . . . . 0.0 109.604 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.7 m-20 -119.25 39.68 3.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.675 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -93.17 26.31 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.9 t -124.43 15.71 8.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -68.33 -39.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.783 0.802 . . . . 0.0 110.409 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 11.68 30.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.552 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.49 ' O ' HG22 ' A' ' 30' ' ' THR . 1.8 m 57.92 22.2 8.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.905 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.74 156.25 2.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.362 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.48 129.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.055 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 134.07 47.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.025 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 HG11 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.23 138.12 31.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.59 144.04 27.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.318 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.544 ' CG2' HG12 ' A' ' 78' ' ' VAL . 32.0 pt -134.21 165.33 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.033 0.444 . . . . 0.0 111.828 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.615 ' HG3' HG22 ' A' ' 24' ' ' THR . 51.6 tt0 -132.16 140.95 48.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 25' ' ' THR . 0.5 OUTLIER -161.17 174.5 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.316 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.534 ' HB2' HG11 ' A' ' 20' ' ' VAL . 14.0 p30 -98.07 119.8 37.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.272 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.81 ' O ' HG21 ' A' ' 20' ' ' VAL . 24.1 m -61.81 104.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.556 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.0 124.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.812 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -137.44 52.67 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 t 65.33 89.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.332 0.587 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 1.016 HG12 HG12 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -118.01 122.34 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.111 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.664 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.8 pp -115.6 89.59 23.3 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.315 0.578 . . . . 0.0 110.328 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.533 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.5 Cg_endo -97.04 169.55 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.211 2.608 . . . . 0.0 113.134 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.2 p -153.58 -66.58 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.145 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 166.3 109.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.02 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.05 -32.72 5.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.401 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.513 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -129.25 102.72 6.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.041 0.448 . . . . 0.0 110.768 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -105.43 125.21 50.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.045 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.546 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -113.73 129.04 56.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.959 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.016 HG12 HG12 ' A' ' 119' ' ' VAL . 31.6 m -114.1 104.69 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.105 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.43 ' HG2' ' HD3' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -87.35 106.57 18.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.781 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 204' ' ' VAL . 0.1 OUTLIER -121.38 136.48 25.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.661 0.267 . . . . 0.0 111.203 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.28 139.81 51.25 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.349 2.033 . . . . 0.0 111.338 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -124.77 158.3 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.674 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.661 ' CG ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -130.48 172.98 11.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.238 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.627 ' CE1' ' HE2' ' A' ' 133' ' ' LYS . 1.4 p-80 -47.23 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -127.43 98.33 5.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.085 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.661 ' HB ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.5 -177.28 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 136' ' ' VAL . 4.5 tt0 -96.35 97.48 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.748 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.856 HD22 HD11 ' A' ' 140' ' ' ILE . 3.1 mt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.758 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.79 3.69 65.95 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.923 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.856 HD11 HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -102.47 137.88 28.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 110.711 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 98.7 m -126.02 128.26 47.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.708 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.883 HD13 HG22 ' A' ' 194' ' ' VAL . 1.7 mt -95.93 163.91 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 142' ' ' ILE . 22.7 t -175.01 177.58 1.93 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.0 t -114.51 134.49 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.622 ' HD3' HG12 ' A' ' 155' ' ' VAL . 94.4 Cg_endo -78.26 176.49 9.89 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.562 2.175 . . . . 0.0 112.297 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.82 -164.8 0.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 58.18 85.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 110.621 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.54 72.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.959 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -80.24 159.78 69.5 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.698 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -44.94 -28.79 3.28 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.805 2.337 . . . . 0.0 112.024 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.37 -71.65 1.0 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.116 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.6 t70 65.14 73.06 0.44 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 0.0 111.267 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.1 -157.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.661 2.241 . . . . 0.0 112.117 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.892 HD21 ' HA ' ' A' ' 190' ' ' MET . 1.6 mp -104.85 -173.43 2.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.506 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 175' ' ' ASP . 7.6 p -178.43 138.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.267 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 1.022 HD13 HD23 ' A' ' 171' ' ' LEU . 12.0 mt -70.27 154.23 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 t -134.89 -8.94 2.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.71 142.29 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.059 0.457 . . . . 0.0 111.451 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' HB2' ' A' ' 166' ' ' HIS . 4.4 mt -141.05 133.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.3 164.83 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.49 163.58 12.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.771 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.589 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . 83.71 -11.89 54.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.902 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.5 m -113.42 148.96 34.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.69 -22.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.227 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 168' ' ' THR . . . -55.12 -64.06 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.743 0.306 . . . . 0.0 111.558 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.789 ' HB2' HG22 ' A' ' 159' ' ' ILE . 9.5 t-160 -81.31 -24.69 37.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.77 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -55.05 -40.86 70.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.193 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.81 HG22 ' O ' ' A' ' 165' ' ' ALA . 5.1 t -52.01 -26.07 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.029 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.01 67.04 2.41 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.808 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.798 HG21 HG11 ' A' ' 119' ' ' VAL . 2.9 t 178.84 40.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 110.825 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.022 HD23 HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -114.39 -77.7 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.718 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 62.11 149.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.091 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.65 107.06 8.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.728 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.38 -18.01 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.613 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.869 ' O ' HG23 ' A' ' 155' ' ' VAL . 1.9 m-20 -60.29 144.66 49.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.222 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 209' ' ' ARG . 0.1 OUTLIER -110.49 114.61 28.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.67 0.271 . . . . 0.0 110.917 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 0.5 OUTLIER -70.15 176.03 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.559 ' C ' HD13 ' A' ' 178' ' ' LEU . 3.4 tm? -156.82 -43.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.494 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -145.87 173.37 12.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.674 HG22 ' OD2' ' A' ' 181' ' ' ASP . 24.3 mm -139.04 105.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.674 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 47.18 -88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.534 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -102.49 -17.96 15.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 184' ' ' ARG . 33.4 mm -100.28 156.68 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 111.747 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.494 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 38.0 mtp180 -125.93 119.33 27.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.555 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 193' ' ' ALA . 2.7 mm? -76.08 -12.93 60.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.055 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.06 -76.56 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.809 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 185' ' ' LEU . 23.9 p -159.57 33.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.725 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 174.4 -171.05 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.679 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 185' ' ' LEU . 0.8 OUTLIER 75.68 39.72 0.32 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.892 ' HA ' HD21 ' A' ' 154' ' ' LEU . 7.8 ptm -53.87 -44.77 70.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.795 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -64.44 -37.23 86.8 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.61 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.851 ' O ' HD12 ' A' ' 196' ' ' ILE . 3.1 m-20 -62.32 -42.21 99.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.31 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -58.9 -49.76 76.57 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.812 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.883 HG22 HD13 ' A' ' 142' ' ' ILE . 7.9 t -55.94 -28.46 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.378 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -50.15 48.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 192' ' ' ASP . 3.1 mp -80.06 -24.39 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.839 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.83 HD22 ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -77.68 -23.9 49.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.579 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.464 ' OE1' HG12 ' A' ' 194' ' ' VAL . 36.5 mt-30 -85.98 -47.69 9.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.202 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.493 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 1.3 pp0? -68.29 -10.31 53.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.5 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.842 ' HB3' HG22 ' A' ' 204' ' ' VAL . 1.3 m -78.48 46.65 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.409 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 7.5 pt-20 -73.15 62.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.358 0.599 . . . . 0.0 111.085 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -170.07 -32.73 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.261 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.2 tt 178.95 108.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 200' ' ' CYS . 25.1 t -109.74 122.82 64.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 35.5 ttpt -109.54 114.35 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 206' ' ' LEU . 2.5 mm? -91.86 119.19 31.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.073 0.463 . . . . 0.0 111.461 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 125' ' ' THR . 3.9 tttm -92.06 93.63 8.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.984 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 209' ' ' ARG . 6.9 mt -94.9 165.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.803 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -105.75 128.52 53.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.786 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -132.33 114.52 14.49 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.234 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.28 54.92 2.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.78 -172.47 2.39 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.197 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 29.1 t0 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.006 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 19' ' ' VAL . 11.9 p -148.9 121.74 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.057 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.5 128.74 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.0 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -119.08 115.59 24.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 p -51.67 116.02 1.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.14 168.49 10.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.583 HG23 ' HG3' ' A' ' 112' ' ' GLU . 1.2 p -125.42 134.75 52.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.512 HG21 ' CE2' ' A' ' 113' ' ' PHE . 7.2 t -121.58 177.23 5.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.35 162.08 16.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.751 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.21 148.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.99 109.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.036 HD21 HD11 ' A' ' 72' ' ' LEU . 3.0 mm? -107.54 118.37 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.47 162.31 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.157 0.503 . . . . 0.0 111.588 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 116.75 33.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.72 153.19 60.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.656 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.32 3.17 6.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.591 2.194 . . . . 0.0 112.624 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.09 -51.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.241 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -132.76 -4.3 3.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.35 -97.16 0.94 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.269 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 42.0 m-85 -119.01 115.57 24.6 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -83.1 11.11 56.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.94 -0.647 . . . . 0.0 114.116 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 72' ' ' LEU . 26.5 mt -92.82 146.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.387 0.593 . . . . 0.0 111.981 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -139.39 99.96 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.948 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 55' ' ' PRO . 1.4 pp -108.92 152.9 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.344 0.592 . . . . 0.0 112.267 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -99.53 170.1 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.329 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -133.21 31.95 2.81 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.872 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.22 68.38 0.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.122 0.486 . . . . 0.0 110.703 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.94 HG22 HD13 ' A' ' 56' ' ' LEU . 12.4 t -57.2 -75.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.928 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 p90 -68.54 -44.65 74.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.34 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 52.55 86.64 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.544 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 70.9 p -159.19 81.15 0.77 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' C ' ' HG1' ' A' ' 50' ' ' THR . 8.4 pt-20 44.2 60.19 2.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.857 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.677 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 177.81 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.339 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HG ' ' C ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 36.16 22.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.367 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -70.78 20.36 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -79.42 120.22 79.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.703 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.81 168.03 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.524 2.149 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.804 ' HB3' HD13 ' A' ' 41' ' ' LEU . 61.1 Cg_exo -51.4 142.45 37.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.709 2.273 . . . . 0.0 112.136 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.94 HD13 HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -144.98 108.34 4.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.65 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.783 ' CD1' HD13 ' A' ' 39' ' ' ILE . 22.6 mt -62.9 117.23 3.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.843 0.354 . . . . 0.0 110.74 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -97.68 -22.82 16.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 58.4 t80 -162.08 127.49 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.027 0.442 . . . . 0.0 111.692 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.761 HG21 ' HB2' ' A' ' 67' ' ' GLU . 2.1 mt -99.17 -173.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.715 ' H ' HG22 ' A' ' 60' ' ' ILE . 68.2 tt0 -116.08 144.01 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.385 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -71.84 100.32 2.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.067 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 8.0 t0 99.33 49.17 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.821 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.03 140.53 38.05 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 14.4 Cg_endo -56.7 -18.66 27.47 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.359 2.04 . . . . 0.0 111.686 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.803 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -67.53 -56.33 9.95 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.761 ' HB2' HG21 ' A' ' 60' ' ' ILE . 2.4 tp10 -77.75 -28.33 50.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.954 0.407 . . . . 0.0 109.986 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 4.0 mmt-85 -89.69 -1.78 58.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.652 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 22.7 t -48.87 -54.7 14.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.926 0.393 . . . . 0.0 110.76 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.01 -22.18 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.967 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.495 HG11 ' HA3' ' A' ' 162' ' ' GLY . 17.5 t -139.34 61.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 111.348 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 39' ' ' ILE . 11.1 mt -147.45 145.34 29.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.305 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -141.49 172.96 11.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.635 HD13 HG13 ' A' ' 60' ' ' ILE . 29.1 mm -68.26 71.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.39 88.3 0.98 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.39 101.56 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 111' ' ' ILE . 23.7 mmt-85 -59.81 139.25 57.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.412 HG23 ' HD2' ' A' ' 55' ' ' PRO . 3.4 m -122.36 148.91 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.002 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -30.21 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.962 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.43 137.88 23.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.228 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.92 HD12 HD12 ' A' ' 97' ' ' LEU . 11.8 mt -120.87 109.84 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.8 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 58.03 23.14 9.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 -28.27 12.28 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.324 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 85' ' ' PRO . 30.1 mt -70.02 137.21 87.2 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.497 0.189 . . . . 0.0 111.316 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 84' ' ' ILE . 41.7 Cg_endo -67.49 -168.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.37 2.046 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.4 p -151.75 -54.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.008 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.42 -13.29 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.48 45.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.797 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.26 -175.87 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 5.4 m -83.73 165.39 18.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.989 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HD2' HD13 ' A' ' 51' ' ' LEU . 5.1 p90 -73.88 -41.53 62.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.3 tt0 -54.64 -32.51 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.034 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -61.42 -49.39 77.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -54.36 -42.51 70.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.526 0.679 . . . . 0.0 110.067 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.6 OUTLIER -59.09 -36.41 75.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.869 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 7.5 mm-40 -61.94 -42.75 99.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.92 HD12 HD12 ' A' ' 81' ' ' ILE . 10.6 mt -55.43 -44.25 76.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.638 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.522 HD13 HD11 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -67.81 -47.42 69.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.216 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 8.9 mtm180 -50.44 -33.1 19.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.715 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.498 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 61.4 m-20 -120.22 38.08 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.106 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -95.19 21.54 7.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.242 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.2 p -125.5 16.58 8.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 111.823 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -62.86 -49.69 82.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.935 0.874 . . . . 0.0 110.413 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.64 8.77 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.555 ' O ' HG22 ' A' ' 30' ' ' THR . 15.4 m 62.6 26.91 15.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.808 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 6.3 mttt -154.95 157.94 38.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.674 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -155.45 114.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.248 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.48 141.23 29.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.832 0.348 . . . . 0.0 110.961 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 81' ' ' ILE . 1.1 mt -137.05 155.89 49.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -121.24 111.19 17.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.243 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.708 HG22 ' O ' ' A' ' 77' ' ' ARG . 41.1 pt -114.73 163.09 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 111.676 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.583 ' HG3' HG23 ' A' ' 24' ' ' THR . 25.3 tt0 -131.28 142.87 50.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.514 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 25' ' ' THR . 0.2 OUTLIER -161.11 174.71 13.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.407 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.32 155.1 21.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.07 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -106.75 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.426 . . . . 0.0 111.691 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 115' ' ' VAL . . . 173.05 117.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.706 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CG ' HG13 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -130.78 30.89 4.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.146 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.1 t 89.45 97.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.409 0.623 . . . . 0.0 111.293 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 170' ' ' THR . 9.3 p -139.91 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.13 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.748 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.5 pp -108.1 101.67 42.6 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.415 ' HA ' ' CE1' ' A' ' 126' ' ' PHE . 15.9 Cg_exo -68.69 156.84 64.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.865 2.376 . . . . 0.0 112.68 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.04 104.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.01 115.27 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.003 0.43 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 102.45 -47.39 1.14 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.546 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.21 107.14 11.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.925 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.477 ' HE2' HG21 ' A' ' 119' ' ' VAL . 1.7 t80 -113.0 120.12 40.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.748 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -113.23 121.48 44.59 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.796 HG11 HG21 ' A' ' 168' ' ' THR . 12.1 t -104.55 99.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.685 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.25 109.43 16.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.554 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.825 HD21 HG22 ' A' ' 168' ' ' THR . 26.1 mt -121.76 116.35 30.39 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.588 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.35 114.78 2.65 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.337 2.025 . . . . 0.0 111.612 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.474 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -87.72 158.96 18.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 111.259 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.601 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -101.77 -164.66 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.66 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.92 -36.53 62.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 m -177.49 70.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 133' ' ' LYS . 21.5 t -118.54 159.26 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.364 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.492 ' N ' HG12 ' A' ' 136' ' ' VAL . 16.0 pt-20 -65.95 133.56 51.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.939 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.769 HD22 HD11 ' A' ' 140' ' ' ILE . 1.9 mt -92.45 -49.4 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.706 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.02 16.11 39.66 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.769 HD11 HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -106.39 141.22 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.19 0.495 . . . . 0.0 111.278 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.8 m -122.3 114.16 20.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.593 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.995 HD12 HG22 ' A' ' 194' ' ' VAL . 5.6 mt -84.98 160.79 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.926 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 142' ' ' ILE . 1.4 m -150.02 156.15 41.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.191 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.2 t -110.12 90.9 10.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.29 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 155' ' ' VAL . 85.5 Cg_exo -44.49 165.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.618 2.212 . . . . 0.0 112.341 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.9 -161.81 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.56 170.02 21.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.006 0.431 . . . . 0.0 111.336 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 149' ' ' LYS . 0.0 OUTLIER 79.24 29.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.485 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 148' ' ' ARG . 1.9 mptp? -145.59 133.9 10.75 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.125 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.65 -23.16 14.56 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.952 1.768 . . . . 0.0 111.554 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 156.19 45.66 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.45 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -53.67 -56.25 27.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.702 ' O ' HD22 ' A' ' 154' ' ' LEU . 72.3 Cg_endo -90.22 157.93 4.68 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.692 2.261 . . . . 0.0 112.973 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 153' ' ' PRO . 4.0 mm? -130.11 133.97 47.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.766 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.516 HG21 ' HG3' ' A' ' 145' ' ' PRO . 73.2 t -156.34 159.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.826 HD12 ' HA3' ' A' ' 174' ' ' GLY . 5.3 mt -105.24 139.54 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.729 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.7 m -127.32 -12.15 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.71 124.84 13.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.503 . . . . 0.0 111.903 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.561 HG22 ' HB2' ' A' ' 166' ' ' HIS . 16.4 mt -117.98 146.63 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.219 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.7 143.88 45.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 111.287 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 168.37 20.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.495 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 83.8 -46.47 3.66 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.741 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.544 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.6 OUTLIER -72.74 175.47 6.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 111.381 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.78 HG12 HD22 ' A' ' 130' ' ' LEU . 40.9 t -73.63 -22.34 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.104 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.755 ' HB2' ' CD1' ' A' ' 140' ' ' ILE . . . -53.67 -71.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.923 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.561 ' HB2' HG22 ' A' ' 159' ' ' ILE . 15.7 t-80 -67.05 -24.76 66.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.69 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -57.12 -34.49 68.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.825 HG22 HD21 ' A' ' 130' ' ' LEU . 36.3 p -39.2 -58.02 1.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.511 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.18 -23.12 35.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.556 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.479 ' CG2' HG11 ' A' ' 119' ' ' VAL . 3.0 t -127.4 35.7 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.477 HD23 HD13 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -104.34 78.88 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.84 78.41 2.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 173' ' ' LEU . 26.5 mt 39.93 28.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.826 ' HA3' HD12 ' A' ' 156' ' ' ILE . . . 70.74 -38.98 0.5 Allowed Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.909 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.86 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 176' ' ' LYS . 4.7 mmmm -136.15 106.29 6.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.347 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.686 HD22 HD11 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -92.6 132.35 36.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.398 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.3 pp -134.77 -16.53 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.04 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 207' ' ' LYS . . . -145.57 132.71 20.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.686 HD11 HD22 ' A' ' 177' ' ' LEU . 50.3 mt -135.65 118.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 16.1 m-20 57.82 43.56 21.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.212 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 3.1 t-20 83.49 -25.11 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.936 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 184' ' ' ARG . 44.8 mm -81.31 157.96 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.744 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.465 ' N ' HG22 ' A' ' 183' ' ' ILE . 19.6 mtm105 -129.59 126.45 38.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 112.175 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.819 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 1.4 mm? -79.89 -4.26 51.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.064 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.72 -32.37 0.38 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.0 t -115.58 -17.06 11.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.9 m -89.0 -169.76 2.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.012 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 m -109.12 -167.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.411 ' O ' HG23 ' A' ' 194' ' ' VAL . 14.5 ttp -74.32 -53.44 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -53.4 -29.79 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 110.732 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.817 ' O ' HD12 ' A' ' 196' ' ' ILE . 1.1 t0 -59.93 -52.3 66.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.228 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.819 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -58.25 -43.02 87.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.279 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.995 HG22 HD12 ' A' ' 142' ' ' ILE . 7.8 t -64.05 -31.81 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.705 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -48.2 77.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.848 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.2 mp -73.1 -24.69 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 180' ' ' ILE . 0.2 OUTLIER -64.02 -37.61 88.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.627 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.588 ' NE2' HG12 ' A' ' 194' ' ' VAL . 14.7 mt-30 -86.43 -52.93 5.29 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.597 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.543 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 1.5 pp0? -56.83 -18.17 11.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.946 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' ' 196' ' ' ILE . 16.5 m -88.4 42.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.119 0.485 . . . . 0.0 110.123 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.48 62.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -163.89 -32.2 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.9 tt 177.39 106.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.55 121.33 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.666 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -104.62 108.74 20.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 206' ' ' LEU . 6.0 mp -91.82 117.43 29.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.459 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 179' ' ' ALA . 16.0 tttt -107.21 108.64 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.221 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.487 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -111.6 175.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.426 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -114.29 120.04 39.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.015 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -125.87 108.85 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -179.01 43.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.122 0.487 . . . . 0.0 110.853 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.67 -168.91 2.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.038 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.439 179.767 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.869 0.366 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.69 131.87 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.066 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.494 HG12 ' OD1' ' A' ' 114' ' ' ASP . 29.1 t -124.98 133.08 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.285 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.49 ' NE2' HG11 ' A' ' 115' ' ' VAL . 26.5 p-80 -127.31 111.54 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.703 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -50.15 131.42 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.346 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -124.6 149.7 46.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.732 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.5 p -110.21 135.93 50.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -134.96 -169.68 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -117.07 163.09 16.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.538 HG13 HG23 ' A' ' 71' ' ' VAL . 1.5 t -141.51 148.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.424 ' C ' HD12 ' A' ' 29' ' ' LEU . 41.3 t -127.73 115.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.276 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 109' ' ' LEU . 10.4 mp -112.25 120.99 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.233 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.681 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -101.92 163.14 12.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.32 0.581 . . . . 0.0 111.512 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -107.5 103.71 13.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.24 149.36 55.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.424 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.28 4.47 5.37 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.532 2.155 . . . . 0.0 112.736 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.0 -46.21 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.528 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.601 HG21 ' OE2' ' A' ' 61' ' ' GLU . 46.3 p -127.91 -11.77 5.37 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.32 -93.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.195 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 37.6 m-85 -130.65 119.97 23.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.058 0.456 . . . . 0.0 110.104 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -79.7 3.41 69.17 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.306 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 72' ' ' LEU . 34.5 mt -92.74 151.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.63 0.715 . . . . 0.0 112.024 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -151.53 99.56 2.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.104 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.793 HD11 HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.52 157.41 16.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.394 0.616 . . . . 0.0 112.575 -178.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' HG2' HD13 ' A' ' 56' ' ' LEU . 1.5 pm0 -95.4 164.64 12.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.778 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -76.83 -98.34 0.17 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.854 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.1 p -112.61 148.46 34.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.115 0.483 . . . . 0.0 111.806 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.6 -64.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.409 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.661 ' CE1' ' HA ' ' A' ' 51' ' ' LEU . 30.2 p90 -40.92 -40.93 1.5 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.661 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 39.79 92.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.891 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER 173.02 70.6 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.252 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 48' ' ' THR . 6.1 pt-20 52.44 162.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.107 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 47.1 m 69.51 -10.57 0.56 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.34 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.661 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 32.3 -103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 t 71.49 12.65 6.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.6 . . . . 0.0 110.096 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -68.51 107.42 1.97 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.581 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.26 149.31 11.85 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.763 2.309 . . . . 0.0 111.333 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.74 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 84.5 Cg_exo -45.3 110.01 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.455 HD13 ' HG2' ' A' ' 42' ' ' GLN . 2.0 mp -105.92 92.9 4.36 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.886 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.816 ' CD1' HD13 ' A' ' 39' ' ' ILE . 40.3 mt -58.21 110.65 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-O 120.787 0.327 . . . . 0.0 110.558 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -91.16 -2.37 57.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.351 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 79.4 t80 178.95 142.92 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.131 0.491 . . . . 0.0 111.608 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.777 HG21 ' HB2' ' A' ' 67' ' ' GLU . 1.8 mt -121.48 170.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.601 ' OE2' HG21 ' A' ' 35' ' ' THR . 56.8 tt0 -108.13 152.03 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.591 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.56 45.58 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.73 41.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.873 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.411 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 1.9 m -139.45 139.86 23.84 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.807 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 18.7 Cg_endo -58.78 -15.3 25.81 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.782 2.321 . . . . 0.0 112.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.673 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -64.18 -56.81 12.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.94 0.4 . . . . 0.0 110.303 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.777 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -78.96 -29.62 44.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.752 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.447 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -64.1 -24.76 67.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.001 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -47.29 -29.65 2.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 137' ' ' GLU . . . 78.16 27.15 58.56 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.789 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.538 HG23 HG13 ' A' ' 27' ' ' VAL . 3.5 m -152.15 36.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.967 0.413 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.011 HD13 HD11 ' A' ' 39' ' ' ILE . 12.0 mt -137.29 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.13 152.65 15.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.9 mt -62.74 103.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.77 29.83 3.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.507 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.557 ' OD2' HD23 ' A' ' 72' ' ' LEU . 15.8 m-20 -73.82 152.74 40.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -116.4 97.48 6.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 109' ' ' LEU . 23.8 t -73.14 151.88 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -30.95 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -157.32 143.7 17.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.189 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.813 ' HB ' HD13 ' A' ' 97' ' ' LEU . 19.2 mt -127.21 115.3 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.8 18.63 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.78 -27.96 10.52 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.604 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.643 HD12 ' CD2' ' A' ' 97' ' ' LEU . 35.8 mt -74.91 132.98 76.44 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-O 120.507 0.194 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.85 168.68 23.98 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.407 2.071 . . . . 0.0 112.286 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.8 p -131.26 -61.68 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -62.61 -18.2 61.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.38 44.51 1.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.611 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.52 -170.67 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.72 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -73.6 139.53 45.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 11.0 p90 -73.12 -32.7 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.5 mt-10 -54.0 -36.51 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.46 -45.38 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.74 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -54.74 -39.31 68.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.21 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -64.79 -35.23 80.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.143 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 mm-40 -67.28 -41.25 85.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.591 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.813 HD13 ' HB ' ' A' ' 81' ' ' ILE . 12.5 mt -63.98 -50.28 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.903 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 HD11 ' A' ' 41' ' ' LEU . 2.1 mt -69.76 -54.74 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -50.91 -29.42 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.187 0.518 . . . . 0.0 109.829 179.064 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -124.76 40.84 3.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.531 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.9 p -87.39 13.88 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.596 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 p -109.24 15.12 23.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 5.6 mt -74.24 -47.42 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.706 0.765 . . . . 0.0 110.776 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.67 9.52 41.37 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.657 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.723 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 56.32 21.38 5.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.681 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.1 OUTLIER -174.81 157.73 2.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.984 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.0 p -164.48 121.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.9 135.65 42.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.961 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -142.1 158.48 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.974 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -104.33 145.53 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.5 pt -131.25 165.98 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.561 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -135.8 124.18 23.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.473 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.414 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 3.6 p90 -141.87 174.1 10.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.376 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' OD1' HG12 ' A' ' 20' ' ' VAL . 1.2 m-20 -94.91 110.52 22.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.203 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 115' ' ' VAL . 8.9 p -61.8 104.88 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.39 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.68 137.23 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.641 ' HB3' HG22 ' A' ' 168' ' ' THR . 3.7 tp10 -130.43 6.43 4.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.5 m 83.44 74.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.964 0.411 . . . . 0.0 111.702 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.857 HG12 ' HA ' ' A' ' 128' ' ' VAL . 7.1 m -100.53 146.28 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.738 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.1 pp -117.39 104.12 50.38 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.853 0.359 . . . . 0.0 111.459 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 96.0 Cg_endo -85.9 152.71 9.88 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.9 2.4 . . . . 0.0 112.85 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.89 24.96 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.33 113.61 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.34 -45.06 2.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -125.66 102.56 7.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.676 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.489 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -111.6 115.93 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.665 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.15 126.06 41.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 110.714 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.857 ' HA ' HG12 ' A' ' 119' ' ' VAL . 13.0 t -99.89 87.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -81.26 105.49 12.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.883 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -129.95 124.94 21.84 Favored Pre-proline 0 C--N 1.333 -0.114 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -56.63 128.98 32.24 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.299 1.999 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 12.0 tptm -98.22 158.19 15.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.739 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.925 ' O ' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -132.82 78.2 1.78 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.268 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 69.2 m-70 45.21 29.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.196 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.402 ' HA ' ' CE ' ' A' ' 132' ' ' LYS . 0.9 OUTLIER 56.31 69.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 133' ' ' LYS . 76.9 t -87.05 -97.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.801 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -101.52 108.82 20.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.779 0.323 . . . . 0.0 111.055 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 163' ' ' SER . 17.6 mt -142.36 102.6 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -90.49 45.84 2.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.642 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 165' ' ' ALA . 47.4 mt -88.35 144.16 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.755 0.312 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.415 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 92.1 m -126.15 129.22 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.8 ' CD1' HG22 ' A' ' 194' ' ' VAL . 5.2 mt -107.52 164.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.836 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.521 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -153.88 149.66 27.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.816 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.01 130.9 23.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.45 170.82 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.448 2.099 . . . . 0.0 112.196 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -57.15 4.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.7 m -165.07 59.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.822 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -93.05 105.23 17.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.984 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER 48.65 167.64 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.047 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 149' ' ' LYS . 15.8 Cg_exo -68.44 63.1 1.15 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.832 2.355 . . . . 0.0 112.269 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.63 -37.74 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.768 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.441 ' HA ' ' HD2' ' A' ' 153' ' ' PRO . 6.4 p-10 43.4 94.36 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 111.373 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 152' ' ' ASP . 19.1 Cg_endo -58.35 151.71 58.84 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.113 . . . . 0.0 112.432 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.818 HD11 ' HA ' ' A' ' 190' ' ' MET . 2.9 mm? -73.16 164.48 26.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.685 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 175' ' ' ASP . 27.6 m -155.38 135.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 111.304 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.37 150.34 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.41 -14.3 5.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.883 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.547 ' HA ' HD21 ' A' ' 173' ' ' LEU . 1.2 t70 179.02 147.04 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -140.66 136.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.401 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -95.66 145.97 24.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.88 0.372 . . . . 0.0 111.122 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -177.92 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 71' ' ' VAL . . . 71.18 -60.45 1.06 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.551 ' HB3' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -56.91 138.76 53.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.0 111.231 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 168' ' ' THR . 3.5 m -51.69 -21.68 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.192 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -49.24 -71.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 61.8 t60 -71.57 -24.8 61.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.84 0.353 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.47 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.8 -34.82 63.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.869 HG21 HD22 ' A' ' 130' ' ' LEU . 24.3 p -52.32 -27.13 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 74.52 64.69 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.58 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.433 HG21 HG22 ' A' ' 128' ' ' VAL . 3.7 t -178.91 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.444 HD11 HD22 ' A' ' 206' ' ' LEU . 0.3 OUTLIER -60.85 86.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.04 -174.1 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 158' ' ' ASP . 4.3 mt -94.01 117.0 29.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.98 31.29 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.58 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.511 ' HB3' HG23 ' A' ' 208' ' ' ILE . 2.9 m-20 -111.32 159.7 17.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.495 0.188 . . . . 0.0 110.623 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -112.84 129.85 56.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.784 HD11 ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -102.44 146.7 27.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.007 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.612 HD21 ' NE ' ' A' ' 184' ' ' ARG . 7.8 tt -132.82 -42.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.117 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -127.77 156.29 42.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.765 HG22 ' OD1' ' A' ' 181' ' ' ASP . 17.8 mt -139.86 135.05 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.765 ' OD1' HG22 ' A' ' 180' ' ' ILE . 3.5 p-10 42.55 41.82 2.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.089 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 81.65 -19.56 0.41 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 183' ' ' ILE . 18.1 mm -90.76 132.2 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.612 ' NE ' HD21 ' A' ' 178' ' ' LEU . 2.3 mtp-105 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.612 HD21 HD12 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -93.46 -17.3 23.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 58.55 39.69 24.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.498 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.4 p 58.54 74.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.005 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 192' ' ' ASP . 31.0 p -136.6 114.34 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 192' ' ' ASP . 0.4 OUTLIER 57.89 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.818 ' HA ' HD11 ' A' ' 154' ' ' LEU . 16.2 tmm? -53.14 -33.73 53.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.58 -29.77 68.38 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.259 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 189' ' ' SER . 3.4 t0 -63.76 -48.91 75.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 185' ' ' LEU . . . -57.8 -43.45 85.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.142 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.8 HG22 ' CD1' ' A' ' 142' ' ' ILE . 14.3 t -59.95 -40.24 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.347 0.594 . . . . 0.0 109.681 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -49.56 75.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.937 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.725 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.9 OUTLIER -65.54 -24.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -68.8 -25.76 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -98.26 -49.19 4.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.968 -178.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -59.23 -17.24 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.58 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.833 ' SG ' HG22 ' A' ' 204' ' ' VAL . 25.6 p -80.27 48.47 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.532 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 1.1 pt-20 -74.46 61.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.85 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.404 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -175.09 -26.49 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.415 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 203' ' ' LEU . 2.4 tt 177.63 112.03 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.0 110.386 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.833 HG22 ' SG ' ' A' ' 200' ' ' CYS . 12.0 t -96.13 111.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.799 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -105.58 108.3 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.784 ' CD2' HD11 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -97.35 119.79 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 111.839 -178.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.686 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 6.9 tttt -91.93 93.19 8.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 175' ' ' ASP . 8.1 mm -84.62 163.86 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.286 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.458 ' N ' HG22 ' A' ' 208' ' ' ILE . 1.5 ttt85 -107.79 116.77 32.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.572 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -103.8 159.78 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -158.02 44.16 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -58.47 177.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.358 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.883 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 19' ' ' VAL . 36.0 m -101.15 115.67 43.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.914 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.814 HG21 HG13 ' A' ' 115' ' ' VAL . 8.4 p 172.49 159.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.773 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.513 ' N ' HG22 ' A' ' 20' ' ' VAL . 18.1 p-80 -99.65 130.28 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.82 171.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.144 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -161.91 166.29 26.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.474 HG23 ' CG ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -120.39 151.03 39.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.527 ' CG2' HD11 ' A' ' 111' ' ' ILE . 12.9 t -136.75 -173.26 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.98 163.07 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 109' ' ' LEU . 2.1 t -135.41 149.38 28.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.6 109.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.554 HD22 ' CB ' ' A' ' 66' ' ' ALA . 52.3 mt -112.21 118.11 34.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.249 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -105.33 162.83 13.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.227 0.537 . . . . 0.0 111.686 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.739 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 109.06 20.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.04 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -78.4 150.14 76.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.74 3.75 5.72 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.43 2.087 . . . . 0.0 112.73 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.76 -43.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.577 0.227 . . . . 0.0 111.596 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.85 -12.14 5.37 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 64.61 -82.89 0.06 OUTLIER Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.159 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 56.2 m-85 -139.09 113.58 9.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.78 26.28 15.18 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.685 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.983 HD11 ' HB2' ' A' ' 66' ' ' ALA . 3.9 mp -93.0 125.03 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -97.88 98.41 9.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.95 HD21 ' HA ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -96.87 156.54 16.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -132.55 169.28 16.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.92 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.72 56.52 0.51 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.708 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -158.21 79.35 0.83 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.489 ' CG2' HD22 ' A' ' 56' ' ' LEU . 1.9 t -98.46 -72.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.394 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 27.8 p90 -34.72 -45.92 0.27 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.43 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 49.25 72.62 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.4 t 167.93 94.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 48' ' ' THR . 7.7 pt-20 49.87 178.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.818 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t 44.08 -161.45 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.359 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.818 HD23 ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.08 -90.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.204 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 51.12 18.46 0.57 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.888 0.375 . . . . 0.0 111.469 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -66.71 111.43 6.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.306 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.725 ' O ' HD23 ' A' ' 56' ' ' LEU . 83.7 Cg_endo -78.34 146.15 21.89 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.343 2.029 . . . . 0.0 111.441 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.95 ' HA ' HD21 ' A' ' 41' ' ' LEU . 5.4 Cg_endo -48.71 104.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.381 2.054 . . . . 0.0 111.747 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -117.33 111.9 20.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.693 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 39' ' ' ILE . 19.3 mt -59.7 157.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 57' ' ' ILE . 26.4 t -128.44 -34.94 2.0 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.9 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -163.97 127.79 2.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.502 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.722 HG21 ' CB ' ' A' ' 67' ' ' GLU . 3.9 mt -96.17 168.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.53 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.71 141.55 46.38 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.52 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -69.13 63.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.456 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.6 p30 162.58 42.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.268 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -134.06 139.92 34.66 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.758 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.06 -12.69 31.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.755 2.303 . . . . 0.0 112.9 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.983 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -74.85 -56.3 4.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.927 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.722 ' CB ' HG21 ' A' ' 60' ' ' ILE . 2.7 tp10 -72.32 -29.9 64.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.742 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.524 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -76.91 -24.5 52.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.1 t -44.4 -52.4 7.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 111.045 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.876 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 118.15 16.73 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.113 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 70' ' ' GLY . 10.0 m -158.58 37.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 111.067 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 71' ' ' VAL . 3.3 mm? -122.32 140.21 52.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -145.18 167.57 22.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.4 mm -65.62 126.91 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.197 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.22 50.05 42.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.538 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.39 102.83 7.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.29 . . . . 0.0 110.931 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.661 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -53.08 156.35 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.757 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 79' ' ' MET . 21.2 t -147.94 157.5 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 111.403 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.46 ' N ' HG12 ' A' ' 78' ' ' VAL . 9.5 tpt -125.11 -41.36 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.74 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.62 137.01 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.838 HG12 HD23 ' A' ' 109' ' ' LEU . 9.5 mt -121.12 112.39 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.616 ' ND2' HG13 ' A' ' 107' ' ' VAL . 18.8 m-20 59.33 20.76 8.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.38 -21.95 37.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.636 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -75.49 119.8 78.7 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 120.439 0.161 . . . . 0.0 111.278 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 86' ' ' THR . 51.3 Cg_exo -55.63 -167.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.516 2.144 . . . . 0.0 112.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -170.75 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.084 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.45 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -117.93 47.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -175.39 179.88 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -76.08 164.23 26.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 31.3 p90 -73.43 -30.35 63.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -31.92 57.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.442 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -37.7 85.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.694 0.283 . . . . 0.0 110.746 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -71.98 -29.34 64.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.459 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.8 -38.11 54.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.849 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -74.44 -35.55 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.787 0.327 . . . . 0.0 111.143 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.2 pp -69.84 -45.08 68.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.569 ' CD1' HD13 ' A' ' 41' ' ' LEU . 9.1 mt -64.09 -58.94 5.17 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.271 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -29.56 11.9 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.505 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -112.92 34.08 4.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.863 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 69.2 p -102.81 17.46 23.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.3 p -102.05 11.81 37.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.505 HD11 ' O ' ' A' ' 100' ' ' ASP . 2.0 mt -68.9 -49.34 64.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.608 0.718 . . . . 0.0 110.998 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.23 6.91 38.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.746 ' O ' HG22 ' A' ' 30' ' ' THR . 27.8 p 55.76 24.68 7.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.256 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -172.72 145.94 1.57 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.711 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.616 HG13 ' ND2' ' A' ' 82' ' ' ASN . 1.0 OUTLIER -146.41 132.59 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.772 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.72 141.25 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.838 HD23 HG12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -137.27 140.14 41.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.352 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.53 115.77 31.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.973 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 77' ' ' ARG . 1.7 pp -117.55 163.75 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 112.144 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' CG ' HG23 ' A' ' 24' ' ' THR . 0.7 OUTLIER -130.59 131.73 45.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.237 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -142.62 174.62 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.117 0.484 . . . . 0.0 111.661 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.82 104.27 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.08 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 20' ' ' VAL . 13.5 p -61.57 145.65 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . 87.39 129.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.344 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.58 24.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.987 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.2 t 176.78 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.185 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.614 HG13 ' CZ ' ' A' ' 126' ' ' PHE . 41.3 t -142.27 118.09 5.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 1.07 HG23 ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -154.74 78.51 4.96 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -177.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.465 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 69.6 Cg_endo -96.38 -167.31 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.455 2.77 . . . . 0.0 112.722 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.93 35.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.32 113.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.523 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.77 -32.77 5.8 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.922 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.582 HG22 ' HD3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -136.66 105.2 5.78 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.823 0.344 . . . . 0.0 111.137 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.614 ' CZ ' HG13 ' A' ' 119' ' ' VAL . 1.4 t80 -100.58 118.45 36.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 1.07 ' HB2' HG23 ' A' ' 120' ' ' ILE . 6.8 m80 -97.8 142.18 29.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 111.294 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 170' ' ' THR . 6.1 t -139.92 90.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.528 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.497 HD21 HG21 ' A' ' 168' ' ' THR . 0.2 OUTLIER -112.47 129.89 23.92 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 136.84 51.16 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.089 1.86 . . . . 0.0 111.293 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.707 ' CG ' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -100.93 158.79 15.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.051 0.453 . . . . 0.0 110.939 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.49 ' CD ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.17 -164.86 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -100.47 -29.09 12.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -164.25 48.8 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 111.497 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.876 HG13 ' HA2' ' A' ' 70' ' ' GLY . 25.3 t -112.09 137.68 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.752 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.51 129.33 38.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.71 -41.17 17.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 100.71 -12.05 59.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.712 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.827 HG23 ' HB1' ' A' ' 165' ' ' ALA . 1.2 pt -89.25 148.92 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.896 0.379 . . . . 0.0 111.374 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 158' ' ' ASP . 86.1 m -126.28 126.18 43.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.331 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.896 ' CG2' HD12 ' A' ' 154' ' ' LEU . 7.4 mt -87.31 164.18 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.095 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.537 ' OG ' HG23 ' A' ' 155' ' ' VAL . 69.2 p -163.5 164.79 24.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.9 109.89 17.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.497 ' HD3' HG22 ' A' ' 155' ' ' VAL . 39.8 Cg_exo -57.16 -39.32 91.46 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.484 2.123 . . . . 0.0 112.37 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.52 88.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 t -99.09 16.11 23.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.276 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 53.43 54.56 9.93 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.888 0.375 . . . . 0.0 111.05 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.19 155.63 39.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.85 82.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.609 2.206 . . . . 0.0 112.133 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 173.54 -82.52 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.526 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 46.1 t0 60.0 77.74 0.37 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.616 0.246 . . . . 0.0 110.997 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -172.51 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.896 HD12 ' CG2' ' A' ' 142' ' ' ILE . 4.2 mm? -107.67 150.9 26.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.689 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 175' ' ' ASP . 18.4 m -150.67 145.72 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.409 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.509 HG12 HD23 ' A' ' 171' ' ' LEU . 1.1 mp -78.33 143.92 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.391 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -11.42 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 141' ' ' THR . 0.6 OUTLIER -162.74 142.31 9.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.142 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.745 HG23 HG22 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -136.21 149.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 173.22 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 167' ' ' ARG . 5.6 mtpp -115.19 145.64 42.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 71' ' ' VAL . . . 115.38 -24.25 10.64 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.322 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.425 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -108.28 159.55 16.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.926 0.394 . . . . 0.0 111.029 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.38 -21.85 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.877 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.827 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.94 -65.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.452 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 28.4 t60 -83.54 -29.92 27.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.484 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -56.83 -40.78 76.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.679 0.276 . . . . 0.0 111.448 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 165' ' ' ALA . 4.5 t -45.04 -29.17 0.81 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.548 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 68.6 1.57 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.514 HG21 HG22 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -178.93 -38.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.344 . . . . 0.0 110.744 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.721 HD21 ' CD2' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -71.86 72.28 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.47 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -100.03 152.76 19.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.458 HD23 HD11 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.48 129.34 36.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.966 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.17 5.33 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.732 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.588 ' O ' HG12 ' A' ' 155' ' ' VAL . 1.2 t0 -113.61 -174.32 2.44 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.883 -0.186 . . . . 0.0 110.693 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.463 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -132.46 106.81 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 0.0 111.381 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.528 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -74.07 157.39 36.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.716 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.2 tt -136.19 -49.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' A' ' 178' ' ' LEU . . . -129.76 157.46 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 111.708 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' A' ' 185' ' ' LEU . 32.6 mt -138.99 105.71 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.76 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 28.5 t70 62.01 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -130.45 -18.64 3.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 196' ' ' ILE . 25.5 mm -96.99 138.03 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.027 0.442 . . . . 0.0 111.629 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.482 ' HE ' HD21 ' A' ' 178' ' ' LEU . 16.2 mtt180 -105.87 124.64 49.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.625 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' A' ' 180' ' ' ILE . 2.0 mm? -72.69 -7.28 49.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.84 -31.12 1.12 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.9 p -124.88 -12.72 7.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.895 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 17.7 m -83.59 -170.64 3.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 m -116.95 -175.83 2.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.728 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -67.58 -57.32 6.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -54.69 -41.81 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.239 0.543 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.71 -45.06 77.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.251 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HB2' ' CD1' ' A' ' 185' ' ' LEU . . . -57.36 -42.05 81.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.69 HG22 HD12 ' A' ' 142' ' ' ILE . 17.0 t -59.1 -36.73 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 29.3 mm-40 -60.83 -50.36 73.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.896 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -68.38 -25.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -64.87 -32.16 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.48 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.54 ' NE2' HG12 ' A' ' 194' ' ' VAL . 10.9 mt-30 -95.44 -41.46 8.97 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.591 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -85.08 13.99 5.54 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.828 ' CB ' HG22 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -65.41 32.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.2 mm-40 34.63 70.26 0.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.496 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 0.7 OUTLIER 42.83 34.61 0.61 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 178.135 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.445 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -171.55 103.87 0.2 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.156 0.503 . . . . 0.0 111.626 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.828 HG22 ' CB ' ' A' ' 200' ' ' CYS . 47.9 t -107.84 108.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.374 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 33.0 ttmt -94.02 107.5 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.721 ' CD2' HD21 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -88.84 107.57 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.475 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.582 ' HD3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -101.44 92.65 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.626 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.505 HG21 ' CG ' ' A' ' 175' ' ' ASP . 2.4 mp -87.31 166.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -111.76 123.39 50.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -115.55 95.09 4.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.22 47.67 1.54 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.323 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -56.85 -169.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.815 0.34 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.12 126.38 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.124 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 114' ' ' ASP . 17.3 t -137.32 150.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -110.66 40.76 1.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.134 0.493 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 51.62 174.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.537 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.15 142.5 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.21 143.88 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.009 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.426 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 5.6 t -141.2 159.11 42.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.84 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.71 159.17 15.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.791 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 109' ' ' LEU . 1.3 t -135.77 147.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG13 ' CD ' ' A' ' 106' ' ' LYS . 61.1 t -125.97 109.51 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.681 HD23 HD13 ' A' ' 109' ' ' LEU . 4.4 mm? -110.01 118.83 37.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.69 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -109.29 162.4 14.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -97.49 115.87 28.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.841 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -74.83 157.74 85.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.635 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.98 6.12 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.503 2.136 . . . . 0.0 112.594 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.14 -49.31 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.513 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.3 p -138.74 -1.58 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 76.04 -99.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.269 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.826 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 2.8 m-85 -116.16 119.63 36.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -92.49 26.91 11.79 Favored Glycine 0 CA--C 1.517 0.17 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.352 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 66' ' ' ALA . 7.0 mt -92.63 135.94 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 121.092 0.473 . . . . 0.0 111.56 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.96 99.51 5.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.067 HD21 HD13 ' A' ' 98' ' ' LEU . 1.9 pp -114.69 156.82 24.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 112.279 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -102.65 169.59 8.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.259 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.401 ' O ' ' CG ' ' A' ' 91' ' ' PHE . . . -137.18 46.28 1.02 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.88 65.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.175 0.512 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.9 HG22 HD13 ' A' ' 56' ' ' LEU . 7.4 t -61.8 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.189 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 47.3 p90 -67.41 -49.76 62.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.026 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.483 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.8 79.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.401 0.62 . . . . 0.0 111.296 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.3 t 170.37 116.8 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.665 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 50' ' ' THR . 1.6 tp10 60.84 84.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 49' ' ' GLU . 3.2 p 89.4 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 pp -166.43 26.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 111.895 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 20.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.666 ' OG ' HG23 ' A' ' 45' ' ' VAL . 1.2 t -58.81 109.3 1.76 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.583 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' O ' HD23 ' A' ' 56' ' ' LEU . 39.4 Cg_endo -66.8 162.54 37.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.377 2.052 . . . . 0.0 112.319 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.647 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 76.1 Cg_exo -49.25 129.27 21.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.524 2.149 . . . . 0.0 112.154 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.9 HD13 HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -133.38 99.65 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.573 HD13 HG23 ' A' ' 39' ' ' ILE . 21.5 mt -60.89 129.5 23.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.76 0.314 . . . . 0.0 110.687 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.4 p -113.66 -2.51 13.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 55.4 t80 177.72 124.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.875 0.369 . . . . 0.0 111.435 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.699 HG22 ' H ' ' A' ' 61' ' ' GLU . 1.9 mt -96.63 -178.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.699 ' H ' HG22 ' A' ' 60' ' ' ILE . 25.3 tt0 -121.55 131.14 53.96 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.347 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.482 ' HA ' ' NH1' ' A' ' 68' ' ' ARG . . . -65.5 70.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.457 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.2 m-20 164.62 44.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -145.04 -179.43 0.94 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 91.0 Cg_endo -97.87 -2.7 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.067 2.511 . . . . 0.0 112.744 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.768 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -76.84 -57.22 3.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.717 0.294 . . . . 0.0 111.648 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -77.37 -29.11 53.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 0.0 110.131 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.592 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -76.53 -30.78 57.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 -67.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.727 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -14.69 5.35 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.954 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 163' ' ' SER . 14.7 m -125.65 45.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.418 . . . . 0.0 110.96 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 66' ' ' ALA . 10.3 mt -135.6 168.95 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -164.16 143.19 7.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.36 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.094 0.473 . . . . 0.0 111.407 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.69 42.32 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.283 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD2' HD13 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -74.83 113.28 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.97 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.77 79.17 2.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.74 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.787 ' HA ' HG22 ' A' ' 111' ' ' ILE . 26.9 m -69.96 132.32 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.75 -30.71 10.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -144.89 131.97 20.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.489 HG21 HD11 ' A' ' 97' ' ' LEU . 17.7 mt -124.89 117.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.651 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 46.56 27.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.439 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.39 -30.27 9.07 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.593 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -68.58 117.79 53.81 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 -167.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.364 2.043 . . . . 0.0 112.187 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.4 p -147.7 -45.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.071 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.69 -9.97 58.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.561 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.3 47.46 2.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.3 168.69 2.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -74.97 157.38 35.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 9.5 p90 -73.3 -31.0 63.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.95 -41.14 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 -33.75 74.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.343 . . . . 0.0 110.978 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.647 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -72.93 -31.8 64.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 110.6 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.31 -36.11 58.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.821 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.8 OUTLIER -73.41 -35.73 65.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.567 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.1 pp -69.96 -41.92 73.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.239 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.067 HD13 HD21 ' A' ' 41' ' ' LEU . 80.7 mt -65.84 -58.78 4.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.416 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.07 -29.7 13.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -109.44 30.7 6.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.962 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -104.5 45.64 0.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.2 p -133.36 13.02 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.88 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.525 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -69.79 -48.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.52 0.676 . . . . 0.0 111.137 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.29 7.11 40.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.817 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.852 ' O ' HG22 ' A' ' 30' ' ' THR . 74.3 m 56.69 25.2 9.81 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.926 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -166.28 152.77 9.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.648 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 108' ' ' THR . 4.8 t -152.84 158.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -125.08 141.25 52.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.696 HD23 HG11 ' A' ' 78' ' ' VAL . 2.0 mp -130.26 156.04 45.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 3.0 mt-10 -130.92 105.85 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.787 HG22 ' HA ' ' A' ' 78' ' ' VAL . 25.5 pt -110.47 160.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.098 0.475 . . . . 0.0 111.806 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -133.02 140.4 47.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.26 174.31 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB3' HG11 ' A' ' 20' ' ' VAL . 68.4 m-20 -97.95 118.34 34.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.68 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 167' ' ' ARG . 2.9 m -61.96 118.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 179.36 117.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 168' ' ' THR . 2.7 tp10 -118.1 13.25 13.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.527 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.35 72.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.163 0.506 . . . . 0.0 111.401 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.905 HG11 ' OG1' ' A' ' 170' ' ' THR . 25.1 m -97.8 147.83 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.613 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.682 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.9 pp -121.45 98.72 46.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.92 0.39 . . . . 0.0 111.304 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HB3' ' CE1' ' A' ' 126' ' ' PHE . 89.2 Cg_endo -90.31 169.12 4.16 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.084 2.522 . . . . 0.0 112.825 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.8 m -166.61 29.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.8 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.82 113.31 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.715 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.78 -39.25 2.96 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.561 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.428 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.22 102.42 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.493 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 170' ' ' THR . 0.7 OUTLIER -109.15 117.8 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.485 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.575 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -99.96 143.01 30.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 HG21 ' A' ' 168' ' ' THR . 14.6 t -118.66 90.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 205' ' ' LYS . 0.3 OUTLIER -80.81 105.96 12.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.445 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.671 HD23 HG12 ' A' ' 128' ' ' VAL . 3.2 pp -136.98 133.45 18.65 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 164' ' ' VAL . 35.3 Cg_exo -56.89 129.08 32.64 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.231 1.954 . . . . 0.0 111.516 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -106.98 139.4 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.075 0.464 . . . . 0.0 110.874 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -76.75 -168.28 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.767 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 4.0 t60 -90.04 -40.0 12.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.235 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.62 45.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.773 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 137' ' ' GLU . 7.3 t -100.46 161.25 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.3 tt0 -51.75 145.91 8.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.274 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.606 ' HB3' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -143.74 -58.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.487 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 92.02 56.94 1.54 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.679 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 165' ' ' ALA . 6.0 mt -125.09 136.7 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.457 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 73.4 m -125.28 142.54 51.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.051 HD12 HG22 ' A' ' 194' ' ' VAL . 10.5 mt -111.49 164.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.96 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 142' ' ' ILE . 29.6 m -165.35 152.52 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.01 145.94 35.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.23 -35.47 11.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.6 m 60.01 52.11 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.964 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.59 29.1 3.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 59.3 59.53 2.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.68 131.98 24.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.16 -25.92 48.44 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.448 2.099 . . . . 0.0 112.263 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.61 -39.33 7.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.678 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.1 t0 56.03 83.81 0.22 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.678 0.275 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 159.36 5.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.665 2.243 . . . . 0.0 112.576 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 190' ' ' MET . 2.2 mm? -101.7 155.03 18.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.302 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 156' ' ' ILE . 14.1 t -153.71 160.55 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.872 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.525 HD11 HD12 ' A' ' 171' ' ' LEU . 8.5 mt -104.02 148.02 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.817 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 -0.36 2.93 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.5 t0 -168.98 134.56 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 111.421 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.514 HG22 ' HB2' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -136.69 149.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.822 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.583 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -122.79 149.12 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.162 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.523 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 2.3 mptt -79.09 165.74 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.725 0.298 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.81 -59.34 1.78 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.595 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.514 ' OG ' HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -61.31 160.85 9.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.922 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 131' ' ' PRO . 28.9 m -72.62 -23.99 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 168' ' ' THR . . . -49.64 -58.51 5.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.514 ' HB2' HG22 ' A' ' 159' ' ' ILE . 15.8 t60 -83.87 -31.31 25.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.646 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -54.99 -29.84 58.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.733 0.302 . . . . 0.0 111.153 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.823 HG21 HG11 ' A' ' 128' ' ' VAL . 9.8 t -54.75 -20.1 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.84 24.74 76.22 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.905 ' OG1' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -133.27 -39.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.896 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 165' ' ' ALA . 12.0 tp -64.96 93.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -110.23 155.26 22.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.692 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.5 OUTLIER -87.73 50.97 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.993 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.09 30.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.48 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -113.88 177.23 4.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.647 0.261 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -117.65 98.34 6.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 111.18 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.647 HD11 ' CD2' ' A' ' 206' ' ' LEU . 3.9 mt -76.97 134.89 38.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.6 2.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.857 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.829 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -165.29 154.68 12.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.876 0.369 . . . . 0.0 111.484 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 179' ' ' ALA . 9.1 mm -139.38 117.79 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.799 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 46.81 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.407 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' ILE . 75.7 m-20 -112.34 -16.5 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 184' ' ' ARG . 39.7 mm -96.67 157.68 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.432 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.485 ' N ' HG22 ' A' ' 183' ' ' ILE . 8.8 mtt180 -127.43 126.56 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.047 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.2 mm? -78.47 -4.92 50.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.8 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -28.92 1.97 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.1 p -135.45 40.05 2.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 15.1 m -140.66 -171.42 3.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.23 173.23 6.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.611 ' HA ' HD21 ' A' ' 154' ' ' LEU . 17.6 ttp -59.0 -53.09 62.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 4.0 mt-10 -51.7 -41.06 61.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.613 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 9.1 t70 -53.26 -51.96 60.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.153 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -52.66 -41.36 63.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.251 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 1.051 HG22 HD12 ' A' ' 142' ' ' ILE . 21.6 t -59.64 -33.45 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.022 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.435 ' HG3' ' HA ' ' A' ' 192' ' ' ASP . 17.1 mm-40 -63.32 -50.27 70.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.0 OUTLIER -70.84 -24.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.822 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.876 HD22 HD11 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -64.76 -35.44 81.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.762 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.71 ' NE2' HG12 ' A' ' 194' ' ' VAL . 12.7 mt-30 -94.76 -44.73 7.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.32 -22.58 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.888 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.707 ' CB ' HG22 ' A' ' 204' ' ' VAL . 19.3 m -89.56 41.99 1.07 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.081 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 12.2 pt-20 -69.06 61.6 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.535 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -168.98 -28.98 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.944 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.5 tt 172.67 113.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.856 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.707 HG22 ' CB ' ' A' ' 200' ' ' CYS . 97.4 t -111.88 137.91 42.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 5.1 ttmt -111.76 108.14 17.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.955 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.647 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -82.76 113.12 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.436 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.633 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 6.4 tttt -100.02 103.43 14.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.521 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -110.34 174.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 23.0 mtp85 -102.73 125.99 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.02 94.55 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -85.32 55.01 3.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.4 168.95 11.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.238 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.226 179.782 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 1.9 tt0 . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.777 0.322 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' N ' ' HG3' ' A' ' 18' ' ' GLN . 21.5 t -123.03 121.06 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.273 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.816 HG12 ' HB2' ' A' ' 116' ' ' ALA . 3.4 m -133.83 92.41 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.508 ' O ' HG23 ' A' ' 115' ' ' VAL . 54.2 t-80 -75.55 114.97 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -55.79 149.95 13.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -155.6 168.71 26.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.91 160.26 16.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.73 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.757 HG23 ' HB3' ' A' ' 161' ' ' LYS . 89.2 m -158.45 155.45 28.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.7 160.2 14.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.68 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.99 150.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.586 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.54 109.35 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.971 0.415 . . . . 0.0 111.246 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.657 HD21 HD11 ' A' ' 72' ' ' LEU . 3.4 mm? -107.26 118.23 36.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.835 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.7 162.57 13.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.175 0.512 . . . . 0.0 111.942 -178.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.28 151.52 20.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.162 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 35.5 m-20 -134.16 150.88 75.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.386 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.11 20.73 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.561 2.174 . . . . 0.0 112.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.7 t -133.79 -54.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.248 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 t -159.81 37.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.692 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA3' ' H ' ' A' ' 32' ' ' ASP . . . -43.43 143.31 1.84 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.437 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 11.0 m-85 61.02 71.83 0.55 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -98.66 26.48 23.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.439 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.979 HD13 HD13 ' A' ' 72' ' ' LEU . 26.9 pt -115.23 143.41 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.06 140.35 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.478 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.863 HD13 HD13 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -112.31 121.56 45.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.966 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -84.69 170.11 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.95 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.06 61.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.54 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.99 110.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 56' ' ' LEU . 20.7 t -129.67 -73.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.376 0.608 . . . . 0.0 110.256 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.83 ' O ' HG22 ' A' ' 48' ' ' THR . 27.0 p90 -43.42 -45.07 6.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.35 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.489 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.66 74.49 0.1 Allowed 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.8 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 166.86 108.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.788 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.52 138.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.549 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER 46.1 -164.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.815 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.673 HD13 HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -138.93 -85.39 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.823 0.344 . . . . 0.0 111.717 179.45 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t 57.41 13.98 2.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 110.974 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -54.13 106.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.329 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 60.6 Cg_endo -72.53 117.9 5.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.279 1.986 . . . . 0.0 111.499 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HG3' HG21 ' A' ' 86' ' ' THR . 9.4 Cg_exo -36.1 118.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.21 2.607 . . . . 0.0 113.231 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 176.37 5.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.198 179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 39' ' ' ILE . 21.3 mm -112.31 138.41 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.49 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 p -119.14 -8.5 10.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 80.5 t80 -172.47 157.74 4.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.362 0.601 . . . . 0.0 111.885 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.788 HG21 ' HB2' ' A' ' 67' ' ' GLU . 8.7 mm -135.05 152.66 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.413 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.8 tm-20 -104.2 156.66 17.71 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.56 47.59 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.115 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.87 65.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.617 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -156.02 -172.25 0.31 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 54.5 Cg_endo -96.77 -10.24 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.817 2.344 . . . . 0.0 113.377 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -77.68 -58.45 3.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.788 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -71.47 -29.1 64.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.415 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.52 -30.59 5.38 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.961 0.41 . . . . 0.0 110.649 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.425 ' HA3' ' CG1' ' A' ' 136' ' ' VAL . . . 78.8 36.67 28.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.855 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 162' ' ' GLY . 16.6 t -154.26 31.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.736 0.303 . . . . 0.0 111.426 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.979 HD13 HD13 ' A' ' 39' ' ' ILE . 9.5 mt -133.11 147.55 52.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.894 0.378 . . . . 0.0 111.054 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.06 148.81 33.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.61 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.37 68.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.785 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.09 45.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -79.71 -179.79 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.668 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -147.03 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 109' ' ' LEU . 86.4 t -65.35 133.73 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.09 -28.33 10.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.706 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.25 120.29 9.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.924 HD13 HD11 ' A' ' 97' ' ' LEU . 2.8 mt -105.34 104.93 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 57.01 21.16 6.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.26 8.16 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -71.6 111.58 10.86 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.83 168.53 24.36 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.48 2.12 . . . . 0.0 112.005 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.456 HG21 ' HG3' ' A' ' 55' ' ' PRO . 17.5 p -143.72 10.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.59 -17.1 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.56 46.36 1.9 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.32 171.73 19.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.779 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.673 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -78.43 151.71 32.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.778 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -71.21 -30.0 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 pt-20 -54.44 -39.78 67.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.152 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -36.48 79.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.691 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -67.56 -33.68 75.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.42 0.629 . . . . 0.0 110.128 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.97 81.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.838 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 4.0 mm100 -70.24 -56.2 7.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.839 0.352 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.924 HD11 HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -52.28 -41.84 63.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.332 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.863 HD13 HD13 ' A' ' 41' ' ' LEU . 2.6 mt -68.65 -56.13 9.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.262 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -50.84 -28.74 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.164 0.507 . . . . 0.0 109.715 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.643 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -120.67 38.96 3.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.544 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.837 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -103.84 36.16 2.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.167 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 1.4 m -121.57 15.88 11.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.643 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.7 mp -71.59 -47.48 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.564 0.697 . . . . 0.0 111.216 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.95 3.67 44.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 m 63.04 18.46 10.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.666 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER -173.22 150.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.095 0.474 . . . . 0.0 111.956 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' A' ' 101' ' ' SER . 45.2 t -145.06 138.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.396 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.594 ' C ' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -113.12 125.48 54.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 110.486 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.624 HD22 HG23 ' A' ' 81' ' ' ILE . 1.3 mt -119.21 164.95 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.89 105.94 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.42 HD13 ' OD2' ' A' ' 76' ' ' ASP . 24.3 pt -104.7 150.24 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.735 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -124.11 115.0 20.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 11.8 p90 -135.71 174.17 10.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.43 . . . . 0.0 111.406 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.24 155.01 18.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.636 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 21' ' ' HIS . 20.9 t -91.77 104.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 0.0 111.471 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.816 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -167.95 137.25 2.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.656 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HG2' ' CB ' ' A' ' 167' ' ' ARG . 6.9 mm-40 -146.63 25.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.635 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.76 65.59 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.249 0.547 . . . . 0.0 111.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.506 HG12 HG12 ' A' ' 128' ' ' VAL . 6.1 m -97.84 147.57 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.215 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.645 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.7 pp -130.04 92.93 35.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 0.0 111.024 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 68.3 Cg_endo -96.37 -178.52 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.349 2.699 . . . . 0.0 112.673 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.33 35.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.415 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.51 119.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.826 0.346 . . . . 0.0 110.776 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.42 -51.73 3.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.434 ' CG2' ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -115.32 105.02 12.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.854 0.359 . . . . 0.0 110.551 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.869 ' CE1' HG21 ' A' ' 170' ' ' THR . 0.9 OUTLIER -113.34 120.94 42.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.783 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.568 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.6 m80 -109.82 152.71 25.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 206' ' ' LEU . 17.8 m -131.07 98.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.284 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.3 105.43 17.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.779 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.472 HD13 HG23 ' A' ' 164' ' ' VAL . 0.6 OUTLIER -128.04 133.11 24.77 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.977 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.76 136.03 37.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.351 2.034 . . . . 0.0 112.075 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.495 ' NZ ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -118.78 158.13 26.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.683 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -115.62 -166.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.796 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -58.5 -57.2 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -164.48 48.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 133' ' ' LYS . 97.2 t -75.94 159.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.504 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.1 tt0 -47.54 111.9 0.48 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.321 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.845 HD22 ' CD1' ' A' ' 140' ' ' ILE . 4.4 mt -116.11 112.5 21.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.565 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.72 45.85 2.92 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.691 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.845 ' CD1' HD22 ' A' ' 138' ' ' LEU . 20.7 mt -111.01 130.26 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 120.65 0.262 . . . . 0.0 111.064 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 157' ' ' SER . 7.4 m -126.73 133.08 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.758 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.73 ' CD1' HD13 ' A' ' 197' ' ' LEU . 3.2 mt -105.4 163.44 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.489 ' N ' HG22 ' A' ' 142' ' ' ILE . 5.3 p -166.43 123.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 p -84.0 117.15 67.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.731 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.08 -174.98 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.311 2.008 . . . . 0.0 112.298 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.2 p -58.85 165.27 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.968 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.4 p -105.66 73.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -119.68 46.06 2.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.422 ' HE3' ' HD2' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -178.33 154.89 0.93 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.952 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.23 75.23 3.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.503 2.135 . . . . 0.0 112.332 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.57 -59.96 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.6 t0 62.45 70.3 0.82 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 111.212 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HD2' ' HE3' ' A' ' 149' ' ' LYS . 87.1 Cg_endo -81.65 -161.71 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.031 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.876 HD22 ' HA ' ' A' ' 190' ' ' MET . 0.3 OUTLIER -134.39 173.74 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.869 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 175' ' ' ASP . 33.8 m -156.38 -176.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.093 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.593 ' N ' HD13 ' A' ' 156' ' ' ILE . 1.4 mm -76.14 154.28 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.694 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.564 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.3 OUTLIER -135.59 -9.18 2.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 173.21 147.44 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.392 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.713 HG21 ' CG ' ' A' ' 166' ' ' HIS . 3.2 mt -130.69 150.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.61 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HE2' ' HA3' ' A' ' 162' ' ' GLY . 0.1 OUTLIER -121.77 134.7 54.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 110.438 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.757 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.6 OUTLIER -80.11 86.33 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 0.0 111.009 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 71' ' ' VAL . . . -177.24 -32.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.241 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.4 169.59 8.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.472 HG23 HD13 ' A' ' 130' ' ' LEU . 8.3 m -58.92 -21.53 19.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.067 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.932 ' O ' HG22 ' A' ' 168' ' ' THR . . . -43.57 -71.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.713 ' CG ' HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.63 -24.93 67.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 0.0 111.266 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.436 HH22 ' N ' ' A' ' 162' ' ' GLY . 19.5 mmt-85 -58.81 -38.23 78.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.022 HG21 HD12 ' A' ' 171' ' ' LEU . 14.9 t -57.68 -30.46 65.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.43 ' HA2' HG11 ' A' ' 115' ' ' VAL . . . 83.49 -72.51 2.82 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.616 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.869 HG21 ' CE1' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -42.46 -29.56 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 1.022 HD12 HG21 ' A' ' 168' ' ' THR . 0.2 OUTLIER -60.24 86.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.38 158.75 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.6 mt -68.31 72.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.834 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.06 40.05 0.02 OUTLIER Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.634 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.538 ' O ' HG12 ' A' ' 155' ' ' VAL . 54.2 m-20 -121.48 118.02 28.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' A' ' 155' ' ' VAL . 29.9 mmtt -75.85 108.36 8.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 206' ' ' LEU . 1.6 mt -75.94 152.18 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.69 HD22 ' NZ ' ' A' ' 207' ' ' LYS . 7.3 tt -139.96 -57.11 0.56 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.744 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -109.97 155.95 21.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.346 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 179' ' ' ALA . 23.2 mm -139.61 110.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.267 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 38.9 t70 53.73 51.81 14.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.394 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.4 t-20 82.82 -30.5 0.09 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 37.3 mm -73.5 151.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.35 119.07 22.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.24 0.543 . . . . 0.0 112.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -82.13 -12.34 58.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.903 178.389 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t70 51.18 52.6 14.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.63 74.51 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.657 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.91 -169.69 2.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.061 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.0 m -58.04 154.88 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.876 ' HA ' HD22 ' A' ' 154' ' ' LEU . 36.2 ttp -74.17 -35.23 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.6 mt-10 -51.8 -48.52 63.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.171 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 0.8 OUTLIER -49.54 -52.13 31.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.646 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 154' ' ' LEU . . . -55.51 -37.83 68.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.314 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.814 HG12 ' NE2' ' A' ' 198' ' ' GLN . 21.6 t -62.78 -30.86 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.077 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 192' ' ' ASP . 13.3 mm-40 -66.54 -50.34 63.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.089 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.478 HG22 ' SG ' ' A' ' 200' ' ' CYS . 1.1 mp -73.72 -24.69 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.124 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.73 HD13 ' CD1' ' A' ' 142' ' ' ILE . 0.1 OUTLIER -63.15 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.474 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.814 ' NE2' HG12 ' A' ' 194' ' ' VAL . 21.9 mt-30 -89.47 -40.09 12.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.57 -14.7 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.804 ' HB3' HG22 ' A' ' 204' ' ' VAL . 2.2 m -85.02 41.78 0.89 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.72 62.59 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.222 0.535 . . . . 0.0 111.076 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -174.48 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.312 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.7 tt 177.56 109.32 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.124 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.804 HG22 ' HB3' ' A' ' 200' ' ' CYS . 24.0 t -103.12 116.03 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.891 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 4.4 ttmm -108.77 108.37 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.624 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.579 HD12 HG21 ' A' ' 128' ' ' VAL . 3.4 mt -97.12 117.16 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.415 . . . . 0.0 111.376 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.69 ' NZ ' HD22 ' A' ' 178' ' ' LEU . 26.2 tttt -97.8 101.07 12.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -109.43 179.38 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 2.4 mtp180 -109.41 135.25 50.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.012 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 211' ' ' ASP . 0.0 OUTLIER -132.37 159.87 37.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER 82.49 85.34 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -60.54 163.18 5.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.176 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 179.872 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.846 0.355 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -150.32 116.82 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.719 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' A' ' 116' ' ' ALA . 35.1 m -145.09 -178.87 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 111.522 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -133.94 116.62 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.834 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -50.58 147.98 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.445 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.4 173.0 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 152.71 39.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.56 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 9.0 t -149.06 170.37 18.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -101.59 162.16 13.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 108' ' ' THR . 0.7 OUTLIER -142.22 145.85 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.58 109.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.791 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.055 HD11 HD11 ' A' ' 72' ' ' LEU . 1.2 mm? -108.18 141.05 40.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.317 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -123.43 160.95 25.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.355 0.597 . . . . 0.0 112.089 -178.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.627 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -101.67 149.24 24.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.34 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -133.42 148.84 70.49 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.75 8.6 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 112.681 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.07 -48.7 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.427 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 t -136.36 -3.27 2.17 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 32' ' ' ASP . . . 89.2 -94.61 2.01 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.308 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 10.4 m-85 -121.68 -70.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.773 -0.251 . . . . 0.0 111.042 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 133.35 0.44 4.13 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 119.779 -1.201 . . . . 0.0 114.374 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.963 HG23 HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -128.05 130.51 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.621 0.71 . . . . 0.0 112.03 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.08 128.77 56.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 98' ' ' LEU . 2.4 pp -121.0 157.54 29.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.631 . . . . 0.0 112.559 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.464 ' O ' HD23 ' A' ' 56' ' ' LEU . 3.3 pt20 -111.25 170.04 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.199 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.57 16.23 14.36 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.385 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -97.51 85.38 3.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.116 0.484 . . . . 0.0 110.639 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.986 HG22 HD22 ' A' ' 56' ' ' LEU . 3.0 t -99.82 -75.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 46.2 p90 -57.19 -46.3 82.96 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.566 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 50.42 74.17 0.23 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.434 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER 163.66 75.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 64.57 163.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.87 -169.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.677 HD13 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -137.42 -105.06 0.19 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.107 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.461 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER 50.31 21.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.533 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.64 ' HB2' HG23 ' A' ' 45' ' ' VAL . 1.4 p -76.04 110.18 10.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.66 ' HD2' HG21 ' A' ' 45' ' ' VAL . 65.0 Cg_endo -72.92 140.48 31.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.292 1.995 . . . . 0.0 112.052 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.627 ' HB3' HD13 ' A' ' 41' ' ' LEU . 72.0 Cg_exo -51.06 125.81 17.22 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.482 2.121 . . . . 0.0 112.221 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.986 HD22 HG22 ' A' ' 45' ' ' VAL . 1.3 pt? -131.06 104.16 6.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.929 0.395 . . . . 0.0 111.515 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.743 HD13 ' HB ' ' A' ' 39' ' ' ILE . 37.6 mt -59.63 153.69 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.659 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.423 ' N ' HG22 ' A' ' 57' ' ' ILE . 35.9 t -145.42 22.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' H ' HG22 ' A' ' 57' ' ' ILE . 75.7 t80 -177.42 146.33 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.256 0.55 . . . . 0.0 112.088 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.963 HD13 HG23 ' A' ' 39' ' ' ILE . 7.5 mm -115.21 162.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.084 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -113.46 121.75 45.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.713 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -58.77 105.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.868 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.0 m-20 89.17 51.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.475 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -130.12 145.88 59.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.795 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 34.5 Cg_exo -57.29 -17.0 24.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.219 1.946 . . . . 0.0 112.044 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.792 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -67.87 -57.22 6.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 4.7 tp10 -78.62 -28.49 45.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 3.0 mmt-85 -87.66 -3.66 58.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.57 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -58.69 -53.32 59.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.504 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.16 -3.0 5.91 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.058 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 71' ' ' VAL . 43.8 t -155.03 61.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 117.001 0.401 . . . . 0.0 111.671 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.055 HD11 HD11 ' A' ' 29' ' ' LEU . 8.2 mt -143.06 154.15 43.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.0 111.163 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -161.85 146.25 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 59' ' ' TYR . 23.2 mt -61.0 108.72 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.7 41.8 0.99 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.92 126.21 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -101.84 86.64 2.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 19.1 m -83.84 134.84 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -108.65 -26.7 10.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.07 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.19 138.95 52.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.815 HG23 ' CD1' ' A' ' 109' ' ' LEU . 12.8 mt -133.77 109.29 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.991 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.0 m120 59.53 24.05 12.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.979 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.49 -27.07 19.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.7 mt -73.06 136.88 79.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.22 -168.27 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.546 2.164 . . . . 0.0 112.3 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.7 p -157.0 -44.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.45 -17.15 62.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.444 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -116.65 41.99 2.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.036 0.446 . . . . 0.0 110.684 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m -166.7 -170.24 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.677 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -83.91 148.21 27.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -70.02 -36.03 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.1 tt0 -54.73 -34.63 62.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -52.18 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 109.766 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -54.84 -31.88 59.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.189 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.12 -35.51 76.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.19 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 17.9 mm-40 -63.16 -41.15 99.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.215 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.687 HD12 ' HA ' ' A' ' 94' ' ' ALA . 8.8 mt -63.04 -50.34 71.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.114 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.836 HD13 HD21 ' A' ' 41' ' ' LEU . 1.5 mt -70.6 -54.1 13.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.8 ppt_? -50.76 -29.39 11.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.186 0.517 . . . . 0.0 109.646 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -123.16 40.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.313 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.849 ' HB2' HG21 ' A' ' 107' ' ' VAL . 6.1 p -90.8 20.18 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.584 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -114.63 15.57 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.7 mt -75.57 -48.75 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.81 -0.36 57.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.883 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.621 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 5.9 p 65.11 18.26 11.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.797 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.66 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER -166.21 157.12 13.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.849 HG21 ' HB2' ' A' ' 101' ' ' SER . 41.7 t -158.63 131.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -111.55 124.56 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.701 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.815 ' CD1' HG23 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -124.48 165.15 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.374 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -126.23 107.17 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.18 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.7 pt -99.58 162.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.841 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -131.08 115.17 16.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.375 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.56 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.6 OUTLIER -132.84 174.04 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.37 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.1 149.05 24.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.211 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 25.8 t -89.98 103.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 111.462 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.62 ' HB2' HG11 ' A' ' 20' ' ' VAL . . . 161.33 -178.96 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.036 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' SER . 6.8 pt-20 172.52 -36.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.15 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 13.2 t 170.69 106.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.795 HG21 HG21 ' A' ' 170' ' ' THR . 12.0 p -144.38 143.96 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.045 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.756 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.2 pp -132.36 101.98 14.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.9 Cg_endo -83.97 156.01 13.29 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.0 112.604 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -162.73 18.42 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.669 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.8 OUTLIER 56.2 117.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 96.46 -42.72 2.18 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.701 HG22 ' CD ' ' A' ' 207' ' ' LYS . 0.0 OUTLIER -135.78 102.66 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.404 . . . . 0.0 110.433 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.696 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.4 OUTLIER -100.75 123.28 44.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.756 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.42 116.76 32.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.338 . . . . 0.0 111.079 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 168' ' ' THR . 12.1 t -100.94 105.49 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.918 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.814 ' CD ' HD11 ' A' ' 203' ' ' LEU . 0.0 OUTLIER -81.25 113.12 19.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.931 -179.23 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 128' ' ' VAL . 1.7 mp -119.53 129.48 25.35 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.76 123.79 8.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.238 1.958 . . . . 0.0 111.314 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.819 ' HZ1' HD21 ' A' ' 138' ' ' LEU . 1.8 mmtp -89.64 159.89 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.225 0.536 . . . . 0.0 111.341 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.477 ' H ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.68 -167.14 1.89 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.259 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -66.79 -69.47 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.18 93.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 133' ' ' LYS . 52.8 t -137.78 152.84 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.678 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.52 125.21 10.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.819 HD21 ' HZ1' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -78.18 -64.18 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.28 -13.45 55.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.483 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.814 HG13 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -99.3 143.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.205 0.502 . . . . 0.0 111.176 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 157' ' ' SER . 10.8 m -126.12 109.72 12.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.377 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.907 HD13 HG22 ' A' ' 194' ' ' VAL . 2.5 mt -74.65 164.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.077 0.465 . . . . 0.0 111.351 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.68 ' HB3' HG23 ' A' ' 155' ' ' VAL . 2.8 t -152.57 152.57 32.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.649 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.452 ' N ' ' HD2' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -94.53 -49.45 0.26 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.359 -179.306 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.87 ' O ' HG21 ' A' ' 155' ' ' VAL . 90.5 Cg_endo -79.1 176.85 9.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.366 2.044 . . . . 0.0 113.094 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.571 ' HB2' HG11 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -178.18 -164.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.747 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.41 46.57 1.21 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.813 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -138.75 -171.9 3.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 162.43 26.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.78 136.69 16.58 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.676 2.251 . . . . 0.0 112.472 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 109.93 -23.3 21.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.413 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -49.6 133.91 19.24 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.497 0.189 . . . . 0.0 111.363 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.39 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.583 2.189 . . . . 0.0 112.445 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 190' ' ' MET . 4.0 mm? -66.61 174.92 2.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.783 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.87 HG21 ' O ' ' A' ' 145' ' ' PRO . 28.3 m -157.31 162.95 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.399 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 172' ' ' GLU . 3.7 mm -78.11 154.73 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -130.91 -33.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.578 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.805 ' O ' HD13 ' A' ' 159' ' ' ILE . 0.9 OUTLIER -175.1 164.75 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.186 0.517 . . . . 0.0 111.775 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 158' ' ' ASP . 3.4 mm -138.45 149.19 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.297 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -129.51 154.93 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -91.05 163.93 14.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 71' ' ' VAL . . . 86.22 -13.84 56.04 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.884 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.549 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 90.2 p -115.06 142.28 46.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.861 0.362 . . . . 0.0 111.02 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.416 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 12.6 m -48.12 -22.19 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.494 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.426 ' CB ' HG12 ' A' ' 140' ' ' ILE . . . -54.59 -52.65 61.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 111.304 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -83.5 -26.53 30.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.011 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 163' ' ' SER . 13.6 mmp_? -55.94 -50.76 69.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.463 HG21 HG11 ' A' ' 128' ' ' VAL . 13.3 t -58.62 -23.83 59.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.066 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 67.29 -152.7 52.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.131 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.795 HG21 HG21 ' A' ' 119' ' ' VAL . 2.6 p 56.16 23.21 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 151.72 40.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.892 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.596 ' O ' HG21 ' A' ' 156' ' ' ILE . 3.5 mt-10 -164.02 -171.68 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.37 122.07 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.34 -7.21 12.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.843 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.508 ' CG ' HG21 ' A' ' 208' ' ' ILE . 0.4 OUTLIER -73.25 170.14 15.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.747 0.274 . . . . 0.0 110.834 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.08 136.07 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 111.118 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.541 HD11 HD23 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.5 135.5 39.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.432 HD12 ' HE ' ' A' ' 209' ' ' ARG . 7.8 tt -108.95 -53.24 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.75 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -141.08 171.9 13.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.315 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.662 HD11 ' HB1' ' A' ' 193' ' ' ALA . 34.1 mt -139.08 105.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 6.6 t70 61.59 -79.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.732 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.01 -25.02 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 184' ' ' ARG . 32.7 mm -91.4 158.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.75 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 72.8 mtt-85 -125.71 128.1 47.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.228 0.537 . . . . 0.0 112.234 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.599 HD11 ' N ' ' A' ' 193' ' ' ALA . 3.6 mm? -81.17 -3.95 53.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.892 178.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.8 -29.27 1.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.26 51.15 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 20.0 m -156.18 160.58 39.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.974 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 60.0 p -77.43 -170.8 1.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.752 ' HA ' HD11 ' A' ' 154' ' ' LEU . 14.0 ptm -74.05 -43.39 57.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.996 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -54.94 -30.36 58.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.02 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.79 ' O ' HD12 ' A' ' 196' ' ' ILE . 3.4 m-20 -60.98 -51.85 67.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.058 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.662 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -57.12 -42.38 80.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.223 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.907 HG22 HD13 ' A' ' 142' ' ' ILE . 43.9 t -61.87 -35.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.818 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.92 -49.88 73.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.966 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.79 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.9 mp -72.71 -24.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.066 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -59.71 -43.27 94.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.87 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.754 HE22 HG12 ' A' ' 194' ' ' VAL . 1.1 mp0 -94.37 -39.87 10.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.534 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.68 -22.1 32.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.054 0.454 . . . . 0.0 110.435 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.546 ' SG ' HG22 ' A' ' 196' ' ' ILE . 17.2 m -85.89 44.62 1.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.11 63.05 0.09 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.486 0.66 . . . . 0.0 111.885 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.456 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 5.1 m-20 -170.36 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.515 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.814 HD11 ' CD ' ' A' ' 129' ' ' LYS . 3.6 tt 174.77 109.29 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 132' ' ' LYS . 6.2 t -102.79 120.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.328 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 16.8 ttmm -106.3 108.13 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.541 HD23 HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -83.37 114.96 21.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.183 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.701 ' CD ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -95.72 93.03 6.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.508 HG21 ' CG ' ' A' ' 175' ' ' ASP . 9.9 mm -83.31 165.04 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.788 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -118.27 121.78 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.055 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.27 108.86 9.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.63 48.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.63 154.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.583 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.546 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.907 0.384 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 19' ' ' VAL . 10.6 p -144.89 116.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.885 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 115' ' ' VAL . 93.4 t -109.53 113.0 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.257 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -107.36 112.01 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.13 144.61 2.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.43 173.07 13.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.716 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -130.84 146.88 52.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.6 t -138.02 -171.28 2.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -111.45 161.65 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.192 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 111' ' ' ILE . 2.2 t -139.37 150.23 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.654 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.97 109.78 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 111.495 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 72' ' ' LEU . 3.1 mm? -107.1 118.66 37.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.14 163.29 12.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 0.0 111.431 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.688 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -98.1 106.47 18.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.153 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.07 147.65 83.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.92 9.43 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.539 2.16 . . . . 0.0 112.838 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.01 -41.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.5 p -117.95 -29.91 5.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.837 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 52.75 73.45 0.4 Allowed Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.353 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.688 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 54.9 m-85 73.46 89.67 0.09 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.027 0.441 . . . . 0.0 110.261 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.07 26.95 5.2 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.302 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.949 HD11 ' HB1' ' A' ' 66' ' ' ALA . 9.4 mt -92.26 151.96 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.159 0.504 . . . . 0.0 111.271 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.04 101.39 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.133 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.969 HD13 HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -95.87 134.96 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.204 0.526 . . . . 0.0 111.755 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -90.37 152.3 21.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.261 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' CA ' ' CE2' ' A' ' 91' ' ' PHE . . . -65.01 -82.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -108.08 157.97 17.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.405 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.024 HG21 HD22 ' A' ' 56' ' ' LEU . 44.7 t -138.09 -63.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.964 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.807 ' O ' HG22 ' A' ' 48' ' ' THR . 18.0 p90 -29.21 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.804 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 42.23 72.2 0.18 Allowed 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.51 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 166.08 90.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.385 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 50' ' ' THR . 29.4 tp10 63.27 156.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 51' ' ' LEU . 3.6 t 47.31 -177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.455 0.645 . . . . 0.0 111.779 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -161.87 22.31 0.11 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.202 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.61 21.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 51' ' ' LEU . 38.0 m -94.08 92.74 0.78 Allowed Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.642 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.58 171.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 0.0 112.092 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.726 ' HB2' HD22 ' A' ' 41' ' ' LEU . 6.6 Cg_endo -48.72 128.72 19.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.641 2.228 . . . . 0.0 111.86 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.024 HD22 HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -119.07 110.39 17.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.179 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.574 HD13 HG23 ' A' ' 39' ' ' ILE . 15.0 mt -56.42 116.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.009 0.433 . . . . 0.0 111.183 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -101.07 -6.84 23.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 60.4 t80 -178.16 131.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 61' ' ' GLU . 2.4 mt -108.29 176.31 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.636 ' H ' HG22 ' A' ' 60' ' ' ILE . 76.5 tt0 -109.56 154.84 22.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.524 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -85.47 50.15 1.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.36 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 16.1 t0 178.07 36.84 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.586 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.426 ' H ' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -133.61 132.12 21.62 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.75 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -10.57 12.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.537 2.158 . . . . 0.0 112.65 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.949 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -70.6 -52.89 18.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.05 0.453 . . . . 0.0 110.393 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' CB ' HG21 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -72.45 -29.18 63.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.205 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -94.21 -2.28 52.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.701 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.409 ' HG ' ' HB2' ' A' ' 72' ' ' LEU . 21.8 p -46.0 -31.52 2.3 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.74 0.305 . . . . 0.0 111.416 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.62 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 93.66 30.02 9.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.852 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 71' ' ' VAL . 14.3 p -179.6 39.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.862 HD12 ' O ' ' A' ' 66' ' ' ALA . 7.8 mt -131.35 174.07 10.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -156.04 163.37 39.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.705 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.532 HD13 HG13 ' A' ' 60' ' ' ILE . 32.4 mm -68.65 70.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.39 79.65 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.756 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.759 ' OD2' HD22 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -114.45 111.83 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.718 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.31 135.21 53.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.097 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 109' ' ' LEU . 20.3 t -104.46 120.61 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.0 tpt -87.59 -29.68 21.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -162.97 141.81 8.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.92 HG23 ' CD2' ' A' ' 109' ' ' LEU . 5.4 mt -113.52 109.42 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.628 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 46.93 27.8 0.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.86 6.5 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.734 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mm -69.19 111.19 7.79 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 120.602 0.239 . . . . 0.0 111.512 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.73 148.62 59.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.49 -24.6 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -73.79 -6.95 50.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.587 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.18 46.4 2.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.889 0.376 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m 177.94 -179.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 m -79.46 158.65 27.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.822 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CE2' ' CA ' ' A' ' 43' ' ' GLY . 12.0 p90 -73.08 -29.45 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.08 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.3 mt-10 -54.56 -34.13 61.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.331 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 94' ' ' ALA . 14.6 pt-20 -61.47 -47.35 86.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.279 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.818 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -57.88 -38.45 75.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.375 0.607 . . . . 0.0 110.097 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 2.5 m120 -58.86 -42.87 90.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.377 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 3.5 mm100 -63.0 -47.3 83.69 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.722 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.821 HD12 HD12 ' A' ' 81' ' ' ILE . 39.3 mt -52.47 -39.72 61.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.969 HD13 HD13 ' A' ' 41' ' ' LEU . 1.2 mt -74.1 -42.56 59.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.738 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 11.0 mtm180 -50.55 -34.97 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.266 0.555 . . . . 0.0 109.669 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -121.07 38.93 3.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.168 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.428 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -86.58 10.39 15.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.644 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -109.14 16.35 22.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.772 0.32 . . . . 0.0 111.757 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.9 mt -71.47 -49.99 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.817 0.818 . . . . 0.0 110.399 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 6.96 47.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.717 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.0 t 56.26 22.71 6.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.6 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.1 OUTLIER -163.76 156.76 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.551 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 109' ' ' LEU . 33.3 t -156.91 125.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.38 131.85 51.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.92 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -139.18 153.33 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 0.0 111.411 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.27 121.91 44.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.165 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.482 HG23 HG21 ' A' ' 27' ' ' VAL . 28.5 pt -112.5 145.49 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 111.848 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -111.36 140.29 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.116 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -153.61 174.34 14.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.621 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -100.89 116.19 32.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.353 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.813 ' O ' HG13 ' A' ' 20' ' ' VAL . 19.2 m -61.61 145.21 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.658 ' HB3' HG22 ' A' ' 20' ' ' VAL . . . 79.57 119.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.42 19.62 0.55 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.325 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER 176.91 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.861 0.362 . . . . 0.0 111.338 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.935 HG11 ' CG2' ' A' ' 170' ' ' THR . 0.0 OUTLIER -158.16 131.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -113.53 94.41 31.99 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.8 Cg_endo -85.69 150.02 9.96 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.8 2.333 . . . . 0.0 112.769 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.27 23.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.212 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.31 116.98 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.57 -45.85 1.99 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.9 102.79 5.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 110.647 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CE1' HG12 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -110.06 115.21 29.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.031 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.569 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -96.66 150.14 21.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.93 0.395 . . . . 0.0 110.791 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.549 HG12 ' HG ' ' A' ' 130' ' ' LEU . 18.3 t -124.59 95.48 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.0 mttt -81.76 98.15 8.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.21 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.549 ' HG ' HG12 ' A' ' 128' ' ' VAL . 7.2 mt -108.12 130.65 22.51 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.69 119.3 6.13 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.511 2.141 . . . . 0.0 111.454 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.828 ' HG3' HG23 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -108.31 158.61 17.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.169 0.509 . . . . 0.0 111.536 -179.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -108.89 -164.84 0.97 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.323 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.39 -47.45 86.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.06 77.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.699 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.62 HG11 ' HA2' ' A' ' 70' ' ' GLY . 16.7 t -112.75 160.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.489 ' N ' HG12 ' A' ' 136' ' ' VAL . 29.6 tt0 -54.95 117.17 3.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.57 HD21 ' HD3' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -98.31 -61.07 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.551 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . 94.43 30.29 8.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.153 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -105.07 143.51 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.748 0.274 . . . . 0.0 110.866 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 157' ' ' SER . 86.6 m -126.09 136.76 53.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.796 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.959 HD13 HG22 ' A' ' 194' ' ' VAL . 2.3 mt -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.497 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -161.65 153.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.2 t -105.12 136.96 19.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.82 130.57 12.57 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.4 m -68.88 -29.84 68.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.7 94.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.59 92.24 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.33 158.31 74.72 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.09 94.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.525 2.15 . . . . 0.0 112.312 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 153.86 -61.69 0.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.561 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.406 ' N ' ' CD ' ' A' ' 153' ' ' PRO . 55.2 t0 59.6 53.71 4.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 152' ' ' ASP . 61.4 Cg_endo -73.31 -179.26 4.24 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.818 HD12 ' CG2' ' A' ' 142' ' ' ILE . 4.4 mm? -100.52 167.4 10.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.695 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 175' ' ' ASP . 6.5 p -155.83 136.07 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.418 HD13 HD23 ' A' ' 171' ' ' LEU . 2.0 mt -65.44 151.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.663 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.401 ' HB3' ' CG2' ' A' ' 141' ' ' THR . 0.1 OUTLIER -124.85 -12.55 7.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.31 143.77 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.902 0.382 . . . . 0.0 111.204 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.43 HG21 ' CA ' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -131.0 149.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -98.36 146.96 25.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 111.132 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 173.16 10.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.995 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.68 -62.78 1.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 5.7 p -61.78 144.06 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 0.0 111.129 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.0 m -48.78 -21.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.144 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 168' ' ' THR . . . -48.04 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.312 . . . . 0.0 111.437 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.43 ' CA ' HG21 ' A' ' 159' ' ' ILE . 36.3 t60 -76.15 -24.26 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.736 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.76 -45.72 74.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 165' ' ' ALA . 5.3 t -61.48 88.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.476 ' C ' HG22 ' A' ' 170' ' ' THR . . . -50.97 88.27 0.01 OUTLIER Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.742 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.935 ' CG2' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER 164.79 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 110.328 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.861 HD11 HD12 ' A' ' 206' ' ' LEU . 3.2 tt -84.21 57.11 4.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.96 162.82 17.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.598 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -82.52 54.66 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.133 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.28 25.72 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.869 ' O ' HG23 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -124.78 -176.79 3.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 110.558 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 209' ' ' ARG . 1.0 OUTLIER -134.6 130.14 36.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 111.368 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 180' ' ' ILE . 0.8 OUTLIER -115.33 152.26 33.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 178' ' ' LEU . 4.0 pp -137.44 10.46 2.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.632 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.866 ' HB3' ' CB ' ' A' ' 207' ' ' LYS . . . -152.89 144.95 23.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 177' ' ' LEU . 31.3 mm -139.27 111.67 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 35.6 t70 51.59 52.64 14.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 31.1 t30 84.72 -34.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 184' ' ' ARG . 45.1 mm -68.64 159.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.752 0.31 . . . . 0.0 110.783 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 183' ' ' ILE . 67.3 mtm180 -133.86 129.76 36.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.192 0.52 . . . . 0.0 112.299 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.561 ' HG ' HD23 ' A' ' 154' ' ' LEU . 3.4 mm? -75.08 -5.27 43.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.623 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -45.93 -29.55 1.45 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 m -123.26 30.28 6.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.42 165.11 36.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.998 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.14 -169.89 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.667 ' CB ' HD11 ' A' ' 154' ' ' LEU . 12.9 ptm -70.34 -42.01 72.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.6 mt-10 -53.9 -34.93 60.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.052 0.453 . . . . 0.0 111.006 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.711 ' O ' HD12 ' A' ' 196' ' ' ILE . 35.8 t70 -61.07 -48.23 82.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.222 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -58.51 -39.11 79.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.959 HG22 HD13 ' A' ' 142' ' ' ILE . 13.5 t -63.0 -33.37 60.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.097 0.475 . . . . 0.0 109.998 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -49.65 70.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.848 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.8 mp -74.71 -24.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.167 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.771 HD22 HD11 ' A' ' 142' ' ' ILE . 0.0 OUTLIER -61.25 -40.67 94.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 110.216 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.647 ' NE2' HG12 ' A' ' 194' ' ' VAL . 18.1 mt-30 -89.7 -41.26 12.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.112 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.58 -18.63 60.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.752 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.65 ' SG ' HG22 ' A' ' 196' ' ' ILE . 4.1 m -81.74 44.95 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.235 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 1.1 pt-20 -74.53 61.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.187 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.8 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.82 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 130' ' ' LEU . 12.4 tp -176.67 104.37 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 132' ' ' LYS . 59.1 t -98.32 108.56 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.147 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 28.1 ttmt -100.21 108.19 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.861 HD12 HD11 ' A' ' 171' ' ' LEU . 43.1 mt -94.36 108.2 20.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.455 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.866 ' CB ' ' HB3' ' A' ' 179' ' ' ALA . 28.8 tttt -83.11 93.43 7.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.648 HD13 ' HB3' ' A' ' 177' ' ' LEU . 9.5 mm -88.99 164.13 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.352 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -126.54 127.8 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.838 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.02 123.14 39.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.111 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -178.59 91.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 46.1 -169.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.504 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.006 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 2.4 tt0 . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.742 ' O ' HG13 ' A' ' 20' ' ' VAL . 12.4 m -130.16 118.3 43.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.404 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -179.78 173.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.448 ' O ' HG22 ' A' ' 115' ' ' VAL . 64.7 t-80 -115.79 111.02 19.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.996 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -55.44 139.53 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' HB2' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -134.89 173.18 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.6 OUTLIER -121.68 150.54 41.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.715 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 8.8 t -142.87 163.48 32.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -102.5 161.14 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.636 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -145.95 147.73 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG13 ' CD ' ' A' ' 106' ' ' LYS . 45.7 t -126.26 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.944 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.88 HD21 HD21 ' A' ' 72' ' ' LEU . 4.3 mm? -107.51 123.23 48.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.449 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -111.16 161.86 15.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.169 0.509 . . . . 0.0 111.821 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.839 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -104.42 116.13 31.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -83.19 154.88 67.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.56 179.597 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.2 6.57 4.6 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.497 2.131 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.39 -49.82 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.489 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.8 p -137.2 -2.73 2.02 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -110.34 3.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.349 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.839 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 6.6 m-85 -106.05 129.24 54.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.906 0.384 . . . . 0.0 110.064 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.47 24.93 20.59 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.884 -0.674 . . . . 0.0 114.473 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.833 ' CG2' HD13 ' A' ' 60' ' ' ILE . 1.1 pp -122.67 128.54 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.578 0.689 . . . . 0.0 111.503 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -111.26 127.4 55.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.235 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -96.73 154.06 17.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.105 0.478 . . . . 0.0 111.715 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.58 168.85 8.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.494 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . -68.41 -117.68 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.801 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -108.57 132.46 53.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 46' ' ' PHE . 2.8 t -89.79 -70.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.871 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.696 ' O ' HG22 ' A' ' 48' ' ' THR . 13.4 p90 -25.3 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.854 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.75 72.28 0.16 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.562 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.7 t 174.12 40.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' THR . 2.7 mt-10 164.71 -169.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.747 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.86 -94.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -152.98 -82.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.365 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.69 16.43 0.99 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -145.12 74.41 14.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' A' ' 91' ' ' PHE . 49.6 Cg_exo -55.47 -175.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.785 ' HB2' HD22 ' A' ' 41' ' ' LEU . 87.4 Cg_exo -46.8 125.23 9.47 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.47 2.113 . . . . 0.0 112.069 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 56' ' ' LEU . 1.9 mp -115.36 113.44 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.62 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 76' ' ' ASP . 56.7 mt -58.17 121.92 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.449 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.431 ' HA ' HG23 ' A' ' 74' ' ' ILE . 7.2 t -124.81 25.88 7.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 60' ' ' ILE . 25.8 t80 -173.52 138.9 0.71 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.053 0.454 . . . . 0.0 111.662 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.833 HD13 ' CG2' ' A' ' 39' ' ' ILE . 30.8 mm -112.21 160.3 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.538 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -112.52 155.79 23.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -100.29 55.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER 166.89 41.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.091 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.42 ' H ' ' NH1' ' A' ' 68' ' ' ARG . 2.9 m -141.2 144.34 34.2 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.8 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 32' ' ' ASP . 55.6 Cg_endo -69.8 -0.11 6.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.633 2.222 . . . . 0.0 112.819 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HA ' HD13 ' A' ' 29' ' ' LEU . . . -68.12 -56.92 7.08 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.341 0.591 . . . . 0.0 110.301 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 7.2 pm0 -80.12 -29.6 38.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.023 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.575 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -70.66 -27.31 63.93 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.018 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 53.6 t -49.46 -43.23 44.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.541 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 106.16 20.88 8.85 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.728 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 71' ' ' VAL . 13.5 t -153.66 41.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.88 HD21 HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -124.44 157.26 35.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.02 158.2 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 60' ' ' ILE . 19.8 mm -66.98 75.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.304 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 148.83 69.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.728 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -106.02 78.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.528 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -55.21 -40.89 71.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 109' ' ' LEU . 46.6 t 65.08 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.263 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -27.98 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -155.78 137.33 14.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.883 HD12 HD12 ' A' ' 97' ' ' LEU . 8.1 mt -114.23 106.96 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.79 ' OD1' HG22 ' A' ' 81' ' ' ILE . 6.6 m120 58.79 20.77 8.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.169 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.46 -34.27 4.61 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.571 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.0 mt -67.73 127.42 93.37 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.497 0.189 . . . . 0.0 110.995 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.36 -179.28 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.456 2.104 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.8 p -147.45 -45.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.91 -13.11 61.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -118.93 46.55 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.4 p -171.92 -177.5 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.649 ' HA ' HD13 ' A' ' 51' ' ' LEU . 54.1 m -81.21 141.5 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.794 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 6.6 p90 -61.74 -37.25 83.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 90' ' ' THR . 1.8 tt0 -55.23 -36.02 65.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.264 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 90' ' ' THR . 0.6 OUTLIER -61.51 -52.34 64.89 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -54.85 -33.58 61.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.412 0.625 . . . . 0.0 110.217 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -63.74 -40.3 96.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.978 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 18.0 mm-40 -61.59 -44.17 97.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.229 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.883 HD12 HD12 ' A' ' 81' ' ' ILE . 44.0 mt -56.29 -43.66 79.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.415 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.751 HD22 HD11 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -70.41 -51.2 31.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.812 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -50.28 -30.53 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.138 0.494 . . . . 0.0 109.801 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.7 t0 -121.71 38.22 4.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.362 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.604 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.75 25.54 6.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.323 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.3 p -119.16 13.09 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.9 mt -68.12 -46.4 81.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 110.565 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -1.55 54.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.573 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.797 ' O ' HG22 ' A' ' 30' ' ' THR . 0.8 OUTLIER 62.86 26.56 15.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -169.35 153.82 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 101' ' ' SER . 60.1 t -153.59 150.9 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.04 135.12 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.337 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.775 ' HB3' HG13 ' A' ' 78' ' ' VAL . 3.2 mt -136.81 149.21 47.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 111.628 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.72 105.9 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.981 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.462 HG13 HG22 ' A' ' 25' ' ' THR . 30.2 pt -103.47 154.52 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.15 0.5 . . . . 0.0 112.165 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 24' ' ' THR . 32.5 tt0 -126.38 138.42 53.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.99 173.58 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 111.327 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.34 106.14 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.252 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 18.5 m -61.92 103.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.823 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.608 ' CB ' HG11 ' A' ' 20' ' ' VAL . . . 153.0 129.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.022 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -161.96 22.54 0.11 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.253 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER 169.48 93.75 0.0 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.033 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.597 HG13 ' CE1' ' A' ' 126' ' ' PHE . 23.2 t -139.6 118.8 12.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.869 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 127' ' ' HIS . 1.1 pp -137.26 78.19 40.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 121.692 0.758 . . . . 0.0 110.691 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 119' ' ' VAL . 70.7 Cg_endo -94.65 176.74 1.02 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.229 2.619 . . . . 0.0 112.878 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -172.96 33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.895 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.73 117.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 89.25 -44.4 3.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.032 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.842 HG22 ' HD3' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -122.7 103.94 8.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.752 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.597 ' CE1' HG13 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -110.62 124.46 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.504 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.587 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -118.08 144.6 45.49 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.687 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.543 HG12 HD12 ' A' ' 130' ' ' LEU . 2.9 t -130.27 111.1 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.506 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' SER . 11.1 mttp -80.72 101.31 9.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.885 HD11 ' CG2' ' A' ' 168' ' ' THR . 1.9 mp -107.32 113.71 61.75 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.515 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.6 115.53 3.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.297 1.998 . . . . 0.0 111.352 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.55 ' HG2' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -100.37 158.75 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.73 -164.62 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.776 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -57.65 -48.39 79.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.71 50.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 111.277 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.673 HG23 ' HB2' ' A' ' 133' ' ' LYS . 46.1 t -89.63 144.13 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.414 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 40.6 tt0 -52.42 124.72 14.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' A' ' 165' ' ' ALA . 1.5 mp -90.57 -66.88 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 113.69 -2.22 24.66 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.05 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.559 HG23 HD21 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -95.78 135.58 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.342 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.689 HG22 ' HB3' ' A' ' 157' ' ' SER . 11.0 m -126.1 136.04 52.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.504 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.872 HD11 ' HG ' ' A' ' 197' ' ' LEU . 5.3 mt -105.35 164.12 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.543 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -154.63 151.61 29.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.691 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.6 p -118.78 107.47 42.38 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.05 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.97 -159.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.474 2.116 . . . . 0.0 112.106 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 53.1 p -59.23 98.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.3 87.15 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mtt180 -151.1 42.8 0.77 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.851 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.39 161.16 45.69 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.751 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.02 -24.66 20.11 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.445 2.097 . . . . 0.0 112.241 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -163.44 59.09 0.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.461 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -49.21 105.72 0.54 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 111.179 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.04 -178.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.435 2.09 . . . . 0.0 112.359 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.552 HD11 ' HG ' ' A' ' 185' ' ' LEU . 2.8 mt -113.78 178.9 4.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.493 HG23 ' OG ' ' A' ' 143' ' ' SER . 24.2 m -157.27 175.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.42 ' HB ' HD23 ' A' ' 173' ' ' LEU . 4.2 mm -79.25 154.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.689 ' HB3' HG22 ' A' ' 141' ' ' THR . 10.7 t -130.8 -10.22 3.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.651 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.449 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 170.62 156.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.805 HG22 ' HB2' ' A' ' 166' ' ' HIS . 4.2 mt -142.49 139.34 29.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.765 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.409 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -114.26 145.47 41.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.933 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -85.78 168.61 14.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.582 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.425 ' N ' ' NH1' ' A' ' 167' ' ' ARG . . . 84.95 -52.73 4.74 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.504 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 34.2 m -81.14 153.69 27.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.854 HG23 HD23 ' A' ' 130' ' ' LEU . 18.3 m -48.72 -21.8 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 138' ' ' LEU . . . -46.88 -66.52 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.886 0.374 . . . . 0.0 111.655 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.805 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -83.36 -24.24 32.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.4 -29.84 50.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.4 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.885 ' CG2' HD11 ' A' ' 130' ' ' LEU . 22.3 p -45.25 -42.2 9.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.788 0.328 . . . . 0.0 111.393 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.83 -26.48 18.33 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.769 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.459 HG21 ' CE1' ' A' ' 126' ' ' PHE . 3.7 t -109.6 31.84 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -117.17 113.62 22.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -142.13 156.81 45.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 156' ' ' ILE . 14.9 mt -75.4 113.7 13.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.23 -17.2 2.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.779 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.631 ' HB3' HG21 ' A' ' 208' ' ' ILE . 5.4 m-20 -70.34 166.04 21.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.73 0.3 . . . . 0.0 110.794 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.28 114.25 24.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.019 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.675 HD12 HD12 ' A' ' 208' ' ' ILE . 0.3 OUTLIER -70.72 142.55 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.691 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.571 ' C ' HD23 ' A' ' 178' ' ' LEU . 7.5 tt -122.27 -55.22 1.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -143.49 176.07 9.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.081 0.467 . . . . 0.0 111.592 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 193' ' ' ALA . 25.3 mt -139.26 107.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.93 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.815 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 48.38 -85.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 180' ' ' ILE . 3.6 m-20 -108.07 -20.33 13.2 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.552 HG21 ' CD1' ' A' ' 196' ' ' ILE . 24.9 mm -100.08 140.95 18.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 111.512 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 0.9 OUTLIER -112.86 120.66 42.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.06 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.901 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 2.9 mm? -82.81 -5.21 58.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.375 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.67 -32.07 1.37 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.367 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 -16.78 9.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.579 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.6 m -85.24 -169.78 2.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 0.0 111.22 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.33 -173.36 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.414 ' CB ' HD22 ' A' ' 154' ' ' LEU . 1.0 OUTLIER -74.05 -52.01 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.01 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -51.8 -30.71 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 111.102 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.4 OUTLIER -62.19 -51.53 67.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.058 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.901 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -56.21 -39.41 72.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.239 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.708 HG12 ' NE2' ' A' ' 198' ' ' GLN . 19.1 t -61.01 -36.81 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.212 0.529 . . . . 0.0 109.902 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -49.86 76.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.843 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.552 ' CD1' HG21 ' A' ' 183' ' ' ILE . 1.5 mp -75.51 -24.13 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.027 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.872 ' HG ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -59.46 -36.17 75.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.708 ' NE2' HG12 ' A' ' 194' ' ' VAL . 5.1 mt-30 -100.11 -37.65 8.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.65 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.52 -19.57 49.17 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.931 ' CB ' HG13 ' A' ' 204' ' ' VAL . 1.1 m -84.4 43.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.41 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -68.56 62.87 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.283 0.563 . . . . 0.0 111.076 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 200' ' ' CYS . 1.8 m-20 -174.98 -32.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.056 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.4 tt 178.06 108.91 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.272 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.931 HG13 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.06 115.24 48.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.215 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HB3' ' CA ' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -96.32 107.9 20.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 208' ' ' ILE . 11.1 mp -81.91 113.58 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.842 ' HD3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -99.75 94.39 6.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.788 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.675 HD12 HD12 ' A' ' 177' ' ' LEU . 1.1 mm -94.16 170.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.989 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -112.82 131.6 55.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.919 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 115.37 29.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 178.95 82.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.58 152.12 7.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.387 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.19 -179.946 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.2 p -114.39 132.53 63.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 115' ' ' VAL . 69.0 t -139.55 150.31 22.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -136.3 108.48 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.658 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 p -49.28 143.16 6.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 173.03 12.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -133.06 159.12 40.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.556 HG21 ' HA2' ' A' ' 162' ' ' GLY . 14.1 t -150.54 -169.96 3.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -121.65 161.0 23.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.428 HG13 ' HG ' ' A' ' 109' ' ' LEU . 1.7 p -136.65 151.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.392 0.615 . . . . 0.0 110.924 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.9 109.79 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.095 HD21 HD11 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -104.36 118.34 36.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.0 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -113.51 161.74 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.34 0.59 . . . . 0.0 112.195 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.891 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -107.0 109.75 21.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.457 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 8.4 p-10 -83.68 157.23 64.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.412 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.08 7.92 2.29 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.459 2.106 . . . . 0.0 112.98 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.64 -47.29 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.634 0.255 . . . . 0.0 111.247 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.3 p -144.58 6.53 1.25 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 61.71 -86.62 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.219 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 7.9 m-85 -128.06 113.98 16.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.51 19.51 47.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.523 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.095 HD13 HD13 ' A' ' 72' ' ' LEU . 16.2 pt -123.89 134.47 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.905 0.353 . . . . 0.0 110.69 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 3.2 pt20 -120.74 142.76 49.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.81 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.891 HD11 ' CD1' ' A' ' 98' ' ' LEU . 1.4 pt? -129.41 154.65 46.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.276 0.56 . . . . 0.0 111.921 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.19 8.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.339 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -104.23 -58.13 0.7 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.289 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -69.53 150.39 47.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.851 0.358 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 56' ' ' LEU . 86.4 t -142.02 -88.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.955 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.563 ' CE1' HG23 ' A' ' 50' ' ' THR . 52.9 p90 -56.78 -46.17 81.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.22 0.533 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.562 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 47.35 82.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.702 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 60.3 p -159.95 98.18 1.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.134 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' C ' HG22 ' A' ' 50' ' ' THR . 4.7 pt-20 52.37 35.36 17.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.525 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.563 HG23 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 165.78 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.773 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -160.67 23.78 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.789 0.328 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.12 21.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -72.28 138.18 81.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.795 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.16 156.91 33.79 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.457 2.105 . . . . 0.0 112.39 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.667 ' CB ' HD12 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -42.71 159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.003 2.469 . . . . 0.0 112.242 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.687 ' CD1' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -160.62 108.88 1.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.548 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.79 ' CD1' HD12 ' A' ' 39' ' ' ILE . 61.5 mt -59.88 135.78 24.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -125.25 17.24 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HB3' ' CG ' ' A' ' 40' ' ' GLN . 37.6 t80 -177.68 141.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.834 HG21 ' HB2' ' A' ' 67' ' ' GLU . 12.1 mm -131.01 148.43 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.077 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 62' ' ' ALA . 39.0 tt0 -95.55 151.84 18.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.943 0.401 . . . . 0.0 111.232 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.39 45.34 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.39 42.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.501 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.24 135.25 23.76 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.779 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 11.8 Cg_endo -54.81 -11.46 3.51 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.787 2.325 . . . . 0.0 113.147 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -66.23 -57.54 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.815 0.34 . . . . 0.0 110.542 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.834 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.41 -31.83 42.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.977 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.501 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -61.32 -30.93 70.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.673 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.63 -31.29 64.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.776 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.818 ' HA3' HG11 ' A' ' 136' ' ' VAL . . . 86.36 34.19 12.67 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.676 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 71' ' ' VAL . 13.1 t -151.41 28.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.652 0.263 . . . . 0.0 111.411 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.095 HD11 HD21 ' A' ' 29' ' ' LEU . 16.8 mt -140.42 148.89 41.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 175.92 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.666 HD13 HG12 ' A' ' 60' ' ' ILE . 21.1 mm -69.26 68.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.18 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.39 59.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.678 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.525 ' OD2' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -88.76 120.88 30.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.75 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.474 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -90.72 104.55 17.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.685 ' HA ' HG22 ' A' ' 111' ' ' ILE . 17.2 t -94.08 158.65 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.051 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.451 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -122.74 -40.45 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.46 149.14 37.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.159 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.766 HG23 ' CD2' ' A' ' 109' ' ' LEU . 17.6 mt -132.71 120.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.68 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 m120 54.53 24.23 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.913 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.97 -18.48 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.636 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.14 137.02 56.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.42 -178.7 3.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.369 2.046 . . . . 0.0 112.254 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.6 p -157.26 -44.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -11.15 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.391 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -117.09 46.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.763 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 t -176.9 -176.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.38 151.24 45.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 16.4 p90 -70.17 -30.94 68.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -55.83 -31.56 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 93' ' ' GLU . 5.6 mm-40 -61.69 -58.62 7.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -54.82 -28.68 51.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.806 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.22 -43.11 34.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -70.61 -36.13 73.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.807 0.336 . . . . 0.0 111.198 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 81' ' ' ILE . 1.1 pp -70.09 -46.1 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.326 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.891 ' CD1' HD11 ' A' ' 41' ' ' LEU . 69.8 mt -64.29 -57.39 9.56 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.264 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -50.75 -29.68 12.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' O ' HD11 ' A' ' 103' ' ' ILE . 5.8 t70 -114.37 35.5 4.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 84.4 p -108.78 15.21 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.134 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.8 p -100.64 15.08 29.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 111.855 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.7 mt -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 5.77 44.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.656 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 30' ' ' THR . 13.1 p 59.2 26.76 15.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -171.12 148.85 2.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.907 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.53 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.5 t -149.68 131.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.31 130.59 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.697 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.766 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -140.32 164.96 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 111.342 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -114.43 145.55 41.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.402 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 78' ' ' VAL . 40.6 pt -137.46 159.94 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.959 0.409 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -123.69 146.42 48.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.318 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -161.05 174.28 13.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.425 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.13 131.23 44.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 20' ' ' VAL . 27.2 m -85.53 145.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.728 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . 82.88 113.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.774 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -153.79 24.32 0.51 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.872 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.35 85.43 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.649 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.678 HG13 ' HE1' ' A' ' 126' ' ' PHE . 34.7 t -142.27 131.63 22.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.028 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.66 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -134.23 86.03 37.35 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-O 121.646 0.736 . . . . 0.0 109.894 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.518 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 60.6 Cg_endo -95.81 175.19 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.268 2.645 . . . . 0.0 113.424 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -163.25 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.463 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 169.78 113.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.2 -30.75 6.48 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.354 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.547 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -134.5 102.67 5.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.999 0.428 . . . . 0.0 110.612 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.678 ' HE1' HG13 ' A' ' 119' ' ' VAL . 1.9 t80 -104.45 127.56 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.66 ' HB2' HG13 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -118.44 141.06 48.93 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.624 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.778 HG21 HD12 ' A' ' 206' ' ' LEU . 4.8 m -129.38 104.37 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -80.56 104.48 11.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.767 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.926 HD11 HG22 ' A' ' 168' ' ' THR . 4.3 mp -113.84 139.08 23.08 Favored Pre-proline 0 C--N 1.333 -0.126 0 CA-C-O 120.588 0.233 . . . . 0.0 111.488 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.11 108.91 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.446 2.097 . . . . 0.0 111.798 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -81.97 158.64 23.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.407 ' HE2' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -127.2 -166.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.265 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.8 -76.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.215 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.9 m -152.99 74.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.198 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.818 HG11 ' HA3' ' A' ' 70' ' ' GLY . 40.8 t -127.84 151.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.796 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -53.04 96.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.045 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.665 HD22 HG12 ' A' ' 140' ' ' ILE . 1.1 tt -55.07 -38.31 67.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.19 -44.38 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.032 HG23 ' HB1' ' A' ' 165' ' ' ALA . 5.1 pt -81.84 146.41 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.857 0.361 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.3 m -126.18 118.95 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.738 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.008 HD13 HG22 ' A' ' 194' ' ' VAL . 1.4 mp -80.58 164.06 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 142' ' ' ILE . 10.8 t -167.68 166.94 13.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -116.77 137.11 23.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -55.56 -39.5 90.7 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.421 2.08 . . . . 0.0 112.128 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.0 t -169.24 -166.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.824 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.1 m -134.05 40.23 3.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.65 74.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.79 153.03 13.75 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.15 -25.93 50.29 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.689 2.259 . . . . 0.0 112.58 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.52 -67.88 1.47 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.595 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' N ' ' HD3' ' A' ' 153' ' ' PRO . 21.5 t70 55.59 50.7 5.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.301 . . . . 0.0 111.249 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 152' ' ' ASP . 86.1 Cg_endo -80.24 -175.16 2.56 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.563 2.175 . . . . 0.0 112.422 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.897 HD12 ' CG2' ' A' ' 142' ' ' ILE . 1.8 mm? -104.83 145.61 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 175' ' ' ASP . 16.8 m -142.19 178.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 111.329 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.651 HG21 HD23 ' A' ' 173' ' ' LEU . 1.3 mm -93.23 154.83 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.58 -26.82 2.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.76 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -176.49 162.11 2.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.199 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.968 HD13 HD23 ' A' ' 171' ' ' LEU . 1.6 mt -140.53 149.08 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.756 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.0 146.23 45.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -83.35 164.93 19.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.556 ' HA2' HG21 ' A' ' 25' ' ' THR . . . 84.33 -19.21 19.58 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.065 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.477 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.2 m -107.05 146.53 31.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.964 0.411 . . . . 0.0 110.997 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.798 HG23 HD23 ' A' ' 130' ' ' LEU . 34.8 m -48.85 -22.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 1.032 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -52.91 -71.17 0.07 Allowed 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.955 0.407 . . . . 0.0 110.979 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.679 ' HB2' HG22 ' A' ' 159' ' ' ILE . 29.0 t60 -71.29 -24.8 62.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.14 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -56.88 -30.99 64.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.995 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.926 HG22 HD11 ' A' ' 130' ' ' LEU . 72.5 p -45.1 -42.71 9.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.253 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.71 -43.61 2.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.581 HG21 HG11 ' A' ' 119' ' ' VAL . 5.6 t -96.9 34.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.968 HD23 HD13 ' A' ' 159' ' ' ILE . 2.9 tt -117.34 99.91 7.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -109.36 -179.98 3.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 156' ' ' ILE . 4.0 mt -107.84 148.66 29.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.806 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.53 -11.17 39.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.814 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 155' ' ' VAL . 3.1 t0 -78.48 175.68 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.641 0.258 . . . . 0.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.448 ' HD3' HG12 ' A' ' 155' ' ' VAL . 41.5 mmtm -117.25 151.53 36.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.326 . . . . 0.0 111.132 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.634 HD23 ' H ' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -101.71 170.8 7.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.063 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.634 ' H ' HD23 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -148.07 -44.89 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.885 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -150.2 169.33 21.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.752 HD11 ' HB1' ' A' ' 193' ' ' ALA . 16.3 mt -139.62 114.38 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 18.3 t0 59.28 -83.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.375 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -128.69 -14.95 4.51 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.775 ' HB ' HG21 ' A' ' 196' ' ' ILE . 20.2 mm -102.32 133.58 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 9.6 mtm105 -100.13 114.47 27.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.597 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.759 HD21 HD13 ' A' ' 196' ' ' ILE . 2.9 mm? -72.32 -17.07 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.411 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.56 -81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 185' ' ' LEU . 8.2 m -153.28 24.44 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.837 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -171.05 0.65 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.071 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.7 14.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.845 ' HA ' HD11 ' A' ' 154' ' ' LEU . 14.8 ptm -74.23 -42.64 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.0 mt-10 -53.7 -31.89 49.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.825 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -62.68 -48.13 80.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.195 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.752 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -59.02 -39.73 82.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.476 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 1.008 HG22 HD13 ' A' ' 142' ' ' ILE . 8.6 t -63.79 -34.42 67.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 109.749 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 199' ' ' GLN . 0.9 OUTLIER -61.44 -50.29 73.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.966 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.825 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.6 mp -70.08 -24.78 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.172 0.51 . . . . 0.0 109.764 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.707 HD12 HD13 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.23 -33.92 76.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.721 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.408 ' HA ' ' NZ ' ' A' ' 132' ' ' LYS . 11.4 mt-30 -87.75 -39.78 14.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.727 ' OE1' HG23 ' A' ' 196' ' ' ILE . 0.0 OUTLIER -86.48 13.26 8.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.833 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 180' ' ' ILE . 0.5 OUTLIER -64.29 33.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.7 pt-20 32.53 68.17 0.15 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.78 24.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.471 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 mt -153.96 93.66 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.135 0.493 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 204' ' ' VAL . 13.8 p -97.11 108.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.714 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 24.1 ttmt -104.54 107.06 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.778 HD12 HG21 ' A' ' 128' ' ' VAL . 3.4 mt -83.4 114.16 21.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.628 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 12.0 tttt -97.16 93.26 6.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.356 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.58 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.7 OUTLIER -84.95 168.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.826 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 10.2 ttp180 -118.98 123.42 44.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.34 159.49 15.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.554 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -164.65 46.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.49 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.936 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.1 t0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.81 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.8 0.333 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 p -125.76 128.63 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 115' ' ' VAL . 10.2 p -137.79 143.38 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 51.6 p-80 -106.04 110.77 23.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 t -55.94 152.17 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 170.44 12.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.764 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.801 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -129.68 137.13 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -139.3 176.88 8.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -106.76 162.93 13.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.33 150.41 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.634 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.53 109.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 111.411 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 72' ' ' LEU . 3.9 mm? -106.63 121.72 44.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.798 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -110.67 162.18 15.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.63 . . . . 0.0 112.406 -178.777 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.754 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -109.34 103.73 12.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.168 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.4 148.32 55.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.41 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.88 1.96 7.1 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.596 2.198 . . . . 0.0 112.674 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.55 -48.45 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.371 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t -125.51 -11.24 6.82 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.02 -87.88 0.57 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.406 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.678 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 27.7 m-85 -130.94 117.94 19.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.0 110.285 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -70.34 -3.69 47.78 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.991 HG21 HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.61 167.6 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.958 0.879 . . . . 0.0 112.189 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 4.8 mt-30 -138.61 122.28 17.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.097 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.754 HD13 ' CD2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -96.34 143.3 27.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 112.061 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' CG ' HD13 ' A' ' 56' ' ' LEU . 6.0 pt20 -105.19 166.09 10.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.559 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -122.41 107.28 1.13 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.299 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 57.24 112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 111.398 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.62 -75.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.485 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 36.1 p90 -49.97 -48.07 52.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.036 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 41.58 80.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.66 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.2 t 170.11 114.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.565 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 50' ' ' THR . 1.9 tt0 61.32 86.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 51' ' ' LEU . 1.3 m 90.56 -179.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.623 ' H ' HG22 ' A' ' 50' ' ' THR . 1.4 pp -167.01 30.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.165 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -64.45 30.73 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -112.75 86.8 9.13 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.601 0.238 . . . . 0.0 110.578 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.29 176.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.486 2.124 . . . . 0.0 112.133 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.504 ' HG3' ' HB3' ' A' ' 94' ' ' ALA . 52.2 Cg_exo -53.16 137.9 63.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.412 2.075 . . . . 0.0 111.838 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.568 HD13 ' CG ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -137.67 113.76 9.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.489 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 81.8 mt -62.21 138.68 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 110.801 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 74' ' ' ILE . 6.3 t -119.82 -24.04 6.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.502 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 72.4 t80 -136.83 159.09 42.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.916 ' CD1' HG22 ' A' ' 39' ' ' ILE . 9.4 mm -138.33 164.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.47 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 60' ' ' ILE . 4.0 tp10 -119.87 147.13 45.07 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.866 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.95 42.72 1.11 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.187 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.15 36.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.068 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -137.17 138.13 24.57 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.081 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.71 -15.83 13.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.038 2.492 . . . . 0.0 113.643 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.871 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -73.9 -44.09 56.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.6 tp10 -76.06 -29.22 57.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.719 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.541 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.41 -14.83 39.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.307 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.7 t -47.25 -40.84 17.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.941 0.4 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.424 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 105.3 11.44 29.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.439 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -153.85 53.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 111.637 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.991 HD13 HG21 ' A' ' 39' ' ' ILE . 10.4 mt -141.3 134.83 29.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -141.08 174.44 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 58' ' ' SER . 26.5 mm -73.11 78.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.28 43.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -75.26 83.31 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.783 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 101.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.643 HG11 HD13 ' A' ' 109' ' ' LEU . 35.9 m -95.77 115.4 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -97.14 24.52 6.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.33 131.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.718 HG23 ' CD2' ' A' ' 109' ' ' LEU . 35.1 mt -131.23 115.71 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.469 ' OD1' HG13 ' A' ' 107' ' ' VAL . 7.7 m120 56.39 23.31 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.8 -26.3 24.53 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.536 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mt -74.26 136.67 75.44 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-O 120.565 0.222 . . . . 0.0 111.229 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.2 171.35 15.11 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.384 2.056 . . . . 0.0 112.162 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 94' ' ' ALA . 1.1 p -139.42 -46.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -71.05 -11.36 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -113.16 45.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.015 0.436 . . . . 0.0 110.794 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -178.09 -170.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.798 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 148.65 32.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.436 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 21.7 p90 -73.52 -31.21 63.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -59.16 -31.78 69.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.24 -58.88 6.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -55.73 -39.9 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.142 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.729 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.4 m120 -64.6 -36.99 86.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.322 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -69.95 -44.07 70.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.354 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.597 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 2.3 pp -62.65 -28.78 70.16 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.754 ' CD2' HD13 ' A' ' 41' ' ' LEU . 39.3 mt -67.62 -46.38 72.66 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 28.8 mtt-85 -50.28 -40.26 47.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.487 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.0 m-20 -115.55 40.93 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.431 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.19 6.46 47.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.619 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -105.23 18.23 22.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.341 . . . . 0.0 111.82 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.487 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.8 mt -71.41 -51.63 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.814 0.816 . . . . 0.0 110.919 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 7.99 31.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.806 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.754 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 45.4 t 57.1 22.47 7.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.337 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.66 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -168.99 159.16 9.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.036 0.446 . . . . 0.0 111.745 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.499 HG21 ' HB3' ' A' ' 101' ' ' SER . 39.8 t -157.5 128.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.683 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.87 133.34 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.585 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.718 ' CD2' HG23 ' A' ' 81' ' ' ILE . 1.6 mt -131.63 157.26 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 0.0 111.439 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 118.03 30.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.197 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 pt -112.27 155.37 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.155 0.503 . . . . 0.0 111.813 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.801 ' HG3' HG23 ' A' ' 24' ' ' THR . 0.4 OUTLIER -132.56 117.52 18.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.198 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 167' ' ' ARG . 6.2 p90 -136.34 174.11 10.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 0.0 111.407 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 3.7 p30 -91.08 155.33 18.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.559 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 115' ' ' VAL . 27.9 m -108.55 104.96 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.455 . . . . 0.0 111.635 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -172.35 95.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.6 OUTLIER -107.15 20.44 19.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.794 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 86.32 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.219 0.533 . . . . 0.0 111.714 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.657 ' CG1' HG13 ' A' ' 128' ' ' VAL . 2.5 m -112.96 140.76 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.115 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.707 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.2 pp -121.53 104.76 39.57 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.771 0.32 . . . . 0.0 111.455 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.488 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 92.7 Cg_endo -86.01 164.28 10.15 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.848 2.365 . . . . 0.0 112.754 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -167.28 22.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.582 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.7 OUTLIER 55.34 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.934 0.397 . . . . 0.0 111.244 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.36 -42.24 2.49 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.877 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.551 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.89 102.59 5.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.512 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.762 ' CE1' HG21 ' A' ' 170' ' ' THR . 6.1 t80 -104.66 130.58 52.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.566 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -112.68 144.76 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.454 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.657 HG13 ' CG1' ' A' ' 119' ' ' VAL . 21.4 t -122.46 89.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.473 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -81.29 106.15 13.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.777 HD13 HG23 ' A' ' 164' ' ' VAL . 4.1 pp -132.31 134.83 25.43 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.128 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 53.8 Cg_endo -69.15 125.63 12.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.407 2.072 . . . . 0.0 111.817 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 158.96 15.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.081 0.467 . . . . 0.0 111.061 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' HG3' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -92.9 -175.27 3.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.804 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -40.79 83.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.21 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 171.79 65.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 137' ' ' GLU . 17.2 t -109.76 165.05 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' N ' HG12 ' A' ' 136' ' ' VAL . 34.9 tt0 -29.19 132.6 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.06 101.29 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.745 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.94 49.24 3.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.342 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.851 HD11 ' HB3' ' A' ' 165' ' ' ALA . 32.7 mm -94.64 134.59 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.581 0.229 . . . . 0.0 110.878 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.691 HG22 ' HB3' ' A' ' 157' ' ' SER . 29.6 m -126.44 139.93 52.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.893 0.377 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.967 HD12 HG22 ' A' ' 194' ' ' VAL . 11.8 mt -113.24 164.09 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.485 ' N ' HG22 ' A' ' 142' ' ' ILE . 1.1 m -160.79 147.56 15.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.9 t -96.08 148.01 33.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.09 -55.55 3.76 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.6 t -154.87 29.92 0.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.3 m 58.75 51.91 7.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.826 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -82.03 177.71 8.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.81 156.62 4.74 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.051 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.05 86.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.691 2.261 . . . . 0.0 112.258 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 171.02 -33.55 0.15 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.494 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -53.22 140.66 43.25 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.62 0.248 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 164.57 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.445 2.097 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.619 ' O ' HG13 ' A' ' 155' ' ' VAL . 12.8 mt -114.72 -177.97 3.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.704 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 154' ' ' LEU . 3.5 m -161.85 154.0 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.615 HG21 HD11 ' A' ' 159' ' ' ILE . 2.7 mt -71.09 147.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.441 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.691 ' HB3' HG22 ' A' ' 141' ' ' THR . 29.2 t -128.09 -2.86 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.416 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 172.4 135.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.828 0.347 . . . . 0.0 110.607 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.809 HG21 ' HB2' ' A' ' 166' ' ' HIS . 6.5 mt -137.16 136.66 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.476 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 150.52 26.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.519 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -85.12 66.97 10.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.33 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.255 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.432 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -154.21 139.86 17.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.054 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.777 HG23 HD13 ' A' ' 130' ' ' LEU . 25.4 m -48.79 -24.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.441 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.955 ' O ' HG22 ' A' ' 168' ' ' THR . . . -46.8 -71.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.809 ' HB2' HG21 ' A' ' 159' ' ' ILE . 86.3 t60 -76.67 -25.52 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 111.099 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -56.47 -29.98 62.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.784 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.955 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.2 t -62.78 -23.94 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.811 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.43 71.08 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.887 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.762 HG21 ' CE1' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -172.39 -42.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.953 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.661 HD13 ' O ' ' A' ' 165' ' ' ALA . 1.1 mp -59.48 100.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -128.3 139.97 52.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.29 102.02 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.22 -18.81 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.641 ' CB ' HG21 ' A' ' 208' ' ' ILE . 8.1 m-20 -72.97 134.6 44.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.73 103.98 16.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.555 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -70.47 137.51 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 178' ' ' LEU . 8.4 tt -133.43 -40.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.655 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -129.78 149.1 51.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.92 0.391 . . . . 0.0 111.387 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.755 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 27.3 mt -139.23 113.86 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.294 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 24.9 t70 47.65 55.35 8.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.18 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.8 t30 84.9 -35.88 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.428 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 184' ' ' ARG . 44.1 mm -67.3 159.18 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 110.63 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.497 ' N ' HG22 ' A' ' 183' ' ' ILE . 10.1 mtp180 -134.74 129.49 34.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 1.036 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.4 mm? -74.53 -6.23 47.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.574 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -41.33 7.91 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.3 t -115.85 -18.06 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -171.14 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -120.7 -176.9 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.557 ' HG3' HD22 ' A' ' 154' ' ' LEU . 6.7 ttp -69.12 -57.14 5.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -54.31 -31.1 53.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.864 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.8 OUTLIER -62.99 -48.79 77.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.097 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 1.036 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -57.02 -39.41 74.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.164 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.967 HG22 HD12 ' A' ' 142' ' ' ILE . 21.7 t -60.14 -41.19 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.867 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -50.04 75.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.856 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 192' ' ' ASP . 3.0 mp -69.51 -24.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.614 HD13 HD11 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -57.92 -37.59 74.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.357 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -96.73 -35.67 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.028 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.82 -16.68 61.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.847 ' HB3' HG22 ' A' ' 204' ' ' VAL . 8.5 m -86.04 41.23 0.91 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.339 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.64 62.37 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.238 0.542 . . . . 0.0 111.068 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -174.18 -30.67 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.465 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 203' ' ' LEU . 3.6 tt 176.72 109.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.393 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 200' ' ' CYS . 21.8 t -104.3 125.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.613 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -108.16 108.32 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.883 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.555 ' HG ' HD21 ' A' ' 177' ' ' LEU . 1.1 mp -87.37 108.2 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.446 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.655 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 7.6 tttt -97.37 98.5 10.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.653 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.641 HG21 ' CB ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -106.34 172.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 3.4 mmt180 -108.94 138.82 44.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.451 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . 0.419 ' HE2' ' CD2' ' A' ' 126' ' ' PHE . 6.4 mptt -119.27 157.25 28.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.46 70.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.971 0.415 . . . . 0.0 110.963 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.65 140.69 50.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.083 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.826 0.346 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.54 139.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 21' ' ' HIS . 11.1 p -162.9 156.22 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.432 ' N ' HG22 ' A' ' 20' ' ' VAL . 51.3 p-80 -109.38 136.09 49.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -54.68 167.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.409 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -162.96 156.66 20.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -113.25 149.05 34.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.179 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.521 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -144.07 165.62 27.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -101.91 158.9 15.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.97 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 109' ' ' LEU . 2.9 p -143.65 151.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.496 0.665 . . . . 0.0 111.612 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.76 110.82 21.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.102 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD21 HD12 ' A' ' 39' ' ' ILE . 5.7 mp -109.77 118.75 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.885 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -109.4 161.54 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.271 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -92.89 112.51 24.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.06 156.0 44.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.609 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.7 7.6 3.06 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.556 2.171 . . . . 0.0 112.953 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 35' ' ' THR . 31.3 t -107.58 -47.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 111.181 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 34' ' ' VAL . 34.8 p -146.35 6.75 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 37' ' ' PHE . . . 66.86 -79.04 0.14 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.501 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 4.8 m-85 -132.67 113.76 13.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.187 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.18 -2.55 62.76 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.916 -0.584 . . . . 0.0 114.07 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.001 HD11 HD13 ' A' ' 72' ' ' LEU . 18.1 mt -92.98 136.32 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 111.944 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 mt-30 -113.84 120.62 41.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.038 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 55' ' ' PRO . 6.8 mp -95.35 136.89 35.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.195 0.521 . . . . 0.0 111.935 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 169.46 8.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.74 64.88 0.35 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.384 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -161.78 63.16 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.126 0.488 . . . . 0.0 111.021 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.523 HG22 HD13 ' A' ' 56' ' ' LEU . 2.1 t -85.76 -70.4 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.671 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.0 p90 -40.85 -43.97 2.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.17 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 54.81 76.24 0.26 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 49' ' ' GLU . 2.7 t 169.88 -164.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.864 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 48' ' ' THR . 16.3 pt-20 -46.81 167.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.603 0.24 . . . . 0.0 110.717 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 49' ' ' GLU . 11.0 t 45.53 -159.42 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.194 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.841 HD13 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -149.18 -85.8 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.342 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.42 14.48 1.15 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.79 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 3.9 t -75.59 113.87 30.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.58 ' O ' HD23 ' A' ' 56' ' ' LEU . 59.9 Cg_endo -72.01 151.48 56.11 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.27 1.98 . . . . 0.0 111.696 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.645 ' HB3' HD23 ' A' ' 41' ' ' LEU . 71.7 Cg_exo -47.84 111.2 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.341 2.027 . . . . 0.0 112.189 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -120.12 110.69 16.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.824 ' CD1' HD13 ' A' ' 39' ' ' ILE . 39.4 mt -56.21 124.92 10.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.858 0.361 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -8.25 27.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 45.7 t80 177.61 138.58 0.08 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.005 0.431 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.815 HG21 ' HB2' ' A' ' 67' ' ' GLU . 5.0 mt -113.82 169.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.337 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.54 ' H ' HG22 ' A' ' 60' ' ' ILE . 65.9 tt0 -108.46 151.97 25.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 111.368 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.423 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -91.61 46.59 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.356 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 177.46 44.34 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.892 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.433 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -142.44 142.18 22.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.998 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.79 -13.06 24.48 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.655 2.237 . . . . 0.0 112.889 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.611 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -64.77 -56.75 11.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 110.255 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.815 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -79.08 -29.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.896 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.44 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -69.42 -20.22 63.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.238 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.0 t -47.3 -29.31 2.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.22 58.24 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.456 HG13 ' HA2' ' A' ' 162' ' ' GLY . 4.0 t -152.63 37.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.001 HD13 HD11 ' A' ' 39' ' ' ILE . 10.7 mt -142.15 172.53 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 111.624 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.22 150.15 10.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.441 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.5 98.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.922 0.392 . . . . 0.0 111.337 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 95.62 40.8 4.05 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.248 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.806 ' CG ' HD12 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -78.17 -14.21 59.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.631 0.253 . . . . 0.0 111.399 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.7 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.8 mtm-85 63.09 136.05 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 109' ' ' LEU . 10.2 t -114.07 152.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.212 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.708 ' HE2' ' HB2' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -114.25 -34.12 5.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.708 ' HB2' ' HE2' ' A' ' 79' ' ' MET . . . -148.7 142.86 26.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.682 HG23 HD22 ' A' ' 109' ' ' LEU . 28.2 mt -128.39 111.13 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.916 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 54.24 25.11 5.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.13 -21.89 36.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.567 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.2 mt -75.32 128.84 83.68 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-O 120.531 0.205 . . . . 0.0 111.142 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 86' ' ' THR . 33.2 Cg_exo -57.65 -160.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.456 2.104 . . . . 0.0 112.212 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 85' ' ' PRO . 23.3 p -158.22 -49.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -7.25 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.42 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -112.22 45.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 t -178.31 175.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.841 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.04 144.32 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -51.61 -27.35 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.155 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.79 -35.07 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 1.7 pp20? -64.28 -37.41 87.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.786 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -69.24 -35.83 76.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.255 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.95 -42.71 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.963 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.788 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 0.9 OUTLIER -69.1 -42.37 76.21 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.164 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 98' ' ' LEU . 4.0 pp -64.8 -32.37 74.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 97' ' ' LEU . 4.2 mt -63.09 -57.42 10.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.788 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -52.33 -30.41 28.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.607 ' O ' HD11 ' A' ' 103' ' ' ILE . 68.6 m-20 -115.67 36.62 3.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.927 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -105.36 15.06 27.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.326 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -112.32 18.73 18.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 100' ' ' ASP . 2.1 mt -63.73 -46.55 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.689 0.757 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.92 0.13 57.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.502 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.885 ' O ' HG22 ' A' ' 30' ' ' THR . 1.2 m 63.26 26.27 15.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -166.16 146.03 6.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.78 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.504 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.2 t -149.02 111.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.624 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.535 ' C ' HD23 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -93.12 133.67 36.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.682 HD22 HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -142.25 165.27 27.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 111.222 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.18 136.98 52.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.393 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.806 HD12 ' CG ' ' A' ' 76' ' ' ASP . 27.6 pt -128.85 166.07 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.677 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -128.48 142.77 50.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.729 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -161.2 174.72 13.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.922 0.392 . . . . 0.0 111.236 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -88.75 150.49 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.401 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.4 m -101.57 104.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.006 0.431 . . . . 0.0 111.41 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -168.09 130.3 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.616 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.618 ' HB2' HG22 ' A' ' 168' ' ' THR . 69.7 mm-40 -130.2 6.56 4.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.01 71.21 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.34 0.59 . . . . 0.0 111.247 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.752 ' CG1' HG13 ' A' ' 128' ' ' VAL . 3.1 m -97.69 147.45 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.718 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.792 HD11 ' CG ' ' A' ' 127' ' ' HIS . 2.1 pp -122.92 102.31 38.09 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.889 0.376 . . . . 0.0 111.473 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.3 Cg_endo -87.71 154.81 7.52 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.96 2.44 . . . . 0.0 112.605 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -162.61 24.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.429 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 118.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.859 0.361 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.61 -45.95 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.5 102.43 6.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.643 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 8.4 t80 -107.14 115.93 31.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.792 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -99.72 144.96 28.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.145 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.752 HG13 ' CG1' ' A' ' 119' ' ' VAL . 2.7 t -118.3 97.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.978 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HE2' HD11 ' A' ' 203' ' ' LEU . 2.0 mttt -81.29 99.01 8.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.072 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 128' ' ' VAL . 3.0 mp -109.82 114.73 56.24 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.415 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.94 110.39 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.164 1.91 . . . . 0.0 111.307 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.754 ' HG3' HG23 ' A' ' 204' ' ' VAL . 1.1 mttt -89.7 158.65 17.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.611 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.791 ' HD2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -122.85 178.23 5.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.629 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.656 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 34.4 t-80 -41.77 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.715 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.422 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 3.0 m -138.63 97.37 3.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.883 0.373 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.791 HG23 ' HD2' ' A' ' 133' ' ' LYS . 2.2 t -143.21 141.46 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.49 141.98 58.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.027 HD23 HD11 ' A' ' 140' ' ' ILE . 1.3 tp -95.88 -41.94 8.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' A' ' 160' ' ' LYS . . . 94.0 13.84 53.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.267 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 1.027 HD11 HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -112.17 139.38 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.424 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 41.0 m -111.86 142.18 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 143' ' ' SER . 6.6 mt -103.35 164.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.033 0.444 . . . . 0.0 111.18 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.553 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -160.18 158.64 30.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.724 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.8 p -129.33 106.38 17.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.611 ' HD3' HG22 ' A' ' 155' ' ' VAL . 76.1 Cg_exo -49.72 -61.51 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.527 2.151 . . . . 0.0 112.381 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.18 -68.95 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.4 30.56 18.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.998 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -131.31 44.55 2.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.5 139.32 0.14 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.741 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.75 106.11 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.352 2.034 . . . . 0.0 112.279 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 117.23 23.24 3.9 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.789 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -55.32 148.75 30.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.536 ' O ' HD22 ' A' ' 154' ' ' LEU . 59.5 Cg_endo -72.17 172.04 15.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.573 2.182 . . . . 0.0 112.404 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.723 HD21 ' HA ' ' A' ' 190' ' ' MET . 4.0 mm? -123.92 141.85 51.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.611 HG22 ' HD3' ' A' ' 145' ' ' PRO . 34.9 m -156.38 148.69 11.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 156' ' ' ILE . 3.4 mp -68.0 152.19 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.17 -6.94 3.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.73 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 179.68 147.82 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.0 111.448 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.569 HG21 ' ND1' ' A' ' 166' ' ' HIS . 17.1 mt -139.13 149.79 23.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.465 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.613 ' HD3' ' N ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -138.7 144.26 39.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.373 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.52 72.58 5.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.613 ' N ' ' HD3' ' A' ' 160' ' ' LYS . . . -134.08 -44.37 0.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.194 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.14 176.61 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.248 0.547 . . . . 0.0 111.424 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.0 m -53.69 -21.52 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.384 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -42.69 -69.72 0.13 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.569 ' ND1' HG21 ' A' ' 159' ' ' ILE . 5.4 t60 -68.07 -27.25 66.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -59.6 -29.42 67.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.27 -179.618 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 128' ' ' VAL . 70.5 p -45.83 -29.83 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.53 58.61 8.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.541 HG21 HG11 ' A' ' 119' ' ' VAL . 4.5 t -178.83 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.67 93.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.019 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.71 146.9 27.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 35.4 mt -69.05 84.3 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.47 43.2 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.585 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.409 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.9 OUTLIER -119.58 145.01 46.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 0.0 110.457 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.401 ' HA ' HG12 ' A' ' 155' ' ' VAL . 10.2 mmtp -97.15 115.71 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 111.151 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.562 HD22 ' CD1' ' A' ' 180' ' ' ILE . 4.6 mt -87.87 135.04 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.75 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.97 -27.13 6.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.742 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -148.13 162.23 39.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.943 0.401 . . . . 0.0 111.551 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 179' ' ' ALA . 20.3 mm -139.44 110.22 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.968 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 21.2 t70 63.52 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.157 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -128.29 -22.6 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 184' ' ' ARG . 43.3 mm -87.83 157.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.801 0.334 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.695 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 9.1 mtt180 -126.31 129.75 49.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.076 0.465 . . . . 0.0 112.051 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.881 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.3 mm? -71.98 -6.36 41.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.727 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -45.51 -42.18 10.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.6 p -116.16 -19.67 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.211 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.78 -176.01 5.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -118.34 -175.67 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.723 ' HA ' HD21 ' A' ' 154' ' ' LEU . 11.9 ttp -63.05 -55.18 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.56 -29.87 18.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.799 ' O ' HD12 ' A' ' 196' ' ' ILE . 1.1 m-20 -64.32 -54.09 38.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.749 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.881 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -52.06 -32.57 35.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.899 0.38 . . . . 0.0 110.206 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.474 HG22 HD13 ' A' ' 142' ' ' ILE . 23.0 t -64.77 -47.81 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.819 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.632 ' OE1' ' O ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -70.77 -32.35 69.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.208 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.799 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.5 mt -75.77 -26.21 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -63.93 -40.56 96.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.287 179.033 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -86.64 -42.66 13.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.224 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.12 -18.56 48.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.497 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.861 ' HB3' HG22 ' A' ' 204' ' ' VAL . 4.6 m -86.25 42.23 0.98 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.374 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.98 62.42 0.87 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.247 0.546 . . . . 0.0 111.147 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.42 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 3.2 m-20 -171.3 -33.01 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.058 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.0 tt 177.89 106.93 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.308 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.861 HG22 ' HB3' ' A' ' 200' ' ' CYS . 21.6 t -102.3 121.77 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.349 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 0.6 OUTLIER -100.81 107.71 19.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.935 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.575 ' O ' HD13 ' A' ' 208' ' ' ILE . 3.1 mp -85.81 104.27 15.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.976 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.465 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -89.73 93.79 9.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -101.72 172.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.65 133.52 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.72 159.15 33.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.69 43.58 25.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.5 149.07 46.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.125 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.833 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 4.3 tp60 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.785 0.326 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.404 ' N ' ' HG3' ' A' ' 18' ' ' GLN . 11.9 p -141.35 127.75 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG21 ' O ' ' A' ' 115' ' ' VAL . 9.3 p -158.93 165.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.223 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.448 ' N ' HG22 ' A' ' 20' ' ' VAL . 65.4 t60 -92.93 134.17 35.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.37 174.21 3.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -168.49 162.11 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.711 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -131.21 144.97 51.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -139.52 -173.51 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.944 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -103.15 161.14 14.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 111' ' ' ILE . 2.2 t -147.01 149.08 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.58 113.89 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD22 ' HD2' ' A' ' 37' ' ' PHE . 3.6 mt -110.1 118.92 37.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -110.66 161.81 15.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.22 0.533 . . . . 0.0 111.742 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.892 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.79 119.93 39.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.104 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.777 ' OD1' HG23 ' A' ' 34' ' ' VAL . 8.8 t0 -88.53 141.96 30.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.338 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.18 3.94 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.48 2.12 . . . . 0.0 113.04 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.777 HG23 ' OD1' ' A' ' 32' ' ' ASP . 28.3 t -101.27 -53.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 t -141.25 6.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.947 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 67.96 -107.93 2.25 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.162 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.892 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 6.2 m-85 -106.87 128.26 54.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -91.88 25.15 17.7 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.863 -0.684 . . . . 0.0 114.798 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -126.39 130.93 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.68 0.74 . . . . 0.0 111.826 179.213 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 116.21 29.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.175 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -96.87 145.6 25.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.389 0.614 . . . . 0.0 112.552 -178.179 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -122.25 169.59 10.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.818 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 45' ' ' VAL . . . -116.46 -47.59 0.5 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.791 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -47.04 123.92 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.554 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 43' ' ' GLY . 98.8 t -140.2 -83.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.901 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 39.0 p90 -40.5 -45.54 2.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.175 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.511 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 51.94 73.63 0.31 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.264 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER 165.33 90.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.636 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 50' ' ' THR . 0.3 OUTLIER 55.17 176.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 49' ' ' GLU . 12.7 t 44.89 -163.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -147.8 -101.41 0.09 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.193 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.94 18.36 1.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.842 0.353 . . . . 0.0 111.555 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.46 107.85 1.75 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.038 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.441 ' O ' ' CD2' ' A' ' 56' ' ' LEU . 7.7 Cg_exo -72.91 167.4 27.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.653 2.235 . . . . 0.0 111.998 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.698 ' HA ' HD21 ' A' ' 41' ' ' LEU . 24.4 Cg_exo -63.83 128.63 22.51 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.711 2.274 . . . . 0.0 112.132 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.737 HD13 HG22 ' A' ' 45' ' ' VAL . 1.3 pt? -145.84 100.65 3.44 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.811 0.339 . . . . 0.0 111.804 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 39' ' ' ILE . 46.2 mt -64.62 156.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.519 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 57' ' ' ILE . 2.0 m -139.15 8.14 2.46 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' H ' HG22 ' A' ' 57' ' ' ILE . 52.8 t80 -178.14 134.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 112.081 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.709 HG13 HG23 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.89 -173.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.655 ' N ' HG23 ' A' ' 60' ' ' ILE . 29.0 tt0 -125.3 125.61 43.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.967 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -53.01 109.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.963 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER 84.72 46.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.353 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.92 154.28 76.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.89 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 22.4 Cg_exo -63.4 -12.04 28.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.392 2.061 . . . . 0.0 112.261 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.648 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -72.01 -57.1 4.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HB2' HG21 ' A' ' 60' ' ' ILE . 1.1 tp10 -79.08 -29.03 43.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.093 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -89.11 -7.19 56.25 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.582 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -46.88 -46.85 21.37 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.844 0.354 . . . . 0.0 111.204 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.791 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 123.16 -25.45 6.36 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.264 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.616 HG13 ' CA ' ' A' ' 162' ' ' GLY . 40.3 t -139.39 63.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.437 . . . . 0.0 110.803 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 66' ' ' ALA . 15.0 mt -148.28 169.67 19.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.012 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -164.07 162.09 22.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.742 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.7 mm -60.54 85.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.286 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.08 90.94 1.87 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.659 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB2' HG21 ' A' ' 111' ' ' ILE . 13.5 p30 -112.26 115.63 29.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.735 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 109' ' ' LEU . 29.0 t -72.98 115.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.5 tpt -83.25 -42.04 17.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.21 28.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.728 HG21 ' CD1' ' A' ' 97' ' ' LEU . 9.2 mt -131.54 119.64 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.95 23.16 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.94 -22.39 31.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.645 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' THR . 45.2 mt -70.39 127.77 91.83 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.429 0.157 . . . . 0.0 111.229 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.543 ' C ' HG23 ' A' ' 86' ' ' THR . 33.3 Cg_endo -64.14 -31.15 65.06 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.44 2.094 . . . . 0.0 112.238 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.543 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 75.74 -54.96 0.62 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.152 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -66.93 -13.79 62.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.09 44.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.78 -175.91 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.787 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 m -68.52 156.58 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -73.1 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.007 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -55.54 -32.78 63.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -66.18 -36.09 82.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.801 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.709 ' HA ' HD23 ' A' ' 97' ' ' LEU . . . -71.16 -34.96 71.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -74.13 -32.15 63.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.651 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -72.5 -37.27 68.45 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' CD1' HG21 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -70.58 -38.74 74.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.206 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 41' ' ' LEU . 71.1 mt -73.47 -55.81 5.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.308 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.25 -30.01 16.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.4 OUTLIER -119.01 37.95 3.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.584 178.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -95.87 26.67 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.004 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -119.17 12.01 12.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.65 -47.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.642 0.734 . . . . 0.0 110.596 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -2.89 56.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.62 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.742 ' O ' HG22 ' A' ' 30' ' ' THR . 0.3 OUTLIER 62.69 26.97 15.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.992 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -170.03 154.95 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.101 0.477 . . . . 0.0 111.099 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 101' ' ' SER . 27.4 t -155.8 145.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.38 120.42 32.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.315 . . . . 0.0 110.805 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -142.05 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -105.6 145.85 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 27' ' ' VAL . 28.5 pt -125.49 142.65 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.702 ' HG3' HG23 ' A' ' 24' ' ' THR . 17.3 tt0 -107.97 129.35 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.401 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 3.4 p90 -153.87 174.42 14.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.188 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.522 ' HB3' HG11 ' A' ' 20' ' ' VAL . 2.3 m-20 -98.5 135.41 40.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.62 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.617 ' O ' HG21 ' A' ' 20' ' ' VAL . 35.1 m -75.47 104.97 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.995 0.426 . . . . 0.0 111.395 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.17 124.45 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' OE2' HG12 ' A' ' 164' ' ' VAL . 1.4 mm-40 -135.62 33.3 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 2.1 t 80.7 91.53 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.297 0.57 . . . . 0.0 110.982 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.815 ' CG1' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -128.28 127.15 67.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.668 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.614 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.7 pp -109.95 97.18 28.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.537 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 88.9 Cg_endo -84.11 159.91 13.47 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.752 2.301 . . . . 0.0 112.691 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.74 27.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.68 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.84 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.7 -40.97 3.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.233 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.402 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -126.86 102.93 7.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 0.0 110.994 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -109.98 119.43 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.487 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -105.59 120.76 42.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.311 . . . . 0.0 110.774 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.815 HG13 ' CG1' ' A' ' 119' ' ' VAL . 4.3 t -99.74 95.52 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -81.49 102.75 10.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -115.6 125.01 29.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 121.37 7.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.403 2.069 . . . . 0.0 111.762 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.82 ' HZ1' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -92.5 159.4 15.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 111.345 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -108.78 -164.88 0.98 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.863 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.17 -38.74 78.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 m -175.57 69.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.232 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.791 HG13 ' HA2' ' A' ' 70' ' ' GLY . 90.3 t -107.3 145.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 145.62 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.956 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.82 HD21 ' HZ1' ' A' ' 132' ' ' LYS . 10.6 mt -105.93 -60.38 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 91.64 19.61 40.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.125 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -98.45 146.86 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.73 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 157' ' ' SER . 27.1 m -126.19 128.41 47.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 1.006 HD12 HG22 ' A' ' 194' ' ' VAL . 7.2 mt -101.87 163.07 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.061 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -144.84 149.12 34.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.1 t -97.48 106.64 34.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.432 ' HG3' HG23 ' A' ' 155' ' ' VAL . 89.9 Cg_endo -81.62 -168.96 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.614 2.209 . . . . 0.0 112.334 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.3 m -72.66 100.44 2.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' A' ' 149' ' ' LYS . 25.4 t -53.02 -82.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.272 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 65.82 35.61 6.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.323 0.582 . . . . 0.0 110.529 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.407 ' CD ' ' O ' ' A' ' 147' ' ' SER . 0.0 OUTLIER 178.96 154.69 0.57 Allowed Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.521 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 62.62 1.72 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.4 2.067 . . . . 0.0 112.218 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.41 -55.05 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.721 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.9 t0 65.59 109.75 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.529 0.204 . . . . 0.0 110.976 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.521 ' O ' HD22 ' A' ' 154' ' ' LEU . 56.2 Cg_endo -70.35 -167.95 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.537 2.158 . . . . 0.0 112.435 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.951 HD12 ' CG2' ' A' ' 142' ' ' ILE . 3.1 mm? -131.15 155.88 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 156' ' ' ILE . 11.9 t -142.22 162.23 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.335 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.513 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.7 mm -89.72 154.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.546 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.666 ' HB3' HG22 ' A' ' 141' ' ' THR . 8.8 t -132.45 -20.93 2.31 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.4 OUTLIER 174.78 136.19 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.861 HG12 HD12 ' A' ' 171' ' ' LEU . 0.7 OUTLIER -123.64 149.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.837 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.408 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -105.78 164.4 11.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -96.86 166.16 11.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.616 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . 91.47 -30.18 6.65 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.988 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 1.6 t -97.95 149.65 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 111.476 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.486 HG12 ' OE2' ' A' ' 117' ' ' GLU . 17.0 m -52.76 -21.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.843 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.716 ' O ' HG22 ' A' ' 168' ' ' THR . . . -51.08 -64.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.412 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 16.5 t60 -83.19 -24.26 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.52 -39.27 67.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.038 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.792 HG21 HG11 ' A' ' 128' ' ' VAL . 2.7 t -56.41 -28.14 58.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.947 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.607 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.633 ' CG2' HG11 ' A' ' 119' ' ' VAL . 66.9 p -57.57 -25.15 59.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.861 HD12 HG12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.58 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.795 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.29 166.61 11.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.973 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.5 mt -92.38 116.65 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.04 29.25 2.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.698 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 138.12 41.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.767 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -90.31 106.17 18.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.775 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.039 HD22 HD11 ' A' ' 180' ' ' ILE . 9.1 mt -70.56 134.9 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.043 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.637 HD22 ' NZ ' ' A' ' 207' ' ' LYS . 7.3 tt -120.18 -51.37 2.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.674 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -128.19 156.54 42.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 1.039 HD11 HD22 ' A' ' 177' ' ' LEU . 28.6 mm -139.59 105.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.081 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.675 ' OD2' HG12 ' A' ' 204' ' ' VAL . 0.4 OUTLIER 68.13 -67.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.038 0.447 . . . . 0.0 110.738 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' ILE . 1.5 m120 -147.99 -24.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.665 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.52 139.69 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.161 0.505 . . . . 0.0 111.199 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 4.1 mtp-105 -102.48 123.7 46.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.803 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.782 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 3.2 mm? -74.89 -5.52 44.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.446 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -45.87 -28.92 1.21 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 m -134.31 42.73 2.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.685 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.29 153.55 38.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -177.53 0.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.458 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.696 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.03 -54.47 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.55 -29.82 18.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.81 -52.15 66.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.25 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.782 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -57.18 -40.59 77.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.191 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 1.006 HG22 HD12 ' A' ' 142' ' ' ILE . 11.9 t -62.31 -39.4 84.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.674 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -46.92 87.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.117 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -72.52 -24.71 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -58.94 -36.14 74.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.848 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 1.0 OUTLIER -104.04 -44.57 4.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.262 -179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.58 -26.02 19.79 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.014 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 196' ' ' ILE . 0.2 OUTLIER -95.43 44.52 1.09 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.394 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 3.2 tt0 -68.76 53.34 0.08 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.241 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.572 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -141.59 -25.93 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.719 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 203' ' ' LEU . 1.3 tt 165.14 112.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.675 HG12 ' OD2' ' A' ' 181' ' ' ASP . 3.5 m -105.26 132.51 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -107.89 107.97 18.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.457 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.28 104.3 15.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.402 . . . . 0.0 111.807 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.674 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 19.6 tttt -97.29 93.69 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.165 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.546 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -106.82 -177.54 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.208 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.42 127.33 44.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -115.97 159.56 21.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.92 50.24 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.622 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -54.91 165.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.344 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.888 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.853 0.359 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -142.95 132.15 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.031 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 115' ' ' VAL . 11.5 p -178.34 159.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.102 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.485 ' N ' HG22 ' A' ' 20' ' ' VAL . 86.5 t60 -76.06 120.7 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.6 p -55.29 174.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.275 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' OE1' HG11 ' A' ' 115' ' ' VAL . 6.5 mt-10 -164.55 140.99 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -107.13 160.31 15.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.439 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -151.12 -178.49 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.29 162.7 15.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG13 HG23 ' A' ' 71' ' ' VAL . 2.2 t -141.93 150.5 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.414 HG13 ' HD3' ' A' ' 106' ' ' LYS . 28.2 t -122.83 112.68 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HG ' HD11 ' A' ' 72' ' ' LEU . 3.5 mt -108.51 118.71 37.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.181 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -107.4 162.27 14.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 111.883 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.89 128.5 45.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.411 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -97.29 147.1 32.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.412 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.63 16.59 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.479 2.119 . . . . 0.0 112.666 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.06 -47.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 t -131.58 -18.92 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 62.17 87.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.278 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.724 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 54.4 m-85 65.62 93.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 109.767 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -74.49 13.96 4.57 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.567 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.981 HG22 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -109.9 133.91 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 117.38 0.59 . . . . 0.0 111.707 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.607 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.3 mt-30 -97.65 128.27 44.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -96.15 155.82 16.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.306 0.574 . . . . 0.0 112.239 -178.272 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.5 169.1 17.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.204 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.74 23.92 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.821 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -122.12 93.63 4.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.537 HG22 HD13 ' A' ' 56' ' ' LEU . 34.8 t -111.08 -78.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.2 p90 -39.87 -44.36 1.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.207 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.524 ' O ' ' HB ' ' A' ' 48' ' ' THR . . . 51.77 73.27 0.33 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.94 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 47' ' ' ALA . 4.3 t 165.87 -166.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.677 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' N ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -46.01 147.93 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.871 179.652 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 66.9 178.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.482 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -142.63 -101.43 0.13 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.362 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.67 16.75 3.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 0.0 111.572 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 1.9 t -62.0 118.41 38.88 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.11 155.29 52.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.31 2.006 . . . . 0.0 111.922 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.759 ' HG2' HD11 ' A' ' 81' ' ' ILE . 45.9 Cg_exo -54.85 123.8 14.65 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.243 1.962 . . . . 0.0 111.952 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD13 HG22 ' A' ' 45' ' ' VAL . 1.1 pt? -136.23 118.03 15.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 111.264 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.981 HG21 HG22 ' A' ' 39' ' ' ILE . 78.2 mt -76.12 141.23 16.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -113.4 -19.64 11.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.727 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.6 t80 -152.22 139.18 19.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.763 ' CD1' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -107.72 177.17 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.731 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 60' ' ' ILE . 40.5 tt0 -117.49 119.09 34.0 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.186 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -57.35 122.31 12.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.182 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 1.6 t0 82.53 42.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.254 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -138.29 154.53 73.89 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.409 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 46.2 Cg_endo -67.72 -1.38 6.65 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.363 2.042 . . . . 0.0 112.8 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -70.97 -56.62 5.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.694 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -78.92 -29.21 44.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.273 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -92.22 -1.66 56.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.668 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -44.75 -30.74 1.01 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.316 . . . . 0.0 111.315 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.75 -50.34 0.89 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 HG13 ' A' ' 27' ' ' VAL . 29.0 m -137.93 53.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.576 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.8 mt -127.68 137.7 52.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -131.85 -179.5 5.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.038 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.24 73.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.99 77.48 0.22 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.457 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' OD2' HD23 ' A' ' 72' ' ' LEU . 5.5 m-20 -103.29 92.42 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -65.18 101.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 55' ' ' PRO . 28.6 m -97.78 149.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -114.57 -30.15 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -132.91 130.24 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.902 HG23 ' CD1' ' A' ' 109' ' ' LEU . 21.9 mt -128.26 116.64 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.42 25.48 3.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.35 -26.13 24.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.582 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 97' ' ' LEU . 50.6 mt -69.82 124.73 91.22 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-O 120.541 0.21 . . . . 0.0 111.134 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.27 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 79' ' ' MET . 33.1 p -143.42 -45.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -68.31 -12.57 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -113.83 44.33 1.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.38 -174.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.867 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 165.4 12.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -73.1 -27.26 61.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -54.92 -41.4 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -34.19 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.731 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -71.43 -32.52 68.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.248 0.547 . . . . 0.0 110.582 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.27 -36.42 63.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.076 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -74.89 -39.63 61.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.382 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.525 HD11 HG21 ' A' ' 81' ' ' ILE . 2.1 pp -67.61 -40.22 84.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.539 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 41' ' ' LEU . 22.4 mt -65.43 -56.03 14.72 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.6 ppt_? -50.7 -31.31 16.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.493 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.8 p30 -112.28 33.22 5.01 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.801 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 97.9 p -100.26 9.39 42.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.4 t -100.02 15.3 27.69 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.6 mt -67.99 -42.09 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.664 0.745 . . . . 0.0 110.504 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.52 11.19 37.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.598 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 30' ' ' THR . 5.8 m 54.53 24.58 5.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.235 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -162.9 154.68 18.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.46 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -155.31 126.86 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.683 ' C ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -99.88 128.4 45.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.902 ' CD1' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -123.68 158.27 31.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -118.18 118.38 31.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.535 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 25' ' ' THR . 5.4 pt -113.34 163.89 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.424 . . . . 0.0 111.685 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -131.62 144.62 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.46 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.36 174.18 15.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.937 0.399 . . . . 0.0 111.343 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.1 114.45 27.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.492 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.562 HG11 ' OE1' ' A' ' 23' ' ' GLU . 17.4 m -61.88 105.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.337 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -176.07 -135.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 116' ' ' ALA . 9.9 pt-20 48.3 30.55 2.31 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 128' ' ' VAL . 14.6 t 176.89 61.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.076 0.465 . . . . 0.0 111.153 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 119' ' ' VAL . 13.1 p -158.66 118.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.295 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.627 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.5 pp -138.31 97.96 9.35 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.791 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.436 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 90.7 Cg_endo -83.27 150.93 13.63 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.75 2.3 . . . . 0.0 112.91 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -153.55 19.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.18 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.75 114.75 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.051 0.453 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.7 -41.18 2.58 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.128 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.605 HG22 ' HG3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -135.12 108.49 7.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -102.76 128.09 49.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.549 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.627 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.3 134.26 52.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.0 110.487 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 2.9 t -118.22 94.79 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.628 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -83.38 97.94 9.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.402 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.919 HD22 ' HB ' ' A' ' 164' ' ' VAL . 26.7 mt -104.3 117.73 58.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.67 95.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.177 1.918 . . . . 0.0 111.371 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -81.55 159.25 24.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.717 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -114.5 -165.95 1.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.654 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -66.08 -43.64 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.85 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.5 m -179.3 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.717 HG23 ' HB2' ' A' ' 133' ' ' LYS . 40.1 t -94.32 159.84 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.509 ' N ' HG12 ' A' ' 136' ' ' VAL . 33.3 tt0 -51.04 113.63 0.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.686 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.769 HD12 HG12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -117.11 112.08 20.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.915 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . -90.45 47.88 3.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.029 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.971 HG23 ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -109.95 137.06 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.599 0.238 . . . . 0.0 110.384 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 157' ' ' SER . 88.1 m -120.78 109.76 15.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.781 0.324 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.909 HD11 HD22 ' A' ' 197' ' ' LEU . 5.4 mt -87.68 164.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.505 ' N ' HG22 ' A' ' 142' ' ' ILE . 31.1 t -157.67 161.01 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.912 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 21.0 p -115.25 107.79 48.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.548 ' HD3' HG22 ' A' ' 155' ' ' VAL . 50.9 Cg_exo -52.8 -176.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.32 97.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.865 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.4 t -59.17 95.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.63 44.79 2.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.43 158.65 0.73 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.834 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.4 70.48 1.92 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.498 2.132 . . . . 0.0 112.236 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -170.14 -60.44 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.604 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.9 t0 61.57 82.14 0.23 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -174.13 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.656 2.237 . . . . 0.0 112.434 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 190' ' ' MET . 1.1 mp -121.84 165.41 15.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 175' ' ' ASP . 22.1 m -158.22 148.08 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.474 HG22 ' CD2' ' A' ' 173' ' ' LEU . 7.7 mt -74.97 150.7 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.373 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.45 ' HB2' HG22 ' A' ' 141' ' ' THR . 24.5 m -136.48 -12.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.17 150.09 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 166' ' ' HIS . 1.1 mt -139.94 145.43 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.198 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.467 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -114.85 154.77 28.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 111.398 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.78 76.65 3.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.69 -36.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.568 ' OG ' HD13 ' A' ' 138' ' ' LEU . 8.4 t -101.81 158.87 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.094 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HB ' HD22 ' A' ' 130' ' ' LEU . 16.8 m -48.88 -22.34 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.096 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.971 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.82 -59.41 2.26 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.65 ' HB2' HG22 ' A' ' 159' ' ' ILE . 42.5 t60 -83.66 -25.2 30.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.862 0.363 . . . . 0.0 110.8 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 164' ' ' VAL . 0.0 OUTLIER -58.4 -29.61 66.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.379 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.85 ' HB ' HD21 ' A' ' 130' ' ' LEU . 3.4 t -55.96 -44.9 78.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.1 -20.41 46.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.836 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.506 HG21 HG23 ' A' ' 119' ' ' VAL . 9.2 t -113.2 37.58 3.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.468 HD21 HG22 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -108.49 41.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.764 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.64 144.45 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD2' HG22 ' A' ' 156' ' ' ILE . 19.2 mt -85.05 108.02 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.82 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.99 -20.28 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 155' ' ' VAL . 1.9 m-20 -63.33 157.79 22.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.671 0.272 . . . . 0.0 110.751 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -108.33 100.91 10.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -69.74 165.93 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 179' ' ' ALA . 2.6 pp -158.25 -40.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.076 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 178' ' ' LEU . . . -125.95 129.88 50.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.892 0.377 . . . . 0.0 111.061 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.991 HD12 ' HB1' ' A' ' 193' ' ' ALA . 46.9 mt -118.68 107.47 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.1 t70 66.05 -72.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.7 -19.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.571 ' HB ' HD13 ' A' ' 196' ' ' ILE . 40.7 mm -96.8 157.13 3.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 120.99 0.424 . . . . 0.0 111.251 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.468 ' N ' HG22 ' A' ' 183' ' ' ILE . 79.2 mtt180 -122.38 132.9 54.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.911 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 1.128 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.4 mm? -67.7 -8.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.558 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -47.56 -28.09 2.12 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.038 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.1 p -144.1 46.78 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.26 160.65 30.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.17 -175.92 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.99 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.843 ' HA ' HD11 ' A' ' 154' ' ' LEU . 8.7 ptm -74.24 -45.59 46.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.419 ' N ' ' HG3' ' A' ' 190' ' ' MET . 1.5 mm-40 -52.05 -50.09 62.18 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.197 0.522 . . . . 0.0 110.89 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -52.12 -45.58 64.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.128 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 1.128 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -56.62 -41.58 77.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.517 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.705 HG22 HD12 ' A' ' 142' ' ' ILE . 10.7 t -60.75 -33.9 56.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 109.82 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -61.92 -50.2 73.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.708 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.3 mt -71.08 -24.93 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -60.98 -37.46 82.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.21 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -92.17 -34.5 14.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.656 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -84.9 11.77 8.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.643 178.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 196' ' ' ILE . 30.0 p -66.1 28.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.503 ' H ' ' C ' ' A' ' 199' ' ' GLN . 1.5 mm-40 46.82 46.45 15.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.73 27.51 16.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.769 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 203' ' ' LEU . 1.6 mt -162.87 94.39 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 204' ' ' VAL . 13.1 p -90.34 123.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 2.9 ttmp? -108.8 107.73 18.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.219 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.612 ' HG ' HD21 ' A' ' 177' ' ' LEU . 10.3 mp -89.35 107.09 18.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.605 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.9 OUTLIER -96.99 100.74 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.759 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.54 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -109.77 173.39 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 8.0 mtp180 -105.06 132.88 50.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.23 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -115.88 159.21 21.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.828 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -176.82 101.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.992 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.89 160.15 3.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.236 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.036 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.91 129.61 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.197 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 116' ' ' ALA . 2.7 m -123.37 170.73 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.163 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -139.72 107.68 5.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.01 133.63 38.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.147 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -148.78 157.73 43.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 112' ' ' GLU . 73.0 p -110.43 144.93 38.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 26' ' ' GLU . 27.4 m -140.57 163.29 33.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' N ' HG22 ' A' ' 25' ' ' THR . 1.2 pm0 -104.63 159.33 15.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 136.18 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' C ' HD12 ' A' ' 29' ' ' LEU . 3.9 p -115.97 122.42 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 28' ' ' VAL . 7.1 mp -115.66 118.99 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.896 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -102.49 162.58 12.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.271 0.558 . . . . 0.0 111.932 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -107.33 103.86 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.441 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -75.02 153.27 86.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.332 179.547 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.4 7.89 3.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.447 2.098 . . . . 0.0 112.675 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.42 -45.29 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.567 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -133.7 -8.59 2.8 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 65.6 -90.48 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.929 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.708 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 3.5 m-85 -131.66 119.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.58 28.27 15.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.361 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.988 HD13 HD13 ' A' ' 72' ' ' LEU . 25.5 pt -126.84 133.35 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -122.36 139.96 53.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.86 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.758 HD12 HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -130.09 157.51 42.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 112.054 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.766 ' HG3' HD13 ' A' ' 56' ' ' LEU . 10.7 pt20 -112.1 170.07 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.204 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.58 17.59 6.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -111.28 67.8 0.65 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.351 0.596 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.005 HG22 HD21 ' A' ' 56' ' ' LEU . 3.4 t -71.43 -35.11 55.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.961 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 45.6 p90 -132.07 -49.59 0.94 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.252 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 42.09 85.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.099 0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 171.0 120.86 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.232 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 58.5 80.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER 85.5 -178.17 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.18 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' H ' HG22 ' A' ' 50' ' ' THR . 1.1 pp -154.82 -147.2 0.2 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.355 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.454 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 2.0 t 81.43 20.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.227 0.537 . . . . 0.0 111.588 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.643 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -47.51 139.13 8.47 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.964 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' HG21 ' A' ' 45' ' ' VAL . 25.0 Cg_endo -61.96 133.33 43.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.551 2.167 . . . . 0.0 112.406 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.49 141.67 25.21 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.513 2.142 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.005 HD21 HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -141.11 115.98 9.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.637 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -66.12 141.35 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.441 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.486 ' C ' HG23 ' A' ' 74' ' ' ILE . 64.0 p -113.69 -26.16 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.519 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB3' ' HG3' ' A' ' 40' ' ' GLN . 56.2 t80 -144.18 154.49 43.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 0.0 111.496 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' A' ' 67' ' ' GLU . 25.7 mm -137.51 151.24 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.718 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.01 148.99 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.209 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.55 44.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.038 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.72 41.5 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.724 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.494 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 17.5 m -136.93 138.49 26.05 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.958 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.4 Cg_endo -56.75 -12.77 9.61 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.79 2.327 . . . . 0.0 113.276 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -65.41 -58.33 6.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 0.0 110.349 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.633 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -80.12 -30.97 39.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.041 178.607 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -57.84 -33.41 68.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.0 t -49.58 -30.44 8.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.006 0.432 . . . . 0.0 110.523 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 137' ' ' GLU . . . 87.95 26.13 29.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.982 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -151.52 29.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 0.0 110.912 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.988 HD13 HD13 ' A' ' 39' ' ' ILE . 6.8 mt -133.55 121.63 22.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -136.01 154.95 50.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.295 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.486 HG23 ' C ' ' A' ' 58' ' ' SER . 54.3 mt -58.14 87.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.233 0.54 . . . . 0.0 111.194 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 132.66 39.55 0.22 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -87.01 132.08 33.9 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.8 102.19 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 109' ' ' LEU . 35.0 t -85.68 121.89 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -29.28 17.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.53 143.51 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 97' ' ' LEU . 1.7 mt -119.39 110.36 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.459 ' OD1' HG13 ' A' ' 107' ' ' VAL . 3.8 m120 59.98 20.13 9.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.73 -33.79 4.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.632 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.4 mt -69.71 116.81 47.21 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 120.45 0.166 . . . . 0.0 111.167 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.53 ' C ' HG23 ' A' ' 86' ' ' THR . 31.2 Cg_endo -63.93 -33.36 63.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.403 2.069 . . . . 0.0 112.049 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.53 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 74.17 0.52 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.66 -20.73 27.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.924 0.392 . . . . 0.0 111.199 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -101.9 44.53 1.01 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 m -179.12 -176.95 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.12 161.97 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -73.28 -29.74 62.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.012 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.18 -31.65 63.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.355 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.37 -53.49 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.765 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -54.85 -42.19 71.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.29 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -65.05 -39.91 93.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -35.42 80.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.922 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.515 HD12 HD12 ' A' ' 81' ' ' ILE . 86.1 mt -57.44 -51.08 70.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 94' ' ' ALA . 3.2 mp -58.81 -45.12 90.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.427 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.21 -38.01 49.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.232 0.539 . . . . 0.0 109.939 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.5 m-20 -122.06 40.86 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.516 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.415 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 54.7 p -94.32 6.74 47.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 p -102.7 15.56 28.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.838 0.351 . . . . 0.0 111.81 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.0 mt -69.24 -47.85 71.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.789 0.804 . . . . 0.0 110.338 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.4 12.11 28.24 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.396 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 14.5 m 52.58 26.13 4.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HD3' HG22 ' A' ' 28' ' ' VAL . 2.2 mmtp -162.83 156.93 20.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.459 HG13 ' OD1' ' A' ' 82' ' ' ASN . 1.4 t -155.9 99.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.696 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 132.49 35.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.618 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -142.12 157.0 45.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.271 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.68 127.85 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.424 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.8 pt -114.19 145.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 111.571 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.531 ' HG3' HG22 ' A' ' 24' ' ' THR . 2.3 tt0 -116.7 115.72 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -132.89 174.12 10.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 0.0 111.274 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.15 131.7 54.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.4 m -66.58 105.69 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.458 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.722 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -170.08 108.43 0.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.88 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.877 ' HB3' HG22 ' A' ' 168' ' ' THR . 2.9 tp10 -133.86 39.47 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.3 t 66.78 89.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.374 0.607 . . . . 0.0 111.286 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.878 HG11 HG21 ' A' ' 170' ' ' THR . 0.0 OUTLIER -125.53 120.3 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.901 179.51 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.616 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.9 pp -102.41 103.81 33.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.338 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 94.0 Cg_endo -85.85 148.21 9.53 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 112.55 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -154.49 22.89 0.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.83 113.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.004 0.431 . . . . 0.0 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.5 -43.86 2.62 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.162 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.01 103.73 7.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 110.995 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -107.65 119.56 39.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.577 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.38 124.1 47.35 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.796 0.332 . . . . 0.0 110.483 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.726 HG13 ' CG1' ' A' ' 119' ' ' VAL . 3.4 t -101.76 90.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.63 98.36 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.293 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 168' ' ' THR . 0.5 OUTLIER -126.68 144.15 48.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 0.0 111.56 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.405 ' HD2' ' HG3' ' A' ' 117' ' ' GLU . 45.1 Cg_endo -68.55 119.68 6.66 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.528 2.152 . . . . 0.0 111.48 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -86.94 153.39 21.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.336 0.588 . . . . 0.0 111.628 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -88.72 -164.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.28 34.96 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.693 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.04 47.99 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.824 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 137' ' ' GLU . 7.4 t -89.84 -121.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 1.1 tt0 -90.72 102.62 15.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 122.1 -0.375 . . . . 0.0 111.442 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 138' ' ' LEU . 10.7 tp -122.63 95.24 4.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.88 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -86.1 45.37 3.46 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.2 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.52 HD11 ' HB2' ' A' ' 165' ' ' ALA . 62.5 mt -92.81 123.61 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 157' ' ' SER . 97.8 m -110.41 101.81 10.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.767 ' CG2' HD12 ' A' ' 154' ' ' LEU . 3.0 mt -91.8 163.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.52 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.509 ' N ' HG22 ' A' ' 142' ' ' ILE . 3.2 t -176.22 176.66 1.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.021 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 t -129.38 129.43 23.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.809 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.58 -62.06 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.491 2.127 . . . . 0.0 112.237 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.0 p -133.99 122.08 22.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -106.28 51.48 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -134.74 55.55 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.159 0.504 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.54 157.86 0.44 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.62 82.81 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.612 2.208 . . . . 0.0 112.306 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 173.81 -68.03 0.1 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 42.43 82.87 0.22 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.858 0.361 . . . . 0.0 111.554 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.09 -167.32 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.586 2.191 . . . . 0.0 112.333 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.767 HD12 ' CG2' ' A' ' 142' ' ' ILE . 2.6 mm? -126.94 149.88 49.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 175' ' ' ASP . 34.0 m -154.01 156.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.286 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 172' ' ' GLU . 1.7 mp -87.3 152.57 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.768 ' HB2' HG22 ' A' ' 141' ' ' THR . 1.6 m -130.95 -19.03 2.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.922 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.433 ' N ' ' HB ' ' A' ' 141' ' ' THR . 28.6 t70 -177.8 143.66 0.34 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -136.77 131.82 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.566 ' HG3' ' H ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -63.59 130.59 44.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 0.9 5.92 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.566 ' H ' ' HG3' ' A' ' 160' ' ' LYS . . . -124.35 0.15 8.78 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.868 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.426 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 4.6 t -95.11 145.97 24.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 168' ' ' THR . 4.3 m -48.89 -25.87 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.765 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -53.62 -69.46 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 8.8 t-160 -64.53 -25.66 68.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -56.7 -39.85 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 110.926 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.877 HG22 ' HB3' ' A' ' 117' ' ' GLU . 17.1 p -49.0 -27.75 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.323 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 71.04 1.06 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.878 HG21 HG11 ' A' ' 119' ' ' VAL . 0.1 OUTLIER 176.51 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.863 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 tp -66.45 74.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.441 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -87.91 -170.87 3.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.25 119.97 40.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.78 20.5 4.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.82 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.558 ' O ' HG12 ' A' ' 155' ' ' VAL . 2.0 m-20 -106.98 173.66 6.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.653 0.226 . . . . 0.0 110.459 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.34 142.63 47.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 111.177 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.946 ' CD2' HD11 ' A' ' 180' ' ' ILE . 1.2 tp -101.96 138.63 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.581 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.46 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.364 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.707 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -146.96 165.45 29.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.011 0.434 . . . . 0.0 111.541 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.946 HD11 ' CD2' ' A' ' 177' ' ' LEU . 25.5 mm -139.61 107.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.182 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER 64.98 -73.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.39 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -134.59 -25.24 1.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 184' ' ' ARG . 46.4 mm -87.59 157.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.707 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 8.2 mtp180 -123.57 124.54 43.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 112.113 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.0 mm? -78.94 -4.62 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -45.33 -29.39 1.03 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 m -141.7 51.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.792 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.48 159.31 37.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.45 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -68.29 175.95 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' MET . . . . . 0.677 ' HB2' HD11 ' A' ' 154' ' ' LEU . 25.8 ptm -74.11 -41.86 60.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.988 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 190' ' ' MET . 0.7 OUTLIER -53.81 -29.98 42.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.99 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.8 OUTLIER -61.58 -52.49 64.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.093 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.667 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -56.24 -39.49 72.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.209 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 142' ' ' ILE . 18.4 t -61.61 -39.9 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.673 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -50.33 74.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.124 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.6 mt -69.79 -24.92 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -58.59 -35.48 72.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.588 179.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.29 -40.74 7.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.733 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -22.98 41.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.714 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' CYS . . . . . 0.71 ' CB ' HG22 ' A' ' 204' ' ' VAL . 2.0 m -91.16 42.68 1.11 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.72 62.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.353 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -171.91 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.543 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 203' ' ' LEU . 3.2 tt 175.13 110.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.71 HG22 ' CB ' ' A' ' 200' ' ' CYS . 98.9 t -108.18 138.81 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.477 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 7.3 tttt -109.12 108.03 18.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 7.1 mp -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 111.412 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.583 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 2.9 tttt -92.73 93.17 8.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.298 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.473 HD13 HD12 ' A' ' 177' ' ' LEU . 6.6 mm -90.71 163.39 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.015 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 5.7 mtp-105 -107.98 120.72 43.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 150.53 21.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.63 84.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.798 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -57.18 170.42 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.082 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 21' ' ' HIS . 20.3 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.792 0.33 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.2 t60 -131.03 98.61 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.408 HG23 ' OD1' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -60.67 119.65 8.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.931 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.1 156.55 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.16 161.29 16.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -149.63 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -122.6 163.1 20.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.58 135.68 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.76 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 28' ' ' VAL . 8.8 p -108.66 122.89 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.525 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 39' ' ' ILE . 31.9 mt -120.07 118.66 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.95 162.12 14.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.601 -179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.898 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.48 140.3 32.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.123 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.73 154.69 37.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.701 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.97 11.16 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.611 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.0 t -114.32 -46.98 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 t -144.64 8.77 1.33 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.21 -117.29 7.77 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.46 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 3.6 m-85 -103.77 128.92 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.424 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -92.47 27.34 10.82 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.305 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 29' ' ' LEU . 3.3 mt -94.08 157.61 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.359 0.6 . . . . 0.0 111.779 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.494 ' N ' HG22 ' A' ' 39' ' ' ILE . 4.2 mt-30 -137.85 104.99 5.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.826 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.829 HD22 HD12 ' A' ' 98' ' ' LEU . 1.1 tp -95.69 144.7 25.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.272 0.558 . . . . 0.0 112.403 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -114.68 151.56 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.25 88.35 0.88 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.135 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.81 104.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.599 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.904 HG23 HD11 ' A' ' 56' ' ' LEU . 13.4 t -76.21 -65.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.549 0.69 . . . . 0.0 109.913 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 21.3 p90 -33.03 -43.75 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.037 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.61 88.65 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.933 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 49' ' ' GLU . 0.9 OUTLIER 170.08 114.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.682 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 48' ' ' THR . 11.5 pt-20 47.09 108.16 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.92 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 49' ' ' GLU . 1.4 p 67.25 -162.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.635 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.5 mt -129.0 -72.89 0.59 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.499 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.7 t 63.69 8.83 3.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.465 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.518 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.1 m -175.63 58.76 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.569 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.608 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 8.0 Cg_exo -67.65 -59.0 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.063 1.842 . . . . 0.0 112.787 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.697 ' HB2' HD21 ' A' ' 41' ' ' LEU . 59.2 Cg_endo -99.82 108.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.919 2.413 . . . . 0.0 112.694 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 45' ' ' VAL . 1.9 pt? -143.89 127.39 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.549 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.675 HD13 HG23 ' A' ' 39' ' ' ILE . 37.6 mt -67.66 136.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.057 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.95 -6.23 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.612 ' HA ' HD12 ' A' ' 74' ' ' ILE . 33.8 t80 -178.02 138.39 0.2 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.043 0.449 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.727 HG21 ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -102.07 -167.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 60' ' ' ILE . 51.7 tt0 -129.14 151.73 49.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.355 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -82.81 114.72 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.411 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 2.9 t70 91.73 39.55 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.534 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 2.5 p -132.92 143.96 50.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.35 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 69' ' ' CYS . 31.5 Cg_exo -58.61 -2.92 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.465 2.11 . . . . 0.0 112.953 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -63.68 -56.89 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.727 ' HG2' HG21 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -78.51 -28.66 46.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.617 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 4.1 mmt-85 -85.49 -1.55 57.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.277 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.533 ' SG ' HD23 ' A' ' 72' ' ' LEU . 31.3 p -58.64 -40.94 84.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 137' ' ' GLU . . . 149.18 -23.75 1.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.96 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.4 p -175.05 84.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' SG ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -134.69 123.4 23.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.726 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.26 159.59 34.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.963 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 59' ' ' TYR . 22.5 mm -61.12 106.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.275 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.74 45.88 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.496 ' OD1' HG21 ' A' ' 111' ' ' ILE . 1.1 t70 -70.88 101.36 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -70.73 66.06 0.34 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.013 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.757 HG12 HD13 ' A' ' 109' ' ' LEU . 34.3 m -64.85 129.85 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.59 -29.6 11.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.23 148.7 31.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.404 . . . . 0.0 111.608 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.461 HD12 HD12 ' A' ' 97' ' ' LEU . 6.7 mt -130.24 112.41 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.769 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 62.25 21.84 12.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.025 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.76 16.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.679 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.2 mt -74.32 136.24 75.51 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 120.537 0.208 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 -170.7 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.514 2.143 . . . . 0.0 112.232 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.6 p -150.76 -60.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -64.83 -16.62 63.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.376 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -106.35 43.9 1.1 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.652 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.47 -175.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -71.41 149.06 46.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.465 ' CB ' ' HB3' ' A' ' 54' ' ' PRO . 9.0 p90 -73.42 -33.64 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -54.92 -42.53 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.953 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 pt-20 -61.17 -39.27 89.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.498 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.61 94.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.232 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.501 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -61.36 -39.55 91.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.791 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.402 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 2.1 mm-40 -62.49 -39.81 94.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.484 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.461 HD12 HD12 ' A' ' 81' ' ' ILE . 14.8 mt -57.05 -49.98 74.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.829 HD12 HD22 ' A' ' 41' ' ' LEU . 7.1 mt -60.46 -58.77 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 49.8 mtt180 -50.28 -29.84 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 109.94 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.548 ' O ' HD11 ' A' ' 103' ' ' ILE . 3.6 m-20 -114.89 33.15 5.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.845 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.664 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.8 45.27 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.865 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -142.75 16.82 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.548 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.8 mp -65.4 -45.24 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.552 0.691 . . . . 0.0 110.901 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.23 11.89 38.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.495 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.8 ' O ' HG22 ' A' ' 30' ' ' THR . 20.5 t 57.92 25.31 11.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.033 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 1.5 ttpt -165.88 145.46 6.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.744 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.512 HG11 ' OG ' ' A' ' 101' ' ' SER . 2.7 t -141.73 135.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.559 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.757 HD13 HG12 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -139.1 165.12 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.391 . . . . 0.0 111.335 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -118.14 141.04 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 78' ' ' VAL . 30.4 pt -133.15 159.12 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -123.14 143.0 50.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.527 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.44 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 1.2 p90 -161.11 174.29 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.281 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' OD1' HG23 ' A' ' 22' ' ' THR . 3.1 m-20 -102.95 149.6 24.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.376 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.7 m -97.98 104.8 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -179.68 -147.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.1 12.52 2.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.822 0.344 . . . . 0.0 110.811 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.6 t -178.8 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.665 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.412 HG22 ' CG2' ' A' ' 170' ' ' THR . 41.3 t -156.29 117.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.478 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 1.039 HG23 ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -157.24 84.53 2.91 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-O 121.233 0.539 . . . . 0.0 111.084 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 65.1 Cg_endo -94.65 -169.49 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.299 2.666 . . . . 0.0 112.636 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -178.49 34.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.745 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 58.9 114.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.89 -39.48 2.87 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.309 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.706 HG22 ' HG3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.9 113.43 12.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -103.57 126.29 50.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.653 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 1.039 ' HB2' HG23 ' A' ' 120' ' ' ILE . 7.3 m80 -101.58 135.26 43.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.756 HG12 HD13 ' A' ' 130' ' ' LEU . 14.6 t -137.82 86.59 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.748 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -81.51 106.21 13.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.38 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.792 HD11 ' HB ' ' A' ' 168' ' ' THR . 2.8 mp -109.11 132.22 21.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.372 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 108.45 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.159 1.906 . . . . 0.0 111.057 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.1 OUTLIER -86.64 158.62 19.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.477 . . . . 0.0 111.471 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.428 ' HG3' ' CG2' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -128.36 -174.93 3.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.167 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -56.36 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.5 m -153.94 74.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 137' ' ' GLU . 95.5 t -113.37 156.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' HG12 ' A' ' 136' ' ' VAL . 36.7 tt0 -56.45 110.44 0.78 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.437 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 140' ' ' ILE . 2.8 mt -96.61 -52.89 3.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.357 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . 93.57 9.03 60.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.799 HD12 HD13 ' A' ' 138' ' ' LEU . 21.2 mt -79.38 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.841 0.321 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 157' ' ' SER . 39.7 m -116.19 128.7 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.924 0.392 . . . . 0.0 110.199 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.898 HG23 HD11 ' A' ' 154' ' ' LEU . 9.0 mt -103.17 164.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.585 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.551 ' N ' HG22 ' A' ' 142' ' ' ILE . 45.9 p -163.57 152.9 14.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.265 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p -122.57 139.55 31.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 C--N 1.345 0.39 0 C-N-CA 122.494 2.129 . . . . 0.0 112.416 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.646 0.26 . . . . 0.0 111.03 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.69 149.97 30.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.976 2.45 . . . . 0.0 112.779 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.898 HD11 HG23 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -76.64 144.13 39.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.84 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.482 ' N ' HD13 ' A' ' 154' ' ' LEU . 5.1 t -129.18 142.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.975 0.416 . . . . 0.0 111.941 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.52 150.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.218 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.751 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.5 OUTLIER -124.94 -20.9 4.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 111.723 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 177.71 153.39 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 0.0 111.168 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -140.1 125.6 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.453 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -80.63 154.07 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -74.81 -178.93 3.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.521 ' C ' HG21 ' A' ' 71' ' ' VAL . . . 72.01 -61.42 1.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.724 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.492 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.9 OUTLIER -56.67 161.72 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.969 0.414 . . . . 0.0 111.274 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.68 ' O ' HD21 ' A' ' 130' ' ' LEU . 5.5 m -69.42 -20.92 24.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.77 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.794 ' O ' HG22 ' A' ' 168' ' ' THR . . . -47.71 -70.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 33.6 t60 -76.48 -23.92 53.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.23 -44.68 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.307 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 165' ' ' ALA . 3.2 t -52.48 -25.85 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.54 48.91 81.98 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.412 ' CG2' HG22 ' A' ' 119' ' ' VAL . 35.2 p -137.95 -44.33 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 0.0 111.083 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 206' ' ' LEU . 3.6 mp -59.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.24 139.44 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.24 119.89 16.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.19 18.47 5.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.681 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.421 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.5 OUTLIER -114.31 -177.25 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.695 0.283 . . . . 0.0 110.738 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -132.38 161.54 33.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 154' ' ' LEU . 1.7 mp -124.54 170.9 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -139.56 -39.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.223 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -139.44 142.36 37.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.572 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.674 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 46.7 mt -127.48 111.57 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.881 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.0 t70 66.3 -70.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.096 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -144.92 -20.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.602 ' HB ' HG21 ' A' ' 196' ' ' ILE . 23.1 mm -98.0 156.95 3.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.17 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 38.1 mtt85 -116.18 139.3 50.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 112.241 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.932 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.9 mm? -70.86 -2.89 16.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.628 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.52 -27.91 1.99 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.094 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m -75.17 -18.93 60.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 111.299 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 152' ' ' ASP . 4.5 m 76.02 102.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.49 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 192' ' ' ASP . 1.4 m 168.58 95.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.543 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.1 ptm -53.82 -41.56 67.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.265 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.4 mm-40 -55.63 -39.29 70.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.987 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.657 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -55.65 -52.07 65.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.061 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -53.7 -36.4 62.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.834 HG22 ' CD1' ' A' ' 142' ' ' ILE . 11.8 t -66.42 -32.68 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.605 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 191' ' ' GLU . 3.0 mm-40 -76.02 -45.06 36.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.66 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.7 mt -73.43 -31.17 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.605 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.792 HD21 HD11 ' A' ' 142' ' ' ILE . 1.6 pp -78.39 -24.73 46.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.692 ' NE2' HG12 ' A' ' 194' ' ' VAL . 27.3 mt-30 -88.01 -45.55 10.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.059 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -20.56 63.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.365 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' A' ' 204' ' ' VAL . 27.6 p -88.41 45.99 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.285 0.564 . . . . 0.0 109.784 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -68.12 60.66 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.782 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -169.27 -33.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.4 tt -175.01 105.02 0.09 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.776 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.572 HG23 ' SG ' ' A' ' 200' ' ' CYS . 9.8 p -96.14 126.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -100.73 107.82 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.579 ' CD2' HD21 ' A' ' 171' ' ' LEU . 3.6 mp -94.79 113.77 25.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.0 111.408 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.1 OUTLIER -101.1 93.5 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 208' ' ' ILE . 1.4 mm -83.32 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.888 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.504 ' H ' HG22 ' A' ' 208' ' ' ILE . 15.7 mmt180 -118.44 128.18 54.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.001 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.24 151.32 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.934 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.741 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 114' ' ' ASP . 18.0 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.903 0.383 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -105.28 105.78 15.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -54.55 158.41 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -146.97 153.16 39.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.706 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -109.76 136.31 49.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 t -126.66 174.96 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -103.84 157.77 16.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.75 147.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.28 109.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 29' ' ' LEU . 3.9 mt -101.26 118.61 37.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.212 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.42 161.78 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 111.674 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -93.97 172.57 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.051 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -163.22 140.76 6.0 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.347 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.86 19.09 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.464 2.11 . . . . 0.0 112.739 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 35' ' ' THR . 62.2 t -129.82 -51.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 34' ' ' VAL . 20.5 p -156.81 36.22 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.778 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.32 127.07 7.88 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.711 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 24.5 m-85 63.55 71.69 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.45 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -83.31 21.79 8.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.146 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.982 HG23 HD13 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -111.79 133.2 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.458 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 6.4 mt-30 -97.92 126.88 43.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.049 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -96.03 141.52 29.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.122 0.487 . . . . 0.0 111.82 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.67 165.63 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.357 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.81 -111.11 0.11 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.532 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 90.8 p -115.53 104.2 11.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.846 0.355 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.896 HG23 HD13 ' A' ' 56' ' ' LEU . 59.5 t -46.38 -78.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 15.5 p90 -40.65 -51.75 2.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.75 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 44' ' ' SER . . . 38.22 93.17 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.052 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.662 ' O ' HG22 ' A' ' 50' ' ' THR . 0.1 OUTLIER 175.55 110.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.471 ' C ' HG22 ' A' ' 50' ' ' THR . 6.4 pt-20 49.45 36.8 10.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.331 0.586 . . . . 0.0 110.324 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER 166.81 177.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.307 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 51' ' ' LEU . 2.4 pp -176.71 33.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -63.09 29.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.711 ' HB3' HD11 ' A' ' 56' ' ' LEU . 1.8 t -147.25 73.05 12.01 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-O 120.844 0.354 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HB3' ' HA ' ' A' ' 91' ' ' PHE . 20.9 Cg_exo -63.46 -53.07 1.56 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.544 2.163 . . . . 0.0 113.169 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.619 ' HA ' HD23 ' A' ' 41' ' ' LEU . 57.2 Cg_endo -96.14 102.44 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.827 2.351 . . . . 0.0 113.039 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.896 HD13 HG23 ' A' ' 45' ' ' VAL . 27.8 mt -131.71 85.21 2.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.714 HD13 ' HB ' ' A' ' 39' ' ' ILE . 85.7 mt -58.58 136.64 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.5 p -120.97 -8.43 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 91.3 t80 -144.47 150.52 37.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.302 0.572 . . . . 0.0 112.322 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.982 HD13 HG23 ' A' ' 39' ' ' ILE . 1.7 mm -123.4 152.7 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.266 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 72.8 tt0 -104.47 106.6 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.884 0.373 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -63.45 116.51 5.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 12.4 t0 95.24 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.191 0.519 . . . . 0.0 110.558 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.537 ' H ' ' CZ ' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -139.71 -173.85 0.38 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 64.6 Cg_endo -95.01 -6.73 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.451 2.101 . . . . 0.0 113.535 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 38' ' ' GLY . . . -74.7 -58.0 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' H ' ' NH2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -77.03 -29.03 55.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.961 0.41 . . . . 0.0 110.447 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.537 ' CZ ' ' H ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -93.36 -7.33 45.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.781 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -41.89 -42.46 2.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.015 0.436 . . . . 0.0 111.263 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.39 -22.77 0.75 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.532 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.2 p -173.07 82.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -134.56 159.04 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.992 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.87 143.01 7.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.679 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.5 mt -55.2 132.31 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.35 16.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.893 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.725 ' HB3' HG21 ' A' ' 111' ' ' ILE . 50.7 m-20 -55.58 -43.8 76.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.707 0.289 . . . . 0.0 111.255 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 75.56 72.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 109' ' ' LEU . 86.1 t -71.13 152.69 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.296 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.615 ' HE2' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -121.21 -27.78 4.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB2' ' HE2' ' A' ' 79' ' ' MET . . . -155.13 134.76 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.935 HD13 HD11 ' A' ' 97' ' ' LEU . 2.1 mp -114.79 109.62 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 52.94 24.07 3.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.123 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.34 -35.74 4.11 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.496 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.03 117.59 37.65 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 120.526 0.203 . . . . 0.0 111.315 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.09 171.65 9.82 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.405 2.07 . . . . 0.0 112.248 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 p -143.97 -45.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.9 -16.35 58.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.515 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -129.91 52.75 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -177.22 166.81 2.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.43 140.03 56.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 5.4 p90 -73.58 -29.74 62.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 mm-40 -54.55 -43.78 72.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -61.23 -37.0 81.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.759 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.7 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -64.98 -34.36 78.24 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.295 0.569 . . . . 0.0 110.528 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.546 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.9 m120 -67.06 -39.51 86.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.345 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 8.7 mm-40 -64.27 -55.98 17.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.935 HD11 HD13 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -52.16 -43.67 64.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.049 HD13 HD13 ' A' ' 41' ' ' LEU . 12.7 mt -59.57 -59.99 4.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.473 0.178 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 61.3 mtt180 -50.23 -29.78 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.394 0.616 . . . . 0.0 109.602 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.674 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -113.5 33.69 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.21 179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -104.77 21.08 17.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.979 179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 m -110.46 18.0 20.23 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.674 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -68.13 -47.73 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.561 0.696 . . . . 0.0 110.948 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 6.94 37.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.684 ' O ' HG22 ' A' ' 30' ' ' THR . 8.3 m 59.14 25.94 14.56 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.113 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.64 153.69 2.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.264 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -149.58 146.03 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 124.54 51.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.723 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.9 OUTLIER -131.21 154.8 48.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.491 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.59 123.14 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.918 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.725 HG21 ' HB3' ' A' ' 76' ' ' ASP . 33.0 pt -114.71 148.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 111.904 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.19 145.15 45.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.47 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.11 174.34 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 0.0 111.141 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.715 ' HB2' HG11 ' A' ' 20' ' ' VAL . 2.7 p-10 -96.62 147.01 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.481 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' A' ' 167' ' ' ARG . 2.8 m -99.58 107.37 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.21 124.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 118' ' ' SER . 12.5 mm-40 -127.36 10.54 6.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.643 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.2 75.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.342 0.591 . . . . 0.0 111.366 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 128' ' ' VAL . 15.9 m -97.82 148.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.737 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.8 pp -126.75 92.25 45.25 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 63.3 Cg_endo -95.32 -165.57 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.318 2.679 . . . . 0.0 112.876 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.0 t 177.95 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 3.0 p 168.56 116.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.199 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.28 -40.68 2.7 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.204 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.8 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.41 104.3 7.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 1.9 t80 -100.34 115.79 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.759 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.737 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -91.75 134.25 34.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.293 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.883 ' HA ' HG12 ' A' ' 119' ' ' VAL . 3.2 t -117.49 82.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -80.87 102.26 9.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.662 HD22 HG21 ' A' ' 168' ' ' THR . 0.8 OUTLIER -129.1 144.71 53.73 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.135 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.44 135.73 22.74 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.428 2.085 . . . . 0.0 112.059 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 200' ' ' CYS . 0.1 OUTLIER -107.8 159.23 16.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.059 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.515 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -106.66 -171.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.583 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -66.82 -76.11 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.254 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.4 m -149.74 70.72 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 137' ' ' GLU . 42.3 t -122.02 159.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.772 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' HG12 ' A' ' 136' ' ' VAL . 32.8 tt0 -50.71 103.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.179 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.86 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -61.8 -45.43 93.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.401 ' CA ' ' HB3' ' A' ' 160' ' ' LYS . . . 94.24 -0.38 66.18 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.977 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.86 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -108.46 141.36 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.086 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 55.9 m -126.07 131.89 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.519 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.054 HD13 HG22 ' A' ' 194' ' ' VAL . 1.3 mt -98.1 163.31 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.79 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.491 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -158.97 149.46 19.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.3 p -112.47 132.39 22.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo . . . . . 0 C--N 1.345 0.372 0 C-N-CA 122.455 2.103 . . . . 0.0 112.317 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.02 174.78 11.43 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.425 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.848 HD11 ' HA ' ' A' ' 190' ' ' MET . 4.4 mm? -91.97 169.96 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.433 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 175' ' ' ASP . 20.1 m -150.56 149.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.0 111.525 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.6 mt -67.72 146.58 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.632 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.38 -8.51 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.23 143.08 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.01 0.433 . . . . 0.0 111.46 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.2 mt -132.7 149.32 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.628 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.401 ' HB3' ' CA ' ' A' ' 139' ' ' GLY . 1.5 tttm -124.2 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -80.91 151.94 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.456 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.41 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . 86.75 -16.45 46.17 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.898 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 1.1 m -96.45 136.96 36.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.438 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.7 m -48.2 -22.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.255 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -55.77 -50.12 71.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.403 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.442 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 2.0 t60 -83.88 -26.65 29.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HA ' HG12 ' A' ' 115' ' ' VAL . 14.2 mmp_? -56.57 -50.04 73.08 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.662 HG21 HD22 ' A' ' 130' ' ' LEU . 6.5 t -53.1 -25.36 12.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 170' ' ' THR . . . 77.81 -162.73 50.61 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.548 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 169' ' ' GLY . 14.4 t 44.78 31.53 0.67 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.843 0.354 . . . . 0.0 111.403 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.47 98.49 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.44 149.71 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.7 138.62 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.74 -17.35 33.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.689 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.58 ' CG ' HG21 ' A' ' 208' ' ' ILE . 0.8 OUTLIER -74.92 166.39 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 110.651 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -117.91 122.88 44.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.78 HD23 HD11 ' A' ' 180' ' ' ILE . 2.6 mp -82.66 138.73 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.769 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.03 -66.49 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.076 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.869 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -121.36 161.82 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.78 HD11 HD23 ' A' ' 177' ' ' LEU . 33.8 mm -139.74 105.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 2.8 t0 63.82 -71.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 180' ' ' ILE . 2.6 t-20 -138.59 -23.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.629 ' HB ' HG21 ' A' ' 196' ' ' ILE . 26.1 mm -94.23 138.51 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 111.296 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.51 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 65.8 mtt180 -102.07 119.97 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.969 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -72.16 -13.87 61.67 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.133 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.21 -29.99 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.507 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.9 m -127.43 -4.37 6.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.508 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.43 148.85 22.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -176.51 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.848 ' HA ' HD11 ' A' ' 154' ' ' LEU . 1.4 ttt -68.46 -57.27 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.829 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -55.29 -32.02 62.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.64 -48.49 80.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.068 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.718 ' HB2' HD13 ' A' ' 185' ' ' LEU . . . -57.29 -41.11 79.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.378 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 1.054 HG22 HD13 ' A' ' 142' ' ' ILE . 11.7 t -62.76 -32.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.05 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -45.91 85.97 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.877 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -69.98 -24.35 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.523 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 142' ' ' ILE . 0.0 OUTLIER -68.43 -35.83 78.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.533 ' NE2' HG12 ' A' ' 194' ' ' VAL . 14.9 mt-30 -89.43 -49.81 6.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.508 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.55 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -58.18 -15.89 11.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.557 ' CB ' HG13 ' A' ' 204' ' ' VAL . 8.4 m -89.42 32.53 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.23 65.72 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.406 0.622 . . . . 0.0 111.418 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -172.3 -29.91 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.672 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 203' ' ' LEU . 2.8 tt 171.84 111.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.768 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.557 HG13 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.72 128.8 64.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.204 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 1.7 ttmt -107.85 107.68 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.776 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 128' ' ' VAL . 5.4 mp -90.55 119.67 31.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.001 0.429 . . . . 0.0 111.662 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.869 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -98.01 93.84 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.092 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.58 HG21 ' CG ' ' A' ' 175' ' ' ASP . 3.9 mm -82.33 163.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.364 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -106.45 118.02 35.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.831 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 124' ' ' GLY . 25.5 mttt -129.58 114.54 16.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.858 0.361 . . . . 0.0 111.42 -179.915 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.878 0.371 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -114.26 113.35 24.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -52.0 140.06 21.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -135.28 159.99 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.0 p -110.03 136.22 49.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.581 HG23 ' HB3' ' A' ' 161' ' ' LYS . 4.2 m -132.54 169.6 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.855 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' H ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.67 160.59 14.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.948 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.8 HG13 HG23 ' A' ' 71' ' ' VAL . 1.8 t -147.27 148.22 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -127.14 110.0 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.751 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.731 HD12 HD21 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -106.83 120.62 42.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -113.26 160.48 18.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 111.43 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.705 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -90.4 132.02 35.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.849 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.87 148.93 36.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.567 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.67 14.57 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.552 2.168 . . . . 0.0 112.567 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.0 -48.97 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.48 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.65 -17.29 4.11 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 71.69 74.61 0.72 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.705 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 79.5 m-85 83.58 -25.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.113 0.565 . . . . 0.0 110.873 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 59.61 14.95 30.96 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 114.412 0.525 . . . . 0.0 114.412 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.104 ' CG2' HD13 ' A' ' 60' ' ' ILE . 1.1 pp -133.98 144.44 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 117.796 0.798 . . . . 0.0 112.676 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -106.8 129.01 54.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.748 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.938 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -95.75 115.98 28.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.883 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.866 ' HB3' HD12 ' A' ' 56' ' ' LEU . 4.0 tt0 -70.13 157.24 37.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.299 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.6 106.36 2.51 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.106 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.6 p 52.5 -170.79 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.595 0.236 . . . . 0.0 110.46 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' PHE . 58.4 t -144.45 -96.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.708 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 53' ' ' SER . 40.7 p90 -45.79 -52.11 11.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 45.35 78.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 15.9 p -153.7 96.68 2.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.073 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.6 pt-20 54.66 118.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.736 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 28.1 m 75.1 -12.13 0.99 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.601 ' O ' ' CB ' ' A' ' 52' ' ' SER . 0.8 OUTLIER 33.56 -129.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.289 0.236 . . . . 0.0 111.464 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 7.7 t 104.84 4.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.401 0.68 . . . . 0.0 110.263 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.505 ' CB ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -76.51 110.13 10.62 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.012 178.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 52' ' ' SER . 96.0 Cg_endo -78.93 160.34 27.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.344 2.03 . . . . 0.0 112.714 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 10.2 Cg_endo -53.34 147.88 35.05 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.694 2.263 . . . . 0.0 111.357 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.866 HD12 ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -156.85 123.9 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.812 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 59' ' ' TYR . 68.7 mt -60.71 130.79 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -109.93 10.67 24.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.424 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.581 ' O ' HG22 ' A' ' 39' ' ' ILE . 35.6 t80 -167.2 134.09 2.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.914 0.387 . . . . 0.0 111.712 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.104 HD13 ' CG2' ' A' ' 39' ' ' ILE . 4.1 mm -121.04 141.92 39.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.198 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -95.22 155.04 16.9 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.833 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.62 44.79 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.31 45.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.868 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -137.81 140.5 29.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 64' ' ' SER . 44.3 Cg_exo -56.68 -12.13 8.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.618 2.212 . . . . 0.0 113.221 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.793 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -66.69 -57.85 6.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.446 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.24 -30.19 43.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.888 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.441 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -71.84 -18.13 62.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.758 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 51.4 t -48.15 -50.61 28.16 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.749 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' HA3' ' HB3' ' A' ' 137' ' ' GLU . . . 127.62 -4.29 7.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.441 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.8 HG23 HG13 ' A' ' 27' ' ' VAL . 27.3 m -152.21 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.164 0.482 . . . . 0.0 111.613 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 66' ' ' ALA . 6.9 mt -135.27 142.38 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.019 0.438 . . . . 0.0 111.198 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.52 -175.47 4.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.646 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.645 HD13 ' CG1' ' A' ' 60' ' ' ILE . 29.4 mm -69.62 67.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.33 71.79 0.22 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.762 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.733 ' OD2' HD23 ' A' ' 72' ' ' LEU . 4.2 t0 -97.14 111.18 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.5 mpt_? -68.76 144.03 54.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.909 ' CG1' HD13 ' A' ' 109' ' ' LEU . 9.4 m -126.6 133.62 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.16 -24.95 15.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.13 133.63 12.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.108 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 97' ' ' LEU . 24.6 mt -122.56 114.86 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.811 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 53.02 24.02 3.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.106 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.52 15.69 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.621 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.47 131.06 88.46 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 120.438 0.161 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 86' ' ' THR . 31.9 Cg_exo -58.16 -157.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.498 2.132 . . . . 0.0 112.045 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 85' ' ' PRO . 22.7 p -158.79 -67.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.054 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -69.88 -11.64 61.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.461 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.07 42.15 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.978 0.418 . . . . 0.0 110.765 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.07 176.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.771 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 1.4 m -70.41 121.6 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -49.63 -28.39 5.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -54.73 -36.65 64.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.185 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 90' ' ' THR . 1.6 pp20? -61.66 -41.16 97.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HA ' HD11 ' A' ' 97' ' ' LEU . . . -63.02 -37.5 87.44 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.52 0.676 . . . . 0.0 109.868 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.9 OUTLIER -61.78 -41.07 97.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.102 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.86 -56.49 16.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.571 HD11 HD12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -53.75 -30.16 43.02 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.938 HD13 HD13 ' A' ' 41' ' ' LEU . 48.7 mt -76.21 -48.06 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.207 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 6.3 mtt85 -50.1 -31.06 12.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.8 p30 -120.54 38.34 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.352 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.12 34.13 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.187 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -131.77 13.4 4.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.839 0.352 . . . . 0.0 111.802 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.43 -46.28 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.753 0.787 . . . . 0.0 110.403 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -2.11 56.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.549 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.806 ' O ' HG22 ' A' ' 30' ' ' THR . 9.5 p 62.39 25.69 15.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -167.59 153.48 7.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.071 0.462 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 101' ' ' SER . 25.1 t -154.71 137.53 7.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.75 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.15 123.66 49.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.744 0.307 . . . . 0.0 110.482 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.909 HD13 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -140.49 153.76 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.903 0.382 . . . . 0.0 111.371 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.27 137.19 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.457 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 27' ' ' VAL . 45.7 pt -117.12 142.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 111.612 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -112.94 118.57 35.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.385 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.473 ' CE1' ' CG ' ' A' ' 167' ' ' ARG . 2.4 p90 -136.84 174.22 10.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.933 0.396 . . . . 0.0 111.382 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -102.21 155.18 18.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.594 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 167' ' ' ARG . 3.0 m -99.12 105.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.0 111.435 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 115' ' ' VAL . . . 175.9 132.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.696 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.536 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -140.57 12.89 2.33 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.87 88.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.193 0.52 . . . . 0.0 110.963 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 128' ' ' VAL . 1.3 m -110.18 145.99 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.957 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.68 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.6 pp -130.44 90.9 39.75 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 121.233 0.539 . . . . 0.0 110.632 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.497 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 62.6 Cg_endo -91.33 -173.79 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.176 2.584 . . . . 0.0 113.504 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER 178.75 36.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.784 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.5 OUTLIER 54.25 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.374 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.62 -42.63 2.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.457 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.702 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -127.51 102.35 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.811 0.339 . . . . 0.0 110.393 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 9.7 t80 -100.54 116.08 31.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.68 ' HB2' HG13 ' A' ' 120' ' ' ILE . 38.5 m80 -95.52 138.06 33.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.689 ' HA ' HG12 ' A' ' 119' ' ' VAL . 8.0 p -126.76 98.15 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.566 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.482 ' HD3' HD21 ' A' ' 203' ' ' LEU . 0.1 OUTLIER -84.14 105.1 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.345 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' A' ' 168' ' ' THR . 0.7 OUTLIER -113.41 125.55 29.46 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 130' ' ' LEU . 16.5 Cg_exo -65.76 115.29 3.33 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.181 1.921 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HD3' HG12 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -94.36 159.08 15.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.272 0.558 . . . . 0.0 111.928 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -113.61 -165.84 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.011 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -73.9 0.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 m -152.83 82.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.283 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 137' ' ' GLU . 65.1 t -130.46 159.2 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.491 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.0 tt0 -50.37 151.53 2.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.059 0.456 . . . . 0.0 111.555 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 140' ' ' ILE . 5.2 mt -138.64 -52.95 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 89.92 36.38 7.26 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.154 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.784 HG23 HD21 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -109.61 126.1 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.354 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 157' ' ' SER . 90.9 m -126.38 131.48 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.373 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.962 HD13 HG22 ' A' ' 194' ' ' VAL . 1.6 mt -105.89 163.29 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 142' ' ' ILE . 5.0 m -166.93 159.85 13.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.017 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.4 p -115.02 130.13 24.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.583 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HG3' ' HG2' ' A' ' 153' ' ' PRO . 25.7 Cg_endo . . . . . 0 C--N 1.347 0.462 0 C-N-CA 122.359 2.039 . . . . 0.0 112.206 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.589 0.233 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.421 ' HG2' ' HG3' ' A' ' 145' ' ' PRO . 92.6 Cg_endo -90.95 174.62 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.572 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 190' ' ' MET . 2.1 mp -122.71 145.51 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.457 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 175' ' ' ASP . 29.8 m -149.17 172.5 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.507 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.433 HG21 HG12 ' A' ' 159' ' ' ILE . 2.8 mp -81.56 152.7 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.74 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.477 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.3 OUTLIER -127.73 -11.39 5.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.57 136.21 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' ' 166' ' ' HIS . 1.5 mt -131.97 143.52 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.279 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.419 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -101.58 178.89 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.581 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.0 OUTLIER -116.25 152.83 33.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.267 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.453 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 93.47 -30.44 7.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.775 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -82.79 140.01 33.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.969 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.0 m -49.43 -23.19 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.183 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' ' 168' ' ' THR . . . -44.92 -67.6 0.27 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.559 ' HB2' HG21 ' A' ' 159' ' ' ILE . 54.6 t60 -83.62 -26.55 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.483 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -58.54 -29.89 66.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.85 HG22 ' O ' ' A' ' 165' ' ' ALA . 6.9 t -58.8 -21.28 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.84 49.92 4.61 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.268 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 168' ' ' THR . 1.6 p -150.61 -52.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 110.958 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.784 HD21 HG23 ' A' ' 140' ' ' ILE . 4.0 mp -55.31 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -139.15 142.81 37.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.821 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 68.9 mt -56.97 114.39 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.76 16.91 4.38 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.996 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.719 ' O ' HG12 ' A' ' 155' ' ' VAL . 2.1 m-20 -100.83 148.16 25.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.775 0.287 . . . . 0.0 110.485 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.432 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -107.18 130.37 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 111.281 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.04 127.84 40.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.804 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.64 -44.94 2.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -137.42 155.29 49.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.506 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.69 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 20.6 mt -139.28 128.95 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.195 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 2.2 t70 49.45 42.6 22.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 2.1 t-20 82.64 -24.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 184' ' ' ARG . 38.3 mm -76.56 155.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 11.7 mtp180 -128.63 127.15 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.453 0.644 . . . . 0.0 112.318 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -90.19 -17.01 28.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.399 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.9 t0 63.94 -71.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.23 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 185' ' ' LEU . 1.0 OUTLIER -158.27 56.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.442 . . . . 0.0 110.617 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 0.0 OUTLIER 170.06 -166.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.221 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 192' ' ' ASP . 0.6 OUTLIER 68.77 43.79 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.872 179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.642 ' HA ' HD21 ' A' ' 154' ' ' LEU . 4.4 tpt -57.9 -58.17 9.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 109.888 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.53 -32.86 74.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 109.876 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.417 ' CB ' ' HB3' ' A' ' 189' ' ' SER . 0.2 OUTLIER -63.88 -43.73 95.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.864 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.815 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -57.87 -43.75 86.21 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.962 HG22 HD13 ' A' ' 142' ' ' ILE . 14.5 t -58.02 -38.93 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.73 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -50.67 71.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.104 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.1 mt -67.93 -24.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.718 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -61.1 -32.71 72.38 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.551 179.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.66 -32.97 10.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.048 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -16.2 39.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.527 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.792 ' SG ' HG23 ' A' ' 204' ' ' VAL . 67.3 m -84.14 41.97 0.85 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.77 59.2 0.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.119 0.485 . . . . 0.0 111.696 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.35 -33.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.101 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.5 tt -179.69 106.86 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.792 HG23 ' SG ' ' A' ' 200' ' ' CYS . 3.5 p -98.93 124.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.143 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -110.67 107.78 17.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.667 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.6 mm? -100.18 128.77 46.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.974 0.416 . . . . 0.0 111.932 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.759 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 0.2 OUTLIER -97.2 93.25 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.078 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.669 HG21 ' OD2' ' A' ' 175' ' ' ASP . 2.9 mm -90.63 169.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.158 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.541 ' H ' HG22 ' A' ' 208' ' ' ILE . 62.5 mtt180 -108.6 130.95 55.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 142.14 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.894 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.837 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.814 0.34 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 8.3 p-80 -100.06 115.07 28.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.697 HG22 ' OD1' ' A' ' 114' ' ' ASP . 36.0 p -53.35 125.59 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -120.45 162.7 19.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 p -113.11 135.71 53.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 161' ' ' LYS . 93.6 m -132.79 160.42 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' N ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.77 162.08 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.518 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.656 ' CG1' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -142.03 133.12 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.926 0.393 . . . . 0.0 111.081 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 28' ' ' VAL . 5.2 p -110.9 116.3 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.976 HD21 HD11 ' A' ' 72' ' ' LEU . 11.2 mt -112.56 136.25 52.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -119.61 159.82 23.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -98.92 129.12 45.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.368 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.461 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -107.48 152.82 41.49 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.96 14.46 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.42 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.01 -47.15 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.4 t -148.92 11.05 0.82 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 59.3 -102.58 0.31 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.461 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CE2' ' O ' ' A' ' 30' ' ' THR . 41.4 m-85 -121.37 124.22 44.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -96.23 28.21 13.91 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.709 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.804 HD13 HD13 ' A' ' 72' ' ' LEU . 7.4 pt -128.35 134.86 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 120.842 0.353 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.407 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -124.0 145.31 49.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.977 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.93 HD23 ' CD1' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.26 138.68 51.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.42 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -78.32 169.8 17.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.324 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -108.34 -68.2 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.764 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.3 144.26 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 56' ' ' LEU . 72.8 t -141.45 -89.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.8 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.608 ' CE1' HG23 ' A' ' 50' ' ' THR . 48.3 p90 -58.14 -46.51 85.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.665 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.579 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 46.61 100.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.08 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.473 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER 171.64 105.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.979 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' C ' HG22 ' A' ' 50' ' ' THR . 9.1 pt-20 52.92 33.61 14.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 110.539 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.608 HG23 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 161.49 174.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.035 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -163.64 23.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.544 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.81 23.31 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.07 139.93 97.88 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.008 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.17 157.46 50.39 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.392 2.061 . . . . 0.0 111.922 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.889 ' HB3' HD13 ' A' ' 41' ' ' LEU . 77.4 Cg_exo -50.3 155.15 5.08 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.434 2.089 . . . . 0.0 112.19 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.59 HD13 HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -148.88 112.66 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.93 ' CD1' HD23 ' A' ' 41' ' ' LEU . 13.2 mm -53.89 141.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.0 110.996 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.82 -32.36 2.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.457 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 86.2 t80 -141.92 156.02 45.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.325 0.584 . . . . 0.0 111.861 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.709 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 17.8 mm -136.34 161.27 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.087 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.456 ' N ' HG22 ' A' ' 60' ' ' ILE . 1.5 tt0 -107.18 150.29 26.77 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 121.922 -0.486 . . . . 0.0 111.877 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.32 39.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.028 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 36.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.923 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.443 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 41.2 p -128.58 138.67 33.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 32' ' ' ASP . 17.6 Cg_endo -57.7 -16.05 23.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.724 2.282 . . . . 0.0 112.869 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.853 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -73.59 -48.74 30.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.564 0.697 . . . . 0.0 109.692 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.709 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.5 tp10 -70.25 -32.46 70.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.422 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.562 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -93.88 -5.43 48.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -42.59 62.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.824 0.345 . . . . 0.0 110.674 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 136' ' ' VAL . . . 133.9 -19.3 4.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.38 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.656 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.2 m -146.89 75.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 117.108 0.454 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.976 HD11 HD21 ' A' ' 29' ' ' LEU . 13.8 mt -157.87 121.62 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.931 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -144.24 -176.31 4.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.544 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.6 126.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.0 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.469 ' N ' ' HB ' ' A' ' 57' ' ' ILE . . . 57.88 84.54 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.669 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 72' ' ' LEU . 70.6 m-20 -95.07 -30.54 14.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.036 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.702 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER 63.45 105.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' HB2' ' A' ' 109' ' ' LEU . 14.8 p -98.47 148.39 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.494 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.7 ttp -109.34 -24.93 10.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.462 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -158.48 145.27 17.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.56 HD12 HD12 ' A' ' 97' ' ' LEU . 1.2 mt -133.14 113.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.92 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 54.09 24.18 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.34 -31.83 6.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.485 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -69.53 110.45 6.4 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.383 0.135 . . . . 0.0 111.301 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.522 ' C ' HG23 ' A' ' 86' ' ' THR . 31.6 Cg_endo -63.96 -27.93 66.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.304 2.003 . . . . 0.0 112.046 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.522 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.2 p 72.28 2.15 4.22 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.678 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -14.3 42.8 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.297 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -120.95 45.72 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.93 153.04 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.784 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 91' ' ' PHE . 9.7 m -60.15 163.83 4.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 6.5 p90 -65.59 -39.27 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.683 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 58.1 mt-10 -54.97 -32.94 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.478 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -53.34 58.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.135 0.493 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -54.68 -37.97 66.41 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.673 0.749 . . . . 0.0 109.863 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -59.93 -36.85 77.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.619 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 5.3 mm-40 -62.23 -43.29 99.17 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.827 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.56 HD12 HD12 ' A' ' 81' ' ' ILE . 17.6 mt -53.72 -41.93 67.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.854 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.828 HD21 HD21 ' A' ' 41' ' ' LEU . 3.4 mp -75.23 -44.65 45.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.628 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 3.5 mtt-85 -50.92 -31.99 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.275 0.559 . . . . 0.0 109.693 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 5.1 p30 -127.52 42.75 3.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.265 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.783 ' HB2' HG21 ' A' ' 107' ' ' VAL . 2.5 p -81.27 6.53 13.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.639 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.27 18.52 19.81 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 9.6 mt -70.79 -53.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.913 0.863 . . . . 0.0 110.418 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.72 9.51 29.64 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.484 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 m 58.93 20.87 8.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.272 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.561 ' HG2' HG23 ' A' ' 30' ' ' THR . 1.6 mttt -166.61 158.42 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.575 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.783 HG21 ' HB2' ' A' ' 101' ' ' SER . 66.1 t -155.29 106.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.426 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.77 132.82 39.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.767 ' HB2' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.07 163.59 32.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.067 0.461 . . . . 0.0 111.611 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -120.34 128.59 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 77' ' ' ARG . 26.6 pt -119.41 153.65 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.929 0.395 . . . . 0.0 111.623 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -120.43 119.14 32.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.465 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 6.5 p90 -138.08 174.21 10.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.275 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.697 ' OD1' HG22 ' A' ' 22' ' ' THR . 7.5 m-20 -91.3 142.25 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.579 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 115' ' ' VAL . 26.8 m -87.26 108.25 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.38 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.47 133.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 168' ' ' THR . 0.2 OUTLIER -149.91 23.85 0.86 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.1 t 83.68 100.84 0.05 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.197 0.523 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.922 HG11 HG21 ' A' ' 170' ' ' THR . 2.0 t -135.39 123.02 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.175 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.705 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.6 pp -96.9 106.97 34.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.267 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 69.9 Cg_endo -95.34 137.02 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.291 2.661 . . . . 0.0 112.679 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -139.81 -80.55 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.62 113.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.85 -31.9 6.53 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.529 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.502 HG22 ' CG ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -138.38 102.65 4.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.964 0.411 . . . . 0.0 111.316 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.812 ' CE1' HG12 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -103.31 121.01 41.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.861 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.705 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -105.75 130.79 53.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.369 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.833 HG11 HG21 ' A' ' 168' ' ' THR . 3.6 t -109.46 86.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 118' ' ' SER . 0.3 OUTLIER -81.14 98.91 8.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.722 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -120.53 125.35 27.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.005 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.58 115.77 2.78 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.353 2.035 . . . . 0.0 111.646 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.545 ' HB2' HG23 ' A' ' 204' ' ' VAL . 18.1 tttp -90.59 151.35 21.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.499 ' CD ' HG21 ' A' ' 136' ' ' VAL . 2.4 mttt -84.95 -168.52 2.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.921 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -72.44 -33.46 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.796 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 m 175.2 40.42 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.799 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.628 HG22 ' HA2' ' A' ' 70' ' ' GLY . 1.2 t -72.24 162.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.58 157.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.985 0.421 . . . . 0.0 111.341 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.495 HD12 ' OG ' ' A' ' 163' ' ' SER . 0.9 OUTLIER -164.99 107.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -89.93 39.55 3.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.394 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.628 HD11 ' CB ' ' A' ' 165' ' ' ALA . 4.4 mm -84.75 124.2 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.801 0.3 . . . . 0.0 110.34 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.754 HG22 ' HB2' ' A' ' 157' ' ' SER . 85.3 m -115.75 141.57 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.974 HD11 HD22 ' A' ' 197' ' ' LEU . 1.9 mt -114.42 163.88 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.868 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.493 ' N ' HG22 ' A' ' 142' ' ' ILE . 48.0 t -166.61 156.38 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.766 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.0 t -115.5 144.85 33.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.345 0.371 0 C-N-CA 122.449 2.099 . . . . 0.0 112.203 179.937 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.517 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.717 ' O ' HD22 ' A' ' 154' ' ' LEU . 54.3 Cg_endo -93.59 -179.77 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.906 2.404 . . . . 0.0 112.884 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 190' ' ' MET . 2.9 mm? -137.46 155.46 49.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.077 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 156' ' ' ILE . 14.1 t -151.68 161.21 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.872 0.367 . . . . 0.0 111.922 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.515 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.5 mt -94.26 152.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.096 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.754 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.4 OUTLIER -127.16 -16.71 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 178.91 137.83 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.28 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.591 HG22 ' HB2' ' A' ' 166' ' ' HIS . 1.0 OUTLIER -129.68 122.99 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.578 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -86.2 155.6 20.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 111.111 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.517 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.4 OUTLIER -79.58 179.83 7.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.608 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 80.55 -54.7 4.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.495 ' OG ' HD12 ' A' ' 138' ' ' LEU . 0.6 OUTLIER -59.24 144.2 46.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.157 0.503 . . . . 0.0 111.376 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 26.8 m -56.4 -21.08 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.046 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.945 ' O ' HG22 ' A' ' 168' ' ' THR . . . -59.36 -71.73 0.12 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.731 0.3 . . . . 0.0 111.361 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.591 ' HB2' HG22 ' A' ' 159' ' ' ILE . 21.3 t60 -66.46 -24.76 66.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.952 0.406 . . . . 0.0 110.499 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.486 ' NH2' ' HB3' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -56.88 -42.58 80.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.501 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.945 HG22 ' O ' ' A' ' 165' ' ' ALA . 13.2 t -50.3 -30.08 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 170' ' ' THR . . . 59.37 89.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.77 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.922 HG21 HG11 ' A' ' 119' ' ' VAL . 15.3 t -177.75 -38.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 110.866 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -69.43 152.66 44.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.814 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -147.63 151.8 36.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.451 HD23 ' HB ' ' A' ' 156' ' ' ILE . 6.5 mt -82.23 127.82 33.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.43 23.55 4.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.61 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.416 ' CB ' ' CG2' ' A' ' 208' ' ' ILE . 21.3 m-20 -116.22 -168.98 1.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.684 0.278 . . . . 0.0 110.604 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.71 120.84 28.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.858 0.361 . . . . 0.0 111.275 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 180' ' ' ILE . 2.5 mt -78.06 144.53 36.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.5 tt -120.24 -41.43 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.695 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -148.87 166.74 27.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.814 HD11 HD22 ' A' ' 177' ' ' LEU . 27.6 mm -139.84 117.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.246 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 25.5 t0 57.91 -86.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -127.25 -13.85 5.5 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.856 ' HB ' HG21 ' A' ' 196' ' ' ILE . 27.4 mm -96.59 159.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.628 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 15.9 mtt85 -118.61 123.68 45.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.386 0.612 . . . . 0.0 112.321 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 185' ' ' LEU . 0.8 OUTLIER -77.49 -13.42 59.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.789 178.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.17 -28.99 1.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.2 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.73 -5.14 6.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.642 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -96.0 133.1 40.62 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -57.39 -178.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.074 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.742 ' HA ' HD11 ' A' ' 154' ' ' LEU . 5.6 ttp -66.15 -57.25 8.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.57 -38.0 71.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.256 0.55 . . . . 0.0 110.72 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.792 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -59.7 -44.81 93.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.935 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 185' ' ' LEU . . . -57.76 -42.96 85.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.442 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.937 HG22 HD13 ' A' ' 142' ' ' ILE . 8.9 t -60.7 -33.72 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.245 0.545 . . . . 0.0 109.786 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -50.18 74.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.949 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.856 HG21 ' HB ' ' A' ' 183' ' ' ILE . 2.3 mp -73.79 -24.6 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.885 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.974 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -64.37 -28.45 69.7 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.775 ' NE2' HG12 ' A' ' 194' ' ' VAL . 19.7 mt-30 -103.44 -33.71 8.97 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -16.04 60.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.167 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.794 ' SG ' HG22 ' A' ' 204' ' ' VAL . 13.8 p -85.97 43.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.195 0.521 . . . . 0.0 110.456 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 5.5 pt-20 -70.75 62.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.539 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.426 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 1.9 m-20 -178.14 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.404 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.404 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 20.5 tp -176.89 107.05 0.06 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.765 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.794 HG22 ' SG ' ' A' ' 200' ' ' CYS . 6.9 t -102.01 115.7 44.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.655 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 13.2 ttmm -104.51 108.32 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.906 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.523 ' N ' HD22 ' A' ' 206' ' ' LEU . 3.4 mm? -87.49 102.7 14.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.915 0.388 . . . . 0.0 111.303 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.552 ' NZ ' HD22 ' A' ' 178' ' ' LEU . 0.1 OUTLIER -92.51 93.43 8.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.216 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 209' ' ' ARG . 6.9 mm -92.92 163.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 21.8 mtm-85 -107.96 126.38 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.037 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 1.6 tttm -113.22 159.49 19.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 114' ' ' ASP . 26.6 t . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.94 0.4 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.638 ' CE1' HG11 ' A' ' 115' ' ' VAL . 46.1 p-80 -128.1 113.77 16.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.739 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -50.27 142.87 9.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -147.77 172.02 14.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.471 HG22 ' HB2' ' A' ' 112' ' ' GLU . 28.7 p -125.61 151.97 45.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 26' ' ' GLU . 89.9 m -145.74 164.4 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.07 161.89 13.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.551 HG11 HD21 ' A' ' 72' ' ' LEU . 2.2 t -135.48 150.16 28.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.87 109.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.442 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -115.09 118.54 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -105.81 162.22 13.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.05 123.05 32.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.07 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.15 153.72 66.51 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.627 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -78.28 9.7 3.01 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.525 2.15 . . . . 0.0 112.506 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 t -112.11 -49.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 120.638 0.256 . . . . 0.0 111.356 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -145.7 3.83 0.98 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 -93.82 0.86 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.366 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.642 ' HD1' HD22 ' A' ' 29' ' ' LEU . 44.5 m-85 -125.6 120.74 31.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.2 9.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.465 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.979 HD11 ' HB2' ' A' ' 66' ' ' ALA . 2.7 mp -93.14 151.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.32 0.581 . . . . 0.0 111.995 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -124.55 99.83 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.763 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 98' ' ' LEU . 1.5 tp -96.17 148.55 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 28.4 pt20 -129.43 170.08 14.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.968 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.58 26.53 3.47 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.296 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.6 106.25 14.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 110.483 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 56' ' ' LEU . 27.4 t -135.14 -85.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.616 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 4.3 p90 -34.92 -44.63 0.23 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.116 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 55.08 66.58 1.19 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.528 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 30.8 p -161.07 -166.31 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.938 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' HG22 ' A' ' 50' ' ' THR . 2.3 pt-20 -51.7 171.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 49' ' ' GLU . 11.9 t 45.25 -153.85 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.993 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.708 HD22 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -146.02 -94.29 0.09 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.707 0.289 . . . . 0.0 111.171 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 16.54 1.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.797 0.332 . . . . 0.0 111.823 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.51 133.74 85.59 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.17 137.29 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.391 2.061 . . . . 0.0 111.85 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.885 ' CB ' HD21 ' A' ' 41' ' ' LEU . 8.1 Cg_endo -49.98 123.09 10.2 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.56 2.173 . . . . 0.0 111.963 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.494 ' CD1' HG22 ' A' ' 45' ' ' VAL . 1.4 pt? -139.42 119.88 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 111.512 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.596 HD13 HG23 ' A' ' 39' ' ' ILE . 48.3 mt -64.44 157.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.996 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.493 ' N ' HG22 ' A' ' 57' ' ' ILE . 12.1 m -130.65 -12.6 3.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.354 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.0 t80 179.78 137.47 0.11 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.936 0.398 . . . . 0.0 111.259 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 61' ' ' GLU . 4.0 mt -111.28 171.95 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 60' ' ' ILE . 43.0 tt0 -111.13 155.1 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.663 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -79.05 59.23 2.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.286 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.08 41.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.313 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 5.2 p -131.27 137.67 31.11 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 64' ' ' SER . 28.5 Cg_exo -61.6 -11.62 21.1 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.5 2.133 . . . . 0.0 112.764 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.001 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -76.88 -56.06 4.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.013 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -73.46 -29.54 62.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.292 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.52 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.24 -42.65 68.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.4 t -47.78 -30.41 3.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.92 -9.31 74.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.916 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 162' ' ' GLY . 18.1 t -101.71 31.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.981 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.741 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 34.1 mt -146.77 134.37 20.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -125.81 161.38 27.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.25 82.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.06 48.24 0.15 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.426 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -76.42 107.64 8.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.87 0.366 . . . . 0.0 110.74 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -69.96 73.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.39 125.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 ttp -95.58 -30.27 13.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -152.03 153.97 35.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.284 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.691 HD12 HD12 ' A' ' 97' ' ' LEU . 4.0 mt -133.98 117.06 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 62.56 19.98 11.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.82 -24.22 22.15 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -71.23 123.14 88.88 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-O 120.519 0.2 . . . . 0.0 111.091 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.52 ' C ' HG23 ' A' ' 86' ' ' THR . 50.3 Cg_endo -68.71 -26.3 33.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 73.84 1.3 3.88 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.619 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -15.02 41.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.898 0.38 . . . . 0.0 111.358 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.18 46.37 0.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m 179.33 -177.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.708 HG23 HD22 ' A' ' 51' ' ' LEU . 15.4 m -93.3 153.17 18.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -52.17 -27.19 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 9.9 mt-10 -54.79 -36.73 65.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.944 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.356 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -61.77 -38.65 88.8 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.555 0.693 . . . . 0.0 109.991 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -59.52 -40.82 88.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.081 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 50.0 mm-40 -61.97 -44.3 97.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 110.21 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 81' ' ' ILE . 36.4 mt -54.37 -41.11 68.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.203 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.904 HD11 HD22 ' A' ' 41' ' ' LEU . 36.7 mt -73.56 -51.9 15.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.878 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 1.5 mtp180 -50.85 -29.84 12.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.962 0.41 . . . . 0.0 110.3 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 53.4 m-20 -126.63 39.66 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.657 ' HB3' ' HA ' ' A' ' 98' ' ' LEU . 1.2 p -89.22 10.98 20.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.84 18.88 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.1 mt -68.79 -49.73 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.877 0.846 . . . . 0.0 110.311 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.48 13.09 32.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.397 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.843 ' O ' HG22 ' A' ' 30' ' ' THR . 24.2 p 54.8 24.32 5.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.258 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -165.17 148.1 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 101' ' ' SER . 2.0 t -145.99 133.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.84 141.2 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' VAL . 1.6 mp -136.31 146.87 47.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.569 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 106.1 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.03 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.3 pt -105.96 160.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 112.104 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 24' ' ' THR . 50.6 tt0 -133.94 137.99 45.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.169 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 167' ' ' ARG . 5.9 p90 -161.24 174.11 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.723 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.548 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -86.25 113.15 22.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.807 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.638 HG11 ' CE1' ' A' ' 21' ' ' HIS . 12.7 p -61.8 104.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.236 0.541 . . . . 0.0 111.94 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 167' ' ' ARG . . . 178.21 177.56 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.625 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 118' ' ' SER . 4.9 tp10 -177.95 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.449 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.5 t 163.55 109.21 0.0 OUTLIER 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.795 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.966 HG21 HG21 ' A' ' 170' ' ' THR . 7.1 p -140.52 147.59 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.133 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -123.34 77.87 53.51 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.95 0.405 . . . . 0.0 111.191 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 126' ' ' PHE . 20.9 Cg_exo -68.65 145.9 65.3 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.351 2.701 . . . . 0.0 112.333 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.43 13.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.47 140.37 0.01 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.857 0.361 . . . . 0.0 111.254 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 77.97 -59.93 3.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.131 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 23.0 m -146.37 102.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.713 ' HB2' ' HA ' ' A' ' 121' ' ' PRO . 2.3 p90 -124.94 164.77 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.67 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.927 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -120.51 163.9 17.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.274 0.559 . . . . 0.0 111.84 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 128' ' ' VAL . 28.0 m -130.81 104.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.007 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -81.99 112.69 19.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.922 HD21 HG23 ' A' ' 168' ' ' THR . 3.4 mp -126.72 117.13 22.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 131.59 46.89 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.249 1.966 . . . . 0.0 111.745 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.615 ' HE3' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -95.64 159.55 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.032 0.444 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.09 -168.69 2.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.856 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -68.96 65.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.463 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 46.52 65.46 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.044 0.449 . . . . 0.0 111.652 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 137' ' ' GLU . 15.0 t -111.35 164.98 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 136' ' ' VAL . 20.9 tt0 -38.07 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.939 0.4 . . . . 0.0 111.663 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -68.76 -42.52 77.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 163' ' ' SER . . . 90.04 -3.32 82.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.763 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -110.73 133.68 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 157' ' ' SER . 75.4 m -116.43 140.42 49.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.349 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.009 HD11 HD22 ' A' ' 197' ' ' LEU . 5.7 mt -97.8 162.87 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.54 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.6 OUTLIER -158.14 147.03 19.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.382 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 54.5 p -107.65 134.8 19.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.969 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.415 ' HD3' HG23 ' A' ' 155' ' ' VAL . 83.8 Cg_endo . . . . . 0 C--N 1.345 0.358 0 C-N-CA 122.582 2.188 . . . . 0.0 112.419 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.531 0.223 0 CA-C-O 120.615 0.245 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.72 -175.23 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.492 2.128 . . . . 0.0 112.612 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 142' ' ' ILE . 5.9 tp -89.7 169.84 10.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 156' ' ' ILE . 22.0 t -147.77 160.51 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.906 0.384 . . . . 0.0 111.61 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' HG12 ' A' ' 155' ' ' VAL . 39.0 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.882 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.435 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.4 OUTLIER -131.32 -7.19 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.0 OUTLIER -177.2 146.1 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.294 0.569 . . . . 0.0 112.072 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.658 HG22 ' HB2' ' A' ' 166' ' ' HIS . 7.8 mt -130.72 149.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.709 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 138.6 54.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.004 0.431 . . . . 0.0 111.609 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.419 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -81.76 -9.08 59.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.864 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 71' ' ' VAL . . . -89.95 -16.89 55.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.673 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 2.9 m -114.12 169.94 8.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.899 0.38 . . . . 0.0 110.99 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.786 ' HB ' HD23 ' A' ' 130' ' ' LEU . 5.6 m -61.74 -22.58 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.773 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.49 -71.21 0.08 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.789 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.658 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -64.94 -24.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.975 0.417 . . . . 0.0 110.528 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.54 ' HA ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -57.61 -29.91 64.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.922 HG23 HD21 ' A' ' 130' ' ' LEU . 42.8 p -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.97 74.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.589 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.966 HG21 HG21 ' A' ' 119' ' ' VAL . 3.2 t -168.62 32.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.966 0.412 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 159' ' ' ILE . 1.0 OUTLIER -113.51 107.15 15.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.689 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.53 150.87 40.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.4 mt -74.95 131.42 40.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.54 -25.7 8.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.45 -172.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.309 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.93 134.43 42.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -99.92 142.18 31.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.439 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 178' ' ' LEU . 6.0 tt -120.85 -35.73 3.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.744 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.841 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -142.07 162.45 35.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.879 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.707 ' CD1' HD21 ' A' ' 185' ' ' LEU . 31.9 mt -139.34 116.71 11.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.37 -74.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -144.54 -19.3 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.932 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 196' ' ' ILE . 28.5 mm -96.55 140.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 111.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.841 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 5.8 mtt180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.905 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.707 HD21 ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -75.55 -6.72 51.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.243 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -41.18 -32.53 0.28 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.456 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m -121.48 -11.72 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.667 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 6.2 m -88.01 -169.78 2.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.142 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 80.5 p -112.3 -175.76 2.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.418 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.7 OUTLIER -70.91 -56.89 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -53.97 -47.11 71.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.785 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -43.6 72.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.059 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.66 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -56.86 -42.05 79.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.415 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.683 HG22 ' CD1' ' A' ' 142' ' ' ILE . 15.3 t -58.98 -39.15 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.291 0.567 . . . . 0.0 109.642 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.948 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.3 mt -69.81 -24.88 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 1.009 HD22 HD11 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -59.34 -31.59 69.32 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.482 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -103.98 -33.55 8.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.141 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -19.67 55.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.709 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 19.8 p -85.49 47.12 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.281 0.563 . . . . 0.0 109.866 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.445 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 22.4 tt0 -68.37 63.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.65 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.402 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 8.8 m-20 -173.23 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.875 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.547 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -178.72 107.46 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 132' ' ' LYS . 2.9 t -85.6 108.35 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.604 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 8.9 ttmm -104.83 107.88 19.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.588 HD12 HG21 ' A' ' 128' ' ' VAL . 2.5 mt -99.91 121.51 41.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.616 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 3.9 tttt -89.7 101.96 14.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.284 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 208' ' ' ILE . 2.0 mm -91.97 158.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.409 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 29.9 mtp85 -113.81 121.79 45.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -114.14 106.17 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.058 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.81 HG21 ' O ' ' A' ' 115' ' ' VAL . 5.3 p . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 120.695 0.283 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.434 ' O ' HG22 ' A' ' 115' ' ' VAL . 33.0 t60 -88.24 106.24 18.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.797 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 p -53.29 161.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.202 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -168.68 169.13 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.615 HG22 ' HG3' ' A' ' 112' ' ' GLU . 29.7 p -129.33 164.74 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.494 HG22 ' CE2' ' A' ' 113' ' ' PHE . 12.4 t -147.78 -170.6 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.71 162.93 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.11 146.8 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.421 HG13 ' CD ' ' A' ' 106' ' ' LYS . 45.2 t -129.31 118.78 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.994 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.006 HD21 ' HB2' ' A' ' 66' ' ' ALA . 1.2 mt -114.38 118.86 35.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.82 163.27 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.526 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.83 115.75 29.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.267 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.48 152.03 59.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.576 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.65 9.21 3.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.636 2.224 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.33 -50.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 120.613 0.244 . . . . 0.0 111.428 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -132.39 -11.81 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -87.73 0.8 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.371 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 29' ' ' LEU . 4.5 m-85 -133.38 118.98 19.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.094 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -95.29 28.51 11.72 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.915 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 66' ' ' ALA . 4.0 mp -93.27 149.17 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.189 0.519 . . . . 0.0 112.012 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.422 ' NE2' ' HB3' ' A' ' 58' ' ' SER . 0.0 OUTLIER -145.0 99.08 3.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.049 HD21 HD13 ' A' ' 98' ' ' LEU . 1.8 pp -112.03 157.27 20.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 169.63 10.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.867 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -119.41 -5.89 11.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.051 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 p -137.46 151.59 48.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.153 0.501 . . . . 0.0 111.537 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.619 ' CG2' HD13 ' A' ' 56' ' ' LEU . 95.1 t -151.98 -76.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.133 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.783 ' O ' HG22 ' A' ' 48' ' ' THR . 21.0 p90 -35.46 -46.77 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.25 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.0 69.23 0.46 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.783 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER 166.96 95.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.2 146.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.104 0.478 . . . . 0.0 111.736 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.417 ' O ' ' CE2' ' A' ' 46' ' ' PHE . 63.1 p 45.59 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.703 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -132.76 -77.32 0.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.889 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.66 17.36 0.09 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.036 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.528 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 1.7 t -108.36 99.36 32.05 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.553 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 172.44 16.19 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.426 2.084 . . . . 0.0 111.978 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.53 ' HB3' HD13 ' A' ' 41' ' ' LEU . 2.4 Cg_endo -45.61 133.46 13.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.712 2.275 . . . . 0.0 112.003 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.619 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -129.0 97.23 4.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.507 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.634 HD13 HG23 ' A' ' 39' ' ' ILE . 27.4 mt -59.43 139.16 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.948 0.404 . . . . 0.0 110.904 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' HG23 ' A' ' 74' ' ' ILE . 2.5 t -124.2 1.48 8.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HA ' HD12 ' A' ' 74' ' ' ILE . 58.2 t80 179.15 134.76 0.09 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.047 0.451 . . . . 0.0 111.626 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.705 HG21 ' CB ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -108.58 162.91 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 40.9 tt0 -98.71 152.56 19.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.401 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.504 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -82.52 56.45 3.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER 165.76 42.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.431 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 t -132.05 139.95 36.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.92 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.34 -10.23 20.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.442 2.095 . . . . 0.0 112.626 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 1.006 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -73.09 -56.18 5.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.978 0.418 . . . . 0.0 110.841 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.705 ' CB ' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -76.81 -29.81 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.159 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -74.49 -29.89 61.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -44.91 69.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 100.06 28.05 7.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 162' ' ' GLY . 10.4 t -148.23 26.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.845 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 12.0 mt -137.36 129.77 29.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -128.72 174.61 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 59' ' ' TYR . 25.2 mm -66.81 74.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 128.28 46.04 0.19 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.37 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -74.89 98.46 3.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -78.54 115.8 18.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 109' ' ' LEU . 14.4 m -101.64 167.5 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 tpt -117.65 -40.96 2.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.43 133.48 22.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.682 HD12 HD12 ' A' ' 97' ' ' LEU . 7.0 mt -119.12 116.27 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.7 p30 47.38 26.07 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.378 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.34 -28.73 10.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.872 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 97' ' ' LEU . 13.0 mm -70.43 136.85 86.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-O 120.718 0.294 . . . . 0.0 111.567 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.3 167.47 19.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.555 2.17 . . . . 0.0 112.213 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 44.8 p -141.12 -54.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.004 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.45 -8.37 55.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.13 44.76 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.95 176.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 92' ' ' GLU . 7.9 m -62.87 145.45 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.477 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 8.2 p90 -73.34 -27.06 61.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.151 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.547 ' H ' HG22 ' A' ' 90' ' ' THR . 6.9 mt-10 -54.63 -42.17 70.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.843 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.6 pt-20 -61.0 -44.49 97.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.317 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -59.83 -35.63 75.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.6 m120 -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.88 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 39.3 mm-40 -62.07 -37.34 84.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.042 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.682 HD12 HD12 ' A' ' 81' ' ' ILE . 23.5 mt -57.43 -49.6 75.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.049 HD13 HD21 ' A' ' 41' ' ' LEU . 1.1 mt -69.92 -57.5 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 63.3 mtt180 -50.5 -31.66 16.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.44 0.638 . . . . 0.0 109.604 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.7 m-20 -119.25 39.68 3.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.675 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -93.17 26.31 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.9 t -124.43 15.71 8.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -68.33 -39.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.783 0.802 . . . . 0.0 110.409 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 11.68 30.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.552 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.49 ' O ' HG22 ' A' ' 30' ' ' THR . 1.8 m 57.92 22.2 8.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.905 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.74 156.25 2.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.362 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.48 129.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.055 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 134.07 47.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.025 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 HG11 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.23 138.12 31.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.59 144.04 27.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.318 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.544 ' CG2' HG12 ' A' ' 78' ' ' VAL . 32.0 pt -134.21 165.33 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.033 0.444 . . . . 0.0 111.828 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.615 ' HG3' HG22 ' A' ' 24' ' ' THR . 51.6 tt0 -132.16 140.95 48.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 25' ' ' THR . 0.5 OUTLIER -161.17 174.5 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.316 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.534 ' HB2' HG11 ' A' ' 20' ' ' VAL . 14.0 p30 -98.07 119.8 37.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.272 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.81 ' O ' HG21 ' A' ' 20' ' ' VAL . 24.1 m -61.81 104.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.556 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.0 124.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.812 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -137.44 52.67 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 t 65.33 89.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.332 0.587 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 1.016 HG12 HG12 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -118.01 122.34 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.111 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.664 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.8 pp -115.6 89.59 23.3 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.315 0.578 . . . . 0.0 110.328 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.533 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.5 Cg_endo -97.04 169.55 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.211 2.608 . . . . 0.0 113.134 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.2 p -153.58 -66.58 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.145 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 166.3 109.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.02 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.05 -32.72 5.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.401 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.513 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -129.25 102.72 6.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.041 0.448 . . . . 0.0 110.768 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -105.43 125.21 50.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.045 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.546 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -113.73 129.04 56.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.959 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.016 HG12 HG12 ' A' ' 119' ' ' VAL . 31.6 m -114.1 104.69 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.105 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.43 ' HG2' ' HD3' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -87.35 106.57 18.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.781 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 204' ' ' VAL . 0.1 OUTLIER -121.38 136.48 25.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.661 0.267 . . . . 0.0 111.203 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.28 139.81 51.25 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.349 2.033 . . . . 0.0 111.338 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -124.77 158.3 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.674 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.661 ' CG ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -130.48 172.98 11.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.238 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 133' ' ' LYS . 1.4 p80 -47.23 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -127.43 98.33 5.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.661 ' HB ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.5 -177.28 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 136' ' ' VAL . 4.5 tt0 -96.35 97.48 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.748 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.856 HD22 HD11 ' A' ' 140' ' ' ILE . 3.1 mt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.758 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.79 3.69 65.95 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.923 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.856 HD11 HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -102.47 137.88 28.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 110.711 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 98.7 m -126.02 128.26 47.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.708 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.883 HD13 HG22 ' A' ' 194' ' ' VAL . 1.7 mt -95.93 163.91 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 142' ' ' ILE . 22.7 t -175.01 177.58 1.93 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.0 t -114.51 134.49 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.622 ' HD3' HG12 ' A' ' 155' ' ' VAL . 94.4 Cg_endo . . . . . 0 C--N 1.345 0.367 0 C-N-CA 122.562 2.175 . . . . 0.0 112.297 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.803 0.335 . . . . 0.0 111.267 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.1 -157.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.661 2.241 . . . . 0.0 112.117 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.892 HD21 ' HA ' ' A' ' 190' ' ' MET . 1.6 mp -104.85 -173.43 2.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.506 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 175' ' ' ASP . 7.6 p -178.43 138.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.267 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 1.022 HD13 HD23 ' A' ' 171' ' ' LEU . 12.0 mt -70.27 154.23 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 t -134.89 -8.94 2.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.71 142.29 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.059 0.457 . . . . 0.0 111.451 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' HB2' ' A' ' 166' ' ' HIS . 4.4 mt -141.05 133.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.3 164.83 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.49 163.58 12.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.771 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.589 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . 83.71 -11.89 54.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.902 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.5 m -113.42 148.96 34.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.69 -22.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.227 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 168' ' ' THR . . . -55.12 -64.06 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.743 0.306 . . . . 0.0 111.558 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.789 ' HB2' HG22 ' A' ' 159' ' ' ILE . 13.2 t60 -81.31 -24.69 37.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.77 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -55.05 -40.86 70.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.193 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.81 HG22 ' O ' ' A' ' 165' ' ' ALA . 5.1 t -52.01 -26.07 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.029 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.01 67.04 2.41 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.808 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.798 HG21 HG11 ' A' ' 119' ' ' VAL . 2.9 t 178.84 40.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 110.825 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.022 HD23 HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -114.39 -77.7 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.718 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 62.11 149.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.091 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.65 107.06 8.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.728 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.38 -18.01 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.613 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.869 ' O ' HG23 ' A' ' 155' ' ' VAL . 1.9 m-20 -60.29 144.66 49.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.222 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 209' ' ' ARG . 0.1 OUTLIER -110.49 114.61 28.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.67 0.271 . . . . 0.0 110.917 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 0.5 OUTLIER -70.15 176.03 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.559 ' C ' HD13 ' A' ' 178' ' ' LEU . 3.4 tm? -156.82 -43.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.494 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -145.87 173.37 12.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.674 HG22 ' OD2' ' A' ' 181' ' ' ASP . 24.3 mm -139.04 105.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.674 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 47.18 -88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.534 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -102.49 -17.96 15.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 184' ' ' ARG . 33.4 mm -100.28 156.68 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 111.747 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.494 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 38.0 mtp180 -125.93 119.33 27.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.555 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 193' ' ' ALA . 2.7 mm? -76.08 -12.93 60.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.055 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.06 -76.56 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.809 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 185' ' ' LEU . 23.9 p -159.57 33.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.725 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 174.4 -171.05 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.679 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 185' ' ' LEU . 0.8 OUTLIER 75.68 39.72 0.32 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.892 ' HA ' HD21 ' A' ' 154' ' ' LEU . 7.8 ptm -53.87 -44.77 70.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.795 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -64.44 -37.23 86.8 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.61 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.851 ' O ' HD12 ' A' ' 196' ' ' ILE . 3.1 m-20 -62.32 -42.21 99.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.31 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -58.9 -49.76 76.57 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.812 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.883 HG22 HD13 ' A' ' 142' ' ' ILE . 7.9 t -55.94 -28.46 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.378 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -50.15 48.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 192' ' ' ASP . 3.1 mp -80.06 -24.39 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.839 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.83 HD22 ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -77.68 -23.9 49.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.579 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.649 HE21 HG12 ' A' ' 194' ' ' VAL . 27.2 mt-30 -85.98 -47.69 9.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.202 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.493 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -68.29 -10.31 53.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.5 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.842 ' HB3' HG22 ' A' ' 204' ' ' VAL . 1.3 m -78.48 46.65 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.409 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 7.5 pt-20 -73.15 62.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.358 0.599 . . . . 0.0 111.085 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -170.07 -32.73 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.261 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.2 tt 178.95 108.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 200' ' ' CYS . 25.1 t -109.74 122.82 64.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 35.5 ttpt -109.54 114.35 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 206' ' ' LEU . 2.5 mm? -91.86 119.19 31.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.073 0.463 . . . . 0.0 111.461 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 125' ' ' THR . 3.9 tttm -92.06 93.63 8.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.984 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 209' ' ' ARG . 6.9 mt -94.9 165.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.803 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -105.75 128.52 53.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.786 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -132.33 114.52 14.49 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.234 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.828 0.347 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -119.08 115.59 24.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 p -51.67 116.02 1.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.14 168.49 10.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.583 HG23 ' HG3' ' A' ' 112' ' ' GLU . 1.2 p -125.42 134.75 52.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.512 HG21 ' CE2' ' A' ' 113' ' ' PHE . 7.2 t -121.58 177.23 5.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.35 162.08 16.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.751 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.21 148.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.99 109.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.036 HD21 HD11 ' A' ' 72' ' ' LEU . 3.0 mm? -107.54 118.37 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.47 162.31 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.157 0.503 . . . . 0.0 111.588 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 116.75 33.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.72 153.19 60.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.656 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.32 3.17 6.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.591 2.194 . . . . 0.0 112.624 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.09 -51.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.241 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -132.76 -4.3 3.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.35 -97.16 0.94 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.269 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 42.0 m-85 -119.01 115.57 24.6 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -83.1 11.11 56.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.94 -0.647 . . . . 0.0 114.116 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 72' ' ' LEU . 26.5 mt -92.82 146.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.387 0.593 . . . . 0.0 111.981 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -139.39 99.96 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.948 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 55' ' ' PRO . 1.4 pp -108.92 152.9 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.344 0.592 . . . . 0.0 112.267 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -99.53 170.1 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.329 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -133.21 31.95 2.81 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.872 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.22 68.38 0.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.122 0.486 . . . . 0.0 110.703 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.94 HG22 HD13 ' A' ' 56' ' ' LEU . 12.4 t -57.2 -75.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.928 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 p90 -68.54 -44.65 74.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.34 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.535 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 52.55 86.64 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.544 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 70.9 p -159.19 81.15 0.77 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' C ' ' HG1' ' A' ' 50' ' ' THR . 8.4 pt-20 44.2 60.19 2.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.857 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.677 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 177.81 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.339 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HG ' ' C ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 36.16 22.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.367 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -70.78 20.36 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -79.42 120.22 79.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.703 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.81 168.03 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.524 2.149 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.804 ' HB3' HD13 ' A' ' 41' ' ' LEU . 61.1 Cg_exo -51.4 142.45 37.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.709 2.273 . . . . 0.0 112.136 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.94 HD13 HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -144.98 108.34 4.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.65 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.783 ' CD1' HD13 ' A' ' 39' ' ' ILE . 22.6 mt -62.9 117.23 3.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.843 0.354 . . . . 0.0 110.74 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -97.68 -22.82 16.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 58.4 t80 -162.08 127.49 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.027 0.442 . . . . 0.0 111.692 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.761 HG21 ' HB2' ' A' ' 67' ' ' GLU . 2.1 mt -99.17 -173.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.715 ' H ' HG22 ' A' ' 60' ' ' ILE . 68.2 tt0 -116.08 144.01 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.385 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -71.84 100.32 2.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.067 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 8.0 t0 99.33 49.17 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.821 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.03 140.53 38.05 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 14.4 Cg_endo -56.7 -18.66 27.47 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.359 2.04 . . . . 0.0 111.686 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.803 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -67.53 -56.33 9.95 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.761 ' HB2' HG21 ' A' ' 60' ' ' ILE . 2.4 tp10 -77.75 -28.33 50.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.954 0.407 . . . . 0.0 109.986 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 4.0 mmt-85 -89.69 -1.78 58.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.652 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 22.7 t -48.87 -54.7 14.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.926 0.393 . . . . 0.0 110.76 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.01 -22.18 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.967 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.495 HG11 ' HA3' ' A' ' 162' ' ' GLY . 17.5 t -139.34 61.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 111.348 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 39' ' ' ILE . 11.1 mt -147.45 145.34 29.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.305 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -141.49 172.96 11.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.635 HD13 HG13 ' A' ' 60' ' ' ILE . 29.1 mm -68.26 71.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.39 88.3 0.98 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.39 101.56 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 111' ' ' ILE . 23.7 mmt-85 -59.81 139.25 57.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.412 HG23 ' HD2' ' A' ' 55' ' ' PRO . 3.4 m -122.36 148.91 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.002 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -30.21 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.962 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.43 137.88 23.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.228 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.92 HD12 HD12 ' A' ' 97' ' ' LEU . 11.8 mt -120.87 109.84 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.8 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 58.03 23.14 9.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 -28.27 12.28 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.324 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 85' ' ' PRO . 30.1 mt -70.02 137.21 87.2 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.497 0.189 . . . . 0.0 111.316 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 84' ' ' ILE . 41.7 Cg_endo -67.49 -168.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.37 2.046 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.4 p -151.75 -54.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.008 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.42 -13.29 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.48 45.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.797 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.26 -175.87 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 5.4 m -83.73 165.39 18.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.989 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HD2' HD13 ' A' ' 51' ' ' LEU . 5.1 p90 -73.88 -41.53 62.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.3 tt0 -54.64 -32.51 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.034 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -61.42 -49.39 77.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -54.36 -42.51 70.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.526 0.679 . . . . 0.0 110.067 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.6 OUTLIER -59.09 -36.41 75.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.869 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 7.5 mm-40 -61.94 -42.75 99.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.92 HD12 HD12 ' A' ' 81' ' ' ILE . 10.6 mt -55.43 -44.25 76.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.638 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.522 HD13 HD11 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -67.81 -47.42 69.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.216 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 8.9 mtm180 -50.44 -33.1 19.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.715 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.498 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 61.4 m-20 -120.22 38.08 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.106 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -95.19 21.54 7.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.242 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.2 p -125.5 16.58 8.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 111.823 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -62.86 -49.69 82.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.935 0.874 . . . . 0.0 110.413 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.64 8.77 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.555 ' O ' HG22 ' A' ' 30' ' ' THR . 15.4 m 62.6 26.91 15.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.808 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 6.3 mttt -154.95 157.94 38.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.674 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -155.45 114.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.248 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.48 141.23 29.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.832 0.348 . . . . 0.0 110.961 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 81' ' ' ILE . 1.1 mt -137.05 155.89 49.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -121.24 111.19 17.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.243 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.708 HG22 ' O ' ' A' ' 77' ' ' ARG . 41.1 pt -114.73 163.09 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 111.676 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.583 ' HG3' HG23 ' A' ' 24' ' ' THR . 25.3 tt0 -131.28 142.87 50.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.514 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 25' ' ' THR . 0.2 OUTLIER -161.11 174.71 13.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.407 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.32 155.1 21.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.07 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -106.75 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.426 . . . . 0.0 111.691 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 115' ' ' VAL . . . 173.05 117.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.706 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CG ' HG13 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -130.78 30.89 4.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.146 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.1 t 89.45 97.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.409 0.623 . . . . 0.0 111.293 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 170' ' ' THR . 9.3 p -139.91 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.13 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.748 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.5 pp -108.1 101.67 42.6 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.415 ' HA ' ' CE1' ' A' ' 126' ' ' PHE . 15.9 Cg_exo -68.69 156.84 64.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.865 2.376 . . . . 0.0 112.68 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.04 104.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.01 115.27 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.003 0.43 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 102.45 -47.39 1.14 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.546 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.21 107.14 11.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.925 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.477 ' HE2' HG21 ' A' ' 119' ' ' VAL . 1.7 t80 -113.0 120.12 40.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.748 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -113.23 121.48 44.59 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.796 HG11 HG21 ' A' ' 168' ' ' THR . 12.1 t -104.55 99.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.685 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.25 109.43 16.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.554 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.825 HD21 HG22 ' A' ' 168' ' ' THR . 26.1 mt -121.76 116.35 30.39 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.588 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.35 114.78 2.65 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.337 2.025 . . . . 0.0 111.612 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.474 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -87.72 158.96 18.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 111.259 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.601 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -101.77 -164.66 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.66 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.92 -36.53 62.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 m -177.49 70.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 133' ' ' LYS . 21.5 t -118.54 159.26 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.364 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.492 ' N ' HG12 ' A' ' 136' ' ' VAL . 16.0 pt-20 -65.95 133.56 51.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.939 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.769 HD22 HD11 ' A' ' 140' ' ' ILE . 1.9 mt -92.45 -49.4 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.706 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.02 16.11 39.66 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.769 HD11 HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -106.39 141.22 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.19 0.495 . . . . 0.0 111.278 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.8 m -122.3 114.16 20.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.593 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.995 HD12 HG22 ' A' ' 194' ' ' VAL . 5.6 mt -84.98 160.79 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.926 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 142' ' ' ILE . 1.4 m -150.02 156.15 41.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.191 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.2 t -110.12 90.9 10.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.29 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 155' ' ' VAL . 85.5 Cg_exo . . . . . 0 C--N 1.347 0.476 0 C-N-CA 122.618 2.212 . . . . 0.0 112.341 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.45 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.165 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.702 ' O ' HD22 ' A' ' 154' ' ' LEU . 72.3 Cg_endo -90.22 157.93 4.68 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.692 2.261 . . . . 0.0 112.973 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 153' ' ' PRO . 4.0 mm? -130.11 133.97 47.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.766 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.516 HG21 ' HG3' ' A' ' 145' ' ' PRO . 73.2 t -156.34 159.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.826 HD12 ' HA3' ' A' ' 174' ' ' GLY . 5.3 mt -105.24 139.54 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.729 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.7 m -127.32 -12.15 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.71 124.84 13.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.503 . . . . 0.0 111.903 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.561 HG22 ' HB2' ' A' ' 166' ' ' HIS . 16.4 mt -117.98 146.63 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.219 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.7 143.88 45.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 111.287 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 168.37 20.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.495 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 83.8 -46.47 3.66 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.741 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.544 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.6 OUTLIER -72.74 175.47 6.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 111.381 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.78 HG12 HD22 ' A' ' 130' ' ' LEU . 40.9 t -73.63 -22.34 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.104 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.755 ' HB2' ' CD1' ' A' ' 140' ' ' ILE . . . -53.67 -71.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.923 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.561 ' HB2' HG22 ' A' ' 159' ' ' ILE . 50.4 t60 -67.05 -24.76 66.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.69 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -57.12 -34.49 68.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.825 HG22 HD21 ' A' ' 130' ' ' LEU . 36.3 p -39.2 -58.02 1.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.511 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.18 -23.12 35.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.556 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.479 ' CG2' HG11 ' A' ' 119' ' ' VAL . 3.0 t -127.4 35.7 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.477 HD23 HD13 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -104.34 78.88 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.84 78.41 2.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 173' ' ' LEU . 26.5 mt 39.93 28.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.826 ' HA3' HD12 ' A' ' 156' ' ' ILE . . . 70.74 -38.98 0.5 Allowed Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.909 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.86 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 176' ' ' LYS . 4.7 mmmm -136.15 106.29 6.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.347 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.686 HD22 HD11 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -92.6 132.35 36.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.398 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.3 pp -134.77 -16.53 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.04 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 207' ' ' LYS . . . -145.57 132.71 20.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.686 HD11 HD22 ' A' ' 177' ' ' LEU . 50.3 mt -135.65 118.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 16.1 m-20 57.82 43.56 21.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.212 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 3.1 t-20 83.49 -25.11 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.936 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 184' ' ' ARG . 44.8 mm -81.31 157.96 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.744 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.465 ' N ' HG22 ' A' ' 183' ' ' ILE . 19.6 mtm105 -129.59 126.45 38.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 112.175 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.819 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 1.4 mm? -79.89 -4.26 51.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.064 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.72 -32.37 0.38 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.0 t -115.58 -17.06 11.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.9 m -89.0 -169.76 2.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.012 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 m -109.12 -167.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.411 ' O ' HG23 ' A' ' 194' ' ' VAL . 14.5 ttp -74.32 -53.44 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -53.4 -29.79 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 110.732 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.817 ' O ' HD12 ' A' ' 196' ' ' ILE . 1.1 t0 -59.93 -52.3 66.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.228 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.819 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -58.25 -43.02 87.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.279 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.995 HG22 HD12 ' A' ' 142' ' ' ILE . 7.8 t -64.05 -31.81 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.705 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -48.2 77.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.848 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.2 mp -73.1 -24.69 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 180' ' ' ILE . 0.2 OUTLIER -64.02 -37.61 88.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.627 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.588 ' NE2' HG12 ' A' ' 194' ' ' VAL . 14.7 mt-30 -86.43 -52.93 5.29 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.597 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.543 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -56.83 -18.17 11.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.946 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' ' 196' ' ' ILE . 16.5 m -88.4 42.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.119 0.485 . . . . 0.0 110.123 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.48 62.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -163.89 -32.2 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.9 tt 177.39 106.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.55 121.33 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.666 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -104.62 108.74 20.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 206' ' ' LEU . 6.0 mp -91.82 117.43 29.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.459 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 179' ' ' ALA . 16.0 tttt -107.21 108.64 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.221 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.487 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -111.6 175.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.426 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -114.29 120.04 39.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.015 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -125.87 108.85 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.331 -0.23 0 CA-C-O 121.122 0.487 . . . . 0.0 110.853 179.624 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.494 HG12 ' OD1' ' A' ' 114' ' ' ASP . 29.1 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.847 0.356 . . . . 0.0 111.285 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.49 ' NE2' HG11 ' A' ' 115' ' ' VAL . 26.5 p-80 -127.31 111.54 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.703 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -50.15 131.42 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.346 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -124.6 149.7 46.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.732 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.5 p -110.21 135.93 50.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -134.96 -169.68 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -117.07 163.09 16.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.538 HG13 HG23 ' A' ' 71' ' ' VAL . 1.5 t -141.51 148.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.424 ' C ' HD12 ' A' ' 29' ' ' LEU . 41.3 t -127.73 115.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.276 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 109' ' ' LEU . 10.4 mp -112.25 120.99 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.233 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.681 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -101.92 163.14 12.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.32 0.581 . . . . 0.0 111.512 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -107.5 103.71 13.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.24 149.36 55.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.424 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.28 4.47 5.37 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.532 2.155 . . . . 0.0 112.736 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.0 -46.21 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.528 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.601 HG21 ' OE2' ' A' ' 61' ' ' GLU . 46.3 p -127.91 -11.77 5.37 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.32 -93.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.195 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 37.6 m-85 -130.65 119.97 23.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.058 0.456 . . . . 0.0 110.104 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -79.7 3.41 69.17 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.306 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 72' ' ' LEU . 34.5 mt -92.74 151.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.63 0.715 . . . . 0.0 112.024 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -151.53 99.56 2.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.104 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.793 HD11 HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.52 157.41 16.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.394 0.616 . . . . 0.0 112.575 -178.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' HG2' HD13 ' A' ' 56' ' ' LEU . 1.5 pm0 -95.4 164.64 12.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.778 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -76.83 -98.34 0.17 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.854 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.1 p -112.61 148.46 34.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.115 0.483 . . . . 0.0 111.806 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.6 -64.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.409 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.661 ' CE1' ' HA ' ' A' ' 51' ' ' LEU . 30.2 p90 -40.92 -40.93 1.5 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.661 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 39.79 92.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.891 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER 173.02 70.6 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.252 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 48' ' ' THR . 6.1 pt-20 52.44 162.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.107 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 47.1 m 69.51 -10.57 0.56 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.34 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.661 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 32.3 -103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 t 71.49 12.65 6.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.6 . . . . 0.0 110.096 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -68.51 107.42 1.97 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.581 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.26 149.31 11.85 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.763 2.309 . . . . 0.0 111.333 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.74 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 84.5 Cg_exo -45.3 110.01 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.455 HD13 ' HG2' ' A' ' 42' ' ' GLN . 2.0 mp -105.92 92.9 4.36 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.886 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.816 ' CD1' HD13 ' A' ' 39' ' ' ILE . 40.3 mt -58.21 110.65 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-O 120.787 0.327 . . . . 0.0 110.558 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -91.16 -2.37 57.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.351 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 79.4 t80 178.95 142.92 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.131 0.491 . . . . 0.0 111.608 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.777 HG21 ' HB2' ' A' ' 67' ' ' GLU . 1.8 mt -121.48 170.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.601 ' OE2' HG21 ' A' ' 35' ' ' THR . 56.8 tt0 -108.13 152.03 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.591 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.56 45.58 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.73 41.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.873 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.411 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 1.9 m -139.45 139.86 23.84 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.807 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 18.7 Cg_endo -58.78 -15.3 25.81 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.782 2.321 . . . . 0.0 112.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.673 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -64.18 -56.81 12.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.94 0.4 . . . . 0.0 110.303 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.777 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -78.96 -29.62 44.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.752 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.447 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -64.1 -24.76 67.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.001 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -47.29 -29.65 2.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 137' ' ' GLU . . . 78.16 27.15 58.56 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.789 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.538 HG23 HG13 ' A' ' 27' ' ' VAL . 3.5 m -152.15 36.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.967 0.413 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.011 HD13 HD11 ' A' ' 39' ' ' ILE . 12.0 mt -137.29 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.13 152.65 15.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.9 mt -62.74 103.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.77 29.83 3.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.507 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.557 ' OD2' HD23 ' A' ' 72' ' ' LEU . 15.8 m-20 -73.82 152.74 40.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -116.4 97.48 6.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 109' ' ' LEU . 23.8 t -73.14 151.88 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -30.95 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -157.32 143.7 17.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.189 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.813 ' HB ' HD13 ' A' ' 97' ' ' LEU . 19.2 mt -127.21 115.3 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.8 18.63 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.78 -27.96 10.52 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.604 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.643 HD12 ' CD2' ' A' ' 97' ' ' LEU . 35.8 mt -74.91 132.98 76.44 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-O 120.507 0.194 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.85 168.68 23.98 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.407 2.071 . . . . 0.0 112.286 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.8 p -131.26 -61.68 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -62.61 -18.2 61.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.38 44.51 1.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.611 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.52 -170.67 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.72 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -73.6 139.53 45.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 11.0 p90 -73.12 -32.7 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.5 mt-10 -54.0 -36.51 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.46 -45.38 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.74 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -54.74 -39.31 68.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.21 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -35.23 80.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.143 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 mm-40 -67.28 -41.25 85.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.591 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.813 HD13 ' HB ' ' A' ' 81' ' ' ILE . 12.5 mt -63.98 -50.28 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.903 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 HD11 ' A' ' 41' ' ' LEU . 2.1 mt -69.76 -54.74 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -50.91 -29.42 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.187 0.518 . . . . 0.0 109.829 179.064 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -124.76 40.84 3.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.531 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.9 p -87.39 13.88 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.596 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 p -109.24 15.12 23.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 5.6 mt -74.24 -47.42 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.706 0.765 . . . . 0.0 110.776 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.67 9.52 41.37 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.657 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.723 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 56.32 21.38 5.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.681 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.1 OUTLIER -174.81 157.73 2.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.984 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.0 p -164.48 121.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.9 135.65 42.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.961 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -142.1 158.48 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.974 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -104.33 145.53 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.5 pt -131.25 165.98 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.561 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -135.8 124.18 23.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.473 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.414 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 3.6 p90 -141.87 174.1 10.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.376 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.494 ' OD1' HG12 ' A' ' 20' ' ' VAL . 1.2 m-20 -94.91 110.52 22.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.203 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 115' ' ' VAL . 8.9 p -61.8 104.88 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.39 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.68 137.23 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.641 ' HB3' HG22 ' A' ' 168' ' ' THR . 3.7 tp10 -130.43 6.43 4.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.5 m 83.44 74.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.964 0.411 . . . . 0.0 111.702 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.857 HG12 ' HA ' ' A' ' 128' ' ' VAL . 7.1 m -100.53 146.28 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.738 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.1 pp -117.39 104.12 50.38 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.853 0.359 . . . . 0.0 111.459 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 96.0 Cg_endo -85.9 152.71 9.88 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.9 2.4 . . . . 0.0 112.85 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.89 24.96 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.33 113.61 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.34 -45.06 2.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -125.66 102.56 7.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.676 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.489 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -111.6 115.93 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.665 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.15 126.06 41.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 110.714 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.857 ' HA ' HG12 ' A' ' 119' ' ' VAL . 13.0 t -99.89 87.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -81.26 105.49 12.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.883 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -129.95 124.94 21.84 Favored Pre-proline 0 C--N 1.333 -0.114 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -56.63 128.98 32.24 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.299 1.999 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 12.0 tptm -98.22 158.19 15.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.739 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.925 ' O ' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -132.82 78.2 1.78 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.268 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 69.2 m-70 45.21 29.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.196 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.402 ' HA ' ' CE ' ' A' ' 132' ' ' LYS . 0.9 OUTLIER 56.31 69.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 133' ' ' LYS . 76.9 t -87.05 -97.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.801 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -101.52 108.82 20.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.779 0.323 . . . . 0.0 111.055 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 163' ' ' SER . 17.6 mt -142.36 102.6 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -90.49 45.84 2.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.642 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 165' ' ' ALA . 47.4 mt -88.35 144.16 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.755 0.312 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.415 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 92.1 m -126.15 129.22 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.8 ' CD1' HG22 ' A' ' 194' ' ' VAL . 5.2 mt -107.52 164.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.836 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.521 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -153.88 149.66 27.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.816 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.01 130.9 23.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo . . . . . 0 C--N 1.347 0.455 0 C-N-CA 122.448 2.099 . . . . 0.0 112.196 179.945 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.441 ' HA ' ' HD2' ' A' ' 153' ' ' PRO . 6.4 p-10 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 152' ' ' ASP . 19.1 Cg_endo -58.35 151.71 58.84 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.113 . . . . 0.0 112.432 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.818 HD11 ' HA ' ' A' ' 190' ' ' MET . 2.9 mm? -73.16 164.48 26.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.685 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 175' ' ' ASP . 27.6 m -155.38 135.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 111.304 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.37 150.34 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.41 -14.3 5.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.883 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.547 ' HA ' HD21 ' A' ' 173' ' ' LEU . 1.2 t70 179.02 147.04 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -140.66 136.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.401 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -95.66 145.97 24.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.88 0.372 . . . . 0.0 111.122 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -177.92 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 71' ' ' VAL . . . 71.18 -60.45 1.06 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.551 ' HB3' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -56.91 138.76 53.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.0 111.231 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 168' ' ' THR . 3.5 m -51.69 -21.68 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.192 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -49.24 -71.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 61.8 t60 -71.57 -24.8 61.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.84 0.353 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.47 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.8 -34.82 63.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.869 HG21 HD22 ' A' ' 130' ' ' LEU . 24.3 p -52.32 -27.13 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 74.52 64.69 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.58 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.433 HG21 HG22 ' A' ' 128' ' ' VAL . 3.7 t -178.91 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.444 HD11 HD22 ' A' ' 206' ' ' LEU . 0.3 OUTLIER -60.85 86.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.04 -174.1 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 158' ' ' ASP . 4.3 mt -94.01 117.0 29.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.98 31.29 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.58 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.511 ' HB3' HG23 ' A' ' 208' ' ' ILE . 2.9 m-20 -111.32 159.7 17.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.495 0.188 . . . . 0.0 110.623 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -112.84 129.85 56.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.784 HD11 ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -102.44 146.7 27.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.007 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.612 HD21 ' NE ' ' A' ' 184' ' ' ARG . 7.8 tt -132.82 -42.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.117 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -127.77 156.29 42.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.765 HG22 ' OD1' ' A' ' 181' ' ' ASP . 17.8 mt -139.86 135.05 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.765 ' OD1' HG22 ' A' ' 180' ' ' ILE . 3.5 p-10 42.55 41.82 2.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.089 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 81.65 -19.56 0.41 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 183' ' ' ILE . 18.1 mm -90.76 132.2 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.612 ' NE ' HD21 ' A' ' 178' ' ' LEU . 2.3 mtp-105 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.612 HD21 HD12 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -93.46 -17.3 23.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 58.55 39.69 24.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.498 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.4 p 58.54 74.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.005 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 192' ' ' ASP . 31.0 p -136.6 114.34 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 192' ' ' ASP . 0.4 OUTLIER 57.89 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.818 ' HA ' HD11 ' A' ' 154' ' ' LEU . 16.2 tmm? -53.14 -33.73 53.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.58 -29.77 68.38 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.259 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 189' ' ' SER . 3.4 t0 -63.76 -48.91 75.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 185' ' ' LEU . . . -57.8 -43.45 85.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.142 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.8 HG22 ' CD1' ' A' ' 142' ' ' ILE . 14.3 t -59.95 -40.24 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.347 0.594 . . . . 0.0 109.681 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -49.56 75.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.937 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.725 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.9 OUTLIER -65.54 -24.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -68.8 -25.76 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -98.26 -49.19 4.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.968 -178.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -59.23 -17.24 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.58 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.833 ' SG ' HG22 ' A' ' 204' ' ' VAL . 25.6 p -80.27 48.47 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.532 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 1.1 pt-20 -74.46 61.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.85 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.404 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -175.09 -26.49 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.415 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 203' ' ' LEU . 2.4 tt 177.63 112.03 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.0 110.386 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.833 HG22 ' SG ' ' A' ' 200' ' ' CYS . 12.0 t -96.13 111.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.799 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -105.58 108.3 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.784 ' CD2' HD11 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -97.35 119.79 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 111.839 -178.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.686 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 6.9 tttt -91.93 93.19 8.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 175' ' ' ASP . 8.1 mm -84.62 163.86 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.286 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.458 ' N ' HG22 ' A' ' 208' ' ' ILE . 1.5 ttt85 -107.79 116.77 32.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.572 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -103.8 159.78 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.722 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.814 HG21 HG13 ' A' ' 115' ' ' VAL . 8.4 p . . . . . 0 N--CA 1.461 0.086 0 CA-C-O 120.764 0.316 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.513 ' N ' HG22 ' A' ' 20' ' ' VAL . 18.1 p-80 -99.65 130.28 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.82 171.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.144 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -161.91 166.29 26.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.474 HG23 ' CG ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -120.39 151.03 39.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.527 ' CG2' HD11 ' A' ' 111' ' ' ILE . 12.9 t -136.75 -173.26 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.98 163.07 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 109' ' ' LEU . 2.1 t -135.41 149.38 28.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.6 109.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.554 HD22 ' CB ' ' A' ' 66' ' ' ALA . 52.3 mt -112.21 118.11 34.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.249 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -105.33 162.83 13.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.227 0.537 . . . . 0.0 111.686 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.739 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 109.06 20.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.04 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.426 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -78.4 150.14 76.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.74 3.75 5.72 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.43 2.087 . . . . 0.0 112.73 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.76 -43.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.577 0.227 . . . . 0.0 111.596 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.85 -12.14 5.37 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 64.61 -82.89 0.06 OUTLIER Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.159 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 56.2 m-85 -139.09 113.58 9.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.78 26.28 15.18 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.685 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.983 HD11 ' HB2' ' A' ' 66' ' ' ALA . 3.9 mp -93.0 125.03 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -97.88 98.41 9.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.95 HD21 ' HA ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -96.87 156.54 16.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -132.55 169.28 16.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.92 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.72 56.52 0.51 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.708 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -158.21 79.35 0.83 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.489 ' CG2' HD22 ' A' ' 56' ' ' LEU . 1.9 t -98.46 -72.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.394 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 27.8 p90 -34.72 -45.92 0.27 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.43 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.479 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 49.25 72.62 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.4 t 167.93 94.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 48' ' ' THR . 7.7 pt-20 49.87 178.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.818 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t 44.08 -161.45 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.359 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.818 HD23 ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.08 -90.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.204 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 51.12 18.46 0.57 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.888 0.375 . . . . 0.0 111.469 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -66.71 111.43 6.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.306 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.725 ' O ' HD23 ' A' ' 56' ' ' LEU . 83.7 Cg_endo -78.34 146.15 21.89 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.343 2.029 . . . . 0.0 111.441 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.95 ' HA ' HD21 ' A' ' 41' ' ' LEU . 5.4 Cg_endo -48.71 104.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.381 2.054 . . . . 0.0 111.747 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -117.33 111.9 20.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.693 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 39' ' ' ILE . 19.3 mt -59.7 157.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 57' ' ' ILE . 26.4 t -128.44 -34.94 2.0 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.9 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -163.97 127.79 2.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.502 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.722 HG21 ' CB ' ' A' ' 67' ' ' GLU . 3.9 mt -96.17 168.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.53 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.71 141.55 46.38 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.52 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -69.13 63.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.456 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.6 p30 162.58 42.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.268 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -134.06 139.92 34.66 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.758 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.06 -12.69 31.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.755 2.303 . . . . 0.0 112.9 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.983 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -74.85 -56.3 4.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.927 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.722 ' CB ' HG21 ' A' ' 60' ' ' ILE . 2.7 tp10 -72.32 -29.9 64.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.742 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.524 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -76.91 -24.5 52.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.1 t -44.4 -52.4 7.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 111.045 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.876 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 118.15 16.73 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.113 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 70' ' ' GLY . 10.0 m -158.58 37.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 111.067 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 71' ' ' VAL . 3.3 mm? -122.32 140.21 52.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -145.18 167.57 22.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.4 mm -65.62 126.91 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.197 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.22 50.05 42.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.538 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.39 102.83 7.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.29 . . . . 0.0 110.931 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.661 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -53.08 156.35 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.757 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 79' ' ' MET . 21.2 t -147.94 157.5 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 111.403 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.46 ' N ' HG12 ' A' ' 78' ' ' VAL . 9.5 tpt -125.11 -41.36 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.74 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.62 137.01 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.838 HG12 HD23 ' A' ' 109' ' ' LEU . 9.5 mt -121.12 112.39 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.616 ' ND2' HG13 ' A' ' 107' ' ' VAL . 18.8 m-20 59.33 20.76 8.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.38 -21.95 37.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.636 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -75.49 119.8 78.7 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 120.439 0.161 . . . . 0.0 111.278 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 86' ' ' THR . 51.3 Cg_exo -55.63 -167.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.516 2.144 . . . . 0.0 112.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -170.75 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.084 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.45 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -117.93 47.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -175.39 179.88 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -76.08 164.23 26.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 31.3 p90 -73.43 -30.35 63.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -31.92 57.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.442 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -37.7 85.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.694 0.283 . . . . 0.0 110.746 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -71.98 -29.34 64.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.459 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.8 -38.11 54.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.849 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.44 -35.55 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.787 0.327 . . . . 0.0 111.143 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.2 pp -69.84 -45.08 68.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.569 ' CD1' HD13 ' A' ' 41' ' ' LEU . 9.1 mt -64.09 -58.94 5.17 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.271 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -29.56 11.9 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.505 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -112.92 34.08 4.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.863 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 69.2 p -102.81 17.46 23.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.3 p -102.05 11.81 37.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.505 HD11 ' O ' ' A' ' 100' ' ' ASP . 2.0 mt -68.9 -49.34 64.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.608 0.718 . . . . 0.0 110.998 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.23 6.91 38.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.746 ' O ' HG22 ' A' ' 30' ' ' THR . 27.8 p 55.76 24.68 7.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.256 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -172.72 145.94 1.57 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.711 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.616 HG13 ' ND2' ' A' ' 82' ' ' ASN . 1.0 OUTLIER -146.41 132.59 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.772 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.72 141.25 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.838 HD23 HG12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -137.27 140.14 41.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.352 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.53 115.77 31.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.973 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 77' ' ' ARG . 1.7 pp -117.55 163.75 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 112.144 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' CG ' HG23 ' A' ' 24' ' ' THR . 0.7 OUTLIER -130.59 131.73 45.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.237 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -142.62 174.62 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.117 0.484 . . . . 0.0 111.661 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.82 104.27 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.08 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 20' ' ' VAL . 13.5 p -61.57 145.65 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . 87.39 129.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.344 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.58 24.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.987 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.2 t 176.78 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.185 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.614 HG13 ' CZ ' ' A' ' 126' ' ' PHE . 41.3 t -142.27 118.09 5.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 1.07 HG23 ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -154.74 78.51 4.96 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -177.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.465 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 69.6 Cg_endo -96.38 -167.31 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.455 2.77 . . . . 0.0 112.722 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.93 35.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.32 113.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.523 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.77 -32.77 5.8 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.922 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.582 HG22 ' HD3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -136.66 105.2 5.78 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.823 0.344 . . . . 0.0 111.137 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.614 ' CZ ' HG13 ' A' ' 119' ' ' VAL . 1.4 t80 -100.58 118.45 36.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 1.07 ' HB2' HG23 ' A' ' 120' ' ' ILE . 6.8 m80 -97.8 142.18 29.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 111.294 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 170' ' ' THR . 6.1 t -139.92 90.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.528 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.497 HD21 HG21 ' A' ' 168' ' ' THR . 0.2 OUTLIER -112.47 129.89 23.92 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 136.84 51.16 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.089 1.86 . . . . 0.0 111.293 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.707 ' CG ' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -100.93 158.79 15.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.051 0.453 . . . . 0.0 110.939 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.49 ' CD ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.17 -164.86 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -100.47 -29.09 12.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -164.25 48.8 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 111.497 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.876 HG13 ' HA2' ' A' ' 70' ' ' GLY . 25.3 t -112.09 137.68 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.752 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.51 129.33 38.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.71 -41.17 17.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 100.71 -12.05 59.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.712 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.827 HG23 ' HB1' ' A' ' 165' ' ' ALA . 1.2 pt -89.25 148.92 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.896 0.379 . . . . 0.0 111.374 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 158' ' ' ASP . 86.1 m -126.28 126.18 43.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.331 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.896 ' CG2' HD12 ' A' ' 154' ' ' LEU . 7.4 mt -87.31 164.18 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.095 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.537 ' OG ' HG23 ' A' ' 155' ' ' VAL . 69.2 p -163.5 164.79 24.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.9 109.89 17.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.497 ' HD3' HG22 ' A' ' 155' ' ' VAL . 39.8 Cg_exo . . . . . 0 C--N 1.347 0.467 0 C-N-CA 122.484 2.123 . . . . 0.0 112.37 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 46.1 t0 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.616 0.246 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -172.51 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.896 HD12 ' CG2' ' A' ' 142' ' ' ILE . 4.2 mm? -107.67 150.9 26.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.689 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 175' ' ' ASP . 18.4 m -150.67 145.72 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.409 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.509 HG12 HD23 ' A' ' 171' ' ' LEU . 1.1 mp -78.33 143.92 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.391 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -11.42 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 141' ' ' THR . 0.6 OUTLIER -162.74 142.31 9.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.142 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.745 HG23 HG22 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -136.21 149.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 173.22 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 167' ' ' ARG . 5.6 mtpp -115.19 145.64 42.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 71' ' ' VAL . . . 115.38 -24.25 10.64 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.322 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.425 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -108.28 159.55 16.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.926 0.394 . . . . 0.0 111.029 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.38 -21.85 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.877 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.827 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.94 -65.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.452 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 28.4 t60 -83.54 -29.92 27.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.484 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -56.83 -40.78 76.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.679 0.276 . . . . 0.0 111.448 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 165' ' ' ALA . 4.5 t -45.04 -29.17 0.81 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.548 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 68.6 1.57 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.514 HG21 HG22 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -178.93 -38.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.344 . . . . 0.0 110.744 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.721 HD21 ' CD2' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -71.86 72.28 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.47 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -100.03 152.76 19.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.458 HD23 HD11 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.48 129.34 36.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.966 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.17 5.33 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.732 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.588 ' O ' HG12 ' A' ' 155' ' ' VAL . 1.2 t0 -113.61 -174.32 2.44 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.883 -0.186 . . . . 0.0 110.693 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.463 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -132.46 106.81 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 0.0 111.381 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.528 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -74.07 157.39 36.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.716 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.2 tt -136.19 -49.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' A' ' 178' ' ' LEU . . . -129.76 157.46 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 111.708 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' A' ' 185' ' ' LEU . 32.6 mt -138.99 105.71 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.76 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 28.5 t70 62.01 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.45 -18.64 3.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 196' ' ' ILE . 25.5 mm -96.99 138.03 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.027 0.442 . . . . 0.0 111.629 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.482 ' HE ' HD21 ' A' ' 178' ' ' LEU . 16.2 mtt180 -105.87 124.64 49.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.625 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' A' ' 180' ' ' ILE . 2.0 mm? -72.69 -7.28 49.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.84 -31.12 1.12 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.9 p -124.88 -12.72 7.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.895 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 17.7 m -83.59 -170.64 3.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 m -116.95 -175.83 2.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.728 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -67.58 -57.32 6.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -54.69 -41.81 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.239 0.543 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.71 -45.06 77.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.251 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HB2' ' CD1' ' A' ' 185' ' ' LEU . . . -57.36 -42.05 81.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.69 HG22 HD12 ' A' ' 142' ' ' ILE . 17.0 t -59.1 -36.73 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 29.3 mm-40 -60.83 -50.36 73.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.896 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -68.38 -25.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -64.87 -32.16 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.48 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.54 ' NE2' HG12 ' A' ' 194' ' ' VAL . 10.9 mt-30 -95.44 -41.46 8.97 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.591 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -85.08 13.99 5.54 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.828 ' CB ' HG22 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -65.41 32.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.2 mm-40 34.63 70.26 0.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.496 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 0.7 OUTLIER 42.83 34.61 0.61 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 178.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.445 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -171.55 103.87 0.2 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.156 0.503 . . . . 0.0 111.626 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.828 HG22 ' CB ' ' A' ' 200' ' ' CYS . 47.9 t -107.84 108.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.374 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 33.0 ttmt -94.02 107.5 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.721 ' CD2' HD21 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -88.84 107.57 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.475 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.582 ' HD3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -101.44 92.65 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.626 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.505 HG21 ' CG ' ' A' ' 175' ' ' ASP . 2.4 mp -87.31 166.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -111.76 123.39 50.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -115.55 95.09 4.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.323 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 114' ' ' ASP . 17.3 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.776 0.322 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.66 40.76 1.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.134 0.493 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 51.62 174.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.537 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.15 142.5 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.21 143.88 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.009 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.426 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 5.6 t -141.2 159.11 42.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.84 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.71 159.17 15.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.791 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 109' ' ' LEU . 1.3 t -135.77 147.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.442 HG13 ' CD ' ' A' ' 106' ' ' LYS . 61.1 t -125.97 109.51 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.681 HD23 HD13 ' A' ' 109' ' ' LEU . 4.4 mm? -110.01 118.83 37.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.69 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -109.29 162.4 14.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -97.49 115.87 28.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.841 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -74.83 157.74 85.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.635 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.98 6.12 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.503 2.136 . . . . 0.0 112.594 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.14 -49.31 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.513 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.3 p -138.74 -1.58 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 76.04 -99.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.269 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.826 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 2.8 m-85 -116.16 119.63 36.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -92.49 26.91 11.79 Favored Glycine 0 CA--C 1.517 0.17 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.352 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 66' ' ' ALA . 7.0 mt -92.63 135.94 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 121.092 0.473 . . . . 0.0 111.56 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.96 99.51 5.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.067 HD21 HD13 ' A' ' 98' ' ' LEU . 1.9 pp -114.69 156.82 24.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 112.279 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -102.65 169.59 8.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.259 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.401 ' O ' ' CG ' ' A' ' 91' ' ' PHE . . . -137.18 46.28 1.02 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.88 65.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.175 0.512 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.9 HG22 HD13 ' A' ' 56' ' ' LEU . 7.4 t -61.8 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.189 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 47.3 p90 -67.41 -49.76 62.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.026 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.483 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.8 79.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.401 0.62 . . . . 0.0 111.296 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.3 t 170.37 116.8 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.665 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 50' ' ' THR . 1.6 tp10 60.84 84.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 49' ' ' GLU . 3.2 p 89.4 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 pp -166.43 26.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 111.895 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 20.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.666 ' OG ' HG23 ' A' ' 45' ' ' VAL . 1.2 t -58.81 109.3 1.76 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.583 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.405 ' O ' HD23 ' A' ' 56' ' ' LEU . 39.4 Cg_endo -66.8 162.54 37.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.377 2.052 . . . . 0.0 112.319 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.647 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 76.1 Cg_exo -49.25 129.27 21.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.524 2.149 . . . . 0.0 112.154 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.9 HD13 HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -133.38 99.65 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.573 HD13 HG23 ' A' ' 39' ' ' ILE . 21.5 mt -60.89 129.5 23.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.76 0.314 . . . . 0.0 110.687 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.4 p -113.66 -2.51 13.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 55.4 t80 177.72 124.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.875 0.369 . . . . 0.0 111.435 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.699 HG22 ' H ' ' A' ' 61' ' ' GLU . 1.9 mt -96.63 -178.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.699 ' H ' HG22 ' A' ' 60' ' ' ILE . 25.3 tt0 -121.55 131.14 53.96 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.347 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.482 ' HA ' ' NH1' ' A' ' 68' ' ' ARG . . . -65.5 70.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.457 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.2 m-20 164.62 44.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -145.04 -179.43 0.94 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 91.0 Cg_endo -97.87 -2.7 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.067 2.511 . . . . 0.0 112.744 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.768 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -76.84 -57.22 3.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.717 0.294 . . . . 0.0 111.648 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -77.37 -29.11 53.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 0.0 110.131 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.592 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -76.53 -30.78 57.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 -67.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.727 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -14.69 5.35 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.954 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 163' ' ' SER . 14.7 m -125.65 45.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.418 . . . . 0.0 110.96 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 66' ' ' ALA . 10.3 mt -135.6 168.95 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -164.16 143.19 7.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.36 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.094 0.473 . . . . 0.0 111.407 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.69 42.32 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.283 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD2' HD13 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -74.83 113.28 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.97 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.77 79.17 2.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.74 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.787 ' HA ' HG22 ' A' ' 111' ' ' ILE . 26.9 m -69.96 132.32 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.75 -30.71 10.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -144.89 131.97 20.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.489 HG21 HD11 ' A' ' 97' ' ' LEU . 17.7 mt -124.89 117.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.651 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 46.56 27.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.439 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.39 -30.27 9.07 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.593 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -68.58 117.79 53.81 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 -167.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.364 2.043 . . . . 0.0 112.187 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.4 p -147.7 -45.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.071 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.69 -9.97 58.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.561 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.3 47.46 2.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.3 168.69 2.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -74.97 157.38 35.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 9.5 p90 -73.3 -31.0 63.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.95 -41.14 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 -33.75 74.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.343 . . . . 0.0 110.978 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.647 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -72.93 -31.8 64.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 110.6 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.31 -36.11 58.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.821 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -73.41 -35.73 65.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.567 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.1 pp -69.96 -41.92 73.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.239 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.067 HD13 HD21 ' A' ' 41' ' ' LEU . 80.7 mt -65.84 -58.78 4.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.416 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.07 -29.7 13.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.525 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -109.44 30.7 6.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.962 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -104.5 45.64 0.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.2 p -133.36 13.02 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.88 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.525 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -69.79 -48.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.52 0.676 . . . . 0.0 111.137 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.29 7.11 40.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.817 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.852 ' O ' HG22 ' A' ' 30' ' ' THR . 74.3 m 56.69 25.2 9.81 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.926 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -166.28 152.77 9.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.648 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 108' ' ' THR . 4.8 t -152.84 158.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -125.08 141.25 52.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.696 HD23 HG11 ' A' ' 78' ' ' VAL . 2.0 mp -130.26 156.04 45.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 3.0 mt-10 -130.92 105.85 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.787 HG22 ' HA ' ' A' ' 78' ' ' VAL . 25.5 pt -110.47 160.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.098 0.475 . . . . 0.0 111.806 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -133.02 140.4 47.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.26 174.31 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB3' HG11 ' A' ' 20' ' ' VAL . 68.4 m-20 -97.95 118.34 34.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.68 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 167' ' ' ARG . 2.9 m -61.96 118.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 179.36 117.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 168' ' ' THR . 2.7 tp10 -118.1 13.25 13.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.527 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.35 72.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.163 0.506 . . . . 0.0 111.401 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.905 HG11 ' OG1' ' A' ' 170' ' ' THR . 25.1 m -97.8 147.83 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.613 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.682 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.9 pp -121.45 98.72 46.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.92 0.39 . . . . 0.0 111.304 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HB3' ' CE1' ' A' ' 126' ' ' PHE . 89.2 Cg_endo -90.31 169.12 4.16 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.084 2.522 . . . . 0.0 112.825 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.8 m -166.61 29.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.8 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.82 113.31 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.715 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.78 -39.25 2.96 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.561 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.428 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.22 102.42 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.493 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 170' ' ' THR . 0.7 OUTLIER -109.15 117.8 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.485 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.575 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -99.96 143.01 30.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 HG21 ' A' ' 168' ' ' THR . 14.6 t -118.66 90.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 205' ' ' LYS . 0.3 OUTLIER -80.81 105.96 12.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.445 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.671 HD23 HG12 ' A' ' 128' ' ' VAL . 3.2 pp -136.98 133.45 18.65 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 164' ' ' VAL . 35.3 Cg_exo -56.89 129.08 32.64 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.231 1.954 . . . . 0.0 111.516 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -106.98 139.4 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.075 0.464 . . . . 0.0 110.874 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -76.75 -168.28 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.767 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 0.9 OUTLIER -90.04 -40.0 12.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.235 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.62 45.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.773 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 137' ' ' GLU . 7.3 t -100.46 161.25 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.472 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.3 tt0 -51.75 145.91 8.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.274 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.606 ' HB3' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -143.74 -58.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.487 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 92.02 56.94 1.54 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.679 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 165' ' ' ALA . 6.0 mt -125.09 136.7 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.457 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 73.4 m -125.28 142.54 51.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.051 HD12 HG22 ' A' ' 194' ' ' VAL . 10.5 mt -111.49 164.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.96 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 142' ' ' ILE . 29.6 m -165.35 152.52 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.01 145.94 35.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.1 t0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.678 0.275 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 159.36 5.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.665 2.243 . . . . 0.0 112.576 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 190' ' ' MET . 2.2 mm? -101.7 155.03 18.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.302 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 156' ' ' ILE . 14.1 t -153.71 160.55 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.872 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.525 HD11 HD12 ' A' ' 171' ' ' LEU . 8.5 mt -104.02 148.02 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.817 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 -0.36 2.93 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.5 t0 -168.98 134.56 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 111.421 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.514 HG22 ' HB2' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -136.69 149.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.822 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.583 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -122.79 149.12 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.162 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.523 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 2.3 mptt -79.09 165.74 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.725 0.298 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.81 -59.34 1.78 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.595 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.514 ' OG ' HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -61.31 160.85 9.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.922 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 131' ' ' PRO . 28.9 m -72.62 -23.99 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 168' ' ' THR . . . -49.64 -58.51 5.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.514 ' HB2' HG22 ' A' ' 159' ' ' ILE . 15.8 t60 -83.87 -31.31 25.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.646 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -54.99 -29.84 58.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.733 0.302 . . . . 0.0 111.153 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.823 HG21 HG11 ' A' ' 128' ' ' VAL . 9.8 t -54.75 -20.1 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.84 24.74 76.22 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.905 ' OG1' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -133.27 -39.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.896 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 165' ' ' ALA . 12.0 tp -64.96 93.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -110.23 155.26 22.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.692 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.5 OUTLIER -87.73 50.97 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.993 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.09 30.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.48 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -113.88 177.23 4.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.647 0.261 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -117.65 98.34 6.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 111.18 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.647 HD11 ' CD2' ' A' ' 206' ' ' LEU . 3.9 mt -76.97 134.89 38.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.6 2.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.857 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.829 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -165.29 154.68 12.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.876 0.369 . . . . 0.0 111.484 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 179' ' ' ALA . 9.1 mm -139.38 117.79 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.799 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 46.81 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.407 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' ILE . 75.7 m-20 -112.34 -16.5 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 184' ' ' ARG . 39.7 mm -96.67 157.68 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.432 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.485 ' N ' HG22 ' A' ' 183' ' ' ILE . 8.8 mtt180 -127.43 126.56 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.047 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.2 mm? -78.47 -4.92 50.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.8 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -28.92 1.97 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.1 p -135.45 40.05 2.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 15.1 m -140.66 -171.42 3.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.23 173.23 6.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.611 ' HA ' HD21 ' A' ' 154' ' ' LEU . 17.6 ttp -59.0 -53.09 62.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 4.0 mt-10 -51.7 -41.06 61.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.613 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 9.1 t70 -53.26 -51.96 60.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.153 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -52.66 -41.36 63.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.251 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 1.051 HG22 HD12 ' A' ' 142' ' ' ILE . 21.6 t -59.64 -33.45 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.022 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.435 ' HG3' ' HA ' ' A' ' 192' ' ' ASP . 17.1 mm-40 -63.32 -50.27 70.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.0 OUTLIER -70.84 -24.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.822 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.876 HD22 HD11 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -64.76 -35.44 81.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.762 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.71 ' NE2' HG12 ' A' ' 194' ' ' VAL . 12.7 mt-30 -94.76 -44.73 7.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.32 -22.58 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.888 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.707 ' CB ' HG22 ' A' ' 204' ' ' VAL . 19.3 m -89.56 41.99 1.07 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.081 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 12.2 pt-20 -69.06 61.6 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.535 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -168.98 -28.98 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.944 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.5 tt 172.67 113.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.856 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.707 HG22 ' CB ' ' A' ' 200' ' ' CYS . 97.4 t -111.88 137.91 42.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 5.1 ttmt -111.76 108.14 17.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.955 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.647 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -82.76 113.12 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.436 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.633 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 6.4 tttt -100.02 103.43 14.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.521 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -110.34 174.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 23.0 mtp85 -102.73 125.99 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.02 94.55 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.451 -0.386 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 -179.931 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.816 HG12 ' HB2' ' A' ' 116' ' ' ALA . 3.4 m . . . . . 0 C--O 1.233 0.216 0 CA-C-O 120.806 0.336 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.508 ' O ' HG23 ' A' ' 115' ' ' VAL . 30.2 t60 -75.55 114.97 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -55.79 149.95 13.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -155.6 168.71 26.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.91 160.26 16.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.73 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.757 HG23 ' HB3' ' A' ' 161' ' ' LYS . 89.2 m -158.45 155.45 28.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.7 160.2 14.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.68 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.99 150.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.586 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.54 109.35 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.971 0.415 . . . . 0.0 111.246 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.657 HD21 HD11 ' A' ' 72' ' ' LEU . 3.4 mm? -107.26 118.23 36.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.835 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.7 162.57 13.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.175 0.512 . . . . 0.0 111.942 -178.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.28 151.52 20.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.162 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 35.5 m-20 -134.16 150.88 75.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.386 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.11 20.73 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.561 2.174 . . . . 0.0 112.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.7 t -133.79 -54.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.248 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 t -159.81 37.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.692 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA3' ' H ' ' A' ' 32' ' ' ASP . . . -43.43 143.31 1.84 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.437 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 11.0 m-85 61.02 71.83 0.55 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -98.66 26.48 23.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.439 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.979 HD13 HD13 ' A' ' 72' ' ' LEU . 26.9 pt -115.23 143.41 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.06 140.35 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.478 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.863 HD13 HD13 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -112.31 121.56 45.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.966 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -84.69 170.11 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.95 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.06 61.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.54 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.99 110.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 56' ' ' LEU . 20.7 t -129.67 -73.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.376 0.608 . . . . 0.0 110.256 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.83 ' O ' HG22 ' A' ' 48' ' ' THR . 27.0 p90 -43.42 -45.07 6.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.35 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.489 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.66 74.49 0.1 Allowed 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.8 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 166.86 108.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.788 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.52 138.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.549 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER 46.1 -164.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.815 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.673 HD13 HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -138.93 -85.39 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.823 0.344 . . . . 0.0 111.717 179.45 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t 57.41 13.98 2.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 110.974 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -54.13 106.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.329 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 60.6 Cg_endo -72.53 117.9 5.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.279 1.986 . . . . 0.0 111.499 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HG3' HG21 ' A' ' 86' ' ' THR . 9.4 Cg_exo -36.1 118.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.21 2.607 . . . . 0.0 113.231 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 176.37 5.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.198 179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 39' ' ' ILE . 21.3 mm -112.31 138.41 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.49 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 p -119.14 -8.5 10.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 80.5 t80 -172.47 157.74 4.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.362 0.601 . . . . 0.0 111.885 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.788 HG21 ' HB2' ' A' ' 67' ' ' GLU . 8.7 mm -135.05 152.66 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.413 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.8 tm-20 -104.2 156.66 17.71 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.56 47.59 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.115 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.87 65.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.617 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -156.02 -172.25 0.31 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 54.5 Cg_endo -96.77 -10.24 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.817 2.344 . . . . 0.0 113.377 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -77.68 -58.45 3.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.788 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -71.47 -29.1 64.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.415 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.52 -30.59 5.38 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.961 0.41 . . . . 0.0 110.649 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.425 ' HA3' ' CG1' ' A' ' 136' ' ' VAL . . . 78.8 36.67 28.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.855 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 162' ' ' GLY . 16.6 t -154.26 31.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.736 0.303 . . . . 0.0 111.426 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.979 HD13 HD13 ' A' ' 39' ' ' ILE . 9.5 mt -133.11 147.55 52.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.894 0.378 . . . . 0.0 111.054 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.06 148.81 33.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.61 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.37 68.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.785 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.09 45.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -79.71 -179.79 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.668 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -147.03 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 109' ' ' LEU . 86.4 t -65.35 133.73 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.09 -28.33 10.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.706 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.25 120.29 9.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.924 HD13 HD11 ' A' ' 97' ' ' LEU . 2.8 mt -105.34 104.93 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 57.01 21.16 6.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.26 8.16 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -71.6 111.58 10.86 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.83 168.53 24.36 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.48 2.12 . . . . 0.0 112.005 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.456 HG21 ' HG3' ' A' ' 55' ' ' PRO . 17.5 p -143.72 10.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.59 -17.1 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.56 46.36 1.9 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.32 171.73 19.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.779 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.673 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -78.43 151.71 32.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.778 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -71.21 -30.0 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 pt-20 -54.44 -39.78 67.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.152 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -36.48 79.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.691 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -67.56 -33.68 75.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.42 0.629 . . . . 0.0 110.128 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.97 81.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.838 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 4.0 mm100 -70.24 -56.2 7.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.839 0.352 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.924 HD11 HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -52.28 -41.84 63.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.332 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.863 HD13 HD13 ' A' ' 41' ' ' LEU . 2.6 mt -68.65 -56.13 9.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.262 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -50.84 -28.74 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.164 0.507 . . . . 0.0 109.715 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.643 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -120.67 38.96 3.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.544 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.837 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -103.84 36.16 2.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.167 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 1.4 m -121.57 15.88 11.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.643 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.7 mp -71.59 -47.48 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.564 0.697 . . . . 0.0 111.216 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.95 3.67 44.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 m 63.04 18.46 10.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.666 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER -173.22 150.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.095 0.474 . . . . 0.0 111.956 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' A' ' 101' ' ' SER . 45.2 t -145.06 138.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.396 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.594 ' C ' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -113.12 125.48 54.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 110.486 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.624 HD22 HG23 ' A' ' 81' ' ' ILE . 1.3 mt -119.21 164.95 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.89 105.94 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.42 HD13 ' OD2' ' A' ' 76' ' ' ASP . 24.3 pt -104.7 150.24 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.735 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -124.11 115.0 20.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 11.8 p90 -135.71 174.17 10.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.43 . . . . 0.0 111.406 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.24 155.01 18.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.636 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 21' ' ' HIS . 20.9 t -91.77 104.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 0.0 111.471 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.816 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -167.95 137.25 2.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.656 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HG2' ' CB ' ' A' ' 167' ' ' ARG . 6.9 mm-40 -146.63 25.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.635 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.76 65.59 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.249 0.547 . . . . 0.0 111.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.506 HG12 HG12 ' A' ' 128' ' ' VAL . 6.1 m -97.84 147.57 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.215 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.645 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.7 pp -130.04 92.93 35.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 0.0 111.024 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 68.3 Cg_endo -96.37 -178.52 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.349 2.699 . . . . 0.0 112.673 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.33 35.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.415 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.51 119.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.826 0.346 . . . . 0.0 110.776 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.42 -51.73 3.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.434 ' CG2' ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -115.32 105.02 12.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.854 0.359 . . . . 0.0 110.551 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.869 ' CE1' HG21 ' A' ' 170' ' ' THR . 0.9 OUTLIER -113.34 120.94 42.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.783 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.568 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.6 m80 -109.82 152.71 25.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 206' ' ' LEU . 17.8 m -131.07 98.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.284 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.3 105.43 17.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.779 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.472 HD13 HG23 ' A' ' 164' ' ' VAL . 0.6 OUTLIER -128.04 133.11 24.77 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.977 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.76 136.03 37.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.351 2.034 . . . . 0.0 112.075 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.495 ' NZ ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -118.78 158.13 26.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.683 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -115.62 -166.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.796 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -58.5 -57.2 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -164.48 48.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 133' ' ' LYS . 97.2 t -75.94 159.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.504 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.1 tt0 -47.54 111.9 0.48 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.321 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.845 HD22 ' CD1' ' A' ' 140' ' ' ILE . 4.4 mt -116.11 112.5 21.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.565 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.72 45.85 2.92 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.691 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.845 ' CD1' HD22 ' A' ' 138' ' ' LEU . 20.7 mt -111.01 130.26 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 120.65 0.262 . . . . 0.0 111.064 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 157' ' ' SER . 7.4 m -126.73 133.08 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.758 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.73 ' CD1' HD13 ' A' ' 197' ' ' LEU . 3.2 mt -105.4 163.44 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.489 ' N ' HG22 ' A' ' 142' ' ' ILE . 5.3 p -166.43 123.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 p -84.0 117.15 67.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.731 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo . . . . . 0 C--N 1.347 0.452 0 C-N-CA 122.311 2.008 . . . . 0.0 112.298 -179.988 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.6 t0 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.823 0.344 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.65 -161.71 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.031 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.876 HD22 ' HA ' ' A' ' 190' ' ' MET . 0.3 OUTLIER -134.39 173.74 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.869 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 175' ' ' ASP . 33.8 m -156.38 -176.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.093 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.593 ' N ' HD13 ' A' ' 156' ' ' ILE . 1.4 mm -76.14 154.28 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.694 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.564 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.3 OUTLIER -135.59 -9.18 2.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 173.21 147.44 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.392 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.713 HG21 ' CG ' ' A' ' 166' ' ' HIS . 3.2 mt -130.69 150.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.61 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HE2' ' HA3' ' A' ' 162' ' ' GLY . 0.1 OUTLIER -121.77 134.7 54.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 110.438 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.757 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.6 OUTLIER -80.11 86.33 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 0.0 111.009 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 71' ' ' VAL . . . -177.24 -32.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.241 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.4 169.59 8.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.472 HG23 HD13 ' A' ' 130' ' ' LEU . 8.3 m -58.92 -21.53 19.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.067 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.932 ' O ' HG22 ' A' ' 168' ' ' THR . . . -43.57 -71.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.713 ' CG ' HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.63 -24.93 67.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 0.0 111.266 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.436 HH22 ' N ' ' A' ' 162' ' ' GLY . 19.5 mmt-85 -58.81 -38.23 78.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.022 HG21 HD12 ' A' ' 171' ' ' LEU . 14.9 t -57.68 -30.46 65.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.43 ' HA2' HG11 ' A' ' 115' ' ' VAL . . . 83.49 -72.51 2.82 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.616 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.869 HG21 ' CE1' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -42.46 -29.56 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 1.022 HD12 HG21 ' A' ' 168' ' ' THR . 0.2 OUTLIER -60.24 86.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.38 158.75 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.6 mt -68.31 72.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.834 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.06 40.05 0.02 OUTLIER Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.634 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.538 ' O ' HG12 ' A' ' 155' ' ' VAL . 54.2 m-20 -121.48 118.02 28.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' A' ' 155' ' ' VAL . 29.9 mmtt -75.85 108.36 8.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 206' ' ' LEU . 1.6 mt -75.94 152.18 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.69 HD22 ' NZ ' ' A' ' 207' ' ' LYS . 7.3 tt -139.96 -57.11 0.56 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.744 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -109.97 155.95 21.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.346 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 179' ' ' ALA . 23.2 mm -139.61 110.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.267 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 38.9 t70 53.73 51.81 14.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.394 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.4 t-20 82.82 -30.5 0.09 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 37.3 mm -73.5 151.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.35 119.07 22.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.24 0.543 . . . . 0.0 112.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -82.13 -12.34 58.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.903 178.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t70 51.18 52.6 14.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.63 74.51 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.657 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.91 -169.69 2.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.061 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.0 m -58.04 154.88 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.876 ' HA ' HD22 ' A' ' 154' ' ' LEU . 36.2 ttp -74.17 -35.23 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.6 mt-10 -51.8 -48.52 63.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.171 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 0.8 OUTLIER -49.54 -52.13 31.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.646 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 154' ' ' LEU . . . -55.51 -37.83 68.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.314 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.814 HG12 ' NE2' ' A' ' 198' ' ' GLN . 21.6 t -62.78 -30.86 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.077 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 192' ' ' ASP . 13.3 mm-40 -66.54 -50.34 63.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.089 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.478 HG22 ' SG ' ' A' ' 200' ' ' CYS . 1.1 mp -73.72 -24.69 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.124 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.73 HD13 ' CD1' ' A' ' 142' ' ' ILE . 0.1 OUTLIER -63.15 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.474 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.814 ' NE2' HG12 ' A' ' 194' ' ' VAL . 21.9 mt-30 -89.47 -40.09 12.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -14.7 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.804 ' HB3' HG22 ' A' ' 204' ' ' VAL . 2.2 m -85.02 41.78 0.89 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.72 62.59 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.222 0.535 . . . . 0.0 111.076 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -174.48 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.312 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.7 tt 177.56 109.32 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.124 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.804 HG22 ' HB3' ' A' ' 200' ' ' CYS . 24.0 t -103.12 116.03 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.891 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 4.4 ttmm -108.77 108.37 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.624 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.579 HD12 HG21 ' A' ' 128' ' ' VAL . 3.4 mt -97.12 117.16 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.415 . . . . 0.0 111.376 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.69 ' NZ ' HD22 ' A' ' 178' ' ' LEU . 26.2 tttt -97.8 101.07 12.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -109.43 179.38 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 2.4 mtp180 -109.41 135.25 50.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.012 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 211' ' ' ASP . 0.0 OUTLIER -132.37 159.87 37.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' A' ' 116' ' ' ALA . 35.1 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.883 0.373 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -133.94 116.62 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.834 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -50.58 147.98 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.445 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.4 173.0 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 152.71 39.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.56 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 9.0 t -149.06 170.37 18.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -101.59 162.16 13.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 108' ' ' THR . 0.7 OUTLIER -142.22 145.85 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.58 109.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.791 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.055 HD11 HD11 ' A' ' 72' ' ' LEU . 1.2 mm? -108.18 141.05 40.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.317 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -123.43 160.95 25.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.355 0.597 . . . . 0.0 112.089 -178.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.627 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -101.67 149.24 24.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.34 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -133.42 148.84 70.49 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.75 8.6 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 112.681 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.07 -48.7 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.427 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 t -136.36 -3.27 2.17 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 32' ' ' ASP . . . 89.2 -94.61 2.01 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.308 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 10.4 m-85 -121.68 -70.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.773 -0.251 . . . . 0.0 111.042 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 133.35 0.44 4.13 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 119.779 -1.201 . . . . 0.0 114.374 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.963 HG23 HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -128.05 130.51 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.621 0.71 . . . . 0.0 112.03 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.08 128.77 56.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 98' ' ' LEU . 2.4 pp -121.0 157.54 29.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.631 . . . . 0.0 112.559 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.464 ' O ' HD23 ' A' ' 56' ' ' LEU . 8.8 pt20 -111.25 170.04 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.199 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.57 16.23 14.36 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.385 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -97.51 85.38 3.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.116 0.484 . . . . 0.0 110.639 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.986 HG22 HD22 ' A' ' 56' ' ' LEU . 3.0 t -99.82 -75.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 46.2 p90 -57.19 -46.3 82.96 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.566 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.519 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 50.42 74.17 0.23 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.434 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER 163.66 75.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 64.57 163.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.87 -169.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.677 HD13 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -137.42 -105.06 0.19 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.107 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.461 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER 50.31 21.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.533 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.64 ' HB2' HG23 ' A' ' 45' ' ' VAL . 1.4 p -76.04 110.18 10.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.66 ' HD2' HG21 ' A' ' 45' ' ' VAL . 65.0 Cg_endo -72.92 140.48 31.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.292 1.995 . . . . 0.0 112.052 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.627 ' HB3' HD13 ' A' ' 41' ' ' LEU . 72.0 Cg_exo -51.06 125.81 17.22 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.482 2.121 . . . . 0.0 112.221 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.986 HD22 HG22 ' A' ' 45' ' ' VAL . 1.3 pt? -131.06 104.16 6.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.929 0.395 . . . . 0.0 111.515 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.743 HD13 ' HB ' ' A' ' 39' ' ' ILE . 37.6 mt -59.63 153.69 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.659 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.423 ' N ' HG22 ' A' ' 57' ' ' ILE . 35.9 t -145.42 22.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' H ' HG22 ' A' ' 57' ' ' ILE . 75.7 t80 -177.42 146.33 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.256 0.55 . . . . 0.0 112.088 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.963 HD13 HG23 ' A' ' 39' ' ' ILE . 7.5 mm -115.21 162.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.084 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -113.46 121.75 45.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.713 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -58.77 105.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.868 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.0 m-20 89.17 51.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.475 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -130.12 145.88 59.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.795 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 34.5 Cg_exo -57.29 -17.0 24.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.219 1.946 . . . . 0.0 112.044 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.792 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -67.87 -57.22 6.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 4.7 tp10 -78.62 -28.49 45.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 3.0 mmt-85 -87.66 -3.66 58.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.57 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -58.69 -53.32 59.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.504 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.16 -3.0 5.91 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.058 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 71' ' ' VAL . 43.8 t -155.03 61.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 117.001 0.401 . . . . 0.0 111.671 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.055 HD11 HD11 ' A' ' 29' ' ' LEU . 8.2 mt -143.06 154.15 43.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.0 111.163 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -161.85 146.25 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 59' ' ' TYR . 23.2 mt -61.0 108.72 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.7 41.8 0.99 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.92 126.21 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -101.84 86.64 2.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 19.1 m -83.84 134.84 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -108.65 -26.7 10.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.07 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.19 138.95 52.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.815 HG23 ' CD1' ' A' ' 109' ' ' LEU . 12.8 mt -133.77 109.29 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.991 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.0 m120 59.53 24.05 12.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.979 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.49 -27.07 19.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.7 mt -73.06 136.88 79.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.22 -168.27 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.546 2.164 . . . . 0.0 112.3 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.7 p -157.0 -44.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.45 -17.15 62.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.444 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -116.65 41.99 2.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.036 0.446 . . . . 0.0 110.684 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m -166.7 -170.24 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.677 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -83.91 148.21 27.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -70.02 -36.03 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.1 tt0 -54.73 -34.63 62.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -52.18 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 109.766 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -54.84 -31.88 59.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.189 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.12 -35.51 76.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.19 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 17.9 mm-40 -63.16 -41.15 99.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.215 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.687 HD12 ' HA ' ' A' ' 94' ' ' ALA . 8.8 mt -63.04 -50.34 71.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.114 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.836 HD13 HD21 ' A' ' 41' ' ' LEU . 1.5 mt -70.6 -54.1 13.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.8 ppt_? -50.76 -29.39 11.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.186 0.517 . . . . 0.0 109.646 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -123.16 40.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.313 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.849 ' HB2' HG21 ' A' ' 107' ' ' VAL . 6.1 p -90.8 20.18 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.584 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -114.63 15.57 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.7 mt -75.57 -48.75 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.81 -0.36 57.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.883 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.621 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 5.9 p 65.11 18.26 11.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.797 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.66 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER -166.21 157.12 13.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.849 HG21 ' HB2' ' A' ' 101' ' ' SER . 41.7 t -158.63 131.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -111.55 124.56 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.701 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.815 ' CD1' HG23 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -124.48 165.15 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.374 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -126.23 107.17 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.18 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.7 pt -99.58 162.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.841 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -131.08 115.17 16.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.375 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.56 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.6 OUTLIER -132.84 174.04 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.37 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.1 149.05 24.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.211 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 25.8 t -89.98 103.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 111.462 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.62 ' HB2' HG11 ' A' ' 20' ' ' VAL . . . 161.33 -178.96 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.036 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' SER . 6.8 pt-20 172.52 -36.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.15 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 13.2 t 170.69 106.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.795 HG21 HG21 ' A' ' 170' ' ' THR . 12.0 p -144.38 143.96 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.045 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.756 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.2 pp -132.36 101.98 14.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.9 Cg_endo -83.97 156.01 13.29 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.0 112.604 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -162.73 18.42 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.669 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.8 OUTLIER 56.2 117.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 96.46 -42.72 2.18 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.701 HG22 ' CD ' ' A' ' 207' ' ' LYS . 0.0 OUTLIER -135.78 102.66 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.404 . . . . 0.0 110.433 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.696 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.4 OUTLIER -100.75 123.28 44.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.756 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.42 116.76 32.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.338 . . . . 0.0 111.079 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 168' ' ' THR . 12.1 t -100.94 105.49 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.918 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.814 ' CD ' HD11 ' A' ' 203' ' ' LEU . 0.0 OUTLIER -81.25 113.12 19.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.931 -179.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 128' ' ' VAL . 1.7 mp -119.53 129.48 25.35 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.76 123.79 8.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.238 1.958 . . . . 0.0 111.314 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.819 ' HZ1' HD21 ' A' ' 138' ' ' LEU . 1.8 mmtp -89.64 159.89 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.225 0.536 . . . . 0.0 111.341 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.477 ' H ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.68 -167.14 1.89 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.259 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -66.79 -69.47 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.18 93.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 133' ' ' LYS . 52.8 t -137.78 152.84 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.678 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.52 125.21 10.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.819 HD21 ' HZ1' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -78.18 -64.18 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.28 -13.45 55.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.483 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.814 HG13 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -99.3 143.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.205 0.502 . . . . 0.0 111.176 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 157' ' ' SER . 10.8 m -126.12 109.72 12.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.377 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.907 HD13 HG22 ' A' ' 194' ' ' VAL . 2.5 mt -74.65 164.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.077 0.465 . . . . 0.0 111.351 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.68 ' HB3' HG23 ' A' ' 155' ' ' VAL . 2.8 t -152.57 152.57 32.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.649 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.452 ' N ' ' HD2' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -94.53 -49.45 0.26 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.359 -179.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.87 ' O ' HG21 ' A' ' 155' ' ' VAL . 90.5 Cg_endo . . . . . 0 C--N 1.346 0.447 0 C-N-CA 122.366 2.044 . . . . 0.0 113.094 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.497 0.189 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.39 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.583 2.189 . . . . 0.0 112.445 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 190' ' ' MET . 4.0 mm? -66.61 174.92 2.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.783 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.87 HG21 ' O ' ' A' ' 145' ' ' PRO . 28.3 m -157.31 162.95 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.399 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 172' ' ' GLU . 3.7 mm -78.11 154.73 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -130.91 -33.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.578 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.805 ' O ' HD13 ' A' ' 159' ' ' ILE . 0.9 OUTLIER -175.1 164.75 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.186 0.517 . . . . 0.0 111.775 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 158' ' ' ASP . 3.4 mm -138.45 149.19 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.297 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -129.51 154.93 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -91.05 163.93 14.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 71' ' ' VAL . . . 86.22 -13.84 56.04 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.884 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.549 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 90.2 p -115.06 142.28 46.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.861 0.362 . . . . 0.0 111.02 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.416 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 12.6 m -48.12 -22.19 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.494 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.426 ' CB ' HG12 ' A' ' 140' ' ' ILE . . . -54.59 -52.65 61.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 111.304 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -83.5 -26.53 30.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.011 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 163' ' ' SER . 13.6 mmp_? -55.94 -50.76 69.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.463 HG21 HG11 ' A' ' 128' ' ' VAL . 13.3 t -58.62 -23.83 59.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.066 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 67.29 -152.7 52.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.131 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.795 HG21 HG21 ' A' ' 119' ' ' VAL . 2.6 p 56.16 23.21 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 151.72 40.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.892 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.596 ' O ' HG21 ' A' ' 156' ' ' ILE . 3.5 mt-10 -164.02 -171.68 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.37 122.07 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.34 -7.21 12.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.843 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.508 ' CG ' HG21 ' A' ' 208' ' ' ILE . 0.4 OUTLIER -73.25 170.14 15.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.747 0.274 . . . . 0.0 110.834 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.08 136.07 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 111.118 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.541 HD11 HD23 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.5 135.5 39.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.432 HD12 ' HE ' ' A' ' 209' ' ' ARG . 7.8 tt -108.95 -53.24 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.75 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -141.08 171.9 13.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.315 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.662 HD11 ' HB1' ' A' ' 193' ' ' ALA . 34.1 mt -139.08 105.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 6.6 t70 61.59 -79.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.732 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.01 -25.02 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 184' ' ' ARG . 32.7 mm -91.4 158.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.75 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 72.8 mtt-85 -125.71 128.1 47.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.228 0.537 . . . . 0.0 112.234 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.599 HD11 ' N ' ' A' ' 193' ' ' ALA . 3.6 mm? -81.17 -3.95 53.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.892 178.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.8 -29.27 1.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.26 51.15 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 20.0 m -156.18 160.58 39.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.974 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 60.0 p -77.43 -170.8 1.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.752 ' HA ' HD11 ' A' ' 154' ' ' LEU . 14.0 ptm -74.05 -43.39 57.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.996 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -54.94 -30.36 58.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.02 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.79 ' O ' HD12 ' A' ' 196' ' ' ILE . 3.4 m-20 -60.98 -51.85 67.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.058 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.662 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -57.12 -42.38 80.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.223 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.907 HG22 HD13 ' A' ' 142' ' ' ILE . 43.9 t -61.87 -35.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.818 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.92 -49.88 73.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.966 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.79 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.9 mp -72.71 -24.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.066 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -59.71 -43.27 94.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.87 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.754 HE22 HG12 ' A' ' 194' ' ' VAL . 1.1 mp0 -94.37 -39.87 10.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.534 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.68 -22.1 32.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.054 0.454 . . . . 0.0 110.435 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.546 ' SG ' HG22 ' A' ' 196' ' ' ILE . 17.2 m -85.89 44.62 1.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.11 63.05 0.09 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.486 0.66 . . . . 0.0 111.885 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.456 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 5.1 m-20 -170.36 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.515 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.814 HD11 ' CD ' ' A' ' 129' ' ' LYS . 3.6 tt 174.77 109.29 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 132' ' ' LYS . 6.2 t -102.79 120.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.328 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 16.8 ttmm -106.3 108.13 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.541 HD23 HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -83.37 114.96 21.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.183 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.701 ' CD ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -95.72 93.03 6.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.508 HG21 ' CG ' ' A' ' 175' ' ' ASP . 9.9 mm -83.31 165.04 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.788 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -118.27 121.78 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.055 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.27 108.86 9.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 115' ' ' VAL . 93.4 t . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.936 0.398 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -107.36 112.01 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.13 144.61 2.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.43 173.07 13.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.716 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -130.84 146.88 52.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.6 t -138.02 -171.28 2.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -111.45 161.65 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.192 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 111' ' ' ILE . 2.2 t -139.37 150.23 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.654 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.97 109.78 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 111.495 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 72' ' ' LEU . 3.1 mm? -107.1 118.66 37.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.14 163.29 12.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 0.0 111.431 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.688 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -98.1 106.47 18.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.153 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.07 147.65 83.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.92 9.43 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.539 2.16 . . . . 0.0 112.838 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.01 -41.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.5 p -117.95 -29.91 5.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.837 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 52.75 73.45 0.4 Allowed Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.353 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.688 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 54.9 m-85 73.46 89.67 0.09 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.027 0.441 . . . . 0.0 110.261 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.07 26.95 5.2 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.302 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.949 HD11 ' HB1' ' A' ' 66' ' ' ALA . 9.4 mt -92.26 151.96 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.159 0.504 . . . . 0.0 111.271 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.04 101.39 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.133 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.969 HD13 HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -95.87 134.96 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.204 0.526 . . . . 0.0 111.755 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -90.37 152.3 21.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.261 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' CA ' ' CE2' ' A' ' 91' ' ' PHE . . . -65.01 -82.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -108.08 157.97 17.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.405 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.024 HG21 HD22 ' A' ' 56' ' ' LEU . 44.7 t -138.09 -63.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.964 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.807 ' O ' HG22 ' A' ' 48' ' ' THR . 18.0 p90 -29.21 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.804 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.469 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 42.23 72.2 0.18 Allowed 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.51 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 166.08 90.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.385 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 50' ' ' THR . 29.4 tp10 63.27 156.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 51' ' ' LEU . 3.6 t 47.31 -177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.455 0.645 . . . . 0.0 111.779 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -161.87 22.31 0.11 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.202 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.61 21.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 51' ' ' LEU . 38.0 m -94.08 92.74 0.78 Allowed Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.642 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.58 171.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 0.0 112.092 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.726 ' HB2' HD22 ' A' ' 41' ' ' LEU . 6.6 Cg_endo -48.72 128.72 19.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.641 2.228 . . . . 0.0 111.86 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.024 HD22 HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -119.07 110.39 17.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.179 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.574 HD13 HG23 ' A' ' 39' ' ' ILE . 15.0 mt -56.42 116.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.009 0.433 . . . . 0.0 111.183 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -101.07 -6.84 23.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 60.4 t80 -178.16 131.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 61' ' ' GLU . 2.4 mt -108.29 176.31 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.636 ' H ' HG22 ' A' ' 60' ' ' ILE . 76.5 tt0 -109.56 154.84 22.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.524 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -85.47 50.15 1.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.36 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 16.1 t0 178.07 36.84 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.586 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.426 ' H ' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -133.61 132.12 21.62 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.75 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -10.57 12.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.537 2.158 . . . . 0.0 112.65 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.949 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -70.6 -52.89 18.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.05 0.453 . . . . 0.0 110.393 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' CB ' HG21 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -72.45 -29.18 63.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.205 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.437 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -94.21 -2.28 52.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.701 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.409 ' HG ' ' HB2' ' A' ' 72' ' ' LEU . 21.8 p -46.0 -31.52 2.3 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.74 0.305 . . . . 0.0 111.416 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.62 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 93.66 30.02 9.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.852 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 71' ' ' VAL . 14.3 p -179.6 39.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.862 HD12 ' O ' ' A' ' 66' ' ' ALA . 7.8 mt -131.35 174.07 10.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -156.04 163.37 39.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.705 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.532 HD13 HG13 ' A' ' 60' ' ' ILE . 32.4 mm -68.65 70.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.39 79.65 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.756 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.759 ' OD2' HD22 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -114.45 111.83 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.718 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.31 135.21 53.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.097 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 109' ' ' LEU . 20.3 t -104.46 120.61 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.0 tpt -87.59 -29.68 21.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -162.97 141.81 8.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.92 HG23 ' CD2' ' A' ' 109' ' ' LEU . 5.4 mt -113.52 109.42 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.628 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.532 HD22 HG22 ' A' ' 81' ' ' ILE . 12.9 p30 46.93 27.8 0.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.86 6.5 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.734 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mm -69.19 111.19 7.79 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 120.602 0.239 . . . . 0.0 111.512 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.73 148.62 59.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.49 -24.6 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -73.79 -6.95 50.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.587 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.18 46.4 2.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.889 0.376 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m 177.94 -179.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 m -79.46 158.65 27.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.822 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CE2' ' CA ' ' A' ' 43' ' ' GLY . 12.0 p90 -73.08 -29.45 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.08 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.3 mt-10 -54.56 -34.13 61.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.331 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 94' ' ' ALA . 14.6 pt-20 -61.47 -47.35 86.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.279 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.818 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -57.88 -38.45 75.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.375 0.607 . . . . 0.0 110.097 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 2.5 m120 -58.86 -42.87 90.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.377 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 3.5 mm100 -63.0 -47.3 83.69 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.722 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.821 HD12 HD12 ' A' ' 81' ' ' ILE . 39.3 mt -52.47 -39.72 61.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.969 HD13 HD13 ' A' ' 41' ' ' LEU . 1.2 mt -74.1 -42.56 59.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.738 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 11.0 mtm180 -50.55 -34.97 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.266 0.555 . . . . 0.0 109.669 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -121.07 38.93 3.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.168 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.428 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -86.58 10.39 15.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.644 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -109.14 16.35 22.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.772 0.32 . . . . 0.0 111.757 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.9 mt -71.47 -49.99 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.817 0.818 . . . . 0.0 110.399 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 6.96 47.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.717 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.0 t 56.26 22.71 6.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.6 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.1 OUTLIER -163.76 156.76 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.551 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 109' ' ' LEU . 33.3 t -156.91 125.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.38 131.85 51.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.92 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -139.18 153.33 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 0.0 111.411 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.27 121.91 44.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.165 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.482 HG23 HG21 ' A' ' 27' ' ' VAL . 28.5 pt -112.5 145.49 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 111.848 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -111.36 140.29 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.116 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -153.61 174.34 14.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.621 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -100.89 116.19 32.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.353 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.813 ' O ' HG13 ' A' ' 20' ' ' VAL . 19.2 m -61.61 145.21 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.658 ' HB3' HG22 ' A' ' 20' ' ' VAL . . . 79.57 119.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.42 19.62 0.55 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.325 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER 176.91 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.861 0.362 . . . . 0.0 111.338 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.935 HG11 ' CG2' ' A' ' 170' ' ' THR . 0.0 OUTLIER -158.16 131.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -113.53 94.41 31.99 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.8 Cg_endo -85.69 150.02 9.96 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.8 2.333 . . . . 0.0 112.769 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.27 23.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.212 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.31 116.98 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.57 -45.85 1.99 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.9 102.79 5.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 110.647 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CE1' HG12 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -110.06 115.21 29.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.031 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.569 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -96.66 150.14 21.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.93 0.395 . . . . 0.0 110.791 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.549 HG12 ' HG ' ' A' ' 130' ' ' LEU . 18.3 t -124.59 95.48 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.0 mttt -81.76 98.15 8.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.21 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.549 ' HG ' HG12 ' A' ' 128' ' ' VAL . 7.2 mt -108.12 130.65 22.51 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.69 119.3 6.13 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.511 2.141 . . . . 0.0 111.454 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.828 ' HG3' HG23 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -108.31 158.61 17.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.169 0.509 . . . . 0.0 111.536 -179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -108.89 -164.84 0.97 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.323 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.39 -47.45 86.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.06 77.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.699 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.62 HG11 ' HA2' ' A' ' 70' ' ' GLY . 16.7 t -112.75 160.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.489 ' N ' HG12 ' A' ' 136' ' ' VAL . 29.6 tt0 -54.95 117.17 3.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.57 HD21 ' HD3' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -98.31 -61.07 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.551 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . 94.43 30.29 8.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.153 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -105.07 143.51 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.748 0.274 . . . . 0.0 110.866 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 157' ' ' SER . 86.6 m -126.09 136.76 53.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.796 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.959 HD13 HG22 ' A' ' 194' ' ' VAL . 2.3 mt -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.497 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -161.65 153.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.2 t -105.12 136.96 19.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo . . . . . 0 C--N 1.345 0.36 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.406 ' N ' ' CD ' ' A' ' 153' ' ' PRO . 55.2 t0 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 152' ' ' ASP . 61.4 Cg_endo -73.31 -179.26 4.24 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.818 HD12 ' CG2' ' A' ' 142' ' ' ILE . 4.4 mm? -100.52 167.4 10.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.695 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 175' ' ' ASP . 6.5 p -155.83 136.07 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.418 HD13 HD23 ' A' ' 171' ' ' LEU . 2.0 mt -65.44 151.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.663 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.401 ' HB3' ' CG2' ' A' ' 141' ' ' THR . 0.1 OUTLIER -124.85 -12.55 7.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.31 143.77 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.902 0.382 . . . . 0.0 111.204 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.43 HG21 ' CA ' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -131.0 149.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -98.36 146.96 25.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 111.132 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 173.16 10.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.995 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.68 -62.78 1.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 5.7 p -61.78 144.06 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 0.0 111.129 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.0 m -48.78 -21.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.144 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 168' ' ' THR . . . -48.04 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.312 . . . . 0.0 111.437 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.43 ' CA ' HG21 ' A' ' 159' ' ' ILE . 36.3 t60 -76.15 -24.26 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.736 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.76 -45.72 74.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 165' ' ' ALA . 5.3 t -61.48 88.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.476 ' C ' HG22 ' A' ' 170' ' ' THR . . . -50.97 88.27 0.01 OUTLIER Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.742 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.935 ' CG2' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER 164.79 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 110.328 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.861 HD11 HD12 ' A' ' 206' ' ' LEU . 3.2 tt -84.21 57.11 4.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.96 162.82 17.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.598 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -82.52 54.66 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.133 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.28 25.72 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.869 ' O ' HG23 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -124.78 -176.79 3.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 110.558 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 209' ' ' ARG . 1.0 OUTLIER -134.6 130.14 36.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 111.368 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 180' ' ' ILE . 0.8 OUTLIER -115.33 152.26 33.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 178' ' ' LEU . 4.0 pp -137.44 10.46 2.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.632 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.866 ' HB3' ' CB ' ' A' ' 207' ' ' LYS . . . -152.89 144.95 23.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 177' ' ' LEU . 31.3 mm -139.27 111.67 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 35.6 t70 51.59 52.64 14.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 31.1 t30 84.72 -34.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 184' ' ' ARG . 45.1 mm -68.64 159.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.752 0.31 . . . . 0.0 110.783 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 183' ' ' ILE . 67.3 mtm180 -133.86 129.76 36.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.192 0.52 . . . . 0.0 112.299 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.561 ' HG ' HD23 ' A' ' 154' ' ' LEU . 3.4 mm? -75.08 -5.27 43.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.623 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -45.93 -29.55 1.45 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 m -123.26 30.28 6.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.42 165.11 36.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.998 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.14 -169.89 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.667 ' CB ' HD11 ' A' ' 154' ' ' LEU . 12.9 ptm -70.34 -42.01 72.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.6 mt-10 -53.9 -34.93 60.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.052 0.453 . . . . 0.0 111.006 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.711 ' O ' HD12 ' A' ' 196' ' ' ILE . 35.8 t70 -61.07 -48.23 82.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.222 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -58.51 -39.11 79.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.959 HG22 HD13 ' A' ' 142' ' ' ILE . 13.5 t -63.0 -33.37 60.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.097 0.475 . . . . 0.0 109.998 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -49.65 70.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.848 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.8 mp -74.71 -24.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.167 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.771 HD22 HD11 ' A' ' 142' ' ' ILE . 0.0 OUTLIER -61.25 -40.67 94.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 110.216 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.647 ' NE2' HG12 ' A' ' 194' ' ' VAL . 18.1 mt-30 -89.7 -41.26 12.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.112 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.58 -18.63 60.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.752 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.65 ' SG ' HG22 ' A' ' 196' ' ' ILE . 4.1 m -81.74 44.95 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.235 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 1.1 pt-20 -74.53 61.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.187 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.8 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.82 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 130' ' ' LEU . 12.4 tp -176.67 104.37 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 132' ' ' LYS . 59.1 t -98.32 108.56 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.147 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 28.1 ttmt -100.21 108.19 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.861 HD12 HD11 ' A' ' 171' ' ' LEU . 43.1 mt -94.36 108.2 20.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.455 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.866 ' CB ' ' HB3' ' A' ' 179' ' ' ALA . 28.8 tttt -83.11 93.43 7.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.648 HD13 ' HB3' ' A' ' 177' ' ' LEU . 9.5 mm -88.99 164.13 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.352 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -126.54 127.8 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.838 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.02 123.14 39.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.111 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.786 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.608 HG11 ' CB ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.448 ' O ' HG22 ' A' ' 115' ' ' VAL . 12.7 t60 -115.79 111.02 19.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.996 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -55.44 139.53 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' HB2' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -134.89 173.18 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.6 OUTLIER -121.68 150.54 41.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.715 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 8.8 t -142.87 163.48 32.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -102.5 161.14 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.636 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -145.95 147.73 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG13 ' CD ' ' A' ' 106' ' ' LYS . 45.7 t -126.26 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.944 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.88 HD21 HD21 ' A' ' 72' ' ' LEU . 4.3 mm? -107.51 123.23 48.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.449 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -111.16 161.86 15.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.169 0.509 . . . . 0.0 111.821 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.839 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -104.42 116.13 31.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -83.19 154.88 67.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.56 179.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.2 6.57 4.6 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.497 2.131 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.39 -49.82 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.489 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.8 p -137.2 -2.73 2.02 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -110.34 3.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.349 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.839 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 6.6 m-85 -106.05 129.24 54.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.906 0.384 . . . . 0.0 110.064 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.47 24.93 20.59 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.884 -0.674 . . . . 0.0 114.473 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.833 ' CG2' HD13 ' A' ' 60' ' ' ILE . 1.1 pp -122.67 128.54 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.578 0.689 . . . . 0.0 111.503 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -111.26 127.4 55.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.235 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -96.73 154.06 17.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.105 0.478 . . . . 0.0 111.715 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.58 168.85 8.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.494 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . -68.41 -117.68 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.801 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -108.57 132.46 53.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 46' ' ' PHE . 2.8 t -89.79 -70.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.871 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.696 ' O ' HG22 ' A' ' 48' ' ' THR . 13.4 p90 -25.3 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.854 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.75 72.28 0.16 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.562 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.7 t 174.12 40.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' THR . 2.7 mt-10 164.71 -169.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.747 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.86 -94.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -152.98 -82.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.365 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.69 16.43 0.99 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -145.12 74.41 14.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' A' ' 91' ' ' PHE . 49.6 Cg_exo -55.47 -175.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.785 ' HB2' HD22 ' A' ' 41' ' ' LEU . 87.4 Cg_exo -46.8 125.23 9.47 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.47 2.113 . . . . 0.0 112.069 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 56' ' ' LEU . 1.9 mp -115.36 113.44 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.62 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 76' ' ' ASP . 56.7 mt -58.17 121.92 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.449 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.431 ' HA ' HG23 ' A' ' 74' ' ' ILE . 7.2 t -124.81 25.88 7.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 60' ' ' ILE . 25.8 t80 -173.52 138.9 0.71 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.053 0.454 . . . . 0.0 111.662 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.833 HD13 ' CG2' ' A' ' 39' ' ' ILE . 30.8 mm -112.21 160.3 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.538 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -112.52 155.79 23.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -100.29 55.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER 166.89 41.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.091 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.42 ' H ' ' NH1' ' A' ' 68' ' ' ARG . 2.9 m -141.2 144.34 34.2 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.8 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 32' ' ' ASP . 55.6 Cg_endo -69.8 -0.11 6.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.633 2.222 . . . . 0.0 112.819 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HA ' HD13 ' A' ' 29' ' ' LEU . . . -68.12 -56.92 7.08 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.341 0.591 . . . . 0.0 110.301 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 7.2 pm0 -80.12 -29.6 38.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.023 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.575 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -70.66 -27.31 63.93 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.018 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 53.6 t -49.46 -43.23 44.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.541 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 106.16 20.88 8.85 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.728 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 71' ' ' VAL . 13.5 t -153.66 41.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.88 HD21 HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -124.44 157.26 35.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.02 158.2 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 60' ' ' ILE . 19.8 mm -66.98 75.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.304 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 148.83 69.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.728 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -106.02 78.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.528 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -55.21 -40.89 71.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 109' ' ' LEU . 46.6 t 65.08 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.263 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -27.98 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -155.78 137.33 14.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.883 HD12 HD12 ' A' ' 97' ' ' LEU . 8.1 mt -114.23 106.96 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.79 ' OD1' HG22 ' A' ' 81' ' ' ILE . 6.6 m120 58.79 20.77 8.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.169 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.46 -34.27 4.61 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.571 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.0 mt -67.73 127.42 93.37 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.497 0.189 . . . . 0.0 110.995 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.36 -179.28 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.456 2.104 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.8 p -147.45 -45.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.91 -13.11 61.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -118.93 46.55 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.4 p -171.92 -177.5 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.649 ' HA ' HD13 ' A' ' 51' ' ' LEU . 54.1 m -81.21 141.5 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.794 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 6.6 p90 -61.74 -37.25 83.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 90' ' ' THR . 1.8 tt0 -55.23 -36.02 65.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.264 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 90' ' ' THR . 0.6 OUTLIER -61.51 -52.34 64.89 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -54.85 -33.58 61.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.412 0.625 . . . . 0.0 110.217 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -63.74 -40.3 96.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.978 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 18.0 mm-40 -61.59 -44.17 97.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.229 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.883 HD12 HD12 ' A' ' 81' ' ' ILE . 44.0 mt -56.29 -43.66 79.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.415 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.751 HD22 HD11 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -70.41 -51.2 31.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.812 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -50.28 -30.53 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.138 0.494 . . . . 0.0 109.801 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.7 t0 -121.71 38.22 4.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.362 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.604 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.75 25.54 6.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.323 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.3 p -119.16 13.09 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.9 mt -68.12 -46.4 81.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 110.565 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -1.55 54.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.573 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.797 ' O ' HG22 ' A' ' 30' ' ' THR . 0.8 OUTLIER 62.86 26.56 15.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -169.35 153.82 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 101' ' ' SER . 60.1 t -153.59 150.9 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.04 135.12 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.337 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.775 ' HB3' HG13 ' A' ' 78' ' ' VAL . 3.2 mt -136.81 149.21 47.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 111.628 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.72 105.9 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.981 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.462 HG13 HG22 ' A' ' 25' ' ' THR . 30.2 pt -103.47 154.52 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.15 0.5 . . . . 0.0 112.165 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 24' ' ' THR . 32.5 tt0 -126.38 138.42 53.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.99 173.58 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 111.327 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.34 106.14 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.252 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 18.5 m -61.92 103.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.823 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.608 ' CB ' HG11 ' A' ' 20' ' ' VAL . . . 153.0 129.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.022 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -161.96 22.54 0.11 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.253 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER 169.48 93.75 0.0 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.033 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.597 HG13 ' CE1' ' A' ' 126' ' ' PHE . 23.2 t -139.6 118.8 12.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.869 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 127' ' ' HIS . 1.1 pp -137.26 78.19 40.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 121.692 0.758 . . . . 0.0 110.691 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 119' ' ' VAL . 70.7 Cg_endo -94.65 176.74 1.02 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.229 2.619 . . . . 0.0 112.878 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -172.96 33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.895 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.73 117.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 89.25 -44.4 3.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.032 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.842 HG22 ' HD3' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -122.7 103.94 8.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.752 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.597 ' CE1' HG13 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -110.62 124.46 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.504 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.587 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -118.08 144.6 45.49 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.687 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.543 HG12 HD12 ' A' ' 130' ' ' LEU . 2.9 t -130.27 111.1 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.506 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' SER . 11.1 mttp -80.72 101.31 9.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.885 HD11 ' CG2' ' A' ' 168' ' ' THR . 1.9 mp -107.32 113.71 61.75 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.515 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.6 115.53 3.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.297 1.998 . . . . 0.0 111.352 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.55 ' HG2' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -100.37 158.75 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.73 -164.62 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.776 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -57.65 -48.39 79.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.71 50.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 111.277 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.673 HG23 ' HB2' ' A' ' 133' ' ' LYS . 46.1 t -89.63 144.13 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.414 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 40.6 tt0 -52.42 124.72 14.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' A' ' 165' ' ' ALA . 1.5 mp -90.57 -66.88 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 113.69 -2.22 24.66 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.05 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.559 HG23 HD21 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -95.78 135.58 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.342 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.689 HG22 ' HB3' ' A' ' 157' ' ' SER . 11.0 m -126.1 136.04 52.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.504 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.872 HD11 ' HG ' ' A' ' 197' ' ' LEU . 5.3 mt -105.35 164.12 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.543 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -154.63 151.61 29.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.691 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.6 p -118.78 107.47 42.38 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.05 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo . . . . . 0 C--N 1.346 0.414 0 C-N-CA 122.474 2.116 . . . . 0.0 112.106 179.85 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.8 t70 . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.04 -178.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.435 2.09 . . . . 0.0 112.359 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.552 HD11 ' HG ' ' A' ' 185' ' ' LEU . 2.8 mt -113.78 178.9 4.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.493 HG23 ' OG ' ' A' ' 143' ' ' SER . 24.2 m -157.27 175.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.42 ' HB ' HD23 ' A' ' 173' ' ' LEU . 4.2 mm -79.25 154.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.689 ' HB3' HG22 ' A' ' 141' ' ' THR . 10.7 t -130.8 -10.22 3.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.651 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.449 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 170.62 156.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.805 HG22 ' HB2' ' A' ' 166' ' ' HIS . 4.2 mt -142.49 139.34 29.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.765 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.409 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -114.26 145.47 41.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.933 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -85.78 168.61 14.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.582 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.425 ' N ' ' NH1' ' A' ' 167' ' ' ARG . . . 84.95 -52.73 4.74 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.504 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 34.2 m -81.14 153.69 27.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.854 HG23 HD23 ' A' ' 130' ' ' LEU . 18.3 m -48.72 -21.8 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 138' ' ' LEU . . . -46.88 -66.52 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.886 0.374 . . . . 0.0 111.655 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.805 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -83.36 -24.24 32.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.4 -29.84 50.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.4 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.885 ' CG2' HD11 ' A' ' 130' ' ' LEU . 22.3 p -45.25 -42.2 9.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.788 0.328 . . . . 0.0 111.393 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.83 -26.48 18.33 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.769 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.459 HG21 ' CE1' ' A' ' 126' ' ' PHE . 3.7 t -109.6 31.84 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -117.17 113.62 22.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -142.13 156.81 45.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 156' ' ' ILE . 14.9 mt -75.4 113.7 13.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.23 -17.2 2.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.779 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.631 ' HB3' HG21 ' A' ' 208' ' ' ILE . 5.4 m-20 -70.34 166.04 21.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.73 0.3 . . . . 0.0 110.794 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.28 114.25 24.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.019 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.675 HD12 HD12 ' A' ' 208' ' ' ILE . 0.3 OUTLIER -70.72 142.55 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.691 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.571 ' C ' HD23 ' A' ' 178' ' ' LEU . 7.5 tt -122.27 -55.22 1.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -143.49 176.07 9.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.081 0.467 . . . . 0.0 111.592 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 193' ' ' ALA . 25.3 mt -139.26 107.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.93 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.815 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 48.38 -85.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 180' ' ' ILE . 3.6 m-20 -108.07 -20.33 13.2 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.552 HG21 ' CD1' ' A' ' 196' ' ' ILE . 24.9 mm -100.08 140.95 18.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 111.512 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 0.9 OUTLIER -112.86 120.66 42.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.06 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.901 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 2.9 mm? -82.81 -5.21 58.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.375 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.67 -32.07 1.37 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.367 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 -16.78 9.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.579 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.6 m -85.24 -169.78 2.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 0.0 111.22 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.33 -173.36 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.414 ' CB ' HD22 ' A' ' 154' ' ' LEU . 1.0 OUTLIER -74.05 -52.01 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.01 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -51.8 -30.71 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 111.102 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.4 OUTLIER -62.19 -51.53 67.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.058 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.901 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -56.21 -39.41 72.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.239 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.708 HG12 ' NE2' ' A' ' 198' ' ' GLN . 19.1 t -61.01 -36.81 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.212 0.529 . . . . 0.0 109.902 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -49.86 76.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.843 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.552 ' CD1' HG21 ' A' ' 183' ' ' ILE . 1.5 mp -75.51 -24.13 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.027 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.872 ' HG ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -59.46 -36.17 75.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.708 ' NE2' HG12 ' A' ' 194' ' ' VAL . 5.1 mt-30 -100.11 -37.65 8.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.65 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.52 -19.57 49.17 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.931 ' CB ' HG13 ' A' ' 204' ' ' VAL . 1.1 m -84.4 43.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.41 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -68.56 62.87 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.283 0.563 . . . . 0.0 111.076 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 200' ' ' CYS . 1.8 m-20 -174.98 -32.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.056 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.4 tt 178.06 108.91 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.272 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.931 HG13 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.06 115.24 48.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.215 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HB3' ' CA ' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -96.32 107.9 20.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 208' ' ' ILE . 11.1 mp -81.91 113.58 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.842 ' HD3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -99.75 94.39 6.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.788 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.675 HD12 HD12 ' A' ' 177' ' ' LEU . 1.1 mm -94.16 170.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.989 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -112.82 131.6 55.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.919 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 115.37 29.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.824 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 115' ' ' VAL . 69.0 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -136.3 108.48 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.658 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 p -49.28 143.16 6.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 173.03 12.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -133.06 159.12 40.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.556 HG21 ' HA2' ' A' ' 162' ' ' GLY . 14.1 t -150.54 -169.96 3.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -121.65 161.0 23.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.428 HG13 ' HG ' ' A' ' 109' ' ' LEU . 1.7 p -136.65 151.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.392 0.615 . . . . 0.0 110.924 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.9 109.79 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.095 HD21 HD11 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -104.36 118.34 36.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.0 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -113.51 161.74 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.34 0.59 . . . . 0.0 112.195 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.891 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -107.0 109.75 21.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.457 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 8.4 p-10 -83.68 157.23 64.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.412 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.08 7.92 2.29 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.459 2.106 . . . . 0.0 112.98 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.64 -47.29 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.634 0.255 . . . . 0.0 111.247 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.3 p -144.58 6.53 1.25 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 61.71 -86.62 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.219 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 7.9 m-85 -128.06 113.98 16.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.51 19.51 47.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.523 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.095 HD13 HD13 ' A' ' 72' ' ' LEU . 16.2 pt -123.89 134.47 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.905 0.353 . . . . 0.0 110.69 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 3.2 pt20 -120.74 142.76 49.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.81 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.891 HD11 ' CD1' ' A' ' 98' ' ' LEU . 1.4 pt? -129.41 154.65 46.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.276 0.56 . . . . 0.0 111.921 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.19 8.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.339 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -104.23 -58.13 0.7 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.289 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -69.53 150.39 47.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.851 0.358 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 56' ' ' LEU . 86.4 t -142.02 -88.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.955 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.563 ' CE1' HG23 ' A' ' 50' ' ' THR . 52.9 p90 -56.78 -46.17 81.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.22 0.533 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.562 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 47.35 82.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.702 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 60.3 p -159.95 98.18 1.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.134 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' C ' HG22 ' A' ' 50' ' ' THR . 4.7 pt-20 52.37 35.36 17.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.525 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.563 HG23 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 165.78 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.773 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -160.67 23.78 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.789 0.328 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.12 21.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -72.28 138.18 81.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.795 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.16 156.91 33.79 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.457 2.105 . . . . 0.0 112.39 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.667 ' CB ' HD12 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -42.71 159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.003 2.469 . . . . 0.0 112.242 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.687 ' CD1' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -160.62 108.88 1.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.548 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.79 ' CD1' HD12 ' A' ' 39' ' ' ILE . 61.5 mt -59.88 135.78 24.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -125.25 17.24 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HB3' ' CG ' ' A' ' 40' ' ' GLN . 37.6 t80 -177.68 141.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.834 HG21 ' HB2' ' A' ' 67' ' ' GLU . 12.1 mm -131.01 148.43 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.077 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 62' ' ' ALA . 39.0 tt0 -95.55 151.84 18.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.943 0.401 . . . . 0.0 111.232 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.39 45.34 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.39 42.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.501 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.24 135.25 23.76 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.779 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 11.8 Cg_endo -54.81 -11.46 3.51 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.787 2.325 . . . . 0.0 113.147 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -66.23 -57.54 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.815 0.34 . . . . 0.0 110.542 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.834 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.41 -31.83 42.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.977 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.501 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -61.32 -30.93 70.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.673 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.63 -31.29 64.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.776 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.818 ' HA3' HG11 ' A' ' 136' ' ' VAL . . . 86.36 34.19 12.67 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.676 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 71' ' ' VAL . 13.1 t -151.41 28.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.652 0.263 . . . . 0.0 111.411 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.095 HD11 HD21 ' A' ' 29' ' ' LEU . 16.8 mt -140.42 148.89 41.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 175.92 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.666 HD13 HG12 ' A' ' 60' ' ' ILE . 21.1 mm -69.26 68.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.18 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.39 59.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.678 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.525 ' OD2' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -88.76 120.88 30.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.75 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.474 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -90.72 104.55 17.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.685 ' HA ' HG22 ' A' ' 111' ' ' ILE . 17.2 t -94.08 158.65 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.051 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.451 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -122.74 -40.45 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.46 149.14 37.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.159 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.766 HG23 ' CD2' ' A' ' 109' ' ' LEU . 17.6 mt -132.71 120.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.68 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 m120 54.53 24.23 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.913 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.97 -18.48 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.636 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.14 137.02 56.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.42 -178.7 3.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.369 2.046 . . . . 0.0 112.254 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.6 p -157.26 -44.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -11.15 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.391 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -117.09 46.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.763 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 t -176.9 -176.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.38 151.24 45.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 16.4 p90 -70.17 -30.94 68.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -55.83 -31.56 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 93' ' ' GLU . 5.6 mm-40 -61.69 -58.62 7.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -54.82 -28.68 51.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.806 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.22 -43.11 34.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -70.61 -36.13 73.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.807 0.336 . . . . 0.0 111.198 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 81' ' ' ILE . 1.1 pp -70.09 -46.1 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.326 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.891 ' CD1' HD11 ' A' ' 41' ' ' LEU . 69.8 mt -64.29 -57.39 9.56 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.264 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -50.75 -29.68 12.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.625 ' O ' HD11 ' A' ' 103' ' ' ILE . 5.8 t70 -114.37 35.5 4.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 84.4 p -108.78 15.21 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.134 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.8 p -100.64 15.08 29.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 111.855 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.7 mt -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 5.77 44.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.656 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 30' ' ' THR . 13.1 p 59.2 26.76 15.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -171.12 148.85 2.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.907 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.53 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.5 t -149.68 131.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.31 130.59 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.697 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.766 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -140.32 164.96 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 111.342 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -114.43 145.55 41.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.402 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 78' ' ' VAL . 40.6 pt -137.46 159.94 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.959 0.409 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -123.69 146.42 48.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.318 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -161.05 174.28 13.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.425 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.13 131.23 44.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 20' ' ' VAL . 27.2 m -85.53 145.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.728 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . 82.88 113.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.774 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -153.79 24.32 0.51 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.872 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.35 85.43 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.649 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.678 HG13 ' HE1' ' A' ' 126' ' ' PHE . 34.7 t -142.27 131.63 22.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.028 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.66 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -134.23 86.03 37.35 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-O 121.646 0.736 . . . . 0.0 109.894 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.518 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 60.6 Cg_endo -95.81 175.19 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.268 2.645 . . . . 0.0 113.424 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -163.25 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.463 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 169.78 113.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.2 -30.75 6.48 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.354 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.547 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -134.5 102.67 5.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.999 0.428 . . . . 0.0 110.612 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.678 ' HE1' HG13 ' A' ' 119' ' ' VAL . 1.9 t80 -104.45 127.56 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.66 ' HB2' HG13 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -118.44 141.06 48.93 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.624 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.778 HG21 HD12 ' A' ' 206' ' ' LEU . 4.8 m -129.38 104.37 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -80.56 104.48 11.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.767 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.926 HD11 HG22 ' A' ' 168' ' ' THR . 4.3 mp -113.84 139.08 23.08 Favored Pre-proline 0 C--N 1.333 -0.126 0 CA-C-O 120.588 0.233 . . . . 0.0 111.488 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.11 108.91 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.446 2.097 . . . . 0.0 111.798 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -81.97 158.64 23.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.407 ' HE2' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -127.2 -166.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.265 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.8 -76.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.215 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.9 m -152.99 74.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.198 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.818 HG11 ' HA3' ' A' ' 70' ' ' GLY . 40.8 t -127.84 151.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.796 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -53.04 96.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.045 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.665 HD22 HG12 ' A' ' 140' ' ' ILE . 1.1 tt -55.07 -38.31 67.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.19 -44.38 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.032 HG23 ' HB1' ' A' ' 165' ' ' ALA . 5.1 pt -81.84 146.41 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.857 0.361 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.3 m -126.18 118.95 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.738 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.008 HD13 HG22 ' A' ' 194' ' ' VAL . 1.4 mp -80.58 164.06 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 142' ' ' ILE . 10.8 t -167.68 166.94 13.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -116.77 137.11 23.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo . . . . . 0 C--N 1.347 0.473 0 C-N-CA 122.421 2.08 . . . . 0.0 112.128 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.438 ' N ' ' HD3' ' A' ' 153' ' ' PRO . 21.5 t70 . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.731 0.301 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 152' ' ' ASP . 86.1 Cg_endo -80.24 -175.16 2.56 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.563 2.175 . . . . 0.0 112.422 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.897 HD12 ' CG2' ' A' ' 142' ' ' ILE . 1.8 mm? -104.83 145.61 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 175' ' ' ASP . 16.8 m -142.19 178.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 111.329 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.651 HG21 HD23 ' A' ' 173' ' ' LEU . 1.3 mm -93.23 154.83 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.58 -26.82 2.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.76 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -176.49 162.11 2.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.199 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.968 HD13 HD23 ' A' ' 171' ' ' LEU . 1.6 mt -140.53 149.08 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.756 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.0 146.23 45.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -83.35 164.93 19.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.556 ' HA2' HG21 ' A' ' 25' ' ' THR . . . 84.33 -19.21 19.58 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.065 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.477 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.2 m -107.05 146.53 31.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.964 0.411 . . . . 0.0 110.997 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.798 HG23 HD23 ' A' ' 130' ' ' LEU . 34.8 m -48.85 -22.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 1.032 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -52.91 -71.17 0.07 Allowed 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.955 0.407 . . . . 0.0 110.979 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.679 ' HB2' HG22 ' A' ' 159' ' ' ILE . 29.0 t60 -71.29 -24.8 62.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.14 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -56.88 -30.99 64.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.995 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.926 HG22 HD11 ' A' ' 130' ' ' LEU . 72.5 p -45.1 -42.71 9.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.253 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.71 -43.61 2.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.581 HG21 HG11 ' A' ' 119' ' ' VAL . 5.6 t -96.9 34.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.968 HD23 HD13 ' A' ' 159' ' ' ILE . 2.9 tt -117.34 99.91 7.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -109.36 -179.98 3.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 156' ' ' ILE . 4.0 mt -107.84 148.66 29.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.806 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.53 -11.17 39.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.814 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 155' ' ' VAL . 3.1 t0 -78.48 175.68 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.641 0.258 . . . . 0.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.448 ' HD3' HG12 ' A' ' 155' ' ' VAL . 41.5 mmtm -117.25 151.53 36.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.326 . . . . 0.0 111.132 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.634 HD23 ' H ' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -101.71 170.8 7.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.063 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.634 ' H ' HD23 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -148.07 -44.89 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.885 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -150.2 169.33 21.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.752 HD11 ' HB1' ' A' ' 193' ' ' ALA . 16.3 mt -139.62 114.38 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 18.3 t0 59.28 -83.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.375 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -128.69 -14.95 4.51 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.775 ' HB ' HG21 ' A' ' 196' ' ' ILE . 20.2 mm -102.32 133.58 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 9.6 mtm105 -100.13 114.47 27.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.597 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.759 HD21 HD13 ' A' ' 196' ' ' ILE . 2.9 mm? -72.32 -17.07 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.411 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.56 -81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 185' ' ' LEU . 8.2 m -153.28 24.44 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.837 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -171.05 0.65 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.071 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.7 14.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.845 ' HA ' HD11 ' A' ' 154' ' ' LEU . 14.8 ptm -74.23 -42.64 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.0 mt-10 -53.7 -31.89 49.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.825 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -62.68 -48.13 80.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.195 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.752 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -59.02 -39.73 82.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.476 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 1.008 HG22 HD13 ' A' ' 142' ' ' ILE . 8.6 t -63.79 -34.42 67.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 109.749 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 199' ' ' GLN . 0.9 OUTLIER -61.44 -50.29 73.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.966 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.825 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.6 mp -70.08 -24.78 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.172 0.51 . . . . 0.0 109.764 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.707 HD12 HD13 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.23 -33.92 76.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.721 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.408 ' HA ' ' NZ ' ' A' ' 132' ' ' LYS . 11.4 mt-30 -87.75 -39.78 14.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.727 ' OE1' HG23 ' A' ' 196' ' ' ILE . 0.0 OUTLIER -86.48 13.26 8.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.833 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 180' ' ' ILE . 0.5 OUTLIER -64.29 33.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.7 pt-20 32.53 68.17 0.15 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.78 24.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.471 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 mt -153.96 93.66 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.135 0.493 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 204' ' ' VAL . 13.8 p -97.11 108.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.714 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 24.1 ttmt -104.54 107.06 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.778 HD12 HG21 ' A' ' 128' ' ' VAL . 3.4 mt -83.4 114.16 21.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.628 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 12.0 tttt -97.16 93.26 6.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.356 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.58 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.7 OUTLIER -84.95 168.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.826 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 10.2 ttp180 -118.98 123.42 44.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.34 159.49 15.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.554 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 115' ' ' VAL . 10.2 p . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.823 0.344 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 51.6 p-80 -106.04 110.77 23.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 t -55.94 152.17 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 170.44 12.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.764 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.801 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -129.68 137.13 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -139.3 176.88 8.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -106.76 162.93 13.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.33 150.41 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.634 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.53 109.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 111.411 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 72' ' ' LEU . 3.9 mm? -106.63 121.72 44.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.798 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -110.67 162.18 15.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.63 . . . . 0.0 112.406 -178.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.754 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -109.34 103.73 12.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.168 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.4 148.32 55.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.41 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.88 1.96 7.1 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.596 2.198 . . . . 0.0 112.674 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.55 -48.45 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.371 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t -125.51 -11.24 6.82 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.02 -87.88 0.57 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.406 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.678 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 27.7 m-85 -130.94 117.94 19.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.0 110.285 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -70.34 -3.69 47.78 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.991 HG21 HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.61 167.6 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.958 0.879 . . . . 0.0 112.189 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 4.8 mt-30 -138.61 122.28 17.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.097 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.754 HD13 ' CD2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -96.34 143.3 27.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 112.061 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.568 ' CG ' HD13 ' A' ' 56' ' ' LEU . 6.0 pt20 -105.19 166.09 10.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.559 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -122.41 107.28 1.13 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.299 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 57.24 112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 111.398 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.62 -75.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.485 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 36.1 p90 -49.97 -48.07 52.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.036 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 41.58 80.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.66 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.2 t 170.11 114.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.565 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 50' ' ' THR . 1.9 tt0 61.32 86.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 51' ' ' LEU . 1.3 m 90.56 -179.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.623 ' H ' HG22 ' A' ' 50' ' ' THR . 1.4 pp -167.01 30.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.165 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -64.45 30.73 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -112.75 86.8 9.13 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.601 0.238 . . . . 0.0 110.578 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.29 176.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.486 2.124 . . . . 0.0 112.133 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.504 ' HG3' ' HB3' ' A' ' 94' ' ' ALA . 52.2 Cg_exo -53.16 137.9 63.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.412 2.075 . . . . 0.0 111.838 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.568 HD13 ' CG ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -137.67 113.76 9.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.489 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 81.8 mt -62.21 138.68 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 110.801 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 74' ' ' ILE . 6.3 t -119.82 -24.04 6.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.502 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 72.4 t80 -136.83 159.09 42.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.916 ' CD1' HG22 ' A' ' 39' ' ' ILE . 9.4 mm -138.33 164.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.47 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 60' ' ' ILE . 4.0 tp10 -119.87 147.13 45.07 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.866 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.95 42.72 1.11 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.187 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.15 36.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.068 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -137.17 138.13 24.57 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.081 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.71 -15.83 13.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.038 2.492 . . . . 0.0 113.643 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.871 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -73.9 -44.09 56.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.6 tp10 -76.06 -29.22 57.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.719 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.541 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.41 -14.83 39.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.307 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.7 t -47.25 -40.84 17.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.941 0.4 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.424 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 105.3 11.44 29.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.439 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -153.85 53.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 111.637 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.991 HD13 HG21 ' A' ' 39' ' ' ILE . 10.4 mt -141.3 134.83 29.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -141.08 174.44 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 58' ' ' SER . 26.5 mm -73.11 78.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.28 43.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -75.26 83.31 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.783 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 101.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.643 HG11 HD13 ' A' ' 109' ' ' LEU . 35.9 m -95.77 115.4 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -97.14 24.52 6.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.33 131.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.718 HG23 ' CD2' ' A' ' 109' ' ' LEU . 35.1 mt -131.23 115.71 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.605 ' ND2' HG13 ' A' ' 107' ' ' VAL . 22.2 m-80 56.39 23.31 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.8 -26.3 24.53 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.536 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mt -74.26 136.67 75.44 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-O 120.565 0.222 . . . . 0.0 111.229 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.2 171.35 15.11 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.384 2.056 . . . . 0.0 112.162 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 94' ' ' ALA . 1.1 p -139.42 -46.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -71.05 -11.36 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -113.16 45.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.015 0.436 . . . . 0.0 110.794 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -178.09 -170.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.798 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 148.65 32.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.436 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 21.7 p90 -73.52 -31.21 63.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -59.16 -31.78 69.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.24 -58.88 6.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -55.73 -39.9 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.142 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.729 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.4 m120 -64.6 -36.99 86.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.322 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -69.95 -44.07 70.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.354 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.597 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 2.3 pp -62.65 -28.78 70.16 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.754 ' CD2' HD13 ' A' ' 41' ' ' LEU . 39.3 mt -67.62 -46.38 72.66 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 28.8 mtt-85 -50.28 -40.26 47.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.487 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.0 m-20 -115.55 40.93 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.431 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.19 6.46 47.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.619 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -105.23 18.23 22.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.341 . . . . 0.0 111.82 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.487 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.8 mt -71.41 -51.63 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.814 0.816 . . . . 0.0 110.919 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 7.99 31.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.806 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.754 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 45.4 t 57.1 22.47 7.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.337 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.66 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -168.99 159.16 9.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.036 0.446 . . . . 0.0 111.745 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.605 HG13 ' ND2' ' A' ' 82' ' ' ASN . 39.8 t -157.5 128.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.683 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.87 133.34 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.585 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.718 ' CD2' HG23 ' A' ' 81' ' ' ILE . 1.6 mt -131.63 157.26 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 0.0 111.439 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 118.03 30.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.197 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 pt -112.27 155.37 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.155 0.503 . . . . 0.0 111.813 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.801 ' HG3' HG23 ' A' ' 24' ' ' THR . 0.4 OUTLIER -132.56 117.52 18.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.198 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 167' ' ' ARG . 6.2 p90 -136.34 174.11 10.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 0.0 111.407 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 3.7 p30 -91.08 155.33 18.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.559 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 115' ' ' VAL . 27.9 m -108.55 104.96 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.455 . . . . 0.0 111.635 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -172.35 95.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.6 OUTLIER -107.15 20.44 19.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.794 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 86.32 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.219 0.533 . . . . 0.0 111.714 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.657 ' CG1' HG13 ' A' ' 128' ' ' VAL . 2.5 m -112.96 140.76 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.115 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.707 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.2 pp -121.53 104.76 39.57 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.771 0.32 . . . . 0.0 111.455 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.488 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 92.7 Cg_endo -86.01 164.28 10.15 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.848 2.365 . . . . 0.0 112.754 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -167.28 22.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.582 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.7 OUTLIER 55.34 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.934 0.397 . . . . 0.0 111.244 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.36 -42.24 2.49 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.877 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.551 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.89 102.59 5.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.512 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.762 ' CE1' HG21 ' A' ' 170' ' ' THR . 6.1 t80 -104.66 130.58 52.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.566 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -112.68 144.76 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.454 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.657 HG13 ' CG1' ' A' ' 119' ' ' VAL . 21.4 t -122.46 89.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.473 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -81.29 106.15 13.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.777 HD13 HG23 ' A' ' 164' ' ' VAL . 4.1 pp -132.31 134.83 25.43 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.128 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 53.8 Cg_endo -69.15 125.63 12.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.407 2.072 . . . . 0.0 111.817 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 158.96 15.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.081 0.467 . . . . 0.0 111.061 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' HG3' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -92.9 -175.27 3.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.804 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -40.79 83.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.21 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 171.79 65.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 137' ' ' GLU . 17.2 t -109.76 165.05 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' N ' HG12 ' A' ' 136' ' ' VAL . 34.9 tt0 -29.19 132.6 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.06 101.29 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.745 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.94 49.24 3.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.342 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.851 HD11 ' HB3' ' A' ' 165' ' ' ALA . 32.7 mm -94.64 134.59 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.581 0.229 . . . . 0.0 110.878 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.691 HG22 ' HB3' ' A' ' 157' ' ' SER . 29.6 m -126.44 139.93 52.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.893 0.377 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.967 HD12 HG22 ' A' ' 194' ' ' VAL . 11.8 mt -113.24 164.09 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.485 ' N ' HG22 ' A' ' 142' ' ' ILE . 1.1 m -160.79 147.56 15.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.9 t -96.08 148.01 33.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 179.945 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.62 0.248 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 164.57 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.445 2.097 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.619 ' O ' HG13 ' A' ' 155' ' ' VAL . 12.8 mt -114.72 -177.97 3.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.704 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 154' ' ' LEU . 3.5 m -161.85 154.0 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.615 HG21 HD11 ' A' ' 159' ' ' ILE . 2.7 mt -71.09 147.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.441 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.691 ' HB3' HG22 ' A' ' 141' ' ' THR . 29.2 t -128.09 -2.86 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.416 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 172.4 135.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.828 0.347 . . . . 0.0 110.607 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.809 HG21 ' HB2' ' A' ' 166' ' ' HIS . 6.5 mt -137.16 136.66 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.476 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 150.52 26.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.519 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -85.12 66.97 10.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.33 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.255 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.432 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -154.21 139.86 17.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.054 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.777 HG23 HD13 ' A' ' 130' ' ' LEU . 25.4 m -48.79 -24.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.441 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.955 ' O ' HG22 ' A' ' 168' ' ' THR . . . -46.8 -71.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.809 ' HB2' HG21 ' A' ' 159' ' ' ILE . 86.3 t60 -76.67 -25.52 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 111.099 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -56.47 -29.98 62.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.784 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.955 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.2 t -62.78 -23.94 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.811 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.43 71.08 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.887 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.762 HG21 ' CE1' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -172.39 -42.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.953 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.661 HD13 ' O ' ' A' ' 165' ' ' ALA . 1.1 mp -59.48 100.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -128.3 139.97 52.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.29 102.02 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.22 -18.81 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.641 ' CB ' HG21 ' A' ' 208' ' ' ILE . 8.1 m-20 -72.97 134.6 44.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.73 103.98 16.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.555 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -70.47 137.51 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 178' ' ' LEU . 8.4 tt -133.43 -40.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.655 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -129.78 149.1 51.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.92 0.391 . . . . 0.0 111.387 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.755 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 27.3 mt -139.23 113.86 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.294 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 24.9 t70 47.65 55.35 8.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.18 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.8 t30 84.9 -35.88 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.428 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 184' ' ' ARG . 44.1 mm -67.3 159.18 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 110.63 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.497 ' N ' HG22 ' A' ' 183' ' ' ILE . 10.1 mtp180 -134.74 129.49 34.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 1.036 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.4 mm? -74.53 -6.23 47.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.574 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -41.33 7.91 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.3 t -115.85 -18.06 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -171.14 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -120.7 -176.9 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.557 ' HG3' HD22 ' A' ' 154' ' ' LEU . 6.7 ttp -69.12 -57.14 5.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -54.31 -31.1 53.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.864 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.8 OUTLIER -62.99 -48.79 77.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.097 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 1.036 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -57.02 -39.41 74.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.164 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.967 HG22 HD12 ' A' ' 142' ' ' ILE . 21.7 t -60.14 -41.19 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.867 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -50.04 75.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.856 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 192' ' ' ASP . 3.0 mp -69.51 -24.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.614 HD13 HD11 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -57.92 -37.59 74.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.357 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -96.73 -35.67 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.028 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -16.68 61.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.847 ' HB3' HG22 ' A' ' 204' ' ' VAL . 8.5 m -86.04 41.23 0.91 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.339 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.64 62.37 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.238 0.542 . . . . 0.0 111.068 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -174.18 -30.67 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.465 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 203' ' ' LEU . 3.6 tt 176.72 109.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.393 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 200' ' ' CYS . 21.8 t -104.3 125.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.613 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -108.16 108.32 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.883 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.555 ' HG ' HD21 ' A' ' 177' ' ' LEU . 1.1 mp -87.37 108.2 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.446 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.655 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 7.6 tttt -97.37 98.5 10.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.653 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.641 HG21 ' CB ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -106.34 172.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 3.4 mmt180 -108.94 138.82 44.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.451 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . 0.419 ' HE2' ' CD2' ' A' ' 126' ' ' PHE . 6.4 mptt -119.27 157.25 28.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 120.971 0.415 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 21' ' ' HIS . 11.1 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.851 0.357 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.432 ' N ' HG22 ' A' ' 20' ' ' VAL . 51.3 p-80 -109.38 136.09 49.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -54.68 167.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.409 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -162.96 156.66 20.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -113.25 149.05 34.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.179 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.521 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -144.07 165.62 27.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -101.91 158.9 15.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.97 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 109' ' ' LEU . 2.9 p -143.65 151.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.496 0.665 . . . . 0.0 111.612 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.76 110.82 21.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.102 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.684 HD21 HD12 ' A' ' 39' ' ' ILE . 5.7 mp -109.77 118.75 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.885 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -109.4 161.54 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.271 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -92.89 112.51 24.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.06 156.0 44.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.609 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.7 7.6 3.06 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.556 2.171 . . . . 0.0 112.953 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 35' ' ' THR . 31.3 t -107.58 -47.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 111.181 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 34' ' ' VAL . 34.8 p -146.35 6.75 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 37' ' ' PHE . . . 66.86 -79.04 0.14 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.501 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 4.8 m-85 -132.67 113.76 13.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.187 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.18 -2.55 62.76 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.916 -0.584 . . . . 0.0 114.07 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.001 HD11 HD13 ' A' ' 72' ' ' LEU . 18.1 mt -92.98 136.32 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 111.944 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 mt-30 -113.84 120.62 41.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.038 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 55' ' ' PRO . 6.8 mp -95.35 136.89 35.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.195 0.521 . . . . 0.0 111.935 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 169.46 8.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.74 64.88 0.35 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.384 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -161.78 63.16 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.126 0.488 . . . . 0.0 111.021 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.523 HG22 HD13 ' A' ' 56' ' ' LEU . 2.1 t -85.76 -70.4 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.671 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.0 p90 -40.85 -43.97 2.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.17 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 54.81 76.24 0.26 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 49' ' ' GLU . 2.7 t 169.88 -164.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.864 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 48' ' ' THR . 16.3 pt-20 -46.81 167.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.603 0.24 . . . . 0.0 110.717 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 49' ' ' GLU . 11.0 t 45.53 -159.42 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.194 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.841 HD13 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -149.18 -85.8 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.342 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.42 14.48 1.15 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.79 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 3.9 t -75.59 113.87 30.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.58 ' O ' HD23 ' A' ' 56' ' ' LEU . 59.9 Cg_endo -72.01 151.48 56.11 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.27 1.98 . . . . 0.0 111.696 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.645 ' HB3' HD23 ' A' ' 41' ' ' LEU . 71.7 Cg_exo -47.84 111.2 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.341 2.027 . . . . 0.0 112.189 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -120.12 110.69 16.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.824 ' CD1' HD13 ' A' ' 39' ' ' ILE . 39.4 mt -56.21 124.92 10.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.858 0.361 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -8.25 27.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 45.7 t80 177.61 138.58 0.08 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.005 0.431 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.815 HG21 ' HB2' ' A' ' 67' ' ' GLU . 5.0 mt -113.82 169.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.337 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.54 ' H ' HG22 ' A' ' 60' ' ' ILE . 65.9 tt0 -108.46 151.97 25.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 111.368 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.423 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -91.61 46.59 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.356 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 177.46 44.34 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.892 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.433 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -142.44 142.18 22.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.998 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.79 -13.06 24.48 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.655 2.237 . . . . 0.0 112.889 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.611 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -64.77 -56.75 11.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 110.255 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.815 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -79.08 -29.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.896 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.44 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -69.42 -20.22 63.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.238 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.0 t -47.3 -29.31 2.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.22 58.24 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.456 HG13 ' HA2' ' A' ' 162' ' ' GLY . 4.0 t -152.63 37.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.001 HD13 HD11 ' A' ' 39' ' ' ILE . 10.7 mt -142.15 172.53 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 111.624 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.22 150.15 10.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.441 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.5 98.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.922 0.392 . . . . 0.0 111.337 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 95.62 40.8 4.05 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.248 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.806 ' CG ' HD12 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -78.17 -14.21 59.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.631 0.253 . . . . 0.0 111.399 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.7 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.8 mtm-85 63.09 136.05 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 109' ' ' LEU . 10.2 t -114.07 152.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.212 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.708 ' HE2' ' HB2' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -114.25 -34.12 5.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.708 ' HB2' ' HE2' ' A' ' 79' ' ' MET . . . -148.7 142.86 26.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.682 HG23 HD22 ' A' ' 109' ' ' LEU . 28.2 mt -128.39 111.13 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.916 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 54.24 25.11 5.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.13 -21.89 36.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.567 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.2 mt -75.32 128.84 83.68 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-O 120.531 0.205 . . . . 0.0 111.142 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 86' ' ' THR . 33.2 Cg_exo -57.65 -160.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.456 2.104 . . . . 0.0 112.212 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 85' ' ' PRO . 23.3 p -158.22 -49.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -7.25 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.42 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -112.22 45.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 t -178.31 175.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.841 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.04 144.32 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -51.61 -27.35 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.155 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.79 -35.07 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 1.7 pp20? -64.28 -37.41 87.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.786 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -69.24 -35.83 76.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.255 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.95 -42.71 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.963 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.788 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -69.1 -42.37 76.21 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.164 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 98' ' ' LEU . 4.0 pp -64.8 -32.37 74.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 97' ' ' LEU . 4.2 mt -63.09 -57.42 10.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.788 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -52.33 -30.41 28.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.607 ' O ' HD11 ' A' ' 103' ' ' ILE . 68.6 m-20 -115.67 36.62 3.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.927 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -105.36 15.06 27.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.326 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -112.32 18.73 18.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 100' ' ' ASP . 2.1 mt -63.73 -46.55 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.689 0.757 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.92 0.13 57.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.502 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.885 ' O ' HG22 ' A' ' 30' ' ' THR . 1.2 m 63.26 26.27 15.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -166.16 146.03 6.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.78 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.504 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.2 t -149.02 111.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.624 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.535 ' C ' HD23 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -93.12 133.67 36.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.682 HD22 HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -142.25 165.27 27.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 111.222 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.18 136.98 52.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.393 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.806 HD12 ' CG ' ' A' ' 76' ' ' ASP . 27.6 pt -128.85 166.07 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.677 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -128.48 142.77 50.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.729 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -161.2 174.72 13.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.922 0.392 . . . . 0.0 111.236 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -88.75 150.49 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.401 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.4 m -101.57 104.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.006 0.431 . . . . 0.0 111.41 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -168.09 130.3 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.616 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.618 ' HB2' HG22 ' A' ' 168' ' ' THR . 69.7 mm-40 -130.2 6.56 4.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.01 71.21 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.34 0.59 . . . . 0.0 111.247 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.752 ' CG1' HG13 ' A' ' 128' ' ' VAL . 3.1 m -97.69 147.45 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.718 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.792 HD11 ' CG ' ' A' ' 127' ' ' HIS . 2.1 pp -122.92 102.31 38.09 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.889 0.376 . . . . 0.0 111.473 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.3 Cg_endo -87.71 154.81 7.52 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.96 2.44 . . . . 0.0 112.605 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -162.61 24.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.429 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 118.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.859 0.361 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.61 -45.95 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.5 102.43 6.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.643 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 8.4 t80 -107.14 115.93 31.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.792 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -99.72 144.96 28.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.145 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.752 HG13 ' CG1' ' A' ' 119' ' ' VAL . 2.7 t -118.3 97.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.978 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HE2' HD11 ' A' ' 203' ' ' LEU . 2.0 mttt -81.29 99.01 8.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.072 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 128' ' ' VAL . 3.0 mp -109.82 114.73 56.24 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.415 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.94 110.39 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.164 1.91 . . . . 0.0 111.307 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.754 ' HG3' HG23 ' A' ' 204' ' ' VAL . 1.1 mttt -89.7 158.65 17.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.611 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.791 ' HD2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -122.85 178.23 5.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.629 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.656 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 34.4 t-80 -41.77 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.715 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.422 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 3.0 m -138.63 97.37 3.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.883 0.373 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.791 HG23 ' HD2' ' A' ' 133' ' ' LYS . 2.2 t -143.21 141.46 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.49 141.98 58.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.027 HD23 HD11 ' A' ' 140' ' ' ILE . 1.3 tp -95.88 -41.94 8.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' A' ' 160' ' ' LYS . . . 94.0 13.84 53.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.267 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 1.027 HD11 HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -112.17 139.38 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.424 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 41.0 m -111.86 142.18 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 143' ' ' SER . 6.6 mt -103.35 164.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.033 0.444 . . . . 0.0 111.18 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.553 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -160.18 158.64 30.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.724 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.8 p -129.33 106.38 17.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.611 ' HD3' HG22 ' A' ' 155' ' ' VAL . 76.1 Cg_exo . . . . . 0 C--N 1.346 0.411 0 C-N-CA 122.527 2.151 . . . . 0.0 112.381 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.717 0.294 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.536 ' O ' HD22 ' A' ' 154' ' ' LEU . 59.5 Cg_endo -72.17 172.04 15.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.573 2.182 . . . . 0.0 112.404 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.723 HD21 ' HA ' ' A' ' 190' ' ' MET . 4.0 mm? -123.92 141.85 51.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.611 HG22 ' HD3' ' A' ' 145' ' ' PRO . 34.9 m -156.38 148.69 11.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 156' ' ' ILE . 3.4 mp -68.0 152.19 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.17 -6.94 3.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.73 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 179.68 147.82 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.0 111.448 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.569 HG21 ' ND1' ' A' ' 166' ' ' HIS . 17.1 mt -139.13 149.79 23.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.465 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.613 ' HD3' ' N ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -138.7 144.26 39.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.373 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.52 72.58 5.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.613 ' N ' ' HD3' ' A' ' 160' ' ' LYS . . . -134.08 -44.37 0.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.194 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.14 176.61 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.248 0.547 . . . . 0.0 111.424 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.0 m -53.69 -21.52 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.384 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -42.69 -69.72 0.13 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.569 ' ND1' HG21 ' A' ' 159' ' ' ILE . 5.4 t60 -68.07 -27.25 66.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -59.6 -29.42 67.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.27 -179.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 128' ' ' VAL . 70.5 p -45.83 -29.83 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.53 58.61 8.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.541 HG21 HG11 ' A' ' 119' ' ' VAL . 4.5 t -178.83 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.67 93.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.019 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.71 146.9 27.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 35.4 mt -69.05 84.3 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.47 43.2 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.585 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.409 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.9 OUTLIER -119.58 145.01 46.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 0.0 110.457 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.401 ' HA ' HG12 ' A' ' 155' ' ' VAL . 10.2 mmtp -97.15 115.71 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 111.151 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.562 HD22 ' CD1' ' A' ' 180' ' ' ILE . 4.6 mt -87.87 135.04 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.75 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.97 -27.13 6.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.742 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -148.13 162.23 39.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.943 0.401 . . . . 0.0 111.551 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 179' ' ' ALA . 20.3 mm -139.44 110.22 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.968 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 21.2 t70 63.52 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.157 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -128.29 -22.6 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 184' ' ' ARG . 43.3 mm -87.83 157.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.801 0.334 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.695 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 9.1 mtt180 -126.31 129.75 49.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.076 0.465 . . . . 0.0 112.051 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.881 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.3 mm? -71.98 -6.36 41.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.727 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -45.51 -42.18 10.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.6 p -116.16 -19.67 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.211 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.78 -176.01 5.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -118.34 -175.67 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.723 ' HA ' HD21 ' A' ' 154' ' ' LEU . 11.9 ttp -63.05 -55.18 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.56 -29.87 18.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.799 ' O ' HD12 ' A' ' 196' ' ' ILE . 1.1 m-20 -64.32 -54.09 38.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.749 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.881 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -52.06 -32.57 35.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.899 0.38 . . . . 0.0 110.206 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.474 HG22 HD13 ' A' ' 142' ' ' ILE . 23.0 t -64.77 -47.81 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.819 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.771 ' NE2' ' O ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -70.77 -32.35 69.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.208 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.799 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.5 mt -75.77 -26.21 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -63.93 -40.56 96.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.287 179.033 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -86.64 -42.66 13.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.224 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -18.56 48.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.497 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.861 ' HB3' HG22 ' A' ' 204' ' ' VAL . 4.6 m -86.25 42.23 0.98 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.374 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.98 62.42 0.87 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.247 0.546 . . . . 0.0 111.147 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.42 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 3.2 m-20 -171.3 -33.01 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.058 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.0 tt 177.89 106.93 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.308 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.861 HG22 ' HB3' ' A' ' 200' ' ' CYS . 21.6 t -102.3 121.77 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.349 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 0.6 OUTLIER -100.81 107.71 19.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.935 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.575 ' O ' HD13 ' A' ' 208' ' ' ILE . 3.1 mp -85.81 104.27 15.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.976 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.465 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -89.73 93.79 9.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -101.72 172.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.65 133.52 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.72 159.15 33.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.617 HG21 ' O ' ' A' ' 115' ' ' VAL . 9.3 p . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.732 0.301 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.448 ' N ' HG22 ' A' ' 20' ' ' VAL . 65.4 t60 -92.93 134.17 35.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.37 174.21 3.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -168.49 162.11 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.711 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -131.21 144.97 51.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -139.52 -173.51 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.944 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -103.15 161.14 14.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 111' ' ' ILE . 2.2 t -147.01 149.08 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.58 113.89 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.578 HD22 ' HD2' ' A' ' 37' ' ' PHE . 3.6 mt -110.1 118.92 37.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -110.66 161.81 15.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.22 0.533 . . . . 0.0 111.742 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.892 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.79 119.93 39.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.104 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.777 ' OD1' HG23 ' A' ' 34' ' ' VAL . 8.8 t0 -88.53 141.96 30.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.338 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.18 3.94 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.48 2.12 . . . . 0.0 113.04 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.777 HG23 ' OD1' ' A' ' 32' ' ' ASP . 28.3 t -101.27 -53.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 t -141.25 6.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.947 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 67.96 -107.93 2.25 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.162 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.892 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 6.2 m-85 -106.87 128.26 54.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -91.88 25.15 17.7 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.863 -0.684 . . . . 0.0 114.798 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -126.39 130.93 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.68 0.74 . . . . 0.0 111.826 179.213 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 116.21 29.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.175 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -96.87 145.6 25.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.389 0.614 . . . . 0.0 112.552 -178.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.25 169.59 10.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.818 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 45' ' ' VAL . . . -116.46 -47.59 0.5 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.791 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -47.04 123.92 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.554 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 43' ' ' GLY . 98.8 t -140.2 -83.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.901 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 39.0 p90 -40.5 -45.54 2.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.175 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.511 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 51.94 73.63 0.31 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.264 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER 165.33 90.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.636 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 50' ' ' THR . 0.3 OUTLIER 55.17 176.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 49' ' ' GLU . 12.7 t 44.89 -163.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -147.8 -101.41 0.09 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.193 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.94 18.36 1.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.842 0.353 . . . . 0.0 111.555 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.46 107.85 1.75 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.038 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.441 ' O ' ' CD2' ' A' ' 56' ' ' LEU . 7.7 Cg_exo -72.91 167.4 27.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.653 2.235 . . . . 0.0 111.998 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.698 ' HA ' HD21 ' A' ' 41' ' ' LEU . 24.4 Cg_exo -63.83 128.63 22.51 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.711 2.274 . . . . 0.0 112.132 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.737 HD13 HG22 ' A' ' 45' ' ' VAL . 1.3 pt? -145.84 100.65 3.44 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.811 0.339 . . . . 0.0 111.804 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 39' ' ' ILE . 46.2 mt -64.62 156.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.519 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 57' ' ' ILE . 2.0 m -139.15 8.14 2.46 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.491 ' H ' HG22 ' A' ' 57' ' ' ILE . 52.8 t80 -178.14 134.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 112.081 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.709 HG13 HG23 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.89 -173.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.655 ' N ' HG23 ' A' ' 60' ' ' ILE . 29.0 tt0 -125.3 125.61 43.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.967 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -53.01 109.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.963 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER 84.72 46.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.353 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.92 154.28 76.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.89 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 22.4 Cg_exo -63.4 -12.04 28.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.392 2.061 . . . . 0.0 112.261 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.648 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -72.01 -57.1 4.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HB2' HG21 ' A' ' 60' ' ' ILE . 1.1 tp10 -79.08 -29.03 43.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.093 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -89.11 -7.19 56.25 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.582 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -46.88 -46.85 21.37 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.844 0.354 . . . . 0.0 111.204 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.791 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 123.16 -25.45 6.36 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.264 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.616 HG13 ' CA ' ' A' ' 162' ' ' GLY . 40.3 t -139.39 63.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.437 . . . . 0.0 110.803 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 66' ' ' ALA . 15.0 mt -148.28 169.67 19.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.012 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -164.07 162.09 22.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.742 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.7 mm -60.54 85.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.286 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.08 90.94 1.87 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.659 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB2' HG21 ' A' ' 111' ' ' ILE . 13.5 p30 -112.26 115.63 29.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.735 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 109' ' ' LEU . 29.0 t -72.98 115.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.5 tpt -83.25 -42.04 17.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.21 28.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.728 HG21 ' CD1' ' A' ' 97' ' ' LEU . 9.2 mt -131.54 119.64 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.95 23.16 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.94 -22.39 31.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.645 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' THR . 45.2 mt -70.39 127.77 91.83 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.429 0.157 . . . . 0.0 111.229 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.543 ' C ' HG23 ' A' ' 86' ' ' THR . 33.3 Cg_endo -64.14 -31.15 65.06 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.44 2.094 . . . . 0.0 112.238 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.543 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 75.74 -54.96 0.62 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.152 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -66.93 -13.79 62.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.09 44.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.78 -175.91 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.787 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 m -68.52 156.58 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -73.1 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.007 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -55.54 -32.78 63.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -66.18 -36.09 82.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.801 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.709 ' HA ' HD23 ' A' ' 97' ' ' LEU . . . -71.16 -34.96 71.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -74.13 -32.15 63.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.651 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -72.5 -37.27 68.45 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.728 ' CD1' HG21 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -70.58 -38.74 74.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.206 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 41' ' ' LEU . 71.1 mt -73.47 -55.81 5.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.308 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.25 -30.01 16.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.4 OUTLIER -119.01 37.95 3.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.584 178.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -95.87 26.67 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.004 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -119.17 12.01 12.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.65 -47.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.642 0.734 . . . . 0.0 110.596 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -2.89 56.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.62 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.742 ' O ' HG22 ' A' ' 30' ' ' THR . 0.3 OUTLIER 62.69 26.97 15.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.992 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -170.03 154.95 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.101 0.477 . . . . 0.0 111.099 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 101' ' ' SER . 27.4 t -155.8 145.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.38 120.42 32.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.315 . . . . 0.0 110.805 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -142.05 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -105.6 145.85 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 27' ' ' VAL . 28.5 pt -125.49 142.65 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.702 ' HG3' HG23 ' A' ' 24' ' ' THR . 17.3 tt0 -107.97 129.35 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.401 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 3.4 p90 -153.87 174.42 14.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.188 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.522 ' HB3' HG11 ' A' ' 20' ' ' VAL . 2.3 m-20 -98.5 135.41 40.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.62 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.617 ' O ' HG21 ' A' ' 20' ' ' VAL . 35.1 m -75.47 104.97 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.995 0.426 . . . . 0.0 111.395 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.17 124.45 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' OE2' HG12 ' A' ' 164' ' ' VAL . 1.4 mm-40 -135.62 33.3 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 2.1 t 80.7 91.53 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.297 0.57 . . . . 0.0 110.982 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.815 ' CG1' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -128.28 127.15 67.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.668 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.614 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.7 pp -109.95 97.18 28.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.537 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 88.9 Cg_endo -84.11 159.91 13.47 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.752 2.301 . . . . 0.0 112.691 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.74 27.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.68 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.84 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.7 -40.97 3.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.233 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.402 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -126.86 102.93 7.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 0.0 110.994 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -109.98 119.43 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.487 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -105.59 120.76 42.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.311 . . . . 0.0 110.774 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.815 HG13 ' CG1' ' A' ' 119' ' ' VAL . 4.3 t -99.74 95.52 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -81.49 102.75 10.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -115.6 125.01 29.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 121.37 7.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.403 2.069 . . . . 0.0 111.762 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.82 ' HZ1' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -92.5 159.4 15.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 111.345 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -108.78 -164.88 0.98 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.863 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.17 -38.74 78.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 m -175.57 69.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.232 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.791 HG13 ' HA2' ' A' ' 70' ' ' GLY . 90.3 t -107.3 145.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 145.62 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.956 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.82 HD21 ' HZ1' ' A' ' 132' ' ' LYS . 10.6 mt -105.93 -60.38 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 91.64 19.61 40.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.125 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -98.45 146.86 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.73 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 157' ' ' SER . 27.1 m -126.19 128.41 47.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 1.006 HD12 HG22 ' A' ' 194' ' ' VAL . 7.2 mt -101.87 163.07 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.061 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -144.84 149.12 34.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.1 t -97.48 106.64 34.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.432 ' HG3' HG23 ' A' ' 155' ' ' VAL . 89.9 Cg_endo . . . . . 0 C--N 1.344 0.306 0 C-N-CA 122.614 2.209 . . . . 0.0 112.334 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.9 t0 . . . . . 0 CA--C 1.529 0.173 0 CA-C-O 120.529 0.204 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.521 ' O ' HD22 ' A' ' 154' ' ' LEU . 56.2 Cg_endo -70.35 -167.95 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.537 2.158 . . . . 0.0 112.435 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.951 HD12 ' CG2' ' A' ' 142' ' ' ILE . 3.1 mm? -131.15 155.88 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 156' ' ' ILE . 11.9 t -142.22 162.23 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.335 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.513 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.7 mm -89.72 154.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.546 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.666 ' HB3' HG22 ' A' ' 141' ' ' THR . 8.8 t -132.45 -20.93 2.31 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.4 OUTLIER 174.78 136.19 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.861 HG12 HD12 ' A' ' 171' ' ' LEU . 0.7 OUTLIER -123.64 149.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.837 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.408 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -105.78 164.4 11.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -96.86 166.16 11.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.616 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . 91.47 -30.18 6.65 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.988 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 1.6 t -97.95 149.65 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 111.476 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.486 HG12 ' OE2' ' A' ' 117' ' ' GLU . 17.0 m -52.76 -21.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.843 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.716 ' O ' HG22 ' A' ' 168' ' ' THR . . . -51.08 -64.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.412 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 16.5 t60 -83.19 -24.26 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.52 -39.27 67.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.038 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.792 HG21 HG11 ' A' ' 128' ' ' VAL . 2.7 t -56.41 -28.14 58.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.947 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.607 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.633 ' CG2' HG11 ' A' ' 119' ' ' VAL . 66.9 p -57.57 -25.15 59.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.861 HD12 HG12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.58 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.795 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.29 166.61 11.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.973 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.5 mt -92.38 116.65 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.04 29.25 2.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.698 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 138.12 41.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.767 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -90.31 106.17 18.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.775 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.039 HD22 HD11 ' A' ' 180' ' ' ILE . 9.1 mt -70.56 134.9 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.043 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.637 HD22 ' NZ ' ' A' ' 207' ' ' LYS . 7.3 tt -120.18 -51.37 2.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.674 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -128.19 156.54 42.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 1.039 HD11 HD22 ' A' ' 177' ' ' LEU . 28.6 mm -139.59 105.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.081 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.675 ' OD2' HG12 ' A' ' 204' ' ' VAL . 0.4 OUTLIER 68.13 -67.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.038 0.447 . . . . 0.0 110.738 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' ILE . 1.5 m120 -147.99 -24.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.665 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.52 139.69 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.161 0.505 . . . . 0.0 111.199 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 4.1 mtp-105 -102.48 123.7 46.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.803 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.782 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 3.2 mm? -74.89 -5.52 44.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.446 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -45.87 -28.92 1.21 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 m -134.31 42.73 2.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.685 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.29 153.55 38.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -177.53 0.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.458 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.696 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.03 -54.47 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.55 -29.82 18.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.81 -52.15 66.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.25 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.782 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -57.18 -40.59 77.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.191 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 1.006 HG22 HD12 ' A' ' 142' ' ' ILE . 11.9 t -62.31 -39.4 84.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.674 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -46.92 87.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.117 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -72.52 -24.71 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -58.94 -36.14 74.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.848 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 1.0 OUTLIER -104.04 -44.57 4.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.262 -179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -26.02 19.79 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.014 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 196' ' ' ILE . 0.2 OUTLIER -95.43 44.52 1.09 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 3.2 tt0 -68.76 53.34 0.08 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.241 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.572 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -141.59 -25.93 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.719 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 203' ' ' LEU . 1.3 tt 165.14 112.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.675 HG12 ' OD2' ' A' ' 181' ' ' ASP . 3.5 m -105.26 132.51 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -107.89 107.97 18.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.457 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.28 104.3 15.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.402 . . . . 0.0 111.807 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.674 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 19.6 tttt -97.29 93.69 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.165 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.546 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -106.82 -177.54 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.208 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.42 127.33 44.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -115.97 159.56 21.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.622 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 115' ' ' VAL . 11.5 p . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.746 0.308 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.485 ' N ' HG22 ' A' ' 20' ' ' VAL . 86.5 t60 -76.06 120.7 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.6 p -55.29 174.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.275 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' OE1' HG11 ' A' ' 115' ' ' VAL . 6.5 mt-10 -164.55 140.99 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -107.13 160.31 15.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.439 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -151.12 -178.49 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.29 162.7 15.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG13 HG23 ' A' ' 71' ' ' VAL . 2.2 t -141.93 150.5 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.414 HG13 ' HD3' ' A' ' 106' ' ' LYS . 28.2 t -122.83 112.68 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HG ' HD11 ' A' ' 72' ' ' LEU . 3.5 mt -108.51 118.71 37.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.181 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -107.4 162.27 14.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 111.883 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.89 128.5 45.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.411 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -97.29 147.1 32.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.412 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.63 16.59 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.479 2.119 . . . . 0.0 112.666 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.06 -47.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 t -131.58 -18.92 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 62.17 87.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.278 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.724 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 54.4 m-85 65.62 93.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 109.767 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -74.49 13.96 4.57 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.567 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.981 HG22 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -109.9 133.91 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 117.38 0.59 . . . . 0.0 111.707 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.607 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.3 mt-30 -97.65 128.27 44.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -96.15 155.82 16.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.306 0.574 . . . . 0.0 112.239 -178.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.5 169.1 17.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.204 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.74 23.92 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.821 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -122.12 93.63 4.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.537 HG22 HD13 ' A' ' 56' ' ' LEU . 34.8 t -111.08 -78.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.2 p90 -39.87 -44.36 1.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.207 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.524 ' O ' ' HB ' ' A' ' 48' ' ' THR . . . 51.77 73.27 0.33 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.94 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 47' ' ' ALA . 4.3 t 165.87 -166.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.677 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' N ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -46.01 147.93 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.871 179.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 66.9 178.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.482 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -142.63 -101.43 0.13 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.362 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.67 16.75 3.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 0.0 111.572 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 1.9 t -62.0 118.41 38.88 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.11 155.29 52.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.31 2.006 . . . . 0.0 111.922 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.759 ' HG2' HD11 ' A' ' 81' ' ' ILE . 45.9 Cg_exo -54.85 123.8 14.65 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.243 1.962 . . . . 0.0 111.952 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD13 HG22 ' A' ' 45' ' ' VAL . 1.1 pt? -136.23 118.03 15.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 111.264 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.981 HG21 HG22 ' A' ' 39' ' ' ILE . 78.2 mt -76.12 141.23 16.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -113.4 -19.64 11.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.727 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.6 t80 -152.22 139.18 19.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.763 ' CD1' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -107.72 177.17 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 60' ' ' ILE . 40.5 tt0 -117.49 119.09 34.0 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.186 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -57.35 122.31 12.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.182 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 1.6 t0 82.53 42.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.254 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -138.29 154.53 73.89 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.409 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 46.2 Cg_endo -67.72 -1.38 6.65 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.363 2.042 . . . . 0.0 112.8 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -70.97 -56.62 5.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.694 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -78.92 -29.21 44.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.273 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -92.22 -1.66 56.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.668 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -44.75 -30.74 1.01 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.316 . . . . 0.0 111.315 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.75 -50.34 0.89 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 HG13 ' A' ' 27' ' ' VAL . 29.0 m -137.93 53.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.576 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.8 mt -127.68 137.7 52.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -131.85 -179.5 5.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.038 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.24 73.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.99 77.48 0.22 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.457 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.422 ' OD2' HD23 ' A' ' 72' ' ' LEU . 5.5 m-20 -103.29 92.42 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -65.18 101.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 55' ' ' PRO . 28.6 m -97.78 149.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -114.57 -30.15 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -132.91 130.24 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.902 HG23 ' CD1' ' A' ' 109' ' ' LEU . 21.9 mt -128.26 116.64 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.42 25.48 3.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.35 -26.13 24.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.582 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 97' ' ' LEU . 50.6 mt -69.82 124.73 91.22 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-O 120.541 0.21 . . . . 0.0 111.134 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.27 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 79' ' ' MET . 33.1 p -143.42 -45.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -68.31 -12.57 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -113.83 44.33 1.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.38 -174.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.867 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 165.4 12.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -73.1 -27.26 61.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -54.92 -41.4 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -34.19 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.731 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -71.43 -32.52 68.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.248 0.547 . . . . 0.0 110.582 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.27 -36.42 63.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.076 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.89 -39.63 61.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.382 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.525 HD11 HG21 ' A' ' 81' ' ' ILE . 2.1 pp -67.61 -40.22 84.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.539 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 41' ' ' LEU . 22.4 mt -65.43 -56.03 14.72 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.6 ppt_? -50.7 -31.31 16.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.493 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.8 p30 -112.28 33.22 5.01 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.801 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 97.9 p -100.26 9.39 42.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.4 t -100.02 15.3 27.69 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.6 mt -67.99 -42.09 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.664 0.745 . . . . 0.0 110.504 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.52 11.19 37.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.598 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 30' ' ' THR . 5.8 m 54.53 24.58 5.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.235 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -162.9 154.68 18.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.46 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -155.31 126.86 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.683 ' C ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -99.88 128.4 45.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.902 ' CD1' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -123.68 158.27 31.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -118.18 118.38 31.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.535 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 25' ' ' THR . 5.4 pt -113.34 163.89 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.424 . . . . 0.0 111.685 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -131.62 144.62 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.46 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.36 174.18 15.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.937 0.399 . . . . 0.0 111.343 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.1 114.45 27.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.492 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.562 HG11 ' OE1' ' A' ' 23' ' ' GLU . 17.4 m -61.88 105.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.337 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -176.07 -135.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 116' ' ' ALA . 9.9 pt-20 48.3 30.55 2.31 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 128' ' ' VAL . 14.6 t 176.89 61.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.076 0.465 . . . . 0.0 111.153 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 119' ' ' VAL . 13.1 p -158.66 118.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.295 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.627 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.5 pp -138.31 97.96 9.35 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.791 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.436 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 90.7 Cg_endo -83.27 150.93 13.63 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.75 2.3 . . . . 0.0 112.91 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -153.55 19.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.18 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.75 114.75 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.051 0.453 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.7 -41.18 2.58 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.128 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.605 HG22 ' HG3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -135.12 108.49 7.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -102.76 128.09 49.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.549 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.627 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.3 134.26 52.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.0 110.487 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 2.9 t -118.22 94.79 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.628 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -83.38 97.94 9.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.402 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.919 HD22 ' HB ' ' A' ' 164' ' ' VAL . 26.7 mt -104.3 117.73 58.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.67 95.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.177 1.918 . . . . 0.0 111.371 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -81.55 159.25 24.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.717 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -114.5 -165.95 1.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.654 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -66.08 -43.64 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.85 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.5 m -179.3 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.717 HG23 ' HB2' ' A' ' 133' ' ' LYS . 40.1 t -94.32 159.84 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.509 ' N ' HG12 ' A' ' 136' ' ' VAL . 33.3 tt0 -51.04 113.63 0.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.686 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.769 HD12 HG12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -117.11 112.08 20.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.915 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . -90.45 47.88 3.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.029 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.971 HG23 ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -109.95 137.06 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.599 0.238 . . . . 0.0 110.384 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 157' ' ' SER . 88.1 m -120.78 109.76 15.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.781 0.324 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.909 HD11 HD22 ' A' ' 197' ' ' LEU . 5.4 mt -87.68 164.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.505 ' N ' HG22 ' A' ' 142' ' ' ILE . 31.1 t -157.67 161.01 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.912 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 21.0 p -115.25 107.79 48.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.548 ' HD3' HG22 ' A' ' 155' ' ' VAL . 50.9 Cg_exo . . . . . 0 C--N 1.346 0.434 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.9 t0 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.756 0.312 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -174.13 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.656 2.237 . . . . 0.0 112.434 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 190' ' ' MET . 1.1 mp -121.84 165.41 15.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 175' ' ' ASP . 22.1 m -158.22 148.08 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.474 HG22 ' CD2' ' A' ' 173' ' ' LEU . 7.7 mt -74.97 150.7 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.373 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.45 ' HB2' HG22 ' A' ' 141' ' ' THR . 24.5 m -136.48 -12.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.17 150.09 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 166' ' ' HIS . 1.1 mt -139.94 145.43 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.198 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.467 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -114.85 154.77 28.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 111.398 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.78 76.65 3.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.69 -36.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.568 ' OG ' HD13 ' A' ' 138' ' ' LEU . 8.4 t -101.81 158.87 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.094 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HB ' HD22 ' A' ' 130' ' ' LEU . 16.8 m -48.88 -22.34 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.096 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.971 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.82 -59.41 2.26 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.65 ' HB2' HG22 ' A' ' 159' ' ' ILE . 42.5 t60 -83.66 -25.2 30.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.862 0.363 . . . . 0.0 110.8 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 164' ' ' VAL . 0.0 OUTLIER -58.4 -29.61 66.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.379 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.85 ' HB ' HD21 ' A' ' 130' ' ' LEU . 3.4 t -55.96 -44.9 78.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.1 -20.41 46.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.836 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.506 HG21 HG23 ' A' ' 119' ' ' VAL . 9.2 t -113.2 37.58 3.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.468 HD21 HG22 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -108.49 41.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.764 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.64 144.45 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD2' HG22 ' A' ' 156' ' ' ILE . 19.2 mt -85.05 108.02 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.82 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.99 -20.28 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 155' ' ' VAL . 1.9 m-20 -63.33 157.79 22.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.671 0.272 . . . . 0.0 110.751 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -108.33 100.91 10.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -69.74 165.93 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 179' ' ' ALA . 2.6 pp -158.25 -40.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.076 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 178' ' ' LEU . . . -125.95 129.88 50.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.892 0.377 . . . . 0.0 111.061 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.991 HD12 ' HB1' ' A' ' 193' ' ' ALA . 46.9 mt -118.68 107.47 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.1 t70 66.05 -72.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.7 -19.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.571 ' HB ' HD13 ' A' ' 196' ' ' ILE . 40.7 mm -96.8 157.13 3.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 120.99 0.424 . . . . 0.0 111.251 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.468 ' N ' HG22 ' A' ' 183' ' ' ILE . 79.2 mtt180 -122.38 132.9 54.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.911 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 1.128 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.4 mm? -67.7 -8.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.558 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -47.56 -28.09 2.12 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.038 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.1 p -144.1 46.78 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.26 160.65 30.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.17 -175.92 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.99 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.843 ' HA ' HD11 ' A' ' 154' ' ' LEU . 8.7 ptm -74.24 -45.59 46.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.419 ' N ' ' HG3' ' A' ' 190' ' ' MET . 1.5 mm-40 -52.05 -50.09 62.18 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.197 0.522 . . . . 0.0 110.89 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -52.12 -45.58 64.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.128 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 1.128 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -56.62 -41.58 77.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.517 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.705 HG22 HD12 ' A' ' 142' ' ' ILE . 10.7 t -60.75 -33.9 56.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 109.82 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -61.92 -50.2 73.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.708 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.3 mt -71.08 -24.93 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -60.98 -37.46 82.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.21 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -92.17 -34.5 14.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.656 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -84.9 11.77 8.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.643 178.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 196' ' ' ILE . 30.0 p -66.1 28.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.503 ' H ' ' C ' ' A' ' 199' ' ' GLN . 1.5 mm-40 46.82 46.45 15.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.73 27.51 16.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.769 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 203' ' ' LEU . 1.6 mt -162.87 94.39 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 204' ' ' VAL . 13.1 p -90.34 123.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 2.9 ttmp? -108.8 107.73 18.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.219 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.612 ' HG ' HD21 ' A' ' 177' ' ' LEU . 10.3 mp -89.35 107.09 18.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.605 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.9 OUTLIER -96.99 100.74 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.759 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.54 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -109.77 173.39 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 8.0 mtp180 -105.06 132.88 50.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.23 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -115.88 159.21 21.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.828 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.0 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.992 -179.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 116' ' ' ALA . 2.7 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.9 0.381 . . . . 0.0 111.163 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -139.72 107.68 5.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.01 133.63 38.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.147 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -148.78 157.73 43.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 112' ' ' GLU . 73.0 p -110.43 144.93 38.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 26' ' ' GLU . 27.4 m -140.57 163.29 33.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' N ' HG22 ' A' ' 25' ' ' THR . 1.2 pm0 -104.63 159.33 15.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 136.18 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 ' C ' HD12 ' A' ' 29' ' ' LEU . 3.9 p -115.97 122.42 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 28' ' ' VAL . 7.1 mp -115.66 118.99 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.896 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -102.49 162.58 12.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.271 0.558 . . . . 0.0 111.932 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -107.33 103.86 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.441 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -75.02 153.27 86.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.332 179.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.4 7.89 3.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.447 2.098 . . . . 0.0 112.675 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.42 -45.29 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.567 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -133.7 -8.59 2.8 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.441 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 65.6 -90.48 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.929 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.708 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 3.5 m-85 -131.66 119.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.58 28.27 15.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.361 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.988 HD13 HD13 ' A' ' 72' ' ' LEU . 25.5 pt -126.84 133.35 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -122.36 139.96 53.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.86 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.758 HD12 HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -130.09 157.51 42.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 112.054 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.766 ' HG3' HD13 ' A' ' 56' ' ' LEU . 10.7 pt20 -112.1 170.07 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.204 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.58 17.59 6.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -111.28 67.8 0.65 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.351 0.596 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.005 HG22 HD21 ' A' ' 56' ' ' LEU . 3.4 t -71.43 -35.11 55.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.961 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 45.6 p90 -132.07 -49.59 0.94 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.252 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.558 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 42.09 85.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.099 0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 171.0 120.86 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.232 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 58.5 80.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER 85.5 -178.17 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' H ' HG22 ' A' ' 50' ' ' THR . 1.1 pp -154.82 -147.2 0.2 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.355 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.454 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 2.0 t 81.43 20.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.227 0.537 . . . . 0.0 111.588 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.643 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -47.51 139.13 8.47 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.964 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' HG21 ' A' ' 45' ' ' VAL . 25.0 Cg_endo -61.96 133.33 43.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.551 2.167 . . . . 0.0 112.406 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.49 141.67 25.21 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.513 2.142 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.005 HD21 HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -141.11 115.98 9.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.637 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -66.12 141.35 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.441 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.486 ' C ' HG23 ' A' ' 74' ' ' ILE . 64.0 p -113.69 -26.16 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.519 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB3' ' HG3' ' A' ' 40' ' ' GLN . 56.2 t80 -144.18 154.49 43.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 0.0 111.496 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' A' ' 67' ' ' GLU . 25.7 mm -137.51 151.24 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.718 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.01 148.99 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.209 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.55 44.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.038 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.72 41.5 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.724 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.494 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 17.5 m -136.93 138.49 26.05 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.958 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.4 Cg_endo -56.75 -12.77 9.61 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.79 2.327 . . . . 0.0 113.276 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -65.41 -58.33 6.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 0.0 110.349 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.633 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -80.12 -30.97 39.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.041 178.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -57.84 -33.41 68.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.0 t -49.58 -30.44 8.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.006 0.432 . . . . 0.0 110.523 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 137' ' ' GLU . . . 87.95 26.13 29.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.982 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -151.52 29.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 0.0 110.912 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.988 HD13 HD13 ' A' ' 39' ' ' ILE . 6.8 mt -133.55 121.63 22.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -136.01 154.95 50.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.295 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.486 HG23 ' C ' ' A' ' 58' ' ' SER . 54.3 mt -58.14 87.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.233 0.54 . . . . 0.0 111.194 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.444 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 132.66 39.55 0.22 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -87.01 132.08 33.9 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.8 102.19 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 109' ' ' LEU . 35.0 t -85.68 121.89 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -29.28 17.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.53 143.51 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 97' ' ' LEU . 1.7 mt -119.39 110.36 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.614 ' ND2' HG13 ' A' ' 107' ' ' VAL . 29.1 m-20 59.98 20.13 9.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.73 -33.79 4.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.632 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.4 mt -69.71 116.81 47.21 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 120.45 0.166 . . . . 0.0 111.167 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.53 ' C ' HG23 ' A' ' 86' ' ' THR . 31.2 Cg_endo -63.93 -33.36 63.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.403 2.069 . . . . 0.0 112.049 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.53 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 74.17 0.52 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.66 -20.73 27.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.924 0.392 . . . . 0.0 111.199 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -101.9 44.53 1.01 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 m -179.12 -176.95 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.12 161.97 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -73.28 -29.74 62.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.012 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.18 -31.65 63.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.355 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.37 -53.49 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.765 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -54.85 -42.19 71.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.29 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -65.05 -39.91 93.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -35.42 80.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.922 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.515 HD12 HD12 ' A' ' 81' ' ' ILE . 86.1 mt -57.44 -51.08 70.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 94' ' ' ALA . 3.2 mp -58.81 -45.12 90.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.427 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.21 -38.01 49.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.232 0.539 . . . . 0.0 109.939 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.5 m-20 -122.06 40.86 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.516 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.415 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 54.7 p -94.32 6.74 47.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 p -102.7 15.56 28.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.838 0.351 . . . . 0.0 111.81 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.0 mt -69.24 -47.85 71.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.789 0.804 . . . . 0.0 110.338 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.4 12.11 28.24 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.396 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 14.5 m 52.58 26.13 4.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HD3' HG22 ' A' ' 28' ' ' VAL . 2.2 mmtp -162.83 156.93 20.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.614 HG13 ' ND2' ' A' ' 82' ' ' ASN . 1.4 t -155.9 99.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.696 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 132.49 35.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.618 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -142.12 157.0 45.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.271 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.68 127.85 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.424 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.8 pt -114.19 145.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 111.571 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.531 ' HG3' HG22 ' A' ' 24' ' ' THR . 2.3 tt0 -116.7 115.72 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -132.89 174.12 10.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 0.0 111.274 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.15 131.7 54.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.4 m -66.58 105.69 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.458 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.722 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -170.08 108.43 0.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.88 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.877 ' HB3' HG22 ' A' ' 168' ' ' THR . 2.9 tp10 -133.86 39.47 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.3 t 66.78 89.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.374 0.607 . . . . 0.0 111.286 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.878 HG11 HG21 ' A' ' 170' ' ' THR . 0.0 OUTLIER -125.53 120.3 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.901 179.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.616 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.9 pp -102.41 103.81 33.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.338 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 94.0 Cg_endo -85.85 148.21 9.53 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 112.55 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -154.49 22.89 0.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.83 113.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.004 0.431 . . . . 0.0 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.5 -43.86 2.62 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.162 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.01 103.73 7.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 110.995 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -107.65 119.56 39.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.577 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.38 124.1 47.35 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.796 0.332 . . . . 0.0 110.483 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.726 HG13 ' CG1' ' A' ' 119' ' ' VAL . 3.4 t -101.76 90.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.63 98.36 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.293 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 168' ' ' THR . 0.5 OUTLIER -126.68 144.15 48.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 0.0 111.56 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.405 ' HD2' ' HG3' ' A' ' 117' ' ' GLU . 45.1 Cg_endo -68.55 119.68 6.66 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.528 2.152 . . . . 0.0 111.48 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -86.94 153.39 21.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.336 0.588 . . . . 0.0 111.628 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -88.72 -164.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.28 34.96 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.693 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.04 47.99 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.824 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 137' ' ' GLU . 7.4 t -89.84 -121.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 1.1 tt0 -90.72 102.62 15.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 122.1 -0.375 . . . . 0.0 111.442 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 138' ' ' LEU . 10.7 tp -122.63 95.24 4.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.88 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -86.1 45.37 3.46 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.2 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.52 HD11 ' HB2' ' A' ' 165' ' ' ALA . 62.5 mt -92.81 123.61 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 157' ' ' SER . 97.8 m -110.41 101.81 10.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.767 ' CG2' HD12 ' A' ' 154' ' ' LEU . 3.0 mt -91.8 163.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.52 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.509 ' N ' HG22 ' A' ' 142' ' ' ILE . 3.2 t -176.22 176.66 1.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.021 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 t -129.38 129.43 23.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.809 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo . . . . . 0 C--N 1.345 0.368 0 C-N-CA 122.491 2.127 . . . . 0.0 112.237 -179.955 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 CA--C 1.531 0.231 0 CA-C-O 120.858 0.361 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.09 -167.32 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.586 2.191 . . . . 0.0 112.333 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.767 HD12 ' CG2' ' A' ' 142' ' ' ILE . 2.6 mm? -126.94 149.88 49.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 175' ' ' ASP . 34.0 m -154.01 156.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.286 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 172' ' ' GLU . 1.7 mp -87.3 152.57 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.768 ' HB2' HG22 ' A' ' 141' ' ' THR . 1.6 m -130.95 -19.03 2.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.922 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.433 ' N ' ' HB ' ' A' ' 141' ' ' THR . 28.6 t70 -177.8 143.66 0.34 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -136.77 131.82 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.566 ' HG3' ' H ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -63.59 130.59 44.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 0.9 5.92 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.566 ' H ' ' HG3' ' A' ' 160' ' ' LYS . . . -124.35 0.15 8.78 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.868 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.426 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 4.6 t -95.11 145.97 24.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 168' ' ' THR . 4.3 m -48.89 -25.87 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.765 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -53.62 -69.46 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' HIS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 12.0 t60 -64.53 -25.66 68.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -56.7 -39.85 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 110.926 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.877 HG22 ' HB3' ' A' ' 117' ' ' GLU . 17.1 p -49.0 -27.75 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.323 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 71.04 1.06 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.878 HG21 HG11 ' A' ' 119' ' ' VAL . 0.1 OUTLIER 176.51 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.863 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 tp -66.45 74.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.441 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -87.91 -170.87 3.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.25 119.97 40.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.78 20.5 4.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.82 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.558 ' O ' HG12 ' A' ' 155' ' ' VAL . 2.0 m-20 -106.98 173.66 6.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.653 0.226 . . . . 0.0 110.459 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.34 142.63 47.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 111.177 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.946 ' CD2' HD11 ' A' ' 180' ' ' ILE . 1.2 tp -101.96 138.63 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.581 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.46 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.364 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.707 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -146.96 165.45 29.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.011 0.434 . . . . 0.0 111.541 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.946 HD11 ' CD2' ' A' ' 177' ' ' LEU . 25.5 mm -139.61 107.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.182 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER 64.98 -73.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.39 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -134.59 -25.24 1.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 184' ' ' ARG . 46.4 mm -87.59 157.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.707 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 8.2 mtp180 -123.57 124.54 43.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 112.113 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.0 mm? -78.94 -4.62 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -45.33 -29.39 1.03 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 m -141.7 51.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.792 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.48 159.31 37.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.45 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -68.29 175.95 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' MET . . . . . 0.677 ' HB2' HD11 ' A' ' 154' ' ' LEU . 25.8 ptm -74.11 -41.86 60.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.988 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 190' ' ' MET . 0.7 OUTLIER -53.81 -29.98 42.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.99 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.8 OUTLIER -61.58 -52.49 64.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.093 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.667 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -56.24 -39.49 72.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.209 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 142' ' ' ILE . 18.4 t -61.61 -39.9 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.673 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -50.33 74.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.124 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.6 mt -69.79 -24.92 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -58.59 -35.48 72.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.588 179.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.29 -40.74 7.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.733 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -22.98 41.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.714 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' CYS . . . . . 0.71 ' CB ' HG22 ' A' ' 204' ' ' VAL . 2.0 m -91.16 42.68 1.11 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.72 62.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.353 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -171.91 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.543 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 203' ' ' LEU . 3.2 tt 175.13 110.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.71 HG22 ' CB ' ' A' ' 200' ' ' CYS . 98.9 t -108.18 138.81 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.477 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 7.3 tttt -109.12 108.03 18.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 7.1 mp -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 111.412 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . 0.583 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 2.9 tttt -92.73 93.17 8.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.298 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.473 HD13 HD12 ' A' ' 177' ' ' LEU . 6.6 mm -90.71 163.39 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.015 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 5.7 mtp-105 -107.98 120.72 43.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 150.53 21.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.798 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.77 0.319 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.1 m -130.31 136.3 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.212 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 21' ' ' HIS . 20.3 t -139.8 158.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.977 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.474 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.2 t60 -131.03 98.61 4.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.408 HG23 ' OD1' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -60.67 119.65 8.53 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.931 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -134.1 156.55 48.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.16 161.29 16.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -149.63 -169.79 3.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -122.6 163.1 20.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.857 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.58 135.68 23.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.76 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 28' ' ' VAL . 8.8 p -108.66 122.89 63.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.525 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 39' ' ' ILE . 31.9 mt -120.07 118.66 31.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.497 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.8 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.95 162.12 14.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.193 0.521 . . . . 0.0 111.601 -179.315 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.898 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.48 140.3 32.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.123 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.73 154.69 37.32 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.701 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.97 11.16 2.88 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.52 2.147 . . . . 0.0 112.611 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.0 t -114.32 -46.98 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 t -144.64 8.77 1.33 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 69.21 -117.29 7.77 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.46 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 3.6 m-85 -103.77 128.92 51.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.851 0.357 . . . . 0.0 110.424 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -92.47 27.34 10.82 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.305 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 29' ' ' LEU . 3.3 mt -94.08 157.61 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.359 0.6 . . . . 0.0 111.779 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.494 ' N ' HG22 ' A' ' 39' ' ' ILE . 4.2 mt-30 -137.85 104.99 5.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.826 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.829 HD22 HD12 ' A' ' 98' ' ' LEU . 1.1 tp -95.69 144.7 25.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.272 0.558 . . . . 0.0 112.403 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -114.68 151.56 33.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.976 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.25 88.35 0.88 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.135 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.81 104.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.599 179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.904 HG23 HD11 ' A' ' 56' ' ' LEU . 13.4 t -76.21 -65.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.549 0.69 . . . . 0.0 109.913 178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.58 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 21.3 p90 -33.03 -43.75 0.1 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.037 178.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.61 88.65 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.933 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.436 ' O ' ' O ' ' A' ' 49' ' ' GLU . 0.9 OUTLIER 170.08 114.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.682 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 48' ' ' THR . 11.5 pt-20 47.09 108.16 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.92 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 49' ' ' GLU . 1.4 p 67.25 -162.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.635 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.58 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.5 mt -129.0 -72.89 0.59 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.334 0.588 . . . . 0.0 111.499 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.7 t 63.69 8.83 3.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.465 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.518 ' N ' ' HD3' ' A' ' 54' ' ' PRO . 1.1 m -175.63 58.76 0.19 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.569 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.608 ' CB ' ' HD3' ' A' ' 55' ' ' PRO . 8.0 Cg_exo -67.65 -59.0 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.063 1.842 . . . . 0.0 112.787 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.697 ' HB2' HD21 ' A' ' 41' ' ' LEU . 59.2 Cg_endo -99.82 108.93 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.919 2.413 . . . . 0.0 112.694 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HG23 ' A' ' 45' ' ' VAL . 1.9 pt? -143.89 127.39 16.94 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.671 -0.411 . . . . 0.0 111.549 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.675 HD13 HG23 ' A' ' 39' ' ' ILE . 37.6 mt -67.66 136.75 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.057 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.95 -6.23 12.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.612 ' HA ' HD12 ' A' ' 74' ' ' ILE . 33.8 t80 -178.02 138.39 0.2 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.043 0.449 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.727 HG21 ' HG2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -102.07 -167.81 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 60' ' ' ILE . 51.7 tt0 -129.14 151.73 49.5 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.355 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -82.81 114.72 21.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.411 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 2.9 t70 91.73 39.55 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.534 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 2.5 p -132.92 143.96 50.8 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.35 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 69' ' ' CYS . 31.5 Cg_exo -58.61 -2.92 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.465 2.11 . . . . 0.0 112.953 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -63.68 -56.89 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.602 0.239 . . . . 0.0 110.883 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.727 ' HG2' HG21 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -78.51 -28.66 46.32 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.617 ' HD3' ' N ' ' A' ' 68' ' ' ARG . 4.1 mmt-85 -85.49 -1.55 57.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.277 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.533 ' SG ' HD23 ' A' ' 72' ' ' LEU . 31.3 p -58.64 -40.94 84.81 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.744 0.307 . . . . 0.0 110.893 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 137' ' ' GLU . . . 149.18 -23.75 1.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.96 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.4 p -175.05 84.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.822 0.344 . . . . 0.0 111.128 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD23 ' SG ' ' A' ' 69' ' ' CYS . 0.4 OUTLIER -134.69 123.4 23.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.726 -179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -128.26 159.59 34.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.963 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 59' ' ' TYR . 22.5 mm -61.12 106.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.275 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.74 45.88 0.87 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.559 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.496 ' OD1' HG21 ' A' ' 111' ' ' ILE . 1.1 t70 -70.88 101.36 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.816 0.341 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.7 mmm-85 -70.73 66.06 0.34 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.013 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.757 HG12 HD13 ' A' ' 109' ' ' LEU . 34.3 m -64.85 129.85 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -102.59 -29.6 11.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.383 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.23 148.7 31.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.947 0.404 . . . . 0.0 111.608 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.461 HD12 HD12 ' A' ' 97' ' ' LEU . 6.7 mt -130.24 112.41 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.769 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 62.25 21.84 12.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.025 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.76 16.39 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.679 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.2 mt -74.32 136.24 75.51 Favored Pre-proline 0 N--CA 1.449 -0.494 0 CA-C-O 120.537 0.208 . . . . 0.0 111.186 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.05 -170.7 0.43 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.514 2.143 . . . . 0.0 112.232 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 78.6 p -150.76 -60.19 0.18 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -64.83 -16.62 63.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.376 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -106.35 43.9 1.1 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.051 0.453 . . . . 0.0 110.652 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 179.47 -175.36 0.25 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.803 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 m -71.41 149.06 46.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.954 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.465 ' CB ' ' HB3' ' A' ' 54' ' ' PRO . 9.0 p90 -73.42 -33.64 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.983 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -54.92 -42.53 72.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.953 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 1.9 pt-20 -61.17 -39.27 89.49 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.784 -0.366 . . . . 0.0 110.498 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.43 -39.61 94.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.435 0.636 . . . . 0.0 110.232 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.501 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -61.36 -39.55 91.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.791 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.402 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 2.1 mm-40 -62.49 -39.81 94.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.484 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.461 HD12 HD12 ' A' ' 81' ' ' ILE . 14.8 mt -57.05 -49.98 74.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.776 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.829 HD12 HD22 ' A' ' 41' ' ' LEU . 7.1 mt -60.46 -58.77 7.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 49.8 mtt180 -50.28 -29.84 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.205 0.526 . . . . 0.0 109.94 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.548 ' O ' HD11 ' A' ' 103' ' ' ILE . 3.6 m-20 -114.89 33.15 5.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.845 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.664 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.8 45.27 0.97 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.865 179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.5 m -142.75 16.82 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.548 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.8 mp -65.4 -45.24 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.552 0.691 . . . . 0.0 110.901 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.23 11.89 38.32 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.495 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.8 ' O ' HG22 ' A' ' 30' ' ' THR . 20.5 t 57.92 25.31 11.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.033 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 1.5 ttpt -165.88 145.46 6.3 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.744 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.512 HG11 ' OG ' ' A' ' 101' ' ' SER . 2.7 t -141.73 135.81 30.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.787 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.86 131.12 57.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.559 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.757 HD13 HG12 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -139.1 165.12 27.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.92 0.391 . . . . 0.0 111.335 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -118.14 141.04 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.615 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.565 HG22 ' HA ' ' A' ' 78' ' ' VAL . 30.4 pt -133.15 159.12 43.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.074 0.464 . . . . 0.0 111.522 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -123.14 143.0 50.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.527 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.44 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 1.2 p90 -161.11 174.29 13.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 111.281 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' OD1' HG23 ' A' ' 22' ' ' THR . 3.1 m-20 -102.95 149.6 24.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.376 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.7 m -97.98 104.8 16.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.933 0.397 . . . . 0.0 111.452 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -179.68 -147.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.596 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 76.1 12.52 2.79 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.822 0.344 . . . . 0.0 110.811 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.6 t -178.8 84.46 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.665 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.412 HG22 ' CG2' ' A' ' 170' ' ' THR . 41.3 t -156.29 117.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.478 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 1.039 HG23 ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -157.24 84.53 2.91 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-O 121.233 0.539 . . . . 0.0 111.084 -178.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 65.1 Cg_endo -94.65 -169.49 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.299 2.666 . . . . 0.0 112.636 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.5 t -178.49 34.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.745 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 58.9 114.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.89 -39.48 2.87 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.309 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.706 HG22 ' HG3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.9 113.43 12.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.835 0.35 . . . . 0.0 111.021 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.454 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -103.57 126.29 50.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.653 179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 1.039 ' HB2' HG23 ' A' ' 120' ' ' ILE . 7.3 m80 -101.58 135.26 43.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.859 0.362 . . . . 0.0 110.943 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.756 HG12 HD13 ' A' ' 130' ' ' LEU . 14.6 t -137.82 86.59 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.748 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -81.51 106.21 13.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.38 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.792 HD11 ' HB ' ' A' ' 168' ' ' THR . 2.8 mp -109.11 132.22 21.34 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.372 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.44 108.45 1.39 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.159 1.906 . . . . 0.0 111.057 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.1 OUTLIER -86.64 158.62 19.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.103 0.477 . . . . 0.0 111.471 -178.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.428 ' HG3' ' CG2' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -128.36 -174.93 3.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.167 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -56.36 -78.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.197 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.5 m -153.94 74.7 1.0 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.129 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 137' ' ' GLU . 95.5 t -113.37 156.91 14.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.901 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' N ' HG12 ' A' ' 136' ' ' VAL . 36.7 tt0 -56.45 110.44 0.78 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.437 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 140' ' ' ILE . 2.8 mt -96.61 -52.89 3.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.357 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.453 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . 93.57 9.03 60.49 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.13 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.799 HD12 HD13 ' A' ' 138' ' ' LEU . 21.2 mt -79.38 128.97 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.841 0.321 . . . . 0.0 111.232 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.751 HG22 ' HB2' ' A' ' 157' ' ' SER . 39.7 m -116.19 128.7 55.84 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.924 0.392 . . . . 0.0 110.199 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.898 HG23 HD11 ' A' ' 154' ' ' LEU . 9.0 mt -103.17 164.12 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.585 -179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.551 ' N ' HG22 ' A' ' 142' ' ' ILE . 45.9 p -163.57 152.9 14.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.265 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p -122.57 139.55 31.21 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.848 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.83 -45.3 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.494 2.129 . . . . 0.0 112.416 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.5 m -179.26 132.17 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 59.9 m -94.73 59.14 2.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.004 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.58 46.53 1.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.018 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.58 145.63 1.77 Allowed Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.876 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.19 113.67 3.84 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.521 2.147 . . . . 0.0 112.45 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 115.19 21.68 5.15 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.841 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER -46.48 99.96 0.22 Allowed Pre-proline 0 CA--C 1.53 0.199 0 CA-C-O 120.646 0.26 . . . . 0.0 111.03 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.69 149.97 30.62 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.976 2.45 . . . . 0.0 112.779 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.898 HD11 HG23 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -76.64 144.13 39.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.84 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.482 ' N ' HD13 ' A' ' 154' ' ' LEU . 5.1 t -129.18 142.15 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.975 0.416 . . . . 0.0 111.941 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.4 mt -88.52 150.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.218 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.751 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.5 OUTLIER -124.94 -20.9 4.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 111.723 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 177.71 153.39 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.019 0.438 . . . . 0.0 111.168 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -140.1 125.6 20.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.453 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -80.63 154.07 27.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.132 -179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mmtp -74.81 -178.93 3.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.521 ' C ' HG21 ' A' ' 71' ' ' VAL . . . 72.01 -61.42 1.35 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.724 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.492 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.9 OUTLIER -56.67 161.72 2.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.969 0.414 . . . . 0.0 111.274 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.68 ' O ' HD21 ' A' ' 130' ' ' LEU . 5.5 m -69.42 -20.92 24.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.77 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.794 ' O ' HG22 ' A' ' 168' ' ' THR . . . -47.71 -70.87 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 33.6 t60 -76.48 -23.92 53.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.232 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.492 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.23 -44.68 71.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.307 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.794 HG22 ' O ' ' A' ' 165' ' ' ALA . 3.2 t -52.48 -25.85 11.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.034 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 61.54 48.91 81.98 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.412 ' CG2' HG22 ' A' ' 119' ' ' VAL . 35.2 p -137.95 -44.33 0.52 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.911 0.386 . . . . 0.0 111.083 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.579 HD21 ' CD2' ' A' ' 206' ' ' LEU . 3.6 mp -59.51 87.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -95.24 139.44 31.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.82 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.24 119.89 16.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.19 18.47 5.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.681 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.421 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.5 OUTLIER -114.31 -177.25 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.695 0.283 . . . . 0.0 110.738 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -132.38 161.54 33.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.852 0.358 . . . . 0.0 111.03 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 154' ' ' LEU . 1.7 mp -124.54 170.9 10.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.038 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.458 ' C ' HD12 ' A' ' 178' ' ' LEU . 0.5 OUTLIER -139.56 -39.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.223 179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.456 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -139.44 142.36 37.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.008 0.432 . . . . 0.0 111.572 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.674 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 46.7 mt -127.48 111.57 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.881 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.0 t70 66.3 -70.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.096 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -144.92 -20.78 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.602 ' HB ' HG21 ' A' ' 196' ' ' ILE . 23.1 mm -98.0 156.95 3.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.17 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 38.1 mtt85 -116.18 139.3 50.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.141 0.496 . . . . 0.0 112.241 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.932 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.9 mm? -70.86 -2.89 16.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.628 177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.52 -27.91 1.99 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.094 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 13.6 m -75.17 -18.93 60.09 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.891 0.377 . . . . 0.0 111.299 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 152' ' ' ASP . 4.5 m 76.02 102.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.49 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 192' ' ' ASP . 1.4 m 168.58 95.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.543 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.1 ptm -53.82 -41.56 67.47 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.152 0.501 . . . . 0.0 110.265 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.454 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.4 mm-40 -55.63 -39.29 70.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.987 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.657 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.3 OUTLIER -55.65 -52.07 65.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.061 179.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.932 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -53.7 -36.4 62.17 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.35 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.834 HG22 ' CD1' ' A' ' 142' ' ' ILE . 11.8 t -66.42 -32.68 59.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.605 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 191' ' ' GLU . 3.0 mm-40 -76.02 -45.06 36.37 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.66 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.657 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.7 mt -73.43 -31.17 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.605 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.792 HD21 HD11 ' A' ' 142' ' ' ILE . 1.6 pp -78.39 -24.73 46.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.089 0.471 . . . . 0.0 110.697 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.692 ' NE2' HG12 ' A' ' 194' ' ' VAL . 27.3 mt-30 -88.01 -45.55 10.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.059 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -20.56 63.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.365 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' A' ' 204' ' ' VAL . 27.6 p -88.41 45.99 1.34 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.285 0.564 . . . . 0.0 109.784 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -68.12 60.66 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.782 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -169.27 -33.96 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.109 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.4 tt -175.01 105.02 0.09 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.776 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.572 HG23 ' SG ' ' A' ' 200' ' ' CYS . 9.8 p -96.14 126.57 48.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.478 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 0.3 OUTLIER -100.73 107.82 19.51 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.127 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.579 ' CD2' HD21 ' A' ' 171' ' ' LEU . 3.6 mp -94.79 113.77 25.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.916 0.389 . . . . 0.0 111.408 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.1 OUTLIER -101.1 93.5 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.447 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 208' ' ' ILE . 1.4 mm -83.32 169.79 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.888 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.504 ' H ' HG22 ' A' ' 208' ' ' ILE . 15.7 mmt180 -118.44 128.18 54.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.001 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.24 151.32 26.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.934 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 176.43 78.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.741 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.68 174.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.226 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 . . . . . 0 N--CA 1.453 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.234 -179.855 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.822 0.344 . . . . 0.0 110.812 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -89.9 116.68 31.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 114' ' ' ASP . 18.0 t -136.07 133.65 50.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.383 . . . . 0.0 111.183 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -105.28 105.78 15.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.809 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p -54.55 158.41 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.171 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -146.97 153.16 39.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.706 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.2 p -109.76 136.31 49.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.091 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.9 t -126.66 174.96 8.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -103.84 157.77 16.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -147.75 147.65 17.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.28 109.96 19.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.194 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 29' ' ' LEU . 3.9 mt -101.26 118.61 37.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.212 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.42 161.78 14.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.125 0.488 . . . . 0.0 111.674 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -93.97 172.57 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.051 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -163.22 140.76 6.0 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.347 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.86 19.09 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.464 2.11 . . . . 0.0 112.739 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 35' ' ' THR . 62.2 t -129.82 -51.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-O 120.751 0.31 . . . . 0.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 34' ' ' VAL . 20.5 p -156.81 36.22 0.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.778 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -45.32 127.07 7.88 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.711 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.575 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 24.5 m-85 63.55 71.69 0.49 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.45 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -83.31 21.79 8.08 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.146 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.982 HG23 HD13 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -111.79 133.2 58.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.95 0.405 . . . . 0.0 111.458 179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 6.4 mt-30 -97.92 126.88 43.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.049 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -96.03 141.52 29.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.122 0.487 . . . . 0.0 111.82 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.67 165.63 12.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.357 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.81 -111.11 0.11 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.532 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.629 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 90.8 p -115.53 104.2 11.5 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.846 0.355 . . . . 0.0 110.931 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.896 HG23 HD13 ' A' ' 56' ' ' LEU . 59.5 t -46.38 -78.8 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 15.5 p90 -40.65 -51.75 2.98 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.75 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.629 ' HB2' ' O ' ' A' ' 44' ' ' SER . . . 38.22 93.17 0.01 OUTLIER 'General case' 0 C--O 1.231 0.111 0 CA-C-N 115.593 -0.731 . . . . 0.0 112.052 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.662 ' O ' HG22 ' A' ' 50' ' ' THR . 0.1 OUTLIER 175.55 110.42 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.846 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' C ' HG22 ' A' ' 50' ' ' THR . 6.4 pt-20 49.45 36.8 10.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.331 0.586 . . . . 0.0 110.324 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.662 HG22 ' O ' ' A' ' 48' ' ' THR . 0.1 OUTLIER 166.81 177.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.307 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 51' ' ' LEU . 2.4 pp -176.71 33.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.518 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.9 m -63.09 29.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.642 0.979 . . . . 0.0 113.642 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.711 ' HB3' HD11 ' A' ' 56' ' ' LEU . 1.8 t -147.25 73.05 12.01 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-O 120.844 0.354 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HB3' ' HA ' ' A' ' 91' ' ' PHE . 20.9 Cg_exo -63.46 -53.07 1.56 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.544 2.163 . . . . 0.0 113.169 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.619 ' HA ' HD23 ' A' ' 41' ' ' LEU . 57.2 Cg_endo -96.14 102.44 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.827 2.351 . . . . 0.0 113.039 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.896 HD13 HG23 ' A' ' 45' ' ' VAL . 27.8 mt -131.71 85.21 2.23 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.714 HD13 ' HB ' ' A' ' 39' ' ' ILE . 85.7 mt -58.58 136.64 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 70.5 p -120.97 -8.43 9.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.41 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 91.3 t80 -144.47 150.52 37.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.302 0.572 . . . . 0.0 112.322 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.982 HD13 HG23 ' A' ' 39' ' ' ILE . 1.7 mm -123.4 152.7 28.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.266 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 72.8 tt0 -104.47 106.6 17.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.884 0.373 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.54 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -63.45 116.51 5.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.036 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.54 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 12.4 t0 95.24 45.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.191 0.519 . . . . 0.0 110.558 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.537 ' H ' ' CZ ' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -139.71 -173.85 0.38 Allowed Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.908 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.51 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 64.6 Cg_endo -95.01 -6.73 1.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.451 2.101 . . . . 0.0 113.535 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.61 ' HB2' ' H ' ' A' ' 38' ' ' GLY . . . -74.7 -58.0 3.56 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' H ' ' NH2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -77.03 -29.03 55.08 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.961 0.41 . . . . 0.0 110.447 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.537 ' CZ ' ' H ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -93.36 -7.33 45.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.781 -179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -41.89 -42.46 2.74 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.015 0.436 . . . . 0.0 111.263 179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.39 -22.77 0.75 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.532 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 71' ' ' VAL . 7.2 p -173.07 82.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.886 0.374 . . . . 0.0 110.964 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -134.56 159.04 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.992 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.87 143.01 7.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.679 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.5 mt -55.2 132.31 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.095 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.25 43.35 16.51 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.893 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.725 ' HB3' HG21 ' A' ' 111' ' ' ILE . 50.7 m-20 -55.58 -43.8 76.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.707 0.289 . . . . 0.0 111.255 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 75.56 72.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 109' ' ' LEU . 86.1 t -71.13 152.69 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.296 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.615 ' HE2' ' HB2' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -121.21 -27.78 4.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.91 179.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB2' ' HE2' ' A' ' 79' ' ' MET . . . -155.13 134.76 12.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.958 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.935 HD13 HD11 ' A' ' 97' ' ' LEU . 2.1 mp -114.79 109.62 29.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 52.94 24.07 3.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.123 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.34 -35.74 4.11 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.496 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.4 mm -64.03 117.59 37.65 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 120.526 0.203 . . . . 0.0 111.315 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.09 171.65 9.82 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.405 2.07 . . . . 0.0 112.248 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 p -143.97 -45.5 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.9 -16.35 58.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.515 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -129.91 52.75 1.97 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.949 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 t -177.22 166.81 2.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.43 140.03 56.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.933 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 5.4 p90 -73.58 -29.74 62.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.164 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.3 mm-40 -54.55 -43.78 72.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.411 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -61.23 -37.0 81.48 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.989 -0.285 . . . . 0.0 110.759 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.7 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -64.98 -34.36 78.24 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.295 0.569 . . . . 0.0 110.528 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.546 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.9 m120 -67.06 -39.51 86.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.345 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 8.7 mm-40 -64.27 -55.98 17.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.906 0.384 . . . . 0.0 110.936 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.935 HD11 HD13 ' A' ' 81' ' ' ILE . 0.3 OUTLIER -52.16 -43.67 64.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.749 -179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.049 HD13 HD13 ' A' ' 41' ' ' LEU . 12.7 mt -59.57 -59.99 4.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.473 0.178 . . . . 0.0 111.14 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 61.3 mtt180 -50.23 -29.78 10.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.394 0.616 . . . . 0.0 109.602 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.674 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -113.5 33.69 4.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.21 179.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -104.77 21.08 17.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.979 179.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.3 m -110.46 18.0 20.23 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.674 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -68.13 -47.73 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 121.561 0.696 . . . . 0.0 110.948 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.19 6.94 37.82 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.8 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.684 ' O ' HG22 ' A' ' 30' ' ' THR . 8.3 m 59.14 25.94 14.56 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.113 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.64 153.69 2.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.264 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 t -149.58 146.03 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.777 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.26 124.54 51.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.336 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.723 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.9 OUTLIER -131.21 154.8 48.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.132 0.491 . . . . 0.0 111.558 -179.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.59 123.14 46.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.918 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.725 HG21 ' HB3' ' A' ' 76' ' ' ASP . 33.0 pt -114.71 148.94 17.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 111.904 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -118.19 145.15 45.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.154 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.47 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.11 174.34 13.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.956 0.408 . . . . 0.0 111.141 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.715 ' HB2' HG11 ' A' ' 20' ' ' VAL . 2.7 p-10 -96.62 147.01 24.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.481 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.702 HG12 ' HA ' ' A' ' 167' ' ' ARG . 2.8 m -99.58 107.37 20.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.911 0.386 . . . . 0.0 111.314 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.21 124.96 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 118' ' ' SER . 12.5 mm-40 -127.36 10.54 6.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.643 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.2 75.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.342 0.591 . . . . 0.0 111.366 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 128' ' ' VAL . 15.9 m -97.82 148.12 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.68 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.737 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.8 pp -126.75 92.25 45.25 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 121.353 0.597 . . . . 0.0 110.898 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.479 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 63.3 Cg_endo -95.32 -165.57 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.318 2.679 . . . . 0.0 112.876 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.0 t 177.95 -66.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.453 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 213' ' ' ASP . 3.0 p 168.56 116.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.199 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.28 -40.68 2.7 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.204 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.8 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.41 104.3 7.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.982 0.42 . . . . 0.0 110.826 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 1.9 t80 -100.34 115.79 30.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.759 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.737 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -91.75 134.25 34.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.293 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.883 ' HA ' HG12 ' A' ' 119' ' ' VAL . 3.2 t -117.49 82.18 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.044 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -80.87 102.26 9.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.605 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.662 HD22 HG21 ' A' ' 168' ' ' THR . 0.8 OUTLIER -129.1 144.71 53.73 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.135 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.44 135.73 22.74 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.428 2.085 . . . . 0.0 112.059 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 200' ' ' CYS . 0.1 OUTLIER -107.8 159.23 16.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.059 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.515 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -106.66 -171.11 1.83 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.583 -179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -66.82 -76.11 0.09 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.254 -179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.4 m -149.74 70.72 1.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.521 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 137' ' ' GLU . 42.3 t -122.02 159.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.772 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' N ' HG12 ' A' ' 136' ' ' VAL . 32.8 tt0 -50.71 103.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.179 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.86 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -61.8 -45.43 93.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.721 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.401 ' CA ' ' HB3' ' A' ' 160' ' ' LYS . . . 94.24 -0.38 66.18 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.977 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.86 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -108.46 141.36 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.086 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 55.9 m -126.07 131.89 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.519 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.054 HD13 HG22 ' A' ' 194' ' ' VAL . 1.3 mt -98.1 163.31 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.79 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.491 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -158.97 149.46 19.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.3 p -112.47 132.39 22.19 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.74 -59.2 0.31 Allowed 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.455 2.103 . . . . 0.0 112.317 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 70.7 m -166.06 -177.11 4.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.811 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.2 t -117.41 29.58 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -112.3 43.79 1.55 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.713 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.48 149.93 32.68 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.809 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.14 -25.49 29.61 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.446 2.097 . . . . 0.0 112.194 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 169.23 55.8 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.342 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.44 145.61 14.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.679 0.276 . . . . 0.0 111.29 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.02 174.78 11.43 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.636 2.224 . . . . 0.0 112.425 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.848 HD11 ' HA ' ' A' ' 190' ' ' MET . 4.4 mm? -91.97 169.96 10.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.433 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 175' ' ' ASP . 20.1 m -150.56 149.37 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.921 0.391 . . . . 0.0 111.525 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.6 mt -67.72 146.58 12.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.632 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.38 -8.51 3.73 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.23 143.08 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.01 0.433 . . . . 0.0 111.46 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.2 mt -132.7 149.32 31.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.628 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.401 ' HB3' ' CA ' ' A' ' 139' ' ' GLY . 1.5 tttm -124.2 142.79 50.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -80.91 151.94 28.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.456 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.41 ' HA2' ' CZ ' ' A' ' 113' ' ' PHE . . . 86.75 -16.45 46.17 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.898 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.514 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 1.1 m -96.45 136.96 36.23 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.86 0.362 . . . . 0.0 110.945 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.438 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 6.7 m -48.2 -22.62 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.255 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -55.77 -50.12 71.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.945 0.403 . . . . 0.0 111.136 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.442 ' HB3' ' NH2' ' A' ' 167' ' ' ARG . 2.0 t60 -83.88 -26.65 29.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.101 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.702 ' HA ' HG12 ' A' ' 115' ' ' VAL . 14.2 mmp_? -56.57 -50.04 73.08 Favored 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 120.93 0.395 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.662 HG21 HD22 ' A' ' 130' ' ' LEU . 6.5 t -53.1 -25.36 12.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.132 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 170' ' ' THR . . . 77.81 -162.73 50.61 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.548 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 169' ' ' GLY . 14.4 t 44.78 31.53 0.67 Allowed 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.843 0.354 . . . . 0.0 111.403 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.47 98.49 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -138.44 149.71 45.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.871 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.7 138.62 52.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 108.74 -17.35 33.06 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.689 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.58 ' CG ' HG21 ' A' ' 208' ' ' ILE . 0.8 OUTLIER -74.92 166.39 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.68 0.276 . . . . 0.0 110.651 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 11.6 mmtm -117.91 122.88 44.45 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.847 0.356 . . . . 0.0 111.167 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.78 HD23 HD11 ' A' ' 180' ' ' ILE . 2.6 mp -82.66 138.73 34.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.769 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 tt -116.03 -66.49 1.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.076 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.869 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -121.36 161.82 21.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.78 HD11 HD23 ' A' ' 177' ' ' LEU . 33.8 mm -139.74 105.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.137 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.432 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 2.8 t0 63.82 -71.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.155 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.435 ' N ' ' O ' ' A' ' 180' ' ' ILE . 2.6 t-20 -138.59 -23.39 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.629 ' HB ' HG21 ' A' ' 196' ' ' ILE . 26.1 mm -94.23 138.51 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.915 0.388 . . . . 0.0 111.296 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.51 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 65.8 mtt180 -102.07 119.97 39.67 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.969 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.718 HD13 ' HB2' ' A' ' 193' ' ' ALA . 0.8 OUTLIER -72.16 -13.87 61.67 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.133 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -44.21 -29.99 0.72 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.507 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 25.9 m -127.43 -4.37 6.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.508 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.43 148.85 22.03 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.826 0.346 . . . . 0.0 111.058 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.02 -176.51 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.984 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.848 ' HA ' HD11 ' A' ' 154' ' ' LEU . 1.4 ttt -68.46 -57.27 6.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.829 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -55.29 -32.02 62.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.211 0.529 . . . . 0.0 110.69 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.64 -48.49 80.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.068 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.718 ' HB2' HD13 ' A' ' 185' ' ' LEU . . . -57.29 -41.11 79.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.378 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 1.054 HG22 HD13 ' A' ' 142' ' ' ILE . 11.7 t -62.76 -32.12 54.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.198 0.523 . . . . 0.0 110.05 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -45.91 85.97 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.877 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -69.98 -24.35 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.523 178.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.501 HD13 HD11 ' A' ' 142' ' ' ILE . 0.0 OUTLIER -68.43 -35.83 78.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.533 ' NE2' HG12 ' A' ' 194' ' ' VAL . 14.9 mt-30 -89.43 -49.81 6.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.508 -178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.55 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -58.18 -15.89 11.53 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.557 ' CB ' HG13 ' A' ' 204' ' ' VAL . 8.4 m -89.42 32.53 0.85 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.765 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -66.23 65.72 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.406 0.622 . . . . 0.0 111.418 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -172.3 -29.91 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.672 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 203' ' ' LEU . 2.8 tt 171.84 111.63 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.768 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.557 HG13 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.72 128.8 64.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.204 -179.545 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.432 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 1.7 ttmt -107.85 107.68 18.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.776 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 128' ' ' VAL . 5.4 mp -90.55 119.67 31.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.001 0.429 . . . . 0.0 111.662 -179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.869 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -98.01 93.84 6.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.092 179.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.58 HG21 ' CG ' ' A' ' 175' ' ' ASP . 3.9 mm -82.33 163.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.364 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -106.45 118.02 35.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.831 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 124' ' ' GLY . 25.5 mttt -129.58 114.54 16.18 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -87.47 43.57 1.12 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.858 0.361 . . . . 0.0 111.42 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 213' ' ' ASP . 25.0 mt-10 -125.59 156.82 38.56 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.258 0.551 . . . . 0.0 111.691 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 212' ' ' GLU . 18.1 t70 . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.622 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.831 0.348 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.4 m -150.0 116.86 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.257 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.7 t -115.96 95.65 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.063 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -114.26 113.35 24.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 p -52.0 140.06 21.23 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.111 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -135.28 159.99 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.967 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.0 p -110.03 136.22 49.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.581 HG23 ' HB3' ' A' ' 161' ' ' LYS . 4.2 m -132.54 169.6 16.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.855 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' H ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.67 160.59 14.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.948 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.8 HG13 HG23 ' A' ' 71' ' ' VAL . 1.8 t -147.27 148.22 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 50.2 t -127.14 110.0 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.751 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.731 HD12 HD21 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -106.83 120.62 42.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.556 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -113.26 160.48 18.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.094 0.473 . . . . 0.0 111.43 -179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.705 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -90.4 132.02 35.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.849 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.87 148.93 36.02 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.567 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.67 14.57 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.552 2.168 . . . . 0.0 112.567 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.1 t -119.0 -48.97 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.48 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.65 -17.29 4.11 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 71.69 74.61 0.72 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.347 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.705 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 79.5 m-85 83.58 -25.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.113 0.565 . . . . 0.0 110.873 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . 59.61 14.95 30.96 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 114.412 0.525 . . . . 0.0 114.412 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.104 ' CG2' HD13 ' A' ' 60' ' ' ILE . 1.1 pp -133.98 144.44 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 117.796 0.798 . . . . 0.0 112.676 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -106.8 129.01 54.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.748 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.938 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -95.75 115.98 28.22 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.077 0.465 . . . . 0.0 111.883 -178.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.866 ' HB3' HD12 ' A' ' 56' ' ' LEU . 4.0 tt0 -70.13 157.24 37.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.299 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.6 106.36 2.51 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.106 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.6 p 52.5 -170.79 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.595 0.236 . . . . 0.0 110.46 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' PHE . 58.4 t -144.45 -96.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.708 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE1' ' CB ' ' A' ' 53' ' ' SER . 40.7 p90 -45.79 -52.11 11.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.278 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 45.35 78.35 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.373 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.486 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 15.9 p -153.7 96.68 2.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.073 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 50' ' ' THR . 2.6 pt-20 54.66 118.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.736 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 28.1 m 75.1 -12.13 0.99 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.601 ' O ' ' CB ' ' A' ' 52' ' ' SER . 0.8 OUTLIER 33.56 -129.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 122.289 0.236 . . . . 0.0 111.464 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.601 ' CB ' ' O ' ' A' ' 51' ' ' LEU . 7.7 t 104.84 4.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.401 0.68 . . . . 0.0 110.263 -178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.505 ' CB ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -76.51 110.13 10.62 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.012 178.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 52' ' ' SER . 96.0 Cg_endo -78.93 160.34 27.27 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.344 2.03 . . . . 0.0 112.714 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 10.2 Cg_endo -53.34 147.88 35.05 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.694 2.263 . . . . 0.0 111.357 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.866 HD12 ' HB3' ' A' ' 42' ' ' GLN . 0.1 OUTLIER -156.85 123.9 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.812 -179.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 59' ' ' TYR . 68.7 mt -60.71 130.79 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.877 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.5 t -109.93 10.67 24.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.424 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.581 ' O ' HG22 ' A' ' 39' ' ' ILE . 35.6 t80 -167.2 134.09 2.33 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.914 0.387 . . . . 0.0 111.712 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.104 HD13 ' CG2' ' A' ' 39' ' ' ILE . 4.1 mm -121.04 141.92 39.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.198 179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -95.22 155.04 16.9 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.833 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.429 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.62 44.79 1.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.366 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 173.31 45.87 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.868 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -137.81 140.5 29.76 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 64' ' ' SER . 44.3 Cg_exo -56.68 -12.13 8.22 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.618 2.212 . . . . 0.0 113.221 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.793 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -66.69 -57.85 6.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.767 0.318 . . . . 0.0 110.446 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.24 -30.19 43.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.888 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.441 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -71.84 -18.13 62.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.758 179.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 51.4 t -48.15 -50.61 28.16 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.749 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' HA3' ' HB3' ' A' ' 137' ' ' GLU . . . 127.62 -4.29 7.07 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.537 -0.839 . . . . 0.0 113.441 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.8 HG23 HG13 ' A' ' 27' ' ' VAL . 27.3 m -152.21 48.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 117.164 0.482 . . . . 0.0 111.613 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 66' ' ' ALA . 6.9 mt -135.27 142.38 45.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.019 0.438 . . . . 0.0 111.198 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -141.52 -175.47 4.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.646 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.645 HD13 ' CG1' ' A' ' 60' ' ' ILE . 29.4 mm -69.62 67.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.089 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.33 71.79 0.22 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.762 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.733 ' OD2' HD23 ' A' ' 72' ' ' LEU . 4.2 t0 -97.14 111.18 23.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.479 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.5 mpt_? -68.76 144.03 54.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.002 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.909 ' CG1' HD13 ' A' ' 109' ' ' LEU . 9.4 m -126.6 133.62 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.16 -24.95 15.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.886 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.13 133.63 12.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.108 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.571 HD12 HD11 ' A' ' 97' ' ' LEU . 24.6 mt -122.56 114.86 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.811 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 53.02 24.02 3.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.106 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 107.09 -27.52 15.69 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.621 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.0 mt -70.47 131.06 88.46 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 120.438 0.161 . . . . 0.0 111.312 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.476 ' O ' HG23 ' A' ' 86' ' ' THR . 31.9 Cg_exo -58.16 -157.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.498 2.132 . . . . 0.0 112.045 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 85' ' ' PRO . 22.7 p -158.79 -67.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.054 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -69.88 -11.64 61.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.461 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -100.07 42.15 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.978 0.418 . . . . 0.0 110.765 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.07 176.97 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.771 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 1.4 m -70.41 121.6 18.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.71 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -49.63 -28.39 5.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.986 0.422 . . . . 0.0 111.15 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -54.73 -36.65 64.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.185 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 90' ' ' THR . 1.6 pp20? -61.66 -41.16 97.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.632 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.546 ' HA ' HD11 ' A' ' 97' ' ' LEU . . . -63.02 -37.5 87.44 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.52 0.676 . . . . 0.0 109.868 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.436 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.9 OUTLIER -61.78 -41.07 97.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.102 179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -62.86 -56.49 16.91 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.022 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.571 HD11 HD12 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -53.75 -30.16 43.02 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.768 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.938 HD13 HD13 ' A' ' 41' ' ' LEU . 48.7 mt -76.21 -48.06 21.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.207 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 6.3 mtt85 -50.1 -31.06 12.35 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 3.8 p30 -120.54 38.34 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.352 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.427 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.12 34.13 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.187 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 99.1 p -131.77 13.4 4.87 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.839 0.352 . . . . 0.0 111.802 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.43 -46.28 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.753 0.787 . . . . 0.0 110.403 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.14 -2.11 56.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.549 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.806 ' O ' HG22 ' A' ' 30' ' ' THR . 9.5 p 62.39 25.69 15.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.13 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.5 OUTLIER -167.59 153.48 7.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.071 0.462 . . . . 0.0 110.925 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 101' ' ' SER . 25.1 t -154.71 137.53 7.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.75 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.15 123.66 49.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.744 0.307 . . . . 0.0 110.482 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.909 HD13 ' CG1' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -140.49 153.76 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.903 0.382 . . . . 0.0 111.371 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -104.27 137.19 42.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.457 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.48 HG23 HG21 ' A' ' 27' ' ' VAL . 45.7 pt -117.12 142.78 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.025 0.44 . . . . 0.0 111.612 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -112.94 118.57 35.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.385 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.473 ' CE1' ' CG ' ' A' ' 167' ' ' ARG . 2.4 p90 -136.84 174.22 10.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.933 0.396 . . . . 0.0 111.382 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -102.21 155.18 18.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.594 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.444 HG12 ' HA ' ' A' ' 167' ' ' ARG . 3.0 m -99.12 105.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.0 111.435 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 115' ' ' VAL . . . 175.9 132.71 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.696 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.536 ' HG2' HD23 ' A' ' 130' ' ' LEU . 0.4 OUTLIER -140.57 12.89 2.33 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 84.87 88.34 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.193 0.52 . . . . 0.0 110.963 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 128' ' ' VAL . 1.3 m -110.18 145.99 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.957 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.68 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.6 pp -130.44 90.9 39.75 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-O 121.233 0.539 . . . . 0.0 110.632 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.497 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 62.6 Cg_endo -91.33 -173.79 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 123.176 2.584 . . . . 0.0 113.504 -178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER 178.75 36.66 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.784 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.5 OUTLIER 54.25 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.374 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.62 -42.63 2.29 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.457 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.702 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -127.51 102.35 6.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.811 0.339 . . . . 0.0 110.393 179.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.497 ' CD2' ' HB3' ' A' ' 121' ' ' PRO . 9.7 t80 -100.54 116.08 31.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.598 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.68 ' HB2' HG13 ' A' ' 120' ' ' ILE . 38.5 m80 -95.52 138.06 33.71 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.689 ' HA ' HG12 ' A' ' 119' ' ' VAL . 8.0 p -126.76 98.15 4.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.206 0.527 . . . . 0.0 110.566 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.482 ' HD3' HD21 ' A' ' 203' ' ' LEU . 0.1 OUTLIER -84.14 105.1 14.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.345 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.654 HD21 ' HB ' ' A' ' 168' ' ' THR . 0.7 OUTLIER -113.41 125.55 29.46 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.096 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 130' ' ' LEU . 16.5 Cg_exo -65.76 115.29 3.33 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.181 1.921 . . . . 0.0 110.702 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.452 ' HD3' HG12 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -94.36 159.08 15.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.272 0.558 . . . . 0.0 111.928 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -113.61 -165.84 1.04 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.011 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.29 -73.9 0.13 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.5 m -152.83 82.4 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.283 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 137' ' ' GLU . 65.1 t -130.46 159.2 42.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.785 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.491 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.0 tt0 -50.37 151.53 2.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.059 0.456 . . . . 0.0 111.555 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.73 HD13 HD11 ' A' ' 140' ' ' ILE . 5.2 mt -138.64 -52.95 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 89.92 36.38 7.26 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.154 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.784 HG23 HD21 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -109.61 126.1 66.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.75 0.309 . . . . 0.0 111.354 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.477 HG22 ' HB3' ' A' ' 157' ' ' SER . 90.9 m -126.38 131.48 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.373 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.962 HD13 HG22 ' A' ' 194' ' ' VAL . 1.6 mt -105.89 163.29 4.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.817 0.341 . . . . 0.0 110.587 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 142' ' ' ILE . 5.0 m -166.93 159.85 13.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.017 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.4 p -115.02 130.13 24.48 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.583 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.421 ' HG3' ' HG2' ' A' ' 153' ' ' PRO . 25.7 Cg_endo -62.39 -52.1 2.86 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.359 2.039 . . . . 0.0 112.206 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 3.4 m -161.86 140.62 9.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 19.1 t -103.88 31.07 4.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.019 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.33 45.22 1.01 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.833 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.79 152.35 0.89 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.816 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.72 -9.22 25.57 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.657 2.238 . . . . 0.0 112.782 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -98.4 26.24 24.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.648 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -47.16 102.21 0.3 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 120.589 0.233 . . . . 0.0 111.395 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.421 ' HG2' ' HG3' ' A' ' 145' ' ' PRO . 92.6 Cg_endo -90.95 174.62 2.65 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.857 2.371 . . . . 0.0 112.572 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 190' ' ' MET . 2.1 mp -122.71 145.51 48.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.457 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.719 HG12 ' O ' ' A' ' 175' ' ' ASP . 29.8 m -149.17 172.5 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 0.0 111.507 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.433 HG21 HG12 ' A' ' 159' ' ' ILE . 2.8 mp -81.56 152.7 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.74 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.477 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.3 OUTLIER -127.73 -11.39 5.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.57 136.21 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.559 HG21 ' HB2' ' A' ' 166' ' ' HIS . 1.5 mt -131.97 143.52 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.279 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.419 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -101.58 178.89 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.795 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.581 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.0 OUTLIER -116.25 152.83 33.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.267 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.453 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 93.47 -30.44 7.31 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.775 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.441 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -82.79 140.01 33.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.967 0.413 . . . . 0.0 110.969 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 17.0 m -49.43 -23.19 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.183 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.85 ' O ' HG22 ' A' ' 168' ' ' THR . . . -44.92 -67.6 0.27 Allowed 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.559 ' HB2' HG21 ' A' ' 159' ' ' ILE . 54.6 t60 -83.62 -26.55 29.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 111.286 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.483 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.2 OUTLIER -58.54 -29.89 66.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.114 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.85 HG22 ' O ' ' A' ' 165' ' ' ALA . 6.9 t -58.8 -21.28 55.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.814 0.34 . . . . 0.0 110.824 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.84 49.92 4.61 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.268 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 168' ' ' THR . 1.6 p -150.61 -52.93 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.839 0.352 . . . . 0.0 110.958 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.784 HD21 HG23 ' A' ' 140' ' ' ILE . 4.0 mp -55.31 94.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.05 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -139.15 142.81 37.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.821 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 68.9 mt -56.97 114.39 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 120.76 16.91 4.38 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.996 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.719 ' O ' HG12 ' A' ' 155' ' ' VAL . 2.1 m-20 -100.83 148.16 25.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.775 0.287 . . . . 0.0 110.485 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.432 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -107.18 130.37 54.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 111.281 -179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.04 127.84 40.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.804 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.64 -44.94 2.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.759 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -137.42 155.29 49.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.506 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.69 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 20.6 mt -139.28 128.95 30.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.195 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 2.2 t70 49.45 42.6 22.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.276 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 2.1 t-20 82.64 -24.25 0.18 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.318 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 184' ' ' ARG . 38.3 mm -76.56 155.85 5.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.87 0.367 . . . . 0.0 110.557 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.68 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 11.7 mtp180 -128.63 127.15 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.453 0.644 . . . . 0.0 112.318 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -90.19 -17.01 28.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.399 178.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.9 t0 63.94 -71.96 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.23 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 185' ' ' LEU . 1.0 OUTLIER -158.27 56.32 0.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.442 . . . . 0.0 110.617 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 0.0 OUTLIER 170.06 -166.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.221 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.417 ' HB3' ' CB ' ' A' ' 192' ' ' ASP . 0.6 OUTLIER 68.77 43.79 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.872 179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.642 ' HA ' HD21 ' A' ' 154' ' ' LEU . 4.4 tpt -57.9 -58.17 9.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 0.0 109.888 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -64.53 -32.86 74.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 109.876 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.417 ' CB ' ' HB3' ' A' ' 189' ' ' SER . 0.2 OUTLIER -63.88 -43.73 95.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.864 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.815 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -57.87 -43.75 86.21 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.962 HG22 HD13 ' A' ' 142' ' ' ILE . 14.5 t -58.02 -38.93 69.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.312 0.577 . . . . 0.0 109.73 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -50.67 71.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.104 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.815 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.1 mt -67.93 -24.48 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.718 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -61.1 -32.71 72.38 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.551 179.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.66 -32.97 10.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.048 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -16.2 39.24 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.527 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.792 ' SG ' HG23 ' A' ' 204' ' ' VAL . 67.3 m -84.14 41.97 0.85 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.604 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.77 59.2 0.66 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.119 0.485 . . . . 0.0 111.696 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -179.35 -33.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.101 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.789 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.5 tt -179.69 106.86 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.2 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.792 HG23 ' SG ' ' A' ' 200' ' ' CYS . 3.5 p -98.93 124.25 52.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.143 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -110.67 107.78 17.46 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.667 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.6 mm? -100.18 128.77 46.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.974 0.416 . . . . 0.0 111.932 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.759 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 0.2 OUTLIER -97.2 93.25 6.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.078 179.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.669 HG21 ' OD2' ' A' ' 175' ' ' ASP . 2.9 mm -90.63 169.46 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.158 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.541 ' H ' HG22 ' A' ' 208' ' ' ILE . 62.5 mtt180 -108.6 130.95 55.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.67 142.14 34.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.894 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 30.8 p-10 178.65 80.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -52.08 161.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.178 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.178 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.843 0.354 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.8 m -143.4 129.74 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.15 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.57 96.25 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.078 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.406 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 8.3 p-80 -100.06 115.07 28.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.697 HG22 ' OD1' ' A' ' 114' ' ' ASP . 36.0 p -53.35 125.59 18.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -120.45 162.7 19.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.934 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 p -113.11 135.71 53.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 161' ' ' LYS . 93.6 m -132.79 160.42 36.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' N ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.77 162.08 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.518 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.656 ' CG1' HG23 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -142.03 133.12 25.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.926 0.393 . . . . 0.0 111.081 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 28' ' ' VAL . 5.2 p -110.9 116.3 52.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.083 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.976 HD21 HD11 ' A' ' 72' ' ' LEU . 11.2 mt -112.56 136.25 52.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.541 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -119.61 159.82 23.67 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.36 0.6 . . . . 0.0 111.734 -179.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -98.92 129.12 45.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.368 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.461 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -107.48 152.82 41.49 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.562 179.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.96 14.46 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.555 2.17 . . . . 0.0 112.42 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 33.9 t -115.01 -47.15 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.421 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.4 t -148.92 11.05 0.82 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.461 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 59.3 -102.58 0.31 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.05 -1.071 . . . . 0.0 112.461 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CE2' ' O ' ' A' ' 30' ' ' THR . 41.4 m-85 -121.37 124.22 44.02 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -96.23 28.21 13.91 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.709 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.804 HD13 HD13 ' A' ' 72' ' ' LEU . 7.4 pt -128.35 134.86 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 CA-C-O 120.842 0.353 . . . . 0.0 110.559 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.407 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -124.0 145.31 49.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.977 -179.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.93 HD23 ' CD1' ' A' ' 57' ' ' ILE . 0.2 OUTLIER -129.26 138.68 51.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.42 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -78.32 169.8 17.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.324 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.471 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -108.34 -68.2 0.63 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.797 . . . . 0.0 112.764 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.3 144.26 36.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.59 HG22 HD13 ' A' ' 56' ' ' LEU . 72.8 t -141.45 -89.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.8 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.608 ' CE1' HG23 ' A' ' 50' ' ' THR . 48.3 p90 -58.14 -46.51 85.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.665 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.579 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 46.61 100.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.08 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.473 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER 171.64 105.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.979 179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' C ' HG22 ' A' ' 50' ' ' THR . 9.1 pt-20 52.92 33.61 14.94 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.248 0.547 . . . . 0.0 110.539 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.608 HG23 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 161.49 174.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.035 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -163.64 23.65 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.544 -179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.81 23.31 0.08 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -65.07 139.93 97.88 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.008 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.17 157.46 50.39 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.392 2.061 . . . . 0.0 111.922 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.889 ' HB3' HD13 ' A' ' 41' ' ' LEU . 77.4 Cg_exo -50.3 155.15 5.08 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.434 2.089 . . . . 0.0 112.19 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.59 HD13 HG22 ' A' ' 45' ' ' VAL . 0.3 OUTLIER -148.88 112.66 5.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 -179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.93 ' CD1' HD23 ' A' ' 41' ' ' LEU . 13.2 mm -53.89 141.78 8.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.868 0.366 . . . . 0.0 110.996 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.82 -32.36 2.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.457 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 86.2 t80 -141.92 156.02 45.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.325 0.584 . . . . 0.0 111.861 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.709 ' CG2' ' HB2' ' A' ' 67' ' ' GLU . 17.8 mm -136.34 161.27 37.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.201 -0.908 . . . . 0.0 109.087 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.456 ' N ' HG22 ' A' ' 60' ' ' ILE . 1.5 tt0 -107.18 150.29 26.77 Favored 'General case' 0 C--N 1.334 -0.103 0 O-C-N 121.922 -0.486 . . . . 0.0 111.877 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.32 39.37 1.15 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.028 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 178.83 36.83 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.923 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.443 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 41.2 p -128.58 138.67 33.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.913 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 32' ' ' ASP . 17.6 Cg_endo -57.7 -16.05 23.35 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.724 2.282 . . . . 0.0 112.869 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.853 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -73.59 -48.74 30.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.564 0.697 . . . . 0.0 109.692 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.709 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.5 tp10 -70.25 -32.46 70.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.422 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.562 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -93.88 -5.43 48.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.059 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -42.59 62.18 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.824 0.345 . . . . 0.0 110.674 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.628 ' HA2' HG22 ' A' ' 136' ' ' VAL . . . 133.9 -19.3 4.18 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.38 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.656 HG23 ' CG1' ' A' ' 27' ' ' VAL . 3.2 m -146.89 75.95 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 117.108 0.454 . . . . 0.0 111.991 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.976 HD11 HD21 ' A' ' 29' ' ' LEU . 13.8 mt -157.87 121.62 4.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.931 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -144.24 -176.31 4.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.544 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.6 126.5 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.0 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.469 ' N ' ' HB ' ' A' ' 57' ' ' ILE . . . 57.88 84.54 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.669 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 72' ' ' LEU . 70.6 m-20 -95.07 -30.54 14.02 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.036 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.702 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER 63.45 105.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 -179.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.767 HG23 ' HB2' ' A' ' 109' ' ' LEU . 14.8 p -98.47 148.39 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.494 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.7 ttp -109.34 -24.93 10.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.462 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -158.48 145.27 17.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.722 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.56 HD12 HD12 ' A' ' 97' ' ' LEU . 1.2 mt -133.14 113.21 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.871 0.367 . . . . 0.0 110.92 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 54.09 24.18 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.026 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.34 -31.83 6.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.485 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -69.53 110.45 6.4 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.383 0.135 . . . . 0.0 111.301 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.522 ' C ' HG23 ' A' ' 86' ' ' THR . 31.6 Cg_endo -63.96 -27.93 66.51 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.304 2.003 . . . . 0.0 112.046 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.522 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.2 p 72.28 2.15 4.22 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.678 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -14.3 42.8 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.297 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -120.95 45.72 2.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.746 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.93 153.04 5.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.784 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 91' ' ' PHE . 9.7 m -60.15 163.83 4.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.87 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.471 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 6.5 p90 -65.59 -39.27 91.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.683 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 58.1 mt-10 -54.97 -32.94 61.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.478 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.22 -53.34 58.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.135 0.493 . . . . 0.0 109.892 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.556 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -54.68 -37.97 66.41 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.673 0.749 . . . . 0.0 109.863 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -59.93 -36.85 77.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.619 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 5.3 mm-40 -62.23 -43.29 99.17 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.827 178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.56 HD12 HD12 ' A' ' 81' ' ' ILE . 17.6 mt -53.72 -41.93 67.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.854 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.828 HD21 HD21 ' A' ' 41' ' ' LEU . 3.4 mp -75.23 -44.65 45.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.628 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 3.5 mtt-85 -50.92 -31.99 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.275 0.559 . . . . 0.0 109.693 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 5.1 p30 -127.52 42.75 3.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.265 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.783 ' HB2' HG21 ' A' ' 107' ' ' VAL . 2.5 p -81.27 6.53 13.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.639 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.27 18.52 19.81 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 9.6 mt -70.79 -53.93 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.913 0.863 . . . . 0.0 110.418 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.72 9.51 29.64 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.484 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 m 58.93 20.87 8.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.272 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.561 ' HG2' HG23 ' A' ' 30' ' ' THR . 1.6 mttt -166.61 158.42 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.575 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.783 HG21 ' HB2' ' A' ' 101' ' ' SER . 66.1 t -155.29 106.28 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.426 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.77 132.82 39.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.781 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.767 ' HB2' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.07 163.59 32.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.067 0.461 . . . . 0.0 111.611 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -120.34 128.59 53.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 77' ' ' ARG . 26.6 pt -119.41 153.65 21.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.929 0.395 . . . . 0.0 111.623 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -120.43 119.14 32.17 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.465 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.42 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 6.5 p90 -138.08 174.21 10.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 111.275 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.697 ' OD1' HG22 ' A' ' 22' ' ' THR . 7.5 m-20 -91.3 142.25 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.579 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 115' ' ' VAL . 26.8 m -87.26 108.25 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.38 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.47 133.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.044 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 168' ' ' THR . 0.2 OUTLIER -149.91 23.85 0.86 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.946 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.1 t 83.68 100.84 0.05 OUTLIER 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.197 0.523 . . . . 0.0 111.177 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.922 HG11 HG21 ' A' ' 170' ' ' THR . 2.0 t -135.39 123.02 37.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.175 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.705 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.6 pp -96.9 106.97 34.41 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.267 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 69.9 Cg_endo -95.34 137.02 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.291 2.661 . . . . 0.0 112.679 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -139.81 -80.55 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.609 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 167.62 113.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.85 -31.9 6.53 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.504 -0.855 . . . . 0.0 111.529 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.502 HG22 ' CG ' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -138.38 102.65 4.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.964 0.411 . . . . 0.0 111.316 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.812 ' CE1' HG12 ' A' ' 119' ' ' VAL . 0.7 OUTLIER -103.31 121.01 41.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.861 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.705 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -105.75 130.79 53.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.369 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.833 HG11 HG21 ' A' ' 168' ' ' THR . 3.6 t -109.46 86.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.616 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.411 ' O ' ' HB3' ' A' ' 118' ' ' SER . 0.3 OUTLIER -81.14 98.91 8.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.722 -179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -120.53 125.35 27.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.005 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.58 115.77 2.78 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.353 2.035 . . . . 0.0 111.646 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.545 ' HB2' HG23 ' A' ' 204' ' ' VAL . 18.1 tttp -90.59 151.35 21.34 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.167 0.508 . . . . 0.0 110.638 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.499 ' CD ' HG21 ' A' ' 136' ' ' VAL . 2.4 mttt -84.95 -168.52 2.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.921 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 59.8 t60 -72.44 -33.46 67.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.796 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 m 175.2 40.42 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.799 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.628 HG22 ' HA2' ' A' ' 70' ' ' GLY . 1.2 t -72.24 162.71 4.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -51.58 157.68 1.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.985 0.421 . . . . 0.0 111.341 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.495 HD12 ' OG ' ' A' ' 163' ' ' SER . 0.9 OUTLIER -164.99 107.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.001 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -89.93 39.55 3.1 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.394 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.628 HD11 ' CB ' ' A' ' 165' ' ' ALA . 4.4 mm -84.75 124.2 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 116.801 0.3 . . . . 0.0 110.34 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.754 HG22 ' HB2' ' A' ' 157' ' ' SER . 85.3 m -115.75 141.57 47.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.946 0.403 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.974 HD11 HD22 ' A' ' 197' ' ' LEU . 1.9 mt -114.42 163.88 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.868 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.493 ' N ' HG22 ' A' ' 142' ' ' ILE . 48.0 t -166.61 156.38 11.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.766 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 46.0 t -115.5 144.85 33.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.941 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.4 174.42 10.1 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.449 2.099 . . . . 0.0 112.203 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.77 47.83 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.974 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.2 t -86.74 2.92 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.294 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 60.72 45.17 10.4 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.984 0.421 . . . . 0.0 111.12 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.477 ' HD3' ' CD ' ' A' ' 153' ' ' PRO . 0.0 OUTLIER -124.2 161.03 49.71 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.504 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.34 61.78 2.06 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.459 2.106 . . . . 0.0 112.354 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 50.43 41.59 41.15 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.42 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.517 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.3 OUTLIER -55.34 -59.98 9.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 111.563 0.209 . . . . 0.0 111.563 -179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.717 ' O ' HD22 ' A' ' 154' ' ' LEU . 54.3 Cg_endo -93.59 -179.77 0.89 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.906 2.404 . . . . 0.0 112.884 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 190' ' ' MET . 2.9 mm? -137.46 155.46 49.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.077 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 156' ' ' ILE . 14.1 t -151.68 161.21 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.872 0.367 . . . . 0.0 111.922 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.515 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.5 mt -94.26 152.28 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.096 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.754 ' HB2' HG22 ' A' ' 141' ' ' THR . 0.4 OUTLIER -127.16 -16.71 4.95 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 178.91 137.83 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.053 0.454 . . . . 0.0 111.28 -179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.591 HG22 ' HB2' ' A' ' 166' ' ' HIS . 1.0 OUTLIER -129.68 122.99 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.578 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.422 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -86.2 155.6 20.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.904 0.383 . . . . 0.0 111.111 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.517 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.4 OUTLIER -79.58 179.83 7.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.608 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 80.55 -54.7 4.63 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.804 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.495 ' OG ' HD12 ' A' ' 138' ' ' LEU . 0.6 OUTLIER -59.24 144.2 46.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.157 0.503 . . . . 0.0 111.376 -179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 167' ' ' ARG . 26.8 m -56.4 -21.08 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.046 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.945 ' O ' HG22 ' A' ' 168' ' ' THR . . . -59.36 -71.73 0.12 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.731 0.3 . . . . 0.0 111.361 -179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.591 ' HB2' HG22 ' A' ' 159' ' ' ILE . 21.3 t60 -66.46 -24.76 66.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.952 0.406 . . . . 0.0 110.499 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.486 ' NH2' ' HB3' ' A' ' 166' ' ' HIS . 0.0 OUTLIER -56.88 -42.58 80.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.501 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.945 HG22 ' O ' ' A' ' 165' ' ' ALA . 13.2 t -50.3 -30.08 11.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 170' ' ' THR . . . 59.37 89.18 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.77 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.922 HG21 HG11 ' A' ' 119' ' ' VAL . 15.3 t -177.75 -38.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.7 0.286 . . . . 0.0 110.866 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.611 ' O ' HD12 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -69.43 152.66 44.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.814 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -147.63 151.8 36.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.743 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.451 HD23 ' HB ' ' A' ' 156' ' ' ILE . 6.5 mt -82.23 127.82 33.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.43 23.55 4.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.61 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.416 ' CB ' ' CG2' ' A' ' 208' ' ' ILE . 21.3 m-20 -116.22 -168.98 1.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.684 0.278 . . . . 0.0 110.604 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.71 120.84 28.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.858 0.361 . . . . 0.0 111.275 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.814 HD22 HD11 ' A' ' 180' ' ' ILE . 2.5 mt -78.06 144.53 36.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.613 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.5 tt -120.24 -41.43 2.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.695 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -148.87 166.74 27.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.639 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.814 HD11 HD22 ' A' ' 177' ' ' LEU . 27.6 mm -139.84 117.66 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.246 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.433 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 25.5 t0 57.91 -86.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.059 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -127.25 -13.85 5.5 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.856 ' HB ' HG21 ' A' ' 196' ' ' ILE . 27.4 mm -96.59 159.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.621 0.248 . . . . 0.0 110.583 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.628 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 15.9 mtt85 -118.61 123.68 45.6 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.386 0.612 . . . . 0.0 112.321 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.656 HD23 ' N ' ' A' ' 185' ' ' LEU . 0.8 OUTLIER -77.49 -13.42 59.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.789 178.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -46.17 -28.99 1.39 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.2 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.73 -5.14 6.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.642 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -96.0 133.1 40.62 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.853 0.359 . . . . 0.0 110.912 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 t -57.39 -178.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.074 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.742 ' HA ' HD11 ' A' ' 154' ' ' LEU . 5.6 ttp -66.15 -57.25 8.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.951 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.57 -38.0 71.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.256 0.55 . . . . 0.0 110.72 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.792 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -59.7 -44.81 93.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.935 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 185' ' ' LEU . . . -57.76 -42.96 85.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.442 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.937 HG22 HD13 ' A' ' 142' ' ' ILE . 8.9 t -60.7 -33.72 56.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.245 0.545 . . . . 0.0 109.786 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -50.18 74.46 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.949 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.856 HG21 ' HB ' ' A' ' 183' ' ' ILE . 2.3 mp -73.79 -24.6 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.885 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.974 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -64.37 -28.45 69.7 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.347 179.24 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.775 ' NE2' HG12 ' A' ' 194' ' ' VAL . 19.7 mt-30 -103.44 -33.71 8.97 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.319 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -16.04 60.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.167 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.794 ' SG ' HG22 ' A' ' 204' ' ' VAL . 13.8 p -85.97 43.9 1.08 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.195 0.521 . . . . 0.0 110.456 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.433 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 5.5 pt-20 -70.75 62.02 0.26 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.539 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.426 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 1.9 m-20 -178.14 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.404 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.404 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 20.5 tp -176.89 107.05 0.06 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.974 0.416 . . . . 0.0 110.765 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.794 HG22 ' SG ' ' A' ' 200' ' ' CYS . 6.9 t -102.01 115.7 44.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.655 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 13.2 ttmm -104.51 108.32 19.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.906 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.523 ' N ' HD22 ' A' ' 206' ' ' LEU . 3.4 mm? -87.49 102.7 14.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.915 0.388 . . . . 0.0 111.303 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.552 ' NZ ' HD22 ' A' ' 178' ' ' LEU . 0.1 OUTLIER -92.51 93.43 8.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.216 179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.436 HG22 ' N ' ' A' ' 209' ' ' ARG . 6.9 mm -92.92 163.54 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 21.8 mtm-85 -107.96 126.38 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.037 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.407 ' O ' ' HA2' ' A' ' 124' ' ' GLY . 1.6 tttm -113.22 159.49 19.25 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.892 0.377 . . . . 0.0 111.118 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 179.92 44.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.956 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -57.56 168.35 0.85 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.957 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 . . . . . 0 N--CA 1.451 -0.395 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.14 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.71 0.291 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' O ' HG13 ' A' ' 19' ' ' VAL . 12.6 p -107.57 118.48 55.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 114' ' ' ASP . 26.6 t -152.99 152.55 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.124 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.638 ' CE1' HG11 ' A' ' 115' ' ' VAL . 46.1 p-80 -128.1 113.77 16.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.739 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 p -50.27 142.87 9.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.149 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -147.77 172.02 14.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.471 HG22 ' HB2' ' A' ' 112' ' ' GLU . 28.7 p -125.61 151.97 45.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.72 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 26' ' ' GLU . 89.9 m -145.74 164.4 31.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.886 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 25' ' ' THR . 0.9 OUTLIER -101.07 161.89 13.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.551 HG11 HD21 ' A' ' 72' ' ' LEU . 2.2 t -135.48 150.16 28.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.018 0.437 . . . . 0.0 111.187 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.87 109.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.442 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -115.09 118.54 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.928 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -105.81 162.22 13.74 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.003 0.43 . . . . 0.0 111.02 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.05 123.05 32.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.07 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.15 153.72 66.51 Favored Pre-proline 0 N--CA 1.455 -0.211 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.627 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -78.28 9.7 3.01 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.525 2.15 . . . . 0.0 112.506 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.4 t -112.11 -49.52 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 120.638 0.256 . . . . 0.0 111.356 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 t -145.7 3.83 0.98 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.88 -93.82 0.86 Allowed Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.366 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.642 ' HD1' HD22 ' A' ' 29' ' ' LEU . 44.5 m-85 -125.6 120.74 31.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.893 0.377 . . . . 0.0 110.355 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.31 29.2 9.85 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.465 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.979 HD11 ' HB2' ' A' ' 66' ' ' ALA . 2.7 mp -93.14 151.18 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.32 0.581 . . . . 0.0 111.995 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -124.55 99.83 6.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.763 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 98' ' ' LEU . 1.5 tp -96.17 148.55 22.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.364 0.602 . . . . 0.0 112.505 -177.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' CG ' ' HG ' ' A' ' 56' ' ' LEU . 28.4 pt20 -129.43 170.08 14.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.968 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.58 26.53 3.47 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.296 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -114.6 106.25 14.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.146 0.498 . . . . 0.0 110.483 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' A' ' 56' ' ' LEU . 27.4 t -135.14 -85.25 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.616 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.544 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 4.3 p90 -34.92 -44.63 0.23 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.42 0.688 . . . . 0.0 111.116 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.447 ' N ' ' CG ' ' A' ' 46' ' ' PHE . . . 55.08 66.58 1.19 Allowed 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.528 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.404 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 30.8 p -161.07 -166.31 1.54 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.938 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' O ' HG22 ' A' ' 50' ' ' THR . 2.3 pt-20 -51.7 171.11 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 49' ' ' GLU . 11.9 t 45.25 -153.85 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.993 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.708 HD22 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -146.02 -94.29 0.09 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.707 0.289 . . . . 0.0 111.171 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 54.87 16.54 1.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.797 0.332 . . . . 0.0 111.823 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.51 133.74 85.59 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.17 137.29 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.391 2.061 . . . . 0.0 111.85 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.885 ' CB ' HD21 ' A' ' 41' ' ' LEU . 8.1 Cg_endo -49.98 123.09 10.2 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.56 2.173 . . . . 0.0 111.963 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.494 ' CD1' HG22 ' A' ' 45' ' ' VAL . 1.4 pt? -139.42 119.88 13.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.78 0.324 . . . . 0.0 111.512 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.596 HD13 HG23 ' A' ' 39' ' ' ILE . 48.3 mt -64.44 157.26 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 CA-C-O 120.942 0.401 . . . . 0.0 110.996 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.493 ' N ' HG22 ' A' ' 57' ' ' ILE . 12.1 m -130.65 -12.6 3.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.354 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.0 t80 179.78 137.47 0.11 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.936 0.398 . . . . 0.0 111.259 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.612 HG22 ' H ' ' A' ' 61' ' ' GLU . 4.0 mt -111.28 171.95 2.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 60' ' ' ILE . 43.0 tt0 -111.13 155.1 23.37 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.663 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.52 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -79.05 59.23 2.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.286 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 167.08 41.71 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.313 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 65' ' ' PRO . 5.2 p -131.27 137.67 31.11 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.908 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 64' ' ' SER . 28.5 Cg_exo -61.6 -11.62 21.1 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.5 2.133 . . . . 0.0 112.764 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.001 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -76.88 -56.06 4.93 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 111.013 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.519 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -73.46 -29.54 62.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.292 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.52 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -71.24 -42.65 68.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.12 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 46.4 t -47.78 -30.41 3.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.212 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.92 -9.31 74.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.916 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 162' ' ' GLY . 18.1 t -101.71 31.85 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.917 0.389 . . . . 0.0 110.981 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.741 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 34.1 mt -146.77 134.37 20.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.974 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -125.81 161.38 27.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 26.3 mm -62.25 82.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.06 48.24 0.15 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.426 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -76.42 107.64 8.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.87 0.366 . . . . 0.0 110.74 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -69.96 73.47 0.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.096 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.39 125.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 ttp -95.58 -30.27 13.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.104 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -152.03 153.97 35.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.284 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.691 HD12 HD12 ' A' ' 97' ' ' LEU . 4.0 mt -133.98 117.06 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 53.4 m-20 62.56 19.98 11.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.191 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.82 -24.22 22.15 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.8 mt -71.23 123.14 88.88 Favored Pre-proline 0 N--CA 1.45 -0.455 0 CA-C-O 120.519 0.2 . . . . 0.0 111.091 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.52 ' C ' HG23 ' A' ' 86' ' ' THR . 50.3 Cg_endo -68.71 -26.3 33.07 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.33 2.02 . . . . 0.0 112.323 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 73.84 1.3 3.88 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.619 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -15.02 41.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.898 0.38 . . . . 0.0 111.358 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.18 46.37 0.99 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.832 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 m 179.33 -177.08 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.947 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.708 HG23 HD22 ' A' ' 51' ' ' LEU . 15.4 m -93.3 153.17 18.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -52.17 -27.19 13.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 9.9 mt-10 -54.79 -36.73 65.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.944 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 0.7 OUTLIER -61.24 -41.28 96.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.356 179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -61.77 -38.65 88.8 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.555 0.693 . . . . 0.0 109.991 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -59.52 -40.82 88.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.957 -1.019 . . . . 0.0 110.081 179.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 50.0 mm-40 -61.97 -44.3 97.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.923 0.392 . . . . 0.0 110.21 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.691 HD12 HD12 ' A' ' 81' ' ' ILE . 36.4 mt -54.37 -41.11 68.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.203 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.904 HD11 HD22 ' A' ' 41' ' ' LEU . 36.7 mt -73.56 -51.9 15.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.878 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 1.5 mtp180 -50.85 -29.84 12.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.962 0.41 . . . . 0.0 110.3 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.48 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 53.4 m-20 -126.63 39.66 3.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.792 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.657 ' HB3' ' HA ' ' A' ' 98' ' ' LEU . 1.2 p -89.22 10.98 20.1 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.393 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.84 18.88 17.07 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 0.0 111.748 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.48 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.1 mt -68.79 -49.73 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.877 0.846 . . . . 0.0 110.311 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.48 13.09 32.98 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.147 -1.388 . . . . 0.0 110.397 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.843 ' O ' HG22 ' A' ' 30' ' ' THR . 24.2 p 54.8 24.32 5.61 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.258 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.536 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -165.17 148.1 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.882 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.596 HG21 ' HB2' ' A' ' 101' ' ' SER . 2.0 t -145.99 133.51 15.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.594 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.84 141.2 36.04 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' VAL . 1.6 mp -136.31 146.87 47.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.996 0.426 . . . . 0.0 111.569 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.4 106.1 13.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.03 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.3 pt -105.96 160.61 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.083 0.468 . . . . 0.0 112.104 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' ' 24' ' ' THR . 50.6 tt0 -133.94 137.99 45.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.169 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.459 ' CE1' ' CD ' ' A' ' 167' ' ' ARG . 5.9 p90 -161.24 174.11 14.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.993 0.425 . . . . 0.0 111.723 -179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.548 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -86.25 113.15 22.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.807 178.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.638 HG11 ' CE1' ' A' ' 21' ' ' HIS . 12.7 p -61.8 104.74 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.236 0.541 . . . . 0.0 111.94 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 167' ' ' ARG . . . 178.21 177.56 0.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.625 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 118' ' ' SER . 4.9 tp10 -177.95 -42.95 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.449 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.5 t 163.55 109.21 0.0 OUTLIER 'General case' 0 C--O 1.231 0.095 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.795 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.966 HG21 HG21 ' A' ' 170' ' ' THR . 7.1 p -140.52 147.59 22.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.133 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.927 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -123.34 77.87 53.51 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.95 0.405 . . . . 0.0 111.191 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 126' ' ' PHE . 20.9 Cg_exo -68.65 145.9 65.3 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.351 2.701 . . . . 0.0 112.333 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.43 13.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.47 140.37 0.01 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.857 0.361 . . . . 0.0 111.254 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 77.97 -59.93 3.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.131 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.422 ' CG2' ' CE ' ' A' ' 207' ' ' LYS . 23.0 m -146.37 102.95 3.65 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.713 ' HB2' ' HA ' ' A' ' 121' ' ' PRO . 2.3 p90 -124.94 164.77 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.67 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.927 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -120.51 163.9 17.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.274 0.559 . . . . 0.0 111.84 -178.14 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.599 ' O ' HG23 ' A' ' 128' ' ' VAL . 28.0 m -130.81 104.74 10.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.007 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -81.99 112.69 19.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.216 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.922 HD21 HG23 ' A' ' 168' ' ' THR . 3.4 mp -126.72 117.13 22.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.035 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.79 131.59 46.89 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.249 1.966 . . . . 0.0 111.745 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.615 ' HE3' HD21 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -95.64 159.55 14.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.032 0.444 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.477 ' N ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.09 -168.69 2.13 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.856 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -68.96 65.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.854 0.359 . . . . 0.0 111.463 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 46.52 65.46 1.2 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.044 0.449 . . . . 0.0 111.652 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 137' ' ' GLU . 15.0 t -111.35 164.98 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.713 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.529 ' N ' HG12 ' A' ' 136' ' ' VAL . 20.9 tt0 -38.07 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.939 0.4 . . . . 0.0 111.663 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.949 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -68.76 -42.52 77.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 163' ' ' SER . . . 90.04 -3.32 82.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.763 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.949 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -110.73 133.68 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 111.157 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 157' ' ' SER . 75.4 m -116.43 140.42 49.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.349 179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.009 HD11 HD22 ' A' ' 197' ' ' LEU . 5.7 mt -97.8 162.87 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.54 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.499 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.6 OUTLIER -158.14 147.03 19.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.382 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 54.5 p -107.65 134.8 19.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.969 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.415 ' HD3' HG23 ' A' ' 155' ' ' VAL . 83.8 Cg_endo -78.59 79.16 3.42 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.582 2.188 . . . . 0.0 112.419 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.0 p 58.2 -174.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.67 133.94 47.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.4 ' HG3' ' HB3' ' A' ' 152' ' ' ASP . 0.0 OUTLIER -163.76 -170.59 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.868 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.429 ' H ' ' HG3' ' A' ' 149' ' ' LYS . 0.1 OUTLIER -57.32 161.85 5.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.2 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.25 62.56 0.7 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.901 2.401 . . . . 0.0 112.118 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -143.21 -38.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.637 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.4 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . 10.7 p-10 -45.75 126.68 6.65 Favored Pre-proline 0 CA--C 1.531 0.223 0 CA-C-O 120.615 0.245 . . . . 0.0 111.254 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.72 -175.23 1.77 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.492 2.128 . . . . 0.0 112.612 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.501 HD21 HG21 ' A' ' 142' ' ' ILE . 5.9 tp -89.7 169.84 10.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.797 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 156' ' ' ILE . 22.0 t -147.77 160.51 7.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.906 0.384 . . . . 0.0 111.61 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.522 ' N ' HG12 ' A' ' 155' ' ' VAL . 39.0 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.882 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.435 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.4 OUTLIER -131.32 -7.19 3.78 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.431 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.0 OUTLIER -177.2 146.1 0.48 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.294 0.569 . . . . 0.0 112.072 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.658 HG22 ' HB2' ' A' ' 166' ' ' HIS . 7.8 mt -130.72 149.15 33.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.709 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.51 138.6 54.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.004 0.431 . . . . 0.0 111.609 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.419 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -81.76 -9.08 59.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.864 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 71' ' ' VAL . . . -89.95 -16.89 55.43 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.673 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.422 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 2.9 m -114.12 169.94 8.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.899 0.38 . . . . 0.0 110.99 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.786 ' HB ' HD23 ' A' ' 130' ' ' LEU . 5.6 m -61.74 -22.58 28.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.773 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.49 -71.21 0.08 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.789 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.658 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -64.94 -24.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.975 0.417 . . . . 0.0 110.528 179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.54 ' HA ' HG23 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -57.61 -29.91 64.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.039 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.922 HG23 HD21 ' A' ' 130' ' ' LEU . 42.8 p -43.26 -30.45 0.5 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.363 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.65 25.97 74.84 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.589 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.966 HG21 HG21 ' A' ' 119' ' ' VAL . 3.2 t -168.62 32.05 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.966 0.412 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 159' ' ' ILE . 1.0 OUTLIER -113.51 107.15 15.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.689 179.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.53 150.87 40.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 12.4 mt -74.95 131.42 40.67 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.9 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.54 -25.7 8.0 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.45 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.45 -172.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.75 0.309 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.93 134.43 42.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.422 HD21 ' HB3' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -99.92 142.18 31.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.439 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 178' ' ' LEU . 6.0 tt -120.85 -35.73 3.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.744 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.841 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -142.07 162.45 35.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.08 0.467 . . . . 0.0 111.879 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.707 ' CD1' HD21 ' A' ' 185' ' ' LEU . 31.9 mt -139.34 116.71 11.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.858 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.5 t0 64.37 -74.0 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.947 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.421 ' N ' ' O ' ' A' ' 180' ' ' ILE . 0.1 OUTLIER -144.54 -19.3 0.53 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.932 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.569 ' HB ' HG21 ' A' ' 196' ' ' ILE . 28.5 mm -96.55 140.74 16.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.064 0.459 . . . . 0.0 111.258 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.841 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 5.8 mtt180 -104.4 127.94 52.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.905 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.707 HD21 ' CD1' ' A' ' 180' ' ' ILE . 1.0 OUTLIER -75.55 -6.72 51.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.243 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -41.18 -32.53 0.28 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.456 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.4 m -121.48 -11.72 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.667 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 6.2 m -88.01 -169.78 2.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.934 0.397 . . . . 0.0 111.142 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 80.5 p -112.3 -175.76 2.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.418 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.7 OUTLIER -70.91 -56.89 5.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -53.97 -47.11 71.72 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 110.785 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -43.6 72.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.059 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.66 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -56.86 -42.05 79.05 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.415 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.683 HG22 ' CD1' ' A' ' 142' ' ' ILE . 15.3 t -58.98 -39.15 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 121.291 0.567 . . . . 0.0 109.642 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 39.4 mm-40 -56.2 -50.32 71.57 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.948 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.3 mt -69.81 -24.88 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.009 HD22 HD11 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -59.34 -31.59 69.32 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.482 179.123 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -103.98 -33.55 8.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.141 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -19.67 55.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.709 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . . . . . . . . . 19.8 p -85.49 47.12 1.38 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.281 0.563 . . . . 0.0 109.866 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.445 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 22.4 tt0 -68.37 63.3 0.1 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.65 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.402 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 8.8 m-20 -173.23 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.875 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.547 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.4 OUTLIER -178.72 107.46 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.091 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 132' ' ' LYS . 2.9 t -85.6 108.35 17.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.604 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 8.9 ttmm -104.83 107.88 19.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.566 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.588 HD12 HG21 ' A' ' 128' ' ' VAL . 2.5 mt -99.91 121.51 41.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.969 0.414 . . . . 0.0 111.723 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.616 ' HD2' ' NE2' ' A' ' 127' ' ' HIS . 3.9 tttt -89.7 101.96 14.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.284 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 208' ' ' ILE . 2.0 mm -91.97 158.39 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.0 0.428 . . . . 0.0 111.409 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 29.9 mtp85 -113.81 121.79 45.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.686 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.6 tttp -114.14 106.17 14.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.058 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 177.89 42.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.839 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -75.65 168.69 19.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.949 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.162 -179.93 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.072 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.55 ' O ' HG13 ' A' ' 19' ' ' VAL . 12.7 p -112.96 115.18 49.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.74 0.305 . . . . 0.0 111.133 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.81 HG21 ' O ' ' A' ' 115' ' ' VAL . 5.3 p 172.71 163.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.758 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.434 ' O ' HG22 ' A' ' 115' ' ' VAL . 33.0 t60 -88.24 106.24 18.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.797 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.1 p -53.29 161.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.202 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -168.68 169.13 10.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.615 HG22 ' HG3' ' A' ' 112' ' ' GLU . 29.7 p -129.33 164.74 22.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.494 HG22 ' CE2' ' A' ' 113' ' ' PHE . 12.4 t -147.78 -170.6 3.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -121.71 162.93 19.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.807 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.6 t -144.11 146.8 20.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG13 ' CD ' ' A' ' 106' ' ' LYS . 45.2 t -129.31 118.78 46.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.994 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.006 HD21 ' HB2' ' A' ' 66' ' ' ALA . 1.2 mt -114.38 118.86 35.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.681 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.82 163.27 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.453 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.526 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.83 115.75 29.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.267 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.48 152.03 59.96 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.576 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.65 9.21 3.31 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.636 2.224 . . . . 0.0 112.581 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.33 -50.8 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 120.613 0.244 . . . . 0.0 111.428 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.8 t -132.39 -11.81 3.16 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.33 -87.73 0.8 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.286 -0.959 . . . . 0.0 112.371 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.595 ' CD2' HD22 ' A' ' 29' ' ' LEU . 4.5 m-85 -133.38 118.98 19.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.836 0.35 . . . . 0.0 110.094 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -95.29 28.51 11.72 Favored Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.898 -0.667 . . . . 0.0 113.915 -178.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.783 HD11 ' HB2' ' A' ' 66' ' ' ALA . 4.0 mp -93.27 149.17 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.189 0.519 . . . . 0.0 112.012 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.422 ' NE2' ' HB3' ' A' ' 58' ' ' SER . 0.0 OUTLIER -145.0 99.08 3.28 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.049 HD21 HD13 ' A' ' 98' ' ' LEU . 1.8 pp -112.03 157.27 20.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.15 169.63 10.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.867 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -119.41 -5.89 11.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.051 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.4 p -137.46 151.59 48.65 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.153 0.501 . . . . 0.0 111.537 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.619 ' CG2' HD13 ' A' ' 56' ' ' LEU . 95.1 t -151.98 -76.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.133 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.783 ' O ' HG22 ' A' ' 48' ' ' THR . 21.0 p90 -35.46 -46.77 0.41 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.25 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.0 69.23 0.46 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.491 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.783 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER 166.96 95.68 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.122 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.2 146.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.104 0.478 . . . . 0.0 111.736 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.417 ' O ' ' CE2' ' A' ' 46' ' ' PHE . 63.1 p 45.59 -169.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.703 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -132.76 -77.32 0.49 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.889 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 47.66 17.36 0.09 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.036 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.528 ' HB2' ' CD1' ' A' ' 46' ' ' PHE . 1.7 t -108.36 99.36 32.05 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.553 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.6 172.44 16.19 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.426 2.084 . . . . 0.0 111.978 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.53 ' HB3' HD13 ' A' ' 41' ' ' LEU . 2.4 Cg_endo -45.61 133.46 13.18 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.712 2.275 . . . . 0.0 112.003 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.619 HD13 ' CG2' ' A' ' 45' ' ' VAL . 0.4 OUTLIER -129.0 97.23 4.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.507 -179.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.634 HD13 HG23 ' A' ' 39' ' ' ILE . 27.4 mt -59.43 139.16 19.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 CA-C-O 120.948 0.404 . . . . 0.0 110.904 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.446 ' C ' HG23 ' A' ' 74' ' ' ILE . 2.5 t -124.2 1.48 8.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.115 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HA ' HD12 ' A' ' 74' ' ' ILE . 58.2 t80 179.15 134.76 0.09 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.047 0.451 . . . . 0.0 111.626 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.705 HG21 ' CB ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -108.58 162.91 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . 40.9 tt0 -98.71 152.56 19.52 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.401 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.504 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -82.52 56.45 3.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.457 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.3 OUTLIER 165.76 42.51 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.431 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.7 t -132.05 139.95 36.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.92 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.34 -10.23 20.58 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.442 2.095 . . . . 0.0 112.626 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 1.006 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -73.09 -56.18 5.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.978 0.418 . . . . 0.0 110.841 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.705 ' CB ' HG21 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -76.81 -29.81 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.159 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -74.49 -29.89 61.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -53.39 -44.91 69.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.983 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 136' ' ' VAL . . . 100.06 28.05 7.49 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.493 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 162' ' ' GLY . 10.4 t -148.23 26.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.845 ' CD1' ' HB1' ' A' ' 66' ' ' ALA . 12.0 mt -137.36 129.77 29.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -128.72 174.61 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.866 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 59' ' ' TYR . 25.2 mm -66.81 74.99 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.174 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 128.28 46.04 0.19 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.37 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -74.89 98.46 3.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.866 0.365 . . . . 0.0 110.94 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.5 mtm-85 -78.54 115.8 18.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.771 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.545 HG11 HD13 ' A' ' 109' ' ' LEU . 14.4 m -101.64 167.5 2.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.184 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.1 tpt -117.65 -40.96 2.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -144.43 133.48 22.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.143 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.682 HD12 HD12 ' A' ' 97' ' ' LEU . 7.0 mt -119.12 116.27 50.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.614 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.7 p30 47.38 26.07 0.69 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.378 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.34 -28.73 10.46 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.872 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 97' ' ' LEU . 13.0 mm -70.43 136.85 86.21 Favored Pre-proline 0 N--CA 1.45 -0.443 0 CA-C-O 120.718 0.294 . . . . 0.0 111.567 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.3 167.47 19.44 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.555 2.17 . . . . 0.0 112.213 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 44.8 p -141.12 -54.69 0.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.004 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -73.45 -8.37 55.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -126.13 44.76 2.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.938 0.399 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.95 176.71 0.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 92' ' ' GLU . 7.9 m -62.87 145.45 55.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.477 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 8.2 p90 -73.34 -27.06 61.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.151 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.547 ' H ' HG22 ' A' ' 90' ' ' THR . 6.9 mt-10 -54.63 -42.17 70.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.843 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 8.6 pt-20 -61.0 -44.49 97.34 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.317 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.402 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -59.83 -35.63 75.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.339 0.59 . . . . 0.0 110.357 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.6 m120 -62.43 -42.05 99.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.88 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 39.3 mm-40 -62.07 -37.34 84.64 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.042 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.682 HD12 HD12 ' A' ' 81' ' ' ILE . 23.5 mt -57.43 -49.6 75.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.049 HD13 HD21 ' A' ' 41' ' ' LEU . 1.1 mt -69.92 -57.5 4.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.321 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 63.3 mtt180 -50.5 -31.66 16.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.44 0.638 . . . . 0.0 109.604 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.7 m-20 -119.25 39.68 3.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.675 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -93.17 26.31 2.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.9 t -124.43 15.71 8.94 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 111.77 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.497 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -68.33 -39.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 121.783 0.802 . . . . 0.0 110.409 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.52 11.68 30.38 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.552 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.49 ' O ' HG22 ' A' ' 30' ' ' THR . 1.8 m 57.92 22.2 8.47 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.905 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -173.74 156.25 2.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.362 -179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.6 p -157.48 129.74 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.055 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 134.07 47.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.025 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.545 HD13 HG11 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -142.23 138.12 31.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -97.59 144.04 27.67 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.318 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.544 ' CG2' HG12 ' A' ' 78' ' ' VAL . 32.0 pt -134.21 165.33 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.033 0.444 . . . . 0.0 111.828 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.615 ' HG3' HG22 ' A' ' 24' ' ' THR . 51.6 tt0 -132.16 140.95 48.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.417 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CE2' HG22 ' A' ' 25' ' ' THR . 0.5 OUTLIER -161.17 174.5 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.914 0.388 . . . . 0.0 111.316 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.534 ' HB2' HG11 ' A' ' 20' ' ' VAL . 14.0 p30 -98.07 119.8 37.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.272 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.81 ' O ' HG21 ' A' ' 20' ' ' VAL . 24.1 m -61.81 104.84 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.556 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -178.0 124.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.812 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -137.44 52.67 1.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.774 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 2.9 t 65.33 89.53 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.332 0.587 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 1.016 HG12 HG12 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -118.01 122.34 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.111 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.664 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.8 pp -115.6 89.59 23.3 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 121.315 0.578 . . . . 0.0 110.328 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.533 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.5 Cg_endo -97.04 169.55 0.88 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.211 2.608 . . . . 0.0 113.134 -178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.2 p -153.58 -66.58 0.15 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.145 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 166.3 109.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.02 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.05 -32.72 5.48 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.401 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.513 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -129.25 102.72 6.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.041 0.448 . . . . 0.0 110.768 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 121' ' ' PRO . 0.6 OUTLIER -105.43 125.21 50.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.045 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.546 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -113.73 129.04 56.63 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.959 179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.016 HG12 HG12 ' A' ' 119' ' ' VAL . 31.6 m -114.1 104.69 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.105 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.43 ' HG2' ' HD3' ' A' ' 205' ' ' LYS . 0.0 OUTLIER -87.35 106.57 18.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.781 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 204' ' ' VAL . 0.1 OUTLIER -121.38 136.48 25.9 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.661 0.267 . . . . 0.0 111.203 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.28 139.81 51.25 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.349 2.033 . . . . 0.0 111.338 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.46 ' HG3' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -124.77 158.3 33.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.152 0.501 . . . . 0.0 111.674 -179.337 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.661 ' CG ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -130.48 172.98 11.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.238 -179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 133' ' ' LYS . 1.4 p80 -47.23 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -127.43 98.33 5.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.661 ' HB ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.5 -177.28 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.227 179.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 136' ' ' VAL . 4.5 tt0 -96.35 97.48 9.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.748 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.856 HD22 HD11 ' A' ' 140' ' ' ILE . 3.1 mt -68.34 -63.25 1.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.758 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.79 3.69 65.95 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.923 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.856 HD11 HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -102.47 137.88 28.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 110.711 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 98.7 m -126.02 128.26 47.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.708 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.883 HD13 HG22 ' A' ' 194' ' ' VAL . 1.7 mt -95.93 163.91 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.663 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 142' ' ' ILE . 22.7 t -175.01 177.58 1.93 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 20.0 t -114.51 134.49 22.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.622 ' HD3' HG12 ' A' ' 155' ' ' VAL . 94.4 Cg_endo -78.26 176.49 9.89 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.562 2.175 . . . . 0.0 112.297 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.82 -164.8 0.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.588 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 58.18 85.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 0.0 110.621 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.54 72.77 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.959 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -80.24 159.78 69.5 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.698 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -44.94 -28.79 3.28 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.805 2.337 . . . . 0.0 112.024 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -99.37 -71.65 1.0 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.116 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 16.6 t70 65.14 73.06 0.44 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.803 0.335 . . . . 0.0 111.267 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.1 -157.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.661 2.241 . . . . 0.0 112.117 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.892 HD21 ' HA ' ' A' ' 190' ' ' MET . 1.6 mp -104.85 -173.43 2.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.506 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 175' ' ' ASP . 7.6 p -178.43 138.5 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.009 0.433 . . . . 0.0 111.267 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 1.022 HD13 HD23 ' A' ' 171' ' ' LEU . 12.0 mt -70.27 154.23 8.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 1.6 t -134.89 -8.94 2.37 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.71 142.29 15.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.059 0.457 . . . . 0.0 111.451 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.789 HG22 ' HB2' ' A' ' 166' ' ' HIS . 4.4 mt -141.05 133.36 29.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.447 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.3 164.83 12.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.924 0.392 . . . . 0.0 111.273 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -100.49 163.58 12.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.771 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.589 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . 83.71 -11.89 54.69 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.902 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.489 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.5 m -113.42 148.96 34.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.0 111.096 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.69 -22.28 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.227 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.81 ' O ' HG22 ' A' ' 168' ' ' THR . . . -55.12 -64.06 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.743 0.306 . . . . 0.0 111.558 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.789 ' HB2' HG22 ' A' ' 159' ' ' ILE . 13.2 t60 -81.31 -24.69 37.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.77 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.489 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -55.05 -40.86 70.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.193 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.81 HG22 ' O ' ' A' ' 165' ' ' ALA . 5.1 t -52.01 -26.07 9.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.029 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 58.01 67.04 2.41 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.808 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.798 HG21 HG11 ' A' ' 119' ' ' VAL . 2.9 t 178.84 40.16 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.877 0.37 . . . . 0.0 110.825 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.022 HD23 HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -114.39 -77.7 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.718 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 62.11 149.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.091 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.65 107.06 8.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.728 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 145.38 -18.01 1.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.613 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.869 ' O ' HG23 ' A' ' 155' ' ' VAL . 1.9 m-20 -60.29 144.66 49.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.567 0.222 . . . . 0.0 110.672 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 209' ' ' ARG . 0.1 OUTLIER -110.49 114.61 28.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.67 0.271 . . . . 0.0 110.917 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 154' ' ' LEU . 0.5 OUTLIER -70.15 176.03 4.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.559 ' C ' HD13 ' A' ' 178' ' ' LEU . 3.4 tm? -156.82 -43.6 0.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.945 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.494 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -145.87 173.37 12.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.674 HG22 ' OD2' ' A' ' 181' ' ' ASP . 24.3 mm -139.04 105.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.063 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.674 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 47.18 -88.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.534 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -102.49 -17.96 15.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 184' ' ' ARG . 33.4 mm -100.28 156.68 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.034 0.445 . . . . 0.0 111.747 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.494 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 38.0 mtp180 -125.93 119.33 27.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.555 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.648 HD11 ' HB2' ' A' ' 193' ' ' ALA . 2.7 mm? -76.08 -12.93 60.21 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.055 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.06 -76.56 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.809 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 185' ' ' LEU . 23.9 p -159.57 33.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.725 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 174.4 -171.05 0.05 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.679 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.486 ' HB2' HD12 ' A' ' 185' ' ' LEU . 0.8 OUTLIER 75.68 39.72 0.32 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.493 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.892 ' HA ' HD21 ' A' ' 154' ' ' LEU . 7.8 ptm -53.87 -44.77 70.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.795 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -64.44 -37.23 86.8 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.61 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.851 ' O ' HD12 ' A' ' 196' ' ' ILE . 3.1 m-20 -62.32 -42.21 99.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.31 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.648 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -58.9 -49.76 76.57 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.812 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.883 HG22 HD13 ' A' ' 142' ' ' ILE . 7.9 t -55.94 -28.46 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.378 179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.44 -50.15 48.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.851 HD12 ' O ' ' A' ' 192' ' ' ASP . 3.1 mp -80.06 -24.39 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.839 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.83 HD22 ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -77.68 -23.9 49.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.579 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.649 HE21 HG12 ' A' ' 194' ' ' VAL . 27.2 mt-30 -85.98 -47.69 9.38 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.202 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.493 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -68.29 -10.31 53.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.5 179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.842 ' HB3' HG22 ' A' ' 204' ' ' VAL . 1.3 m -78.48 46.65 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.409 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . 7.5 pt-20 -73.15 62.82 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.358 0.599 . . . . 0.0 111.085 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -170.07 -32.73 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.261 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.756 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.2 tt 178.95 108.05 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.408 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.842 HG22 ' HB3' ' A' ' 200' ' ' CYS . 25.1 t -109.74 122.82 64.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.219 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 35.5 ttpt -109.54 114.35 27.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 206' ' ' LEU . 2.5 mm? -91.86 119.19 31.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.073 0.463 . . . . 0.0 111.461 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 125' ' ' THR . 3.9 tttm -92.06 93.63 8.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.984 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 209' ' ' ARG . 6.9 mt -94.9 165.63 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.803 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -105.75 128.52 53.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.786 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -132.33 114.52 14.49 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.805 0.336 . . . . 0.0 111.234 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.28 54.92 2.09 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.213 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -97.78 -172.47 2.39 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.197 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 29.1 t0 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.006 179.81 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 19' ' ' VAL . 11.9 p -148.9 121.74 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.057 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.5 128.74 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.0 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -119.08 115.59 24.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 p -51.67 116.02 1.92 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.148 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.14 168.49 10.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.957 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.583 HG23 ' HG3' ' A' ' 112' ' ' GLU . 1.2 p -125.42 134.75 52.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.809 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.512 HG21 ' CE2' ' A' ' 113' ' ' PHE . 7.2 t -121.58 177.23 5.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.963 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.35 162.08 16.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.751 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -134.21 148.76 29.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.532 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.3 t -128.99 109.53 19.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.248 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.036 HD21 HD11 ' A' ' 72' ' ' LEU . 3.0 mm? -107.54 118.37 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.311 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -108.47 162.31 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.157 0.503 . . . . 0.0 111.588 -179.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.868 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 116.75 33.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.72 153.19 60.87 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.656 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.32 3.17 6.51 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.591 2.194 . . . . 0.0 112.624 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.09 -51.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.241 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.1 t -132.76 -4.3 3.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 74.35 -97.16 0.94 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.269 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.868 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 42.0 m-85 -119.01 115.57 24.6 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -83.1 11.11 56.31 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 120.94 -0.647 . . . . 0.0 114.116 -178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 72' ' ' LEU . 26.5 mt -92.82 146.37 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-N 117.387 0.593 . . . . 0.0 111.981 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -139.39 99.96 3.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.276 -0.875 . . . . 0.0 108.948 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.804 HD13 ' HB3' ' A' ' 55' ' ' PRO . 1.4 pp -108.92 152.9 24.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.344 0.592 . . . . 0.0 112.267 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -99.53 170.1 8.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.329 179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -133.21 31.95 2.81 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.872 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.22 68.38 0.26 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 121.122 0.486 . . . . 0.0 110.703 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.94 HG22 HD13 ' A' ' 56' ' ' LEU . 12.4 t -57.2 -75.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.928 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.535 ' CD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 p90 -68.54 -44.65 74.07 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.34 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.535 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 52.55 86.64 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.544 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 47' ' ' ALA . 70.9 p -159.19 81.15 0.77 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.043 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' C ' ' HG1' ' A' ' 50' ' ' THR . 8.4 pt-20 44.2 60.19 2.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.857 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.677 ' C ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER 177.81 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.339 179.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.677 ' HG ' ' C ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 36.16 22.15 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.367 178.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 50' ' ' THR . 0.9 OUTLIER -70.78 20.36 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -79.42 120.22 79.63 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.703 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.81 168.03 1.95 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.524 2.149 . . . . 0.0 112.485 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.804 ' HB3' HD13 ' A' ' 41' ' ' LEU . 61.1 Cg_exo -51.4 142.45 37.93 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.709 2.273 . . . . 0.0 112.136 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.94 HD13 HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -144.98 108.34 4.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.65 -179.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.783 ' CD1' HD13 ' A' ' 39' ' ' ILE . 22.6 mt -62.9 117.23 3.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.843 0.354 . . . . 0.0 110.74 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.7 t -97.68 -22.82 16.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.191 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.437 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 58.4 t80 -162.08 127.49 3.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.027 0.442 . . . . 0.0 111.692 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.761 HG21 ' HB2' ' A' ' 67' ' ' GLU . 2.1 mt -99.17 -173.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.715 ' H ' HG22 ' A' ' 60' ' ' ILE . 68.2 tt0 -116.08 144.01 44.71 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.351 -0.539 . . . . 0.0 111.385 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -71.84 100.32 2.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.067 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.572 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 8.0 t0 99.33 49.17 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.821 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.03 140.53 38.05 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.656 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 69' ' ' CYS . 14.4 Cg_endo -56.7 -18.66 27.47 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.359 2.04 . . . . 0.0 111.686 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.803 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -67.53 -56.33 9.95 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.758 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.761 ' HB2' HG21 ' A' ' 60' ' ' ILE . 2.4 tp10 -77.75 -28.33 50.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.954 0.407 . . . . 0.0 109.986 179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 4.0 mmt-85 -89.69 -1.78 58.1 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.652 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 65' ' ' PRO . 22.7 t -48.87 -54.7 14.2 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.926 0.393 . . . . 0.0 110.76 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 140.01 -22.18 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.967 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.495 HG11 ' HA3' ' A' ' 162' ' ' GLY . 17.5 t -139.34 61.65 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.871 0.367 . . . . 0.0 111.348 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 39' ' ' ILE . 11.1 mt -147.45 145.34 29.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 111.305 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -141.49 172.96 11.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.604 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.635 HD13 HG13 ' A' ' 60' ' ' ILE . 29.1 mm -68.26 71.56 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.186 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.39 88.3 0.98 Allowed Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.486 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -125.39 101.56 7.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.763 0.316 . . . . 0.0 110.868 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.708 ' O ' HG22 ' A' ' 111' ' ' ILE . 23.7 mmt-85 -59.81 139.25 57.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.933 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.412 HG23 ' HD2' ' A' ' 55' ' ' PRO . 3.4 m -122.36 148.91 25.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.002 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -30.21 8.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.962 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -147.43 137.88 23.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.228 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.92 HD12 HD12 ' A' ' 97' ' ' LEU . 11.8 mt -120.87 109.84 26.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.8 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 58.03 23.14 9.66 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.2 -28.27 12.28 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.324 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.412 HG23 ' HD2' ' A' ' 85' ' ' PRO . 30.1 mt -70.02 137.21 87.2 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 120.497 0.189 . . . . 0.0 111.316 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.412 ' HD2' HG23 ' A' ' 84' ' ' ILE . 41.7 Cg_endo -67.49 -168.97 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.37 2.046 . . . . 0.0 112.239 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.4 p -151.75 -54.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.008 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -68.42 -13.29 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -107.48 45.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.916 0.389 . . . . 0.0 110.797 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.26 -175.87 0.6 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.815 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 5.4 m -83.73 165.39 18.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.989 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.524 ' HD2' HD13 ' A' ' 51' ' ' LEU . 5.1 p90 -73.88 -41.53 62.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.3 tt0 -54.64 -32.51 59.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.034 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HA ' ' HG3' ' A' ' 96' ' ' GLN . 0.2 OUTLIER -61.42 -49.39 77.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -54.36 -42.51 70.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.526 0.679 . . . . 0.0 110.067 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 0.6 OUTLIER -59.09 -36.41 75.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.869 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 7.5 mm-40 -61.94 -42.75 99.47 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.902 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.92 HD12 HD12 ' A' ' 81' ' ' ILE . 10.6 mt -55.43 -44.25 76.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.638 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.522 HD13 HD11 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -67.81 -47.42 69.11 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.216 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 8.9 mtm180 -50.44 -33.1 19.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.715 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.498 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 61.4 m-20 -120.22 38.08 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.106 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.613 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.8 OUTLIER -95.19 21.54 7.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.242 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.2 p -125.5 16.58 8.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 111.823 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.8 mt -62.86 -49.69 82.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.935 0.874 . . . . 0.0 110.413 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -104.64 8.77 35.33 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.35 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.555 ' O ' HG22 ' A' ' 30' ' ' THR . 15.4 m 62.6 26.91 15.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.808 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 6.3 mttt -154.95 157.94 38.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.155 0.502 . . . . 0.0 111.674 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 101' ' ' SER . 0.7 OUTLIER -155.45 114.25 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.248 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.48 141.23 29.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.832 0.348 . . . . 0.0 110.961 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.619 HD23 HG23 ' A' ' 81' ' ' ILE . 1.1 mt -137.05 155.89 49.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.168 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -121.24 111.19 17.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.243 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.708 HG22 ' O ' ' A' ' 77' ' ' ARG . 41.1 pt -114.73 163.09 12.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.062 0.458 . . . . 0.0 111.676 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.583 ' HG3' HG23 ' A' ' 24' ' ' THR . 25.3 tt0 -131.28 142.87 50.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.514 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 25' ' ' THR . 0.2 OUTLIER -161.11 174.71 13.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.904 0.383 . . . . 0.0 111.407 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.32 155.1 21.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.07 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -106.75 104.92 17.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.996 0.426 . . . . 0.0 111.691 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 115' ' ' VAL . . . 173.05 117.52 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.706 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.574 ' CG ' HG13 ' A' ' 164' ' ' VAL . 0.1 OUTLIER -130.78 30.89 4.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.146 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 5.1 t 89.45 97.6 0.02 OUTLIER 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.409 0.623 . . . . 0.0 111.293 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.479 HG11 ' CG2' ' A' ' 170' ' ' THR . 9.3 p -139.91 131.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.13 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.748 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.5 pp -108.1 101.67 42.6 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.415 ' HA ' ' CE1' ' A' ' 126' ' ' PHE . 15.9 Cg_exo -68.69 156.84 64.17 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.865 2.376 . . . . 0.0 112.68 -179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.04 104.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.223 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.01 115.27 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.003 0.43 . . . . 0.0 111.128 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 102.45 -47.39 1.14 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.546 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.21 107.14 11.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.925 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.477 ' HE2' HG21 ' A' ' 119' ' ' VAL . 1.7 t80 -113.0 120.12 40.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.748 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -113.23 121.48 44.59 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.537 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.796 HG11 HG21 ' A' ' 168' ' ' THR . 12.1 t -104.55 99.94 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.685 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.25 109.43 16.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.554 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.825 HD21 HG22 ' A' ' 168' ' ' THR . 26.1 mt -121.76 116.35 30.39 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.588 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -63.35 114.78 2.65 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.337 2.025 . . . . 0.0 111.612 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.474 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -87.72 158.96 18.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.131 0.491 . . . . 0.0 111.259 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.601 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -101.77 -164.66 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.66 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.92 -36.53 62.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.854 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.9 m -177.49 70.13 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.601 HG23 ' HB2' ' A' ' 133' ' ' LYS . 21.5 t -118.54 159.26 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.364 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.492 ' N ' HG12 ' A' ' 136' ' ' VAL . 16.0 pt-20 -65.95 133.56 51.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.939 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.769 HD22 HD11 ' A' ' 140' ' ' ILE . 1.9 mt -92.45 -49.4 6.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.706 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.02 16.11 39.66 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.591 -0.814 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.769 HD11 HD22 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -106.39 141.22 22.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 117.19 0.495 . . . . 0.0 111.278 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.8 m -122.3 114.16 20.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.593 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.995 HD12 HG22 ' A' ' 194' ' ' VAL . 5.6 mt -84.98 160.79 3.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.05 0.452 . . . . 0.0 111.926 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.451 ' N ' HG22 ' A' ' 142' ' ' ILE . 1.4 m -150.02 156.15 41.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.191 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 13.2 t -110.12 90.9 10.32 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.29 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.516 ' HG3' HG21 ' A' ' 155' ' ' VAL . 85.5 Cg_exo -44.49 165.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.618 2.212 . . . . 0.0 112.341 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 50.9 -161.81 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.884 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.56 170.02 21.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.006 0.431 . . . . 0.0 111.336 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' O ' ' HG3' ' A' ' 149' ' ' LYS . 0.0 OUTLIER 79.24 29.01 0.36 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.485 179.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 148' ' ' ARG . 1.9 mptp? -145.59 133.9 10.75 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.125 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.65 -23.16 14.56 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 121.952 1.768 . . . . 0.0 111.554 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 156.19 45.66 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.45 ' CB ' ' HD3' ' A' ' 153' ' ' PRO . 0.4 OUTLIER -53.67 -56.25 27.01 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.702 ' O ' HD22 ' A' ' 154' ' ' LEU . 72.3 Cg_endo -90.22 157.93 4.68 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.692 2.261 . . . . 0.0 112.973 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 153' ' ' PRO . 4.0 mm? -130.11 133.97 47.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.766 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.516 HG21 ' HG3' ' A' ' 145' ' ' PRO . 73.2 t -156.34 159.08 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.826 HD12 ' HA3' ' A' ' 174' ' ' GLY . 5.3 mt -105.24 139.54 26.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.729 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 74.7 m -127.32 -12.15 5.69 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.71 124.84 13.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.155 0.503 . . . . 0.0 111.903 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.561 HG22 ' HB2' ' A' ' 166' ' ' HIS . 16.4 mt -117.98 146.63 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.219 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.7 143.88 45.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.861 0.362 . . . . 0.0 111.287 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.47 168.37 20.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.471 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.495 ' HA3' HG11 ' A' ' 71' ' ' VAL . . . 83.8 -46.47 3.66 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.741 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.544 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 0.6 OUTLIER -72.74 175.47 6.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.131 0.491 . . . . 0.0 111.381 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.78 HG12 HD22 ' A' ' 130' ' ' LEU . 40.9 t -73.63 -22.34 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.104 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.755 ' HB2' ' CD1' ' A' ' 140' ' ' ILE . . . -53.67 -71.59 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.923 -178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.561 ' HB2' HG22 ' A' ' 159' ' ' ILE . 50.4 t60 -67.05 -24.76 66.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.69 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.544 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -57.12 -34.49 68.42 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.516 179.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.825 HG22 HD21 ' A' ' 130' ' ' LEU . 36.3 p -39.2 -58.02 1.24 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.511 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.18 -23.12 35.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.556 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.479 ' CG2' HG11 ' A' ' 119' ' ' VAL . 3.0 t -127.4 35.7 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.882 0.372 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.477 HD23 HD13 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -104.34 78.88 1.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -74.84 78.41 2.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.081 0.467 . . . . 0.0 110.39 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 173' ' ' LEU . 26.5 mt 39.93 28.9 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.289 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.826 ' HA3' HD12 ' A' ' 156' ' ' ILE . . . 70.74 -38.98 0.5 Allowed Glycine 0 CA--C 1.52 0.388 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.909 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 72.86 -81.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 176' ' ' LYS . 4.7 mmmm -136.15 106.29 6.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.734 0.302 . . . . 0.0 110.347 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.686 HD22 HD11 ' A' ' 180' ' ' ILE . 0.1 OUTLIER -92.6 132.35 36.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.86 0.362 . . . . 0.0 111.398 -179.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.3 pp -134.77 -16.53 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.04 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 207' ' ' LYS . . . -145.57 132.71 20.42 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.86 0.362 . . . . 0.0 111.594 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.686 HD11 HD22 ' A' ' 177' ' ' LEU . 50.3 mt -135.65 118.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.025 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.431 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 16.1 m-20 57.82 43.56 21.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.212 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.431 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 3.1 t-20 83.49 -25.11 0.15 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.936 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.465 HG22 ' N ' ' A' ' 184' ' ' ARG . 44.8 mm -81.31 157.96 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.724 0.297 . . . . 0.0 110.744 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.465 ' N ' HG22 ' A' ' 183' ' ' ILE . 19.6 mtm105 -129.59 126.45 38.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.17 0.51 . . . . 0.0 112.175 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.819 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 1.4 mm? -79.89 -4.26 51.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.064 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -41.72 -32.37 0.38 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.236 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.0 t -115.58 -17.06 11.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.9 m -89.0 -169.76 2.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.012 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 m -109.12 -167.49 1.22 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.983 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.411 ' O ' HG23 ' A' ' 194' ' ' VAL . 14.5 ttp -74.32 -53.44 9.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.621 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -53.4 -29.79 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.148 0.499 . . . . 0.0 110.732 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.817 ' O ' HD12 ' A' ' 196' ' ' ILE . 1.1 t0 -59.93 -52.3 66.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.228 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.819 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -58.25 -43.02 87.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.279 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.995 HG22 HD12 ' A' ' 142' ' ' ILE . 7.8 t -64.05 -31.81 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.705 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.92 -48.2 77.54 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.848 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.817 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.2 mp -73.1 -24.69 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.891 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.437 HD12 HG21 ' A' ' 180' ' ' ILE . 0.2 OUTLIER -64.02 -37.61 88.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.627 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.588 ' NE2' HG12 ' A' ' 194' ' ' VAL . 14.7 mt-30 -86.43 -52.93 5.29 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.597 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.543 ' CG ' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -56.83 -18.17 11.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.946 179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.451 ' SG ' HG22 ' A' ' 196' ' ' ILE . 16.5 m -88.4 42.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.119 0.485 . . . . 0.0 110.123 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.48 62.55 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.0 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -163.89 -32.2 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 203' ' ' LEU . 5.9 tt 177.39 106.83 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.443 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.55 121.33 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.666 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 7.4 ttpt -104.62 108.74 20.35 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 206' ' ' LEU . 6.0 mp -91.82 117.43 29.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.459 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 179' ' ' ALA . 16.0 tttt -107.21 108.64 20.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.221 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.487 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -111.6 175.19 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.426 -179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -114.29 120.04 39.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.015 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.411 ' O ' ' N ' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -125.87 108.85 11.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.112 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -179.01 43.58 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.122 0.487 . . . . 0.0 110.853 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.67 -168.91 2.28 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.038 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.439 179.767 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.869 0.366 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.69 131.87 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.066 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.494 HG12 ' OD1' ' A' ' 114' ' ' ASP . 29.1 t -124.98 133.08 70.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.285 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.49 ' NE2' HG11 ' A' ' 115' ' ' VAL . 26.5 p-80 -127.31 111.54 14.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.703 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.3 p -50.15 131.42 23.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.346 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -124.6 149.7 46.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.732 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.5 p -110.21 135.93 50.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -134.96 -169.68 2.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.865 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -117.07 163.09 16.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.049 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.538 HG13 HG23 ' A' ' 71' ' ' VAL . 1.5 t -141.51 148.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.522 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.424 ' C ' HD12 ' A' ' 29' ' ' LEU . 41.3 t -127.73 115.64 40.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.276 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.65 HD13 HD21 ' A' ' 109' ' ' LEU . 10.4 mp -112.25 120.99 43.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.233 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.681 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -101.92 163.14 12.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.32 0.581 . . . . 0.0 111.512 -179.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -107.5 103.71 13.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.311 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.24 149.36 55.28 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.424 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.28 4.47 5.37 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.532 2.155 . . . . 0.0 112.736 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.0 -46.21 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.528 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.601 HG21 ' OE2' ' A' ' 61' ' ' GLU . 46.3 p -127.91 -11.77 5.37 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 62.32 -93.24 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.195 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.63 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 37.6 m-85 -130.65 119.97 23.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.058 0.456 . . . . 0.0 110.104 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 60' ' ' ILE . . . -79.7 3.41 69.17 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.755 -0.657 . . . . 0.0 114.306 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 72' ' ' LEU . 34.5 mt -92.74 151.66 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 117.63 0.715 . . . . 0.0 112.024 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 40' ' ' GLN . 0.6 OUTLIER -151.53 99.56 2.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.104 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.793 HD11 HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.52 157.41 16.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.394 0.616 . . . . 0.0 112.575 -178.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' HG2' HD13 ' A' ' 56' ' ' LEU . 1.5 pm0 -95.4 164.64 12.73 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.778 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' CE1' ' A' ' 91' ' ' PHE . . . -76.83 -98.34 0.17 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.854 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 9.1 p -112.61 148.46 34.54 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.115 0.483 . . . . 0.0 111.806 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.6 -64.46 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.409 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.661 ' CE1' ' HA ' ' A' ' 51' ' ' LEU . 30.2 p90 -40.92 -40.93 1.5 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.661 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.613 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 39.79 92.1 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.891 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 0.2 OUTLIER 173.02 70.6 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.252 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 48' ' ' THR . 6.1 pt-20 52.44 162.39 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.107 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' ' 49' ' ' GLU . 47.1 m 69.51 -10.57 0.56 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.34 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.661 ' HA ' ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 32.3 -103.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.4 t 71.49 12.65 6.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.361 0.6 . . . . 0.0 110.096 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.488 ' HB3' ' CE2' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -68.51 107.42 1.97 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.581 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.26 149.31 11.85 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.763 2.309 . . . . 0.0 111.333 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.74 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 84.5 Cg_exo -45.3 110.01 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.455 HD13 ' HG2' ' A' ' 42' ' ' GLN . 2.0 mp -105.92 92.9 4.36 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 120.819 -0.353 . . . . 0.0 111.886 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.816 ' CD1' HD13 ' A' ' 39' ' ' ILE . 40.3 mt -58.21 110.65 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-O 120.787 0.327 . . . . 0.0 110.558 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.1 t -91.16 -2.37 57.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.351 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 79.4 t80 178.95 142.92 0.12 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.131 0.491 . . . . 0.0 111.608 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.777 HG21 ' HB2' ' A' ' 67' ' ' GLU . 1.8 mt -121.48 170.2 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.601 ' OE2' HG21 ' A' ' 35' ' ' THR . 56.8 tt0 -108.13 152.03 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.591 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.56 45.58 1.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 178.73 41.04 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.873 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.411 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 1.9 m -139.45 139.86 23.84 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.807 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 18.7 Cg_endo -58.78 -15.3 25.81 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.782 2.321 . . . . 0.0 112.979 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.673 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -64.18 -56.81 12.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.94 0.4 . . . . 0.0 110.303 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.777 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -78.96 -29.62 44.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.752 178.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.447 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -64.1 -24.76 67.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.001 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -47.29 -29.65 2.62 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.786 0.327 . . . . 0.0 111.132 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 137' ' ' GLU . . . 78.16 27.15 58.56 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.789 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.538 HG23 HG13 ' A' ' 27' ' ' VAL . 3.5 m -152.15 36.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.967 0.413 . . . . 0.0 110.935 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.011 HD13 HD11 ' A' ' 39' ' ' ILE . 12.0 mt -137.29 169.55 17.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.925 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.13 152.65 15.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.9 mt -62.74 103.65 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.171 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.77 29.83 3.71 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.507 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.557 ' OD2' HD23 ' A' ' 72' ' ' LEU . 15.8 m-20 -73.82 152.74 40.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.7 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 21.9 mtm180 -116.4 97.48 6.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.921 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 109' ' ' LEU . 23.8 t -73.14 151.88 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.134 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.9 -30.95 7.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -157.32 143.7 17.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.189 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.813 ' HB ' HD13 ' A' ' 97' ' ' LEU . 19.2 mt -127.21 115.3 40.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.8 18.63 9.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.16 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 110.78 -27.96 10.52 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.604 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.643 HD12 ' CD2' ' A' ' 97' ' ' LEU . 35.8 mt -74.91 132.98 76.44 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-O 120.507 0.194 . . . . 0.0 111.167 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.85 168.68 23.98 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.407 2.071 . . . . 0.0 112.286 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.8 p -131.26 -61.68 0.91 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -62.61 -18.2 61.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.209 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -113.38 44.51 1.55 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.611 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -179.52 -170.67 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.72 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.3 m -73.6 139.53 45.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CE1' ' HA3' ' A' ' 43' ' ' GLY . 11.0 p90 -73.12 -32.7 65.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.08 0.467 . . . . 0.0 110.901 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 3.5 mt-10 -54.0 -36.51 63.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.697 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -61.46 -45.38 94.49 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.74 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -54.74 -39.31 68.17 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.21 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.79 -35.23 80.42 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.143 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 11.1 mm-40 -67.28 -41.25 85.78 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.591 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.813 HD13 ' HB ' ' A' ' 81' ' ' ILE . 12.5 mt -63.98 -50.28 69.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.903 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 HD11 ' A' ' 41' ' ' LEU . 2.1 mt -69.76 -54.74 12.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HG2' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -50.91 -29.42 11.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.187 0.518 . . . . 0.0 109.829 179.064 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.5 OUTLIER -124.76 40.84 3.65 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.531 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.9 p -87.39 13.88 9.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.596 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 p -109.24 15.12 23.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 5.6 mt -74.24 -47.42 41.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.706 0.765 . . . . 0.0 110.776 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.67 9.52 41.37 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.657 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.723 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 0.3 OUTLIER 56.32 21.38 5.36 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.294 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.681 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.1 OUTLIER -174.81 157.73 2.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.984 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 107' ' ' VAL . 9.0 p -164.48 121.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.063 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.9 135.65 42.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.961 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.65 HD21 HD13 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -142.1 158.48 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.974 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -104.33 145.53 30.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.797 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.5 pt -131.25 165.98 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.561 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -135.8 124.18 23.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.473 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.414 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 3.6 p90 -141.87 174.1 10.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.376 -179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.494 ' OD1' HG12 ' A' ' 20' ' ' VAL . 1.2 m-20 -94.91 110.52 22.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.203 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.611 ' O ' HG13 ' A' ' 115' ' ' VAL . 8.9 p -61.8 104.88 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.39 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.68 137.23 0.09 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.594 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.641 ' HB3' HG22 ' A' ' 168' ' ' THR . 3.7 tp10 -130.43 6.43 4.84 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 1.5 m 83.44 74.07 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.964 0.411 . . . . 0.0 111.702 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.857 HG12 ' HA ' ' A' ' 128' ' ' VAL . 7.1 m -100.53 146.28 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.738 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.1 pp -117.39 104.12 50.38 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 120.853 0.359 . . . . 0.0 111.459 -179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 96.0 Cg_endo -85.9 152.71 9.88 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.9 2.4 . . . . 0.0 112.85 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.89 24.96 0.22 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.113 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.33 113.61 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.955 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.34 -45.06 2.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.802 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -125.66 102.56 7.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.676 179.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.489 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -111.6 115.93 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.37 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.665 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.15 126.06 41.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.885 0.374 . . . . 0.0 110.714 -179.736 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.857 ' HA ' HG12 ' A' ' 119' ' ' VAL . 13.0 t -99.89 87.97 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.144 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.1 mttt -81.26 105.49 12.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.883 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.869 HD22 HG21 ' A' ' 168' ' ' THR . 0.3 OUTLIER -129.95 124.94 21.84 Favored Pre-proline 0 C--N 1.333 -0.114 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.264 -179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -56.63 128.98 32.24 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.299 1.999 . . . . 0.0 111.628 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.532 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 12.0 tptm -98.22 158.19 15.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.739 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.925 ' O ' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -132.82 78.2 1.78 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.268 -179.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 69.2 m-70 45.21 29.21 0.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.196 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.402 ' HA ' ' CE ' ' A' ' 132' ' ' LYS . 0.9 OUTLIER 56.31 69.2 0.76 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -179.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 133' ' ' LYS . 76.9 t -87.05 -97.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.801 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.61 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -101.52 108.82 20.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.779 0.323 . . . . 0.0 111.055 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 163' ' ' SER . 17.6 mt -142.36 102.6 4.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.6 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -90.49 45.84 2.96 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.642 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.807 HD11 ' HB2' ' A' ' 165' ' ' ALA . 47.4 mt -88.35 144.16 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 120.755 0.312 . . . . 0.0 111.038 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.415 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 92.1 m -126.15 129.22 48.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.8 ' CD1' HG22 ' A' ' 194' ' ' VAL . 5.2 mt -107.52 164.01 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.836 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.521 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -153.88 149.66 27.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.816 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.01 130.9 23.83 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.45 170.82 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.448 2.099 . . . . 0.0 112.196 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -57.15 4.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.835 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.7 m -165.07 59.31 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.822 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 149' ' ' LYS . 0.0 OUTLIER -93.05 105.23 17.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.984 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER 48.65 167.64 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.313 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.047 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 149' ' ' LYS . 15.8 Cg_exo -68.44 63.1 1.15 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.832 2.355 . . . . 0.0 112.269 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 175.63 -37.74 0.1 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.768 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.441 ' HA ' ' HD2' ' A' ' 153' ' ' PRO . 6.4 p-10 43.4 94.36 0.04 OUTLIER Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.702 0.287 . . . . 0.0 111.373 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 152' ' ' ASP . 19.1 Cg_endo -58.35 151.71 58.84 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.469 2.113 . . . . 0.0 112.432 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.818 HD11 ' HA ' ' A' ' 190' ' ' MET . 2.9 mm? -73.16 164.48 26.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.685 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 175' ' ' ASP . 27.6 m -155.38 135.32 4.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.897 0.379 . . . . 0.0 111.304 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.37 150.34 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.846 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.41 -14.3 5.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.883 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.547 ' HA ' HD21 ' A' ' 173' ' ' LEU . 1.2 t70 179.02 147.04 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.986 0.422 . . . . 0.0 111.275 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.5 OUTLIER -140.66 136.28 35.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.664 179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.401 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -95.66 145.97 24.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.88 0.372 . . . . 0.0 111.122 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -177.92 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.711 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.413 ' CA ' HG12 ' A' ' 71' ' ' VAL . . . 71.18 -60.45 1.06 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.503 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.551 ' HB3' HD23 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -56.91 138.76 53.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.064 0.459 . . . . 0.0 111.231 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.675 ' O ' HG23 ' A' ' 168' ' ' THR . 3.5 m -51.69 -21.68 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.192 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.807 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -49.24 -71.55 0.06 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.415 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 61.8 t60 -71.57 -24.8 61.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.84 0.353 . . . . 0.0 110.795 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.47 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.8 -34.82 63.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.781 179.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.869 HG21 HD22 ' A' ' 130' ' ' LEU . 24.3 p -52.32 -27.13 14.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 74.52 64.69 2.32 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.58 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.433 HG21 HG22 ' A' ' 128' ' ' VAL . 3.7 t -178.91 -39.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.97 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.444 HD11 HD22 ' A' ' 206' ' ' LEU . 0.3 OUTLIER -60.85 86.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.866 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.04 -174.1 2.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.771 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 158' ' ' ASP . 4.3 mt -94.01 117.0 29.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.98 31.29 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.58 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.511 ' HB3' HG23 ' A' ' 208' ' ' ILE . 2.9 m-20 -111.32 159.7 17.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.495 0.188 . . . . 0.0 110.623 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -112.84 129.85 56.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.784 HD11 ' CD2' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -102.44 146.7 27.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.007 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.612 HD21 ' NE ' ' A' ' 184' ' ' ARG . 7.8 tt -132.82 -42.81 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.117 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.686 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -127.77 156.29 42.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.933 0.397 . . . . 0.0 111.338 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.765 HG22 ' OD1' ' A' ' 181' ' ' ASP . 17.8 mt -139.86 135.05 38.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.335 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.765 ' OD1' HG22 ' A' ' 180' ' ' ILE . 3.5 p-10 42.55 41.82 2.5 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.089 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 81.65 -19.56 0.41 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 183' ' ' ILE . 18.1 mm -90.76 132.2 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.154 0.502 . . . . 0.0 110.743 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.612 ' NE ' HD21 ' A' ' 178' ' ' LEU . 2.3 mtp-105 -102.1 120.89 41.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.166 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.612 HD21 HD12 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -93.46 -17.3 23.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.963 178.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 14.5 t0 58.55 39.69 24.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.498 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 34.4 p 58.54 74.19 0.44 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.005 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.411 ' O ' ' CB ' ' A' ' 192' ' ' ASP . 31.0 p -136.6 114.34 11.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.277 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 192' ' ' ASP . 0.4 OUTLIER 57.89 109.9 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.818 ' HA ' HD11 ' A' ' 154' ' ' LEU . 16.2 tmm? -53.14 -33.73 53.7 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.58 -29.77 68.38 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.259 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.417 ' HB2' ' CB ' ' A' ' 189' ' ' SER . 3.4 t0 -63.76 -48.91 75.07 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.841 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 185' ' ' LEU . . . -57.8 -43.45 85.69 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.142 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.8 HG22 ' CD1' ' A' ' 142' ' ' ILE . 14.3 t -59.95 -40.24 82.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.347 0.594 . . . . 0.0 109.681 178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.21 -49.56 75.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.937 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.725 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.9 OUTLIER -65.54 -24.16 34.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -68.8 -25.76 64.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.428 179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -98.26 -49.19 4.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.968 -178.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.478 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -59.23 -17.24 26.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.58 -179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.833 ' SG ' HG22 ' A' ' 204' ' ' VAL . 25.6 p -80.27 48.47 1.01 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.532 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 1.1 pt-20 -74.46 61.82 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.85 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.404 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -175.09 -26.49 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.415 179.331 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 203' ' ' LEU . 2.4 tt 177.63 112.03 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.045 0.45 . . . . 0.0 110.386 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.833 HG22 ' SG ' ' A' ' 200' ' ' CYS . 12.0 t -96.13 111.59 26.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.799 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -105.58 108.3 19.75 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.784 ' CD2' HD11 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -97.35 119.79 36.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.849 0.357 . . . . 0.0 111.839 -178.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.686 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 6.9 tttt -91.93 93.19 8.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.253 179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.511 HG23 ' HB3' ' A' ' 175' ' ' ASP . 8.1 mm -84.62 163.86 2.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.286 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.458 ' N ' HG22 ' A' ' 208' ' ' ILE . 1.5 ttt85 -107.79 116.77 32.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.572 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -103.8 159.78 15.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.159 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -158.02 44.16 0.31 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.637 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -58.47 177.98 0.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.358 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.883 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.81 0.338 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 19' ' ' VAL . 36.0 m -101.15 115.67 43.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.914 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.814 HG21 HG13 ' A' ' 115' ' ' VAL . 8.4 p 172.49 159.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.773 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.513 ' N ' HG22 ' A' ' 20' ' ' VAL . 18.1 p-80 -99.65 130.28 45.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.853 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -50.82 171.18 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.144 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -161.91 166.29 26.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.939 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.474 HG23 ' CG ' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -120.39 151.03 39.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.953 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.527 ' CG2' HD11 ' A' ' 111' ' ' ILE . 12.9 t -136.75 -173.26 3.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.98 163.07 17.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 109' ' ' LEU . 2.1 t -135.41 149.38 28.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.851 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.6 109.77 18.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.302 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.554 HD22 ' CB ' ' A' ' 66' ' ' ALA . 52.3 mt -112.21 118.11 34.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.249 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.746 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -105.33 162.83 13.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.227 0.537 . . . . 0.0 111.686 -179.26 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.739 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.11 109.06 20.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.04 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.426 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -78.4 150.14 76.36 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.446 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.74 3.75 5.72 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.43 2.087 . . . . 0.0 112.73 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.7 t -116.76 -43.36 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.577 0.227 . . . . 0.0 111.596 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.85 -12.14 5.37 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 64.61 -82.89 0.06 OUTLIER Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.159 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 56.2 m-85 -139.09 113.58 9.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.78 26.28 15.18 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.685 -178.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.983 HD11 ' HB2' ' A' ' 66' ' ' ALA . 3.9 mp -93.0 125.03 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -97.88 98.41 9.79 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.95 HD21 ' HA ' ' A' ' 55' ' ' PRO . 0.4 OUTLIER -96.87 156.54 16.31 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -132.55 169.28 16.83 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.92 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.72 56.52 0.51 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.708 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.2 m -158.21 79.35 0.83 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.017 0.437 . . . . 0.0 110.577 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.489 ' CG2' HD22 ' A' ' 56' ' ' LEU . 1.9 t -98.46 -72.95 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.394 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.554 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 27.8 p90 -34.72 -45.92 0.27 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.43 179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.479 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 49.25 72.62 0.29 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.251 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.4 t 167.93 94.23 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.378 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.44 ' CG ' ' O ' ' A' ' 48' ' ' THR . 7.7 pt-20 49.87 178.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.31 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.818 ' O ' HD23 ' A' ' 51' ' ' LEU . 13.3 t 44.08 -161.45 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.359 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.818 HD23 ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -150.08 -90.67 0.07 Allowed 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.204 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.462 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER 51.12 18.46 0.57 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.888 0.375 . . . . 0.0 111.469 -179.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -66.71 111.43 6.89 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.306 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.725 ' O ' HD23 ' A' ' 56' ' ' LEU . 83.7 Cg_endo -78.34 146.15 21.89 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.343 2.029 . . . . 0.0 111.441 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.95 ' HA ' HD21 ' A' ' 41' ' ' LEU . 5.4 Cg_endo -48.71 104.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.381 2.054 . . . . 0.0 111.747 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -117.33 111.9 20.0 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.693 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.627 HD13 HG23 ' A' ' 39' ' ' ILE . 19.3 mt -59.7 157.67 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.507 ' N ' HG22 ' A' ' 57' ' ' ILE . 26.4 t -128.44 -34.94 2.0 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.9 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -163.97 127.79 2.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.989 0.423 . . . . 0.0 111.502 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.722 HG21 ' CB ' ' A' ' 67' ' ' GLU . 3.9 mt -96.17 168.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.53 ' H ' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -112.71 141.55 46.38 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.52 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -69.13 63.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.456 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.6 p30 162.58 42.38 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.268 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.8 t -134.06 139.92 34.66 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.758 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.06 -12.69 31.05 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.755 2.303 . . . . 0.0 112.9 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.983 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -74.85 -56.3 4.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.84 0.352 . . . . 0.0 110.927 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.722 ' CB ' HG21 ' A' ' 60' ' ' ILE . 2.7 tp10 -72.32 -29.9 64.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.742 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.524 ' NH2' ' HA ' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -76.91 -24.5 52.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.904 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.1 t -44.4 -52.4 7.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 111.045 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.876 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 118.15 16.73 5.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.113 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 70' ' ' GLY . 10.0 m -158.58 37.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 111.067 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 71' ' ' VAL . 3.3 mm? -122.32 140.21 52.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.944 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.4 mm-40 -145.18 167.57 22.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.936 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.4 mm -65.62 126.91 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.197 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.22 50.05 42.05 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.538 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.39 102.83 7.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.708 0.29 . . . . 0.0 110.931 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.661 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -53.08 156.35 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.757 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 79' ' ' MET . 21.2 t -147.94 157.5 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.935 0.398 . . . . 0.0 111.403 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.46 ' N ' HG12 ' A' ' 78' ' ' VAL . 9.5 tpt -125.11 -41.36 2.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.74 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -148.62 137.01 21.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.838 HG12 HD23 ' A' ' 109' ' ' LEU . 9.5 mt -121.12 112.39 35.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.813 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.616 ' ND2' HG13 ' A' ' 107' ' ' VAL . 18.8 m-20 59.33 20.76 8.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.38 -21.95 37.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.636 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.1 mt -75.49 119.8 78.7 Favored Pre-proline 0 N--CA 1.449 -0.498 0 CA-C-O 120.439 0.161 . . . . 0.0 111.278 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.423 ' O ' HG23 ' A' ' 86' ' ' THR . 51.3 Cg_exo -55.63 -167.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.516 2.144 . . . . 0.0 112.142 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -170.75 -41.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.084 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.45 -11.19 60.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.526 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -117.93 47.15 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m -175.39 179.88 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.91 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.0 t -76.08 164.23 26.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 31.3 p90 -73.43 -30.35 63.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.19 -179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.53 -31.92 57.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.442 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -37.7 85.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.694 0.283 . . . . 0.0 110.746 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -71.98 -29.34 64.14 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.282 0.563 . . . . 0.0 110.459 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -76.8 -38.11 54.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.849 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.44 -35.55 63.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.787 0.327 . . . . 0.0 111.143 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.602 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.2 pp -69.84 -45.08 68.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.569 ' CD1' HD13 ' A' ' 41' ' ' LEU . 9.1 mt -64.09 -58.94 5.17 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.271 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.79 -29.56 11.9 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.505 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.5 OUTLIER -112.92 34.08 4.64 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.863 178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 69.2 p -102.81 17.46 23.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.204 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.3 p -102.05 11.81 37.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.505 HD11 ' O ' ' A' ' 100' ' ' ASP . 2.0 mt -68.9 -49.34 64.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.608 0.718 . . . . 0.0 110.998 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.23 6.91 38.04 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.012 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.746 ' O ' HG22 ' A' ' 30' ' ' THR . 27.8 p 55.76 24.68 7.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.256 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.6 OUTLIER -172.72 145.94 1.57 Allowed 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.711 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.616 HG13 ' ND2' ' A' ' 82' ' ' ASN . 1.0 OUTLIER -146.41 132.59 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.772 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.72 141.25 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.62 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.838 HD23 HG12 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -137.27 140.14 41.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.914 0.387 . . . . 0.0 111.352 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -101.53 115.77 31.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.973 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 77' ' ' ARG . 1.7 pp -117.55 163.75 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.448 . . . . 0.0 112.144 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' CG ' HG23 ' A' ' 24' ' ' THR . 0.7 OUTLIER -130.59 131.73 45.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.237 179.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.512 ' CE2' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -142.62 174.62 10.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.117 0.484 . . . . 0.0 111.661 -179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -92.82 104.27 16.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.08 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.814 HG13 HG21 ' A' ' 20' ' ' VAL . 13.5 p -61.57 145.65 12.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.576 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . 87.39 129.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.344 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -162.58 24.86 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.987 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.2 t 176.78 91.85 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.185 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.614 HG13 ' CZ ' ' A' ' 126' ' ' PHE . 41.3 t -142.27 118.09 5.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 1.07 HG23 ' HB2' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -154.74 78.51 4.96 Favored Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 121.293 0.568 . . . . 0.0 111.351 -177.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.465 ' HB3' ' CD2' ' A' ' 126' ' ' PHE . 69.6 Cg_endo -96.38 -167.31 0.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.455 2.77 . . . . 0.0 112.722 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -177.93 35.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.551 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.32 113.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.523 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.77 -32.77 5.8 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.922 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.582 HG22 ' HD3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -136.66 105.2 5.78 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.823 0.344 . . . . 0.0 111.137 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.614 ' CZ ' HG13 ' A' ' 119' ' ' VAL . 1.4 t80 -100.58 118.45 36.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.255 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 1.07 ' HB2' HG23 ' A' ' 120' ' ' ILE . 6.8 m80 -97.8 142.18 29.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.044 0.449 . . . . 0.0 111.294 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 170' ' ' THR . 6.1 t -139.92 90.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.853 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.39 99.01 8.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.528 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.497 HD21 HG21 ' A' ' 168' ' ' THR . 0.2 OUTLIER -112.47 129.89 23.92 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -64.76 136.84 51.16 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.089 1.86 . . . . 0.0 111.293 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.707 ' CG ' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -100.93 158.79 15.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.051 0.453 . . . . 0.0 110.939 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.49 ' CD ' ' HB ' ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.17 -164.86 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.02 -179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -100.47 -29.09 12.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.6 m -164.25 48.8 0.12 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.772 0.32 . . . . 0.0 111.497 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.876 HG13 ' HA2' ' A' ' 70' ' ' GLY . 25.3 t -112.09 137.68 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.752 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.51 129.33 38.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.71 -41.17 17.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.786 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 100.71 -12.05 59.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.712 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.827 HG23 ' HB1' ' A' ' 165' ' ' ALA . 1.2 pt -89.25 148.92 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 120.896 0.379 . . . . 0.0 111.374 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 158' ' ' ASP . 86.1 m -126.28 126.18 43.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.331 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.896 ' CG2' HD12 ' A' ' 154' ' ' LEU . 7.4 mt -87.31 164.18 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.095 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.537 ' OG ' HG23 ' A' ' 155' ' ' VAL . 69.2 p -163.5 164.79 24.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.9 109.89 17.03 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.937 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.497 ' HD3' HG22 ' A' ' 155' ' ' VAL . 39.8 Cg_exo -57.16 -39.32 91.46 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.484 2.123 . . . . 0.0 112.37 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.52 88.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.8 t -99.09 16.11 23.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.276 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 53.43 54.56 9.93 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.888 0.375 . . . . 0.0 111.05 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.19 155.63 39.9 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.85 82.71 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.609 2.206 . . . . 0.0 112.133 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 173.54 -82.52 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.526 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 46.1 t0 60.0 77.74 0.37 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.616 0.246 . . . . 0.0 110.997 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.66 -172.51 0.81 Allowed 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.568 2.179 . . . . 0.0 112.345 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.896 HD12 ' CG2' ' A' ' 142' ' ' ILE . 4.2 mm? -107.67 150.9 26.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.689 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 175' ' ' ASP . 18.4 m -150.67 145.72 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.409 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.509 HG12 HD23 ' A' ' 171' ' ' LEU . 1.1 mp -78.33 143.92 11.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.391 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.25 -11.42 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 141' ' ' THR . 0.6 OUTLIER -162.74 142.31 9.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.982 0.42 . . . . 0.0 111.142 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.745 HG23 HG22 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -136.21 149.37 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.849 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 173.22 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.936 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 167' ' ' ARG . 5.6 mtpp -115.19 145.64 42.2 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.916 0.389 . . . . 0.0 110.902 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.426 ' C ' HG12 ' A' ' 71' ' ' VAL . . . 115.38 -24.25 10.64 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.322 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.425 ' O ' ' NH2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -108.28 159.55 16.55 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.926 0.394 . . . . 0.0 111.029 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.1 m -60.38 -21.85 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.877 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.827 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.94 -65.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.452 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 28.4 t60 -83.54 -29.92 27.49 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.484 ' O ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -56.83 -40.78 76.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.679 0.276 . . . . 0.0 111.448 -179.412 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 165' ' ' ALA . 4.5 t -45.04 -29.17 0.81 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.548 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 68.6 1.57 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.539 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.514 HG21 HG22 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -178.93 -38.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.821 0.344 . . . . 0.0 110.744 179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.721 HD21 ' CD2' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -71.86 72.28 0.81 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.796 179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.47 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -100.03 152.76 19.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.924 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.458 HD23 HD11 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -76.48 129.34 36.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.966 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.12 23.17 5.33 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.732 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.588 ' O ' HG12 ' A' ' 155' ' ' VAL . 1.2 t0 -113.61 -174.32 2.44 Favored 'General case' 0 C--N 1.331 -0.214 0 O-C-N 122.883 -0.186 . . . . 0.0 110.693 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.463 ' HA ' HG12 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -132.46 106.81 8.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 0.0 111.381 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.528 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -74.07 157.39 36.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.716 179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.542 HD23 ' C ' ' A' ' 178' ' ' LEU . 7.2 tt -136.19 -49.59 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.389 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.487 ' HB2' HD23 ' A' ' 178' ' ' LEU . . . -129.76 157.46 42.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.05 0.452 . . . . 0.0 111.708 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.83 ' CD1' HD21 ' A' ' 185' ' ' LEU . 32.6 mt -138.99 105.71 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.76 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 28.5 t70 62.01 -79.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.065 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -130.45 -18.64 3.17 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.668 ' HB ' HG21 ' A' ' 196' ' ' ILE . 25.5 mm -96.99 138.03 23.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.027 0.442 . . . . 0.0 111.629 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.482 ' HE ' HD21 ' A' ' 178' ' ' LEU . 16.2 mtt180 -105.87 124.64 49.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.625 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.83 HD21 ' CD1' ' A' ' 180' ' ' ILE . 2.0 mm? -72.69 -7.28 49.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.258 178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.84 -31.12 1.12 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.425 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.9 p -124.88 -12.72 7.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.895 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 17.7 m -83.59 -170.64 3.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.227 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 m -116.95 -175.83 2.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.728 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.4 OUTLIER -67.58 -57.32 6.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -54.69 -41.81 70.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.239 0.543 . . . . 0.0 110.579 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -55.71 -45.06 77.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.251 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HB2' ' CD1' ' A' ' 185' ' ' LEU . . . -57.36 -42.05 81.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.206 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.69 HG22 HD12 ' A' ' 142' ' ' ILE . 17.0 t -59.1 -36.73 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.224 0.535 . . . . 0.0 110.101 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.411 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 29.3 mm-40 -60.83 -50.36 73.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.896 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.699 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -68.38 -25.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 178.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -64.87 -32.16 73.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.48 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.54 ' NE2' HG12 ' A' ' 194' ' ' VAL . 10.9 mt-30 -95.44 -41.46 8.97 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.961 0.41 . . . . 0.0 111.2 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.591 ' HG3' ' HA ' ' A' ' 196' ' ' ILE . 0.0 OUTLIER -85.08 13.99 5.54 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.828 ' CB ' HG22 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -65.41 32.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.2 mm-40 34.63 70.26 0.14 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.496 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . 0.7 OUTLIER 42.83 34.61 0.61 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 178.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.445 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 0.8 OUTLIER -171.55 103.87 0.2 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.156 0.503 . . . . 0.0 111.626 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.828 HG22 ' CB ' ' A' ' 200' ' ' CYS . 47.9 t -107.84 108.54 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.374 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 33.0 ttmt -94.02 107.5 19.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.721 ' CD2' HD21 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -88.84 107.57 19.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.475 -179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.582 ' HD3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -101.44 92.65 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.626 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.505 HG21 ' CG ' ' A' ' 175' ' ' ASP . 2.4 mp -87.31 166.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.7 OUTLIER -111.76 123.39 50.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.109 -179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.0 mmmm -115.55 95.09 4.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.803 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.22 47.67 1.54 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.323 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -56.85 -169.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.993 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.399 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.815 0.34 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.12 126.38 41.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.124 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 ' HB3' ' A' ' 114' ' ' ASP . 17.3 t -137.32 150.71 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.009 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.66 40.76 1.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.134 0.493 . . . . 0.0 110.895 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 51.62 174.3 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.537 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.15 142.5 1.78 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.622 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.21 143.88 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.009 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.426 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 5.6 t -141.2 159.11 42.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.84 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.71 159.17 15.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.791 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 109' ' ' LEU . 1.3 t -135.77 147.06 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG13 ' CD ' ' A' ' 106' ' ' LYS . 61.1 t -125.97 109.51 21.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.831 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.681 HD23 HD13 ' A' ' 109' ' ' LEU . 4.4 mm? -110.01 118.83 37.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.69 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.852 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -109.29 162.4 14.34 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.346 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.826 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -97.49 115.87 28.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.841 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -74.83 157.74 85.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.635 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.98 6.12 4.84 Favored 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.503 2.136 . . . . 0.0 112.594 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -112.14 -49.31 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.513 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 60.3 p -138.74 -1.58 1.81 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 76.04 -99.73 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.225 -0.988 . . . . 0.0 112.269 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.826 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 2.8 m-85 -116.16 119.63 36.41 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 61' ' ' GLU . . . -92.49 26.91 11.79 Favored Glycine 0 CA--C 1.517 0.17 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.352 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.768 HD11 ' HB2' ' A' ' 66' ' ' ALA . 7.0 mt -92.63 135.94 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 121.092 0.473 . . . . 0.0 111.56 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.96 99.51 5.76 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.067 HD21 HD13 ' A' ' 98' ' ' LEU . 1.9 pp -114.69 156.82 24.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 112.279 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -102.65 169.59 8.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.259 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.401 ' O ' ' CG ' ' A' ' 91' ' ' PHE . . . -137.18 46.28 1.02 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.342 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.88 65.4 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.175 0.512 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.9 HG22 HD13 ' A' ' 56' ' ' LEU . 7.4 t -61.8 -74.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.189 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 47.3 p90 -67.41 -49.76 62.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.026 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.483 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 45.8 79.77 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.401 0.62 . . . . 0.0 111.296 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.3 t 170.37 116.8 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.665 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.61 ' O ' HG23 ' A' ' 50' ' ' THR . 1.6 tp10 60.84 84.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.61 HG23 ' O ' ' A' ' 49' ' ' GLU . 3.2 p 89.4 -175.78 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.562 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.3 pp -166.43 26.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.858 0.361 . . . . 0.0 111.895 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.07 20.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.666 ' OG ' HG23 ' A' ' 45' ' ' VAL . 1.2 t -58.81 109.3 1.76 Allowed Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.583 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' O ' HD23 ' A' ' 56' ' ' LEU . 39.4 Cg_endo -66.8 162.54 37.11 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.377 2.052 . . . . 0.0 112.319 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.647 ' HG3' ' HB1' ' A' ' 94' ' ' ALA . 76.1 Cg_exo -49.25 129.27 21.93 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.524 2.149 . . . . 0.0 112.154 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.9 HD13 HG22 ' A' ' 45' ' ' VAL . 0.4 OUTLIER -133.38 99.65 4.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.523 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.573 HD13 HG23 ' A' ' 39' ' ' ILE . 21.5 mt -60.89 129.5 23.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.76 0.314 . . . . 0.0 110.687 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.4 p -113.66 -2.51 13.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.222 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.42 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 55.4 t80 177.72 124.08 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.875 0.369 . . . . 0.0 111.435 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.699 HG22 ' H ' ' A' ' 61' ' ' GLU . 1.9 mt -96.63 -178.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.699 ' H ' HG22 ' A' ' 60' ' ' ILE . 25.3 tt0 -121.55 131.14 53.96 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.347 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.482 ' HA ' ' NH1' ' A' ' 68' ' ' ARG . . . -65.5 70.52 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.457 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.2 m-20 164.62 44.21 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.724 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.592 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -145.04 -179.43 0.94 Allowed Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 91.0 Cg_endo -97.87 -2.7 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.067 2.511 . . . . 0.0 112.744 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.768 ' HB2' HD11 ' A' ' 39' ' ' ILE . . . -76.84 -57.22 3.97 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.717 0.294 . . . . 0.0 111.648 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.597 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -77.37 -29.11 53.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.974 0.416 . . . . 0.0 110.131 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.592 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -76.53 -30.78 57.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.88 -67.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.727 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.32 -14.69 5.35 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.954 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 163' ' ' SER . 14.7 m -125.65 45.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.418 . . . . 0.0 110.96 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.761 HD12 ' O ' ' A' ' 66' ' ' ALA . 10.3 mt -135.6 168.95 18.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.148 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -164.16 143.19 7.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.564 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.36 92.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.094 0.473 . . . . 0.0 111.407 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.69 42.32 0.46 Allowed Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.283 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' OD2' HD13 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -74.83 113.28 11.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.841 0.353 . . . . 0.0 110.97 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.77 79.17 2.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.74 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.787 ' HA ' HG22 ' A' ' 111' ' ' ILE . 26.9 m -69.96 132.32 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.75 -30.71 10.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.498 ' HB3' ' HB2' ' A' ' 110' ' ' GLU . . . -144.89 131.97 20.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.145 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.489 HG21 HD11 ' A' ' 97' ' ' LEU . 17.7 mt -124.89 117.73 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.651 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 46.56 27.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.439 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.39 -30.27 9.07 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.593 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.7 mm -68.58 117.79 53.81 Favored Pre-proline 0 N--CA 1.45 -0.447 0 CA-C-O 120.575 0.226 . . . . 0.0 111.409 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.68 -167.29 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.364 2.043 . . . . 0.0 112.187 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.4 p -147.7 -45.39 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.071 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -70.69 -9.97 58.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.561 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -128.3 47.46 2.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.817 0.342 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.3 168.69 2.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.0 m -74.97 157.38 35.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.401 ' CG ' ' O ' ' A' ' 43' ' ' GLY . 9.5 p90 -73.3 -31.0 63.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.952 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -54.95 -41.14 70.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.369 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 -33.75 74.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.819 0.343 . . . . 0.0 110.978 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.647 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -72.93 -31.8 64.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.35 0.595 . . . . 0.0 110.6 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -76.31 -36.11 58.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.821 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -73.41 -35.73 65.89 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.0 111.055 -179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.567 ' C ' HD12 ' A' ' 97' ' ' LEU . 1.1 pp -69.96 -41.92 73.87 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.239 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.067 HD13 HD21 ' A' ' 41' ' ' LEU . 80.7 mt -65.84 -58.78 4.81 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.357 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.416 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.07 -29.7 13.7 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.525 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.4 OUTLIER -109.44 30.7 6.39 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.962 178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -104.5 45.64 0.95 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.286 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 72.2 p -133.36 13.02 4.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.88 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.525 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.6 mp -69.79 -48.91 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-O 121.52 0.676 . . . . 0.0 111.137 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.29 7.11 40.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.817 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.852 ' O ' HG22 ' A' ' 30' ' ' THR . 74.3 m 56.69 25.2 9.81 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.926 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -166.28 152.77 9.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.648 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 108' ' ' THR . 4.8 t -152.84 158.56 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.645 ' C ' HD12 ' A' ' 109' ' ' LEU . 0.1 OUTLIER -125.08 141.25 52.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.878 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.696 HD23 HG11 ' A' ' 78' ' ' VAL . 2.0 mp -130.26 156.04 45.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.187 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 80' ' ' ALA . 3.0 mt-10 -130.92 105.85 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.787 HG22 ' HA ' ' A' ' 78' ' ' VAL . 25.5 pt -110.47 160.08 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.098 0.475 . . . . 0.0 111.806 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -133.02 140.4 47.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 167' ' ' ARG . 0.5 OUTLIER -161.26 174.31 13.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.888 0.375 . . . . 0.0 111.151 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB3' HG11 ' A' ' 20' ' ' VAL . 68.4 m-20 -97.95 118.34 34.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.68 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 167' ' ' ARG . 2.9 m -61.96 118.56 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.426 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 167' ' ' ARG . . . 179.36 117.11 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 168' ' ' THR . 2.7 tp10 -118.1 13.25 13.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.527 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.35 72.06 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.163 0.506 . . . . 0.0 111.401 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.905 HG11 ' OG1' ' A' ' 170' ' ' THR . 25.1 m -97.8 147.83 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.613 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.682 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.9 pp -121.45 98.72 46.09 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-O 120.92 0.39 . . . . 0.0 111.304 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HB3' ' CE1' ' A' ' 126' ' ' PHE . 89.2 Cg_endo -90.31 169.12 4.16 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.084 2.522 . . . . 0.0 112.825 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.8 m -166.61 29.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.8 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 57.82 113.31 0.01 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.715 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 93.78 -39.25 2.96 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.596 -0.811 . . . . 0.0 111.561 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.428 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -128.22 102.42 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.346 . . . . 0.0 110.493 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.511 ' CZ ' ' CG2' ' A' ' 170' ' ' THR . 0.7 OUTLIER -109.15 117.8 35.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.485 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.575 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.8 m80 -99.96 143.01 30.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.769 0.318 . . . . 0.0 110.648 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.823 HG11 HG21 ' A' ' 168' ' ' THR . 14.6 t -118.66 90.66 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.793 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.448 ' HG2' ' HG3' ' A' ' 205' ' ' LYS . 0.3 OUTLIER -80.81 105.96 12.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.445 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.671 HD23 HG12 ' A' ' 128' ' ' VAL . 3.2 pp -136.98 133.45 18.65 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.382 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 164' ' ' VAL . 35.3 Cg_exo -56.89 129.08 32.64 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.231 1.954 . . . . 0.0 111.516 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -106.98 139.4 41.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.075 0.464 . . . . 0.0 110.874 -179.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -76.75 -168.28 1.0 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.767 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.483 ' HA ' ' HB2' ' A' ' 201' ' ' GLU . 0.9 OUTLIER -90.04 -40.0 12.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.235 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.62 45.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.773 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 137' ' ' GLU . 7.3 t -100.46 161.25 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.064 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' N ' HG12 ' A' ' 136' ' ' VAL . 17.3 tt0 -51.75 145.91 8.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.978 0.418 . . . . 0.0 111.274 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.606 ' HB3' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -143.74 -58.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.487 179.838 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 92.02 56.94 1.54 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.679 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.761 HD11 ' HB2' ' A' ' 165' ' ' ALA . 6.0 mt -125.09 136.7 60.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.457 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 73.4 m -125.28 142.54 51.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.031 0.443 . . . . 0.0 111.283 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.051 HD12 HG22 ' A' ' 194' ' ' VAL . 10.5 mt -111.49 164.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.96 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.488 ' N ' HG22 ' A' ' 142' ' ' ILE . 29.6 m -165.35 152.52 10.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.01 145.94 35.97 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.23 -35.47 11.21 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.594 2.196 . . . . 0.0 112.215 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.6 m 60.01 52.11 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.964 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.59 29.1 3.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 59.3 59.53 2.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.828 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.68 131.98 24.08 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.16 -25.92 48.44 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.448 2.099 . . . . 0.0 112.263 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -86.61 -39.33 7.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.678 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 12.1 t0 56.03 83.81 0.22 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.678 0.275 . . . . 0.0 110.854 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.19 159.36 5.78 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.665 2.243 . . . . 0.0 112.576 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 190' ' ' MET . 2.2 mm? -101.7 155.03 18.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.302 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.511 HG12 ' N ' ' A' ' 156' ' ' ILE . 14.1 t -153.71 160.55 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.872 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.525 HD11 HD12 ' A' ' 171' ' ' LEU . 8.5 mt -104.02 148.02 9.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.817 179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.53 -0.36 2.93 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.457 ' N ' ' HB ' ' A' ' 141' ' ' THR . 1.5 t0 -168.98 134.56 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 111.421 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.514 HG22 ' HB2' ' A' ' 166' ' ' HIS . 0.1 OUTLIER -136.69 149.34 26.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.822 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.583 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -122.79 149.12 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.162 179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.523 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 2.3 mptt -79.09 165.74 23.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.725 0.298 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 94.81 -59.34 1.78 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.595 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.514 ' OG ' HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -61.31 160.85 9.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 110.922 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 131' ' ' PRO . 28.9 m -72.62 -23.99 21.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 168' ' ' THR . . . -49.64 -58.51 5.13 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.514 ' HB2' HG22 ' A' ' 159' ' ' ILE . 15.8 t60 -83.87 -31.31 25.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.646 -179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -54.99 -29.84 58.09 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.733 0.302 . . . . 0.0 111.153 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.823 HG21 HG11 ' A' ' 128' ' ' VAL . 9.8 t -54.75 -20.1 7.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.266 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.84 24.74 76.22 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.354 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.905 ' OG1' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -133.27 -39.11 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.84 0.352 . . . . 0.0 110.896 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.658 HD22 ' HB1' ' A' ' 165' ' ' ALA . 12.0 tp -64.96 93.73 0.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.888 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -110.23 155.26 22.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.692 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.5 OUTLIER -87.73 50.97 2.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.023 0.439 . . . . 0.0 110.993 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.09 30.16 0.19 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.48 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -113.88 177.23 4.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.647 0.261 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -117.65 98.34 6.33 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.82 0.343 . . . . 0.0 111.18 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.647 HD11 ' CD2' ' A' ' 206' ' ' LEU . 3.9 mt -76.97 134.89 38.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.723 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 178' ' ' LEU . 0.0 OUTLIER -140.6 2.88 1.85 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.857 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.829 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -165.29 154.68 12.6 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.876 0.369 . . . . 0.0 111.484 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 179' ' ' ALA . 9.1 mm -139.38 117.79 12.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.799 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 46.81 -87.31 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.407 179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' ILE . 75.7 m-20 -112.34 -16.5 12.93 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.485 HG22 ' N ' ' A' ' 184' ' ' ARG . 39.7 mm -96.67 157.68 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.948 0.404 . . . . 0.0 111.432 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.485 ' N ' HG22 ' A' ' 183' ' ' ILE . 8.8 mtt180 -127.43 126.56 42.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.047 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.2 mm? -78.47 -4.92 50.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.8 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.13 -28.92 1.97 Allowed 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 87.1 p -135.45 40.05 2.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 15.1 m -140.66 -171.42 3.23 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.23 173.23 6.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.976 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.611 ' HA ' HD21 ' A' ' 154' ' ' LEU . 17.6 ttp -59.0 -53.09 62.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.958 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 4.0 mt-10 -51.7 -41.06 61.17 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.613 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.435 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 9.1 t70 -53.26 -51.96 60.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.153 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.754 ' HA ' HD12 ' A' ' 196' ' ' ILE . . . -52.66 -41.36 63.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.251 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 1.051 HG22 HD12 ' A' ' 142' ' ' ILE . 21.6 t -59.64 -33.45 51.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.022 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.435 ' HG3' ' HA ' ' A' ' 192' ' ' ASP . 17.1 mm-40 -63.32 -50.27 70.69 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.75 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.0 OUTLIER -70.84 -24.62 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.822 178.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.876 HD22 HD11 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -64.76 -35.44 81.07 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.762 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.71 ' NE2' HG12 ' A' ' 194' ' ' VAL . 12.7 mt-30 -94.76 -44.73 7.64 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.32 -22.58 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.888 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.707 ' CB ' HG22 ' A' ' 204' ' ' VAL . 19.3 m -89.56 41.99 1.07 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.081 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.497 ' HA ' ' HG2' ' A' ' 132' ' ' LYS . 12.2 pt-20 -69.06 61.6 0.11 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.535 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -168.98 -28.98 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.944 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.681 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.5 tt 172.67 113.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.856 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.707 HG22 ' CB ' ' A' ' 200' ' ' CYS . 97.4 t -111.88 137.91 42.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.771 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 5.1 ttmt -111.76 108.14 17.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.955 178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.647 ' CD2' HD11 ' A' ' 177' ' ' LEU . 0.4 OUTLIER -82.76 113.12 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.436 -179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.633 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 6.4 tttt -100.02 103.43 14.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.521 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -110.34 174.9 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 23.0 mtp85 -102.73 125.99 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.973 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.02 94.55 4.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.86 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -85.32 55.01 3.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.144 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.4 168.95 11.81 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.238 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.3 t70 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.226 179.782 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.401 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 1.9 tt0 . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.777 0.322 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.401 ' N ' ' HG3' ' A' ' 18' ' ' GLN . 21.5 t -123.03 121.06 62.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.273 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.816 HG12 ' HB2' ' A' ' 116' ' ' ALA . 3.4 m -133.83 92.41 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.016 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.508 ' O ' HG23 ' A' ' 115' ' ' VAL . 30.2 t60 -75.55 114.97 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.024 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 p -55.79 149.95 13.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.121 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -155.6 168.71 26.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.972 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.91 160.26 16.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.73 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.757 HG23 ' HB3' ' A' ' 161' ' ' LYS . 89.2 m -158.45 155.45 28.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -101.7 160.2 14.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.68 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.99 150.1 34.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.586 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.6 t -124.54 109.35 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.971 0.415 . . . . 0.0 111.246 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.657 HD21 HD11 ' A' ' 72' ' ' LEU . 3.4 mm? -107.26 118.23 36.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.835 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.673 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.7 162.57 13.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.175 0.512 . . . . 0.0 111.942 -178.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . . . -98.28 151.52 20.4 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.162 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' H ' ' HA3' ' A' ' 36' ' ' GLY . 35.5 m-20 -134.16 150.88 75.39 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.386 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.11 20.73 1.05 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.561 2.174 . . . . 0.0 112.471 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.7 t -133.79 -54.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.248 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.6 t -159.81 37.8 0.19 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.692 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' HA3' ' H ' ' A' ' 32' ' ' ASP . . . -43.43 143.31 1.84 Allowed Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.437 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.545 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 11.0 m-85 61.02 71.83 0.55 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 61' ' ' GLU . . . -98.66 26.48 23.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.439 -178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.979 HD13 HD13 ' A' ' 72' ' ' LEU . 26.9 pt -115.23 143.41 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -96.06 140.35 30.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.837 0.351 . . . . 0.0 110.478 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.863 HD13 HD13 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -112.31 121.56 45.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.966 -179.084 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -84.69 170.11 13.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.95 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.06 61.37 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.54 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 178.99 110.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.985 0.421 . . . . 0.0 111.31 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 56' ' ' LEU . 20.7 t -129.67 -73.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 121.376 0.608 . . . . 0.0 110.256 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.83 ' O ' HG22 ' A' ' 48' ' ' THR . 27.0 p90 -43.42 -45.07 6.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.03 -0.987 . . . . 0.0 110.35 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.489 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.66 74.49 0.1 Allowed 'General case' 0 CA--C 1.524 -0.056 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.8 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.83 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 166.86 108.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.788 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 62.52 138.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.549 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.2 OUTLIER 46.1 -164.27 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.815 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.673 HD13 HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -138.93 -85.39 0.25 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.823 0.344 . . . . 0.0 111.717 179.45 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.4 t 57.41 13.98 2.03 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.079 0.466 . . . . 0.0 110.974 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.4 t -54.13 106.66 0.69 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.329 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 60.6 Cg_endo -72.53 117.9 5.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.279 1.986 . . . . 0.0 111.499 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HG3' HG21 ' A' ' 86' ' ' THR . 9.4 Cg_exo -36.1 118.68 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.21 2.607 . . . . 0.0 113.231 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.17 176.37 5.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.198 179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.539 HD12 HD12 ' A' ' 39' ' ' ILE . 21.3 mm -112.31 138.41 41.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.49 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 54.2 p -119.14 -8.5 10.15 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.425 ' CE2' ' O ' ' A' ' 60' ' ' ILE . 80.5 t80 -172.47 157.74 4.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.362 0.601 . . . . 0.0 111.885 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.788 HG21 ' HB2' ' A' ' 67' ' ' GLU . 8.7 mm -135.05 152.66 33.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.413 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 38' ' ' GLY . 4.8 tm-20 -104.2 156.66 17.71 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.108 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.56 47.59 0.98 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.979 0.419 . . . . 0.0 111.115 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 174.87 65.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.974 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.617 ' O ' ' NE ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER -156.02 -172.25 0.31 Allowed Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.552 ' CD ' ' CB ' ' A' ' 64' ' ' SER . 54.5 Cg_endo -96.77 -10.24 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.817 2.344 . . . . 0.0 113.377 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB1' ' CD1' ' A' ' 72' ' ' LEU . . . -77.68 -58.45 3.26 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.788 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -71.47 -29.1 64.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.092 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -72.35 -37.72 68.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.415 179.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.52 -30.59 5.38 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.961 0.41 . . . . 0.0 110.649 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.425 ' HA3' ' CG1' ' A' ' 136' ' ' VAL . . . 78.8 36.67 28.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.855 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 162' ' ' GLY . 16.6 t -154.26 31.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.736 0.303 . . . . 0.0 111.426 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.979 HD13 HD13 ' A' ' 39' ' ' ILE . 9.5 mt -133.11 147.55 52.14 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.894 0.378 . . . . 0.0 111.054 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.06 148.81 33.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.61 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.37 68.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.215 0.531 . . . . 0.0 111.785 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.09 45.44 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.743 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.428 ' HB2' HG12 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -79.71 -179.79 7.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.741 0.305 . . . . 0.0 110.668 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -147.03 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.571 HG21 HD13 ' A' ' 109' ' ' LEU . 86.4 t -65.35 133.73 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.022 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 ttp -106.09 -28.33 10.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.706 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -146.25 120.29 9.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.924 HD13 HD11 ' A' ' 97' ' ' LEU . 2.8 mt -105.34 104.93 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.513 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 57.01 21.16 6.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.38 -27.26 8.16 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.534 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.9 mm -71.6 111.58 10.86 Favored Pre-proline 0 N--CA 1.451 -0.378 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.83 168.53 24.36 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.48 2.12 . . . . 0.0 112.005 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.456 HG21 ' HG3' ' A' ' 55' ' ' PRO . 17.5 p -143.72 10.82 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -86.59 -17.1 34.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.829 0.347 . . . . 0.0 111.278 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -139.56 46.36 1.9 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.741 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -156.32 171.73 19.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.779 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.673 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -78.43 151.71 32.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.778 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -71.21 -30.0 65.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 6.3 pt-20 -54.44 -39.78 67.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.152 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -61.11 -36.48 79.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.583 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.691 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -67.56 -33.68 75.52 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.42 0.629 . . . . 0.0 110.128 178.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.2 -35.97 81.83 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.838 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 4.0 mm100 -70.24 -56.2 7.38 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.839 0.352 . . . . 0.0 110.936 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.924 HD11 HD13 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -52.28 -41.84 63.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.332 -179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.863 HD13 HD13 ' A' ' 41' ' ' LEU . 2.6 mt -68.65 -56.13 9.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.262 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.435 ' HG3' ' N ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -50.84 -28.74 10.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.164 0.507 . . . . 0.0 109.715 178.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.643 ' O ' HD11 ' A' ' 103' ' ' ILE . 0.2 OUTLIER -120.67 38.96 3.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.544 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.837 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.5 OUTLIER -103.84 36.16 2.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.167 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 37' ' ' PHE . 1.4 m -121.57 15.88 11.17 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.643 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.7 mp -71.59 -47.48 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.564 0.697 . . . . 0.0 111.216 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.95 3.67 44.8 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.903 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 m 63.04 18.46 10.94 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.666 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.673 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER -173.22 150.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.095 0.474 . . . . 0.0 111.956 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' A' ' 101' ' ' SER . 45.2 t -145.06 138.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.396 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.594 ' C ' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -113.12 125.48 54.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.81 0.338 . . . . 0.0 110.486 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.624 HD22 HG23 ' A' ' 81' ' ' ILE . 1.3 mt -119.21 164.95 14.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.318 -179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -126.89 105.94 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.36 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.42 HD13 ' OD2' ' A' ' 76' ' ' ASP . 24.3 pt -104.7 150.24 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.735 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -124.11 115.0 20.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.129 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.415 ' CE1' ' NE ' ' A' ' 167' ' ' ARG . 11.8 p90 -135.71 174.17 10.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.43 . . . . 0.0 111.406 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.24 155.01 18.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.636 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 21' ' ' HIS . 20.9 t -91.77 104.83 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.965 0.412 . . . . 0.0 111.471 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.816 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -167.95 137.25 2.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.656 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.401 ' HG2' ' CB ' ' A' ' 167' ' ' ARG . 6.9 mm-40 -146.63 25.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.635 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 76.76 65.59 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.249 0.547 . . . . 0.0 111.212 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.506 HG12 HG12 ' A' ' 128' ' ' VAL . 6.1 m -97.84 147.57 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.215 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.645 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.7 pp -130.04 92.93 35.11 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 121.109 0.48 . . . . 0.0 111.024 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.476 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 68.3 Cg_endo -96.37 -178.52 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.349 2.699 . . . . 0.0 112.673 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.33 35.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.415 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.51 119.5 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.826 0.346 . . . . 0.0 110.776 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.42 -51.73 3.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.619 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.434 ' CG2' ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -115.32 105.02 12.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.854 0.359 . . . . 0.0 110.551 179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.869 ' CE1' HG21 ' A' ' 170' ' ' THR . 0.9 OUTLIER -113.34 120.94 42.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.783 -179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.568 ' HB2' HG13 ' A' ' 120' ' ' ILE . 1.6 m80 -109.82 152.71 25.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 0.0 110.936 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 206' ' ' LEU . 17.8 m -131.07 98.28 3.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.284 179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.3 105.43 17.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.779 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.472 HD13 HG23 ' A' ' 164' ' ' VAL . 0.6 OUTLIER -128.04 133.11 24.77 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.977 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.76 136.03 37.48 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.351 2.034 . . . . 0.0 112.075 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.495 ' NZ ' HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -118.78 158.13 26.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.683 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -115.62 -166.82 1.17 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.796 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -58.5 -57.2 14.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.914 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 m -164.48 48.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.683 HG23 ' HB2' ' A' ' 133' ' ' LYS . 97.2 t -75.94 159.35 5.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.987 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.504 ' N ' HG12 ' A' ' 136' ' ' VAL . 1.1 tt0 -47.54 111.9 0.48 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.321 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.845 HD22 ' CD1' ' A' ' 140' ' ' ILE . 4.4 mt -116.11 112.5 21.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.565 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.72 45.85 2.92 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.691 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.845 ' CD1' HD22 ' A' ' 138' ' ' LEU . 20.7 mt -111.01 130.26 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-O 120.65 0.262 . . . . 0.0 111.064 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.564 HG22 ' HB3' ' A' ' 157' ' ' SER . 7.4 m -126.73 133.08 50.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.758 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.73 ' CD1' HD13 ' A' ' 197' ' ' LEU . 3.2 mt -105.4 163.44 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.896 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.489 ' N ' HG22 ' A' ' 142' ' ' ILE . 5.3 p -166.43 123.06 1.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.937 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 p -84.0 117.15 67.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.731 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.08 -174.98 0.2 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.311 2.008 . . . . 0.0 112.298 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.2 p -58.85 165.27 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.968 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.4 p -105.66 73.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -119.68 46.06 2.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.422 ' HE3' ' HD2' ' A' ' 153' ' ' PRO . 0.2 OUTLIER -178.33 154.89 0.93 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.952 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.23 75.23 3.39 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.503 2.135 . . . . 0.0 112.332 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -179.57 -59.96 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.456 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 28.6 t0 62.45 70.3 0.82 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 111.212 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HD2' ' HE3' ' A' ' 149' ' ' LYS . 87.1 Cg_endo -81.65 -161.71 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.031 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.876 HD22 ' HA ' ' A' ' 190' ' ' MET . 0.3 OUTLIER -134.39 173.74 11.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.869 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 175' ' ' ASP . 33.8 m -156.38 -176.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.093 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.593 ' N ' HD13 ' A' ' 156' ' ' ILE . 1.4 mm -76.14 154.28 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.694 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.564 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.3 OUTLIER -135.59 -9.18 2.16 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.692 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.441 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 173.21 147.44 0.05 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.091 0.472 . . . . 0.0 111.392 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.713 HG21 ' CG ' ' A' ' 166' ' ' HIS . 3.2 mt -130.69 150.24 34.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.61 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HE2' ' HA3' ' A' ' 162' ' ' GLY . 0.1 OUTLIER -121.77 134.7 54.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.774 0.321 . . . . 0.0 110.438 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.757 ' HB3' HG23 ' A' ' 25' ' ' THR . 0.6 OUTLIER -80.11 86.33 5.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.201 0.524 . . . . 0.0 111.009 -179.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 71' ' ' VAL . . . -177.24 -32.43 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.241 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.4 169.59 8.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 111.139 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.472 HG23 HD13 ' A' ' 130' ' ' LEU . 8.3 m -58.92 -21.53 19.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.067 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.932 ' O ' HG22 ' A' ' 168' ' ' THR . . . -43.57 -71.48 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.713 ' CG ' HG21 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.63 -24.93 67.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.672 0.272 . . . . 0.0 111.266 -179.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.436 HH22 ' N ' ' A' ' 162' ' ' GLY . 19.5 mmt-85 -58.81 -38.23 78.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.831 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.022 HG21 HD12 ' A' ' 171' ' ' LEU . 14.9 t -57.68 -30.46 65.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.94 0.4 . . . . 0.0 110.137 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.43 ' HA2' HG11 ' A' ' 115' ' ' VAL . . . 83.49 -72.51 2.82 Favored Glycine 0 C--N 1.332 0.344 0 CA-C-N 115.934 -0.576 . . . . 0.0 113.616 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.869 HG21 ' CE1' ' A' ' 126' ' ' PHE . 0.2 OUTLIER -42.46 -29.56 0.28 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 1.022 HD12 HG21 ' A' ' 168' ' ' THR . 0.2 OUTLIER -60.24 86.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.867 0.365 . . . . 0.0 110.863 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -118.38 158.75 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.644 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 31.6 mt -68.31 72.14 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.963 0.411 . . . . 0.0 110.834 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 164.06 40.05 0.02 OUTLIER Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.634 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.538 ' O ' HG12 ' A' ' 155' ' ' VAL . 54.2 m-20 -121.48 118.02 28.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.538 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.429 ' HA ' HG12 ' A' ' 155' ' ' VAL . 29.9 mmtt -75.85 108.36 8.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.2 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.509 HD21 ' HB3' ' A' ' 206' ' ' LEU . 1.6 mt -75.94 152.18 37.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.026 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.69 HD22 ' NZ ' ' A' ' 207' ' ' LYS . 7.3 tt -139.96 -57.11 0.56 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.744 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -109.97 155.95 21.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.346 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.744 HD13 ' O ' ' A' ' 179' ' ' ALA . 23.2 mm -139.61 110.98 4.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.267 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 38.9 t70 53.73 51.81 14.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.394 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.4 t-20 82.82 -30.5 0.09 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 37.3 mm -73.5 151.56 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.839 0.352 . . . . 0.0 110.702 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -130.35 119.07 22.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.24 0.543 . . . . 0.0 112.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 178' ' ' LEU . 0.6 OUTLIER -82.13 -12.34 58.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.903 178.389 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t70 51.18 52.6 14.56 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.63 74.51 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.657 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.91 -169.69 2.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.061 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.0 m -58.04 154.88 11.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.053 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.876 ' HA ' HD22 ' A' ' 154' ' ' LEU . 36.2 ttp -74.17 -35.23 63.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.921 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 195' ' ' GLN . 1.6 mt-10 -51.8 -48.52 63.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.989 0.423 . . . . 0.0 111.171 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 0.8 OUTLIER -49.54 -52.13 31.9 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.646 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.551 ' CB ' HD11 ' A' ' 154' ' ' LEU . . . -55.51 -37.83 68.4 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.314 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.814 HG12 ' NE2' ' A' ' 198' ' ' GLN . 21.6 t -62.78 -30.86 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.077 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 192' ' ' ASP . 13.3 mm-40 -66.54 -50.34 63.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.089 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.478 HG22 ' SG ' ' A' ' 200' ' ' CYS . 1.1 mp -73.72 -24.69 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.124 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.73 HD13 ' CD1' ' A' ' 142' ' ' ILE . 0.1 OUTLIER -63.15 -39.99 96.27 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.474 179.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.814 ' NE2' HG12 ' A' ' 194' ' ' VAL . 21.9 mt-30 -89.47 -40.09 12.92 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.235 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -14.7 53.91 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.85 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.804 ' HB3' HG22 ' A' ' 204' ' ' VAL . 2.2 m -85.02 41.78 0.89 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.807 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -71.72 62.59 0.41 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.222 0.535 . . . . 0.0 111.076 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -174.48 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.312 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.7 tt 177.56 109.32 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.124 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.804 HG22 ' HB3' ' A' ' 200' ' ' CYS . 24.0 t -103.12 116.03 46.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.891 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 4.4 ttmm -108.77 108.37 19.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.624 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.579 HD12 HG21 ' A' ' 128' ' ' VAL . 3.4 mt -97.12 117.16 30.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.415 . . . . 0.0 111.376 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.69 ' NZ ' HD22 ' A' ' 178' ' ' LEU . 26.2 tttt -97.8 101.07 12.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.425 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.576 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -109.43 179.38 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.094 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 2.4 mtp180 -109.41 135.25 50.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.012 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.423 ' O ' ' CB ' ' A' ' 211' ' ' ASP . 0.0 OUTLIER -132.37 159.87 37.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.796 0.331 . . . . 0.0 111.049 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 210' ' ' LYS . 0.4 OUTLIER 82.49 85.34 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.891 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -60.54 163.18 5.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.176 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 179.872 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.846 0.355 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -150.32 116.82 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.719 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG11 ' HB2' ' A' ' 116' ' ' ALA . 35.1 m -145.09 -178.87 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 111.522 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -133.94 116.62 15.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.834 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -50.58 147.98 4.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.445 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.4 173.0 12.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.658 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 152.71 39.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.033 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.56 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 9.0 t -149.06 170.37 18.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -101.59 162.16 13.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 108' ' ' THR . 0.7 OUTLIER -142.22 145.85 23.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.641 179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.58 109.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.886 0.374 . . . . 0.0 110.791 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.055 HD11 HD11 ' A' ' 72' ' ' LEU . 1.2 mm? -108.18 141.05 40.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.317 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -123.43 160.95 25.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.355 0.597 . . . . 0.0 112.089 -178.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.627 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -101.67 149.24 24.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.34 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -133.42 148.84 70.49 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.54 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.75 8.6 3.91 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.704 2.269 . . . . 0.0 112.681 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.07 -48.7 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.427 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 t -136.36 -3.27 2.17 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 32' ' ' ASP . . . 89.2 -94.61 2.01 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.308 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 10.4 m-85 -121.68 -70.16 0.8 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.773 -0.251 . . . . 0.0 111.042 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 133.35 0.44 4.13 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 119.779 -1.201 . . . . 0.0 114.374 178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.963 HG23 HD13 ' A' ' 60' ' ' ILE . 1.0 OUTLIER -128.05 130.51 69.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 117.621 0.71 . . . . 0.0 112.03 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.08 128.77 56.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.836 HD21 HD13 ' A' ' 98' ' ' LEU . 2.4 pp -121.0 157.54 29.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.424 0.631 . . . . 0.0 112.559 -178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.464 ' O ' HD23 ' A' ' 56' ' ' LEU . 8.8 pt20 -111.25 170.04 8.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.199 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.57 16.23 14.36 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.385 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -97.51 85.38 3.61 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.116 0.484 . . . . 0.0 110.639 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.986 HG22 HD22 ' A' ' 56' ' ' LEU . 3.0 t -99.82 -75.9 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.157 -179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 46.2 p90 -57.19 -46.3 82.96 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.566 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 50.42 74.17 0.23 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.434 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER 163.66 75.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 64.57 163.36 0.13 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.86 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 61.87 -169.52 0.17 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.66 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.677 HD13 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -137.42 -105.06 0.19 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.107 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.461 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER 50.31 21.04 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.944 0.402 . . . . 0.0 111.533 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.64 ' HB2' HG23 ' A' ' 45' ' ' VAL . 1.4 p -76.04 110.18 10.33 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.218 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.66 ' HD2' HG21 ' A' ' 45' ' ' VAL . 65.0 Cg_endo -72.92 140.48 31.79 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.292 1.995 . . . . 0.0 112.052 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.627 ' HB3' HD13 ' A' ' 41' ' ' LEU . 72.0 Cg_exo -51.06 125.81 17.22 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.482 2.121 . . . . 0.0 112.221 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.986 HD22 HG22 ' A' ' 45' ' ' VAL . 1.3 pt? -131.06 104.16 6.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.929 0.395 . . . . 0.0 111.515 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.743 HD13 ' HB ' ' A' ' 39' ' ' ILE . 37.6 mt -59.63 153.69 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.659 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.423 ' N ' HG22 ' A' ' 57' ' ' ILE . 35.9 t -145.42 22.22 1.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' H ' HG22 ' A' ' 57' ' ' ILE . 75.7 t80 -177.42 146.33 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.256 0.55 . . . . 0.0 112.088 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.963 HD13 HG23 ' A' ' 39' ' ' ILE . 7.5 mm -115.21 162.71 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.084 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' N ' ' CG2' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -113.46 121.75 45.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.713 -179.9 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -58.77 105.81 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.868 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 4.0 m-20 89.17 51.07 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.475 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -130.12 145.88 59.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.795 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 34.5 Cg_exo -57.29 -17.0 24.48 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.219 1.946 . . . . 0.0 112.044 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.792 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -67.87 -57.22 6.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.782 0.325 . . . . 0.0 111.026 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' NH1' ' A' ' 68' ' ' ARG . 4.7 tp10 -78.62 -28.49 45.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 3.0 mmt-85 -87.66 -3.66 58.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.57 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.429 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.0 OUTLIER -58.69 -53.32 59.7 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.943 0.401 . . . . 0.0 110.504 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.16 -3.0 5.91 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.058 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 71' ' ' VAL . 43.8 t -155.03 61.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 117.001 0.401 . . . . 0.0 111.671 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.055 HD11 HD11 ' A' ' 29' ' ' LEU . 8.2 mt -143.06 154.15 43.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.01 0.433 . . . . 0.0 111.163 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -161.85 146.25 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.591 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.404 HG23 ' N ' ' A' ' 59' ' ' TYR . 23.2 mt -61.0 108.72 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.437 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.7 41.8 0.99 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.531 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -84.92 126.21 33.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.784 0.326 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -101.84 86.64 2.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.403 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 19.1 m -83.84 134.84 26.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.096 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.4 ptm -108.65 -26.7 10.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.07 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -128.19 138.95 52.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.815 HG23 ' CD1' ' A' ' 109' ' ' LEU . 12.8 mt -133.77 109.29 12.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.991 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 30.0 m120 59.53 24.05 12.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.979 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.49 -27.07 19.5 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.573 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.7 mt -73.06 136.88 79.23 Favored Pre-proline 0 N--CA 1.449 -0.499 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.22 -168.27 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.546 2.164 . . . . 0.0 112.3 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 81.7 p -157.0 -44.44 0.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -63.45 -17.15 62.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.444 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -116.65 41.99 2.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.036 0.446 . . . . 0.0 110.684 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m -166.7 -170.24 1.55 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.665 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.677 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -83.91 148.21 27.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -70.02 -36.03 74.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.859 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 1.1 tt0 -54.73 -34.63 62.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.034 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -52.18 65.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.204 0.526 . . . . 0.0 109.766 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.687 ' HA ' HD12 ' A' ' 97' ' ' LEU . . . -54.84 -31.88 59.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.189 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -69.12 -35.51 76.48 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.19 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 17.9 mm-40 -63.16 -41.15 99.21 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 110.215 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.687 HD12 ' HA ' ' A' ' 94' ' ' ALA . 8.8 mt -63.04 -50.34 71.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.114 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.836 HD13 HD21 ' A' ' 41' ' ' LEU . 1.5 mt -70.6 -54.1 13.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.8 ppt_? -50.76 -29.39 11.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.186 0.517 . . . . 0.0 109.646 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.3 OUTLIER -123.16 40.73 3.64 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.313 178.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.849 ' HB2' HG21 ' A' ' 107' ' ' VAL . 6.1 p -90.8 20.18 4.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.584 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -114.63 15.57 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.7 mt -75.57 -48.75 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 121.692 0.758 . . . . 0.0 110.817 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.81 -0.36 57.69 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.883 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.621 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 5.9 p 65.11 18.26 11.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.797 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.66 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.4 OUTLIER -166.21 157.12 13.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.272 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.849 HG21 ' HB2' ' A' ' 101' ' ' SER . 41.7 t -158.63 131.83 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.839 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -111.55 124.56 52.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.701 179.697 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.815 ' CD1' HG23 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -124.48 165.15 18.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.99 0.424 . . . . 0.0 111.374 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -126.23 107.17 10.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.18 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 23.7 pt -99.58 162.1 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.069 0.462 . . . . 0.0 111.841 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -131.08 115.17 16.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.375 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.56 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.6 OUTLIER -132.84 174.04 10.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.37 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.1 149.05 24.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.211 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 25.8 t -89.98 103.7 14.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.834 0.35 . . . . 0.0 111.462 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.62 ' HB2' HG11 ' A' ' 20' ' ' VAL . . . 161.33 -178.96 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.036 179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 118' ' ' SER . 6.8 pt-20 172.52 -36.53 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.15 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 117' ' ' GLU . 13.2 t 170.69 106.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.795 HG21 HG21 ' A' ' 170' ' ' THR . 12.0 p -144.38 143.96 22.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.045 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.756 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.2 pp -132.36 101.98 14.41 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.9 Cg_endo -83.97 156.01 13.29 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.84 2.36 . . . . 0.0 112.604 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 123' ' ' SER . 0.0 OUTLIER -162.73 18.42 0.08 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.669 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.8 OUTLIER 56.2 117.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.912 0.387 . . . . 0.0 111.173 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 96.46 -42.72 2.18 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.503 -0.856 . . . . 0.0 111.674 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.701 HG22 ' CD ' ' A' ' 207' ' ' LYS . 0.0 OUTLIER -135.78 102.66 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.947 0.404 . . . . 0.0 110.433 179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.696 ' CE1' HG22 ' A' ' 119' ' ' VAL . 0.4 OUTLIER -100.75 123.28 44.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.567 -179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.756 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.42 116.76 32.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.811 0.338 . . . . 0.0 111.079 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.463 HG11 HG21 ' A' ' 168' ' ' THR . 12.1 t -100.94 105.49 17.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.918 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.814 ' CD ' HD11 ' A' ' 203' ' ' LEU . 0.0 OUTLIER -81.25 113.12 19.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.931 -179.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 128' ' ' VAL . 1.7 mp -119.53 129.48 25.35 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.011 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.76 123.79 8.76 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.238 1.958 . . . . 0.0 111.314 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.819 ' HZ1' HD21 ' A' ' 138' ' ' LEU . 1.8 mmtp -89.64 159.89 16.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.225 0.536 . . . . 0.0 111.341 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.477 ' H ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -133.68 -167.14 1.89 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.259 -179.505 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -66.79 -69.47 0.3 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.117 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.18 93.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.919 0.39 . . . . 0.0 111.078 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.406 ' CG2' ' HG3' ' A' ' 133' ' ' LYS . 52.8 t -137.78 152.84 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.678 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.52 125.21 10.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.431 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.819 HD21 ' HZ1' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -78.18 -64.18 1.22 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.693 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.28 -13.45 55.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.483 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.814 HG13 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -99.3 143.34 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 117.205 0.502 . . . . 0.0 111.176 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 157' ' ' SER . 10.8 m -126.12 109.72 12.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.377 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.907 HD13 HG22 ' A' ' 194' ' ' VAL . 2.5 mt -74.65 164.1 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.077 0.465 . . . . 0.0 111.351 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.68 ' HB3' HG23 ' A' ' 155' ' ' VAL . 2.8 t -152.57 152.57 32.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.649 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.452 ' N ' ' HD2' ' A' ' 145' ' ' PRO . 0.1 OUTLIER -94.53 -49.45 0.26 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.359 -179.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.87 ' O ' HG21 ' A' ' 155' ' ' VAL . 90.5 Cg_endo -79.1 176.85 9.33 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.366 2.044 . . . . 0.0 113.094 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.571 ' HB2' HG11 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -178.18 -164.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.747 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.41 46.57 1.21 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.813 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -138.75 -171.9 3.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.888 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 162.43 26.7 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -46.78 136.69 16.58 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.676 2.251 . . . . 0.0 112.472 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 109.93 -23.3 21.78 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.413 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -49.6 133.91 19.24 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.497 0.189 . . . . 0.0 111.363 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.39 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.583 2.189 . . . . 0.0 112.445 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.752 HD11 ' HA ' ' A' ' 190' ' ' MET . 4.0 mm? -66.61 174.92 2.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.783 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.87 HG21 ' O ' ' A' ' 145' ' ' PRO . 28.3 m -157.31 162.95 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.399 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.596 HG21 ' O ' ' A' ' 172' ' ' GLU . 3.7 mm -78.11 154.73 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.518 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 141' ' ' THR . 0.2 OUTLIER -130.91 -33.09 1.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 111.578 -179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.805 ' O ' HD13 ' A' ' 159' ' ' ILE . 0.9 OUTLIER -175.1 164.75 3.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.186 0.517 . . . . 0.0 111.775 -179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.805 HD13 ' O ' ' A' ' 158' ' ' ASP . 3.4 mm -138.45 149.19 24.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.297 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -129.51 154.93 46.53 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.92 0.391 . . . . 0.0 111.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -91.05 163.93 14.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.438 ' O ' HG13 ' A' ' 71' ' ' VAL . . . 86.22 -13.84 56.04 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.884 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.549 ' O ' ' HG2' ' A' ' 167' ' ' ARG . 90.2 p -115.06 142.28 46.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.861 0.362 . . . . 0.0 111.02 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.416 ' HA ' ' CG ' ' A' ' 167' ' ' ARG . 12.6 m -48.12 -22.19 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.494 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.426 ' CB ' HG12 ' A' ' 140' ' ' ILE . . . -54.59 -52.65 61.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.959 0.409 . . . . 0.0 111.304 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.565 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -83.5 -26.53 30.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.011 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 163' ' ' SER . 13.6 mmp_? -55.94 -50.76 69.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.738 0.304 . . . . 0.0 110.882 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.463 HG21 HG11 ' A' ' 128' ' ' VAL . 13.3 t -58.62 -23.83 59.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.066 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 67.29 -152.7 52.8 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.131 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.795 HG21 HG21 ' A' ' 119' ' ' VAL . 2.6 p 56.16 23.21 6.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.73 151.72 40.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.892 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.596 ' O ' HG21 ' A' ' 156' ' ' ILE . 3.5 mt-10 -164.02 -171.68 2.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.76 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.37 122.07 46.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 119.34 -7.21 12.63 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.843 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.508 ' CG ' HG21 ' A' ' 208' ' ' ILE . 0.4 OUTLIER -73.25 170.14 15.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.747 0.274 . . . . 0.0 110.834 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.08 136.07 54.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 111.118 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.541 HD11 HD23 ' A' ' 206' ' ' LEU . 0.1 OUTLIER -98.5 135.5 39.95 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.791 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.432 HD12 ' HE ' ' A' ' 209' ' ' ARG . 7.8 tt -108.95 -53.24 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.146 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.75 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -141.08 171.9 13.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.315 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.662 HD11 ' HB1' ' A' ' 193' ' ' ALA . 34.1 mt -139.08 105.74 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.286 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 6.6 t70 61.59 -79.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.732 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.01 -25.02 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.482 HG22 ' N ' ' A' ' 184' ' ' ARG . 32.7 mm -91.4 158.22 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 111.0 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.75 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 72.8 mtt-85 -125.71 128.1 47.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.228 0.537 . . . . 0.0 112.234 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.599 HD11 ' N ' ' A' ' 193' ' ' ALA . 3.6 mm? -81.17 -3.95 53.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.892 178.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -45.8 -29.27 1.27 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.141 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -138.26 51.15 1.87 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 20.0 m -156.18 160.58 39.99 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.974 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 60.0 p -77.43 -170.8 1.89 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.031 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.752 ' HA ' HD11 ' A' ' 154' ' ' LEU . 14.0 ptm -74.05 -43.39 57.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.996 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 190' ' ' MET . 3.8 mt-10 -54.94 -30.36 58.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.054 0.454 . . . . 0.0 111.02 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.79 ' O ' HD12 ' A' ' 196' ' ' ILE . 3.4 m-20 -60.98 -51.85 67.5 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.058 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.662 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -57.12 -42.38 80.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.223 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.907 HG22 HD13 ' A' ' 142' ' ' ILE . 43.9 t -61.87 -35.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.818 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -62.92 -49.88 73.05 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.966 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.79 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.9 mp -72.71 -24.64 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.066 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.755 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -59.71 -43.27 94.18 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.87 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.754 HE22 HG12 ' A' ' 194' ' ' VAL . 1.1 mp0 -94.37 -39.87 10.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.534 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.68 -22.1 32.41 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.054 0.454 . . . . 0.0 110.435 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.546 ' SG ' HG22 ' A' ' 196' ' ' ILE . 17.2 m -85.89 44.62 1.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.853 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -68.11 63.05 0.09 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.486 0.66 . . . . 0.0 111.885 -179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.456 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 5.1 m-20 -170.36 -30.08 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.515 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.814 HD11 ' CD ' ' A' ' 129' ' ' LYS . 3.6 tt 174.77 109.29 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.229 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.699 HG23 ' HG3' ' A' ' 132' ' ' LYS . 6.2 t -102.79 120.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.328 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 16.8 ttmm -106.3 108.13 19.49 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.541 HD23 HD11 ' A' ' 177' ' ' LEU . 0.9 OUTLIER -83.37 114.96 21.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.183 -179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.701 ' CD ' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -95.72 93.03 6.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.816 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.508 HG21 ' CG ' ' A' ' 175' ' ' ASP . 9.9 mm -83.31 165.04 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.788 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -118.27 121.78 41.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.055 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -132.27 108.86 9.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.942 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.63 48.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.009 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 57.63 154.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.583 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.546 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.907 0.384 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 19' ' ' VAL . 10.6 p -144.89 116.97 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.885 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 115' ' ' VAL . 93.4 t -109.53 113.0 42.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.257 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -107.36 112.01 24.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.578 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -47.13 144.61 2.57 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.445 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.43 173.07 13.47 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.716 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 p -130.84 146.88 52.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.035 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.6 t -138.02 -171.28 2.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.812 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -111.45 161.65 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.192 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.482 HG21 HG23 ' A' ' 111' ' ' ILE . 2.2 t -139.37 150.23 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.654 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.97 109.78 22.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.892 0.377 . . . . 0.0 111.495 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 72' ' ' LEU . 3.1 mm? -107.1 118.66 37.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.307 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -106.14 163.29 12.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 0.0 111.431 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.688 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . . . -98.1 106.47 18.77 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.153 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.07 147.65 83.63 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.92 9.43 3.55 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.539 2.16 . . . . 0.0 112.838 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -126.01 -41.58 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.25 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 66.5 p -117.95 -29.91 5.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.837 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' PHE . . . 52.75 73.45 0.4 Allowed Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.353 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.688 ' CE2' ' HB2' ' A' ' 31' ' ' ALA . 54.9 m-85 73.46 89.67 0.09 Allowed 'General case' 0 N--CA 1.456 -0.175 0 CA-C-O 121.027 0.441 . . . . 0.0 110.261 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -85.07 26.95 5.2 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.302 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.949 HD11 ' HB1' ' A' ' 66' ' ' ALA . 9.4 mt -92.26 151.96 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.159 0.504 . . . . 0.0 111.271 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -136.04 101.39 4.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.133 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.969 HD13 HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -95.87 134.96 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.204 0.526 . . . . 0.0 111.755 -178.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -90.37 152.3 21.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.261 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' CA ' ' CE2' ' A' ' 91' ' ' PHE . . . -65.01 -82.0 0.11 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.515 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -108.08 157.97 17.8 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.405 -179.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.024 HG21 HD22 ' A' ' 56' ' ' LEU . 44.7 t -138.09 -63.47 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.964 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.807 ' O ' HG22 ' A' ' 48' ' ' THR . 18.0 p90 -29.21 -43.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.804 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.469 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 42.23 72.2 0.18 Allowed 'General case' 0 CA--C 1.523 -0.093 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.51 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.807 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 166.08 90.39 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.385 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 50' ' ' THR . 29.4 tp10 63.27 156.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.896 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.465 ' OG1' ' N ' ' A' ' 51' ' ' LEU . 3.6 t 47.31 -177.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.455 0.645 . . . . 0.0 111.779 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.607 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -161.87 22.31 0.11 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.202 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.61 21.71 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 51' ' ' LEU . 38.0 m -94.08 92.74 0.78 Allowed Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.642 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.58 171.98 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.55 2.167 . . . . 0.0 112.092 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.726 ' HB2' HD22 ' A' ' 41' ' ' LEU . 6.6 Cg_endo -48.72 128.72 19.1 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.641 2.228 . . . . 0.0 111.86 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.024 HD22 HG21 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -119.07 110.39 17.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.179 -179.327 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.574 HD13 HG23 ' A' ' 39' ' ' ILE . 15.0 mt -56.42 116.77 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 CA-C-O 121.009 0.433 . . . . 0.0 111.183 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -101.07 -6.84 23.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.052 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.404 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 60.4 t80 -178.16 131.95 0.14 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.636 HG22 ' H ' ' A' ' 61' ' ' GLU . 2.4 mt -108.29 176.31 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.636 ' H ' HG22 ' A' ' 60' ' ' ILE . 76.5 tt0 -109.56 154.84 22.17 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.524 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.431 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -85.47 50.15 1.9 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.36 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 16.1 t0 178.07 36.84 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.586 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.426 ' H ' ' NH1' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -133.61 132.12 21.62 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.75 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -10.57 12.57 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.537 2.158 . . . . 0.0 112.65 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.949 ' HB1' HD11 ' A' ' 39' ' ' ILE . . . -70.6 -52.89 18.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.05 0.453 . . . . 0.0 110.393 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' CB ' HG21 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -72.45 -29.18 63.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.205 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.437 ' CZ ' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -94.21 -2.28 52.74 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.701 -179.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.409 ' HG ' ' HB2' ' A' ' 72' ' ' LEU . 21.8 p -46.0 -31.52 2.3 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.74 0.305 . . . . 0.0 111.416 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.62 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 93.66 30.02 9.44 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.852 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 71' ' ' VAL . 14.3 p -179.6 39.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.938 0.399 . . . . 0.0 111.17 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.862 HD12 ' O ' ' A' ' 66' ' ' ALA . 7.8 mt -131.35 174.07 10.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.217 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -156.04 163.37 39.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.705 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.532 HD13 HG13 ' A' ' 60' ' ' ILE . 32.4 mm -68.65 70.03 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.301 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 125.39 79.65 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.756 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.759 ' OD2' HD22 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -114.45 111.83 22.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.947 0.403 . . . . 0.0 110.718 179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.31 135.21 53.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.097 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.663 HG13 ' HB3' ' A' ' 109' ' ' LEU . 20.3 t -104.46 120.61 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.127 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.0 tpt -87.59 -29.68 21.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -162.97 141.81 8.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.92 HG23 ' CD2' ' A' ' 109' ' ' LEU . 5.4 mt -113.52 109.42 28.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.628 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.532 HD22 HG22 ' A' ' 81' ' ' ILE . 12.9 p30 46.93 27.8 0.77 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.279 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 115.26 -30.86 6.5 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.734 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.6 mm -69.19 111.19 7.79 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-O 120.602 0.239 . . . . 0.0 111.512 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.73 148.62 59.18 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.432 2.088 . . . . 0.0 112.236 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.49 -24.6 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -73.79 -6.95 50.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.587 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -126.18 46.4 2.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.889 0.376 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.9 m 177.94 -179.15 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.863 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.4 m -79.46 158.65 27.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.822 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.446 ' CE2' ' CA ' ' A' ' 43' ' ' GLY . 12.0 p90 -73.08 -29.45 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 111.08 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 96' ' ' GLN . 7.3 mt-10 -54.56 -34.13 61.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.331 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.404 ' CG ' ' N ' ' A' ' 94' ' ' ALA . 14.6 pt-20 -61.47 -47.35 86.1 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.279 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.818 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -57.88 -38.45 75.78 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.375 0.607 . . . . 0.0 110.097 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.422 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 2.5 m120 -58.86 -42.87 90.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.377 179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 3.5 mm100 -63.0 -47.3 83.69 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.956 0.408 . . . . 0.0 110.722 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.821 HD12 HD12 ' A' ' 81' ' ' ILE . 39.3 mt -52.47 -39.72 61.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.056 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.969 HD13 HD13 ' A' ' 41' ' ' LEU . 1.2 mt -74.1 -42.56 59.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.738 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 11.0 mtm180 -50.55 -34.97 27.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.266 0.555 . . . . 0.0 109.669 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.0 OUTLIER -121.07 38.93 3.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.168 179.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.428 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -86.58 10.39 15.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.644 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 p -109.14 16.35 22.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.772 0.32 . . . . 0.0 111.757 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 7.9 mt -71.47 -49.99 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.817 0.818 . . . . 0.0 110.399 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.9 6.96 47.63 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.21 -1.359 . . . . 0.0 110.717 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 31.0 t 56.26 22.71 6.44 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.399 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.6 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.1 OUTLIER -163.76 156.76 18.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.551 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.472 HG12 HD21 ' A' ' 109' ' ' LEU . 33.3 t -156.91 125.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.831 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.38 131.85 51.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.479 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.92 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.6 OUTLIER -139.18 153.33 47.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.861 0.362 . . . . 0.0 111.411 -179.484 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -105.27 121.91 44.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.165 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.482 HG23 HG21 ' A' ' 27' ' ' VAL . 28.5 pt -112.5 145.49 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 0.0 111.848 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -111.36 140.29 46.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.116 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CE1' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -153.61 174.34 14.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.464 -179.336 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.621 ' HB3' HG11 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -100.89 116.19 32.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.353 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.813 ' O ' HG13 ' A' ' 20' ' ' VAL . 19.2 m -61.61 145.21 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.984 0.421 . . . . 0.0 111.431 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.658 ' HB3' HG22 ' A' ' 20' ' ' VAL . . . 79.57 119.68 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.456 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -153.42 19.62 0.55 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.325 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER 176.91 88.14 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.861 0.362 . . . . 0.0 111.338 -179.133 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.935 HG11 ' CG2' ' A' ' 170' ' ' THR . 0.0 OUTLIER -158.16 131.51 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.56 179.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.569 ' CG1' ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -113.53 94.41 31.99 Favored Pre-proline 0 CA--C 1.532 0.281 0 CA-C-O 121.005 0.431 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 92.8 Cg_endo -85.69 150.02 9.96 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.8 2.333 . . . . 0.0 112.769 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.27 23.51 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.212 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 58.31 116.98 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 110.906 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 95.57 -45.85 1.99 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.703 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.9 102.79 5.77 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 0.0 110.647 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CE1' HG12 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -110.06 115.21 29.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.031 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.569 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -96.66 150.14 21.0 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.93 0.395 . . . . 0.0 110.791 -179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.549 HG12 ' HG ' ' A' ' 130' ' ' LEU . 18.3 t -124.59 95.48 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.111 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 118' ' ' SER . 17.0 mttt -81.76 98.15 8.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.21 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.549 ' HG ' HG12 ' A' ' 128' ' ' VAL . 7.2 mt -108.12 130.65 22.51 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.69 119.3 6.13 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.511 2.141 . . . . 0.0 111.454 179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.828 ' HG3' HG23 ' A' ' 204' ' ' VAL . 0.1 OUTLIER -108.31 158.61 17.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.169 0.509 . . . . 0.0 111.536 -179.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -108.89 -164.84 0.97 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.323 179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -60.39 -47.45 86.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.864 0.364 . . . . 0.0 110.788 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.06 77.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.699 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.62 HG11 ' HA2' ' A' ' 70' ' ' GLY . 16.7 t -112.75 160.33 12.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.489 ' N ' HG12 ' A' ' 136' ' ' VAL . 29.6 tt0 -54.95 117.17 3.21 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.57 HD21 ' HD3' ' A' ' 132' ' ' LYS . 0.3 OUTLIER -98.31 -61.07 1.43 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.551 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . 94.43 30.29 8.75 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.153 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.403 HG23 ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -105.07 143.51 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.748 0.274 . . . . 0.0 110.866 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 157' ' ' SER . 86.6 m -126.09 136.76 53.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.796 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.959 HD13 HG22 ' A' ' 194' ' ' VAL . 2.3 mt -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.943 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.497 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.4 OUTLIER -161.65 153.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.765 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 37.2 t -105.12 136.96 19.11 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.889 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.82 130.57 12.57 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.431 2.087 . . . . 0.0 112.356 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.4 m -68.88 -29.84 68.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.931 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.7 94.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.59 92.24 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.33 158.31 74.72 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.09 94.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.525 2.15 . . . . 0.0 112.312 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 153.86 -61.69 0.38 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.561 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.406 ' N ' ' CD ' ' A' ' 153' ' ' PRO . 55.2 t0 59.6 53.71 4.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.793 0.33 . . . . 0.0 110.94 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 152' ' ' ASP . 61.4 Cg_endo -73.31 -179.26 4.24 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.361 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.818 HD12 ' CG2' ' A' ' 142' ' ' ILE . 4.4 mm? -100.52 167.4 10.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.695 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.869 HG23 ' O ' ' A' ' 175' ' ' ASP . 6.5 p -155.83 136.07 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.418 HD13 HD23 ' A' ' 171' ' ' LEU . 2.0 mt -65.44 151.52 9.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.663 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.401 ' HB3' ' CG2' ' A' ' 141' ' ' THR . 0.1 OUTLIER -124.85 -12.55 7.05 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.614 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.31 143.77 0.06 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.902 0.382 . . . . 0.0 111.204 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.43 HG21 ' CA ' ' A' ' 166' ' ' HIS . 0.6 OUTLIER -131.0 149.61 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.472 ' HB2' ' HA3' ' A' ' 139' ' ' GLY . 0.7 OUTLIER -98.36 146.96 25.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.828 0.347 . . . . 0.0 111.132 -179.443 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.79 173.16 10.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.995 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.68 -62.78 1.55 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.595 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 5.7 p -61.78 144.06 55.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.982 0.42 . . . . 0.0 111.129 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.0 m -48.78 -21.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.144 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 168' ' ' THR . . . -48.04 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.756 0.312 . . . . 0.0 111.437 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.43 ' CA ' HG21 ' A' ' 159' ' ' ILE . 36.3 t60 -76.15 -24.26 54.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.736 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.76 -45.72 74.27 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.696 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 165' ' ' ALA . 5.3 t -61.48 88.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.62 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.476 ' C ' HG22 ' A' ' 170' ' ' THR . . . -50.97 88.27 0.01 OUTLIER Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.742 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.935 ' CG2' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER 164.79 -28.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 110.328 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.861 HD11 HD12 ' A' ' 206' ' ' LEU . 3.2 tt -84.21 57.11 4.05 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.752 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -86.96 162.82 17.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.598 HD23 ' H ' ' A' ' 173' ' ' LEU . 0.8 OUTLIER -82.52 54.66 2.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.951 0.405 . . . . 0.0 111.133 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.28 25.72 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.497 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.869 ' O ' HG23 ' A' ' 155' ' ' VAL . 0.3 OUTLIER -124.78 -176.79 3.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.465 0.174 . . . . 0.0 110.558 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 209' ' ' ARG . 1.0 OUTLIER -134.6 130.14 36.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 0.0 111.368 -179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.912 HD13 HD11 ' A' ' 180' ' ' ILE . 0.8 OUTLIER -115.33 152.26 33.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.846 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 178' ' ' LEU . 4.0 pp -137.44 10.46 2.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.632 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.866 ' HB3' ' CB ' ' A' ' 207' ' ' LYS . . . -152.89 144.95 23.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.845 0.355 . . . . 0.0 111.311 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.912 HD11 HD13 ' A' ' 177' ' ' LEU . 31.3 mm -139.27 111.67 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.271 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.425 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 35.6 t70 51.59 52.64 14.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 31.1 t30 84.72 -34.68 0.06 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.501 HG22 ' N ' ' A' ' 184' ' ' ARG . 45.1 mm -68.64 159.66 5.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.752 0.31 . . . . 0.0 110.783 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 183' ' ' ILE . 67.3 mtm180 -133.86 129.76 36.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.192 0.52 . . . . 0.0 112.299 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.561 ' HG ' HD23 ' A' ' 154' ' ' LEU . 3.4 mm? -75.08 -5.27 43.28 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.623 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -45.93 -29.55 1.45 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.954 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.2 m -123.26 30.28 6.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.809 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.3 m -152.42 165.11 36.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.998 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.14 -169.89 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.066 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.667 ' CB ' HD11 ' A' ' 154' ' ' LEU . 12.9 ptm -70.34 -42.01 72.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.059 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.411 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.6 mt-10 -53.9 -34.93 60.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.052 0.453 . . . . 0.0 111.006 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.711 ' O ' HD12 ' A' ' 196' ' ' ILE . 35.8 t70 -61.07 -48.23 82.67 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.222 179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.449 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -58.51 -39.11 79.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.371 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.959 HG22 HD13 ' A' ' 142' ' ' ILE . 13.5 t -63.0 -33.37 60.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.097 0.475 . . . . 0.0 109.998 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -49.65 70.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.848 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 192' ' ' ASP . 1.8 mp -74.71 -24.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.167 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.771 HD22 HD11 ' A' ' 142' ' ' ILE . 0.0 OUTLIER -61.25 -40.67 94.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.038 0.447 . . . . 0.0 110.216 179.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.647 ' NE2' HG12 ' A' ' 194' ' ' VAL . 18.1 mt-30 -89.7 -41.26 12.02 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.112 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -61.58 -18.63 60.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.752 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.65 ' SG ' HG22 ' A' ' 196' ' ' ILE . 4.1 m -81.74 44.95 0.85 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.235 178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 1.1 pt-20 -74.53 61.72 0.96 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.187 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -178.8 -28.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.82 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 130' ' ' LEU . 12.4 tp -176.67 104.37 0.06 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.828 HG23 ' HG3' ' A' ' 132' ' ' LYS . 59.1 t -98.32 108.56 22.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.147 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 28.1 ttmt -100.21 108.19 20.22 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.861 HD12 HD11 ' A' ' 171' ' ' LEU . 43.1 mt -94.36 108.2 20.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.455 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.866 ' CB ' ' HB3' ' A' ' 179' ' ' ALA . 28.8 tttt -83.11 93.43 7.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.991 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.648 HD13 ' HB3' ' A' ' 177' ' ' LEU . 9.5 mm -88.99 164.13 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.352 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -126.54 127.8 45.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.838 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.02 123.14 39.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.111 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -178.59 91.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.97 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 46.1 -169.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.504 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.006 -179.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 2.4 tt0 . . . . . 0 N--CA 1.454 -0.262 0 CA-C-O 120.875 0.369 . . . . 0.0 110.379 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.742 ' O ' HG13 ' A' ' 20' ' ' VAL . 12.4 m -130.16 118.3 43.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.404 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.742 HG13 ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -179.78 173.44 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-O 120.86 0.362 . . . . 0.0 111.266 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.448 ' O ' HG22 ' A' ' 115' ' ' VAL . 12.7 t60 -115.79 111.02 19.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.996 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.9 p -55.44 139.53 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' HB2' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -134.89 173.18 11.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.6 OUTLIER -121.68 150.54 41.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.715 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 8.8 t -142.87 163.48 32.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -102.5 161.14 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.636 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -145.95 147.73 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG13 ' CD ' ' A' ' 106' ' ' LYS . 45.7 t -126.26 109.79 22.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.944 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.88 HD21 HD21 ' A' ' 72' ' ' LEU . 4.3 mm? -107.51 123.23 48.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.449 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -111.16 161.86 15.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.169 0.509 . . . . 0.0 111.821 -179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.839 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -104.42 116.13 31.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 0.2 OUTLIER -83.19 154.88 67.03 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.56 179.597 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.2 6.57 4.6 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.497 2.131 . . . . 0.0 112.643 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.39 -49.82 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.489 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 17.8 p -137.2 -2.73 2.02 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.23 -110.34 3.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.203 -0.998 . . . . 0.0 112.349 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.839 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 6.6 m-85 -106.05 129.24 54.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.906 0.384 . . . . 0.0 110.064 179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -92.47 24.93 20.59 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.884 -0.674 . . . . 0.0 114.473 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.833 ' CG2' HD13 ' A' ' 60' ' ' ILE . 1.1 pp -122.67 128.54 75.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.578 0.689 . . . . 0.0 111.503 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -111.26 127.4 55.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.235 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.785 HD22 ' HB2' ' A' ' 55' ' ' PRO . 0.3 OUTLIER -96.73 154.06 17.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.105 0.478 . . . . 0.0 111.715 -179.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -105.58 168.85 8.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.494 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' HA2' ' CE1' ' A' ' 91' ' ' PHE . . . -68.41 -117.68 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.801 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.494 ' CB ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -108.57 132.46 53.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.966 0.412 . . . . 0.0 111.3 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' O ' ' C ' ' A' ' 46' ' ' PHE . 2.8 t -89.79 -70.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.871 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.696 ' O ' HG22 ' A' ' 48' ' ' THR . 13.4 p90 -25.3 -48.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.854 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.437 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 40.75 72.28 0.16 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.562 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.7 t 174.12 40.38 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.871 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' CB ' ' O ' ' A' ' 48' ' ' THR . 2.7 mt-10 164.71 -169.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.522 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.747 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -48.86 -94.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.636 179.587 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 50' ' ' THR . 0.1 OUTLIER -152.98 -82.43 0.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.365 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.69 16.43 0.99 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.984 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.512 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -145.12 74.41 14.31 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.061 179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' A' ' 91' ' ' PHE . 49.6 Cg_exo -55.47 -175.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.497 2.131 . . . . 0.0 111.865 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.785 ' HB2' HD22 ' A' ' 41' ' ' LEU . 87.4 Cg_exo -46.8 125.23 9.47 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.47 2.113 . . . . 0.0 112.069 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 56' ' ' LEU . 1.9 mp -115.36 113.44 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.62 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.728 HD12 ' HB2' ' A' ' 76' ' ' ASP . 56.7 mt -58.17 121.92 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.449 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.431 ' HA ' HG23 ' A' ' 74' ' ' ILE . 7.2 t -124.81 25.88 7.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.198 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CE1' ' O ' ' A' ' 60' ' ' ILE . 25.8 t80 -173.52 138.9 0.71 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.053 0.454 . . . . 0.0 111.662 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.833 HD13 ' CG2' ' A' ' 39' ' ' ILE . 30.8 mm -112.21 160.3 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.538 178.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.487 ' N ' HG22 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -112.52 155.79 23.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.844 -179.622 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -100.29 55.75 0.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.016 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.5 OUTLIER 166.89 41.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.091 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.42 ' H ' ' NH1' ' A' ' 68' ' ' ARG . 2.9 m -141.2 144.34 34.2 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.8 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 32' ' ' ASP . 55.6 Cg_endo -69.8 -0.11 6.47 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.633 2.222 . . . . 0.0 112.819 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HA ' HD13 ' A' ' 29' ' ' LEU . . . -68.12 -56.92 7.08 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.341 0.591 . . . . 0.0 110.301 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 7.2 pm0 -80.12 -29.6 38.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.023 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.575 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -70.66 -27.31 63.93 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.018 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 53.6 t -49.46 -43.23 44.84 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.925 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.541 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 106.16 20.88 8.85 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.728 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 71' ' ' VAL . 13.5 t -153.66 41.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 0.0 110.907 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.88 HD21 HD21 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -124.44 157.26 35.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.05 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.02 158.2 19.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.456 HD13 HG12 ' A' ' 60' ' ' ILE . 19.8 mm -66.98 75.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.304 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 57' ' ' ILE . . . 148.83 69.66 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.863 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.728 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -106.02 78.48 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.852 0.358 . . . . 0.0 110.528 179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -55.21 -40.89 71.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.952 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.775 HG13 ' HB3' ' A' ' 109' ' ' LEU . 46.6 t 65.08 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.263 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.4 -27.98 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.757 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -155.78 137.33 14.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.883 HD12 HD12 ' A' ' 97' ' ' LEU . 8.1 mt -114.23 106.96 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.972 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.79 ' OD1' HG22 ' A' ' 81' ' ' ILE . 6.6 m120 58.79 20.77 8.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.169 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 117.46 -34.27 4.61 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.571 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 52.0 mt -67.73 127.42 93.37 Favored Pre-proline 0 N--CA 1.45 -0.466 0 CA-C-O 120.497 0.189 . . . . 0.0 110.995 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.36 -179.28 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.456 2.104 . . . . 0.0 112.343 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.8 p -147.45 -45.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.095 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.91 -13.11 61.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -118.93 46.55 1.84 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.738 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.4 p -171.92 -177.5 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.879 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.649 ' HA ' HD13 ' A' ' 51' ' ' LEU . 54.1 m -81.21 141.5 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.794 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 54' ' ' PRO . 6.6 p90 -61.74 -37.25 83.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.538 ' H ' HG22 ' A' ' 90' ' ' THR . 1.8 tt0 -55.23 -36.02 65.56 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.264 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 90' ' ' THR . 0.6 OUTLIER -61.51 -52.34 64.89 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.679 ' HB3' ' CD ' ' A' ' 55' ' ' PRO . . . -54.85 -33.58 61.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.412 0.625 . . . . 0.0 110.217 179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.458 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 1.1 m120 -63.74 -40.3 96.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.978 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 18.0 mm-40 -61.59 -44.17 97.5 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.229 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.883 HD12 HD12 ' A' ' 81' ' ' ILE . 44.0 mt -56.29 -43.66 79.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.415 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.751 HD22 HD11 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -70.41 -51.2 31.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.812 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -50.28 -30.53 12.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.138 0.494 . . . . 0.0 109.801 179.238 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.469 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 1.7 t0 -121.71 38.22 4.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.362 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.604 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.75 25.54 6.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.323 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.3 p -119.16 13.09 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.469 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 2.9 mt -68.12 -46.4 81.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 110.565 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.84 -1.55 54.71 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.573 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.797 ' O ' HG22 ' A' ' 30' ' ' THR . 0.8 OUTLIER 62.86 26.56 15.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.0 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.4 OUTLIER -169.35 153.82 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.963 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.549 HG21 ' HB3' ' A' ' 101' ' ' SER . 60.1 t -153.59 150.9 12.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.742 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.04 135.12 52.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.337 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.775 ' HB3' HG13 ' A' ' 78' ' ' VAL . 3.2 mt -136.81 149.21 47.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.0 0.429 . . . . 0.0 111.628 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -116.72 105.9 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.981 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.462 HG13 HG22 ' A' ' 25' ' ' THR . 30.2 pt -103.47 154.52 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.15 0.5 . . . . 0.0 112.165 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' HG3' HG23 ' A' ' 24' ' ' THR . 32.5 tt0 -126.38 138.42 53.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.208 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.99 173.58 16.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.959 0.409 . . . . 0.0 111.327 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.34 106.14 17.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.252 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.6 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 18.5 m -61.92 103.84 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.823 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.608 ' CB ' HG11 ' A' ' 20' ' ' VAL . . . 153.0 129.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.022 178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -161.96 22.54 0.11 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.253 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER 169.48 93.75 0.0 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.033 -179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.597 HG13 ' CE1' ' A' ' 126' ' ' PHE . 23.2 t -139.6 118.8 12.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.869 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 127' ' ' HIS . 1.1 pp -137.26 78.19 40.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-O 121.692 0.758 . . . . 0.0 110.691 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 119' ' ' VAL . 70.7 Cg_endo -94.65 176.74 1.02 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.229 2.619 . . . . 0.0 112.878 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 3.4 m -172.96 33.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.895 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 59.73 117.17 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.76 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 89.25 -44.4 3.09 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.032 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.842 HG22 ' HD3' ' A' ' 207' ' ' LYS . 0.3 OUTLIER -122.7 103.94 8.99 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.877 0.37 . . . . 0.0 110.752 179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.597 ' CE1' HG13 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -110.62 124.46 51.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.504 -179.705 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.587 ' HB2' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -118.08 144.6 45.49 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.687 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.543 HG12 HD12 ' A' ' 130' ' ' LEU . 2.9 t -130.27 111.1 20.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.506 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.416 ' O ' ' CB ' ' A' ' 118' ' ' SER . 11.1 mttp -80.72 101.31 9.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.885 HD11 ' CG2' ' A' ' 168' ' ' THR . 1.9 mp -107.32 113.71 61.75 Favored Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.515 -179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.6 115.53 3.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.297 1.998 . . . . 0.0 111.352 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.55 ' HG2' HD11 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -100.37 158.75 15.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.079 0.466 . . . . 0.0 111.387 -179.414 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.673 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -116.73 -164.62 0.99 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.776 -179.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -57.65 -48.39 79.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.18 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -170.71 50.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.868 0.366 . . . . 0.0 111.277 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.673 HG23 ' HB2' ' A' ' 133' ' ' LYS . 46.1 t -89.63 144.13 9.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.414 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 40.6 tt0 -52.42 124.72 14.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' A' ' 165' ' ' ALA . 1.5 mp -90.57 -66.88 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 113.69 -2.22 24.66 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.05 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.559 HG23 HD21 ' A' ' 171' ' ' LEU . 0.2 OUTLIER -95.78 135.58 29.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.793 0.33 . . . . 0.0 111.342 -179.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.689 HG22 ' HB3' ' A' ' 157' ' ' SER . 11.0 m -126.1 136.04 52.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.504 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.872 HD11 ' HG ' ' A' ' 197' ' ' LEU . 5.3 mt -105.35 164.12 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.992 0.425 . . . . 0.0 111.493 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.543 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -154.63 151.61 29.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.691 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.6 p -118.78 107.47 42.38 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.05 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.97 -159.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.474 2.116 . . . . 0.0 112.106 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 53.1 p -59.23 98.66 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.3 87.15 1.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.064 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mtt180 -151.1 42.8 0.77 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.851 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.39 161.16 45.69 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.751 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.02 -24.66 20.11 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.445 2.097 . . . . 0.0 112.241 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -163.44 59.09 0.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.461 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -49.21 105.72 0.54 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 120.571 0.224 . . . . 0.0 111.179 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.04 -178.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.435 2.09 . . . . 0.0 112.359 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.552 HD11 ' HG ' ' A' ' 185' ' ' LEU . 2.8 mt -113.78 178.9 4.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.493 HG23 ' OG ' ' A' ' 143' ' ' SER . 24.2 m -157.27 175.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.234 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.42 ' HB ' HD23 ' A' ' 173' ' ' LEU . 4.2 mm -79.25 154.23 4.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.917 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.689 ' HB3' HG22 ' A' ' 141' ' ' THR . 10.7 t -130.8 -10.22 3.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.651 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.449 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.2 OUTLIER 170.62 156.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.937 0.398 . . . . 0.0 110.801 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.805 HG22 ' HB2' ' A' ' 166' ' ' HIS . 4.2 mt -142.49 139.34 29.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.765 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.409 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -114.26 145.47 41.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 0.0 110.933 -179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.9 mttp -85.78 168.61 14.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.582 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.425 ' N ' ' NH1' ' A' ' 167' ' ' ARG . . . 84.95 -52.73 4.74 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.416 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.504 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 34.2 m -81.14 153.69 27.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.96 0.41 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.854 HG23 HD23 ' A' ' 130' ' ' LEU . 18.3 m -48.72 -21.8 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 138' ' ' LEU . . . -46.88 -66.52 0.39 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.886 0.374 . . . . 0.0 111.655 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.805 ' HB2' HG22 ' A' ' 159' ' ' ILE . 0.8 OUTLIER -83.36 -24.24 32.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.388 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.504 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.4 -29.84 50.17 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.4 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.885 ' CG2' HD11 ' A' ' 130' ' ' LEU . 22.3 p -45.25 -42.2 9.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.788 0.328 . . . . 0.0 111.393 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.83 -26.48 18.33 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.769 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.459 HG21 ' CE1' ' A' ' 126' ' ' PHE . 3.7 t -109.6 31.84 5.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.803 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 140' ' ' ILE . 0.1 OUTLIER -117.17 113.62 22.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -142.13 156.81 45.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.42 HD23 ' HB ' ' A' ' 156' ' ' ILE . 14.9 mt -75.4 113.7 13.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.975 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 140.23 -17.2 2.93 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.779 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.631 ' HB3' HG21 ' A' ' 208' ' ' ILE . 5.4 m-20 -70.34 166.04 21.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.73 0.3 . . . . 0.0 110.794 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.28 114.25 24.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.019 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.675 HD12 HD12 ' A' ' 208' ' ' ILE . 0.3 OUTLIER -70.72 142.55 51.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.691 179.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.571 ' C ' HD23 ' A' ' 178' ' ' LEU . 7.5 tt -122.27 -55.22 1.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.551 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -143.49 176.07 9.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.081 0.467 . . . . 0.0 111.592 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.865 HD11 ' HB1' ' A' ' 193' ' ' ALA . 25.3 mt -139.26 107.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.93 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.815 ' OD2' HG22 ' A' ' 180' ' ' ILE . 0.1 OUTLIER 48.38 -85.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.417 ' N ' ' O ' ' A' ' 180' ' ' ILE . 3.6 m-20 -108.07 -20.33 13.2 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.552 HG21 ' CD1' ' A' ' 196' ' ' ILE . 24.9 mm -100.08 140.95 18.01 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 111.512 -179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.551 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 0.9 OUTLIER -112.86 120.66 42.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.06 -179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.901 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 2.9 mm? -82.81 -5.21 58.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.375 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.67 -32.07 1.37 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.367 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.62 -16.78 9.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.579 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 8.6 m -85.24 -169.78 2.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.895 0.378 . . . . 0.0 111.22 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.33 -173.36 2.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.87 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.414 ' CB ' HD22 ' A' ' 154' ' ' LEU . 1.0 OUTLIER -74.05 -52.01 14.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.01 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -51.8 -30.71 24.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.47 . . . . 0.0 111.102 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.462 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.4 OUTLIER -62.19 -51.53 67.44 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.058 179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.901 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -56.21 -39.41 72.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.239 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.708 HG12 ' NE2' ' A' ' 198' ' ' GLN . 19.1 t -61.01 -36.81 74.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.212 0.529 . . . . 0.0 109.902 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.6 -49.86 76.13 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.843 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.552 ' CD1' HG21 ' A' ' 183' ' ' ILE . 1.5 mp -75.51 -24.13 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.027 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.872 ' HG ' HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -59.46 -36.17 75.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.654 179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.708 ' NE2' HG12 ' A' ' 194' ' ' VAL . 5.1 mt-30 -100.11 -37.65 8.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.65 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.52 -19.57 49.17 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.931 ' CB ' HG13 ' A' ' 204' ' ' VAL . 1.1 m -84.4 43.11 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.41 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -68.56 62.87 0.1 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.283 0.563 . . . . 0.0 111.076 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 200' ' ' CYS . 1.8 m-20 -174.98 -32.04 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.056 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.4 tt 178.06 108.91 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.272 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.931 HG13 ' CB ' ' A' ' 200' ' ' CYS . 0.0 OUTLIER -108.06 115.24 48.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.215 -179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HB3' ' CA ' ' A' ' 181' ' ' ASP . 0.3 OUTLIER -96.32 107.9 20.33 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 208' ' ' ILE . 11.1 mp -81.91 113.58 19.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.074 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.842 ' HD3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -99.75 94.39 6.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.788 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.675 HD12 HD12 ' A' ' 177' ' ' LEU . 1.1 mm -94.16 170.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.989 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -112.82 131.6 55.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.919 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 115.37 29.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 178.95 82.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.796 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.58 152.12 7.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.387 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.19 -179.946 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.2 p -114.39 132.53 63.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.912 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 115' ' ' VAL . 69.0 t -139.55 150.31 22.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 111.139 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 t60 -136.3 108.48 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.658 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.7 p -49.28 143.16 6.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.329 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 173.03 12.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -133.06 159.12 40.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.919 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.556 HG21 ' HA2' ' A' ' 162' ' ' GLY . 14.1 t -150.54 -169.96 3.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.01 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -121.65 161.0 23.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.102 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.428 HG13 ' HG ' ' A' ' 109' ' ' LEU . 1.7 p -136.65 151.95 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.392 0.615 . . . . 0.0 110.924 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 45.6 t -123.9 109.79 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.488 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.095 HD21 HD11 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -104.36 118.34 36.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.0 179.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.625 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -113.51 161.74 17.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.34 0.59 . . . . 0.0 112.195 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.891 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -107.0 109.75 21.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.027 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.457 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 8.4 p-10 -83.68 157.23 64.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.412 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.08 7.92 2.29 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.459 2.106 . . . . 0.0 112.98 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 36.7 t -109.64 -47.29 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.634 0.255 . . . . 0.0 111.247 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.3 p -144.58 6.53 1.25 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 61.71 -86.62 0.04 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.219 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.891 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 7.9 m-85 -128.06 113.98 16.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -91.51 19.51 47.1 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.523 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.095 HD13 HD13 ' A' ' 72' ' ' LEU . 16.2 pt -123.89 134.47 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 CA-C-N 116.905 0.353 . . . . 0.0 110.69 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' CG ' ' HB3' ' A' ' 59' ' ' TYR . 3.2 pt20 -120.74 142.76 49.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.81 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.891 HD11 ' CD1' ' A' ' 98' ' ' LEU . 1.4 pt? -129.41 154.65 46.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.276 0.56 . . . . 0.0 111.921 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.54 170.19 8.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.339 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.405 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -104.23 -58.13 0.7 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.289 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.6 m -69.53 150.39 47.19 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.851 0.358 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.687 HG22 ' CD1' ' A' ' 56' ' ' LEU . 86.4 t -142.02 -88.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.955 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.563 ' CE1' HG23 ' A' ' 50' ' ' THR . 52.9 p90 -56.78 -46.17 81.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.22 0.533 . . . . 0.0 110.723 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.562 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 47.35 82.67 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.702 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 60.3 p -159.95 98.18 1.32 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.134 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' C ' HG22 ' A' ' 50' ' ' THR . 4.7 pt-20 52.37 35.36 17.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.414 0.626 . . . . 0.0 110.525 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.563 HG23 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 165.78 175.53 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.773 179.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -160.67 23.78 0.15 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.789 0.328 . . . . 0.0 111.657 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.12 21.84 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -72.28 138.18 81.4 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.795 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.16 156.91 33.79 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.457 2.105 . . . . 0.0 112.39 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.667 ' CB ' HD12 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -42.71 159.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.003 2.469 . . . . 0.0 112.242 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.687 ' CD1' HG22 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -160.62 108.88 1.61 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.548 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.79 ' CD1' HD12 ' A' ' 39' ' ' ILE . 61.5 mt -59.88 135.78 24.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.809 0.338 . . . . 0.0 110.875 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.9 m -125.25 17.24 8.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' HB3' ' CG ' ' A' ' 40' ' ' GLN . 37.6 t80 -177.68 141.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.076 0.465 . . . . 0.0 111.129 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.834 HG21 ' HB2' ' A' ' 67' ' ' GLU . 12.1 mm -131.01 148.43 33.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.077 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 62' ' ' ALA . 39.0 tt0 -95.55 151.84 18.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.943 0.401 . . . . 0.0 111.232 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -92.39 45.34 1.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.052 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 174.39 42.05 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.501 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -134.24 135.25 23.76 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.779 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.402 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 11.8 Cg_endo -54.81 -11.46 3.51 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.787 2.325 . . . . 0.0 113.147 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 29' ' ' LEU . . . -66.23 -57.54 7.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.815 0.34 . . . . 0.0 110.542 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.834 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.41 -31.83 42.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.977 178.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.501 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -61.32 -30.93 70.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.673 -179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.2 m -56.63 -31.29 64.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.776 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.818 ' HA3' HG11 ' A' ' 136' ' ' VAL . . . 86.36 34.19 12.67 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.676 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 71' ' ' VAL . 13.1 t -151.41 28.76 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.652 0.263 . . . . 0.0 111.411 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.095 HD11 HD21 ' A' ' 29' ' ' LEU . 16.8 mt -140.42 148.89 41.88 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.886 0.374 . . . . 0.0 111.073 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.08 175.92 12.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.755 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.666 HD13 HG12 ' A' ' 60' ' ' ILE . 21.1 mm -69.26 68.63 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.18 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.39 59.16 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.678 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.525 ' OD2' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -88.76 120.88 30.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.883 0.373 . . . . 0.0 110.75 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.474 ' O ' HG22 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -90.72 104.55 17.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.077 -179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.685 ' HA ' HG22 ' A' ' 111' ' ' ILE . 17.2 t -94.08 158.65 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.051 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.451 ' N ' HG12 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -122.74 -40.45 2.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.942 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -143.46 149.14 37.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.159 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.766 HG23 ' CD2' ' A' ' 109' ' ' LEU . 17.6 mt -132.71 120.02 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.68 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.0 m120 54.53 24.23 5.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.913 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 99.97 -18.48 55.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.636 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.14 137.02 56.86 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-O 120.675 0.274 . . . . 0.0 111.262 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.42 -178.7 3.84 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.369 2.046 . . . . 0.0 112.254 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 72.6 p -157.26 -44.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.962 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -70.05 -11.15 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.391 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -117.09 46.17 1.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.917 0.389 . . . . 0.0 110.763 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.1 t -176.9 -176.21 0.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.38 151.24 45.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.405 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 16.4 p90 -70.17 -30.94 68.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.802 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -55.83 -31.56 62.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' H ' ' HG2' ' A' ' 93' ' ' GLU . 5.6 mm-40 -61.69 -58.62 7.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 97' ' ' LEU . . . -54.82 -28.68 51.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.806 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -77.22 -43.11 34.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.129 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.488 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -70.61 -36.13 73.34 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.807 0.336 . . . . 0.0 111.198 -179.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.66 HD11 HD13 ' A' ' 81' ' ' ILE . 1.1 pp -70.09 -46.1 65.59 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.326 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.891 ' CD1' HD11 ' A' ' 41' ' ' LEU . 69.8 mt -64.29 -57.39 9.56 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.264 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -50.75 -29.68 12.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.625 ' O ' HD11 ' A' ' 103' ' ' ILE . 5.8 t70 -114.37 35.5 4.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.909 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.538 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 84.4 p -108.78 15.21 23.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.134 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.8 p -100.64 15.08 29.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 111.855 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.625 HD11 ' O ' ' A' ' 100' ' ' ASP . 1.7 mt -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.54 5.77 44.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.656 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.625 ' O ' HG22 ' A' ' 30' ' ' THR . 13.1 p 59.2 26.76 15.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.009 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.53 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -171.12 148.85 2.78 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.907 -179.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.53 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.5 t -149.68 131.35 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.861 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.31 130.59 55.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.697 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.766 ' CD2' HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -140.32 164.96 28.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.971 0.415 . . . . 0.0 111.342 -179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -114.43 145.55 41.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.402 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 78' ' ' VAL . 40.6 pt -137.46 159.94 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.959 0.409 . . . . 0.0 111.78 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -123.69 146.42 48.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.318 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.452 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -161.05 174.28 13.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.92 0.391 . . . . 0.0 111.425 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.13 131.23 44.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.328 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 20' ' ' VAL . 27.2 m -85.53 145.65 7.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.997 0.427 . . . . 0.0 111.728 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 115' ' ' VAL . . . 82.88 113.59 0.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.774 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -153.79 24.32 0.51 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.872 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 178.35 85.43 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.649 -179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.678 HG13 ' HE1' ' A' ' 126' ' ' PHE . 34.7 t -142.27 131.63 22.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.028 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.66 HG13 ' HB2' ' A' ' 127' ' ' HIS . 1.5 pp -134.23 86.03 37.35 Favored Pre-proline 0 N--CA 1.454 -0.257 0 CA-C-O 121.646 0.736 . . . . 0.0 109.894 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.518 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 60.6 Cg_endo -95.81 175.19 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.268 2.645 . . . . 0.0 113.424 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 22.2 t -163.25 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.463 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 169.78 113.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.033 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.2 -30.75 6.48 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.354 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.547 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.1 OUTLIER -134.5 102.67 5.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.999 0.428 . . . . 0.0 110.612 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.678 ' HE1' HG13 ' A' ' 119' ' ' VAL . 1.9 t80 -104.45 127.56 52.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.195 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.66 ' HB2' HG13 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -118.44 141.06 48.93 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.624 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.778 HG21 HD12 ' A' ' 206' ' ' LEU . 4.8 m -129.38 104.37 10.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 178.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -80.56 104.48 11.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.767 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.926 HD11 HG22 ' A' ' 168' ' ' THR . 4.3 mp -113.84 139.08 23.08 Favored Pre-proline 0 C--N 1.333 -0.126 0 CA-C-O 120.588 0.233 . . . . 0.0 111.488 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.11 108.91 1.61 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.446 2.097 . . . . 0.0 111.798 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.471 ' HB2' ' N ' ' A' ' 203' ' ' LEU . 0.5 OUTLIER -81.97 158.64 23.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.407 ' HE2' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -127.2 -166.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.265 -179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.8 -76.2 0.08 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.215 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.9 m -152.99 74.11 1.03 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.888 0.375 . . . . 0.0 111.198 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.818 HG11 ' HA3' ' A' ' 70' ' ' GLY . 40.8 t -127.84 151.28 34.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.796 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -53.04 96.13 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.045 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.665 HD22 HG12 ' A' ' 140' ' ' ILE . 1.1 tt -55.07 -38.31 67.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.123 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 118.19 -44.38 1.43 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.434 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.032 HG23 ' HB1' ' A' ' 165' ' ' ALA . 5.1 pt -81.84 146.41 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.857 0.361 . . . . 0.0 111.322 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.3 m -126.18 118.95 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.738 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.008 HD13 HG22 ' A' ' 194' ' ' VAL . 1.4 mp -80.58 164.06 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.17 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 142' ' ' ILE . 10.8 t -167.68 166.94 13.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 t -116.77 137.11 23.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -55.56 -39.5 90.7 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.421 2.08 . . . . 0.0 112.128 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.0 t -169.24 -166.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.824 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.1 m -134.05 40.23 3.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.95 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.65 74.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.024 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.79 153.03 13.75 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.898 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.15 -25.93 50.29 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.689 2.259 . . . . 0.0 112.58 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.52 -67.88 1.47 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.595 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.438 ' N ' ' HD3' ' A' ' 153' ' ' PRO . 21.5 t70 55.59 50.7 5.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.731 0.301 . . . . 0.0 111.249 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 152' ' ' ASP . 86.1 Cg_endo -80.24 -175.16 2.56 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.563 2.175 . . . . 0.0 112.422 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.897 HD12 ' CG2' ' A' ' 142' ' ' ILE . 1.8 mm? -104.83 145.61 30.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.545 179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 175' ' ' ASP . 16.8 m -142.19 178.92 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.966 0.412 . . . . 0.0 111.329 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.651 HG21 HD23 ' A' ' 173' ' ' LEU . 1.3 mm -93.23 154.83 3.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.817 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.58 -26.82 2.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.76 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -176.49 162.11 2.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.199 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.968 HD13 HD23 ' A' ' 171' ' ' LEU . 1.6 mt -140.53 149.08 21.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.756 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.0 146.23 45.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.884 0.373 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 7.8 ttmt -83.35 164.93 19.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.694 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.556 ' HA2' HG21 ' A' ' 25' ' ' THR . . . 84.33 -19.21 19.58 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.065 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.477 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 2.2 m -107.05 146.53 31.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.964 0.411 . . . . 0.0 110.997 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.798 HG23 HD23 ' A' ' 130' ' ' LEU . 34.8 m -48.85 -22.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.935 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 1.032 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -52.91 -71.17 0.07 Allowed 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.955 0.407 . . . . 0.0 110.979 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.679 ' HB2' HG22 ' A' ' 159' ' ' ILE . 29.0 t60 -71.29 -24.8 62.21 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.14 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.477 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -56.88 -30.99 64.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.995 179.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.926 HG22 HD11 ' A' ' 130' ' ' LEU . 72.5 p -45.1 -42.71 9.03 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.253 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.71 -43.61 2.74 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.581 HG21 HG11 ' A' ' 119' ' ' VAL . 5.6 t -96.9 34.6 1.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.859 0.361 . . . . 0.0 110.905 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.968 HD23 HD13 ' A' ' 159' ' ' ILE . 2.9 tt -117.34 99.91 7.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.836 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -109.36 -179.98 3.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.651 HD23 HG21 ' A' ' 156' ' ' ILE . 4.0 mt -107.84 148.66 29.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.806 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.53 -11.17 39.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.814 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.622 ' O ' HG12 ' A' ' 155' ' ' VAL . 3.1 t0 -78.48 175.68 10.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.641 0.258 . . . . 0.0 110.717 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.448 ' HD3' HG12 ' A' ' 155' ' ' VAL . 41.5 mmtm -117.25 151.53 36.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.786 0.326 . . . . 0.0 111.132 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.634 HD23 ' H ' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -101.71 170.8 7.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.063 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.634 ' H ' HD23 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -148.07 -44.89 0.16 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.008 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.885 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -150.2 169.33 21.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.304 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.752 HD11 ' HB1' ' A' ' 193' ' ' ALA . 16.3 mt -139.62 114.38 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.424 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.496 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 18.3 t0 59.28 -83.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.375 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -128.69 -14.95 4.51 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.775 ' HB ' HG21 ' A' ' 196' ' ' ILE . 20.2 mm -102.32 133.58 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.312 0.577 . . . . 0.0 111.499 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 9.6 mtm105 -100.13 114.47 27.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.597 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.759 HD21 HD13 ' A' ' 196' ' ' ILE . 2.9 mm? -72.32 -17.07 61.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.411 179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.56 -81.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.921 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.473 ' N ' ' O ' ' A' ' 185' ' ' LEU . 8.2 m -153.28 24.44 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.837 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -171.05 0.65 Allowed 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.071 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.59 166.7 14.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.709 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.845 ' HA ' HD11 ' A' ' 154' ' ' LEU . 14.8 ptm -74.23 -42.64 59.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.162 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.429 ' N ' ' HG3' ' A' ' 190' ' ' MET . 6.0 mt-10 -53.7 -31.89 49.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.463 . . . . 0.0 111.011 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.825 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.5 OUTLIER -62.68 -48.13 80.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.195 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.752 ' HB1' HD11 ' A' ' 180' ' ' ILE . . . -59.02 -39.73 82.81 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.476 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 1.008 HG22 HD13 ' A' ' 142' ' ' ILE . 8.6 t -63.79 -34.42 67.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.285 0.564 . . . . 0.0 109.749 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 199' ' ' GLN . 0.9 OUTLIER -61.44 -50.29 73.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.966 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.825 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.6 mp -70.08 -24.78 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.172 0.51 . . . . 0.0 109.764 178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.707 HD12 HD13 ' A' ' 180' ' ' ILE . 0.0 OUTLIER -64.23 -33.92 76.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.721 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.408 ' HA ' ' NZ ' ' A' ' 132' ' ' LYS . 11.4 mt-30 -87.75 -39.78 14.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.23 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.727 ' OE1' HG23 ' A' ' 196' ' ' ILE . 0.0 OUTLIER -86.48 13.26 8.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.833 179.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.627 ' SG ' HG22 ' A' ' 180' ' ' ILE . 0.5 OUTLIER -64.29 33.73 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.277 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 199' ' ' GLN . 5.7 pt-20 32.53 68.17 0.15 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 44.78 24.54 0.11 Allowed 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.471 ' N ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 mt -153.96 93.66 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.135 0.493 . . . . 0.0 110.681 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.631 ' O ' HG13 ' A' ' 204' ' ' VAL . 13.8 p -97.11 108.61 21.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.714 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 24.1 ttmt -104.54 107.06 17.8 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.778 HD12 HG21 ' A' ' 128' ' ' VAL . 3.4 mt -83.4 114.16 21.25 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.227 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.628 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 12.0 tttt -97.16 93.26 6.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.356 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.58 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.7 OUTLIER -84.95 168.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.826 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 10.2 ttp180 -118.98 123.42 44.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.238 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.34 159.49 15.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.554 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -164.65 46.98 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.977 0.417 . . . . 0.0 111.143 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.49 -172.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.936 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.1 t0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.81 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.8 0.333 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.8 p -125.76 128.63 72.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 115' ' ' VAL . 10.2 p -137.79 143.38 33.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.171 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.413 ' CD2' ' O ' ' A' ' 21' ' ' HIS . 51.6 p-80 -106.04 110.77 23.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.88 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 114' ' ' ASP . 1.3 t -55.94 152.17 10.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.216 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.66 170.44 12.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.764 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.801 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.0 OUTLIER -129.68 137.13 50.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -139.3 176.88 8.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.759 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -106.76 162.93 13.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 t -134.33 150.41 30.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.634 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.9 t -121.53 109.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.032 0.444 . . . . 0.0 111.411 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.454 HD11 HD11 ' A' ' 72' ' ' LEU . 3.9 mm? -106.63 121.72 44.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.798 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -110.67 162.18 15.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.422 0.63 . . . . 0.0 112.406 -178.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.754 ' HB3' ' HA ' ' A' ' 105' ' ' SER . . . -109.34 103.73 12.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.168 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.4 148.32 55.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.41 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.88 1.96 7.1 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.596 2.198 . . . . 0.0 112.674 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 t -112.55 -48.45 5.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.371 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 t -125.51 -11.24 6.82 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 73.02 -87.88 0.57 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.406 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.678 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 27.7 m-85 -130.94 117.94 19.95 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.009 0.433 . . . . 0.0 110.285 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.509 ' HA3' ' CB ' ' A' ' 64' ' ' SER . . . -70.34 -3.69 47.78 Favored Glycine 0 C--N 1.332 0.317 0 N-CA-C 114.67 0.628 . . . . 0.0 114.67 -178.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.991 HG21 HD13 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -105.61 167.6 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 117.958 0.879 . . . . 0.0 112.189 -179.407 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 4.8 mt-30 -138.61 122.28 17.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.097 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.754 HD13 ' CD2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -96.34 143.3 27.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.1 0.476 . . . . 0.0 112.061 -178.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.568 ' CG ' HD13 ' A' ' 56' ' ' LEU . 6.0 pt20 -105.19 166.09 10.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.559 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.436 ' HA3' ' CD1' ' A' ' 91' ' ' PHE . . . -122.41 107.28 1.13 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.434 -0.889 . . . . 0.0 113.299 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 t 57.24 112.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.039 0.447 . . . . 0.0 111.398 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.6 t -69.62 -75.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.485 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 51' ' ' LEU . 36.1 p90 -49.97 -48.07 52.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.036 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 41.58 80.81 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.66 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 46' ' ' PHE . 1.2 t 170.11 114.09 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.565 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 50' ' ' THR . 1.9 tt0 61.32 86.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 51' ' ' LEU . 1.3 m 90.56 -179.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.623 ' H ' HG22 ' A' ' 50' ' ' THR . 1.4 pp -167.01 30.64 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.165 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -64.45 30.73 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -112.75 86.8 9.13 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 120.601 0.238 . . . . 0.0 110.578 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.29 176.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.486 2.124 . . . . 0.0 112.133 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.504 ' HG3' ' HB3' ' A' ' 94' ' ' ALA . 52.2 Cg_exo -53.16 137.9 63.25 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.412 2.075 . . . . 0.0 111.838 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.568 HD13 ' CG ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -137.67 113.76 9.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.489 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 81.8 mt -62.21 138.68 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 110.801 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 74' ' ' ILE . 6.3 t -119.82 -24.04 6.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.502 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.435 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 72.4 t80 -136.83 159.09 42.89 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.224 0.535 . . . . 0.0 111.706 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.916 ' CD1' HG22 ' A' ' 39' ' ' ILE . 9.4 mm -138.33 164.14 27.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.47 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' N ' HG22 ' A' ' 60' ' ' ILE . 4.0 tp10 -119.87 147.13 45.07 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.866 -178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.95 42.72 1.11 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.187 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -178.15 36.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.068 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.533 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -137.17 138.13 24.57 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.081 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.71 -15.83 13.65 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.038 2.492 . . . . 0.0 113.643 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.871 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -73.9 -44.09 56.36 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.584 0.707 . . . . 0.0 109.815 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HB2' ' CG2' ' A' ' 60' ' ' ILE . 3.6 tp10 -76.06 -29.22 57.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.719 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.541 ' NH1' ' HB3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -87.41 -14.83 39.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.307 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 49.7 t -47.25 -40.84 17.45 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.941 0.4 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.424 ' HA2' HG11 ' A' ' 136' ' ' VAL . . . 105.3 11.44 29.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.439 179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.0 t -153.85 53.52 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 117.061 0.431 . . . . 0.0 111.637 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.991 HD13 HG21 ' A' ' 39' ' ' ILE . 10.4 mt -141.3 134.83 29.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -141.08 174.44 10.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.783 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 58' ' ' SER . 26.5 mm -73.11 78.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.232 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.28 43.01 0.18 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.549 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.514 ' HB2' HD12 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -75.26 83.31 2.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.925 0.393 . . . . 0.0 110.783 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 101.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.964 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.643 HG11 HD13 ' A' ' 109' ' ' LEU . 35.9 m -95.77 115.4 34.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.079 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -97.14 24.52 6.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.1 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . 178.33 131.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.888 0.375 . . . . 0.0 111.027 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.718 HG23 ' CD2' ' A' ' 109' ' ' LEU . 35.1 mt -131.23 115.71 30.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.605 ' ND2' HG13 ' A' ' 107' ' ' VAL . 22.2 m-80 56.39 23.31 7.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.953 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.8 -26.3 24.53 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.536 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 36.4 mt -74.26 136.67 75.44 Favored Pre-proline 0 N--CA 1.449 -0.483 0 CA-C-O 120.565 0.222 . . . . 0.0 111.229 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.2 171.35 15.11 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.384 2.056 . . . . 0.0 112.162 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' HB2' ' A' ' 94' ' ' ALA . 1.1 p -139.42 -46.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -71.05 -11.36 60.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -113.16 45.32 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.015 0.436 . . . . 0.0 110.794 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 31.8 t -178.09 -170.26 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.798 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.14 148.65 32.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.436 ' CD1' ' HA3' ' A' ' 43' ' ' GLY . 21.7 p90 -73.52 -31.21 63.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.855 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -59.16 -31.78 69.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.172 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -61.24 -58.88 6.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -55.73 -39.9 71.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.142 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.729 ' HA ' HD12 ' A' ' 98' ' ' LEU . 1.4 m120 -64.6 -36.99 86.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.322 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.597 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -69.95 -44.07 70.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.354 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.597 ' N ' ' HG3' ' A' ' 96' ' ' GLN . 2.3 pp -62.65 -28.78 70.16 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.754 ' CD2' HD13 ' A' ' 41' ' ' LEU . 39.3 mt -67.62 -46.38 72.66 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 95' ' ' ASN . 28.8 mtt-85 -50.28 -40.26 47.74 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.487 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.0 m-20 -115.55 40.93 2.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.431 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -93.19 6.46 47.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.619 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.2 p -105.23 18.23 22.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.341 . . . . 0.0 111.82 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.487 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.8 mt -71.41 -51.63 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.814 0.816 . . . . 0.0 110.919 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.0 7.99 31.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.806 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.754 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 45.4 t 57.1 22.47 7.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.337 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.66 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.2 OUTLIER -168.99 159.16 9.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.036 0.446 . . . . 0.0 111.745 179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.605 HG13 ' ND2' ' A' ' 82' ' ' ASN . 39.8 t -157.5 128.14 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.683 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.87 133.34 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.585 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.718 ' CD2' HG23 ' A' ' 81' ' ' ILE . 1.6 mt -131.63 157.26 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 0.0 111.439 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.54 118.03 30.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.197 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.4 pt -112.27 155.37 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.155 0.503 . . . . 0.0 111.813 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.801 ' HG3' HG23 ' A' ' 24' ' ' THR . 0.4 OUTLIER -132.56 117.52 18.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.198 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 167' ' ' ARG . 6.2 p90 -136.34 174.11 10.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.962 0.41 . . . . 0.0 111.407 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 3.7 p30 -91.08 155.33 18.74 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.559 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 115' ' ' VAL . 27.9 m -108.55 104.96 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.455 . . . . 0.0 111.635 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -172.35 95.54 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 118' ' ' SER . 0.6 OUTLIER -107.15 20.44 19.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.794 -179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.2 OUTLIER 86.32 84.78 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.219 0.533 . . . . 0.0 111.714 179.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.657 ' CG1' HG13 ' A' ' 128' ' ' VAL . 2.5 m -112.96 140.76 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.115 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.707 ' O ' HD12 ' A' ' 120' ' ' ILE . 2.2 pp -121.53 104.76 39.57 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.771 0.32 . . . . 0.0 111.455 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.488 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 92.7 Cg_endo -86.01 164.28 10.15 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.848 2.365 . . . . 0.0 112.754 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 123' ' ' SER . 1.0 OUTLIER -167.28 22.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.582 179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.41 ' O ' ' O ' ' A' ' 122' ' ' SER . 0.7 OUTLIER 55.34 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.934 0.397 . . . . 0.0 111.244 179.789 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.36 -42.24 2.49 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.877 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.551 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -132.89 102.59 5.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.884 0.373 . . . . 0.0 110.512 179.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.762 ' CE1' HG21 ' A' ' 170' ' ' THR . 6.1 t80 -104.66 130.58 52.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.698 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.566 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -112.68 144.76 41.64 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.827 0.346 . . . . 0.0 110.454 179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.657 HG13 ' CG1' ' A' ' 119' ' ' VAL . 21.4 t -122.46 89.36 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.473 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -81.29 106.15 13.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.777 HD13 HG23 ' A' ' 164' ' ' VAL . 4.1 pp -132.31 134.83 25.43 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.128 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 53.8 Cg_endo -69.15 125.63 12.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.407 2.072 . . . . 0.0 111.817 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.07 158.96 15.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.081 0.467 . . . . 0.0 111.061 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' HG3' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -92.9 -175.27 3.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.804 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.79 -40.79 83.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.21 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 171.79 65.28 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.997 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 137' ' ' GLU . 17.2 t -109.76 165.05 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' N ' HG12 ' A' ' 136' ' ' VAL . 34.9 tt0 -29.19 132.6 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -158.06 101.29 1.75 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.745 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . -90.94 49.24 3.05 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.342 -178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.851 HD11 ' HB3' ' A' ' 165' ' ' ALA . 32.7 mm -94.64 134.59 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.581 0.229 . . . . 0.0 110.878 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.691 HG22 ' HB3' ' A' ' 157' ' ' SER . 29.6 m -126.44 139.93 52.87 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.893 0.377 . . . . 0.0 111.038 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.967 HD12 HG22 ' A' ' 194' ' ' VAL . 11.8 mt -113.24 164.09 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.485 ' N ' HG22 ' A' ' 142' ' ' ILE . 1.1 m -160.79 147.56 15.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.957 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.9 t -96.08 148.01 33.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.09 -55.55 3.76 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.483 2.122 . . . . 0.0 112.329 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.6 t -154.87 29.92 0.41 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.3 m 58.75 51.91 7.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.826 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -82.03 177.71 8.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -53.81 156.62 4.74 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.051 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.05 86.76 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.691 2.261 . . . . 0.0 112.258 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 171.02 -33.55 0.15 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.494 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -53.22 140.66 43.25 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.62 0.248 . . . . 0.0 111.081 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.56 164.57 4.12 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.445 2.097 . . . . 0.0 112.284 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.619 ' O ' HG13 ' A' ' 155' ' ' VAL . 12.8 mt -114.72 -177.97 3.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.704 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.619 HG13 ' O ' ' A' ' 154' ' ' LEU . 3.5 m -161.85 154.0 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.261 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.615 HG21 HD11 ' A' ' 159' ' ' ILE . 2.7 mt -71.09 147.85 10.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.441 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.691 ' HB3' HG22 ' A' ' 141' ' ' THR . 29.2 t -128.09 -2.86 5.75 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.416 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 172.4 135.51 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.828 0.347 . . . . 0.0 110.607 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.809 HG21 ' HB2' ' A' ' 166' ' ' HIS . 6.5 mt -137.16 136.66 47.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.476 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 150.52 26.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.645 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.519 ' HA ' ' NH1' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -85.12 66.97 10.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.079 0.466 . . . . 0.0 110.912 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -161.86 29.33 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.255 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.432 ' O ' ' NE ' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -154.21 139.86 17.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.054 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.777 HG23 HD13 ' A' ' 130' ' ' LEU . 25.4 m -48.79 -24.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.441 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.955 ' O ' HG22 ' A' ' 168' ' ' THR . . . -46.8 -71.29 0.07 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.809 ' HB2' HG21 ' A' ' 159' ' ' ILE . 86.3 t60 -76.67 -25.52 53.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.644 0.259 . . . . 0.0 111.099 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -56.47 -29.98 62.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.784 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.955 HG22 ' O ' ' A' ' 165' ' ' ALA . 9.2 t -62.78 -23.94 67.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.811 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.43 71.08 1.31 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.887 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.762 HG21 ' CE1' ' A' ' 126' ' ' PHE . 0.0 OUTLIER -172.39 -42.39 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.724 0.297 . . . . 0.0 110.953 179.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.661 HD13 ' O ' ' A' ' 165' ' ' ALA . 1.1 mp -59.48 100.19 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.944 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -128.3 139.97 52.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.017 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 19.7 mt -59.29 102.02 0.12 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.22 -18.81 1.36 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.59 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.641 ' CB ' HG21 ' A' ' 208' ' ' ILE . 8.1 m-20 -72.97 134.6 44.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.752 0.31 . . . . 0.0 110.78 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.73 103.98 16.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.555 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -70.47 137.51 50.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.956 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 178' ' ' LEU . 8.4 tt -133.43 -40.53 0.89 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.175 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.655 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -129.78 149.1 51.67 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.92 0.391 . . . . 0.0 111.387 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.755 ' CD1' ' HB1' ' A' ' 193' ' ' ALA . 27.3 mt -139.23 113.86 7.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.294 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 182' ' ' ASN . 24.9 t70 47.65 55.35 8.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.18 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' A' ' 181' ' ' ASP . 1.8 t30 84.9 -35.88 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.428 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 184' ' ' ARG . 44.1 mm -67.3 159.18 4.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.749 0.309 . . . . 0.0 110.63 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.497 ' N ' HG22 ' A' ' 183' ' ' ILE . 10.1 mtp180 -134.74 129.49 34.75 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 1.036 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.4 mm? -74.53 -6.23 47.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.574 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.14 -41.33 7.91 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.959 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 36.3 t -115.85 -18.06 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.18 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -81.07 -171.14 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.075 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -120.7 -176.9 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.936 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.557 ' HG3' HD22 ' A' ' 154' ' ' LEU . 6.7 ttp -69.12 -57.14 5.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -54.31 -31.1 53.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.864 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.8 OUTLIER -62.99 -48.79 77.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.097 179.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 1.036 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -57.02 -39.41 74.7 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.164 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.967 HG22 HD12 ' A' ' 142' ' ' ILE . 21.7 t -60.14 -41.19 85.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.867 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -50.04 75.3 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.856 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.864 HD12 ' O ' ' A' ' 192' ' ' ASP . 3.0 mp -69.51 -24.53 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.614 HD13 HD11 ' A' ' 142' ' ' ILE . 0.7 OUTLIER -57.92 -37.59 74.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.357 178.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -96.73 -35.67 10.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.028 179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -16.68 61.89 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.637 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.847 ' HB3' HG22 ' A' ' 204' ' ' VAL . 8.5 m -86.04 41.23 0.91 Allowed 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.339 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -73.64 62.37 0.78 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.238 0.542 . . . . 0.0 111.068 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -174.18 -30.67 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.465 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 203' ' ' LEU . 3.6 tt 176.72 109.84 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.393 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 200' ' ' CYS . 21.8 t -104.3 125.94 59.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.613 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -108.16 108.32 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.883 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.555 ' HG ' HD21 ' A' ' 177' ' ' LEU . 1.1 mp -87.37 108.2 18.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.446 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.655 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 7.6 tttt -97.37 98.5 10.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.653 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.641 HG21 ' CB ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -106.34 172.46 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.616 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 3.4 mmt180 -108.94 138.82 44.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.839 0.352 . . . . 0.0 111.451 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . 0.419 ' HE2' ' CD2' ' A' ' 126' ' ' PHE . 6.4 mptt -119.27 157.25 28.43 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.747 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.46 70.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.971 0.415 . . . . 0.0 110.963 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -57.65 140.69 50.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.083 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 9.8 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.144 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.826 0.346 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.2 p -98.54 139.02 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.432 HG22 ' N ' ' A' ' 21' ' ' HIS . 11.1 p -162.9 156.22 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.104 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.432 ' N ' HG22 ' A' ' 20' ' ' VAL . 51.3 p-80 -109.38 136.09 49.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.845 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -54.68 167.69 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.409 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -162.96 156.66 20.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.9 p -113.25 149.05 34.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.179 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.521 HG21 ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -144.07 165.62 27.3 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.716 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -101.91 158.9 15.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.97 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.666 HG12 ' O ' ' A' ' 109' ' ' LEU . 2.9 p -143.65 151.74 16.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.496 0.665 . . . . 0.0 111.612 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 44.5 t -128.76 110.82 21.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.102 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.684 HD21 HD12 ' A' ' 39' ' ' ILE . 5.7 mp -109.77 118.75 37.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.885 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -109.4 161.54 15.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.029 0.443 . . . . 0.0 111.271 -179.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -92.89 112.51 24.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.255 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.06 156.0 44.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.609 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.7 7.6 3.06 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.556 2.171 . . . . 0.0 112.953 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 35' ' ' THR . 31.3 t -107.58 -47.43 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.743 0.306 . . . . 0.0 111.181 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 34' ' ' VAL . 34.8 p -146.35 6.75 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' CD1' ' A' ' 37' ' ' PHE . . . 66.86 -79.04 0.14 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.501 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 4.8 m-85 -132.67 113.76 13.39 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 110.187 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -74.18 -2.55 62.76 Favored Glycine 0 C--N 1.33 0.243 0 CA-C-N 115.916 -0.584 . . . . 0.0 114.07 -178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.001 HD11 HD13 ' A' ' 72' ' ' LEU . 18.1 mt -92.98 136.32 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 121.238 0.542 . . . . 0.0 111.944 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 57' ' ' ILE . 1.8 mt-30 -113.84 120.62 41.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.038 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 55' ' ' PRO . 6.8 mp -95.35 136.89 35.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.195 0.521 . . . . 0.0 111.935 -178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.62 169.46 8.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.179 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.74 64.88 0.35 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.384 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m -161.78 63.16 0.25 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.126 0.488 . . . . 0.0 111.021 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.523 HG22 HD13 ' A' ' 56' ' ' LEU . 2.1 t -85.76 -70.4 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.671 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.598 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.0 p90 -40.85 -43.97 2.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.17 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.528 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 54.81 76.24 0.26 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.934 -179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.476 ' OG1' ' N ' ' A' ' 49' ' ' GLU . 2.7 t 169.88 -164.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.864 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' N ' ' OG1' ' A' ' 48' ' ' THR . 16.3 pt-20 -46.81 167.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.603 0.24 . . . . 0.0 110.717 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.453 HG22 ' O ' ' A' ' 49' ' ' GLU . 11.0 t 45.53 -159.42 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.194 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.841 HD13 HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -149.18 -85.8 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.884 0.374 . . . . 0.0 111.342 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.42 14.48 1.15 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.79 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 3.9 t -75.59 113.87 30.67 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.23 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.58 ' O ' HD23 ' A' ' 56' ' ' LEU . 59.9 Cg_endo -72.01 151.48 56.11 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.27 1.98 . . . . 0.0 111.696 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.645 ' HB3' HD23 ' A' ' 41' ' ' LEU . 71.7 Cg_exo -47.84 111.2 0.39 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.341 2.027 . . . . 0.0 112.189 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -120.12 110.69 16.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.824 ' CD1' HD13 ' A' ' 39' ' ' ILE . 39.4 mt -56.21 124.92 10.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.126 0 CA-C-O 120.858 0.361 . . . . 0.0 111.092 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.43 -8.25 27.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.161 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 45.7 t80 177.61 138.58 0.08 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.005 0.431 . . . . 0.0 111.283 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.815 HG21 ' HB2' ' A' ' 67' ' ' GLU . 5.0 mt -113.82 169.37 5.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.337 178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.54 ' H ' HG22 ' A' ' 60' ' ' ILE . 65.9 tt0 -108.46 151.97 25.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.069 0.462 . . . . 0.0 111.368 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.423 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -91.61 46.59 1.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.356 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 t0 177.46 44.34 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.892 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.433 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -142.44 142.18 22.86 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.998 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -60.79 -13.06 24.48 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.655 2.237 . . . . 0.0 112.889 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.611 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -64.77 -56.75 11.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.021 0.438 . . . . 0.0 110.255 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.815 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -79.08 -29.78 43.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.896 178.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.44 ' NH1' ' HG3' ' A' ' 67' ' ' GLU . 0.0 OUTLIER -69.42 -20.22 63.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.238 -179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 52.0 t -47.3 -29.31 2.41 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.917 0.389 . . . . 0.0 111.146 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.02 25.22 58.24 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.536 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.456 HG13 ' HA2' ' A' ' 162' ' ' GLY . 4.0 t -152.63 37.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.769 0.319 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.001 HD13 HD11 ' A' ' 39' ' ' ILE . 10.7 mt -142.15 172.53 12.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.046 0.451 . . . . 0.0 111.624 -179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -164.22 150.15 10.84 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.441 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.1 mt -57.5 98.69 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 120.922 0.392 . . . . 0.0 111.337 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 95.62 40.8 4.05 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.248 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.806 ' CG ' HD12 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -78.17 -14.21 59.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.631 0.253 . . . . 0.0 111.399 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.7 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.8 mtm-85 63.09 136.05 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.827 0.346 . . . . 0.0 110.895 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 109' ' ' LEU . 10.2 t -114.07 152.38 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.212 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.708 ' HE2' ' HB2' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -114.25 -34.12 5.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.813 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.708 ' HB2' ' HE2' ' A' ' 79' ' ' MET . . . -148.7 142.86 26.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.029 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.682 HG23 HD22 ' A' ' 109' ' ' LEU . 28.2 mt -128.39 111.13 23.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.916 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 54.24 25.11 5.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.13 -21.89 36.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.567 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.2 mt -75.32 128.84 83.68 Favored Pre-proline 0 N--CA 1.45 -0.429 0 CA-C-O 120.531 0.205 . . . . 0.0 111.142 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.454 ' O ' HG23 ' A' ' 86' ' ' THR . 33.2 Cg_exo -57.65 -160.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.456 2.104 . . . . 0.0 112.212 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 85' ' ' PRO . 23.3 p -158.22 -49.55 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.957 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -7.25 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.42 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -112.22 45.08 1.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.863 0.363 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.4 t -178.31 175.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.822 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.841 HG23 HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -85.04 144.32 28.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -51.61 -27.35 10.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.155 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -55.79 -35.07 65.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 1.7 pp20? -64.28 -37.41 87.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.786 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' HD21 ' A' ' 97' ' ' LEU . . . -69.24 -35.83 76.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.488 0.661 . . . . 0.0 110.255 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.95 -42.71 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.963 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.788 ' HA ' ' HD3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -69.1 -42.37 76.21 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.164 -179.72 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.833 HD12 ' N ' ' A' ' 98' ' ' LEU . 4.0 pp -64.8 -32.37 74.03 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 97' ' ' LEU . 4.2 mt -63.09 -57.42 10.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.709 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.788 ' HD3' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -52.33 -30.41 28.37 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.607 ' O ' HD11 ' A' ' 103' ' ' ILE . 68.6 m-20 -115.67 36.62 3.91 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.927 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.527 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -105.36 15.06 27.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.326 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.425 ' HB3' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -112.32 18.73 18.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.739 -179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.607 HD11 ' O ' ' A' ' 100' ' ' ASP . 2.1 mt -63.73 -46.55 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.689 0.757 . . . . 0.0 110.651 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.92 0.13 57.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.469 -1.242 . . . . 0.0 110.502 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.885 ' O ' HG22 ' A' ' 30' ' ' THR . 1.2 m 63.26 26.27 15.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.842 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HG3' ' N ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -166.16 146.03 6.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.055 0.455 . . . . 0.0 110.78 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.504 ' N ' ' HG3' ' A' ' 106' ' ' LYS . 2.2 t -149.02 111.13 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.624 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.535 ' C ' HD23 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -93.12 133.67 36.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 110.761 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.682 HD22 HG23 ' A' ' 81' ' ' ILE . 0.0 OUTLIER -142.25 165.27 27.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.446 . . . . 0.0 111.222 -179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -117.18 136.98 52.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.393 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.806 HD12 ' CG ' ' A' ' 76' ' ' ASP . 27.6 pt -128.85 166.07 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 111.677 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -128.48 142.77 50.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.729 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 25' ' ' THR . 0.0 OUTLIER -161.2 174.72 13.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.922 0.392 . . . . 0.0 111.236 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -88.75 150.49 22.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.52 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.401 ' HA ' ' HG3' ' A' ' 167' ' ' ARG . 2.4 m -101.57 104.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.006 0.431 . . . . 0.0 111.41 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -168.09 130.3 1.47 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.616 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.618 ' HB2' HG22 ' A' ' 168' ' ' THR . 69.7 mm-40 -130.2 6.56 4.95 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 0.1 OUTLIER 80.01 71.21 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.34 0.59 . . . . 0.0 111.247 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.752 ' CG1' HG13 ' A' ' 128' ' ' VAL . 3.1 m -97.69 147.45 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.718 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.792 HD11 ' CG ' ' A' ' 127' ' ' HIS . 2.1 pp -122.92 102.31 38.09 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.889 0.376 . . . . 0.0 111.473 -178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.452 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 65.3 Cg_endo -87.71 154.81 7.52 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.96 2.44 . . . . 0.0 112.605 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -162.61 24.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.429 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 57.86 118.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.859 0.361 . . . . 0.0 111.073 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.61 -45.95 2.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.088 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.5 102.43 6.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.046 0.45 . . . . 0.0 110.643 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.469 ' CZ ' ' HB ' ' A' ' 119' ' ' VAL . 8.4 t80 -107.14 115.93 31.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.175 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.792 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -99.72 144.96 28.18 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.007 0.432 . . . . 0.0 111.145 -179.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.752 HG13 ' CG1' ' A' ' 119' ' ' VAL . 2.7 t -118.3 97.19 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.978 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HE2' HD11 ' A' ' 203' ' ' LEU . 2.0 mttt -81.29 99.01 8.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.072 -179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.715 HD12 ' O ' ' A' ' 128' ' ' VAL . 3.0 mp -109.82 114.73 56.24 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.415 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -60.94 110.39 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.164 1.91 . . . . 0.0 111.307 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.754 ' HG3' HG23 ' A' ' 204' ' ' VAL . 1.1 mttt -89.7 158.65 17.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.1 0.476 . . . . 0.0 111.611 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.791 ' HD2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -122.85 178.23 5.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.629 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.656 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 34.4 t-80 -41.77 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.715 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.422 ' N ' ' HD3' ' A' ' 133' ' ' LYS . 3.0 m -138.63 97.37 3.33 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.883 0.373 . . . . 0.0 111.63 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.791 HG23 ' HD2' ' A' ' 133' ' ' LYS . 2.2 t -143.21 141.46 26.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.533 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -65.49 141.98 58.3 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.027 HD23 HD11 ' A' ' 140' ' ' ILE . 1.3 tp -95.88 -41.94 8.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.932 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.461 ' HA3' ' HG3' ' A' ' 160' ' ' LYS . . . 94.0 13.84 53.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.267 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 1.027 HD11 HD23 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -112.17 139.38 37.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.424 ' HB ' ' N ' ' A' ' 158' ' ' ASP . 41.0 m -111.86 142.18 44.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.607 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 143' ' ' SER . 6.6 mt -103.35 164.27 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.033 0.444 . . . . 0.0 111.18 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.553 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.3 OUTLIER -160.18 158.64 30.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.724 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.8 p -129.33 106.38 17.59 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.611 ' HD3' HG22 ' A' ' 155' ' ' VAL . 76.1 Cg_exo -49.72 -61.51 0.56 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.527 2.151 . . . . 0.0 112.381 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.18 -68.95 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.925 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.4 30.56 18.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.998 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.4 mtt85 -131.31 44.55 2.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.859 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.5 139.32 0.14 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.741 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.75 106.11 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.352 2.034 . . . . 0.0 112.279 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 117.23 23.24 3.9 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.789 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -55.32 148.75 30.44 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.717 0.294 . . . . 0.0 111.105 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.536 ' O ' HD22 ' A' ' 154' ' ' LEU . 59.5 Cg_endo -72.17 172.04 15.61 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.573 2.182 . . . . 0.0 112.404 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.723 HD21 ' HA ' ' A' ' 190' ' ' MET . 4.0 mm? -123.92 141.85 51.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.761 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.611 HG22 ' HD3' ' A' ' 145' ' ' PRO . 34.9 m -156.38 148.69 11.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.836 0.35 . . . . 0.0 111.295 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 156' ' ' ILE . 3.4 mp -68.0 152.19 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.82 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -131.17 -6.94 3.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.73 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.424 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.5 OUTLIER 179.68 147.82 0.25 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.081 0.467 . . . . 0.0 111.448 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.569 HG21 ' ND1' ' A' ' 166' ' ' HIS . 17.1 mt -139.13 149.79 23.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.465 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.613 ' HD3' ' N ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -138.7 144.26 39.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.919 0.39 . . . . 0.0 111.373 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.52 72.58 5.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.613 ' N ' ' HD3' ' A' ' 160' ' ' LYS . . . -134.08 -44.37 0.12 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.194 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.14 176.61 5.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.248 0.547 . . . . 0.0 111.424 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.0 m -53.69 -21.52 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.384 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -42.69 -69.72 0.13 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.569 ' ND1' HG21 ' A' ' 159' ' ' ILE . 5.4 t60 -68.07 -27.25 66.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.0 111.387 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.401 ' HG3' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -59.6 -29.42 67.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.27 -179.618 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.655 HG21 HG11 ' A' ' 128' ' ' VAL . 70.5 p -45.83 -29.83 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.35 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.53 58.61 8.28 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.541 HG21 HG11 ' A' ' 119' ' ' VAL . 4.5 t -178.83 -37.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.797 0.332 . . . . 0.0 111.019 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.67 93.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.019 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -102.71 146.9 27.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 35.4 mt -69.05 84.3 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 151.47 43.2 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.585 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.409 ' HB3' ' CG2' ' A' ' 208' ' ' ILE . 0.9 OUTLIER -119.58 145.01 46.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.667 0.27 . . . . 0.0 110.457 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.401 ' HA ' HG12 ' A' ' 155' ' ' VAL . 10.2 mmtp -97.15 115.71 28.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.894 0.378 . . . . 0.0 111.151 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.562 HD22 ' CD1' ' A' ' 180' ' ' ILE . 4.6 mt -87.87 135.04 33.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.75 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.97 -27.13 6.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.398 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.742 ' O ' HD13 ' A' ' 180' ' ' ILE . . . -148.13 162.23 39.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.943 0.401 . . . . 0.0 111.551 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 179' ' ' ALA . 20.3 mm -139.44 110.22 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.968 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 21.2 t70 63.52 -80.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.157 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -128.29 -22.6 3.38 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 184' ' ' ARG . 43.3 mm -87.83 157.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.801 0.334 . . . . 0.0 111.029 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.695 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 9.1 mtt180 -126.31 129.75 49.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.076 0.465 . . . . 0.0 112.051 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.881 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.3 mm? -71.98 -6.36 41.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.727 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -45.51 -42.18 10.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.6 p -116.16 -19.67 10.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.211 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -81.78 -176.01 5.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.438 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -118.34 -175.67 2.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.021 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.723 ' HA ' HD21 ' A' ' 154' ' ' LEU . 11.9 ttp -63.05 -55.18 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.56 -29.87 18.69 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.799 ' O ' HD12 ' A' ' 196' ' ' ILE . 1.1 m-20 -64.32 -54.09 38.49 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.749 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.881 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -52.06 -32.57 35.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.899 0.38 . . . . 0.0 110.206 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.474 HG22 HD13 ' A' ' 142' ' ' ILE . 23.0 t -64.77 -47.81 87.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.819 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.771 ' NE2' ' O ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -70.77 -32.35 69.44 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.208 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.799 HD12 ' O ' ' A' ' 192' ' ' ASP . 2.5 mt -75.77 -26.21 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.549 HD22 HD11 ' A' ' 142' ' ' ILE . 0.1 OUTLIER -63.93 -40.56 96.74 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.287 179.033 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -86.64 -42.66 13.25 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.224 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.12 -18.56 48.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.497 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.861 ' HB3' HG22 ' A' ' 204' ' ' VAL . 4.6 m -86.25 42.23 0.98 Allowed 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.374 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -73.98 62.42 0.87 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.247 0.546 . . . . 0.0 111.147 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.42 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 3.2 m-20 -171.3 -33.01 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.058 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.788 HD23 ' O ' ' A' ' 203' ' ' LEU . 4.0 tt 177.89 106.93 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.308 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.861 HG22 ' HB3' ' A' ' 200' ' ' CYS . 21.6 t -102.3 121.77 53.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.349 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 0.6 OUTLIER -100.81 107.71 19.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 109.935 179.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.575 ' O ' HD13 ' A' ' 208' ' ' ILE . 3.1 mp -85.81 104.27 15.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.976 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.465 ' HG3' ' CE1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -89.73 93.79 9.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.742 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.575 HD13 ' O ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -101.72 172.31 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.143 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.65 133.52 42.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.72 159.15 33.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 56.69 43.58 25.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.988 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.5 149.07 46.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.125 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.833 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 19' ' ' VAL . 4.3 tp60 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.785 0.326 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.404 ' N ' ' HG3' ' A' ' 18' ' ' GLN . 11.9 p -141.35 127.75 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.876 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG21 ' O ' ' A' ' 115' ' ' VAL . 9.3 p -158.93 165.12 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.223 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.448 ' N ' HG22 ' A' ' 20' ' ' VAL . 65.4 t60 -92.93 134.17 35.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.37 174.21 3.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.088 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -168.49 162.11 12.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.711 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 112' ' ' GLU . 0.2 OUTLIER -131.21 144.97 51.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.932 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.0 t -139.52 -173.51 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.944 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -103.15 161.14 14.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.532 HG21 HG23 ' A' ' 111' ' ' ILE . 2.2 t -147.01 149.08 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.156 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.8 t -129.58 113.89 29.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.9 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD22 ' HD2' ' A' ' 37' ' ' PHE . 3.6 mt -110.1 118.92 37.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 105' ' ' SER . 0.0 OUTLIER -110.66 161.81 15.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.22 0.533 . . . . 0.0 111.742 -179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.892 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -103.79 119.93 39.94 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.104 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.777 ' OD1' HG23 ' A' ' 34' ' ' VAL . 8.8 t0 -88.53 141.96 30.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.338 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.18 3.94 0.67 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.48 2.12 . . . . 0.0 113.04 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.777 HG23 ' OD1' ' A' ' 32' ' ' ASP . 28.3 t -101.27 -53.73 7.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.82 0.343 . . . . 0.0 110.767 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 t -141.25 6.43 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.947 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 67.96 -107.93 2.25 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.162 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.892 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 6.2 m-85 -106.87 128.26 54.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -91.88 25.15 17.7 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.863 -0.684 . . . . 0.0 114.798 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.775 ' HB ' HD13 ' A' ' 57' ' ' ILE . 1.0 OUTLIER -126.39 130.93 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.68 0.74 . . . . 0.0 111.826 179.213 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.83 116.21 29.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.175 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 98' ' ' LEU . 0.9 OUTLIER -96.87 145.6 25.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.389 0.614 . . . . 0.0 112.552 -178.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.25 169.59 10.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.818 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 45' ' ' VAL . . . -116.46 -47.59 0.5 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.791 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -47.04 123.92 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.554 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 43' ' ' GLY . 98.8 t -140.2 -83.87 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.901 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.615 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 39.0 p90 -40.5 -45.54 2.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.175 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.511 ' N ' ' CD2' ' A' ' 46' ' ' PHE . . . 51.94 73.63 0.31 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.264 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER 165.33 90.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.636 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' O ' HG22 ' A' ' 50' ' ' THR . 0.3 OUTLIER 55.17 176.08 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.148 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 49' ' ' GLU . 12.7 t 44.89 -163.13 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.355 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.615 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -147.8 -101.41 0.09 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.193 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.94 18.36 1.62 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.842 0.353 . . . . 0.0 111.555 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.46 107.85 1.75 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.038 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.441 ' O ' ' CD2' ' A' ' 56' ' ' LEU . 7.7 Cg_exo -72.91 167.4 27.41 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.653 2.235 . . . . 0.0 111.998 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.698 ' HA ' HD21 ' A' ' 41' ' ' LEU . 24.4 Cg_exo -63.83 128.63 22.51 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.711 2.274 . . . . 0.0 112.132 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.737 HD13 HG22 ' A' ' 45' ' ' VAL . 1.3 pt? -145.84 100.65 3.44 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.811 0.339 . . . . 0.0 111.804 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.775 HD13 ' HB ' ' A' ' 39' ' ' ILE . 46.2 mt -64.62 156.94 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.519 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.452 ' N ' HG22 ' A' ' 57' ' ' ILE . 2.0 m -139.15 8.14 2.46 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.491 ' H ' HG22 ' A' ' 57' ' ' ILE . 52.8 t80 -178.14 134.13 0.15 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.176 0.512 . . . . 0.0 112.081 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.709 HG13 HG23 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -100.89 -173.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.655 ' N ' HG23 ' A' ' 60' ' ' ILE . 29.0 tt0 -125.3 125.61 43.79 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.967 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -53.01 109.42 0.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.963 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 0.9 OUTLIER 84.72 46.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.353 179.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.92 154.28 76.28 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.89 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 22.4 Cg_exo -63.4 -12.04 28.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.392 2.061 . . . . 0.0 112.261 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.648 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -72.01 -57.1 4.57 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HB2' HG21 ' A' ' 60' ' ' ILE . 1.1 tp10 -79.08 -29.03 43.12 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.093 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' CG ' ' A' ' 67' ' ' GLU . 0.7 OUTLIER -89.11 -7.19 56.25 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.582 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -46.88 -46.85 21.37 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.844 0.354 . . . . 0.0 111.204 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.791 ' HA2' HG13 ' A' ' 136' ' ' VAL . . . 123.16 -25.45 6.36 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.264 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.616 HG13 ' CA ' ' A' ' 162' ' ' GLY . 40.3 t -139.39 63.45 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.019 0.437 . . . . 0.0 110.803 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.648 HD12 ' O ' ' A' ' 66' ' ' ALA . 15.0 mt -148.28 169.67 19.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.012 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -164.07 162.09 22.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.742 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 28.7 mm -60.54 85.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.286 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.08 90.94 1.87 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.659 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.411 ' HB2' HG21 ' A' ' 111' ' ' ILE . 13.5 p30 -112.26 115.63 29.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.83 0.348 . . . . 0.0 110.735 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.11 96.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.004 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.404 HG13 ' HB2' ' A' ' 109' ' ' LEU . 29.0 t -72.98 115.55 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 9.5 tpt -83.25 -42.04 17.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -153.28 150.21 28.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.728 HG21 ' CD1' ' A' ' 97' ' ' LEU . 9.2 mt -131.54 119.64 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 54.95 23.16 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.056 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 105.94 -22.39 31.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.645 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' THR . 45.2 mt -70.39 127.77 91.83 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 120.429 0.157 . . . . 0.0 111.229 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.543 ' C ' HG23 ' A' ' 86' ' ' THR . 33.3 Cg_endo -64.14 -31.15 65.06 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.44 2.094 . . . . 0.0 112.238 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.543 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 75.74 -54.96 0.62 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.152 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -66.93 -13.79 62.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.09 44.53 1.04 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.995 0.426 . . . . 0.0 110.898 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.78 -175.91 0.17 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.787 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 m -68.52 156.58 37.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -73.1 -30.7 63.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.007 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -55.54 -32.78 63.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.38 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -66.18 -36.09 82.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.801 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.709 ' HA ' HD23 ' A' ' 97' ' ' LEU . . . -71.16 -34.96 71.46 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.434 0.635 . . . . 0.0 110.504 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -74.13 -32.15 63.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.651 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -72.5 -37.27 68.45 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.02 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.728 ' CD1' HG21 ' A' ' 81' ' ' ILE . 1.0 OUTLIER -70.58 -38.74 74.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.78 0.324 . . . . 0.0 110.206 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 41' ' ' LEU . 71.1 mt -73.47 -55.81 5.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.308 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.426 ' CG ' ' HA ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -51.25 -30.01 16.27 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 0.4 OUTLIER -119.01 37.95 3.96 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.584 178.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -95.87 26.67 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.004 179.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.7 p -119.17 12.01 12.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.481 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.2 mt -69.65 -47.82 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-O 121.642 0.734 . . . . 0.0 110.596 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.59 -2.89 56.96 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.62 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.742 ' O ' HG22 ' A' ' 30' ' ' THR . 0.3 OUTLIER 62.69 26.97 15.93 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.992 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 30' ' ' THR . 0.1 OUTLIER -170.03 154.95 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.101 0.477 . . . . 0.0 111.099 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' A' ' 101' ' ' SER . 27.4 t -155.8 145.06 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.703 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.38 120.42 32.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.76 0.315 . . . . 0.0 110.805 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -142.05 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -105.6 145.85 30.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 27' ' ' VAL . 28.5 pt -125.49 142.65 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.918 0.39 . . . . 0.0 111.531 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.702 ' HG3' HG23 ' A' ' 24' ' ' THR . 17.3 tt0 -107.97 129.35 55.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.401 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.407 ' CZ ' ' HD3' ' A' ' 167' ' ' ARG . 3.4 p90 -153.87 174.42 14.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 111.188 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.522 ' HB3' HG11 ' A' ' 20' ' ' VAL . 2.3 m-20 -98.5 135.41 40.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.62 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.617 ' O ' HG21 ' A' ' 20' ' ' VAL . 35.1 m -75.47 104.97 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.995 0.426 . . . . 0.0 111.395 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . 178.17 124.45 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' OE2' HG12 ' A' ' 164' ' ' VAL . 1.4 mm-40 -135.62 33.3 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.04 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 117' ' ' GLU . 2.1 t 80.7 91.53 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.297 0.57 . . . . 0.0 110.982 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.815 ' CG1' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -128.28 127.15 67.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.668 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.614 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.7 pp -109.95 97.18 28.13 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.537 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 88.9 Cg_endo -84.11 159.91 13.47 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.752 2.301 . . . . 0.0 112.691 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.74 27.52 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 57.68 115.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.84 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 88.7 -40.97 3.05 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.233 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.402 HG21 ' HE3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -126.86 102.93 7.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.793 0.33 . . . . 0.0 110.994 179.954 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -109.98 119.43 39.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.487 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.522 ' HB2' ' CG1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -105.59 120.76 42.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.752 0.311 . . . . 0.0 110.774 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.815 HG13 ' CG1' ' A' ' 119' ' ' VAL . 4.3 t -99.74 95.52 4.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.549 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.7 mmtt -81.49 102.75 10.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.474 HD21 HG12 ' A' ' 128' ' ' VAL . 0.4 OUTLIER -115.6 125.01 29.2 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.143 -179.585 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.29 121.37 7.71 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.403 2.069 . . . . 0.0 111.762 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.82 ' HZ1' HD21 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -92.5 159.4 15.53 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.151 0.501 . . . . 0.0 111.345 -179.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.603 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -108.78 -164.88 0.98 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.863 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -69.17 -38.74 78.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 3.4 m -175.57 69.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.232 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.791 HG13 ' HA2' ' A' ' 70' ' ' GLY . 90.3 t -107.3 145.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.817 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 145.62 52.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.956 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.82 HD21 ' HZ1' ' A' ' 132' ' ' LYS . 10.6 mt -105.93 -60.38 1.65 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.581 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA3' ' HB3' ' A' ' 160' ' ' LYS . . . 91.64 19.61 40.32 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.125 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -98.45 146.86 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.73 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.666 HG22 ' HB3' ' A' ' 157' ' ' SER . 27.1 m -126.19 128.41 47.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 1.006 HD12 HG22 ' A' ' 194' ' ' VAL . 7.2 mt -101.87 163.07 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.061 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.459 ' N ' HG22 ' A' ' 142' ' ' ILE . 0.8 OUTLIER -144.84 149.12 34.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.804 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.1 t -97.48 106.64 34.08 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.432 ' HG3' HG23 ' A' ' 155' ' ' VAL . 89.9 Cg_endo -81.62 -168.96 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.614 2.209 . . . . 0.0 112.334 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 2.3 m -72.66 100.44 2.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.407 ' O ' ' CD ' ' A' ' 149' ' ' LYS . 25.4 t -53.02 -82.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.272 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 65.82 35.61 6.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.323 0.582 . . . . 0.0 110.529 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.407 ' CD ' ' O ' ' A' ' 147' ' ' SER . 0.0 OUTLIER 178.96 154.69 0.57 Allowed Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.521 179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.66 62.62 1.72 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.4 2.067 . . . . 0.0 112.218 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -172.41 -55.05 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.721 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.9 t0 65.59 109.75 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.529 0.204 . . . . 0.0 110.976 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.521 ' O ' HD22 ' A' ' 154' ' ' LEU . 56.2 Cg_endo -70.35 -167.95 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.537 2.158 . . . . 0.0 112.435 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.951 HD12 ' CG2' ' A' ' 142' ' ' ILE . 3.1 mm? -131.15 155.88 46.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 156' ' ' ILE . 11.9 t -142.22 162.23 19.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.335 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.513 ' N ' HG12 ' A' ' 155' ' ' VAL . 3.7 mm -89.72 154.14 3.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.546 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.666 ' HB3' HG22 ' A' ' 141' ' ' THR . 8.8 t -132.45 -20.93 2.31 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.414 ' N ' ' HB ' ' A' ' 141' ' ' THR . 0.4 OUTLIER 174.78 136.19 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.914 0.387 . . . . 0.0 110.813 -179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.861 HG12 HD12 ' A' ' 171' ' ' LEU . 0.7 OUTLIER -123.64 149.38 27.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.837 179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.408 ' HB3' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -105.78 164.4 11.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.128 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -96.86 166.16 11.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.782 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.616 ' CA ' HG13 ' A' ' 71' ' ' VAL . . . 91.47 -30.18 6.65 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.988 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.497 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 1.6 t -97.95 149.65 22.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.005 0.431 . . . . 0.0 111.476 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.486 HG12 ' OE2' ' A' ' 117' ' ' GLU . 17.0 m -52.76 -21.66 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.843 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.716 ' O ' HG22 ' A' ' 168' ' ' THR . . . -51.08 -64.79 0.7 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.412 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.428 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 16.5 t60 -83.19 -24.26 32.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 163' ' ' SER . 0.0 OUTLIER -54.52 -39.27 67.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.038 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.792 HG21 HG11 ' A' ' 128' ' ' VAL . 2.7 t -56.41 -28.14 58.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.947 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 92.54 -44.5 2.59 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.607 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.633 ' CG2' HG11 ' A' ' 119' ' ' VAL . 66.9 p -57.57 -25.15 59.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.667 0.27 . . . . 0.0 111.208 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.861 HD12 HG12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -61.58 85.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.795 -179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -112.29 166.61 11.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.973 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 42.5 mt -92.38 116.65 29.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 117.04 29.25 2.22 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.698 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.19 138.12 41.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.717 0.294 . . . . 0.0 110.767 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -90.31 106.17 18.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.909 0.385 . . . . 0.0 110.775 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.039 HD22 HD11 ' A' ' 180' ' ' ILE . 9.1 mt -70.56 134.9 48.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.043 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.637 HD22 ' NZ ' ' A' ' 207' ' ' LYS . 7.3 tt -120.18 -51.37 2.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.688 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.674 ' HB3' ' HD3' ' A' ' 207' ' ' LYS . . . -128.19 156.54 42.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 1.039 HD11 HD22 ' A' ' 177' ' ' LEU . 28.6 mm -139.59 105.9 2.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.081 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.675 ' OD2' HG12 ' A' ' 204' ' ' VAL . 0.4 OUTLIER 68.13 -67.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.038 0.447 . . . . 0.0 110.738 179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 180' ' ' ILE . 1.5 m120 -147.99 -24.12 0.35 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.665 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 27.9 mm -93.52 139.69 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.161 0.505 . . . . 0.0 111.199 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 179' ' ' ALA . 4.1 mtp-105 -102.48 123.7 46.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.803 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.782 ' HG ' ' HB2' ' A' ' 193' ' ' ALA . 3.2 mm? -74.89 -5.52 44.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.446 178.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -45.87 -28.92 1.21 Allowed 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.2 m -134.31 42.73 2.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.685 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.29 153.55 38.83 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.993 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.59 -177.53 0.97 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.458 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.696 ' HA ' HD11 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.03 -54.47 7.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.057 -179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -51.55 -29.82 18.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.039 0.447 . . . . 0.0 111.004 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -60.81 -52.15 66.29 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.25 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.782 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . . . -57.18 -40.59 77.63 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.191 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 1.006 HG22 HD12 ' A' ' 142' ' ' ILE . 11.9 t -62.31 -39.4 84.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.674 179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -46.92 87.28 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.117 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.71 HD13 ' N ' ' A' ' 196' ' ' ILE . 0.6 OUTLIER -72.52 -24.71 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.647 HD13 HD11 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -58.94 -36.14 74.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.848 179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.569 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 1.0 OUTLIER -104.04 -44.57 4.97 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.262 -179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -26.02 19.79 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.014 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 196' ' ' ILE . 0.2 OUTLIER -95.43 44.52 1.09 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 178.394 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.413 ' HA ' ' CD ' ' A' ' 132' ' ' LYS . 3.2 tt0 -68.76 53.34 0.08 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.241 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.572 ' N ' ' HB3' ' A' ' 132' ' ' LYS . 0.7 OUTLIER -141.59 -25.93 0.69 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.719 179.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 203' ' ' LEU . 1.3 tt 165.14 112.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.675 HG12 ' OD2' ' A' ' 181' ' ' ASP . 3.5 m -105.26 132.51 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -107.89 107.97 18.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.457 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.28 104.3 15.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.943 0.402 . . . . 0.0 111.807 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.674 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 19.6 tttt -97.29 93.69 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.165 179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.546 ' N ' HD13 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -106.82 -177.54 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.208 -179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -98.42 127.33 44.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -115.97 159.56 21.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.92 50.24 1.53 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.622 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -54.91 165.1 0.69 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.344 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.888 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.853 0.359 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.5 m -142.95 132.15 21.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.031 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 115' ' ' VAL . 11.5 p -178.34 159.36 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.102 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.485 ' N ' HG22 ' A' ' 20' ' ' VAL . 86.5 t60 -76.06 120.7 21.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.6 p -55.29 174.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.275 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' OE1' HG11 ' A' ' 115' ' ' VAL . 6.5 mt-10 -164.55 140.99 6.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.8 p -107.13 160.31 15.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.439 ' CG2' ' CZ ' ' A' ' 113' ' ' PHE . 10.7 t -151.12 -178.49 6.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -112.29 162.7 15.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG13 HG23 ' A' ' 71' ' ' VAL . 2.2 t -141.93 150.5 19.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.414 HG13 ' HD3' ' A' ' 106' ' ' LYS . 28.2 t -122.83 112.68 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.555 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HG ' HD11 ' A' ' 72' ' ' LEU . 3.5 mt -108.51 118.71 37.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.181 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -107.4 162.27 14.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.204 0.526 . . . . 0.0 111.883 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.724 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -98.89 128.5 45.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.411 ' H ' ' HA2' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -97.29 147.1 32.47 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.412 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.63 16.59 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.479 2.119 . . . . 0.0 112.666 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.06 -47.64 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.682 0.277 . . . . 0.0 111.166 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.2 t -131.58 -18.92 2.74 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' HA2' ' H ' ' A' ' 32' ' ' ASP . . . 62.17 87.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.278 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.724 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 54.4 m-85 65.62 93.07 0.07 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.222 0.534 . . . . 0.0 109.767 -179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 61' ' ' GLU . . . -74.49 13.96 4.57 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.491 -0.777 . . . . 0.0 113.567 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.981 HG22 HG21 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -109.9 133.91 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 117.38 0.59 . . . . 0.0 111.707 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.607 ' O ' HG23 ' A' ' 57' ' ' ILE . 3.3 mt-30 -97.65 128.27 44.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -96.15 155.82 16.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.306 0.574 . . . . 0.0 112.239 -178.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.5 169.1 17.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.204 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -142.74 23.92 2.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.821 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -122.12 93.63 4.05 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.052 0.453 . . . . 0.0 110.623 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.537 HG22 HD13 ' A' ' 56' ' ' LEU . 34.8 t -111.08 -78.73 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CZ ' ' HA ' ' A' ' 51' ' ' LEU . 36.2 p90 -39.87 -44.36 1.63 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.207 179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.524 ' O ' ' HB ' ' A' ' 48' ' ' THR . . . 51.77 73.27 0.33 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.94 -179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 47' ' ' ALA . 4.3 t 165.87 -166.26 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.677 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' N ' ' OG1' ' A' ' 48' ' ' THR . 0.3 OUTLIER -46.01 147.93 0.93 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.871 179.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 66.9 178.23 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.482 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.578 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -142.63 -101.43 0.13 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.362 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 57.67 16.75 3.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.992 0.425 . . . . 0.0 111.572 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 1.9 t -62.0 118.41 38.88 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.11 155.29 52.33 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.31 2.006 . . . . 0.0 111.922 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.759 ' HG2' HD11 ' A' ' 81' ' ' ILE . 45.9 Cg_exo -54.85 123.8 14.65 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.243 1.962 . . . . 0.0 111.952 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD13 HG22 ' A' ' 45' ' ' VAL . 1.1 pt? -136.23 118.03 15.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 111.264 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.981 HG21 HG22 ' A' ' 39' ' ' ILE . 78.2 mt -76.12 141.23 16.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 m -113.4 -19.64 11.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.727 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.453 ' CZ ' ' O ' ' A' ' 60' ' ' ILE . 69.6 t80 -152.22 139.18 19.05 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.763 ' CD1' HG23 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -107.72 177.17 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.484 ' N ' HG23 ' A' ' 60' ' ' ILE . 40.5 tt0 -117.49 119.09 34.0 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.186 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 63' ' ' ASP . . . -57.35 122.31 12.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.182 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.416 ' CB ' ' O ' ' A' ' 62' ' ' ALA . 1.6 t0 82.53 42.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.254 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -138.29 154.53 73.89 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.409 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 69' ' ' CYS . 46.2 Cg_endo -67.72 -1.38 6.65 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.363 2.042 . . . . 0.0 112.8 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB1' HG13 ' A' ' 39' ' ' ILE . . . -70.97 -56.62 5.81 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 120.772 0.32 . . . . 0.0 110.694 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' CG ' ' CZ ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -78.92 -29.21 44.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.94 0.4 . . . . 0.0 110.273 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' CZ ' ' CG ' ' A' ' 67' ' ' GLU . 0.2 OUTLIER -92.22 -1.66 56.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.668 -179.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.412 ' CB ' ' O ' ' A' ' 65' ' ' PRO . 0.1 OUTLIER -44.75 -30.74 1.01 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.765 0.316 . . . . 0.0 111.315 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.75 -50.34 0.89 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.43 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG23 HG13 ' A' ' 27' ' ' VAL . 29.0 m -137.93 53.5 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.002 0.43 . . . . 0.0 111.177 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.576 HD11 ' HG ' ' A' ' 29' ' ' LEU . 6.8 mt -127.68 137.7 52.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -131.85 -179.5 5.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.038 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.24 73.69 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.128 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.99 77.48 0.22 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.457 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.422 ' OD2' HD23 ' A' ' 72' ' ' LEU . 5.5 m-20 -103.29 92.42 4.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.828 0.347 . . . . 0.0 110.85 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.3 ttp180 -65.18 101.1 0.5 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 55' ' ' PRO . 28.6 m -97.78 149.94 4.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.434 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -114.57 -30.15 6.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -132.91 130.24 39.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.902 HG23 ' CD1' ' A' ' 109' ' ' LEU . 21.9 mt -128.26 116.64 42.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 52.42 25.48 3.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.35 -26.13 24.69 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.582 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.497 HD12 HD22 ' A' ' 97' ' ' LEU . 50.6 mt -69.82 124.73 91.22 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-O 120.541 0.21 . . . . 0.0 111.134 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.27 -168.2 0.41 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 79' ' ' MET . 33.1 p -143.42 -45.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -68.31 -12.57 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.514 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -113.83 44.33 1.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 176.38 -174.97 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.867 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 165.4 12.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -73.1 -27.26 61.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.978 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -54.92 -41.4 70.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -34.19 75.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.731 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.681 ' HB1' ' HG3' ' A' ' 55' ' ' PRO . . . -71.43 -32.52 68.47 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.248 0.547 . . . . 0.0 110.582 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -74.27 -36.42 63.81 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.076 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.89 -39.63 61.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.036 -0.265 . . . . 0.0 111.382 -179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.525 HD11 HG21 ' A' ' 81' ' ' ILE . 2.1 pp -67.61 -40.22 84.7 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.539 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.04 HD13 HD13 ' A' ' 41' ' ' LEU . 22.4 mt -65.43 -56.03 14.72 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 96' ' ' GLN . 2.6 ppt_? -50.7 -31.31 16.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.493 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 8.8 p30 -112.28 33.22 5.01 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.801 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 97' ' ' LEU . 97.9 p -100.26 9.39 42.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.144 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.4 t -100.02 15.3 27.69 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.493 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 3.6 mt -67.99 -42.09 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-O 121.664 0.745 . . . . 0.0 110.504 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.52 11.19 37.68 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.455 -1.248 . . . . 0.0 110.598 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 30' ' ' THR . 5.8 m 54.53 24.58 5.46 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.235 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -162.9 154.68 18.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.46 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.4 t -155.31 126.86 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.923 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.683 ' C ' HD13 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -99.88 128.4 45.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.902 ' CD1' HG23 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -123.68 158.27 31.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -118.18 118.38 31.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.535 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.416 HG13 HG22 ' A' ' 25' ' ' THR . 5.4 pt -113.34 163.89 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.989 0.424 . . . . 0.0 111.685 -179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -131.62 144.62 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.46 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.439 ' CZ ' ' CG2' ' A' ' 25' ' ' THR . 0.1 OUTLIER -158.36 174.18 15.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.937 0.399 . . . . 0.0 111.343 -179.689 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.1 114.45 27.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.492 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.562 HG11 ' OE1' ' A' ' 23' ' ' GLU . 17.4 m -61.88 105.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.337 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.4 ' O ' ' CG ' ' A' ' 117' ' ' GLU . . . -176.07 -135.22 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.4 ' CG ' ' O ' ' A' ' 116' ' ' ALA . 9.9 pt-20 48.3 30.55 2.31 Favored 'General case' 0 N--CA 1.462 0.141 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 128' ' ' VAL . 14.6 t 176.89 61.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.076 0.465 . . . . 0.0 111.153 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.517 ' O ' HG13 ' A' ' 119' ' ' VAL . 13.1 p -158.66 118.74 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.295 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.627 HD11 ' CG ' ' A' ' 127' ' ' HIS . 1.5 pp -138.31 97.96 9.35 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 110.791 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.436 ' HB3' ' CE2' ' A' ' 126' ' ' PHE . 90.7 Cg_endo -83.27 150.93 13.63 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.75 2.3 . . . . 0.0 112.91 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 m -153.55 19.39 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.18 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 56.75 114.75 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 CA-C-O 121.051 0.453 . . . . 0.0 111.158 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 94.7 -41.18 2.58 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.128 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.605 HG22 ' HG3' ' A' ' 207' ' ' LYS . 0.2 OUTLIER -135.12 108.49 7.82 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.78 0.324 . . . . 0.0 111.04 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -102.76 128.09 49.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.549 179.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.627 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -110.3 134.26 52.44 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.752 0.31 . . . . 0.0 110.487 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 206' ' ' LEU . 2.9 t -118.22 94.79 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.628 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -83.38 97.94 9.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.402 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.919 HD22 ' HB ' ' A' ' 164' ' ' VAL . 26.7 mt -104.3 117.73 58.57 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.332 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.67 95.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.177 1.918 . . . . 0.0 111.371 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -81.55 159.25 24.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.717 ' HB2' HG23 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -114.5 -165.95 1.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.654 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -66.08 -43.64 86.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.85 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.5 m -179.3 62.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.814 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.717 HG23 ' HB2' ' A' ' 133' ' ' LYS . 40.1 t -94.32 159.84 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.509 ' N ' HG12 ' A' ' 136' ' ' VAL . 33.3 tt0 -51.04 113.63 0.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.686 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.769 HD12 HG12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -117.11 112.08 20.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.915 179.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 160' ' ' LYS . . . -90.45 47.88 3.08 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.029 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.971 HG23 ' HB1' ' A' ' 165' ' ' ALA . 0.0 OUTLIER -109.95 137.06 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.599 0.238 . . . . 0.0 110.384 179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 157' ' ' SER . 88.1 m -120.78 109.76 15.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.781 0.324 . . . . 0.0 110.91 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.909 HD11 HD22 ' A' ' 197' ' ' LEU . 5.4 mt -87.68 164.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.843 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.505 ' N ' HG22 ' A' ' 142' ' ' ILE . 31.1 t -157.67 161.01 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.912 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 21.0 p -115.25 107.79 48.96 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.548 ' HD3' HG22 ' A' ' 155' ' ' VAL . 50.9 Cg_exo -52.8 -176.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.396 2.064 . . . . 0.0 112.361 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.32 97.2 0.26 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.865 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.4 t -59.17 95.03 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.958 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.63 44.79 2.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.43 158.65 0.73 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.834 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.4 70.48 1.92 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.498 2.132 . . . . 0.0 112.236 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -170.14 -60.44 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.604 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 44.9 t0 61.57 82.14 0.23 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.8 -174.13 1.6 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.656 2.237 . . . . 0.0 112.434 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.843 HD11 ' HA ' ' A' ' 190' ' ' MET . 1.1 mp -121.84 165.41 15.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.809 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.574 HG12 ' O ' ' A' ' 175' ' ' ASP . 22.1 m -158.22 148.08 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.395 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.474 HG22 ' CD2' ' A' ' 173' ' ' LEU . 7.7 mt -74.97 150.7 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.373 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.45 ' HB2' HG22 ' A' ' 141' ' ' THR . 24.5 m -136.48 -12.19 1.83 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.17 150.09 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.65 HG22 ' HB2' ' A' ' 166' ' ' HIS . 1.1 mt -139.94 145.43 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.198 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.467 ' CB ' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -114.85 154.77 28.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.904 0.383 . . . . 0.0 111.398 -179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.78 76.65 3.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.634 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.69 -36.52 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.568 ' OG ' HD13 ' A' ' 138' ' ' LEU . 8.4 t -101.81 158.87 15.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 0.0 111.094 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.919 ' HB ' HD22 ' A' ' 130' ' ' LEU . 16.8 m -48.88 -22.34 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.096 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.971 ' HB1' HG23 ' A' ' 140' ' ' ILE . . . -43.82 -59.41 2.26 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.65 ' HB2' HG22 ' A' ' 159' ' ' ILE . 42.5 t60 -83.66 -25.2 30.94 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.862 0.363 . . . . 0.0 110.8 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 164' ' ' VAL . 0.0 OUTLIER -58.4 -29.61 66.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.379 -179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.85 ' HB ' HD21 ' A' ' 130' ' ' LEU . 3.4 t -55.96 -44.9 78.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.755 0.312 . . . . 0.0 111.001 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 93.1 -20.41 46.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.836 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.506 HG21 HG23 ' A' ' 119' ' ' VAL . 9.2 t -113.2 37.58 3.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.826 0.346 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.468 HD21 HG22 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -108.49 41.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.764 179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.64 144.45 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.474 ' CD2' HG22 ' A' ' 156' ' ' ILE . 19.2 mt -85.05 108.02 17.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.82 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 148.99 -20.28 1.24 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.611 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 155' ' ' VAL . 1.9 m-20 -63.33 157.79 22.08 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.671 0.272 . . . . 0.0 110.751 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -108.33 100.91 10.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.852 0.358 . . . . 0.0 111.026 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -69.74 165.93 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.137 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 179' ' ' ALA . 2.6 pp -158.25 -40.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.076 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.446 ' HB2' HD12 ' A' ' 178' ' ' LEU . . . -125.95 129.88 50.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.892 0.377 . . . . 0.0 111.061 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.991 HD12 ' HB1' ' A' ' 193' ' ' ALA . 46.9 mt -118.68 107.47 21.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 27.1 t70 66.05 -72.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.7 -19.09 0.93 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.571 ' HB ' HD13 ' A' ' 196' ' ' ILE . 40.7 mm -96.8 157.13 3.32 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 CA-C-O 120.99 0.424 . . . . 0.0 111.251 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.468 ' N ' HG22 ' A' ' 183' ' ' ILE . 79.2 mtt180 -122.38 132.9 54.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.911 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 1.128 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.4 mm? -67.7 -8.39 34.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.558 178.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -47.56 -28.09 2.12 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.038 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 86.1 p -144.1 46.78 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.833 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.9 m -161.26 160.65 30.15 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.972 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.17 -175.92 6.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.99 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.843 ' HA ' HD11 ' A' ' 154' ' ' LEU . 8.7 ptm -74.24 -45.59 46.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.077 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.419 ' N ' ' HG3' ' A' ' 190' ' ' MET . 1.5 mm-40 -52.05 -50.09 62.18 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.197 0.522 . . . . 0.0 110.89 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -52.12 -45.58 64.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.128 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 1.128 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -56.62 -41.58 77.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.517 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.705 HG22 HD12 ' A' ' 142' ' ' ILE . 10.7 t -60.75 -33.9 56.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 109.82 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -61.92 -50.2 73.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.708 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.3 mt -71.08 -24.93 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.839 178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.909 HD22 HD11 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -60.98 -37.46 82.56 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.21 179.316 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -92.17 -34.5 14.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.656 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.503 ' C ' ' H ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -84.9 11.77 8.72 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.643 178.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.405 ' N ' ' O ' ' A' ' 196' ' ' ILE . 30.0 p -66.1 28.09 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.503 ' H ' ' C ' ' A' ' 199' ' ' GLN . 1.5 mm-40 46.82 46.45 15.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.73 27.51 16.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.769 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 203' ' ' LEU . 1.6 mt -162.87 94.39 0.84 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 204' ' ' VAL . 13.1 p -90.34 123.25 42.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 180' ' ' ILE . 2.9 ttmp? -108.8 107.73 18.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.219 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.612 ' HG ' HD21 ' A' ' 177' ' ' LEU . 10.3 mp -89.35 107.09 18.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.084 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.605 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.9 OUTLIER -96.99 100.74 12.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.759 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.54 ' H ' HD13 ' A' ' 208' ' ' ILE . 0.1 OUTLIER -109.77 173.39 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 8.0 mtp180 -105.06 132.88 50.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.23 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -115.88 159.21 21.84 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.828 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -176.82 101.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.992 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.89 160.15 3.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.236 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.0 t70 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.036 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.91 129.61 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.197 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.722 HG12 ' HB2' ' A' ' 116' ' ' ALA . 2.7 m -123.37 170.73 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.163 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 21.2 t60 -139.72 107.68 5.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -53.01 133.63 38.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.147 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -148.78 157.73 43.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.531 HG22 ' HG3' ' A' ' 112' ' ' GLU . 73.0 p -110.43 144.93 38.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.436 HG22 ' N ' ' A' ' 26' ' ' GLU . 27.4 m -140.57 163.29 33.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' N ' HG22 ' A' ' 25' ' ' THR . 1.2 pm0 -104.63 159.33 15.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.013 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.22 136.18 15.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.616 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' C ' HD12 ' A' ' 29' ' ' LEU . 3.9 p -115.97 122.42 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.731 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.57 HD12 ' C ' ' A' ' 28' ' ' VAL . 7.1 mp -115.66 118.99 34.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.896 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 106' ' ' LYS . 0.0 OUTLIER -102.49 162.58 12.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.271 0.558 . . . . 0.0 111.932 -178.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.708 ' HB2' ' CE1' ' A' ' 37' ' ' PHE . . . -107.33 103.86 13.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.441 ' N ' ' HA2' ' A' ' 36' ' ' GLY . 0.2 OUTLIER -75.02 153.27 86.62 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.332 179.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.4 7.89 3.56 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.447 2.098 . . . . 0.0 112.675 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.42 -45.29 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.567 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.4 t -133.7 -8.59 2.8 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.441 ' HA2' ' N ' ' A' ' 32' ' ' ASP . . . 65.6 -90.48 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.929 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.708 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 3.5 m-85 -131.66 119.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.58 28.27 15.01 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.804 -0.713 . . . . 0.0 113.361 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.988 HD13 HD13 ' A' ' 72' ' ' LEU . 25.5 pt -126.84 133.35 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 120.815 0.34 . . . . 0.0 110.646 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -122.36 139.96 53.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.86 -179.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.758 HD12 HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -130.09 157.51 42.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 112.054 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.766 ' HG3' HD13 ' A' ' 56' ' ' LEU . 10.7 pt20 -112.1 170.07 8.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.204 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.58 17.59 6.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.676 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 13.3 t -111.28 67.8 0.65 Allowed 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.351 0.596 . . . . 0.0 111.014 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.005 HG22 HD21 ' A' ' 56' ' ' LEU . 3.4 t -71.43 -35.11 55.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.961 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 47' ' ' ALA . 45.6 p90 -132.07 -49.59 0.94 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.252 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.558 ' N ' ' CD1' ' A' ' 46' ' ' PHE . . . 42.09 85.89 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.099 0.476 . . . . 0.0 111.747 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 46' ' ' PHE . 0.9 OUTLIER 171.0 120.86 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.232 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 50' ' ' THR . 0.6 OUTLIER 58.5 80.58 0.18 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER 85.5 -178.17 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -177.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' H ' HG22 ' A' ' 50' ' ' THR . 1.1 pp -154.82 -147.2 0.2 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 120.754 -0.378 . . . . 0.0 111.355 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.454 ' H ' ' HB2' ' A' ' 51' ' ' LEU . 2.0 t 81.43 20.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.227 0.537 . . . . 0.0 111.588 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.643 ' HB2' HG23 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -47.51 139.13 8.47 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.964 179.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.44 ' O ' HG21 ' A' ' 45' ' ' VAL . 25.0 Cg_endo -61.96 133.33 43.85 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.551 2.167 . . . . 0.0 112.406 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -49.49 141.67 25.21 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.513 2.142 . . . . 0.0 112.914 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.005 HD21 HG22 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -141.11 115.98 9.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.637 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -66.12 141.35 18.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.441 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.486 ' C ' HG23 ' A' ' 74' ' ' ILE . 64.0 p -113.69 -26.16 8.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.519 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.419 ' HB3' ' HG3' ' A' ' 40' ' ' GLN . 56.2 t80 -144.18 154.49 43.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 0.0 111.496 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.633 HG21 ' HB2' ' A' ' 67' ' ' GLU . 25.7 mm -137.51 151.24 26.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.718 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.01 148.99 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.928 0.394 . . . . 0.0 111.209 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . . . -94.55 44.99 1.11 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.038 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p30 175.72 41.5 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.724 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.494 ' O ' ' HD2' ' A' ' 68' ' ' ARG . 17.5 m -136.93 138.49 26.05 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.958 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 68' ' ' ARG . 15.4 Cg_endo -56.75 -12.77 9.61 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.79 2.327 . . . . 0.0 113.276 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.81 ' O ' HD12 ' A' ' 72' ' ' LEU . . . -65.41 -58.33 6.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.977 0.418 . . . . 0.0 110.349 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.633 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -80.12 -30.97 39.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.041 178.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' HD2' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -57.84 -33.41 68.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.624 -179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 46.0 t -49.58 -30.44 8.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.006 0.432 . . . . 0.0 110.523 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.444 ' HA3' ' CB ' ' A' ' 137' ' ' GLU . . . 87.95 26.13 29.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.982 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -151.52 29.42 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.861 0.362 . . . . 0.0 110.912 179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.988 HD13 HD13 ' A' ' 39' ' ' ILE . 6.8 mt -133.55 121.63 22.4 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.032 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -136.01 154.95 50.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.295 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.486 HG23 ' C ' ' A' ' 58' ' ' SER . 54.3 mt -58.14 87.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-O 121.233 0.54 . . . . 0.0 111.194 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.444 ' H ' ' HB ' ' A' ' 57' ' ' ILE . . . 132.66 39.55 0.22 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.245 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -87.01 132.08 33.9 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.891 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -91.8 102.19 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 109' ' ' LEU . 35.0 t -85.68 121.89 37.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.82 -29.28 17.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.739 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -154.53 143.51 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.134 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.515 HD12 HD12 ' A' ' 97' ' ' LEU . 1.7 mt -119.39 110.36 29.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.733 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.614 ' ND2' HG13 ' A' ' 107' ' ' VAL . 29.1 m-20 59.98 20.13 9.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.194 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 116.73 -33.79 4.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.632 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.4 mt -69.71 116.81 47.21 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-O 120.45 0.166 . . . . 0.0 111.167 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.53 ' C ' HG23 ' A' ' 86' ' ' THR . 31.2 Cg_endo -63.93 -33.36 63.82 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.403 2.069 . . . . 0.0 112.049 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.53 HG23 ' C ' ' A' ' 85' ' ' PRO . 1.3 p 74.17 0.52 3.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.776 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -86.66 -20.73 27.37 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.924 0.392 . . . . 0.0 111.199 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -101.9 44.53 1.01 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.607 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 m -179.12 -176.95 0.44 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.877 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.12 161.97 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.843 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -73.28 -29.74 62.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.012 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.18 -31.65 63.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.355 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.37 -53.49 55.99 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.765 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -54.85 -42.19 71.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.431 0.634 . . . . 0.0 110.29 179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -65.05 -39.91 93.99 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.38 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -35.42 80.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.922 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.515 HD12 HD12 ' A' ' 81' ' ' ILE . 86.1 mt -57.44 -51.08 70.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.04 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 94' ' ' ALA . 3.2 mp -58.81 -45.12 90.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.427 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.21 -38.01 49.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.232 0.539 . . . . 0.0 109.939 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.524 ' O ' ' CD1' ' A' ' 103' ' ' ILE . 2.5 m-20 -122.06 40.86 3.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.516 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.415 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 54.7 p -94.32 6.74 47.77 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.222 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 p -102.7 15.56 28.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.838 0.351 . . . . 0.0 111.81 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 100' ' ' ASP . 6.0 mt -69.24 -47.85 71.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.789 0.804 . . . . 0.0 110.338 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.4 12.11 28.24 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.396 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.68 ' HA ' ' HB3' ' A' ' 31' ' ' ALA . 14.5 m 52.58 26.13 4.12 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.069 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HD3' HG22 ' A' ' 28' ' ' VAL . 2.2 mmtp -162.83 156.93 20.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.394 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.614 HG13 ' ND2' ' A' ' 82' ' ' ASN . 1.4 t -155.9 99.48 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.696 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.0 132.49 35.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.831 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.618 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -142.12 157.0 45.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.271 -179.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -111.68 127.85 55.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.424 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 26.8 pt -114.19 145.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 0.0 111.571 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.531 ' HG3' HG22 ' A' ' 24' ' ' THR . 2.3 tt0 -116.7 115.72 26.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -132.89 174.12 10.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.974 0.416 . . . . 0.0 111.274 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.15 131.7 54.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.645 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.4 m -66.58 105.69 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.972 0.415 . . . . 0.0 111.458 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.722 ' HB2' HG12 ' A' ' 20' ' ' VAL . . . -170.08 108.43 0.37 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.88 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.877 ' HB3' HG22 ' A' ' 168' ' ' THR . 2.9 tp10 -133.86 39.47 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 1.3 t 66.78 89.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.374 0.607 . . . . 0.0 111.286 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.878 HG11 HG21 ' A' ' 170' ' ' THR . 0.0 OUTLIER -125.53 120.3 57.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.901 179.51 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.616 ' O ' HD12 ' A' ' 120' ' ' ILE . 1.9 pp -102.41 103.81 33.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.338 -179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 126' ' ' PHE . 94.0 Cg_endo -85.85 148.21 9.53 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.713 2.275 . . . . 0.0 112.55 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.4 m -154.49 22.89 0.47 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.015 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.83 113.95 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.004 0.431 . . . . 0.0 110.922 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 209' ' ' ARG . . . 92.5 -43.86 2.62 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.162 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.01 103.73 7.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.0 0.429 . . . . 0.0 110.995 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.46 ' CE1' ' HB ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -107.65 119.56 39.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.438 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.577 ' CG ' HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -102.38 124.1 47.35 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.796 0.332 . . . . 0.0 110.483 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.726 HG13 ' CG1' ' A' ' 119' ' ' VAL . 3.4 t -101.76 90.16 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.808 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.63 98.36 8.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.293 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.429 HD22 HG21 ' A' ' 168' ' ' THR . 0.5 OUTLIER -126.68 144.15 48.9 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.76 0.314 . . . . 0.0 111.56 -179.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.405 ' HD2' ' HG3' ' A' ' 117' ' ' GLU . 45.1 Cg_endo -68.55 119.68 6.66 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.528 2.152 . . . . 0.0 111.48 179.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.604 ' HG2' HG23 ' A' ' 204' ' ' VAL . 0.0 OUTLIER -86.94 153.39 21.62 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.336 0.588 . . . . 0.0 111.628 -179.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -88.72 -164.81 1.19 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.107 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.28 34.96 2.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.693 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 80.04 47.99 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.824 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 137' ' ' GLU . 7.4 t -89.84 -121.75 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' CB ' ' HA3' ' A' ' 70' ' ' GLY . 1.1 tt0 -90.72 102.62 15.38 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 122.1 -0.375 . . . . 0.0 111.442 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 138' ' ' LEU . 10.7 tp -122.63 95.24 4.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.88 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 160' ' ' LYS . . . -86.1 45.37 3.46 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.2 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.52 HD11 ' HB2' ' A' ' 165' ' ' ALA . 62.5 mt -92.81 123.61 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.768 HG22 ' HB2' ' A' ' 157' ' ' SER . 97.8 m -110.41 101.81 10.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 111.121 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.767 ' CG2' HD12 ' A' ' 154' ' ' LEU . 3.0 mt -91.8 163.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.52 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.509 ' N ' HG22 ' A' ' 142' ' ' ILE . 3.2 t -176.22 176.66 1.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.021 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 10.1 t -129.38 129.43 23.25 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.809 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.58 -62.06 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.491 2.127 . . . . 0.0 112.237 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.0 p -133.99 122.08 22.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.925 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.3 t -106.28 51.48 0.75 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -134.74 55.55 1.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.159 0.504 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.54 157.86 0.44 Allowed Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.62 82.81 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.612 2.208 . . . . 0.0 112.306 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 173.81 -68.03 0.1 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.466 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 42.43 82.87 0.22 Allowed Pre-proline 0 CA--C 1.531 0.231 0 CA-C-O 120.858 0.361 . . . . 0.0 111.554 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.09 -167.32 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.586 2.191 . . . . 0.0 112.333 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.767 HD12 ' CG2' ' A' ' 142' ' ' ILE . 2.6 mm? -126.94 149.88 49.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.702 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 175' ' ' ASP . 34.0 m -154.01 156.97 4.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.286 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 172' ' ' GLU . 1.7 mp -87.3 152.57 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.83 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.768 ' HB2' HG22 ' A' ' 141' ' ' THR . 1.6 m -130.95 -19.03 2.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.922 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.433 ' N ' ' HB ' ' A' ' 141' ' ' THR . 28.6 t70 -177.8 143.66 0.34 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.019 0.438 . . . . 0.0 110.827 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.413 ' CG2' ' HB2' ' A' ' 166' ' ' HIS . 0.7 OUTLIER -136.77 131.82 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.566 ' HG3' ' H ' ' A' ' 162' ' ' GLY . 0.0 OUTLIER -63.59 130.59 44.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.087 179.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.58 0.9 5.92 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.566 ' H ' ' HG3' ' A' ' 160' ' ' LYS . . . -124.35 0.15 8.78 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.868 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.426 ' O ' ' NH1' ' A' ' 167' ' ' ARG . 4.6 t -95.11 145.97 24.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.977 0.418 . . . . 0.0 111.078 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 168' ' ' THR . 4.3 m -48.89 -25.87 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.765 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 140' ' ' ILE . . . -53.62 -69.46 0.12 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.333 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.413 ' HB2' ' CG2' ' A' ' 159' ' ' ILE . 12.0 t60 -64.53 -25.66 68.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.782 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -56.7 -39.85 74.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.903 0.382 . . . . 0.0 110.926 179.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.877 HG22 ' HB3' ' A' ' 117' ' ' GLU . 17.1 p -49.0 -27.75 3.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.323 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 70.19 71.04 1.06 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.465 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.878 HG21 HG11 ' A' ' 119' ' ' VAL . 0.1 OUTLIER 176.51 -35.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.753 0.311 . . . . 0.0 110.863 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 13.5 tp -66.45 74.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.441 ' O ' HD13 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -87.91 -170.87 3.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 11.9 mt -106.25 119.97 40.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.991 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.78 20.5 4.93 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.82 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.558 ' O ' HG12 ' A' ' 155' ' ' VAL . 2.0 m-20 -106.98 173.66 6.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.653 0.226 . . . . 0.0 110.459 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.34 142.63 47.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.932 0.396 . . . . 0.0 111.177 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.946 ' CD2' HD11 ' A' ' 180' ' ' ILE . 1.2 tp -101.96 138.63 38.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.581 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.46 -42.85 2.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.364 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.707 ' HB2' ' HG2' ' A' ' 184' ' ' ARG . . . -146.96 165.45 29.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.011 0.434 . . . . 0.0 111.541 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.946 HD11 ' CD2' ' A' ' 177' ' ' LEU . 25.5 mm -139.61 107.11 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.182 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . 0.462 ' HA ' ' HB3' ' A' ' 205' ' ' LYS . 0.6 OUTLIER 64.98 -73.66 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.39 179.636 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -134.59 -25.24 1.49 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.293 -0.412 . . . . 0.0 112.082 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 184' ' ' ARG . 46.4 mm -87.59 157.66 3.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 0.0 111.102 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.707 ' HG2' ' HB2' ' A' ' 179' ' ' ALA . 8.2 mtp180 -123.57 124.54 43.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.184 0.516 . . . . 0.0 112.113 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' A' ' 193' ' ' ALA . 3.0 mm? -78.94 -4.62 50.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.005 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -45.33 -29.39 1.03 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.7 m -141.7 51.33 1.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.792 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . . . . . . . . . 1.6 m -157.48 159.31 37.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.45 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.3 OUTLIER -68.29 175.95 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.046 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . 0.677 ' HB2' HD11 ' A' ' 154' ' ' LEU . 25.8 ptm -74.11 -41.86 60.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.988 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 190' ' ' MET . 0.7 OUTLIER -53.81 -29.98 42.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.99 -179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' HD12 ' A' ' 196' ' ' ILE . 0.8 OUTLIER -61.58 -52.49 64.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.093 179.533 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.667 ' HB2' HD11 ' A' ' 185' ' ' LEU . . . -56.24 -39.49 72.62 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.209 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 142' ' ' ILE . 18.4 t -61.61 -39.9 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.673 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.93 -50.33 74.46 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.124 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 193' ' ' ALA . 1.6 mt -69.79 -24.92 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 194' ' ' VAL . 0.1 OUTLIER -58.59 -35.48 72.5 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.588 179.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 194' ' ' VAL . 0.0 OUTLIER -99.29 -40.74 7.78 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.733 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.9 -22.98 41.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.714 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' CYS . . . . . 0.71 ' CB ' HG22 ' A' ' 204' ' ' VAL . 2.0 m -91.16 42.68 1.11 Allowed 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.737 178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -67.72 62.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.353 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -171.91 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.543 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.787 HD23 ' O ' ' A' ' 203' ' ' LEU . 3.2 tt 175.13 110.95 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.612 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.71 HG22 ' CB ' ' A' ' 200' ' ' CYS . 98.9 t -108.18 138.81 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.477 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 181' ' ' ASP . 7.3 tttt -109.12 108.03 18.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 128' ' ' VAL . 7.1 mp -88.85 111.69 22.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.909 0.385 . . . . 0.0 111.412 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.583 ' HD3' ' HB3' ' A' ' 179' ' ' ALA . 2.9 tttt -92.73 93.17 8.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.298 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.473 HD13 HD12 ' A' ' 177' ' ' LEU . 6.6 mm -90.71 163.39 2.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.015 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' GLY . 5.7 mtp-105 -107.98 120.72 43.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.81 150.53 21.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 177.63 84.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.798 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -57.18 170.42 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.077 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.082 -179.953 . . . . . . . . 1 1 . 1 stop_ save_